Citrus Sinensis ID: 016537
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | 2.2.26 [Sep-21-2011] | |||||||
| O64816 | 432 | Casein kinase II subunit | yes | no | 0.684 | 0.613 | 0.852 | 1e-123 | |
| P28523 | 332 | Casein kinase II subunit | N/A | no | 0.568 | 0.662 | 0.922 | 1e-110 | |
| Q08466 | 403 | Casein kinase II subunit | no | no | 0.599 | 0.575 | 0.852 | 1e-109 | |
| Q08467 | 409 | Casein kinase II subunit | no | no | 0.609 | 0.577 | 0.848 | 1e-108 | |
| O64817 | 333 | Probable casein kinase II | no | no | 0.568 | 0.660 | 0.881 | 1e-105 | |
| P40231 | 332 | Casein kinase II subunit | yes | no | 0.578 | 0.674 | 0.747 | 1e-100 | |
| Q60737 | 391 | Casein kinase II subunit | yes | no | 0.571 | 0.565 | 0.787 | 2e-94 | |
| P19139 | 391 | Casein kinase II subunit | yes | no | 0.571 | 0.565 | 0.787 | 2e-94 | |
| P21868 | 391 | Casein kinase II subunit | yes | no | 0.571 | 0.565 | 0.787 | 3e-94 | |
| P68400 | 391 | Casein kinase II subunit | yes | no | 0.571 | 0.565 | 0.787 | 3e-94 |
| >sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 441 bits (1135), Expect = e-123, Method: Compositional matrix adjust.
Identities = 232/272 (85%), Positives = 250/272 (91%), Gaps = 7/272 (2%)
Query: 59 TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48 NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGM+
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 319
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 398 bits (1023), Expect = e-110, Method: Compositional matrix adjust.
Identities = 203/220 (92%), Positives = 216/220 (98%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++ +NEKCI
Sbjct: 2 SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGM+
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 394 bits (1013), Expect = e-109, Method: Compositional matrix adjust.
Identities = 202/237 (85%), Positives = 222/237 (93%), Gaps = 5/237 (2%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
D+LA+ + S SKARVY+D+NV+RP++YWDYESL VQWGEQDDYEVVRKVGRGK
Sbjct: 60 DSLAK-----ISLSTVMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGK 114
Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEG++ +NEKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKTP
Sbjct: 115 YSEVFEGINMNNNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTP 174
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE R
Sbjct: 175 SLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELR 234
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGM+
Sbjct: 235 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 291
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 391 bits (1005), Expect = e-108, Method: Compositional matrix adjust.
Identities = 202/238 (84%), Positives = 222/238 (93%), Gaps = 2/238 (0%)
Query: 86 PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRG 145
PD L + I S ++ A SKARVY+++NV+RP++YWDYESL VQWGEQDDYEVVRKVGRG
Sbjct: 62 PDFLVE-ISDS-NQTRAMSKARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRG 119
Query: 146 KYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205
KYSEVFEG++ EKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKT
Sbjct: 120 KYSEVFEGINVNSKEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKT 179
Query: 206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
PSLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE
Sbjct: 180 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHEL 239
Query: 266 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGM+
Sbjct: 240 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 297
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (979), Expect = e-105, Method: Compositional matrix adjust.
Identities = 194/220 (88%), Positives = 209/220 (95%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG + NE+C+
Sbjct: 2 SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61
Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
IKILKPVKKKKIKREIKILQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGM+
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P40231|CSK2A_SCHPO Casein kinase II subunit alpha OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cka1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 365 bits (938), Expect = e-100, Method: Compositional matrix adjust.
Identities = 169/226 (74%), Positives = 196/226 (86%), Gaps = 2/226 (0%)
Query: 100 SGAP--SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCT 157
AP S +RVY+ +N PREYWDYE++ +G QD+YE++RKVGRGKYSEVFEG++
Sbjct: 5 EAAPVVSVSRVYAHVNEEMPREYWDYENMQEVFGYQDNYEIIRKVGRGKYSEVFEGLNVL 64
Query: 158 DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217
+N KCIIK+LKPVK KKIKREIKILQNL GGPNI+ LLDIVRD +SKTPSLIFE V+N D
Sbjct: 65 NNSKCIIKVLKPVKYKKIKREIKILQNLAGGPNIISLLDIVRDPESKTPSLIFEFVDNID 124
Query: 218 FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277
F+ LYPTLSDYD+RYY YELLKALD+CHS+GIMHRDVKPHNVMIDH++RKLRLIDWGLAE
Sbjct: 125 FRTLYPTLSDYDIRYYSYELLKALDFCHSRGIMHRDVKPHNVMIDHKKRKLRLIDWGLAE 184
Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
FYH G EYNVRVASRYFKGPELLVD ++YDYSLD+WS G MFA ++
Sbjct: 185 FYHAGMEYNVRVASRYFKGPELLVDFREYDYSLDIWSFGVMFAALI 230
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Plays a role in the translation of cell polarity into polarized growth. The alpha and alpha' chains contain the catalytic site. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 346 bits (888), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 174/221 (78%), Positives = 200/221 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 346 bits (887), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 174/221 (78%), Positives = 200/221 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 3e-94, Method: Compositional matrix adjust.
Identities = 174/221 (78%), Positives = 200/221 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (885), Expect = 3e-94, Method: Compositional matrix adjust.
Identities = 174/221 (78%), Positives = 200/221 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | ||||||
| 224071301 | 448 | predicted protein [Populus trichocarpa] | 0.813 | 0.703 | 0.750 | 1e-128 | |
| 225438980 | 424 | PREDICTED: casein kinase II subunit alph | 0.677 | 0.617 | 0.875 | 1e-124 | |
| 147841853 | 392 | hypothetical protein VITISV_034030 [Viti | 0.638 | 0.630 | 0.935 | 1e-124 | |
| 255568569 | 489 | casein kinase II, alpha chain, putative | 0.658 | 0.521 | 0.890 | 1e-124 | |
| 17977868 | 414 | casein kinase II alpha subunit [Sinapis | 0.770 | 0.719 | 0.729 | 1e-122 | |
| 297825193 | 432 | hypothetical protein ARALYDRAFT_481178 [ | 0.806 | 0.722 | 0.748 | 1e-121 | |
| 15227778 | 432 | casein kinase 2, alpha polypeptide [Arab | 0.684 | 0.613 | 0.852 | 1e-121 | |
| 449519104 | 441 | PREDICTED: casein kinase II subunit alph | 0.612 | 0.537 | 0.932 | 1e-121 | |
| 357482649 | 418 | Casein kinase II alpha subunit [Medicago | 0.777 | 0.720 | 0.716 | 1e-120 | |
| 224081845 | 361 | predicted protein [Populus trichocarpa] | 0.638 | 0.684 | 0.910 | 1e-120 |
| >gi|224071301|ref|XP_002303393.1| predicted protein [Populus trichocarpa] gi|222840825|gb|EEE78372.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 463 bits (1191), Expect = e-128, Method: Compositional matrix adjust.
Identities = 259/345 (75%), Positives = 277/345 (80%), Gaps = 30/345 (8%)
Query: 1 MAIRPF------------QFTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSP-L 47
MAIRPF Q +NN N TLFSS I R + + +P L
Sbjct: 1 MAIRPFLLQQKLTTILNRQRQKKKNNI-NKTLFSSLLFI-------RNNNNNNNNNNPFL 52
Query: 48 SQSSRIFTPFGTLRGLASSA-SLSHARHQHQ--------RLRQLATPPDTLAQKIGKSVR 98
S + + LR ASS + SH + Q R R L PPDTLAQKIGKS+R
Sbjct: 53 FSSPQSSSISTLLRQFASSTTAFSHQKQGQQEIQHRLPHRFRSLVPPPDTLAQKIGKSIR 112
Query: 99 RSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
R GAPSKARVY+DINV+RP++YWDYESLTVQWGEQDDYEVV+KVGRGKYSEVFEGVHCTD
Sbjct: 113 RPGAPSKARVYADINVIRPKDYWDYESLTVQWGEQDDYEVVKKVGRGKYSEVFEGVHCTD 172
Query: 159 NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDF
Sbjct: 173 NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDF 232
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
KVLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF
Sbjct: 233 KVLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 292
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM+
Sbjct: 293 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438980|ref|XP_002284333.1| PREDICTED: casein kinase II subunit alpha isoform 1 [Vitis vinifera] gi|296087330|emb|CBI33704.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1162), Expect = e-124, Method: Compositional matrix adjust.
Identities = 238/272 (87%), Positives = 250/272 (91%), Gaps = 10/272 (3%)
Query: 61 RGLASSASLSHARHQ---------HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
R +S A LSH + H R L++ P+TLAQ+IGKSVRR GAPSKARVY+D
Sbjct: 42 RLASSPAPLSHPQKSPPPPPPPPSHHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYAD 100
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
INV+RP+EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK
Sbjct: 101 INVIRPKEYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 160
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+R
Sbjct: 161 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIR 220
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 221 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 280
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGM+
Sbjct: 281 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 312
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147841853|emb|CAN71837.1| hypothetical protein VITISV_034030 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1158), Expect = e-124, Method: Compositional matrix adjust.
Identities = 232/248 (93%), Positives = 242/248 (97%), Gaps = 1/248 (0%)
Query: 76 HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
H R L++ P+TLAQ+IGKSVRR GAPSKARVY+DINV+RP+EYWDYESLTVQWGEQDD
Sbjct: 34 HHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYADINVIRPKEYWDYESLTVQWGEQDD 92
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL
Sbjct: 93 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 152
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
DIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMHRDVK
Sbjct: 153 DIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMHRDVK 212
Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 315
PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL
Sbjct: 213 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 272
Query: 316 GCMFAGMV 323
GCMFAGM+
Sbjct: 273 GCMFAGMI 280
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568569|ref|XP_002525258.1| casein kinase II, alpha chain, putative [Ricinus communis] gi|223535416|gb|EEF37086.1| casein kinase II, alpha chain, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1156), Expect = e-124, Method: Compositional matrix adjust.
Identities = 227/255 (89%), Positives = 242/255 (94%)
Query: 69 LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTV 128
++ A H+ +A +TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTV
Sbjct: 124 IAEAIRLHRLKNSVALSSETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTV 183
Query: 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG 188
QWGEQDDYEVVRKVGRGKYSEVFEGVHC DNEKC+IKILKPVKKKKIKREIKILQNLCGG
Sbjct: 184 QWGEQDDYEVVRKVGRGKYSEVFEGVHCADNEKCVIKILKPVKKKKIKREIKILQNLCGG 243
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG 248
PNIVKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQG
Sbjct: 244 PNIVKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQG 303
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY
Sbjct: 304 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 363
Query: 309 SLDLWSLGCMFAGMV 323
SLDLWSLGCMFAGM+
Sbjct: 364 SLDLWSLGCMFAGMI 378
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|17977868|emb|CAD12663.1| casein kinase II alpha subunit [Sinapis alba] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-122, Method: Compositional matrix adjust.
Identities = 237/325 (72%), Positives = 261/325 (80%), Gaps = 27/325 (8%)
Query: 1 MAIRPFQFTIH--RNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFG 58
MA RP +TI R L SF +I S+ + + +S
Sbjct: 1 MAFRPIGYTISSLRKASAANDLRFSFLSIYSSFPAKKNLLLS------------------ 42
Query: 59 TLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPR 118
LRG +S H+ Q+ + +TLAQKIGKS+RR+GAPSKARVY+D+NV++P+
Sbjct: 43 FLRGFSSL-------HRRQQQQSRVNKSETLAQKIGKSIRRAGAPSKARVYADVNVIKPK 95
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE 178
+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKRE
Sbjct: 96 DYWDYESLAVQWGAQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKRE 155
Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYIYELL
Sbjct: 156 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIYELL 215
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
KALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE
Sbjct: 216 KALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 275
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMV 323
LLVDL DYDYSLDLWSLGCMFAGM+
Sbjct: 276 LLVDLMDYDYSLDLWSLGCMFAGMI 300
|
Source: Sinapis alba Species: Sinapis alba Genus: Sinapis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297825193|ref|XP_002880479.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] gi|297326318|gb|EFH56738.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-121, Method: Compositional matrix adjust.
Identities = 247/330 (74%), Positives = 275/330 (83%), Gaps = 18/330 (5%)
Query: 1 MAIRPFQ-FTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGT 59
MA+RP FTI ++ +N + + + SSS + + +LFS L
Sbjct: 1 MALRPCTGFTI--SSLRNASAANDNLFSLLSFSSSSSPAKRNLLFSSLRDH--------- 49
Query: 60 LRGLASSASL--SHARHQHQRLR----QLATPPDTLAQKIGKSVRRSGAPSKARVYSDIN 113
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D+N
Sbjct: 50 LRRFASSASLYRQHLRNQQQQQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYADVN 109
Query: 114 VVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK 173
VVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKK
Sbjct: 110 VVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKK 169
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYY 233
KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYY
Sbjct: 170 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYY 229
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
I+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY
Sbjct: 230 IFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 289
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
FKGPELLVDLQDYDYSLDLWSLGCMFAGM+
Sbjct: 290 FKGPELLVDLQDYDYSLDLWSLGCMFAGMI 319
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15227778|ref|NP_179889.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] gi|75318502|sp|O64816.1|CSK2P_ARATH RecName: Full=Casein kinase II subunit alpha, chloroplastic; Flags: Precursor gi|3169180|gb|AAC17823.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|17065110|gb|AAL32709.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|20148299|gb|AAM10040.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|330252310|gb|AEC07404.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1135), Expect = e-121, Method: Compositional matrix adjust.
Identities = 232/272 (85%), Positives = 250/272 (91%), Gaps = 7/272 (2%)
Query: 59 TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48 NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGM+
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 319
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519104|ref|XP_004166575.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1131), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/237 (93%), Positives = 234/237 (98%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
+TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTVQWG+QD+YEVVRKVGRGK
Sbjct: 93 ETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTVQWGDQDNYEVVRKVGRGK 152
Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEGVHCTDNEKC+IKILKPVKKKKIKREIKILQNLCGG NIVKLLDIVRDQQSKTP
Sbjct: 153 YSEVFEGVHCTDNEKCVIKILKPVKKKKIKREIKILQNLCGGINIVKLLDIVRDQQSKTP 212
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFEHVNN DFKVLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR
Sbjct: 213 SLIFEHVNNIDFKVLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 272
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM+
Sbjct: 273 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 329
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482649|ref|XP_003611611.1| Casein kinase II alpha subunit [Medicago truncatula] gi|355512946|gb|AES94569.1| Casein kinase II alpha subunit [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1128), Expect = e-120, Method: Compositional matrix adjust.
Identities = 235/328 (71%), Positives = 262/328 (79%), Gaps = 27/328 (8%)
Query: 1 MAIRPFQFTIHRNNYKNTTLFSSFFAI-SSNTSSSRTTSVSKILFSPLSQSSRIFTPFGT 59
MAIRPFQ T+ FF+I ++ S S + + + F P PF
Sbjct: 1 MAIRPFQSTLS---------LQRFFSIFRTHHSISSSATTTTTNFLP---------PFSV 42
Query: 60 LRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPRE 119
LR A+S S + PDTLAQ+IGKS+RR GA SKAR+Y+D+NVVRP+E
Sbjct: 43 LRCFATSFSQPRR----PQYPPPPPRPDTLAQRIGKSIRRPGASSKARIYADVNVVRPKE 98
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 179
YWDYESL VQWGEQDDY+V++KVGRGKYSEVFEGVHC ++EKCIIKILKPV+KKKIKREI
Sbjct: 99 YWDYESLAVQWGEQDDYQVLKKVGRGKYSEVFEGVHCGNDEKCIIKILKPVRKKKIKREI 158
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 239
KILQNLCGGPNIVKLLDIVRDQQSKTPSL+FE VNNTDFKVLYPTLSDYD+RYYIYELLK
Sbjct: 159 KILQNLCGGPNIVKLLDIVRDQQSKTPSLVFECVNNTDFKVLYPTLSDYDIRYYIYELLK 218
Query: 240 ----ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
ALDYCHSQGIMHRDVKPHN+MIDH QRKL LIDWGLAEFYHPG+EYNVRVASRYFK
Sbjct: 219 ASFCALDYCHSQGIMHRDVKPHNIMIDHAQRKLCLIDWGLAEFYHPGQEYNVRVASRYFK 278
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMV 323
GPELL+DLQDYDYSLDLWSLGCMFAGM+
Sbjct: 279 GPELLIDLQDYDYSLDLWSLGCMFAGMI 306
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081845|ref|XP_002306501.1| predicted protein [Populus trichocarpa] gi|222855950|gb|EEE93497.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1122), Expect = e-120, Method: Compositional matrix adjust.
Identities = 225/247 (91%), Positives = 234/247 (94%)
Query: 77 QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDY 136
R R PDTLAQKIGKS RR GAPSKARVY+D NV+RP++YWDYESLTVQWGEQDDY
Sbjct: 6 HRFRSSVPLPDTLAQKIGKSFRRPGAPSKARVYADANVIRPKDYWDYESLTVQWGEQDDY 65
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
VV+KVGRGKYSEVFEG+HCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD
Sbjct: 66 MVVKKVGRGKYSEVFEGMHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 125
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
IVRDQQSKTPSLIFE+V NTDFKVLYPTLSD+D RYYIYELLKALDYCHSQGIMHRDVKP
Sbjct: 126 IVRDQQSKTPSLIFEYVKNTDFKVLYPTLSDFDTRYYIYELLKALDYCHSQGIMHRDVKP 185
Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG
Sbjct: 186 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 245
Query: 317 CMFAGMV 323
CMFAGM+
Sbjct: 246 CMFAGMI 252
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | ||||||
| TAIR|locus:2045339 | 432 | AT2G23070 [Arabidopsis thalian | 0.612 | 0.548 | 0.843 | 1.3e-109 | |
| UNIPROTKB|Q9AR27 | 333 | OSCKA2 "Casein kinase II alpha | 0.568 | 0.660 | 0.827 | 4.4e-100 | |
| TAIR|locus:2045349 | 333 | CKA3 "casein kinase II, alpha | 0.568 | 0.660 | 0.795 | 7.6e-96 | |
| UNIPROTKB|P21868 | 391 | CSNK2A1 "Casein kinase II subu | 0.578 | 0.572 | 0.702 | 2.9e-87 | |
| UNIPROTKB|P68399 | 391 | CSNK2A1 "Casein kinase II subu | 0.578 | 0.572 | 0.702 | 2.9e-87 | |
| UNIPROTKB|E2RHZ1 | 391 | CSNK2A1 "Uncharacterized prote | 0.578 | 0.572 | 0.702 | 2.9e-87 | |
| UNIPROTKB|E7EU96 | 385 | CSNK2A1 "Casein kinase II subu | 0.578 | 0.581 | 0.702 | 2.9e-87 | |
| UNIPROTKB|P68400 | 391 | CSNK2A1 "Casein kinase II subu | 0.578 | 0.572 | 0.702 | 2.9e-87 | |
| UNIPROTKB|F2Z5I5 | 391 | CSNK2A1 "Uncharacterized prote | 0.578 | 0.572 | 0.702 | 2.9e-87 | |
| MGI|MGI:88543 | 391 | Csnk2a1 "casein kinase 2, alph | 0.578 | 0.572 | 0.702 | 2.9e-87 |
| TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1083 (386.3 bits), Expect = 1.3e-109, P = 1.3e-109
Identities = 200/237 (84%), Positives = 212/237 (89%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
+TLAQKIGKS+RR+GAPSKARVY+D+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGK
Sbjct: 83 ETLAQKIGKSIRRAGAPSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGK 142
Query: 147 YSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEG+H TDNE LQNLCGGPNIVKLLDIVRDQQSKTP
Sbjct: 143 YSEVFEGIHATDNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 202
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQR
Sbjct: 203 SLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQR 262
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM+
Sbjct: 263 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 319
|
|
| UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
Identities = 182/220 (82%), Positives = 195/220 (88%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++ +NE
Sbjct: 2 SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGM+
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221
|
|
| TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 953 (340.5 bits), Expect = 7.6e-96, P = 7.6e-96
Identities = 175/220 (79%), Positives = 188/220 (85%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG + NE
Sbjct: 2 SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
LQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGM+
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221
|
|
| UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 158/225 (70%), Positives = 182/225 (80%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
|
| UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 158/225 (70%), Positives = 182/225 (80%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
|
| UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 158/225 (70%), Positives = 182/225 (80%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
|
| UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 158/225 (70%), Positives = 182/225 (80%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
|
| UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 158/225 (70%), Positives = 182/225 (80%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
|
| UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 158/225 (70%), Positives = 182/225 (80%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
|
| MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 158/225 (70%), Positives = 182/225 (80%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P19454 | CSK22_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6296 | 0.6098 | 0.6961 | yes | no |
| P21868 | CSK21_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7873 | 0.5710 | 0.5652 | yes | no |
| P68399 | CSK21_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7873 | 0.5710 | 0.5652 | yes | no |
| P28523 | CSK2A_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.9227 | 0.5684 | 0.6626 | N/A | no |
| O64816 | CSK2P_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8529 | 0.6847 | 0.6134 | yes | no |
| P18334 | CSK2A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7556 | 0.5710 | 0.6138 | yes | no |
| P08181 | CSK2A_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7692 | 0.5710 | 0.6577 | yes | no |
| P19139 | CSK21_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7873 | 0.5710 | 0.5652 | yes | no |
| P28547 | CSK2A_THEPA | 2, ., 7, ., 1, 1, ., 1 | 0.7327 | 0.5607 | 0.6235 | yes | no |
| P68400 | CSK21_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7873 | 0.5710 | 0.5652 | yes | no |
| P40231 | CSK2A_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7477 | 0.5788 | 0.6746 | yes | no |
| Q02720 | CSK2A_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7636 | 0.5684 | 0.6528 | yes | no |
| P33674 | CSK21_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.7828 | 0.5710 | 0.5652 | yes | no |
| Q60737 | CSK21_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7873 | 0.5710 | 0.5652 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.III.1773.1 | hypothetical protein (353 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 387 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-37 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-33 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-32 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-32 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-31 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-31 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-29 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-29 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-28 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-28 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-28 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-27 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-27 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-27 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-26 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-26 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-25 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-25 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-24 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-24 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-23 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-23 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-09 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-05 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 4e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 5e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.001 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.001 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.001 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.003 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-56
Identities = 69/196 (35%), Positives = 115/196 (58%), Gaps = 12/196 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNI 191
YE++ K+G G + +V+ + IK++K K KK I REIKIL+ L PNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
V+L D+ D+ L+ E+ D F +L LS+ + R+Y+ ++L AL+Y HS+G
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+KP N+++D E ++L D+GLA PG++ V + + PE+L+ + Y
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175
Query: 309 SLDLWSLGCMFAGMVS 324
++D+WSLG + +++
Sbjct: 176 AVDIWSLGVILYELLT 191
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-54
Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGGPN 190
YE++RK+G G + V++ H + +KILK +K K REI+IL+ L PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQ 247
IV+L+D D L+ E+ D LS+ + + ++L+ L+Y HS
Sbjct: 60 IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI+HRD+KP N+++D +++ D+GLA+ V + ++ PE+L+ Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 307 DYSLDLWSLGCMFAGMVS 324
+D+WSLG + +++
Sbjct: 177 GPKVDVWSLGVILYELLT 194
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
+G G + V+ +K IKI+K + REI+IL+ L PNIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
D+ L+ E+ K L LS+ ++ + ++L+ L+Y HS GI+HRD
Sbjct: 60 FEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 312
+KP N+++D + K++L D+GL++ V + + PE+L+ Y D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 313 WSLGCMFAGM 322
WSLG + +
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-42
Identities = 71/206 (34%), Positives = 118/206 (57%), Gaps = 17/206 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGGPN 190
YE + K+G G Y V++ E +K ++ +++ I REI +L+ L PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
IVKLLD++ ++ L+FE+ + D K LS ++ +Y+LL+ L YCHS
Sbjct: 60 IVKLLDVIHTERKLY--LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N++I+ + L+L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 117 HRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 306 YDYSLDLWSLGCMFAGMVSVSPSVLF 331
Y ++D+WS+GC+FA M++ P LF
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKP--LF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 72/202 (35%), Positives = 117/202 (57%), Gaps = 15/202 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
Y+ + K+G G Y V++ E IK +K K REIK+L+ L PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
I+KLLD+ R + L+FE ++ +K++ L + ++ Y+Y+LL+ L +CHS
Sbjct: 60 IIKLLDVFRHKGDL--YLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
GI+HRD+KP N++I+ + L+L D+GLA F P + Y V +R+++ PELL+ +
Sbjct: 117 HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 306 YDYSLDLWSLGCMFAGMVSVSP 327
Y +D+WS+GC+FA ++S P
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 70/208 (33%), Positives = 114/208 (54%), Gaps = 18/208 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCGGP 189
Y+++ ++G G + VF+ E +K + + I REIK LQ C P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCH 245
+VKLLD+ L+ E++ + +VL P L + V+ Y+ LLK + Y H
Sbjct: 60 YVVKLLDVFPHGSGF--VLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
+ GIMHRD+KP N++I L++ D+GLA + + Y+ +VA+R+++ PELL
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ YD +DLW++GC+FA +++ SP LF
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSP--LF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 63/207 (30%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 190
YE + ++G G Y +V++ + E +K ++ +K+ REIK+LQ L PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHV--------NNTDFKVLYPTLSDYDVRYYIYELLKALD 242
IV+L +IV + + ++FE++ ++ + K ++ ++ Y+ +LL+ L
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQ 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 300
Y HS GI+HRD+K N++I+++ L+L D+GLA Y +Y RV + +++ PELL
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 301 VDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y +D+WS+GC+ A + P
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 74/206 (35%), Positives = 109/206 (52%), Gaps = 16/206 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
YEV+ VG G Y V + + E IK K KK RE+K+L+ L N
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHSQ 247
IV L + R + L+FE+V T ++L P D VR YI++LL+A+ YCHS
Sbjct: 62 IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N+++ E L+L D+G A P VA+R+++ PELLV +
Sbjct: 120 NIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 306 YDYSLDLWSLGCMFAGMVSVSPSVLF 331
Y +D+W++GC+ A ++ P LF
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEP--LF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-36
Identities = 72/217 (33%), Positives = 116/217 (53%), Gaps = 32/217 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 190
YE+++ +G G Y V V K IK I K+I REIK+L++L N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLKAL 241
I+ LLDI+R + F V TD KV+ L+D ++Y++Y++L+ L
Sbjct: 61 IIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYF 294
Y HS ++HRD+KP N++++ L++ D+GLA + G EY V +R++
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWY 172
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ PELL+ Y ++D+WS+GC+FA +++ P LF
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP--LF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 63/191 (32%), Positives = 103/191 (53%), Gaps = 12/191 (6%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGPNI 191
+E++ K+G+G + EV++ H ++ IK++K K+K I EI+IL+ C PNI
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + ++ E + D K TL++ + Y ELLK L+Y HS
Sbjct: 60 VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
GI+HRD+K N+++ + +++LID+GL+ K N V + Y+ PE++ + YD
Sbjct: 118 GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175
Query: 308 YSLDLWSLGCM 318
Y D+WSLG
Sbjct: 176 YKADIWSLGIT 186
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 67/198 (33%), Positives = 112/198 (56%), Gaps = 18/198 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
YE +K+G G Y+ V++ IK +K ++K+ K REIK+LQ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDY 243
PNI+ LLD+ + + +L+FE + TD + + L+ D++ Y+ L+ L+Y
Sbjct: 61 HPNIIGLLDVFGHKSNI--NLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
HS I+HRD+KP+N++I L+L D+GLA + P ++ +V +R+++ PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 303 LQDYDYSLDLWSLGCMFA 320
+ Y +D+WS+GC+FA
Sbjct: 177 ARHYGVGVDMWSVGCIFA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 63/204 (30%), Positives = 120/204 (58%), Gaps = 13/204 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
Y+++ K+G G +SEV + + KC+ K K +++ REI+ L+ L PNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHSQ 247
++L++++ D+++ +L+FE ++ ++++ P L + V+ Y+Y+LLK+LD+ H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRN 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
GI HRD+KP N++I L+L D+G + Y +++R+++ PE L+ Y
Sbjct: 120 GIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 308 YSLDLWSLGCMFAGMVSVSPSVLF 331
+D+W++GC+F ++S+ P LF
Sbjct: 178 PKMDIWAVGCVFFEILSLFP--LF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 73/217 (33%), Positives = 115/217 (52%), Gaps = 33/217 (15%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------KREIKIL 182
YE+++K+G+G Y V++ + E V KKI REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKA 240
Q L PNIVKLL++++ + K L+FE++ TD + L D RY +Y+LLKA
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------VASRYF 294
L Y HS ++HRD+KP N++++ + R ++L D+GLA +E VA+R++
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ PE+L+ Y +D+WS+GC+ M+ P LF
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP--LF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 4e-32
Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGG 188
Y ++RK+G G + EV+ D + +K+L + K REI+IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
PNIVKL D +D+ S L+ E+V+ + L LS+ + + + ++L AL+
Sbjct: 58 PNIVKLYDFFQDEGSLY--LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 295
Y HS+GI+HRD+KP N+++D + R ++LID+GLA+ + V + +
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 296 GPELLVD--LQDYDYSLDLWSLGCMFAGMVS 324
PE+L+ L S D+WSLG +++
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLT 206
|
Length = 384 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 70/207 (33%), Positives = 121/207 (58%), Gaps = 21/207 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQNL 185
+ YE + K+G G Y VF+ C + E I +K PV KK REI++L+ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFK---CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
PN+V L+++ R + + L+FE+ ++T L P + ++ ++ I++ L+A++
Sbjct: 58 -KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
+CH +HRDVKP N++I + + ++L D+G A PG +Y VA+R+++ PELLV
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 302 -DLQDYDYSLDLWSLGCMFAGMVSVSP 327
D Q Y +D+W++GC+FA +++ P
Sbjct: 174 GDTQ-YGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 69/202 (34%), Positives = 114/202 (56%), Gaps = 15/202 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
YE + VG G Y V + H + IK K VKK + REI++L+ L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHS 246
N+V L+++ R + K L+FE V++T L YP D VR Y++++L+ +++CHS
Sbjct: 61 NLVNLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N+++ + ++L D+G A PG+ Y VA+R+++ PELLV
Sbjct: 119 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 306 YDYSLDLWSLGCMFAGMVSVSP 327
Y ++D+W++GC+ M++ P
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
Y+V++++G G + V+ + E IK +K KK RE+K L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDY 243
PNIVKL ++ R+ + +FE++ ++++ S+ +R IY++L+ L +
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
H G HRD+KP N+++ +++ D+GLA Y V++R+++ PE+L+
Sbjct: 115 IHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
Y +D+W+LGC+ A + ++ P LF
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRP--LF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 70/206 (33%), Positives = 116/206 (56%), Gaps = 17/206 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
D YE V K+G G Y V++ NE +K ++ V I REI +L+ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELLKALD 242
G NIV+L D+V + K L+FE+++ D K + D+ ++ Y+Y++L+ +
Sbjct: 61 G-NIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
YCHS ++HRD+KP N++ID L+L D+GLA F P + + V + +++ PE+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y +D+WS+GC+FA MV+ P
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 38/223 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
DD++ + +G G +S V N++ IKIL +K+KK +K E ++L L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF--EHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
P I+KL +D+++ L F E+ N + Y +L + R+Y E+L AL+
Sbjct: 61 HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------------EYNV 287
Y HS+GI+HRD+KP N+++D + +++ D+G A+ P
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 288 RVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMVS 324
R F G PELL + + S DLW+LGC+ M++
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 77/219 (35%), Positives = 117/219 (53%), Gaps = 42/219 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
Y+ V K+G G Y V++ E V KKI+ REI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------VLYPTLSDYDVRYY 233
+ L PNIV+LLD+V ++K L+FE ++ D K L P L ++ Y
Sbjct: 53 KEL-NHPNIVRLLDVVH-SENKL-YLVFEFLD-LDLKKYMDSSPLTGLDPPL----IKSY 104
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASR 292
+Y+LL+ + YCHS ++HRD+KP N++ID E L+L D+GLA F P + Y V +
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTL 163
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+++ PE+L+ + Y +D+WS+GC+FA MV+ P LF
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP--LF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 66/217 (30%), Positives = 116/217 (53%), Gaps = 30/217 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------REIKIL 182
D YE + K+G G Y +V++ + L +KK +++ REI +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54
Query: 183 QNLCGGPNIVKLLDIVR-DQQSKTPSL--IFEHVNNTDFKVLYPT--------LSDYDVR 231
Q L IV+LLD+ ++++ PSL +FE+++ +D K + L ++
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVA 290
++Y+LLK + +CH G+MHRD+KP N+++D ++ L++ D GL F P K Y +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ +++ PE+L+ Y +D+WS+GC+FA M P
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 35/245 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKK---IKREIKILQNLCGGP 189
++ +GRG + V+ + E +K L +++ ++REI+IL +L P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
NIV+ RD++ T ++ E+V+ + + L + +R Y ++L+ L Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 303
GI+HRD+K N+++D + ++L D+G A G+ + Y+ PE++
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSP---------SVLFYVSGLGHS----------CLNTW 344
++Y + D+WSLGC M + P + L+ + G +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD-- 235
Query: 345 FLRTC 349
FLR C
Sbjct: 236 FLRKC 240
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 38/221 (17%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCG 187
DYE++ K+G G + EV++ +K IL +K REIKIL+ L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65
Query: 188 GPNIVKLLDIV---RDQQSKTPSLIF------EH-----VNNTDFKVLYPTLSDYDVRYY 233
PN+V L+D+ D+ + ++ +H + N K L++ ++ Y
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIKCY 120
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--------HPG--- 282
+ +LL+ ++Y H I+HRD+K N++ID+ Q L++ D+GLA Y G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 322
++Y V +R+++ PELL+ + Y ++D+W +GC+FA M
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 60/218 (27%), Positives = 121/218 (55%), Gaps = 22/218 (10%)
Query: 130 WGEQ--DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKIL 182
WG++ D ++++ ++G G Y +V++ E +K ++ +K+ REIKIL
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTP--------SLIFEHVNNTDFKVLYPTLSDYD---VR 231
+ L NIV L +IV D+Q L+FE++++ +L L + ++
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNVRV 289
++ +LL+ L+YCH + +HRD+K N++++++ +++L D+GLA Y+ + Y +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKV 178
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ +++ PELL+ + Y ++D+WS GC+ + + P
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 67/209 (32%), Positives = 117/209 (55%), Gaps = 20/209 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGP 189
Y+ + +G G Y V H K IK + P + + + REIKIL+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63
Query: 190 NIVKLLDIVR--DQQSKTPSLIFEHVNNTD-FKVLYP-TLSDYDVRYYIYELLKALDYCH 245
NI+ +LDI+R +S I + + TD +K++ LS+ ++Y++Y++L+ L Y H
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 298
S ++HRD+KP N++++ L++ D+GLA E H G EY VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
++++ + Y ++D+WS+GC+ A M+S P
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 62/209 (29%), Positives = 112/209 (53%), Gaps = 19/209 (9%)
Query: 136 YEVVRKVGRGKYSEVFEG--VHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGG 188
YE+++++G+G Y V ++ E IK + V KKI RE+K+L++ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 189 PNIVKL--LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDY 243
NI L +DIV L +E + D + + L+D + +IY++L L Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPE 298
HS ++HRD+KP N++++ + +L++ D+GLA + N VA+R+++ PE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+++ Q Y ++D+WS+GC+ A ++ P
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 69/215 (32%), Positives = 121/215 (56%), Gaps = 30/215 (13%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------R 177
+G+ + Y+ + K+G G Y+ V++G + V K+I+ R
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTG--------QLVALKEIRLEHEEGAPFTAIR 52
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPT-LSDYDVRYY 233
E +L++L NIV L DI+ + KT +L+FE+++ TD K LS ++VR +
Sbjct: 53 EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
+++LL+ L YCH + ++HRD+KP N++I E+ +L+L D+GLA P K Y+ V +
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+++ P++L+ +Y SLD+W +GC+F M + P
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 63/207 (30%), Positives = 115/207 (55%), Gaps = 22/207 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGG 188
Y+ + +G G Y V + +K IK + P K+ RE+KIL++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63
Query: 189 PNIVKLLDIVRDQQS--KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYC 244
NI+ + DI+R + K ++ + + + +++ L++ +RY++Y+LL+ L Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 296
HS ++HRD+KP N++++ E +LR+ D+G+A H EY VA+R+++
Sbjct: 124 HSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMV 323
PELL+ L +Y ++D+WS+GC+FA M+
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 64/200 (32%), Positives = 114/200 (57%), Gaps = 16/200 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
++ V K+G G Y V++ + E +K ++ V I REI +L+ L P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
NIVKLLD++ + L+FE ++ K + + + ++ Y+++LL+ L +CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
S ++HRD+KP N++I+ + ++L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 305 DYDYSLDLWSLGCMFAGMVS 324
Y ++D+WSLGC+FA MV+
Sbjct: 177 YYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 64/224 (28%), Positives = 111/224 (49%), Gaps = 44/224 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
YE + ++G G Y V++ + V KK++ REI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52
Query: 183 QNL--CGGPNIVKLLDI---VRDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYY 233
+ L PNIV+LLD+ R + +L+FEHV+ + K P L ++
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----V 289
+ +LL+ +D+ HS I+HRD+KP N+++ + + +++ D+GLA Y + + V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167
Query: 290 ASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMVSVSPSVLFY 332
+ +++ PE+L LQ Y +D+WS+GC+FA + P LF
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAELFRRRP--LFR 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 70/218 (32%), Positives = 116/218 (53%), Gaps = 35/218 (16%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKI 181
DY + K+G G Y V++G + + V KKI+ REI +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIY 235
L+ L PNIV L D++ Q+S+ LIFE ++ D K +L V+ Y+Y
Sbjct: 53 LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 294
++L+ + +CHS+ ++HRD+KP N++ID + ++L D+GLA F P + Y V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLFY 332
+ PE+L+ Y +D+WS+G +FA M + P LF+
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP--LFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 68/214 (31%), Positives = 125/214 (58%), Gaps = 28/214 (13%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ V++G TDN + LK ++ + + RE+ +
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSL 57
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD-------YDVRYYI 234
L++L NIV L DI+ ++S T L+FE+++ K L L D ++V+ ++
Sbjct: 58 LKDL-KHANIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNSINMHNVKLFL 110
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRY 293
++LL+ L+YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
++ P++L+ DY +D+W +GC+F M + P
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 64/200 (32%), Positives = 112/200 (56%), Gaps = 21/200 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCG 187
YE + K+G G Y VF+ + +E I LK V+ REI +L+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDY 243
NIV+L D++ + T L+FE+ + D K + + + V+ ++++LLK L +
Sbjct: 58 HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 302
CHS ++HRD+KP N++I+ + +L+L D+GLA + P + Y+ V + +++ P++L
Sbjct: 115 CHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 303 LQDYDYSLDLWSLGCMFAGM 322
+ Y S+D+WS GC+FA +
Sbjct: 174 AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 60/213 (28%), Positives = 115/213 (53%), Gaps = 32/213 (15%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
W D Y+ + VG G Y +V T + I K+ +P + K+ RE+++L++
Sbjct: 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYP-------------TLSDYDV 230
+ N++ LLD+ TP+ + + D ++ LSD +
Sbjct: 71 MDH-ENVIGLLDVF------TPA---SSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
++ +Y++L+ L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E VA
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVA 177
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+R+++ PE++++ Y+ ++D+WS+GC+ A ++
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 61/204 (29%), Positives = 114/204 (55%), Gaps = 8/204 (3%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
+G Y + K+G G Y+ V++G+ + + +K++ ++ + RE +L+ L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYC 244
NIV L DI+ +++ T + H + + + +P L Y+VR ++++LL+ L Y
Sbjct: 61 -KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 303
H Q I+HRD+KP N++I + +L+L D+GLA P + Y+ V + +++ P++L+
Sbjct: 120 HGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSP 327
DY +LD+W GC+F M+ P
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQP 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 68/211 (32%), Positives = 123/211 (58%), Gaps = 22/211 (10%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 57
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYEL 237
L++L NIV L DIV +S T L+FE+++ D K +S ++V+ ++Y++
Sbjct: 58 LKDL-KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQI 113
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
P++L+ +Y +D+W +GC+F M S P
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 22/206 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLCGG 188
++ + K+G G Y+ V++G + T E I LK + REI +++ L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALD 242
NIV+L D++ + L+FE+++ D K T L V+ + Y+LLK +
Sbjct: 58 ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
+CH ++HRD+KP N++I+ L+L D+GLA F P ++ V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y S+D+WS+GC+ A M++ P
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 66/211 (31%), Positives = 123/211 (58%), Gaps = 22/211 (10%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 56
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYEL 237
L+NL NIV L DI+ ++ T L+FE++++ D K +S ++V+ ++++L
Sbjct: 57 LKNL-KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH + I+HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
P++L+ +Y +D+W +GC+ M + P
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 69/204 (33%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
+ +EV+ VG G Y V + H E IK K + K+ RE+K+L+ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCH 245
NIV+L + R + L+FE+V ++L P + VR YIY+L+KA+ +CH
Sbjct: 60 ENIVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
I+HRD+KP N++I H L+L D+G A G Y VA+R+++ PELL+
Sbjct: 118 KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSP 327
Y ++D+WS+GC+ + P
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
YE+++++G+G + +V+ +D + ++K + +++ E+KIL+ L P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIF-EHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
NI+K + + K I E+ + D K + + + +L AL
Sbjct: 60 NIIKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
Y HS+ I+HRD+KP N+ + ++L D+G+++ + V + Y+ PEL
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 301 VDLQDYDYSLDLWSLGC 317
+ + Y+Y D+WSLGC
Sbjct: 176 QN-KPYNYKSDIWSLGC 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 65/226 (28%), Positives = 119/226 (52%), Gaps = 30/226 (13%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KK 174
Y+ E W D Y +++VG G Y V + K IK L +P + K+
Sbjct: 1 YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------- 223
RE+++L+++ N++ LLD+ TP L + + DF ++ P
Sbjct: 61 AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111
Query: 224 --TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
LS+ +++ +Y++LK L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QT 168
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
E V +R+++ PE++++ Y ++D+WS+GC+ A M++ P
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 26/210 (12%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
W + Y+ + VG G Y V +K +K L +P + ++ RE+++L++
Sbjct: 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYY 233
+ N++ LLD+ TP+ E+ N D V LSD V++
Sbjct: 71 M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IY+LL+ L Y HS GI+HRD+KP NV ++ E +LR++D+GLA E VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADDEMTGYVATRW 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
++ PE++++ Y+ ++D+WS+GC+ A ++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 63/210 (30%), Positives = 116/210 (55%), Gaps = 25/210 (11%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KKIKREIKILQN 184
W + Y +++VG G Y V + EK IK L +P + K+ RE+ +L++
Sbjct: 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDF-KVLYPTLSDYDVRYYI 234
+ N++ LLD+ T ++ + + TD K++ LS+ V+Y +
Sbjct: 71 M-QHENVIGLLDV------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
Y++L L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E V +R++
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWY 180
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ PE++++ Y+ ++D+WS+GC+ A M++
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 61/202 (30%), Positives = 118/202 (58%), Gaps = 12/202 (5%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
+G+ D YE + K+G G Y+ V++G + + +K+++ +++ RE +L+ L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
NIV L DI+ +++ T L+FE+V+ + + +P L +V+ ++++LL+ L
Sbjct: 61 -KHANIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
Y H + I+HRD+KP N++I + +L+L D+GLA P Y+ V + +++ P++L+
Sbjct: 118 YIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 302 DLQDYDYSLDLWSLGCMFAGMV 323
+Y LD+W +GC+F M+
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 68/200 (34%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPN 190
Y ++ VG G + V T I KI+KP V K+ RE+K+L++L N
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70
Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
I+ L DI S + F + TD L + L ++Y++Y++L+ L Y HS
Sbjct: 71 IISLSDIF---ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
G++HRD+KP N++I+ E L++ D+GLA P + V++RY++ PE+++ Q YD
Sbjct: 128 GVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 308 YSLDLWSLGCMFAGMVSVSP 327
+D+WS GC+FA M+ P
Sbjct: 185 VEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 33/206 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 190
Y ++ +GRG Y V + NEK IK + + K+ REIK+L++L N
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDFKVLY---PTLSDYDVRYYIYELLKAL 241
++ + DI+ + F V +TD + TLSD +Y++Y+LL+ L
Sbjct: 66 VIAIKDIMPPPHREA----FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHPGKEYNVRVASRYF 294
Y HS ++HRD+KP N++++ L++ D+GLA +F EY V +R++
Sbjct: 122 KYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFM---TEY---VVTRWY 174
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFA 320
+ PELL++ +Y ++D+WS+GC+FA
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFA 200
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 61/211 (28%), Positives = 113/211 (53%), Gaps = 26/211 (12%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
W + Y+ + VG G Y V + +K L +P + K+ RE+++L++
Sbjct: 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYY 233
+ N++ LLD+ TP+ E N+ D V L+D V++
Sbjct: 73 M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IY++L+ L Y HS I+HRD+KP N+ ++ E +L+++D+GLA H E VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
++ PE++++ Y+ ++D+WS+GC+ A +++
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 65/208 (31%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IK--REIKILQNLCGG 188
D+YE + ++ G Y V+ E +K LK K+K+ I REI IL L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDYC 244
PNIV + ++V ++ E+V + D K L T+ +V+ + +LL + +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
H I+HRD+K N+++++ L++ D+GLA E+ P K Y V + +++ PELL+
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
++Y ++D+WS+GC+FA +++ P LF
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKP--LF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIV 192
Y +R +G G VF V +++ +K + + +K REIKI++ L NIV
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65
Query: 193 KLLDIVRDQQSKTPSLIFE--HVN---------NTDFKVL--YPTLSDYDVRYYIYELLK 239
K+ +++ S + +N TD + LS+ R ++Y+LL+
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 295
L Y HS ++HRD+KP NV I+ E L++ D+GLA P + + + +++++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
P LL+ +Y ++D+W+ GC+FA M++ P
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 71/220 (32%), Positives = 113/220 (51%), Gaps = 31/220 (14%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLC 186
E YE + K+G+G + EVF+ H + +K +L +K+ REIKILQ L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68
Query: 187 GGPNIVKLLDIVRDQQSK------TPSLIFE---H-----VNNTDFKVLYPTLSDYDVRY 232
N+V L++I R + + + L+FE H ++N + K TLS+ ++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF---TLSE--IKK 123
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNV 287
+ LL L Y H I+HRD+K N++I + L+L D+GLA + K Y
Sbjct: 124 VMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
RV + +++ PELL+ +DY +D+W GC+ A M + SP
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-23
Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 21/209 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
YE V ++G G Y +VF+ + + + LK V+ + + RE+ +L++L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 188 --GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELL 238
PN+V+L D+ R + +L+FEHV+ T + KV P + ++ +++LL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+L+ Y +DLWS+GC+FA M P
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGGPNIVK 193
+G G + V+EG++ D + +K + K++++EI +L L PNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L R+ + E V L Y + + +R Y ++L L+Y H + +
Sbjct: 67 YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
HRD+K N+++D ++L D+G+A+ S Y+ PE++ Y +
Sbjct: 125 HRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 311 DLWSLGCMFAGMVSVSP 327
D+WSLGC M + P
Sbjct: 184 DIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
+E+V +G G Y +V++ H + IKI+ ++ +++IK E IL+ PNI
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 192 VKL--LDIVRDQQSKTPSLIF-----------EHVNNTDFKVLYPTLSDYDVRYYIYELL 238
I ++ L + V + L + + Y + E L
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETL 123
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 297
+ L Y H ++HRD+K N+++ ++L+D+G+ A+ N + + Y+ P
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 298 ELLV-DLQD---YDYSLDLWSLG 316
E++ D Q YD D+WSLG
Sbjct: 183 EVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKL 194
Y++ +G G + V+E + +EK IK +L+ + K RE+ I++NL NI+ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124
Query: 195 LD------IVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
D +++++ +++ E + T K + L + V+ Y Y+L +AL
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
Y HS+ I HRD+KP N++ID L+L D+G A+ G+ + SR+++ PEL++
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 303 LQDYDYSLDLWSLGCMFAGMV 323
+Y +DLWSLGC+ A M+
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 18/195 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG 188
D++++ +VG+G Y +VF E +K +K + + + E IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCH 245
+VKLL +D + L E+V DF+ L LS+ R+Y+ E+ +A+D H
Sbjct: 61 EWLVKLLYAFQDDEYLY--LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
G +HRD+KP N +ID ++L D+GL++ Y N V S + PE+L +
Sbjct: 119 ELGYIHRDLKPENFLIDASGH-IKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173
Query: 305 DYDYSLDLWSLGCMF 319
YD+++D WSLGCM
Sbjct: 174 GYDFTVDYWSLGCML 188
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLC 186
++E + ++G G Y V+ T E I LK V+ + REI +L N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDY 243
PNIV+L ++V + + L+ E+ +L S+ V+ + +LL+ L Y
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+K N+++ + L++ D+GLA Y P K +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 303 LQDYDYSLDLWSLGCMFA 320
Y ++D+W++GC+ A
Sbjct: 183 CTTYTTAIDMWAVGCILA 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-22
Identities = 57/220 (25%), Positives = 111/220 (50%), Gaps = 27/220 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKPVKKK---KIKREIKILQNLC 186
++++ +K+G+G++S V++ + C + + + ++I + + K +EI +L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL- 59
Query: 187 GGPNIVKLLD-IVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELL 238
PN++K L + + + +++ E + D FK + + + Y +L
Sbjct: 60 DHPNVIKYLASFIENNEL---NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGP 297
AL++ HS+ IMHRD+KP NV I ++L D GL F+ + V + Y+ P
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVSV-SPSVLFYVSGL 336
E + + Y++ D+WSLGC+ M ++ SP FY +
Sbjct: 176 ERIHE-NGYNFKSDIWSLGCLLYEMAALQSP---FYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 62/218 (28%), Positives = 112/218 (51%), Gaps = 26/218 (11%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGP 189
D E R +G G + V+ D ++ +K + V K++ RE+K+L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59
Query: 190 NIVKLLDIVRDQQSKTPSL-IFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLK 239
N++ LDI+ + P + FE + +D K++ LS V+ ++Y++L+
Sbjct: 60 NVLSALDIL-----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGP 297
L Y HS GI+HRD+KP N++++ L++ D+GLA P K V ++Y++ P
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSG 335
E+L+ + Y ++D+WS+GC+FA + + +LF
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAEL--LGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 20/195 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGP 189
+Y++ +GRG + V++G++ + IK + K K+ I +EI +L+NL P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALDY 243
NIVK + + S +I E+ N L + + V Y+Y++L+ L Y
Sbjct: 60 NIVKYIGSIETSDSL--YIILEYAENGS---LRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 302
H QG++HRD+K N++ + ++L D+G+A + K+ V + Y+ PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172
Query: 303 LQDYDYSLDLWSLGC 317
+ + D+WSLGC
Sbjct: 173 MSGASTASDIWSLGC 187
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 4e-21
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 21/190 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
+G+G + +V + +K+LK KKKI + E IL + P IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGI 249
KL + ++ L+ E+ + F L S+ R+Y E++ AL+Y HS GI
Sbjct: 57 KLHYAFQTEEKL--YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
++RD+KP N+++D ++L D+GLA E G N + + PE+L + Y
Sbjct: 115 IYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LGKGYGK 172
Query: 309 SLDLWSLGCM 318
++D WSLG +
Sbjct: 173 AVDWWSLGVL 182
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVK 193
Y+ + K+G G EV++ ++ IK L+ K+ I EI I+++ C PNIV
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD-CKHPNIVD 79
Query: 194 LLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQ 247
D ++ E+++ TD ++ +++ + Y E+L+ L+Y HSQ
Sbjct: 80 YYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
++HRD+K N+++ + ++L D+G A+ + N V + Y+ PE++ +DY
Sbjct: 136 NVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 307 DYSLDLWSLGCMFAGMV 323
+D+WSLG M M
Sbjct: 194 GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-20
Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL-- 185
YE V ++G G Y V++ D LK V+ + + RE+ +L+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKA---RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 186 CGGPNIVKLLDIV----RDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYE 236
PNIV+L+D+ D+++K +L+FEHV+ D KV P L ++ + +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
L+ LD+ H+ I+HRD+KP N+++ +++L D+GLA Y V + +++
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE+L+ Y +D+WS+GC+FA M P
Sbjct: 176 PEVLLQ-STYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 53/214 (24%), Positives = 116/214 (54%), Gaps = 23/214 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGV--HCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
YE+ +GRG Y V++ + D ++ IK K K++ REI +L+ L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKA 240
N+V L+++ + K+ L+F++ + ++++ ++ V+ ++++L
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRY 293
+ Y HS ++HRD+KP N+++ E+ +++ D GLA ++ P + + V + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
++ PELL+ + Y ++D+W++GC+FA ++++ P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 52/193 (26%), Positives = 106/193 (54%), Gaps = 17/193 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPN 190
++ ++++ K+G G Y V++ +H + IK++ PV++ ++I +EI IL+ C P
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEH-----VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
IVK ++ ++ E+ V++ K+ TL++ ++ +Y+ LK L+Y H
Sbjct: 60 IVKYYGSY--FKNTDLWIVMEYCGAGSVSDI-MKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 246 SQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
S +HRD+K N++++ E Q K L D+G++ + + N + + ++ PE++ +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAK--LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE- 173
Query: 304 QDYDYSLDLWSLG 316
Y+ D+WSLG
Sbjct: 174 IGYNNKADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLCGGPNIVK 193
+ +G Y VF + + IK++K K I++ E IL P +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L Q K L+ E++ D L +L + R YI E++ AL+Y HS GI+
Sbjct: 58 LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 301
HRD+KP N++ID L+L D+GL++ ++ N+ + + PE+++
Sbjct: 116 HRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 302 DLQDYDYSLDLWSLGCMF 319
Q + ++D WSLGC+
Sbjct: 175 -GQGHSKTVDWWSLGCIL 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIK---REIKILQNLCGG 188
+E++R +G+G + +V + K + K K V+K ++ E +ILQ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL-NH 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
P +V L +D+++ L+ + + D + Y S+ V+++I E++ AL+Y
Sbjct: 60 PFLVNLWYSFQDEENMY--LVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
HS+GI+HRD+KP N+++D EQ + + D+ +A P + + PE+L
Sbjct: 116 LHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR- 173
Query: 304 QDYDYSLDLWSLGCMF 319
Q Y ++D WSLG
Sbjct: 174 QGYSVAVDWWSLGVTA 189
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGP 189
DYEV+ +G+G + V + +D + + K + +K+++ E+ IL+ L P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIY----ELLKALD 242
NIV+ D + D+ ++T ++ E+ D L Y +I+ +LL AL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 243 YCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG----KEYNVRVASRY 293
CH ++HRD+KP N+ +D ++L D+GLA+ K Y V + Y
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTY---VGTPY 175
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ PE L YD D+WSLGC+ + ++SP
Sbjct: 176 YMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKC------IIKILKPVKKKKIKREIKILQNLCGG 188
++++ +K+GRG++SEV+ D + I +++ ++ +EI +L+ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 189 PNIVKLLD-IVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K LD + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYLDSFIEDNEL---NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 299
+++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 VEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSV-SPSVLFY 332
+ + Y++ D+WSLGC+ M ++ SP FY
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSP---FY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNI 191
D +E++ +G+G Y +V++ + D +KIL P+ ++I+ E ILQ+L PN+
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
VK + L+ E N L L + + Y +Y L L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H+ I+HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 301 VDLQDYDYSL----DLWSLG 316
Q YDYS D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 60/207 (28%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPN 190
Y++ +G+G Y V + EK IK + V +I REIK+L+ L P+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPD 60
Query: 191 IVKLLDIV---RDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
IV++ I+ ++ K ++FE + + +V+ L+ ++++Y+LL+AL Y H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
+ + HRD+KP N++ + + KL++ D+GLA + VA+R+++ PEL
Sbjct: 121 TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 302 DL-QDYDYSLDLWSLGCMFAGMVSVSP 327
Y ++D+WS+GC+FA +++ P
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 43/215 (20%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKK--KKIKREIKILQNLCGGPNIVK 193
K+G G + +V+ V+ E K I+I K K+I E+K+L+ L PN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVK-EIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK 63
Query: 194 L--LDIVRDQ--------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
+++ R++ T + EH D V +R Y +LL+ L Y
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---------IRVYTLQLLEGLAY 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------- 296
HS GI+HRD+KP N+ +DH ++L D+G A +
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAY 169
Query: 297 --PELLV--DLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE++ + + + D+WSLGC+ M +
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 63/234 (26%), Positives = 97/234 (41%), Gaps = 66/234 (28%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-----------KREIKIL 182
DD+EV++ +GRG + EV+ D + + +K ++K + +R+I
Sbjct: 1 DDFEVIKVIGRGAFGEVWL---VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYE 236
+ P IVKL +D++ L+ E++ D L L DV R+YI E
Sbjct: 58 AD---SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNL---LIRKDVFPEETARFYIAE 109
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLA----------------- 276
L+ ALD H G +HRD+KP N++ID H ++L D+GL
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 277 ---------EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDLWSLGC 317
K+ VR V + + PE+L Y D WSLG
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGV 218
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG--PNIVK-- 193
+GRG Y V+ G H +KI+ I+RE+ +L L PNI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 194 --LLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
L K P L I E+ + L +++ + I E+L AL Y H
Sbjct: 69 GSYL--------KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
G++HRD+K N+++ + ++L D+G+ A + + V + Y+ PE++ + + Y
Sbjct: 121 GVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 307 DYSLDLWSLGCMFAGMVSVSP 327
D D+WSLG M + +P
Sbjct: 180 DTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
D +E++ +G+G Y +VF+ ++ + K +KIL P+ ++I+ E IL+ L PN+
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
VK + + K L+ E N L + + + Y ++E L L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H +HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 301 VDLQD----YDYSLDLWSLG 316
Q YD D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 48/173 (27%), Positives = 97/173 (56%), Gaps = 11/173 (6%)
Query: 161 KCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD- 217
KC+ K I++ +++ I E +IL+ C P IVKL +D++ ++ E+ +
Sbjct: 24 KCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLYRTFKDKKYIY--MLMEYCLGGEL 80
Query: 218 FKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
+ +L +Y R+YI ++ A +Y H++GI++RD+KP N+++D ++L+D+G
Sbjct: 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGF 139
Query: 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMVSVSP 327
A+ G++ + + PE++++ + YD+S+D WSLG ++ + P
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 51/209 (24%), Positives = 107/209 (51%), Gaps = 24/209 (11%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQK 65
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD----------VRYYIYELLKALDYCH 245
+ + L+F++ + + ++ + S + V+ +Y++L + Y H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
LL+ + Y ++D+W++GC+FA +++ P
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 54/202 (26%), Positives = 104/202 (51%), Gaps = 22/202 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C D I K+ +P + K+ RE+ +L
Sbjct: 19 YQNLKPIGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 72
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + L+ E ++ +V+ L + Y +Y++L +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 302 DLQDYDYSLDLWSLGCMFAGMV 323
+ Y ++D+WS+GC+ MV
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 51/209 (24%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQK 65
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 245
+ + L+F++ + + ++ L V+ +Y++L + Y H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
LL+ + Y ++D+W++GC+FA +++ P
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 54/210 (25%), Positives = 111/210 (52%), Gaps = 24/210 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEK------CIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C + + K+ +P + K+ RE+ +L+ +
Sbjct: 23 YQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + L+ E ++ +V++ L + Y +Y++L +
Sbjct: 78 -NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ Y ++D+WS+GC+ + V SV+F
Sbjct: 196 GMG-YKENVDIWSVGCIMGEL--VKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 18/191 (9%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCGGPNIV 192
++ + +G + V+ + + IK+LK + K ++ K E I+ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQG 248
KL QSK L+ E++N D L T L + + YI E++ ++ H +G
Sbjct: 61 KLYYSF---QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+KP N++ID + L+L D+GL+ K++ V + + PE ++ + D D
Sbjct: 118 IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DK 172
Query: 309 SLDLWSLGCMF 319
D WSLGC+
Sbjct: 173 MSDWWSLGCVI 183
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 51/214 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
DDYE++ +G G + V+ + +NEK IK + ++++E++ + + C P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59
Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
N+VK LLDI++ S P +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPG---- 282
+ + E+LK L+Y HS G +HRD+K N+++ E +++ D+G+ A G
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
K V + + PE++ + YD+ D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 24/198 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
+G+G + EV K + K + KK++K+ E KIL+ IV
Sbjct: 1 LGKGGFGEVC-ACQVKATGK--MYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIV 56
Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFK-----VLYPTLSDYDVRYYIYELLKALDYCHS 246
L ++K L+ +N D K V P + +Y +++ L++ H
Sbjct: 57 SL---AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ I++RD+KP NV++D + +R+ D GLA GK+ R + + PE+L + Y
Sbjct: 114 RRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVY 171
Query: 307 DYSLDLWSLGCMFAGMVS 324
D+S+D ++LGC M++
Sbjct: 172 DFSVDWFALGCTLYEMIA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 51/202 (25%), Positives = 104/202 (51%), Gaps = 22/202 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C + I K+ +P + K+ RE+ +L
Sbjct: 26 YQNLKPIGSGA-----QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 79
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + ++ E ++ +V+ L + Y +Y++L +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 302 DLQDYDYSLDLWSLGCMFAGMV 323
+ Y ++D+WS+GC+ M+
Sbjct: 199 GM-GYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 51/183 (27%), Positives = 99/183 (54%), Gaps = 13/183 (7%)
Query: 157 TDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSL 208
T I K+ +P + K+ RE+ +++ L NI+ LL++ Q+S + L
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268
+ E ++ +V+ L + Y +Y++L + + HS GI+HRD+KP N+++ + L
Sbjct: 99 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TL 157
Query: 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPS 328
+++D+GLA V +RY++ PE+++ + Y ++D+WS+GC+ M + +
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEM--IRGT 214
Query: 329 VLF 331
VLF
Sbjct: 215 VLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 9e-15
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 36/209 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKK---IKREIKILQNLCG 187
DD+E ++ +G G + V H + +KIL K VK K+ + E +ILQ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYC 244
P +V L +D + L+ E+V + F L + R+Y +++ AL+Y
Sbjct: 61 -PFLVNLYGSFQDDSNL--YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 296
HS I++RD+KP N+++D +++ D+G A RV R +
Sbjct: 118 HSLDIVYRDLKPENLLLDS-DGYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166
Query: 297 PELLVDLQDYDYSLDLWSLGC----MFAG 321
PE+++ + Y ++D W+LG M AG
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 24/199 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGP 189
Q+DYE+++++G G Y +V++ E IK++K + I++EI +L+ C P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60
Query: 190 NIVKLL-DIVRDQQ-------SKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYIYELLKA 240
NIV +R + SL D ++V LS+ + Y E LK
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSL-------QDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPEL 299
L Y H G +HRD+K N+++ E ++L D+G+ A+ + + + Y+ PE+
Sbjct: 114 LAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 300 LVDLQ--DYDYSLDLWSLG 316
+ YD D+W+LG
Sbjct: 173 AAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCGG 188
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 189 PNIVKL-LDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPEL 299
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSV-SP 327
+ + Y++ D+WSLGC+ M ++ SP
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
+ + ++ +G+G + EV++ + N+ IK++ + + I++EI+ L C P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59
Query: 190 NIVKLLDIVRDQQSKTPSL--IFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCH 245
I K K L I E+ + +L P L + + + + E+L L+Y H
Sbjct: 60 YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+G +HRD+K N+++ E+ ++L D+G++ + + N V + ++ PE++
Sbjct: 116 EEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S 173
Query: 305 DYDYSLDLWSLGC 317
YD D+WSLG
Sbjct: 174 GYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G + +K LK ++ RE +I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
VKLL + +++ ++ E++ D Y P LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ +HRD+ N ++ E +++ D+GL+ + Y R
Sbjct: 121 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD E + ++G G V + +H + K I + +K+I RE+ IL C P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLKALDYCH 245
IV + S+ E+++ + + + +LK L Y H
Sbjct: 60 YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 246 SQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 300
+ I+HRDVKP N++++ + +++L D+G++ G+ N V + + PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 301 VDLQDYDYSLDLWSLGCMF 319
DY D+WSLG
Sbjct: 172 QGN-DYSVKSDIWSLGLSL 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 6e-14
Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 41/207 (19%)
Query: 140 RKVGRGKYSEVFEG-VHCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPNIV 192
+K+G G + EV++G + D + +K LK ++K +E ++++ L G PN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFK------------VLYPTLSDYDVRYYIYELLKA 240
+LL + +++ L+ E++ D TLS D+ + ++ K
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
++Y S+ +HRD+ N ++ E +++ D+GL+ + Y + G
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171
Query: 297 ----PELLVDLQDYDYSL--DLWSLGC 317
PE L+D ++ D+WS G
Sbjct: 172 RWMAPES---LKDGIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
R +GRG Y++V V N++ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
+V L Q + L+ E+VN D L + R+Y E+ AL++ H +
Sbjct: 58 LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D + ++L D+G+ E PG + + + PE+L ++Y
Sbjct: 116 GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173
Query: 307 DYSLDLWSLGC-MFAGMVSVSP 327
+S+D W+LG MF M SP
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 52/183 (28%), Positives = 94/183 (51%), Gaps = 12/183 (6%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
++G+G + EV++G+ E IKI+ + + I++EI +L C P I +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69
Query: 197 IVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
+ +I E++ + +L P L + + + E+LK LDY HS+ +HRD+
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 255 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD+ D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKADIW 185
Query: 314 SLG 316
SLG
Sbjct: 186 SLG 188
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVK 193
+E+V VG G Y +V++G H + IK++ ++++IK+EI +L+ NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 194 LLDIVRDQQSKTPS-------LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKAL 241
K P L+ E L TL + + Y E+L+ L
Sbjct: 68 YYGAF---IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 301 VDLQD----YDYSLDLWSLGCMFAGMVSVSP 327
++ YD+ DLWSLG M +P
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 53/186 (28%), Positives = 97/186 (52%), Gaps = 14/186 (7%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKL 194
+ K+G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67
Query: 195 L-DIVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMH 251
++D + +I E++ + +L P L + + + E+LK LDY HS+ +H
Sbjct: 68 YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
RD+K NV++ E +++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182
Query: 311 DLWSLG 316
D+WSLG
Sbjct: 183 DIWSLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 140 RKVGRGKYSEVFEGV--HCTDN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G D + +K LK ++ RE +I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK-VL----YPTLSDYDVRYYIYELLKALDYCHS 246
VKLL + +++ ++ E++ D L LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ +HRD+ N ++ E +++ D+GL+ + Y V+
Sbjct: 122 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 139 VRKVGRGKYSEVFEGVH--CTDN--EKCIIKILK----PVKKKKIKREIKILQNLCGGPN 190
++++G G + +V + DN E+ +K L + +REI+IL+ L N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR----YYIYELLKALDYCHS 246
IVK + ++ LI E++ + + D + ++ K +DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 302
Q +HRD+ N++++ E +++ D+GLA+ K+Y + ++ PE L
Sbjct: 128 QRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 303 LQDYDYSLDLWSLGC----MFA-GMVSVSPSVLF 331
+ S D+WS G +F G S SP F
Sbjct: 187 SKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------------KKIKREIKILQNLCGG 188
+G+G Y V+ ++ T E +K ++ K ++ EI+ L++L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
NIV+ L + + S+ E+V T ++ VR++ ++L+ L Y H
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 301
S+GI+HRD+K N+++D ++ D+G+ + Y + +++ S ++ PE ++
Sbjct: 126 SKGILHRDLKADNLLVDA-DGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182
Query: 302 DLQDYDYS--LDLWSLGC----MFAG 321
YS +D+WSLGC MFAG
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVK 193
+E+V VG G Y +V++G H + IK++ + +++IK EI +L+ NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 194 LLDIVRDQQSKTPS-------LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 237
K+P L+ E V NT L + + Y E+
Sbjct: 78 YYGAF---IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREI 130
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 296
L+ L + H+ ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 297 PELLVDLQD----YDYSLDLWSLGCMFAGMVSVSP 327
PE++ ++ YDY D+WSLG M +P
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKK----IKREIKILQNLCGGPNIVK 193
R +GRG Y++V +K++K V + ++ E + + P +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 194 LLDIVRDQQSKTPSLIF---EHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
L +T S +F E V+ D L + R+Y E+ AL++ H +
Sbjct: 61 LHSCF-----QTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 307 DYSLDLWSLGC-MFAGMVSVSP 327
+S+D W+LG MF M SP
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 8e-13
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 189
+G G + V+ G++ + E +K + +K+ + REI +L+ L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
NIV+ L D + E+V L Y + VR ++ ++LK L+Y H+
Sbjct: 67 NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 299
+GI+HRD+K N+++D++ +++ D+G+++ +R ++ PE
Sbjct: 125 RGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVS 324
+V Y D+WSLGC+ M++
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLT 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
R +GRG Y++V V E+ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
+V L Q + E+VN D L + R+Y E+ AL+Y H +
Sbjct: 58 LVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 307 DYSLDLWSLGC-MFAGMVSVSP 327
+S+D W+LG MF M SP
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+DYEVV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
P +V+L +D + ++ E++ D L +S+YDV R+Y E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
D HS G +HRDVKP N+++D + L+L D+G KE VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212
Query: 298 ELLVDLQD---YDYSLDLWSLGC-MFAGMVSVSPSVLFYVSGL 336
E+L Y D WS+G ++ +V +P FY L
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP---FYADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 52/227 (22%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------------REIKILQN 184
+G G Y +V + + IK +K ++ RE+KI+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 185 LCGGPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIY 235
+ NI+ L+D +V D + + D K+ L++ V+ +
Sbjct: 77 I-KHENIMGLVDVYVEGDFINLVMDIMASDLKKVV------DRKIR---LTESQVKCILL 126
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---------------EFYH 280
++L L+ H MHRD+ P N+ I+ + ++ D+GLA E
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+E +V + +++ PELL+ + Y +++D+WS+GC+FA +++ P
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+DY+VV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
P +V+L +D K ++ E++ D L +S+YDV ++Y E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 299
D HS G++HRDVKP N+++D + L+L D+G + G + V + + PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 300 LVDLQD---YDYSLDLWSLGC-MFAGMVSVSPSVLFYVSGL 336
L Y D WS+G +F +V +P FY L
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP---FYADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-12
Identities = 60/244 (24%), Positives = 115/244 (47%), Gaps = 43/244 (17%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCI-IKILKPVK 171
P +Y D ES ++YEV++K+G G++ EVF H E K I + LK +
Sbjct: 2 PGKYDDGES------RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPT 224
K ++ E+ +++ L NIV+ +D ++ ++ ++ E + D ++
Sbjct: 56 KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114
Query: 225 LSDYDVRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHEQRKL--------- 268
+ ++ + +LL AL YCH+ + ++HRD+KP N+ + R +
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 269 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDLWSLGCMFA 320
++ D+GL++ + V + Y+ PELL+ + + YD D+W+LGC+
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 321 GMVS 324
+ S
Sbjct: 235 ELCS 238
|
Length = 1021 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP 189
YE +R VGRG + V D + IIK + PV ++ + E ++L+ L P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLL-SHP 59
Query: 190 NIV---------KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
NI+ K L IV + + E++ K L + + ++ ++L A
Sbjct: 60 NIIEYYENFLEDKALMIV--MEYAPGGTLAEYIQ----KRCNSLLDEDTILHFFVQILLA 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L + H++ I+HRD+K N+++D + +++ D+G++ K Y V V + + PE
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCYISPE- 171
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSV 325
L + + Y+ D+W+LGC+ + S+
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G VF + ++ IK + K KK+ I EI +++ L PNIV
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+AL++ H+
Sbjct: 80 NFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K NV++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 308 YSLDLWSLGCMFAGMVSVSPSVL 330
+D+WSLG M MV P L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 59/239 (24%), Positives = 111/239 (46%), Gaps = 34/239 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
YE+++K+G G + +++ +D+E C+IK + PVK+K+ ++ IL PNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK--------VLYPTLSDYDVRYYIYELLKALDY 243
V Q++ ++ E+ + D VL+ S+ + + ++ L +
Sbjct: 62 VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 302
H + I+HRD+K N+ + +L D+G+A + E V + Y+ PE+ +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 303 LQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGLGH----SCLNTWFLRTCSIPFFPLN 357
+ Y+ D+WSLGC VL+ + L H + L+ L+ C F P++
Sbjct: 177 -RPYNNKTDIWSLGC-----------VLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 135 DYEVVRKVGRGKYSEVF----EGVHCTDNEKCIIKILKP---VKKKKI----KREIKILQ 183
++E++R +G G Y +VF G H + +K+LK V+K K + E ++L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKA 240
+ P +V L Q LI ++VN + F LY ++ +VR YI E++ A
Sbjct: 60 AVRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPE 298
LD+ H GI++RD+K N+++D E + L D+GL++ + +E + + PE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 299 LLVDLQD-YDYSLDLWSLGC-MFAGMVSVSPSVLFYVSG 335
++ +D ++D WSLG F + SP F V G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASP---FTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 48/196 (24%), Positives = 97/196 (49%), Gaps = 14/196 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
D E V+ +G+G V++ H + +K + +K++ RE+K L++ C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
+VK + S++ E+++ D + + + Y ++LK LDY H+
Sbjct: 60 YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
+ I+HRD+KP N++I+ + ++++ D+G+++ + N V + + PE + +
Sbjct: 118 KRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 305 DYDYSLDLWSLGCMFA 320
Y Y+ D+WSLG
Sbjct: 176 SYSYAADIWSLGLTLL 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 25/194 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
+GRG + EV+ G D K + +K + KK+IK +K + L I +L +V
Sbjct: 2 IGRGGFGEVY-GCRKADTGK--MYAMKCLDKKRIK--MKQGETLALNERI--MLSLVSTG 54
Query: 202 QS----------KTP---SLIFEHVNNTDFKV---LYPTLSDYDVRYYIYELLKALDYCH 245
TP S I + +N D + S+ ++R+Y E++ L++ H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172
Query: 306 YDYSLDLWSLGCMF 319
YD S D +SLGCM
Sbjct: 173 YDSSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNL 185
D++V VGRG + EV + +K++K V + +R+I + N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-------VRYYIYELL 238
P I +L +D L+ E+ D L L+ Y+ ++Y+ EL+
Sbjct: 60 --SPWIPQLQYAFQD--KDNLYLVMEYQPGGD---LLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKG 296
A+ H G +HRD+KP NV+ID ++L D+G A K N + V + +
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 297 PELLVDLQD-----YDYSLDLWSLGCMFAGMV 323
PE+L + Y D WSLG + M+
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (158), Expect = 9e-12
Identities = 45/201 (22%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G K +K LK ++++ E I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+LL + + ++ E++ D + L+ D+ ++ K ++Y S
Sbjct: 64 VRLLGVCTQGEP--LYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 297
+ +HRD+ N ++ E +++ D+GL+ + Y R +A P
Sbjct: 121 KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173
Query: 298 ELLVDLQDYDYSL--DLWSLG 316
E L+D ++ D+WS G
Sbjct: 174 ES---LKDGKFTSKSDVWSFG 191
|
Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 18/164 (10%)
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD----- 229
+++EI+++ L P+I+++L + +L E + L LS Y
Sbjct: 50 LRKEIRLMARL-NHPHIIRMLGAT--CEDSHFNLFVEWMAGGSVSHL---LSKYGAFKEA 103
Query: 230 -VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK 283
+ Y +LL+ L Y H I+HRDVK N++ID ++LR+ D+G A + G+
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ + F PE+L + Y S D+WS+GC+ M + P
Sbjct: 164 FQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 14/184 (7%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
++G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69
Query: 197 IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
+ +I E++ D P ++ + + E+LK LDY HS+ +HRD
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIHRD 126
Query: 254 VKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 312
+K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD D+
Sbjct: 127 IKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADI 184
Query: 313 WSLG 316
WSLG
Sbjct: 185 WSLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
R +G+G + EV C + K ++KK+IK+ E +IL+ + N
Sbjct: 6 RVLGKGGFGEV---CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV----N 58
Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
++++ ++K L+ +N D K +Y P + +Y E+L L+
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
H + ++RD+KP N+++D + +R+ D GLA G+ RV + + PE+L + Q
Sbjct: 119 HRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-Q 176
Query: 305 DYDYSLDLWSLGCMFAGMV 323
Y S D W LGC+ M+
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
Q+D+E+++++G G Y +V++ + E IK++K P + + ++ I+ C N
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 191 IVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCH 245
IV + RD+ + E + +Y LS+ + Y E L+ L Y H
Sbjct: 68 IVAYFGSYLRRDKLW----ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 305 D--YDYSLDLWSLGCMFAGMVSVSPSVL 330
Y+ D+W++G + + P +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD +T S+ EH+ K Y L++ R Y
Sbjct: 54 EIQLLKNLLH-ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y+ PE ++ + Y D+WS+GC M++ P
Sbjct: 172 TPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR----- 177
YE + + +E++ ++G G + +V++ + E + K ++ K +
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYM 57
Query: 178 -EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYI 234
EI+IL C P IVKLL + F D +L L++ ++
Sbjct: 58 VEIEILAT-CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRY 293
++L+AL Y HS I+HRD+K NV++ + ++L D+G+ A+ + + + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 294 FKGPELLV--DLQD--YDYSLDLWSLGCMFAGMVSVSP 327
+ PE+++ ++D YDY D+WSLG M + P
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
LD +V D+ ++ E++ TD V + + + E L+AL++ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQ 304
++HRD+K N+++ + ++L D+G P E + R V + Y+ PE +V +
Sbjct: 135 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE-VVTRK 190
Query: 305 DYDYSLDLWSLGCMFAGMVSVSPSVL 330
Y +D+WSLG M MV P L
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 36/98 (36%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYN 286
DV++Y+ EL ALD+ HS GI++RD+KP N+++D E+ ++L D+GL++ H K Y+
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
Y PE +V+ + + S D WS G + M++
Sbjct: 158 FCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLC 186
++ +E++ ++G G + +V++ + E ++ K + K + EI IL + C
Sbjct: 4 EEFWEIIGELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS-C 59
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYC 244
PNIVKLLD + + + F D +L L++ +R + L+AL+Y
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV-- 301
H I+HRD+K N++ + ++L D+G+ A+ + + + + Y+ PE+++
Sbjct: 120 HENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 302 --DLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ YDY D+WSLG M + P
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 2/95 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
V +Y ++ + + HS I++RD+KP NV++D +Q RL D GLA GK R
Sbjct: 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA 155
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ + PE+L + + Y Y +D +++GC MV+
Sbjct: 156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+ALD+ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 308 YSLDLWSLGCMFAGMVSVSPSVL 330
+D+WSLG M MV P L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 21/192 (10%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD- 200
+GRG + EV+ G D K + +K + KK+IK +K + L I+ L D
Sbjct: 2 IGRGGFGEVY-GCRKADTGK--MYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDC 56
Query: 201 -------QQSKTPS---LIFEHVNNTDFKV---LYPTLSDYDVRYYIYELLKALDYCHSQ 247
TP I + +N D + S+ ++R+Y E++ L++ H++
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
+++RD+KP N+++D E +R+ D GLA + K + V + + PE+L YD
Sbjct: 117 FVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGTAYD 174
Query: 308 YSLDLWSLGCMF 319
S D +SLGCM
Sbjct: 175 SSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKR---------EIKILQNLCGG 188
R +G+G + EV C + K+ K ++KK+IK+ E +IL+ +
Sbjct: 6 RVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NS 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDY 243
+V L + + L+ +N D K +Y P + +Y E+ L+
Sbjct: 60 RFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE +V
Sbjct: 118 LHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE-VVKN 175
Query: 304 QDYDYSLDLWSLGCMFAGMV 323
+ Y +S D W LGC+ M+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLC 186
D+E++ K+G+G + VF+ V D + +K + K+ R E ++L L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKA 240
I++ + D+ +++ E+ N D L P D R++I LL
Sbjct: 57 DSSYIIRYYESFLDKGKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
L + HS+ I+HRD+K N+ +D +++ D G+A+ + N V + Y+ PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 300 LVDLQDYDYSLDLWSLGCM 318
D + Y+ D+W+LG +
Sbjct: 173 CED-KPYNEKSDVWALGVV 190
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 50/204 (24%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGP 189
Q DYE++++VG G Y +V++ + E +KI+K I++EI +++ C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHS 246
NIV ++ + E+ + +Y LS+ + Y E L+ L Y HS
Sbjct: 67 NIVAYFGSYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ ++
Sbjct: 125 KGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 306 --YDYSLDLWSLGCMFAGMVSVSP 327
Y+ D+W++G + + P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-----EIKILQNLCGGP 189
D++V++K+G+G Y V++ +DN+ +K + + +R EI+IL ++ P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHP 59
Query: 190 NIVK----LLDIVR----DQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LD + + + L + L P R +I +LL+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE--QEIWRIFI-QLLRGL 116
Query: 242 DYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
H Q I+HRD+K N+++ ++ K+ D G+++ + + ++ PE+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAPEVW 173
Query: 301 VDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y Y D+WSLGC+ M + +P
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD+ KT ++ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y+ PE ++ + Y D+WSLGC M++ P
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 139 VRKVGRGKYSEVF--EGVHCTDNEKCIIKILKPVKKKKIKREIK----------ILQNLC 186
++ +G+G Y +VF V D K I +K +KK I R K IL+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGK--IFAMKVLKKATIVRNQKDTAHTKAERNILEAV- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYELLKA 240
P IV L I Q LI E+++ + L+ L + +Y+ E+ A
Sbjct: 58 KHPFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLA 112
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L++ H QGI++RD+KP N+++D Q ++L D+GL E H G + + + PE+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
L+ + ++D WSLG + M++ +P
Sbjct: 172 LMR-SGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 49/189 (25%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
+R++G G + V+ ++E IK + K+ I +E++ LQ L PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 79 QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRDVK N+++ E ++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192
Query: 308 YSLDLWSLG 316
+D+WSLG
Sbjct: 193 GKVDVWSLG 201
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 20/153 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+D++V++ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
IV+L +D K ++ E++ D L +S+YD+ R+Y E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
D HS G +HRDVKP N+++D + L+L D+G
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 47/194 (24%), Positives = 100/194 (51%), Gaps = 14/194 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---EIKILQNLCGGPN 190
D +E++ ++G G + +V++ H KI++ +++++ EI IL C PN
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
IV L + + + F +++ ++ L++ +RY ++L+AL++ HS
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH 122
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV----D 302
++HRD+K N+++ + ++L D+G+ A+ ++ + + + Y+ PE++
Sbjct: 123 KVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 303 LQDYDYSLDLWSLG 316
YDY D+WSLG
Sbjct: 182 DNPYDYKADIWSLG 195
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 48/189 (25%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------KIKREIKILQNLCGGPNIV 192
+ ++G G + V+ + NE +K + K+ I +E+K LQ L PN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 85 EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198
Query: 308 YSLDLWSLG 316
+D+WSLG
Sbjct: 199 GKVDVWSLG 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 34/114 (29%), Positives = 63/114 (55%), Gaps = 5/114 (4%)
Query: 212 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271
H+ N D + P + +Y +++ L++ H + I++RD+KP NV++D++ +R+
Sbjct: 83 HIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRIS 139
Query: 272 DWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
D GLA G+ A + F PELL ++YD+S+D ++LG M++
Sbjct: 140 DLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIA 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEK---CIIKILKP---VKKKKI----KREIKILQN 184
++E+++ +G G Y +VF T ++ +K+L+ V+K K + E +L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
+ P +V L Q LI ++V+ + F LY S+ +VR+Y E++ AL
Sbjct: 61 VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 299
++ H GI++RD+K N+++D E + L D+GL+ EF KE + + PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 300 LVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVL 330
+ + ++D WSLG +F + SP L
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 27/198 (13%)
Query: 139 VRKVGRGKYSEVF------EGVHCTDN--EKCIIKILKPVKKKK----IKREIKILQNLC 186
+R +G G + +V EG DN E+ +K LKP +K+EI+IL+NL
Sbjct: 9 IRDLGEGHFGKVELCRYDPEG----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
NIVK I + LI E + + K P ++ Y ++ K +D
Sbjct: 65 H-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPE 298
Y S+ +HRD+ NV+++ E + +++ D+GL + KEY + ++ PE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 299 LLVDLQDYDYSLDLWSLG 316
L+ + Y S D+WS G
Sbjct: 183 CLIQSKFYIAS-DVWSFG 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 46/202 (22%), Positives = 94/202 (46%), Gaps = 24/202 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
Y +R +G+G + E D+ + K L +++ EI IL L PN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN 60
Query: 191 IVKLLDIVRDQQSKTPSL-------IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
I+ + D + + +++ + ++ + V +Y+++++ A+ Y
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF----EEEMVLWYLFQIVSAVSY 116
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 300
H GI+HRD+K N+ + + ++L D+G+++ G EY++ V + Y+ PE L
Sbjct: 117 IHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPE-L 172
Query: 301 VDLQDYDYSLDLWSLGCMFAGM 322
Y++ D+W+LGC+ +
Sbjct: 173 CQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE----IKILQNLCG-- 187
DD+E ++ +GRG + EV +K L+ K + +++E ++ +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 188 -GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
P +VKL +D LI E++ D L T ++ + R+YI E + A+D
Sbjct: 59 DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 244 CHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYH 280
H G +HRD+KP N+++D H ++L D+GL
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIK-----ILQNLCGGPNIVKL 194
+G+G + +V +D +K+L K + KKK + I +L+NL P +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGL 61
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLKALDYCHSQG 248
Q ++ + ++VN + L+ L + R+Y E+ A+ Y HS
Sbjct: 62 H--YSFQTAEKLYFVLDYVNGGE---LFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
I++RD+KP N+++D Q + L D+GL E P + + + + PE+L + YD
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYD 174
Query: 308 YSLDLWSLGCMFAGMVSVSPSVLFY 332
++D W LG + M+ P FY
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP--FY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 37/204 (18%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
+G+G + +V++ V D + I +K + KK+I + ++ + G NI +VR
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRR--IYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51
Query: 202 QSKTPSLI---FEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLK 239
++P ++ F ++D LY ++DY ++YI EL+
Sbjct: 52 LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 298
AL++ H I++RD+KP N+++D + L D+GL++ K N + + PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGM 322
+L+D + Y +D WSLG + M
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 9e-10
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ I+ + + KK+ I EI +++ PNIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+AL++ HS
Sbjct: 81 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 137 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194
Query: 308 YSLDLWSLGCMFAGMVSVSPSVL 330
+D+WSLG M M+ P L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKK----IKREIKILQNLCGGPNIVKLL 195
+G+G + +V H D + +K+L K + KKK I E +L P +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLKALDYCHSQGI 249
Q + + ++VN + L+ L + R+Y E+ AL Y HS I
Sbjct: 63 --YSFQTADKLYFVLDYVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
++RD+KP N+++D Q + L D+GL E K + + + PE+L Q YD
Sbjct: 118 IYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDR 175
Query: 309 SLDLWSLGCMFAGMVSVSPSVLFY 332
++D W LG + M+ P FY
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--FY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 49/189 (25%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
+R++G G + V+ NE IK + K+ I +E+K LQ + PN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 89 EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202
Query: 308 YSLDLWSLG 316
+D+WSLG
Sbjct: 203 GKVDVWSLG 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
DD+E+++ +GRG + EV V E+ ++LK + + E +L N
Sbjct: 1 DDFEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY---DV-RYYIYELLKALD 242
G + L Q L+ ++ D L D D+ R+YI E++ A+
Sbjct: 58 GDCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
H +HRD+KP NV++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 301 VDLQD----YDYSLDLWSLG-CMFAGMVSVSPSVLFYVSGL 336
++D Y D WSLG CM+ + +P FY L
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP---FYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
+Y E+ L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ PE +V + Y +S D W+LGC+ M++
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIA 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRY 293
+LKAL H+QG++HRD+K ++++ H+ R ++L D+G KE R V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ PEL+ L Y +D+WSLG M MV P
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
+D+E+++ +GRG + EV V + +K ++LK + + E +L N
Sbjct: 1 EDFEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALD 242
G + L Q L+ ++ D L D R+Y+ E++ A+D
Sbjct: 58 GDNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
H +HRD+KP N+++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 301 VDLQD----YDYSLDLWSLG-CMFAGMVSVSPSVLFYVSGL 336
++D Y D WSLG CM+ + +P FY L
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETP---FYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 49/203 (24%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKK---IKREIKILQNLCG 187
DD E ++ VG G + V +K++ ++ K+ + E ++L+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
P I++L DQ+ ++ E+V + F L S+ +Y E++ AL+Y
Sbjct: 60 HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS+ I++RD+KP N+++D E ++L D+G A+ + + + Y PE++ +
Sbjct: 118 HSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173
Query: 305 DYDYSLDLWSLGCMFAGMVSVSP 327
++ ++D W+LG + M+ P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 38/204 (18%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
+G+G + +V H + + +K+L K + KKK ++ I +N+ LL V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--------LLKNV- 53
Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLKA 240
K P L+ H + LY L DY R+Y E+ A
Sbjct: 54 ----KHPFLVGLHFSFQTADKLYFVL-DYINGGELFYHLQRERCFLEPRARFYAAEIASA 108
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L Y HS I++RD+KP N+++D Q + L D+GL E + + + PE+
Sbjct: 109 LGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMV 323
L Q YD ++D W LG + M+
Sbjct: 168 L-HKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
Y VR VG+G Y EV H TD ++ +IK L ++K ++E ++L L PN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--------DVRYYIYELLKALD 242
IV R+ L++ + + LY L + V + ++ AL
Sbjct: 61 IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
Y H + I+HRD+K NV + +++ D G+A + + + + Y+ PEL
Sbjct: 117 YLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSV 325
+ + Y+Y D+W+LGC M ++
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATL 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYD 229
++ EI++L+NL IV+ +RD + T S+ E++ K Y L++
Sbjct: 49 NALECEIQLLKNL-QHERIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETV 105
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEY 285
R Y ++L+ ++Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGM 164
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y+ PE ++ + Y D+WS+GC M++ P
Sbjct: 165 KSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 23/198 (11%)
Query: 139 VRKVGRGKYSEVFEGVHCTD------NEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
+R +G G + +V ++C D E +K LK K+EI IL+ L
Sbjct: 9 IRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YH 65
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
NIVK +Q K LI E+V + P L+ + + ++ + + Y HS
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLV 301
Q +HRD+ NV++D++ R +++ D+GLA+ G EY RV ++ E L
Sbjct: 126 QHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLK 183
Query: 302 DLQDYDYSLDLWSLGCMF 319
+ + Y+ D+WS G
Sbjct: 184 ENKFS-YASDVWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLCGG 188
D+E+ +G G + V H E IK LK + K+K+ E IL L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDV-RYYIYELLKAL 241
P IV ++ +D+ + E V + F L +P DV ++Y EL+ A
Sbjct: 78 PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 298
+Y HS+ I++RD+KP N+++D + +++ D+G A+ +V R F PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAK----------KVPDRTFTLCGTPE 180
Query: 299 LL----VDLQDYDYSLDLWSLGCMFAGMVSVSP 327
L + + + ++D W++G + ++ P
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 39/128 (30%), Positives = 65/128 (50%), Gaps = 9/128 (7%)
Query: 204 KTPSLIF---EHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPH 257
+TP +F E VN D +D R+Y E+ AL + H +GI++RD+K
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 258 NVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
NV++DHE +L D+G+ E GK + + + PE+L ++ Y S+D W++G
Sbjct: 126 NVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183
Query: 317 CMFAGMVS 324
+ M+
Sbjct: 184 VLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 28/198 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPN 190
+ E V ++G G V++ +H +K++ + +++I REI+IL+++ PN
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
+VK D+ + ++ E ++ + + L+D ++L + Y H
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 301
+ I+HRD+KP N++I+ + +++ D+G LA+ P N V + + PE +
Sbjct: 187 RHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242
Query: 302 DLQD--YD-YSLDLWSLG 316
DL YD Y+ D+WSLG
Sbjct: 243 DLNHGAYDGYAGDIWSLG 260
|
Length = 353 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
R +G+G + EV C + K ++KK+IK+ E +IL+ + N
Sbjct: 6 RVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV----N 58
Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
++ + ++K L+ +N D K +Y P + +Y EL L+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+ I++RD+KP N+++D ++ +R+ D GLA G+ RV + + PE++ + +
Sbjct: 119 QRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-E 176
Query: 305 DYDYSLDLWSLGCMFAGMV 323
Y +S D W LGC+ M+
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 169 PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
P +K+I RE++I ++ C P IVK D+ S + + E+ +Y +
Sbjct: 40 PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 229 DVRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYH 280
R L LK L Y HS+ I+HRD+KP N+++ + +++L D+G++ E +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVN 157
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
+ ++ PE + + Y + D+WSLG
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLG 190
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYF 294
LKAL + H+QG++HRD+K ++++ + R ++L D+G KE R V + Y+
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE++ L Y +D+WSLG M MV P
Sbjct: 182 MAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 18/106 (16%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-- 288
R+Y E++ L + H +GI++RD+K NV++D E +++ D+G+ KE +
Sbjct: 99 RFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMC------KE-GILGG 150
Query: 289 VASRYFKG------PELLVDLQDYDYSLDLWSLGC-MFAGMVSVSP 327
V + F G PE+L Q Y ++D W+LG ++ + SP
Sbjct: 151 VTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 174 KIKREIKILQNLCGGPNIVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT 224
I E+ I++ PNIV+ L IV D P + EH N+ K
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109
Query: 225 LSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
++ + +++ AL Y H + I+HRD+ P+N+M+ E K+ + D+GLA+ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ V + + PE++ + Y D+W+ GC+ M ++ P
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 19/41 (46%), Positives = 26/41 (63%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++L ALD HS GI+HRDVKP N++ ++ID G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
+L+AL Y H+QG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE++ L Y +D+WSLG M M+ P
Sbjct: 186 APEVISRLP-YGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD + K S+ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE----FYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G ++ G
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y+ PE ++ + Y D+WS+ C M++ P
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 11/113 (9%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVR 288
R+Y+ E++ A+D H G +HRD+KP NV++D + +RL D+G L + NV
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 289 VASRYFKGPELLVDLQD----YDYSLDLWSLG-CMFAGMVSVSPSVLFYVSGL 336
V + + PE+L ++D Y D WSLG CM+ + +P FY L
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP---FYAESL 213
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 48/205 (23%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
Y V+K+G G + + D ++ +IK + P ++++ ++E+ +L N+ PN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 191 IVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
IV+ L IV D +++ +N VL+P + + + ++ AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGD--LYKKINAQR-GVLFP---EDQILDWFVQICLAL 114
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
+ H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE +
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-I 172
Query: 301 VDLQDYDYSLDLWSLGCMFAGMVSV 325
+ + Y+ D+W+LGC+ M ++
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
+G+G Y V+ + + IK + P + + + EI + L NIV+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72
Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYD--VRYYIYELLKALDYCHSQGIMH 251
D ++ + E V L + L D + + +Y ++L+ L Y H I+H
Sbjct: 73 -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 304
RD+K NV+++ +++ D+G ++ + + + F G PE++ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 305 DYDYSLDLWSLGCMFAGMVSVSP 327
Y D+WSLGC M + P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILK----PVKKKKIKREIKILQNL 185
++D + R +G G++ +V++GV+ + + I +K K P ++K +E I++
Sbjct: 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI------------FEHVNNTDFKVLYPTLSDYDVRYY 233
P+IVKL+ ++ + P I + VN + L Y
Sbjct: 65 -DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL-------Y 112
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
Y+L AL Y S+ +HRD+ NV++ ++L D+GL+ + Y
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 294 FK--GPELLVDLQDYDYSLDLWSLG-CMF 319
K PE ++ + + + D+W G CM+
Sbjct: 172 IKWMAPE-SINFRRFTSASDVWMFGVCMW 199
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 17/155 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKP---VKKKKIKR---EIKILQNLC 186
++ ++ +G+G VF V + +K+L +K+ K+KR E +IL L
Sbjct: 1 KHFKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL- 58
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKAL 241
P + L Q L+ ++ + L LS+ R+Y E+L AL
Sbjct: 59 DHPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+Y H GI++RD+KP N+++ HE + L D+ L+
Sbjct: 117 EYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 34/123 (27%), Positives = 60/123 (48%), Gaps = 6/123 (4%)
Query: 209 IFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
+ E+VN D +D R+Y E+ AL + H G+++RD+K N+++D E
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133
Query: 266 RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+L D+G+ E G + + PE+L + +Y S+D W+LG + M++
Sbjct: 134 H-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMA 191
Query: 325 VSP 327
P
Sbjct: 192 GQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 22/193 (11%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIK----ILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
++GRG + EVF G DN +K L P K K +E +IL+ PNIV+L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCHSQGI 249
+ Q + ++ E V DF L R + EL++ ++Y S+
Sbjct: 61 VC--TQKQPIYIVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 306
+HRD+ N ++ E+ L++ D+G++ G ++ + PE L + Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173
Query: 307 DYSLDLWSLGCMF 319
D+WS G +
Sbjct: 174 SSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 13/151 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
DD+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
G +VK+ +D+++ LI E + D L TLS+ ++YI E + A+D
Sbjct: 60 GAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLD-AKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 22/194 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGP 189
+ +R++G G + V+ NE IK + K+ I +E++ LQ P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75
Query: 190 NIVKLLDI-VRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCH 245
N ++ +R+ T L+ E+ + +D +V L + ++ + L+ L Y H
Sbjct: 76 NTIEYKGCYLREH---TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 246 SQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVD 302
S +HRD+K N+++ + KL D+G A P N V + Y+ PE L +D
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMD 187
Query: 303 LQDYDYSLDLWSLG 316
YD +D+WSLG
Sbjct: 188 EGQYDGKVDVWSLG 201
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KK-----IKREIKILQN 184
+D+ V+ +G+G + EV V D K I +K + K KK +K E +L
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
P +V L +D Q LI E + D + Y T S+ R+Y+ E + A+
Sbjct: 58 -SDSPWVVSLYYSFQDAQYLY--LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
+ H G +HRD+KP N++ID ++L D+GL+ +H
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/222 (26%), Positives = 111/222 (50%), Gaps = 31/222 (13%)
Query: 135 DYEVVRKVGRGKYSEVF--EGVHCTDNEKC-IIKILKP---VKKKKI----KREIKILQN 184
++E+++ +G G Y +VF V D+ K +K+LK V+K K + E ++L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS------DYDVRYYIYELL 238
+ P +V L Q LI +++N + L+ LS + +V+ Y E++
Sbjct: 61 IRQSPFLVTLHYAF--QTDTKLHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIV 115
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFK 295
AL++ H GI++RD+K N+++D + L D+GL++ +H + Y+ Y
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYM- 173
Query: 296 GPELLVDLQD-YDYSLDLWSLGC-MFAGMVSVSPSVLFYVSG 335
P+++ +D ++D WS+G M+ + SP F V G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP---FTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286
R+Y ELL AL+ H +++RD+KP N+++D+ Q + L D+GL + + N
Sbjct: 93 SRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTN 151
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ + PELL+ Y ++D W+LG + M++ P
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
R+Y E++ AL+Y HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFC 156
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+ + PE+L D DY ++D W LG + M+
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPT---L 225
+ +RE + L PNIV LLD + P +FE+V + + L
Sbjct: 23 ARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGL 275
+ + ++L AL H+QGI+HRD+KP N+M+ + +++D+G+
Sbjct: 77 PAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
+L+AL Y HSQG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWM 184
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE ++ Y +D+WSLG M MV P
Sbjct: 185 APE-VISRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 69/332 (20%), Positives = 136/332 (40%), Gaps = 59/332 (17%)
Query: 26 AISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATP 85
+++ + +S + S S+S+ G+ R ++ S R + + A
Sbjct: 23 PVNALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSH---EGAAT 79
Query: 86 PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD-----YEVVR 140
+V + P K +V P + + V GE D ++++
Sbjct: 80 TKQATTTPTTNVEVAPPPKKKKV----TYALPNQSREEGHFYVVLGEDIDVSTQRFKILS 135
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQN--LCGGPNIVKLLD 196
+G G + +V E E C +KI++ V K + K EI+ ++ + L+
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 197 IVRDQQSKT-----------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
I R Q++T P L+ D+ + + S + I++ ALDY H
Sbjct: 196 IQRYFQNETGHMCIVMPKYGPCLL-------DWIMKHGPFSHRHLAQIIFQTGVALDYFH 248
Query: 246 SQ-GIMHRDVKPHNVMIDHEQR---------------KLRLIDWGLAEFYHPGKEYNVR- 288
++ +MH D+KP N++++ ++R+ D G E + R
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-----CDERHSRT 303
Query: 289 --VASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
V++R+++ PE+++ L + YS D+WS+GC+
Sbjct: 304 AIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCI 334
|
Length = 467 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 19/136 (13%)
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA--EFYHPGK 283
+ R+Y E++ L + H +GI++RD+K NV++D + +++ D+G+ GK
Sbjct: 94 DEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGK 152
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM-VSVSPSVLFYVSG---LGHS 339
+ + + PE+L Q Y+ S+D WS G + M + SP F+ L S
Sbjct: 153 A-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSP---FHGEDEDELFDS 207
Query: 340 CLNTWFLRTCSIPFFP 355
LN P FP
Sbjct: 208 ILN-------DRPHFP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQN---LCGG 188
+++ +V+ + RG + +V+ G +++ +K++K K + +++ ++ L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
P IV L + Q + L+ E++ D K L +D YI E+ ALDY H
Sbjct: 64 PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
GI+HRD+KP N++I +E ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 30/120 (25%), Positives = 63/120 (52%), Gaps = 6/120 (5%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYDV---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
+ E++N D + +D+ +Y E++ L + HS+GI++RD+K N+++D +
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132
Query: 265 QRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+++ D+G+ + G + + + PE+L+ Q Y+ S+D WS G + M+
Sbjct: 133 GH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
S+ R+Y E++ AL Y HS +++RD+K N+M+D + +++ D+GL E G
Sbjct: 91 VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDG 149
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+ + PE+L D DY ++D W LG + M+
Sbjct: 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK 283
S+ R+Y E++ ALDY HS I++RD+K N+M+D + +++ D+GL E
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAA 150
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+ + PE+L D DY ++D W LG + M+
Sbjct: 151 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 15/103 (14%)
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--Y 285
Y +Y E++ L + HS+GI++RD+K NVM+D + +++ D+G+ KE +
Sbjct: 96 YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMC------KENVF 148
Query: 286 NVRVASRY-----FKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
AS + + PE+L L+ Y +S+D WS G + M+
Sbjct: 149 GDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
R+Y E+ AL Y HS I++RD+KP N+++D Q + L D+GL E
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+ + PE++ Q YD ++D W LG + M+
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 4/101 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
S+ R+Y E++ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 150
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+ + PE+L D DY ++D W LG + M+
Sbjct: 151 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 3/97 (3%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E GK
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCG 163
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ + PE ++ Q Y S+D W+ G + M++ P
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 58/208 (27%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
Y ++ + G EVF CT +K I+K + K REI IL+ +
Sbjct: 94 YNILSSLTPGSEGEVFV---CTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRA 147
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
I+ L+ R + T ++ F + L LL+AL Y H +G
Sbjct: 148 IINLIHAYRWKS--TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG 205
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDL 303
I+HRDVK N+ +D + + L D+G A P + Y + PELL L
Sbjct: 206 IIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA-L 261
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
Y D+WS G + M SV LF
Sbjct: 262 DPYCAKTDIWSAGLVLFEM-SVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
Y V++ + G VF + ++KI +K E +LQN+ P+++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI-------YELLKALDYCHSQG 248
D + ++ H ++ LY L+ I ++L+ L Y H+Q
Sbjct: 124 DTL--VSGAITCMVLPHYSSD----LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 299
I+HRDVK N+ I+ ++ + D G A+F V + F G PE+
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEV 227
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
L Y+ D+WS G + M++ PS +F
Sbjct: 228 LAR-DKYNSKADIWSAGIVLFEMLAY-PSTIF 257
|
Length = 357 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 20/45 (44%), Positives = 31/45 (68%), Gaps = 1/45 (2%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 55/238 (23%), Positives = 106/238 (44%), Gaps = 34/238 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIK--REIKILQNLCGGPNI 191
Y V+R VG G + H ++K +K ++ P ++ R+ +L PNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF--KV------LYPTLSDYDVRYYIYELLKALDY 243
V + + ++ E+ + D K+ L+P D +++++ ++ + +
Sbjct: 61 VAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFP--EDTILQWFV-QMCLGVQH 115
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
H + ++HRD+K N+ + + K++L D+G A PG V + Y+ PE+ +
Sbjct: 116 IHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 303 LQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGLGHSC-LNTW---FLRTCSIPFFPL 356
+ Y+ D+WSLGC +L+ + L H N+W L+ C + PL
Sbjct: 175 MP-YNNKSDIWSLGC-----------ILYELCTLKHPFQANSWKNLILKVCQGSYKPL 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
+ DD+E + ++G G VF+ H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--------KVLYPTLSDYDVRYYIYELLK 239
P IV S+ EH++ ++ L + ++K
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIK 114
Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
L Y + IMHRDVKP N++++ + +++L D+G++ N V +R + PE
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE 172
Query: 299 LLVDLQDYDYSL--DLWSLGCMFAGM 322
LQ YS+ D+WS+G M
Sbjct: 173 ---RLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 54/211 (25%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G V + +H K I +KP + +I RE+K+L C P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59
Query: 190 NIVKL---------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV LD V + + P I ++
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105
Query: 229 DVRYYIYELLKALDYC---HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+L+ L Y H IMHRDVKP N++++ + +++L D+G++
Sbjct: 106 ------IAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA- 155
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
N V +R + PE L Y D+WSLG
Sbjct: 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
Y + +++G+G + V+ + +K+LK + ++ +E ++L L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALD 242
P IVK ++ + + + D K+ TLS+ V + +LL +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
Y H + I+HRD+K N+ + + L++ D+G++ + + Y+ PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 302 DLQDYDYSLDLWSLGCMFAGM 322
Q YD D+WSLGC+ M
Sbjct: 179 H-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 32/200 (16%)
Query: 156 CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
C DN+ C ++K ++ E IL+ + P+I++L +K LI
Sbjct: 111 CIDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLKGTF--TYNKFTCLILPRYK- 166
Query: 216 TDFKVLYPTLSDY------DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
TD LY L+ D+ +L+A+ Y H I+HRD+K N+ I+H +
Sbjct: 167 TD---LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVC 222
Query: 270 LIDWGLAEFYHPGKEYNVRV-ASRYF--------KGPELLVDLQDYDYSLDLWSLGCMFA 320
L D+G A + V + A++Y+ PELL Y ++D+WS G +
Sbjct: 223 LGDFGAA-------CFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLF 274
Query: 321 GMVSVSPSVLFYVSGLGHSC 340
M + S LF GL C
Sbjct: 275 EMATCHDS-LFEKDGLDGDC 293
|
Length = 391 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 27/84 (32%), Positives = 50/84 (59%), Gaps = 5/84 (5%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
++KAL+Y HS+ ++HRDVKP NV+I+ +++L D+G++ + + + +
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 296 GPELL---VDLQDYDYSLDLWSLG 316
PE + ++ + YD D+WSLG
Sbjct: 171 APERINPELNQKGYDVKSDVWSLG 194
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
+D+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
+VK+ +D+ + LI E + D L TL++ + ++YI E + A+D
Sbjct: 60 SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 235 YELLKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
++KAL Y G++HRDVKP N+++D ++L D+G++ K
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 294 FKGPELLVDLQD----YDYSLDLWSLG 316
+ PE + D D YD D+WSLG
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLG 205
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 48/207 (23%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++V+K+G G++ EV+ G + ++ K +K LKP + + E +++ L
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKA 240
+V+L +V + + +I E++ DF KVL P L D+ ++ +
Sbjct: 63 LVRLYAVV--TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
+ Y + +HRD++ NV++ E ++ D+GLA EY R +++ + P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVS 324
E ++ + D+WS G + +V+
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 15/103 (14%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-VA 290
+Y E+ L + H +GI++RD+K NVM+D E +++ D+G+ KE+ V V
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KEHMVDGVT 157
Query: 291 SRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+R F G PE++ Q Y S+D W+ G + M++ P
Sbjct: 158 TRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 26/107 (24%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE---------FYH 280
R Y E + AL+Y H+ GI+HRD+KP N++I ++L D+GL++ Y
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY- 160
Query: 281 PGKEYNVRVASRYFK-----------GPELLVDLQDYDYSLDLWSLG 316
E ++ +R F PE+++ Q Y +D W++G
Sbjct: 161 ---EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/183 (30%), Positives = 84/183 (45%), Gaps = 43/183 (23%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV------------------MIDHEQR 266
+S+ + Y + +LKALDY H G +HR VK ++ MI+H QR
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG---CMFA-G 321
LR++ H +Y+V+V + PE+L +LQ YD D++S+G C A G
Sbjct: 158 -LRVV--------HDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
Query: 322 MVSVS--PSVLFYVSGLGHS--CLNTWFLRTCSIPFFPLNLLIPICGVYASGLGHIFSVS 377
V P+ + L + CL L T +IP L + P SGLG +VS
Sbjct: 207 HVPFKDMPATQMLLEKLNGTVPCL----LDTTTIPAEELTMK-PSRSGANSGLGESTTVS 261
Query: 378 SPK 380
+P+
Sbjct: 262 TPR 264
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 46/174 (26%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-LKPVK---------KKKIKREIKILQNL 185
Y+++R +G+G EV+ + C ++ LK ++ KK+ RE KI +L
Sbjct: 4 YDIIRLIGKGGMGEVYLAY----DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 186 CGGPNIVKLLDIVRDQQS---------------------KTPSLIFEHVNNTDFKVLYPT 224
P IV + I D + SL E T
Sbjct: 60 IH-PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
+++ ++Y HS+G++HRD+KP N+++ + ++DWG A F
Sbjct: 119 F---------HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
+Y ++ L Y H I++RD+K N+++D E +++ D+GL E G +
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFC 162
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCM-FAGMVSVSP 327
+ F PE+L + Y ++D W LG + + +V SP
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 10/129 (7%)
Query: 157 TDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
T +E ++KI K +RE+ ILQ L V + + + L+ E +
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77
Query: 216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLID 272
+S+ + +L + L H + H D+ P N+++D + + L +ID
Sbjct: 78 ET----LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIID 132
Query: 273 WGLAEFYHP 281
W A + P
Sbjct: 133 WEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 20/45 (44%), Positives = 31/45 (68%), Gaps = 1/45 (2%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 4/58 (6%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEY 285
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL + H K Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYY 160
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279
++L L+Y H GI H D+KP N+M+D R +ID+G+A +
Sbjct: 134 DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 50/263 (19%), Positives = 103/263 (39%), Gaps = 56/263 (21%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGV--HCTDNE---KCIIKILKPV----KKKKIKREIKILQ 183
++ ++R++G+G + V+EG+ E + IK + ++ + E +++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64
Query: 184 NL-CGGPNIVKLLDIVRDQQSKTPSLIF--------------EHVNNTDFKVLYPTLSDY 228
C ++V+LL +V Q P+L+ + +
Sbjct: 65 EFNC--HHVVRLLGVVSTGQ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
E+ + Y ++ +HRD+ N M+ E +++ D+G+ ++Y G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVS--P-------SVLFYV 333
+ + V R+ PE L D + D+WS G + M +++ P VL +V
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
Query: 334 SGLGH-----SCLNTW--FLRTC 349
GH +C + +R C
Sbjct: 235 IDGGHLDLPENCPDKLLELMRMC 257
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 30/109 (27%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 281
L+ D+ Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA H
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNID 188
Query: 282 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPS 328
K N R+ ++ PE L D + Y + D+WS G + + ++ S
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFTLGGS 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 34/198 (17%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKKKKIK----REIKILQNLCGGPNIVK 193
K+G G + V G T K I +K LK K I +E I+ +L N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60
Query: 194 LLDIVRDQQSKTPSLIFE-----------HVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
L +V ++ E + L TL DY V ++ +
Sbjct: 61 LYGVVLTHPLM---MVTELAPLGSLLDRLRKDALGH-FLISTLCDYAV-----QIANGMR 111
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPE 298
Y S+ +HRD+ N+++ K+++ D+GL +++ V PE
Sbjct: 112 YLESKRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 299 LLVDLQDYDYSLDLWSLG 316
L + ++ D+W G
Sbjct: 171 SLRTRT-FSHASDVWMFG 187
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI------LKPVKKKKIKREIKILQNLCGGPNIVK 193
K+G+G + +V++GV + + L P K+K +E +IL+ PNIVK
Sbjct: 1 EKIGKGNFGDVYKGVL---KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56
Query: 194 LLDIVRDQQSKTPSLI-FEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCH 245
L+ + +Q P I E V + R + +LL+ ++Y
Sbjct: 57 LIGVCVQKQ---PIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE 110
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLV 301
S+ +HRD+ N ++ E L++ D+G++ G Y V + + PE L
Sbjct: 111 SKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL- 167
Query: 302 DLQDYDYSLDLWSLG 316
+ Y D+WS G
Sbjct: 168 NYGRYTSESDVWSYG 182
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 44/202 (21%), Positives = 84/202 (41%), Gaps = 26/202 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192
+++G G + V +GV+ + K +K LK KK+ RE ++ L P IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59
Query: 193 KLLDIVRDQQSKTPS--LIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+L+ + K L+ E + + D++ +++ + Y S+
Sbjct: 60 RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 248 GIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVD 302
+HRD+ NV++ + Q K+ D+G++ G + Y A R+ + PE ++
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKIS--DFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CIN 171
Query: 303 LQDYDYSLDLWSLGCMFAGMVS 324
+ D+WS G S
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+Y+V Y+++ ALD HS+ +MHRD+K N+ + ++L D+G ++ Y +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 287 VRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
V + + Y+ PEL + + Y D+WSLG +
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVIL 261
|
Length = 478 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
+ DD+E + ++G G V + H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLYPT--LSDYDVRYYIYELLKALDYC 244
P IV S+ EH++ +VL + + + +L+ L Y
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 245 HSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
+ IMHRDVKP N++++ + +++L D+G++ N V +R + PE L
Sbjct: 120 REKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE---RL 174
Query: 304 QDYDYSL--DLWSLG 316
Q YS+ D+WS+G
Sbjct: 175 QGTHYSVQSDIWSMG 189
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKI-LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 200
+G+G Y V+ G+ + ++ L ++E + LQ +K ++IV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 201 ----QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
T S+ E V + + L + Y ++L + Y H+ ++HRD
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127
Query: 254 VKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQDY 306
+K +NVM+ ++LID+G LA G N+ + Y+ PE++ + Y
Sbjct: 128 IKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGY 185
Query: 307 DYSLDLWSLGCMFAGMVSVSP--------SVLFYV 333
D+WS+GC M + P + +FY+
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVR 288
Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA ++Y K N R
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYK--KTTNGR 200
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
+ ++ PE L D + Y + D+WS G +
Sbjct: 201 LPVKWM-APEALFD-RVYTHQSDVWSFGVL 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 13/48 (27%), Positives = 22/48 (45%)
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
+ L AL ++H D+ P N+++D R +ID+ A P
Sbjct: 152 LLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 18/83 (21%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 197 IVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
++ D + +++ E++ D K VL + ++ + + H GI+H D+
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455
Query: 256 PHNVMIDHEQRKLRLIDWGLAEF 278
N ++ + +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
LS+ +V+ I +L++AL+ H I+H D+K NV+ D + ++ L D+GL +
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
Y+ + YF PE + +YD S D W++G
Sbjct: 166 YDGTLD--YFS-PEKIKG-HNYDVSFDWWAVG 193
|
Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 48/228 (21%), Positives = 98/228 (42%), Gaps = 35/228 (15%)
Query: 132 EQDDYEVVRKVGRGKYSEVFE----GVHCTDNE-KCIIKILKPVKKKK----IKREIKIL 182
+D + + +G G + +V + G+ + +K+LK +K + E++++
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFE---HVNNTDF----------------KVLYP 223
+ + NI+ LL + Q ++ E H N DF +
Sbjct: 70 KMIGKHKNIINLLGVC--TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+ D+ + Y++ + +++ S+ +HRD+ NV++ E +++ D+GLA H
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHID 186
Query: 284 EYNVRVASRY---FKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPS 328
Y R + PE L D + Y + D+WS G + + ++ S
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGS 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+GLA H
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 195
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 196 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 3/97 (3%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E G
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCG 163
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ + PE++ Q Y S+D W+ G + M++
Sbjct: 164 TPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 15/89 (16%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF--------YHPGKEYNV 287
+LL A+DY H +GI+HRD+K NV+++ + + L D+G A F +H G V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLG 316
PE+L Y S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349
|
Length = 461 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 35/202 (17%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEK-CI---IKILK----PVKKKKIKREIKILQNLCGG 188
E ++ +G G + V++GV + EK I IK+L+ P K+I E ++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLI---------FEHV-NNTDFKVLYPTLSDYDVRYYIYELL 238
P++V+LL I S LI ++V N+ D + + + ++
Sbjct: 69 PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 294
K + Y + ++HRD+ NV++ + +++ D+GLA+ KEY+ +V ++
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 295 KGPELLVDLQDYDYSLDLWSLG 316
E ++ + Y + D+WS G
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYG 198
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 46/196 (23%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
+D E + +G G V + H +K + K +K+I RE++I+ C P
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CRSP 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD--FKVLYPTLSDYDVRYYIYELLKALDYCHS- 246
IV ++ + + F + D +K P + + +++ L Y ++
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLYNV 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLVD 302
IMHRD+KP N++++ + +++L D+G++ G+ N V + + PE
Sbjct: 123 HRIMHRDIKPSNILVN-SRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE---R 173
Query: 303 LQDYDYSL--DLWSLG 316
+Q Y++ D+WSLG
Sbjct: 174 IQGGKYTVKSDVWSLG 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---------EKCIIKILKPVKKKKIKREIKILQN 184
+D+ +R +G G + V + ++ EK KI+K + + E KIL N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--DVR-YYIYELLKAL 241
P V L +D+ L+ E V +F + DV +Y +++
Sbjct: 87 YINHPFCVNLYGSFKDESYLY--LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+Y S I++RD+KP N+++D + +++ D+G A+ + Y + Y PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVS 334
++ + + D W+LG ++ P FY +
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPP--FYAN 231
|
Length = 340 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 33/205 (16%)
Query: 142 VGRGKYSEVFEGV------HCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
+G G + EV+EG + + +K L+ +KK+ +E ++ N PNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF----------KVLYPTLSDYDVRYYIYELLKAL 241
VKLL + + + +I E + D + P L+ ++ ++ K
Sbjct: 62 VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 293
Y +HRD+ N ++ + R +++ D+GLA + Y + R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCM 318
PE L+D + S D+WS G +
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVL 202
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 43/198 (21%), Positives = 90/198 (45%), Gaps = 30/198 (15%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVKK----KKIKREIKILQNLCGGPNIV 192
R +G+G + V+ G + + C +K L + ++ +E I+++ PN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHS 246
LL I + +P ++ ++ + D + PT+ D + + ++ K ++Y S
Sbjct: 60 SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 300
+ +HRD+ N M+D E +++ D+GLA E+Y ++ ++ L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171
Query: 301 VDLQDYDYSL--DLWSLG 316
LQ ++ D+WS G
Sbjct: 172 ESLQTQKFTTKSDVWSFG 189
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 37/187 (19%)
Query: 161 KCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
KC I K VK +++ EI L L NI+K+ +I+R + + +
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMITQK 244
Query: 216 TDFKVLYPTLSDYDV-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
DF LY + D R + +LL A++Y H + ++HRD+K N+ ++ +
Sbjct: 245 YDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303
Query: 265 QRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDLWSLGC 317
K+ L D+G A + R A Y PE+L Y D+WS G
Sbjct: 304 G-KIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGL 356
Query: 318 MFAGMVS 324
+ M+S
Sbjct: 357 ILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
E+ D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + P
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR------------YYIYEL 237
N+V+LL + + P I T+F + Y L DY Y ++
Sbjct: 63 NLVQLLGVC---TREPPFYII-----TEF-MTYGNLLDYLRECNRQEVNAVVLLYMATQI 113
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---F 294
A++Y + +HRD+ N ++ E +++ D+GL+ G Y +++ +
Sbjct: 114 SSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 171
Query: 295 KGPELLVDLQDYDYSLDLWSLGCM 318
PE L + D+W+ G +
Sbjct: 172 TAPESLA-YNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
L + +R ++ P F+ + ++ + D+ Y++ + ++Y S+ +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFK-----DLVSCAYQVARGMEYLESRRCIHRD 159
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 309
+ NV++ E +++ D+GLA H K N R+ ++ PE L D + Y +
Sbjct: 160 LAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216
Query: 310 LDLWSLGCM 318
D+WS G +
Sbjct: 217 SDVWSFGIL 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 45/208 (21%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++V+K+G G++ EV+ G + + K IK LK + + E +++ L P
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62
Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLK 239
+V+L +V ++ P I E++ N DF K+ L D ++ +
Sbjct: 63 LVRLYAVV----TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA-----QIAE 113
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 296
+ + + +HRD++ N+++ ++ D+GLA EY R +++ +
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVS 324
PE ++ + D+WS G + +V+
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 47/191 (24%), Positives = 87/191 (45%), Gaps = 33/191 (17%)
Query: 164 IKILKPVKKKKI---KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
+K L+ + + +REI+IL++L NIVK + + L+ E++
Sbjct: 38 VKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLP------ 90
Query: 221 LYPTLSDYDVRY-----------YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
Y +L DY ++ Y ++ K ++Y S+ +HRD+ N++++ E R ++
Sbjct: 91 -YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VK 148
Query: 270 LIDWGLAEFYHPGKE-YNVRVASR---YFKGPELLVDLQDYDYSLDLWSLGCMFAGM--- 322
+ D+GL + KE Y VR ++ PE L + + + D+WS G + +
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTY 207
Query: 323 --VSVSPSVLF 331
S SP F
Sbjct: 208 SDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 47/207 (22%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNI 191
++ + RK+G G + EV+EG+ + + IKILK +K++ ++E++ L+ L ++
Sbjct: 7 EFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64
Query: 192 VKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
+ L I+ + K L F + + + +VL P S D+ + E +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAF--LRSPEGQVL-PVASLIDMACQVAE---GMA 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGP 297
Y Q +HRD+ N+++ E ++ D+GLA + Y + ++ ++ P
Sbjct: 119 YLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLS---SDKKIPYKW-TAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVS 324
E + D+WS G + M +
Sbjct: 174 EAA-SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQ 183
+++ + +G G + +V E K +K+LKP +++ + E+KI+
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELL 238
+L NIV LL +I E+ D + L+ D+ + Y++
Sbjct: 94 HLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 295
K + + S+ +HRD+ NV++ H + +++ D+GLA Y V+ +R +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE + + Y + D+WS G
Sbjct: 211 APESIFNCV-YTFESDVWSYG 230
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVASRYF 294
++K L Y S I+HRDVKP N++++ + +++L D+G++ K Y V + +
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTY---VGTNAY 159
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
PE + Q Y D+WSLG F +
Sbjct: 160 MAPERISGEQ-YGIHSDVWSLGISFMELAL 188
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPVKKKKIKREIKILQNLC----GGPNIVK 193
+ +G G++ V EG D+ K +K +K + + E + + +C PN+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 194 LLDI----VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRY-------YIYELLKA 240
L+ + V + +P +I + + D +LY L D ++ ++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK--GP 297
++Y S+ +HRD+ N M++ E + + D+GL++ + G Y R+A K
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E L D + Y D+WS G
Sbjct: 184 ESLAD-RVYTTKSDVWSFG 201
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 11/81 (13%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY------DVRYYIYELLKALD 242
PN+V L + + S +F + + + L+ +S + V+ + E++ ALD
Sbjct: 45 PNMVCLHKYIVSEDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 243 YCHSQGIMHRDVKPHNVMIDH 263
H +GI+ RD+ P+N+++D
Sbjct: 100 ALHREGIVCRDLNPNNILLDD 120
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
++ +++RK+G G++ EV+EG+ + +K LKP + K E +I++ L P
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61
Query: 190 NIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKA 240
+++L + ++ K SL+ E++ + L P L D ++
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
+ Y +Q +HRD+ NV++ E ++ D+GLA Y R +++ + P
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVS 324
E + D+WS G + +V+
Sbjct: 174 E-AALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 45/206 (21%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++++K+G G++ EV+ G N K +K LKP + + E +I++ L
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62
Query: 191 IVKLLDIVRDQ--------QSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKAL 241
+V+L +V ++ SK L F + + + + L P L D ++ +
Sbjct: 63 LVQLYAVVSEEPIYIVTEYMSKGSLLDF--LKDGEGRALKLPNLVDMAA-----QVAAGM 115
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 298
Y +HRD++ N+++ + ++ D+GLA EY R +++ + PE
Sbjct: 116 AYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ + D+WS G + +V+
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 41/193 (21%), Positives = 77/193 (39%), Gaps = 38/193 (19%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--REIKILQNLCGGPNIVKLLDIVR 199
+G+G++ +V G + +K +K LK E ++ L PN+V+LL +V
Sbjct: 14 IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVL 70
Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ 247
++ E++ +L DY + ++ + ++Y +
Sbjct: 71 QGNPLY--IVTEYMAKG-------SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELLVDL 303
+HRD+ NV++ E ++ D+GLA KE + S PE L
Sbjct: 122 NFVHRDLAARNVLVS-EDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEAL-RE 173
Query: 304 QDYDYSLDLWSLG 316
+ + D+WS G
Sbjct: 174 KKFSTKSDVWSFG 186
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLD 196
RK+G G++ EV+ G K +K LKP + + +E +I++ L +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYA 68
Query: 197 IVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKALDYCH 245
+ +++ P I E+++ DF K+ P L D ++ + + Y
Sbjct: 69 VCSEEE---PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA-----QIAEGMAYLE 120
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
S+ +HRD+ N+++ E ++ D+GLA EY R +++
Sbjct: 121 SRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAKF 166
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 25/151 (16%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKP-----------VKKKKIKREIKILQNL--CGG 188
+ RG +E++ G K +IK P +++++ +RE +I+ G
Sbjct: 4 IKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 189 PN-IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
V +D ++ E++ K L + ++ E+ + + HS
Sbjct: 62 NVPAVYFVDPENF------IIVMEYIEGEPLKDLINSNGMEELELS-REIGRLVGKLHSA 114
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
GI+H D+ N+++ K+ LID+GLAEF
Sbjct: 115 GIIHGDLTTSNMILSG--GKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 235 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVAS 291
+KAL+Y + I+HRDVKP N+++D R ++L D+G++
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 292 RYFKGPELLV--DLQDYDYSLDLWSLG 316
R + PE + YD D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 19/82 (23%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
+V D +++ E++ K + +D + E+ + + H GI+H D+
Sbjct: 63 VVYDVDPDNKTIVMEYIEGKPLKDVIEEGNDE----LLREIGRLVGKLHKAGIVHGDLTT 118
Query: 257 HNVMIDHEQRKLRLIDWGLAEF 278
N+++ KL LID+GL ++
Sbjct: 119 SNIIVR--DDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLD 196
KV +G+ + E + T IK LK P +++ ++E +++ +L PNIV LL
Sbjct: 20 KVYKGELTGPNERLSAT---SVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLG 75
Query: 197 IVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDY----------------DVRYYIYEL 237
+ + + ++FE++ + D F V SD D + ++
Sbjct: 76 VC--TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++Y S +HRD+ N ++ E +++ D+GL+ + Y RV S+
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYY--RVQSK 185
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 39/197 (19%), Positives = 85/197 (43%), Gaps = 22/197 (11%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDI 197
+K+G G++ EV+ + + K +K +KP + + E +++ L +VKL +
Sbjct: 12 KKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAV 69
Query: 198 VRDQQSKTPSLIFEHVNNTDF-------KVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 250
V + + + DF K P L D+ ++ + + + + +
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEGMAFIEQRNYI 124
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYD 307
HRD++ N+++ ++ D+GLA EY R +++ + PE ++ +
Sbjct: 125 HRDLRAANILVS-ASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE-AINFGSFT 181
Query: 308 YSLDLWSLGCMFAGMVS 324
D+WS G + +V+
Sbjct: 182 IKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 39/169 (23%), Positives = 74/169 (43%), Gaps = 14/169 (8%)
Query: 172 KKKIKREIKILQNLCGGPNIVKL-LDIVRDQQSKTPSLIFEHVNNTDFKV-------LYP 223
K K R + +K LD + QS S E + +D + LY
Sbjct: 114 KTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYK 173
Query: 224 T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
L+ D+ Y +++ K +++ S+ +HRD+ N+++ E +++ D+GLA +
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKD 232
Query: 283 KEYNVRVASRY---FKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPS 328
+Y + +R + PE + D + Y D+WS G + + S+ S
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGAS 280
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.78 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.62 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.33 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.21 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.86 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.56 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.55 | |
| PLN02236 | 344 | choline kinase | 97.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.36 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.35 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.12 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.06 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.88 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.65 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.62 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.57 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.33 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.08 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.08 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.07 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.02 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.51 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 95.46 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.25 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 95.02 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=371.34 Aligned_cols=194 Identities=31% Similarity=0.585 Sum_probs=177.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|.+.++||+|+||+||+|+++.++..||||.+... ..+-+..|+.+|+.+ +|||||++++++.+.+ +++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~--~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDD--FIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCC--eEE
Confidence 47899999999999999999999999999999998654 235578999999999 9999999999998754 678
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--C---ceEEEEecccceee
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q---RKLRLIDWGLAEFY 279 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~---~~vkl~DFG~a~~~ 279 (387)
||||||+||+|..+++ .+++..++.++.||+.||++||+++||||||||+||||+.. . ..+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999987763 58999999999999999999999999999999999999753 2 36899999999999
Q ss_pred cCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.++....+.+|++.|||||++.. +.|+.|+|+||+|+|||+|++|++||.
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 98888899999999999999976 789999999999999999999999994
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=357.94 Aligned_cols=194 Identities=28% Similarity=0.547 Sum_probs=175.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++++.||+|+||+||+++.+.+++.+|+|++++. ..+...+|..||.++ +||.||+++-.|.+ ...+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt--~~kL 100 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQT--EEKL 100 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEeccc--CCeE
Confidence 47899999999999999999999999999999998743 236678999999998 99999999998855 4568
Q ss_pred eEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee-cCC
Q 016537 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~-~~~ 282 (387)
|||+||+.||.|...+. .+++..++.|+.+|+.||.|||++|||||||||+|||||.++ +++|+|||+++.. ..+
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccCC
Confidence 89999999999987775 599999999999999999999999999999999999999666 9999999999854 444
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
....+.|||+.|||||++.+ ..|+.++|+|||||++|||++|.+||..
T Consensus 180 ~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 55667899999999999998 6899999999999999999999999953
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=369.87 Aligned_cols=211 Identities=33% Similarity=0.636 Sum_probs=191.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.+.|+.+++||+|.||.||+|++..+|+.||+|.+.... ..-..+||.||++| +||||++|.+++.+.....+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 477999999999999999999999999999999986443 24467999999999 999999999999987677899
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
||+|||++.....+.. .+++.+++.|+.|++.||+|+|.+||+|||||.+|||||.++ .+||+|||+|+++....
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCCCC
Confidence 9999999876554443 489999999999999999999999999999999999999666 89999999999876554
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCcccccc
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWF 345 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~ 345 (387)
.++.++-|.||+|||++.|...|+.++|+||.||||.||++|+|.|.. ++...|.|+++.|+
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 578899999999999999999999999999999999999999999965 78899999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=338.55 Aligned_cols=230 Identities=82% Similarity=1.367 Sum_probs=222.7
Q ss_pred CCCcceeeccCCcCCCCccccccccccccCCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHH
Q 016537 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181 (387)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~i 181 (387)
.++.++++.+++..+++++|+++...+.++.+++|++++++|+|.|++||.|..-.++++++||++++.+++.+++|+.|
T Consensus 6 v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikI 85 (338)
T KOG0668|consen 6 VPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKI 85 (338)
T ss_pred cchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHH
Confidence 45677889999999999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred HHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeE
Q 016537 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (387)
Q Consensus 182 l~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl 261 (387)
|+.|++||||+++++++.++....+.|++||+++.++..+.+.++..+++.++.|++.||.|+|++||+|||+||.|++|
T Consensus 86 L~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 86 LQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI 165 (338)
T ss_pred HHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence 99998999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 262 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
|.....++|+|+|+|....++.+++.++.+.+|..||++.+.+.|+..-|+|||||+|..|+..+.||+.
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 9998899999999999999999999999999999999999999999999999999999999999999964
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=333.39 Aligned_cols=228 Identities=34% Similarity=0.644 Sum_probs=193.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~-----~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|..++.||+|.||.||+|++..+|+.||||.++..+. ....+|+..|+.+ +|+||+.++++|.... .+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~--~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKS--NLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCC--ceEE
Confidence 468888999999999999999999999999999975432 4578999999999 9999999999997654 4669
Q ss_pred EEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|+||++. +|...++ -+...+++.|+.++++||+|||++.|+||||||.|+||+.++ .+||+|||+|+.+.+...
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCc
Confidence 9999995 5554543 288999999999999999999999999999999999999777 899999999998865543
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCcccccccccC-----
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFLRTC----- 349 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~~~~----- 349 (387)
.+..+.|.||+|||++.|.+.|+..+|+||.|||+.||+-|.|.|.+ .++.+|+|.+++|+...+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 34458999999999999999999999999999999999999988865 789999999999986442
Q ss_pred ---CCCCCCccccccccccc
Q 016537 350 ---SIPFFPLNLLIPICGVY 366 (387)
Q Consensus 350 ---~~~~~~~~~~~~~~~~~ 366 (387)
..|..+.+.++++++..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d 256 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSD 256 (318)
T ss_pred HHhcCCCCccccccccccHH
Confidence 23444555566665543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=352.61 Aligned_cols=196 Identities=29% Similarity=0.491 Sum_probs=172.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
.+.|.+.+.||+|+||.|-+|..+.+++.||||++.+.+ .....+|++||++| +|||||++++++..++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPD 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCC
Confidence 467899999999999999999999999999999996432 12357999999999 9999999999998765
Q ss_pred CCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccce
Q 016537 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAE 277 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~ 277 (387)
. .||||||++||+|.+.. +.+.+...+.+.+|++.|+.|||++||+||||||+|||+..+ ...+||+|||+|+
T Consensus 250 s--~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 S--SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred c--eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 4 57999999999987664 457888889999999999999999999999999999999644 3479999999999
Q ss_pred eecCCCcccccccccCCCCchhhccc--CCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
....+..+.+.|||+.|.|||++.+. ..+..++|+||+||+||-+|+|.|||..
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 98888888999999999999999652 2355689999999999999999999953
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=363.48 Aligned_cols=192 Identities=24% Similarity=0.514 Sum_probs=175.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.+|+..+.||+|||+.||.+++..+|+.||+|++.+ ...+++.+|++|.+.| +|||||+++++|+|. .++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs--~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDS--NNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecC--CceE
Confidence 679999999999999999999999999999999853 3457889999999999 999999999999875 5688
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
+|+|+|..++|..+++ .++|.+++.+++||+.||.|||+++|+|||||..|++|+.+. +|||+|||+|..+..+ .
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCccc
Confidence 9999999999877764 599999999999999999999999999999999999999665 8999999999988754 5
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+.|||+.|.|||++.. ...++.+||||+||+||-||.|+|||.
T Consensus 174 rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 6678899999999999986 789999999999999999999999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=343.73 Aligned_cols=193 Identities=34% Similarity=0.653 Sum_probs=175.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+.|+.+.++|+|+||.||||+++.+|+.||||.+.... ++-..+|+++|++| +|+|+|.++++|... ..++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrk--rklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRK--RKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhc--ceeEE
Confidence 56888999999999999999999999999999986432 35568999999999 999999999999764 45679
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCCc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~~ 284 (387)
|+|||+..-|..+- ..++...++.++.|++.|++|+|++++|||||||+||||+..+ .+||||||+|+.+. ++..
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcch
Confidence 99999998766554 4589999999999999999999999999999999999999766 89999999999887 8888
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
++.++.|.||+|||++.+...|+..+||||+||++.||++|+|.|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 8999999999999999998899999999999999999999999984
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=340.86 Aligned_cols=211 Identities=29% Similarity=0.516 Sum_probs=189.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchH-----HHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~-----~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|+.+++|++|+||.||+|+++.+++.||+|.++..+.+ .-.+||.+|.++ +|||||.+..++.......+|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceeee
Confidence 6799999999999999999999999999999999865532 357999999998 8999999999998877777999
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
|||||++. |..++ +.+...+++.++.|+++|++|||.+.|+|||||++|+|+.+.+ .+||+|||+|+.+... .
T Consensus 155 VMe~~EhD-Lksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 155 VMEYVEHD-LKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYGSPLK 232 (419)
T ss_pred eHHHHHhh-HHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhhcCCcc
Confidence 99999965 33333 4688999999999999999999999999999999999999777 8999999999987544 5
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCcccccccc
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFLR 347 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~~ 347 (387)
.++..+-|.||+|||++.+...|+.++|+||+|||+.||++++|.|.+ .+..+|+|++..|+..
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 678889999999999999999999999999999999999999999965 7899999999999863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=345.58 Aligned_cols=193 Identities=22% Similarity=0.387 Sum_probs=176.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEec----ccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~----~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++.+.++.||+|..|+|||++++.+++.+|+|.+. +...+++.+|++++++. +|||||+++|.|..... -+.++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence 56778899999999999999999999999999983 44568889999999998 99999999999988654 57799
Q ss_pred EeccCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 210 FEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||||++|+|..+++. +++.....++.++++||.|||+ ++||||||||+|||++..+ .|||||||.++.+... ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-hc
Confidence 999999999988864 9999999999999999999996 9999999999999999766 8999999999887665 55
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.+.+||..|||||.+.+ ..|+.++||||||+.++||.+|+-||..
T Consensus 235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCC
Confidence 78899999999999998 7899999999999999999999999843
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=343.86 Aligned_cols=210 Identities=30% Similarity=0.569 Sum_probs=185.9
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC---CceEEEe
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFE 211 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~---~~~lv~e 211 (387)
.|.-.+++|+|+||.||+|....+++.||||...+..+ --.+|+++|+.+ +|||||+++-+|....+. +..+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 57788999999999999999999999999998765432 335799999988 999999999988754433 7779999
Q ss_pred ccCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 212 HVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 212 ~~~~~~l~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+......+. .+++...++.+..||++||+|||+.||+||||||+|+|+|.+.+.+||||||.|+.+..+...
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 99976544333 468889999999999999999999999999999999999999889999999999999999888
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccccc
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFL 346 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~ 346 (387)
.....|.+|+|||++.|...|+.+.||||.||++.||+-|+|.|.+ ++..+|+|+.++...
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 8899999999999999999999999999999999999999999965 678888888776654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=327.50 Aligned_cols=191 Identities=24% Similarity=0.460 Sum_probs=173.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|+.++.||.|+||.|.+++.+.+|..+|+|+++..+ .+...+|..+|+.+ .||+++++++.+.+. ..+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~--~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDN--SNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccC--CeE
Confidence 378999999999999999999999999999999997543 25567899999999 899999999988664 568
Q ss_pred eEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+|||||++||.+..+++ ++++..++.|+.||+.||+|||+++|++|||||+|||||.++ .+||+|||+|+.....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc-
Confidence 89999999999877764 599999999999999999999999999999999999999777 8999999999987544
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+.|||+.|+|||++.. ++|+.++|+|||||++|||+.|.+||.
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 567899999999999988 889999999999999999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=336.01 Aligned_cols=194 Identities=27% Similarity=0.559 Sum_probs=171.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~-----~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.+|+++++||+|+||+||++.+..+|..+|.|.+. ...+..+..|+.+|++| +|||||++++.-...+...+++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHH
Confidence 56899999999999999999999999999999875 23346678999999999 9999999999444444556789
Q ss_pred EEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH--cC--ceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~--~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
|||+|.+|+|..++ +.+++..++++..|++.||..+|. .+ |+||||||.||+|+..+ .|||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhHh
Confidence 99999999998775 348999999999999999999999 45 99999999999999666 89999999999
Q ss_pred eecCCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+..... ....+|||+||+||.+.+ .+|+++|||||+||++|||+.-++||.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 8876543 355799999999999988 789999999999999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=351.74 Aligned_cols=212 Identities=29% Similarity=0.564 Sum_probs=188.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch--HH--HHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KK--IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~--~~--~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|.++++||.|.||.||+|+.+.+++.||||.++.... ++ -.+|+..|++|..||||+++.+++.+.+. .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence 3789999999999999999999999999999999875432 22 36899999999449999999999988754 7899
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||||+....+.+. +.+++..++.|+.||++||+|+|.+|+.||||||+|||+.... .+||+|||+|+.+.....+
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSKPPY 166 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccccCCCc
Confidence 99999965443332 3499999999999999999999999999999999999998444 8999999999999999999
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccccc
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFL 346 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~ 346 (387)
+.++.|+||+|||++.....|+.++|+||+|||++|+.+-+|.|.+ +..++|+|....|+.
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 9999999999999998778899999999999999999999999976 678999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=348.36 Aligned_cols=194 Identities=32% Similarity=0.575 Sum_probs=172.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
..+|.+.+.||.|+|++|++|+++.+++.||||++.+ .+.+-+.+|-.+|.+|.+||.|++|+-.|.|+ ..+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--ESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--cce
Confidence 4789999999999999999999999999999999853 33456778999999999999999999998664 567
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
|+|+||+++|+|..++ ..+.+..++.|+.||+.||+|||++|||||||||+|||||.|+ ++||+|||.|+.+.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhh
Confidence 8999999999987766 4589999999999999999999999999999999999999777 89999999998875432
Q ss_pred c--------------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 E--------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~--------------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ...++||..|.+||++.+ +..++.+|+|+||||||+|+.|.|||.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFr 288 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFR 288 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCc
Confidence 1 144799999999999977 789999999999999999999999994
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.61 Aligned_cols=194 Identities=30% Similarity=0.508 Sum_probs=170.0
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
..++|+++++||+|+||.||+|+.+.+|..+|+|++++. ..+..+.|-.+|... ++|+||+++..|.+ ..+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD--~~~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD--KEY 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC--CCe
Confidence 358999999999999999999999999999999999753 236678899999996 99999999998855 567
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~- 281 (387)
+||||||++||++..++ ..+++..++.|+.+++.|++.||+.|+|||||||+|+|||..| ++||+|||+++.+..
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKK 294 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhh
Confidence 88999999999988776 4599999999999999999999999999999999999999777 999999999853311
Q ss_pred ----------------------CCc-----c--------------------cccccccCCCCchhhcccCCCCCccchhh
Q 016537 282 ----------------------GKE-----Y--------------------NVRVASRYFKGPELLVDLQDYDYSLDLWS 314 (387)
Q Consensus 282 ----------------------~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~sDvwS 314 (387)
+.. . ...+|||-|+|||++.+ +.|+..+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence 000 0 01369999999999999 77999999999
Q ss_pred HHHHHHHHHhcCCchh
Q 016537 315 LGCMFAGMVSVSPSVL 330 (387)
Q Consensus 315 lGvil~elltg~~pf~ 330 (387)
||||+||||.|.|||.
T Consensus 374 LG~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFC 389 (550)
T ss_pred HHHHHHHHHhCCCCCC
Confidence 9999999999999994
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=349.40 Aligned_cols=195 Identities=25% Similarity=0.432 Sum_probs=176.5
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
..++|.++++||+|+||+|+++..+.+++.+|||++++. ..+..+.|.+|+....+||.+++++..|.. ..+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CCe
Confidence 358999999999999999999999999999999999753 236678899999988789999999999855 456
Q ss_pred ceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CC
Q 016537 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~ 282 (387)
+++||||+.||++..+. +.+++..++.|+.+++.||.|||++||||||||.+|||||.+| ++||+|||+++... .+
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCC
Confidence 88999999999965554 4599999999999999999999999999999999999999888 89999999998754 55
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+.|||+.|||||++.+ +.|+.++|+|||||+|||||.|++||.
T Consensus 523 ~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 66788999999999999988 889999999999999999999999994
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=327.17 Aligned_cols=212 Identities=31% Similarity=0.595 Sum_probs=184.0
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD---QQ 202 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~---~~ 202 (387)
.....|..++.||+|+||.|..|.++.+|+.||||.+.. ...++..+|+.+|+++ +|+||+.+++++.. ..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccc
Confidence 445677778999999999999999999999999998862 2347788999999999 89999999999876 33
Q ss_pred CCCceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
...+|+|+|+|+ .+|..+++ .+.+..++.+++|++.||.|+|+.+|+||||||.|+|++.+. .+||||||+|+..
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYL 175 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEeccccceeec
Confidence 456789999995 56666653 288999999999999999999999999999999999999777 7899999999988
Q ss_pred cC---CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCcccccc
Q 016537 280 HP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWF 345 (387)
Q Consensus 280 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~ 345 (387)
.. ...++..+.|.||+|||++.....|+.+.||||+||||.||++|+|.|.+ ....+|+|....+.
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 64 55668899999999999999889999999999999999999999999976 45677777666554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=324.56 Aligned_cols=213 Identities=31% Similarity=0.568 Sum_probs=184.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch-----HHHHHHHHHHHHhcCCCC-eeEEEEEEEcCC----C
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPN-IVKLLDIVRDQQ----S 203 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~-----~~~~~E~~il~~l~~hpn-iv~l~~~~~~~~----~ 203 (387)
..|+.+++||+|+||+||+|+.+.+|+.||+|.++-... ....+|+.+|++| +|+| |+++++++.+.. .
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccccc
Confidence 457778889999999999999999999999999875433 4468999999999 9999 999999997643 2
Q ss_pred CCceEEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
..+++|+||++. +|...+. .++...++.+++||+.||+|||+++|+||||||+||||+.++ .+||+|||+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchH
Confidence 367899999985 4443332 366678999999999999999999999999999999999766 8999999999
Q ss_pred eeec-CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccccc
Q 016537 277 EFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFL 346 (387)
Q Consensus 277 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~ 346 (387)
+... +...++..++|.+|+|||++.+...|+..+||||+|||++||+++++.|.. .+..+|+|.++.|+.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8776 556678889999999999999987899999999999999999999999964 789999999999997
Q ss_pred ccC
Q 016537 347 RTC 349 (387)
Q Consensus 347 ~~~ 349 (387)
...
T Consensus 248 v~~ 250 (323)
T KOG0594|consen 248 VSS 250 (323)
T ss_pred ccc
Confidence 553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=331.61 Aligned_cols=194 Identities=22% Similarity=0.392 Sum_probs=167.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeE-EEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK-CIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++..+.+.||+|+||+||+|.+. |+. ||||++.... .+.|.+|+.+|.++ +|||||+++|+|.++.. ..+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ceE
Confidence 34445666999999999999983 455 9999997543 45899999999999 99999999999987542 467
Q ss_pred EEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-ceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~-ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
+||||+++|+|..++ ..++...+..++.||+.||+|||+++ ||||||||+|||++.+..++||||||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999998776 35889999999999999999999999 999999999999996655899999999988765
Q ss_pred C-CcccccccccCCCCchhhcc-cCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 282 G-KEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 282 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
. ...+...||..|||||++.+ ...|+.|+||||||++||||+||+.||..
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 4 34455789999999999985 26799999999999999999999999954
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=338.12 Aligned_cols=192 Identities=30% Similarity=0.556 Sum_probs=171.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~-----~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|-+.+.||+|+||.||||+.+.+.+.||+|.+.+..+ +.+.+|++|++.| +||||+.+++.|+.. ..+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~--~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETS--AHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhccc--ceEEE
Confidence 568888999999999999999999999999999976544 3478999999999 999999999999764 45779
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|.||+.+ +|..++ ..++++.++.++.++..||.|||+++|+|||+||.|||++..+ .+|+||||+|+.+..+...
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCcee
Confidence 9999998 777666 4599999999999999999999999999999999999999655 8999999999987665443
Q ss_pred -cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 286 -~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+...||+.|||||++.+ +.|+..+|+||+|||||||++|+|||+.
T Consensus 157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 44579999999999987 8999999999999999999999999953
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=330.63 Aligned_cols=197 Identities=30% Similarity=0.509 Sum_probs=174.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.+.|++.+.||+|+||.|+.|.+..+++.||+|++... ..+.+.+|+.+++++..||||+++++++.....
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~- 94 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK- 94 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe-
Confidence 47899999999999999999999999999999987643 234667899999999449999999999987644
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee-c
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-H 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~-~ 280 (387)
.++||||+.+|+|...+ .++.+.+++.+.+|++.|++|||++||+||||||+|||++.+.+++||+|||++... .
T Consensus 95 -~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 95 -IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred -EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 78999999999887665 468999999999999999999999999999999999999977358999999999988 4
Q ss_pred CCCcccccccccCCCCchhhcccCCC-CCccchhhHHHHHHHHHhcCCchhh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDY-DYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.+....+.+||+.|+|||++.+...| +.++||||+||+||.|++|..||..
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 66778899999999999999884425 5899999999999999999999953
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=324.99 Aligned_cols=197 Identities=29% Similarity=0.549 Sum_probs=172.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------------hHHHHHHHHHHHHhcCCCCeeEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNIVKLL 195 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------------~~~~~~E~~il~~l~~hpniv~l~ 195 (387)
.++|++.+.||+|.||.|-+|++..+++.||||++.+.. .++..+||.||+++ +|||||+|+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence 488999999999999999999999999999999985321 14678999999999 999999999
Q ss_pred EEEEcCCCCCceEEEeccCCCchhhhcC--C-CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEe
Q 016537 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYP--T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~-~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
.+..++....+|||+|||..|.+...-. . +.+.+++.|+++++.||+|||.+|||||||||+|+||+.++ +|||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeec
Confidence 9999999999999999999998765542 2 78999999999999999999999999999999999999776 899999
Q ss_pred cccceeecCC------CcccccccccCCCCchhhccc---CCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 273 WGLAEFYHPG------KEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 273 FG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
||.+.....+ ......+||+.|+|||...+. ...+.+.||||+||+||.|+.|+-||..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 9999766222 223446899999999998762 2357889999999999999999999954
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=322.18 Aligned_cols=197 Identities=25% Similarity=0.448 Sum_probs=167.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++...+.||+|+||.||++.+..+|+..|||.+...+ .+.+.+|+.+|.+| +|||||+++|..........++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence 45778899999999999999998889999999986554 45689999999999 699999999974443323577999
Q ss_pred eccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC----C
Q 016537 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP----G 282 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~----~ 282 (387)
||+.+|++..++. .+++..++.+++||++||+|||++|||||||||+|||++..++.+||+|||+++.... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999988764 4899999999999999999999999999999999999997444899999999987663 1
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.......||+.|||||++.+....++++|||||||++.||+||++||..
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 2234578999999999998522334599999999999999999999853
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=324.89 Aligned_cols=196 Identities=24% Similarity=0.465 Sum_probs=174.7
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~---~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.....|....+||+|+.|.||.|....+++.||||.+.. ..++-+.+|+.+|+.+ +|+|||++++.|...+ .+.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~d--eLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGD--ELW 346 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccc--eeE
Confidence 345678899999999999999999999999999999863 3346678999999999 9999999999776553 356
Q ss_pred EEEeccCCCchhhhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 208 LIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
.|||||++|+|-++... ++|.++..++++++.||+|||.+||+|||||.+|||++.++ .+||+|||++..+.... .
T Consensus 347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCc
Confidence 99999999999877743 88999999999999999999999999999999999999777 79999999998877665 4
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
..+.+||++|||||++.. +.|++++||||||++++||+-|+|||+.
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC
Confidence 567899999999999876 8899999999999999999999999963
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=320.34 Aligned_cols=192 Identities=28% Similarity=0.463 Sum_probs=166.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||+||+|.++.+++.||+|++.... ...+.+|+.++.++ +|+||+++++.+.+. ...+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~--~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDK--LNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--CeEE
Confidence 47899999999999999999998899999999986422 24577899999999 999999999998764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccc
Confidence 999999999987765 3588999999999999999999999999999999999999666 89999999987543211
Q ss_pred -----------------------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCc
Q 016537 284 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPS 328 (387)
Q Consensus 284 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~p 328 (387)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0123579999999999977 6799999999999999999999999
Q ss_pred hh
Q 016537 329 VL 330 (387)
Q Consensus 329 f~ 330 (387)
|.
T Consensus 236 f~ 237 (363)
T cd05628 236 FC 237 (363)
T ss_pred CC
Confidence 94
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=319.95 Aligned_cols=194 Identities=22% Similarity=0.379 Sum_probs=167.8
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++++|.-.+.||+|+||.||+|.. .+++.||||.+.... .++|.+|++++.++ +|||+|+|+|||.+... ..+
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~-~~~ 148 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEGGE-HRL 148 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecCCc-eEE
Confidence 3458899999999999999999998 555999999987644 56799999999999 89999999999987653 467
Q ss_pred EEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---ceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
||+|||.+|+|.+.+. .++|..+.+|+.++|+||+|||+.. |||||||++|||||.+. .+||+|||+|+..
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKLG 227 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCcccC
Confidence 9999999999987762 5689999999999999999999854 99999999999999555 8999999999765
Q ss_pred cC-CCccccc-ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 280 HP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 280 ~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
.. ....... .||..|+|||.+.. +..+.++|||||||+|.||+||+++.
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~ 278 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAV 278 (361)
T ss_pred CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCccc
Confidence 54 3333333 89999999999876 67999999999999999999999876
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.18 Aligned_cols=204 Identities=29% Similarity=0.526 Sum_probs=171.8
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch--HHHHHHHHHHHHhcCC-----CCeeEEEEEEEcCCCCCce
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGG-----PNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~--~~~~~E~~il~~l~~h-----pniv~l~~~~~~~~~~~~~ 207 (387)
+|++++.||+|+||+|.+|.+..+++.||||+++.... .+...|+.+|..|..| -|+|+++++|... .++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--NHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--ccee
Confidence 78999999999999999999999999999999986543 5667899999999534 4899999999764 4577
Q ss_pred EEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC-CceEEEEecccceeecC
Q 016537 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~~~ 281 (387)
||+|.+.. +|.++++ .++...++.++.||+.||.+||+.+|||+||||+||||.+. ...|||+|||.|.....
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 99999884 4554542 48899999999999999999999999999999999999643 23799999999987543
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccc
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTW 344 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~ 344 (387)
.. .+.+.+.+|+|||++.| ..|+.+.||||||||++||++|.|.|.+ +...+|-|....+
T Consensus 344 ~v--ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 344 RV--YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cc--eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 32 38899999999999999 7899999999999999999999998854 4556665544333
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.47 Aligned_cols=193 Identities=23% Similarity=0.454 Sum_probs=175.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+-|++.+.||.|+-|.|.+|++..+|+.+|||++... ....+++|+-+|+-+ .|||++++++++++. ..+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~--~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENK--QHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccC--ceEE
Confidence 5578899999999999999999999999999998643 236789999999988 999999999999764 5678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+|+||+++|.|.+.+ +.+++.++.++++||+.|+.|+|..+|+||||||+|+|||..+ ++||+|||+|..-.++.-
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCcc
Confidence 999999999887665 5699999999999999999999999999999999999999777 599999999998888888
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+.||++.|.|||++.|...-+.++||||+|||||.||||+.||-
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 8999999999999999996666899999999999999999999993
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=306.73 Aligned_cols=194 Identities=25% Similarity=0.427 Sum_probs=170.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++..+||.|..++||+|+...+++.||||++.-+ ..+.+.+|+..+..+ +||||++++..|.... .+++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~--~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDS--ELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecc--eeEE
Confidence 47899999999999999999999999999999998632 246788999999987 9999999999998754 4679
Q ss_pred EEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
||.||.+|++.++++ .+.|..+..+++++++||.|||++|.||||||+.||||+.+| .|||+|||.+..+...+
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLFDSG 180 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeeeeecccC
Confidence 999999999877763 488999999999999999999999999999999999999777 89999999875554332
Q ss_pred -cc----cccccccCCCCchh-hcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EY----NVRVASRYFKGPEL-LVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~----~~~~gt~~y~aPE~-~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .+.+|+++|||||+ +.....|+.|+||||||++..||.+|+.||.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 22 45699999999999 5556789999999999999999999999994
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.22 Aligned_cols=192 Identities=27% Similarity=0.468 Sum_probs=164.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|.++.+++.||||++... ..+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDA--QYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CeeE
Confidence 4789999999999999999999999999999998532 225678899999998 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+++++|..++ +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence 999999999987765 3478999999999999999999999999999999999999666 899999999864321000
Q ss_pred ------------------------------------------------ccccccccCCCCchhhcccCCCCCccchhhHH
Q 016537 285 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316 (387)
Q Consensus 285 ------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG 316 (387)
....+||+.|+|||++.+ ..++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG 235 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence 012468999999999877 6799999999999
Q ss_pred HHHHHHHhcCCchh
Q 016537 317 CMFAGMVSVSPSVL 330 (387)
Q Consensus 317 vil~elltg~~pf~ 330 (387)
|+||||++|.+||.
T Consensus 236 vil~elltG~~Pf~ 249 (377)
T cd05629 236 AIMFECLIGWPPFC 249 (377)
T ss_pred hhhhhhhcCCCCCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.68 Aligned_cols=191 Identities=25% Similarity=0.451 Sum_probs=164.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.|++++.||+|+||+||+|++..+++.||+|++... ....+.+|+++++++ +||||+++++++.+. ...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~--~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecC--CEEEE
Confidence 588999999999999999999999999999998642 234578899999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
||||+++++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccc
Confidence 99999999987765 3478899999999999999999999999999999999999666 89999999975331000
Q ss_pred ----------------------------------------------cccccccccCCCCchhhcccCCCCCccchhhHHH
Q 016537 284 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317 (387)
Q Consensus 284 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGv 317 (387)
.....+||..|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence 0123479999999999877 67999999999999
Q ss_pred HHHHHHhcCCchh
Q 016537 318 MFAGMVSVSPSVL 330 (387)
Q Consensus 318 il~elltg~~pf~ 330 (387)
++|||++|.+||.
T Consensus 237 il~elltG~~Pf~ 249 (381)
T cd05626 237 ILFEMLVGQPPFL 249 (381)
T ss_pred HHHHHHhCCCCCc
Confidence 9999999999994
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.10 Aligned_cols=192 Identities=28% Similarity=0.488 Sum_probs=166.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDE--NYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC--CeEE
Confidence 4789999999999999999999999999999998642 124567899999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccc
Confidence 999999999997765 3488999999999999999999999999999999999999666 899999999876432110
Q ss_pred ---------------------------------------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhc
Q 016537 285 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSV 325 (387)
Q Consensus 285 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg 325 (387)
....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence 012468999999999876 6799999999999999999999
Q ss_pred CCchh
Q 016537 326 SPSVL 330 (387)
Q Consensus 326 ~~pf~ 330 (387)
.+||.
T Consensus 236 ~~Pf~ 240 (364)
T cd05599 236 YPPFC 240 (364)
T ss_pred CCCCC
Confidence 99984
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=303.15 Aligned_cols=191 Identities=24% Similarity=0.420 Sum_probs=167.1
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+|+.+++++ +|+||+++++++.+. ...++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~--~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETK--DALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccC--CeEEE
Confidence 3788999999999999999999999999999886422 23567899999999 999999999998764 35789
Q ss_pred EEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
||||+++++|...+ ..+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCC
Confidence 99999999986543 2478889999999999999999999999999999999999666 79999999998765554
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 4556689999999999987 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=306.07 Aligned_cols=197 Identities=30% Similarity=0.592 Sum_probs=167.2
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+..++|++.+.||+|+||.||+|.++.+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 78 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTK--ETL 78 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecC--CeE
Confidence 45689999999999999999999998899999999986432 24577899999999 999999999998764 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~- 282 (387)
++||||+.++.+..+. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCC
Confidence 8999999865444333 3478899999999999999999999999999999999999666 7999999999754322
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.......+++.|+|||++.+...++.++|||||||++|||++|.+||..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2334467889999999987656789999999999999999999999953
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=320.31 Aligned_cols=198 Identities=31% Similarity=0.531 Sum_probs=167.3
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------CCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------QSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~------~~~~ 205 (387)
...+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.+ +||||+++++++... ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence 3578999999999999999999998899999999885432 3456799999999 999999999977532 1235
Q ss_pred ceEEEeccCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 206 PSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
+++||||++++....+ ...+++..++.++.||+.||+|||+++|+||||||+|||++.++..+||+|||+|+.+
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 6789999997543322 1348889999999999999999999999999999999999866657999999999877
Q ss_pred cCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
..+......+|++.|+|||++.+...|+.++|||||||+||||++|.+||..
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 6555555678899999999987756799999999999999999999999953
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=317.72 Aligned_cols=191 Identities=25% Similarity=0.438 Sum_probs=164.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.|++++.||+|+||.||+|++..+++.||+|++.... ...+.+|+.+++++ +||||+++++.+.+. ...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~--~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDK--DNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeC--CEEEE
Confidence 5889999999999999999999999999999986432 24678899999999 999999999999764 46789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
|||||++|+|..++ ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCccccccccc
Confidence 99999999987765 3478899999999999999999999999999999999999666 89999999975321000
Q ss_pred ----------------------------------------------cccccccccCCCCchhhcccCCCCCccchhhHHH
Q 016537 284 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317 (387)
Q Consensus 284 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGv 317 (387)
.....+||+.|+|||++.+ ..|+.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechH
Confidence 0112468999999999877 67999999999999
Q ss_pred HHHHHHhcCCchh
Q 016537 318 MFAGMVSVSPSVL 330 (387)
Q Consensus 318 il~elltg~~pf~ 330 (387)
+||||++|++||.
T Consensus 237 il~elltG~~Pf~ 249 (382)
T cd05625 237 ILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999995
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=309.55 Aligned_cols=190 Identities=23% Similarity=0.429 Sum_probs=167.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.++.+++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 94 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDE--NRVY 94 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcC--CEEE
Confidence 7899999999999999999999999999999998643 235678999999999 999999999998764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC--
Confidence 999999999987665 3478899999999999999999999999999999999999666 8999999999876432
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|++.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 172 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCC
Confidence 234578999999999877 678999999999999999999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=321.78 Aligned_cols=197 Identities=25% Similarity=0.468 Sum_probs=175.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----CC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~~ 204 (387)
...+...+.||+|+||.||+|+++.+|+.||||.+++ ...+...+|+++|++| +|+|||+++++-++.. ..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccc
Confidence 3456677889999999999999999999999999875 2346778999999999 7999999999877665 56
Q ss_pred CceEEEeccCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc--CCCc-eEEEEeccc
Q 016537 205 TPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQR-KLRLIDWGL 275 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~-~vkl~DFG~ 275 (387)
...++||||.+|+|...++. +++.+.+.++.++..||.|||++|||||||||.||++- .++. .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 67899999999999888743 89999999999999999999999999999999999983 2222 469999999
Q ss_pred ceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 276 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+.++++...+..+||+.|++||++...+.|+..+|.|||||++|+..||.-||.
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9999999888999999999999999754789999999999999999999999994
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=302.13 Aligned_cols=211 Identities=30% Similarity=0.599 Sum_probs=173.8
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+..++|++.+.||.|+||.||+|.+..+++.||+|.++.. ....+.+|+++++++ +||||+++++++.+. ...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 78 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTE--RCL 78 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCC--CeE
Confidence 3457899999999999999999999889999999998632 234678999999999 999999999998654 467
Q ss_pred eEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+++ ++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCC
Confidence 899999986 555443 2368889999999999999999999999999999999999666 7999999999765322
Q ss_pred -CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccccc
Q 016537 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFL 346 (387)
Q Consensus 283 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~ 346 (387)
.......++..|+|||++.+...++.++|||||||++|||++|++||.. .....+.+....|+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2234457889999999987656789999999999999999999999843 223445555555654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.76 Aligned_cols=192 Identities=26% Similarity=0.439 Sum_probs=164.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.+|++++.||+|+||.||+|++..+++.||+|++... ....+.+|+++++++ +|+||+++++.+.+. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CEEE
Confidence 3689999999999999999999999999999998632 235678899999999 999999999998764 4678
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC--
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-- 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-- 282 (387)
+||||+++++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccc
Confidence 9999999999987753 478888999999999999999999999999999999999666 8999999997532100
Q ss_pred ------------------------------------------CcccccccccCCCCchhhcccCCCCCccchhhHHHHHH
Q 016537 283 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320 (387)
Q Consensus 283 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ 320 (387)
......+||+.|+|||++.+ ..++.++|||||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily 235 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence 00113478999999999877 67899999999999999
Q ss_pred HHHhcCCchh
Q 016537 321 GMVSVSPSVL 330 (387)
Q Consensus 321 elltg~~pf~ 330 (387)
||++|++||.
T Consensus 236 ell~G~~Pf~ 245 (376)
T cd05598 236 EMLVGQPPFL 245 (376)
T ss_pred ehhhCCCCCC
Confidence 9999999994
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=305.10 Aligned_cols=190 Identities=24% Similarity=0.437 Sum_probs=166.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.++.+++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQ--RFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccC--CeEE
Confidence 4689999999999999999999889999999998632 234578899999999 999999999988654 4678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|..++ +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC--
Confidence 999999999987665 3478899999999999999999999999999999999999666 8999999999865432
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+|++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 234578999999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=310.05 Aligned_cols=190 Identities=32% Similarity=0.553 Sum_probs=167.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+|++++..+ +||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDD--EYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcC--CEEE
Confidence 4689999999999999999999889999999998643 235678899999999 899999999998764 4578
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--c
Confidence 9999999999987763 478999999999999999999999999999999999999666 899999999976543 3
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+|++.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC
Confidence 345679999999999887 589999999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=314.00 Aligned_cols=190 Identities=21% Similarity=0.409 Sum_probs=163.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
..++++++||+|.||.||.|.+ .....||+|.++.. ..+.|.+|+++|++| +|+|||+++++|..+. .++||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~--piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQE--PIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecCC--ceEEEEE
Confidence 3456789999999999999999 45568999999863 457899999999999 9999999999998754 5789999
Q ss_pred ccCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
||..|+|.++++. +...+...++.||++|++||+++++|||||.+.|||++++. .+||+|||+|+.. .++.++
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~-~d~~Y~ 359 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARLI-GDDEYT 359 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEccccccccc-CCCcee
Confidence 9999999888753 77788899999999999999999999999999999999666 8999999999944 344444
Q ss_pred ccccc---cCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 VRVAS---RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 ~~~gt---~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...|. ..|.|||.+.. ..++.|||||||||+||||+| |+.||.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCC
Confidence 44443 45999999876 789999999999999999999 777774
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=314.05 Aligned_cols=194 Identities=27% Similarity=0.438 Sum_probs=167.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|.++.+++.+|+|++... ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~--~~~ 118 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDD--KYL 118 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEE
Confidence 47899999999999999999999999999999998632 224577899999998 999999999998764 467
Q ss_pred eEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
++||||+++++|..++. .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCc
Confidence 89999999999987764 478889999999999999999999999999999999999666 899999999987643322
Q ss_pred --ccccccccCCCCchhhccc---CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 --YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 --~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+. ..++.++|||||||+||||++|++||.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 2456799999999998652 237889999999999999999999994
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=310.82 Aligned_cols=190 Identities=16% Similarity=0.359 Sum_probs=163.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++..+...||+|.||+||+|++. ..||||+++. ...+.|++|+.+|++- +|.||+-+.|+|..+. ..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~---~A 463 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPP---LA 463 (678)
T ss_pred HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCc---ee
Confidence 356778899999999999999984 3589999863 3457899999999998 9999999999997654 37
Q ss_pred EEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee---ec
Q 016537 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YH 280 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~---~~ 280 (387)
+|..+|+|.+|..++. ++.....+.|++||++|+.|||.++|||||||..||++..++ .|||+|||++.. +.
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccceeeeeeec
Confidence 9999999999987774 367778899999999999999999999999999999999665 899999999843 34
Q ss_pred CCCcccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+.......|...|||||++.. ..+|++.+|||||||++|||++|.-||.
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 4455566788899999999853 3579999999999999999999999984
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=310.23 Aligned_cols=196 Identities=31% Similarity=0.570 Sum_probs=175.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch------HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~------~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.+.|++.+.||+|.||.||+|+.+.+|+.+|+|.+.+... ..+.+|+++|+++..|||||.+++.+++.. ..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eE
Confidence 4679999999999999999999999999999999865332 578999999999955999999999998765 57
Q ss_pred eEEEeccCCCchhhhc-CC-CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC---ceEEEEecccceeecC
Q 016537 207 SLIFEHVNNTDFKVLY-PT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP 281 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~-~~-~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---~~vkl~DFG~a~~~~~ 281 (387)
++|||+|.||.|.+.+ +. +++.++..++.|++.+++|||+.||+||||||+|+|+.... ..+|++|||++.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 7999999999886655 33 99999999999999999999999999999999999996442 2799999999999888
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||..
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 767788999999999999876 6899999999999999999999999953
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=314.41 Aligned_cols=194 Identities=28% Similarity=0.552 Sum_probs=175.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|.+++++|+|+||.++.++++.++..+++|.+.-. .+....+|+.+++++ .|||||.+.+.|... ..+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence 47899999999999999999999999999999988532 234678999999998 999999999999864 35588
Q ss_pred EEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
+||+||+||++.+.+. .++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++ .|||+|||+|+.+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCc
Confidence 9999999999987763 389999999999999999999999999999999999999887 6899999999999877
Q ss_pred C-cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ...+.+||++||.||++.+ .+|+.|+|||||||++|||++-+++|.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccC
Confidence 6 5577899999999999988 899999999999999999999999994
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=304.79 Aligned_cols=195 Identities=23% Similarity=0.480 Sum_probs=177.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
..+|++.+.||+|.||.|-+|.....|+.||||.+++.+ .-.+.+|++||..| +||||+.++.+|++. ..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENk--dKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENK--DKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCC--ceE
Confidence 367999999999999999999998899999999987543 24578999999999 999999999999764 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++||||..+|.|.+++ +.+++.+++.+.+||..|++|+|.++++|||||.+|||+|.++ ++||+|||++..+..+.
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhcccc
Confidence 7999999999998876 4699999999999999999999999999999999999999666 89999999999999999
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
..+++||++.|.+||++.|...-++.+|-|||||+||.|+.|.-||-+
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 999999999999999998854557899999999999999999999943
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.01 Aligned_cols=195 Identities=26% Similarity=0.499 Sum_probs=170.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcccc
Confidence 47899999999999999999999889999999998632 235678899999999 99999999998865432
Q ss_pred CCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
...++||||++++.+..+...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNF 177 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccCc
Confidence 34689999999876666556788999999999999999999999999999999999999766 89999999998665544
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 4556688999999999977 679999999999999999999999994
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=297.50 Aligned_cols=218 Identities=26% Similarity=0.539 Sum_probs=184.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCC----eEEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~l~~~~~-----~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
..|+.++.||+|.||.||+|+.+.++ +.+|+|.++..+. ....+|+.+++.+ +|||++.+..++... ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-Cc
Confidence 56899999999999999999765443 3789999875532 5578999999999 999999999988765 56
Q ss_pred CceEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC---CceEEEEecc
Q 016537 205 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWG 274 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~~~vkl~DFG 274 (387)
.+++++||.+...+..+. +.++...++.++.||+.|++|||++-|+||||||.|||+..+ .+.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 788999999987665443 358899999999999999999999999999999999999755 2489999999
Q ss_pred cceeecCC----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh------------------h
Q 016537 275 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF------------------Y 332 (387)
Q Consensus 275 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~------------------~ 332 (387)
+++.+... ......+.|.||+|||++.|...|+.+.||||.|||+.||+|-+|.|.. .
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99887533 2345568899999999999999999999999999999999999998843 6
Q ss_pred ccCCCCCcccccccccCCCCC
Q 016537 333 VSGLGHSCLNTWFLRTCSIPF 353 (387)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~ 353 (387)
+..+|+|+.+.|+....-+.+
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~ 282 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEY 282 (438)
T ss_pred HHHcCCCccccchhhhhCcch
Confidence 788999999999875544333
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=312.73 Aligned_cols=192 Identities=29% Similarity=0.490 Sum_probs=166.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|.++.+++.||+|++... ....+.+|+.++..+ +||||+++++.+.+. ...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~--~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDK--RNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEEE
Confidence 4789999999999999999999999999999998632 235677899999999 999999999998764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence 999999999987765 3488999999999999999999999999999999999999666 89999999987543211
Q ss_pred -----------------------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCc
Q 016537 284 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPS 328 (387)
Q Consensus 284 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~p 328 (387)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence 0123479999999999877 6799999999999999999999999
Q ss_pred hh
Q 016537 329 VL 330 (387)
Q Consensus 329 f~ 330 (387)
|.
T Consensus 236 f~ 237 (360)
T cd05627 236 FC 237 (360)
T ss_pred CC
Confidence 94
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=301.17 Aligned_cols=193 Identities=24% Similarity=0.383 Sum_probs=167.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.|++++.||+|.-|+||++....++..+|+|++.+. +..+...|-+||+.+ +||.++.||..+.. ..+.|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeec--cceeE
Confidence 6788999999999999999999999999999999643 335677899999999 99999999999965 46788
Q ss_pred EEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-
Q 016537 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~- 281 (387)
|+||||+||+|..+++ .+++..++.|+.+++.||+|||..|||+|||||+||||..++ +|.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccccCCCC
Confidence 9999999999988774 389999999999999999999999999999999999999666 999999998743210
Q ss_pred --------------------------------C-C-----------------------cccccccccCCCCchhhcccCC
Q 016537 282 --------------------------------G-K-----------------------EYNVRVASRYFKGPELLVDLQD 305 (387)
Q Consensus 282 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~ 305 (387)
. . ....++||-.|+|||++.| ..
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~G 311 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EG 311 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CC
Confidence 0 0 0012478999999999998 67
Q ss_pred CCCccchhhHHHHHHHHHhcCCchhh
Q 016537 306 YDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 306 ~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.+.++|+|+|||+||||+.|..||.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 89999999999999999999999943
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=308.17 Aligned_cols=191 Identities=21% Similarity=0.405 Sum_probs=166.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-eEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.++.++ ..||+|.+... ..+.+.+|+.+++.+ +||||+++++++.+. ..
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDE--SY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeC--CE
Confidence 378999999999999999999876554 68999988532 235677899999999 999999999999764 45
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCCC
Confidence 78999999999987765 3488899999999999999999999999999999999998666 8999999999876432
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 185 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred --cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCC
Confidence 345679999999999977 678999999999999999999999994
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=307.24 Aligned_cols=186 Identities=24% Similarity=0.400 Sum_probs=161.4
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.+++.||+|+++.. ....+.+|+++++++ +||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence 4699999999999999999999999998642 124567899999999 999999999998764 4678999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~~~~~~~ 289 (387)
.+++|...+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .+......+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCccccee
Confidence 999987665 3488999999999999999999999999999999999999666 79999999997542 223334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCC
Confidence 9999999999877 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=286.15 Aligned_cols=193 Identities=26% Similarity=0.459 Sum_probs=172.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|.||.||.|+.+.++-.||+|++.+.. ..++.+|++|-.+| +||||.+++++|.+. ...
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~--~ri 97 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS--KRI 97 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc--cee
Confidence 378999999999999999999999999999999985432 36788999999999 999999999999774 557
Q ss_pred eEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 207 SLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
||++||...|++...+ .++.+.....|+.|++.||.|+|.++||||||||+|+|++.++ .+||+|||.+..-.
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecC-
Confidence 8999999999876554 3588999999999999999999999999999999999999777 89999999997654
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....+.|||.-|.+||+..+ ..++..+|+|++|++.||++.|.+||..
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 555677899999999999888 7899999999999999999999999953
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.95 Aligned_cols=184 Identities=20% Similarity=0.345 Sum_probs=162.8
Q ss_pred EEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCC
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (387)
.-++.||.|+.|-||+|+. .++.||||.++..+ +.+|+.|++| +||||+.+.|+|.. ..+.++|||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~elk----ETdIKHLRkL-kH~NII~FkGVCtq--sPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----ETDIKHLRKL-KHPNIITFKGVCTQ--SPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhhh----hhhHHHHHhc-cCcceeeEeeeecC--CceeEEeeeccccc
Confidence 3567899999999999997 57899999875333 4578889999 99999999999975 46778999999999
Q ss_pred chhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccC
Q 016537 217 DFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293 (387)
Q Consensus 217 ~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~ 293 (387)
-|..+++ .+.......|..+|+.|++|||.++|||||||.-||||..++ .|||+|||-++.+......-.++||..
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhhhhHh
Confidence 9988874 488888999999999999999999999999999999999776 899999999988766555556799999
Q ss_pred CCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 294 y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
|||||+|.+ .+++.|+|||||||+|||||||.-||..
T Consensus 277 WMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 277 WMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccc
Confidence 999999988 7899999999999999999999999853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=305.76 Aligned_cols=195 Identities=21% Similarity=0.392 Sum_probs=161.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+|+.+++++.+||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence 478999999999999999999752 345689999986432 356889999999997899999999988654 3
Q ss_pred CCceEEEeccCCCchhhhcC------------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (387)
...+++|||+++|+|..++.
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45689999999999865542
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc---cccccccCCC
Q 016537 224 -----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFK 295 (387)
Q Consensus 224 -----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~ 295 (387)
.+.+..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........ ....++..|+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCcccc
Confidence 255677888999999999999999999999999999999665 8999999999865433221 1234567899
Q ss_pred CchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 296 aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|||++.+ ..++.++|||||||+||||++ |.+||.
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~ 278 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYP 278 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence 9999877 678999999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.20 Aligned_cols=194 Identities=26% Similarity=0.433 Sum_probs=167.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~--~~~ 118 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDD--KYL 118 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecC--CEE
Confidence 47899999999999999999999999999999998632 224467899999998 999999999988764 457
Q ss_pred eEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
++||||+++++|..++. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCCc
Confidence 89999999999987764 478888999999999999999999999999999999999666 89999999998764332
Q ss_pred -cccccccccCCCCchhhccc---CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+. ..++.++|||||||+||||++|++||.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 22456799999999998652 247899999999999999999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=309.72 Aligned_cols=194 Identities=27% Similarity=0.444 Sum_probs=167.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|.++.+++.+|+|++... ....+.+|+.+++.+ +||||+++++.+.+. ...
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~--~~~ 118 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDD--RYL 118 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcC--CEE
Confidence 47899999999999999999999999999999998532 124467899999988 999999999998754 467
Q ss_pred eEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
++||||+++++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCc
Confidence 89999999999987764 478888999999999999999999999999999999999666 89999999998765332
Q ss_pred -cccccccccCCCCchhhcccC---CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQ---DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~---~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+.. .++.++|||||||+||||++|.+||.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 223567999999999986522 37899999999999999999999994
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=302.32 Aligned_cols=192 Identities=23% Similarity=0.365 Sum_probs=165.2
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+|++.+.||+|+||.||+|.+..+++.||+|+++... ...+..|..++..+.+|++|+++++++.+. ...++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 5889999999999999999998899999999986432 234567888888876789999999998764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~ 284 (387)
||||+++++|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCc
Confidence 99999999987655 3588999999999999999999999999999999999999666 899999999975432 223
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+|++.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC
Confidence 345678999999999877 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=301.48 Aligned_cols=192 Identities=24% Similarity=0.390 Sum_probs=164.2
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+|++++.||+|+||.||+|.++.+++.||+|++... ..+.+..|.+++..+.+|++|+++++++.+. ...++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 588999999999999999999889999999998642 2355778999999985556788999888654 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCCc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~~ 284 (387)
||||+++++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCc
Confidence 99999999987665 3478899999999999999999999999999999999999666 89999999987532 2233
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 345679999999999977 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=306.05 Aligned_cols=195 Identities=26% Similarity=0.496 Sum_probs=169.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~ 203 (387)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+.+++.+ +||||+++++++.... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccccc
Confidence 47899999999999999999999889999999998642 235677899999999 9999999999886532 2
Q ss_pred CCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
...++||||++++....+...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 173 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCcc
Confidence 34689999999876665556788999999999999999999999999999999999999666 89999999998765554
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 174 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 174 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred ccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4556788999999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=302.26 Aligned_cols=203 Identities=27% Similarity=0.437 Sum_probs=179.4
Q ss_pred cccccccCCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEE
Q 016537 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDI 197 (387)
Q Consensus 124 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~ 197 (387)
..++.+....+.|..-++||+||||.||-++...+|+.||.|.+.+.. .....+|-.+|.++ +.+.||.+--.
T Consensus 175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYA 253 (591)
T KOG0986|consen 175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYA 253 (591)
T ss_pred HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeee
Confidence 344556667789999999999999999999999999999999874321 23457899999999 88999999887
Q ss_pred EEcCCCCCceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEe
Q 016537 198 VRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 198 ~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
|+..+ .+++||..|+||+|+.++ +.+++..++.|+.+|+.||++||+.+||+|||||+|||+|+.+ +|+|+|
T Consensus 254 feTkd--~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISD 330 (591)
T KOG0986|consen 254 FETKD--ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISD 330 (591)
T ss_pred ecCCC--ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeec
Confidence 87654 467999999999998765 2488999999999999999999999999999999999999666 899999
Q ss_pred cccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 273 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+|+|..+..+.....++||..|||||++.+ ..|+...|+|||||+||||+.|+.||..
T Consensus 331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred cceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhh
Confidence 999999998888888899999999999988 5699999999999999999999999954
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=304.73 Aligned_cols=192 Identities=25% Similarity=0.457 Sum_probs=169.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..|..++.||+|+||.||+|.+..+++.||+|++.-. ..+.+.+|+.+|.++ +++||.++|+.+.... .+.++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~--~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGT--KLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecc--cHHHH
Confidence 4577789999999999999999999999999998632 236688999999998 9999999999887654 45699
Q ss_pred EeccCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-c
Q 016537 210 FEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~ 285 (387)
||||.+|++..+++. +.+..+..++++++.||.|||.++.+|||||+.|||+..++ .+||+|||.+..+..... .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhhcc
Confidence 999999998877743 47888899999999999999999999999999999999775 899999999977654433 3
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+++||++|||||++.+ ..|+.++||||||++.+||.+|.||+.
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 77899999999999986 789999999999999999999999983
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=286.60 Aligned_cols=195 Identities=24% Similarity=0.487 Sum_probs=173.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-------c----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------K----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-------~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
+.|+-.+.||+|..+.|.++.++.++..+|+|++... . .+.-.+|+.||+++.+||||+++.+++..+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~- 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD- 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-
Confidence 5677778999999999999999999999999998521 1 134567999999999999999999999654
Q ss_pred CCCceEEEeccCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 203 SKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
.+.++|+|.|+.|.|.+.+.. +++.+.+.+++|+.+|+.|||.++||||||||+|||+|++. ++||+|||+|+.+
T Consensus 96 -sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 -AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQL 173 (411)
T ss_pred -chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeecc
Confidence 567799999999999888753 89999999999999999999999999999999999999655 8999999999999
Q ss_pred cCCCcccccccccCCCCchhhc-----ccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 280 HPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.++......|||+.|+|||.+. +...|+..+|+||+|||+|.|+.|.|||-.
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9999999999999999999984 334689999999999999999999999943
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=302.81 Aligned_cols=186 Identities=23% Similarity=0.415 Sum_probs=160.6
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||++.+..+++.||+|+++.. ....+.+|+++++.+ +||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CEEEEEEeCC
Confidence 4699999999999999899999999998642 224567899999999 999999999998764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~~ 289 (387)
++++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCcccccc
Confidence 999986654 3488999999999999999999999999999999999999666 899999999875322 22334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 9999999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.52 Aligned_cols=192 Identities=31% Similarity=0.546 Sum_probs=168.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|++++..+ +||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDE--EHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecC--CeEE
Confidence 4789999999999999999999889999999998642 235678899999999 999999999988764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence 999999999987765 3588999999999999999999999999999999999999666 89999999997664433
Q ss_pred -----------------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......||+.|+|||++.+ ..++.++|||||||+||||++|++||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCC
Confidence 2234578999999999987 689999999999999999999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=301.82 Aligned_cols=193 Identities=31% Similarity=0.628 Sum_probs=162.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---CCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---~~~ 206 (387)
+|++.+.||+|+||.||+|+++.+++.||||.+... ....+.+|+++++++ +||||+++++++..... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 588999999999999999999899999999998632 234678999999999 99999999998864332 346
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++||||+.+ ++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccccccc
Confidence 899999974 555444 2488999999999999999999999999999999999999666 89999999997643221
Q ss_pred ----cccccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ----EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ----~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+|+..|+|||++.+. ..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 12345789999999997642 468899999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=305.82 Aligned_cols=195 Identities=25% Similarity=0.488 Sum_probs=169.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~ 203 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+ +||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeeccccccccc
Confidence 47899999999999999999999889999999998632 235678899999999 9999999999876432 2
Q ss_pred CCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
...++||||++++....+...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 180 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCCC
Confidence 35689999999766655556688899999999999999999999999999999999999666 89999999998765544
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 181 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 181 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 4456688999999999987 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=294.36 Aligned_cols=194 Identities=30% Similarity=0.635 Sum_probs=161.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-CCeEEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCeeEEEEEEEc---CC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRD---QQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~l~~~-----~~~~~~~E~~il~~l~--~hpniv~l~~~~~~---~~ 202 (387)
++|++.+.||+|+||.||+|.+.. +++.||+|.++.. ....+.+|+++++.+. +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368899999999999999999854 5688999988632 1245677888887763 69999999998863 22
Q ss_pred CCCceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 203 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
....++||||+.+ ++..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceE
Confidence 3467899999985 554443 2378899999999999999999999999999999999999666 89999999998
Q ss_pred eecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
............|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 7655544456678999999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=302.09 Aligned_cols=193 Identities=27% Similarity=0.425 Sum_probs=166.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||++.+..+++.||+|++... ..+.+.+|+.++..+ +|+||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDE--NNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecC--CeEE
Confidence 4799999999999999999999899999999998632 224577899999998 999999999998764 4678
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+||||+.+++|..++ ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence 999999999987765 3478999999999999999999999999999999999998666 89999999997664433
Q ss_pred c--ccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~--~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ....+|++.|+|||++.+ ...++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 2 233578999999999863 2457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=302.20 Aligned_cols=186 Identities=25% Similarity=0.407 Sum_probs=160.8
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||++.+..+++.||+|++... ....+.+|+++++.+ +||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTK--DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC--CEEEEEEeCC
Confidence 4699999999999999999999999998642 235677899999999 999999999988764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~~ 289 (387)
++++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccccccccc
Confidence 999986655 3488999999999999999999999999999999999999666 899999999875432 22334467
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCC
Confidence 9999999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.08 Aligned_cols=194 Identities=21% Similarity=0.424 Sum_probs=159.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhc-----CCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~-----~hpniv~l~~~~~~~~~~~ 205 (387)
.++|+++++||+|+||.||+|.+..+++.||||+++.. .......|+++++.+. +|.+++++++++... ...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cce
Confidence 47899999999999999999999889999999998642 2345677888888761 345689999988754 346
Q ss_pred ceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCc---------------e
Q 016537 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR---------------K 267 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~---------------~ 267 (387)
.++|||++.+..+..+. ..+++..++.++.||+.||+|||+ .|||||||||+|||++.++. .
T Consensus 207 ~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 78999988554444333 358899999999999999999998 59999999999999985542 4
Q ss_pred EEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 268 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+||+|||.+.... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 287 vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 287 VRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred EEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999886432 23356789999999999987 679999999999999999999999994
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=300.48 Aligned_cols=184 Identities=23% Similarity=0.416 Sum_probs=159.8
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+. ...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 79999999999999889999999998632 224567899999999 999999999988754 457899999999
Q ss_pred Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccccccccc
Q 016537 216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 291 (387)
Q Consensus 216 ~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt 291 (387)
++|...+ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++..... ......+|+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCC
Confidence 9987665 3488999999999999999999999999999999999999666 8999999999754322 233456799
Q ss_pred cCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcC
Confidence 99999999977 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=295.26 Aligned_cols=192 Identities=35% Similarity=0.655 Sum_probs=166.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|+++.+++.+|+|+++.. ..+.+.+|+++++++ +||||+++++++... ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRR--GKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecC--CEEEE
Confidence 4799999999999999999999889999999998642 235678999999999 999999999998654 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
||||+.++.+..+. ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccc
Confidence 99999998776554 3488899999999999999999999999999999999999666 89999999998764332
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 2234578999999999977 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.47 Aligned_cols=194 Identities=30% Similarity=0.538 Sum_probs=170.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.+.|++.++||+|.|+.||++.+..+|+.+|+|++.. ...+++++|+.|.+.| .||||+++.+.+.. ..+.|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~--~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcc--cceeE
Confidence 3778999999999999999999999999999998753 3457889999999999 99999999998854 45678
Q ss_pred EEEeccCCCchh-hhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC--CCceEEEEecccceeecCC
Q 016537 208 LIFEHVNNTDFK-VLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 208 lv~e~~~~~~l~-~~~~~--~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~~vkl~DFG~a~~~~~~ 282 (387)
+|+|+|.|+++. ++.++ +++..+..+++||++||.|+|.++|||||+||+|+|+.. .+-.+||+|||+|.....+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999999999874 33333 678889999999999999999999999999999999953 2336999999999998877
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++||+.|||||++.. .+|+..+|||+.|||||-|+.|.+||.
T Consensus 167 ~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 67778899999999999877 789999999999999999999999994
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=301.39 Aligned_cols=193 Identities=22% Similarity=0.408 Sum_probs=164.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEecccc-------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~~-------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
+|++.+.||+|+||.||++++. .+++.||+|++.... .+.+.+|+++++++.+|+||+++++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 4889999999999999998863 468899999986321 245678999999997799999999988654 4
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccc
Confidence 577999999999987665 3588999999999999999999999999999999999999666 899999999976543
Q ss_pred CC--cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .....+||..|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 32 22345799999999998774568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=301.88 Aligned_cols=187 Identities=25% Similarity=0.457 Sum_probs=162.4
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.+++.||+|+++... ...+.+|..+++.+.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 46999999999999999999999999997421 245778999999987899999999998764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee-cCCCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~-~~~~~~~~~~ 289 (387)
++++|...+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.. ..+......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccccc
Confidence 999987654 4589999999999999999999999999999999999999666 8999999999753 2333445568
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcc
Confidence 9999999999987 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=300.17 Aligned_cols=190 Identities=22% Similarity=0.380 Sum_probs=162.3
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHH---HhcCCCCeeEEEEEEEcCCCCCc
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQ---NLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~---~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
|++++.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|++++. ++ +||||+++++++.+. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~--~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTE--DHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcC--CEE
Confidence 67899999999999999999899999999998642 1245667776654 44 799999999998764 457
Q ss_pred eEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CC
Q 016537 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~ 283 (387)
++||||+.+++|...+. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCC
Confidence 89999999999876653 489999999999999999999999999999999999999766 899999999875432 22
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~ 202 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP 202 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 3345679999999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=300.81 Aligned_cols=193 Identities=26% Similarity=0.404 Sum_probs=165.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+++++.+++.||+|++.... ...+.+|+.++..+ +|+||+++++++.+. ...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~--~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDE--NYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEEE
Confidence 47999999999999999999998899999999986421 23467788898888 999999999998764 4678
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+||||+.+|+|..++ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence 999999999998765 3478889999999999999999999999999999999999666 79999999998765443
Q ss_pred cc--cccccccCCCCchhhccc----CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EY--NVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~--~~~~gt~~y~aPE~~~~~----~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....|++.|+|||++.+. +.++.++|||||||+||||++|+.||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 22 335799999999998642 357889999999999999999999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.33 Aligned_cols=193 Identities=25% Similarity=0.402 Sum_probs=165.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||++.++.+++.+|+|++... ....+.+|+.++..+ +|+||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDE--NNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CEEE
Confidence 4789999999999999999999889999999998532 123467889999988 999999999998764 4578
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+||||+.+|+|..++ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence 999999999997776 3478889999999999999999999999999999999999666 89999999997654332
Q ss_pred c--ccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~--~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ....+||+.|+|||++.+ ...++.++|||||||+||||++|++||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 2 234579999999999862 2468899999999999999999999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=300.73 Aligned_cols=187 Identities=26% Similarity=0.460 Sum_probs=161.7
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.+++.+|+|+++... ...+.+|+.++.++.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 46999999999999999999999999987431 245678888888877899999999998764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~~~~~~~ 289 (387)
++++|...+ +.+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++... ........+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccccc
Confidence 999987654 4589999999999999999999999999999999999999766 89999999997532 233344567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCc
Confidence 9999999999987 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=298.35 Aligned_cols=187 Identities=23% Similarity=0.397 Sum_probs=159.8
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.+..+++.||+|+++.. ..+.+..|..++..+.+||||+++++++... ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 4699999999999999889999999998642 2234566777777666899999999998764 4678999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~~~ 289 (387)
++++|...+ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++..... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccccc
Confidence 999987665 3588999999999999999999999999999999999999666 8999999999765332 2334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
||..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 9999999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.50 Aligned_cols=192 Identities=23% Similarity=0.362 Sum_probs=164.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+|++.+.||+|+||.||+|.++.+++.||+|++... ..+.+..|..++..+.+|++|+++++++.+. ...++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 477889999999999999999999999999998642 1245677888988886678899999988764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Cc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~ 284 (387)
||||+++++|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCcc
Confidence 99999999987665 3588999999999999999999999999999999999999666 8999999999754322 22
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC
Confidence 334578999999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.21 Aligned_cols=187 Identities=25% Similarity=0.388 Sum_probs=160.9
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.+++.||+|+++.. ....+..|..++..+.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence 4699999999999999999999999998642 2345678888888876899999999998764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~~ 289 (387)
++++|...+ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccc
Confidence 999987654 3588999999999999999999999999999999999999666 899999999876432 22334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|++.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 9999999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.24 Aligned_cols=189 Identities=24% Similarity=0.390 Sum_probs=162.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
.++|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+++++++ +||||+++++++... ...++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTYN--KFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEEC--CeeEEEEec
Confidence 468999999999999999999999999999999753 35578999999999 999999999998764 456799999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC--Ccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNV 287 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~--~~~~~ 287 (387)
+.+ ++...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus 165 ~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 165 YKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCccccccccccccccc
Confidence 975 443332 3588999999999999999999999999999999999999666 7999999999753322 22334
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+||+.|+|||++.+ ..++.++|||||||+||||++|.+||+
T Consensus 243 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 579999999999877 679999999999999999999998874
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=290.72 Aligned_cols=191 Identities=24% Similarity=0.415 Sum_probs=166.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+|+.+++++ +||||+++++.+.+. ...++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCC--CeEEE
Confidence 4789999999999999999998899999999986422 23467899999999 999999999998764 35789
Q ss_pred EEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
||||+.+++|...+ ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGE 156 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCC
Confidence 99999999987554 2478999999999999999999999999999999999999655 89999999998765544
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+|+..|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCC
Confidence 4455678999999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.51 Aligned_cols=187 Identities=24% Similarity=0.382 Sum_probs=160.6
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.+++.||+|+++.. ....+..|.+++..+.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 3699999999999999889999999998642 2245677888988777899999999999764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~~ 289 (387)
++++|...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccccc
Confidence 999987554 3578899999999999999999999999999999999999666 899999999976432 22334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC
Confidence 8999999999876 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.55 Aligned_cols=187 Identities=25% Similarity=0.464 Sum_probs=162.4
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+.++.++.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 46999999999999999999999999997432 245778999999987899999999998764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~~~~~~~ 289 (387)
++++|...+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++... ........+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceeccc
Confidence 999987654 4589999999999999999999999999999999999999666 79999999997532 333345568
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|++.|+|||++.+ ..++.++|||||||+||||++|.+||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCC
Confidence 9999999999877 679999999999999999999999993
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.72 Aligned_cols=193 Identities=27% Similarity=0.416 Sum_probs=166.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.++.+++.||+|+++.. ..+.+.+|+.+++.+ +|+||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~--~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDK--DNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CeEE
Confidence 4689999999999999999999999999999998743 234577899999988 999999999988764 4578
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+||||+++++|..++ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence 999999999988775 3478999999999999999999999999999999999999666 89999999998765443
Q ss_pred cc--cccccccCCCCchhhcc-----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~--~~~~gt~~y~aPE~~~~-----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....|++.|+|||++.. ...++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 22 33478999999999863 2567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=299.99 Aligned_cols=186 Identities=25% Similarity=0.412 Sum_probs=160.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||++.+..+++.||+|+++.. ....+.+|+++++.+ +||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 4699999999999999899999999998642 124567899999998 999999999988764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~ 288 (387)
.+++|...+ +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccc
Confidence 999987655 348899999999999999999997 7999999999999999666 899999999975432 2333456
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.|+..|+|||++.+ ..++.++|||||||+||||++|..||.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCC
Confidence 79999999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=289.15 Aligned_cols=193 Identities=30% Similarity=0.615 Sum_probs=162.7
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEEEEEEEcCC---CC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQ---SK 204 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~--~hpniv~l~~~~~~~~---~~ 204 (387)
+|++.+.||+|+||.||+|.++.+++.||+|.++... ...+.+|+++++.+. +||||+++++++.+.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4889999999999999999999999999999986421 235667888887763 6999999999886432 34
Q ss_pred CceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
..+++|||+.+ ++..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence 57899999986 444333 2378999999999999999999999999999999999999666 7999999999876
Q ss_pred cCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..........++..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 55444455678999999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=292.93 Aligned_cols=196 Identities=30% Similarity=0.613 Sum_probs=165.1
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+..++|.+.+.||+|+||.||+|.++.+++.+|+|.++... ...+.+|+++++++ +||||+++++++.+. ...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~ 79 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTD--KSL 79 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeC--CeE
Confidence 44578999999999999999999998899999999986332 24577899999999 999999999998764 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++||||+.+..+..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCc
Confidence 7999999864433332 2378888999999999999999999999999999999999666 89999999997653322
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 23345678899999998765678999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=294.90 Aligned_cols=187 Identities=22% Similarity=0.386 Sum_probs=160.5
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.+++.||+|+++.. .......|..++..+.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence 4699999999999999999999999998643 2345667888887766999999999998764 4678999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~~ 289 (387)
.+++|...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccC
Confidence 999987655 3578899999999999999999999999999999999999666 899999999875322 22334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 8999999999977 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=294.17 Aligned_cols=190 Identities=25% Similarity=0.560 Sum_probs=158.3
Q ss_pred EeeeeecCCeeEEEEEEe--CCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 139 VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~l~~~~-~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
.++||+|+||.||+|.++ .+++.+|+|.+.... ...+.+|+++++++ +||||+++++++........+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999975 367899999986433 35678999999999 99999999999877666778899999986
Q ss_pred Cchhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc---CCCceEEEEecccceeec
Q 016537 216 TDFKVLY------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 216 ~~l~~~~------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~---~~~~~vkl~DFG~a~~~~ 280 (387)
. +..++ ..+++..++.++.||+.||+|||++||+||||||+|||++ ...+.+||+|||+++...
T Consensus 85 ~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 D-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred C-HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 4 33322 1378889999999999999999999999999999999994 233479999999998764
Q ss_pred CCC----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ......+|+.|+|||++.+...++.++||||+||++|||++|++||.
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 322 23456789999999999875678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=296.52 Aligned_cols=186 Identities=25% Similarity=0.445 Sum_probs=156.5
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHH-HHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~-il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+.||+|+||.||+|++..+++.||+|++.... ...+.+|.. +++.+ +||||+++++++.+. ...++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTA--EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcC--CEEEEEEcC
Confidence 46999999999999998899999999986422 234455554 45666 999999999988764 457899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCCccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVR 288 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~~~~~~ 288 (387)
+++++|...+ ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++... ........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccc
Confidence 9999986554 3478999999999999999999999999999999999999766 89999999987532 22333456
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+|++.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCC
Confidence 78999999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=294.62 Aligned_cols=187 Identities=22% Similarity=0.386 Sum_probs=160.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.+..+++.||+|+++.. .......|..++..+.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 4699999999999999889999999998643 2244667888887766999999999998764 4578999999
Q ss_pred CCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccccccc
Q 016537 214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~~~ 289 (387)
++++|...+. .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++..... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeec
Confidence 9999977763 478899999999999999999999999999999999999666 8999999999754322 2334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 8999999999877 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.83 Aligned_cols=186 Identities=25% Similarity=0.437 Sum_probs=158.4
Q ss_pred eeeeecCCeeEEEEEEe---CCCeEEEEEEecccc-------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~~-------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+.||+|+||.||++.+. .+++.||+|+++... ...+.+|+++++.+ +||||+++++++.+. ...++|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTG--GKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecC--CeEEEE
Confidence 67999999999999863 467899999986421 24567899999999 999999999998764 457899
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccc
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~ 285 (387)
|||+.+++|...+. .+.+..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcc
Confidence 99999999876653 477888999999999999999999999999999999999666 8999999999754332 223
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....|++.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCC
Confidence 44578999999999877 678899999999999999999999984
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.86 Aligned_cols=186 Identities=25% Similarity=0.447 Sum_probs=157.0
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~i-l~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+.||+|+||+||+|.++.+++.+|+|++... ....+..|..+ ++.+ +||||+++++++... ...++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTT--EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecC--CEEEEEEcC
Confidence 4699999999999999999999999998642 22345566554 4556 999999999988764 457899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~ 288 (387)
+.++++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccc
Confidence 9999986554 3588999999999999999999999999999999999999666 899999999875322 2233456
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+|+..|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCC
Confidence 79999999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=296.72 Aligned_cols=186 Identities=25% Similarity=0.438 Sum_probs=156.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~i-l~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+.||+|+||.||+|++..+++.||+|++.... ...+..|... ++.+ +||||+++++++.+. ...++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--DKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcC--CeEEEEEeC
Confidence 46999999999999998899999999986422 1234445444 5566 999999999998764 457899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCCccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVR 288 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~~~~~~ 288 (387)
+.+++|...+ ..+.+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ........
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccc
Confidence 9999987665 3478889999999999999999999999999999999999666 89999999997543 22334456
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+|++.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC
Confidence 79999999999877 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=294.38 Aligned_cols=192 Identities=23% Similarity=0.393 Sum_probs=168.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++++.||+|+||.||++.+..++..+|+|.+... ....+.+|+++++++ +||||+++++++.+. ...++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEEE
Confidence 47899999999999999999999999999999998643 235688999999999 999999999998764 35779
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||||+++++|..++ ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-c
Confidence 99999999998776 3478899999999999999999986 699999999999999666 7999999999765432 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 344578999999999877 679999999999999999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.68 Aligned_cols=186 Identities=26% Similarity=0.459 Sum_probs=156.7
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~i-l~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+.||+|+||+||+|.++.+++.||+|++.... ...+.+|..+ ++.+ +||||+++++++.+. ...++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeC--CEEEEEEcC
Confidence 46999999999999999999999999986421 2344555554 4556 999999999988764 457899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~ 288 (387)
+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccc
Confidence 9999987655 3488999999999999999999999999999999999999666 899999999875322 2333456
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+|++.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCC
Confidence 78999999999877 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.05 Aligned_cols=192 Identities=22% Similarity=0.393 Sum_probs=162.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|+.++.||+|+||.||+|.+..+++.||||++.... ...+.+|+++++.+ +|+||+++++++.+. ...++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHN--GEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccC--CeEEEE
Confidence 56788899999999999999998899999999986432 35688999999999 999999999998654 457799
Q ss_pred EeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccccc
Q 016537 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 288 (387)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~~ 288 (387)
|||+++++|... ....+..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.... .....
T Consensus 151 ~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 151 LEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred EecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceeccccccccccc
Confidence 999999988653 2356777888999999999999999999999999999999665 89999999998765332 23456
Q ss_pred ccccCCCCchhhccc----CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~----~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+|+..|+|||++... ..++.++|||||||++|||++|+.||.
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 899999999987421 234568999999999999999999984
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=307.34 Aligned_cols=192 Identities=24% Similarity=0.410 Sum_probs=165.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC-CeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..|.+.+.||+|+||.||+|....+ ++.||+|.+.... ...+.+|+.+++.+ +||||+++++++... ...++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSD--DKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEEC--CEEEEE
Confidence 4599999999999999999998777 7888998764332 24567899999999 999999999999765 457899
Q ss_pred EeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 210 FEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 210 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
|||+++++|...+. .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDS 222 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCc
Confidence 99999999976432 378889999999999999999999999999999999999666 8999999999876543
Q ss_pred Cc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 22 234579999999999877 679999999999999999999999984
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=299.62 Aligned_cols=194 Identities=29% Similarity=0.576 Sum_probs=163.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---CCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---~~~ 206 (387)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ..+++.+|+++++.+ +|+||+++++++..... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 467889999999999999999889999999988532 235678999999999 99999999999876431 256
Q ss_pred eEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
++||||+.+.....+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc
Confidence 8999999854333332 3488999999999999999999999999999999999999666 89999999998654332
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 23345678999999999875668999999999999999999999984
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=285.43 Aligned_cols=193 Identities=24% Similarity=0.417 Sum_probs=171.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|+.+++||+|.||.|.+++.+.+++.||+|++++.- ...-..|-++|++. +||.+..+.-.|.. ...+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhcc--CceE
Confidence 478999999999999999999999999999999987431 23456788999997 99999998877754 4567
Q ss_pred eEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee-cCC
Q 016537 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~-~~~ 282 (387)
|+||||..||.|...+. .+++..++.+..+|+.||.|||+++||+||||.+|+|+|.|+ ++||+|||+++.- ..+
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhccccc
Confidence 89999999999876663 489999999999999999999999999999999999999888 8999999999753 455
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++|||+.|+|||++.+ ..|+.++|+|.+||++|||+.|+.||.
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccc
Confidence 66788999999999999987 799999999999999999999999994
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.60 Aligned_cols=195 Identities=21% Similarity=0.351 Sum_probs=166.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|.+.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.++..+ +|+||+++++.+...+.
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcc
Confidence 47999999999999999999999899999999998642 235678899999998 99999999887654322
Q ss_pred --CCceEEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 204 --KTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
...++||||+.+|+|...+. .+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFG 188 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFG 188 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecc
Confidence 13579999999999876652 478899999999999999999999999999999999999666 89999999
Q ss_pred cceeecCC---CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 275 LAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 275 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+++.+... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99875432 22345679999999999877 679999999999999999999999984
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=286.34 Aligned_cols=184 Identities=24% Similarity=0.407 Sum_probs=158.7
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
||+|+||+||++.+..+++.+|+|.+.... .+.+..|+++++.+ +|+||+++.+++... ...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 699999999999998899999999986422 24567899999999 999999999988654 457899999999
Q ss_pred Cchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-ccc
Q 016537 216 TDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNV 287 (387)
Q Consensus 216 ~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~~~ 287 (387)
++|...+ ..+++..++.++.||+.||+|||+++|+||||||+||+++.++ .++|+|||++........ ...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccc
Confidence 9986543 2478999999999999999999999999999999999998655 799999999987654332 234
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..|++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 578899999999987 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=292.26 Aligned_cols=187 Identities=22% Similarity=0.386 Sum_probs=161.0
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.+++.||+|+++.. ....+.+|.++++.+.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 4699999999999999889999999998742 2345678889998887899999999998764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~~ 289 (387)
.+++|...+ ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCccccee
Confidence 999987654 3588999999999999999999999999999999999999666 899999999875322 22334457
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 8999999999977 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.44 Aligned_cols=194 Identities=26% Similarity=0.499 Sum_probs=175.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+-|.+.+.||+|.|+.|-+|++--+|++||||++.+.+ ...+.+|++.|+-+ .|||||++|.+...+ ..+||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQ--TKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQ--TKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhccc--ceEEE
Confidence 45788899999999999999998999999999997654 35688999999988 999999999998664 34779
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|+|.-++|+|.+++ ..+.+..+++|..||+.|+.|+|+..+|||||||+|+.+-...+.|||.|||++..+.++..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999987765 35899999999999999999999999999999999999876767999999999999999999
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.++.||+..|-|||++.|...--+++||||||||||.|+.|++||.
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 9999999999999999994444578999999999999999999994
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.61 Aligned_cols=197 Identities=26% Similarity=0.487 Sum_probs=169.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++++.||+|+||.||+|.+..++..+|+|++... ....+..|+.++++| +||||+++++++.+.....++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEE
Confidence 47899999999999999999999999999999998632 235688999999999 999999999998776666788
Q ss_pred EEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHc-------CceeeccCCCCeeEcCC---------
Q 016537 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE--------- 264 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~-------~ivHrDlKp~NILl~~~--------- 264 (387)
+||||+.+++|..++ ..+++..++.++.||+.||.|||+. +||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999987665 2489999999999999999999984 49999999999999642
Q ss_pred -------CceEEEEecccceeecCCCcccccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 265 -------QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 265 -------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+||+|||+++.+.........+||+.|+|||++.+. ..++.++||||||||||||++|.+||.
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 124899999999876544444556899999999998642 458899999999999999999999984
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=284.01 Aligned_cols=191 Identities=24% Similarity=0.420 Sum_probs=166.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+|+.+++++ +|+|++++++.+.+. ...++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecC--CEEEE
Confidence 3778899999999999999999999999999886421 24467899999999 999999999998764 45789
Q ss_pred EEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
||||+.+++|...+ ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++.....+.
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCc
Confidence 99999999997665 2478889999999999999999999999999999999999666 79999999998765544
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 4445678999999999877 679999999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=295.90 Aligned_cols=193 Identities=30% Similarity=0.604 Sum_probs=164.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~ 203 (387)
.++|++++.||+|+||.||+|.+..+++.||||.+... ....+.+|+++++++ +||||+++++++.... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccccc
Confidence 47899999999999999999999889999999998642 224577899999999 9999999999875432 1
Q ss_pred CCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 204 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
...+++++++ ++++..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceecCC
Confidence 3457889987 56666555 3589999999999999999999999999999999999999666 799999999987543
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+++..|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 33456789999999998775678999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=303.55 Aligned_cols=191 Identities=25% Similarity=0.448 Sum_probs=166.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
..|.-++.||.|+||-||-|++..+.+.||||.+.-.. =..+.+|+..|+++ .|||++.+.|+|... ...+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre--~TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE--HTAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc--chHH
Confidence 34667899999999999999999999999999986432 25688999999999 999999999998764 3456
Q ss_pred EEEeccCCCc---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~---l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||||||-|.- +..+.+.+.+.++..|+.+.+.||+|||+++.||||||+.|||+.+.+ .|||+|||.|....+.
T Consensus 103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMAPA-- 179 (948)
T ss_pred HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcCch--
Confidence 9999998752 344557799999999999999999999999999999999999999666 8999999999877654
Q ss_pred ccccccccCCCCchhhc--ccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 285 YNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+.++||++|||||++. +.+.|+-++||||||+++.||.-++||++.
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 5689999999999984 346799999999999999999999999864
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=282.26 Aligned_cols=184 Identities=27% Similarity=0.378 Sum_probs=159.2
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
||+|+||.||++.++.+++.||+|.+... ....+..|+++++++ +||||+++++++.+. ...++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 69999999999999899999999998532 123456799999999 999999999988754 457899999999
Q ss_pred CchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccccc
Q 016537 216 TDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (387)
Q Consensus 216 ~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~g 290 (387)
++|...+. .+.+..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++.............|
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCC
Confidence 99876542 367888889999999999999999999999999999999665 799999999987765544455678
Q ss_pred ccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 999999999877 569999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.98 Aligned_cols=194 Identities=23% Similarity=0.342 Sum_probs=160.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+... +..||+|.++... ...+.+|+++++.+.+|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 36899999999999999999986433 3579999986432 346788999999987899999999998764
Q ss_pred CCceEEEeccCCCchhhhcC------------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (387)
...++||||+.+|+|..++.
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 45779999999999876541
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc---c
Q 016537 224 -------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---V 287 (387)
Q Consensus 224 -------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~---~ 287 (387)
.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccC
Confidence 256677899999999999999999999999999999999655 89999999998654332211 1
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 234567999999876 679999999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=282.67 Aligned_cols=191 Identities=25% Similarity=0.420 Sum_probs=165.9
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.|+..+.||+|+||+||+|.+..+++.+|+|.+.... ...+.+|+++++++ +|+||+.+.+.+.+. ...++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETK--DALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecC--CEEEE
Confidence 3678899999999999999999999999999986432 23467899999999 999999999988764 45789
Q ss_pred EEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+|||+.++++...+ ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCC
Confidence 99999999987554 2488999999999999999999999999999999999999665 79999999997765444
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......|+..|+|||++.+ ..++.++|+|||||++|||++|.+||.
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 4455678999999999876 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=286.70 Aligned_cols=190 Identities=25% Similarity=0.578 Sum_probs=157.3
Q ss_pred eeeeecCCeeEEEEEEeC--CCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCC
Q 016537 140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~l~~~~-~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (387)
.+||+|+||.||+|.++. ++..||+|.+.... ...+.+|+++++++ +||||+++++++........++||||+.++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 579999999999998753 56789999886543 35678999999999 999999999998766667788999999875
Q ss_pred chhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc---CCCceEEEEecccceeecCC
Q 016537 217 DFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 217 ~l~~~~-----------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~---~~~~~vkl~DFG~a~~~~~~ 282 (387)
.+..+. ..+++..++.++.|++.||.|||+++|+||||||+|||+. .+.+.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 433221 1377888999999999999999999999999999999994 23347999999999876433
Q ss_pred C----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 K----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......++..|+|||++.+...++.++|||||||++|||+||++||.
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 2 22345788999999998775568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=293.48 Aligned_cols=186 Identities=28% Similarity=0.441 Sum_probs=159.6
Q ss_pred eeeeecCCeeEEEEEEe---CCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
+.||+|+||.||++.+. .+++.+|+|++.... ...+.+|+++++++ +||||+++++++.+. ...++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTE--GKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--CEEEEEEc
Confidence 57999999999998763 568999999986422 24567899999999 999999999998764 45789999
Q ss_pred ccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccccc
Q 016537 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 287 (387)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~ 287 (387)
|+.+++|...+. .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceec
Confidence 999999876653 488999999999999999999999999999999999999666 8999999999765443 23344
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC
Confidence 678999999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=295.38 Aligned_cols=186 Identities=24% Similarity=0.383 Sum_probs=156.8
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhc--CCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~--~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
||+|+||.||+|+++.+++.||+|++.... ......|..++.++. +||||+++++++.+. ...++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence 799999999999999999999999985321 123455777777664 799999999998764 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~~~~~ 289 (387)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCcc
Confidence 999986654 3488999999999999999999999999999999999999666 899999999875432 23334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
||..|+|||++.+...++.++|||||||++|||++|..||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 99999999998765568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=258.92 Aligned_cols=211 Identities=31% Similarity=0.577 Sum_probs=179.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.+|...++||+|.||+||+|+...+++.||+|.++-.. .....+|+-+|+.+ .|.|||+++++...+ ..+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsd--kkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccC--ceeEE
Confidence 35667789999999999999999999999999986332 36688999999999 999999999988654 44669
Q ss_pred EEeccCCCc---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 209 IFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 209 v~e~~~~~~---l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
|+|||+... +..+...+..+.++.++.|+++||.|+|++++.||||||+|.||+.++ .+||+|||+++-+.-.. .
T Consensus 79 vfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrc 157 (292)
T KOG0662|consen 79 VFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRC 157 (292)
T ss_pred eHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEe
Confidence 999998543 223335688899999999999999999999999999999999999666 89999999998765433 4
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchhh---------hccCCCCCccccccccc
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVLF---------YVSGLGHSCLNTWFLRT 348 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~---------~~~~~~~~~~~~~~~~~ 348 (387)
+...+.|.+|++|.++.+.+-|+...|+||.|||+.|+.. |+|.|.. .+..+|.++++.|+...
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 5677889999999999998899999999999999999987 5666643 68899999999999754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.27 Aligned_cols=197 Identities=21% Similarity=0.335 Sum_probs=162.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEE-EEEcC---C-CC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLD-IVRDQ---Q-SK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~-~~~~~---~-~~ 204 (387)
..++++.+.|.+|||+.||.|.+...+..||+|++-..+ .+.+.+|+++|+.|.+|+|||.+++ ..... . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 357889999999999999999997777999999875433 3667899999999988999999999 22211 1 23
Q ss_pred CceEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 205 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
-++|+||||.+|.|.+++. .|++.++++|+.|+++|+.+||... |||||||-+||||..++ +.||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcccccc
Confidence 4578999999888776653 4899999999999999999999987 99999999999999777 89999999985
Q ss_pred eecCCCc----------ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKE----------YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~----------~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....... ......|+.|+|||++.- ...++.|+|||+|||+||-|+....||.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 4322221 122357899999999832 2578999999999999999999999994
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=290.24 Aligned_cols=192 Identities=24% Similarity=0.414 Sum_probs=167.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+..++..+|+|++... ....+.+|+++++++ +||||+++++++.+. ...++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEEC--CEEEE
Confidence 47899999999999999999999889999999987643 235688999999999 999999999999874 45789
Q ss_pred EEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||||+.+++|..++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~-~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh-c
Confidence 999999999987653 478888999999999999999985 799999999999999666 7999999999765332 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 344578899999999877 678999999999999999999999984
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=320.37 Aligned_cols=195 Identities=27% Similarity=0.427 Sum_probs=169.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|+++++||+|+||.|..++++.+++.||+|++++ ....-|..|-.+|..- +.+=|+.++-.|. +..++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQ--D~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQ--DERYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhc--Cccce
Confidence 4789999999999999999999999999999999864 1224467788888875 7888999988874 46789
Q ss_pred eEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
|+|||||+||+|-.++. .+++..+++|+.+|..||.-||+.|+|||||||+|||||..| ++||+|||.+-.+..++
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCCCC
Confidence 99999999999887764 488999999999999999999999999999999999999777 99999999987666443
Q ss_pred --cccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 --EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 --~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....+|||-|.+||++.. .+.|+..+|+||+||++|||+.|..||+.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 3467799999999999842 25699999999999999999999999953
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=293.91 Aligned_cols=193 Identities=26% Similarity=0.490 Sum_probs=161.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~-----~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
...|+++++||+||.+.||++.. .+.+.||+|.+. ......+.+|++.|.+|.+|.+|+++++|-.. +.++|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lY 436 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLY 436 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEE
Confidence 46799999999999999999987 566777777653 22346789999999999999999999998765 46789
Q ss_pred EEEeccCCCchhhhcCC----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
|||||-+ .+|..++++ .+.+.++.|..||+.|++++|++||||.||||.|+|+- +| .+||+|||+|..+.++.
T Consensus 437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechhcccCccc
Confidence 9999876 455555532 55678999999999999999999999999999999998 55 79999999999887665
Q ss_pred cc---cccccccCCCCchhhcccC----------CCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EY---NVRVASRYFKGPELLVDLQ----------DYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~---~~~~gt~~y~aPE~~~~~~----------~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.. ...+||..||+||.+.... ..+.++||||||||||+|+.|++||..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 43 4469999999999985421 256889999999999999999999965
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.85 Aligned_cols=189 Identities=23% Similarity=0.430 Sum_probs=165.7
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCC
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (387)
-+||+|.||+||.|++..+...+|||-+.... ...+..||.+.++| +|.|||+++|.+.. +.+..+.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 36999999999999999999999999985433 24577899999999 99999999999854 45777999999999
Q ss_pred chhhhcCC----C--CHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-ccccc
Q 016537 217 DFKVLYPT----L--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRV 289 (387)
Q Consensus 217 ~l~~~~~~----~--~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~~~~~ 289 (387)
+|..+++. + .+..+..|.+||++||.|||++.|||||||-+|+||+--.+.+||+|||-++.+..-.. ..++.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 99988853 4 67889999999999999999999999999999999987777999999999988765444 45679
Q ss_pred cccCCCCchhhc-ccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 290 ASRYFKGPELLV-DLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 290 gt~~y~aPE~~~-~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
||..|||||++. |...|+.++|||||||++.||.||+|||..
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 999999999995 445799999999999999999999999953
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=312.72 Aligned_cols=192 Identities=24% Similarity=0.399 Sum_probs=163.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.++||+|+||.||+|.+..+++.||+|++... ..+++.+|+++++++ +||||+++++++.+. ...+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~--~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDG--DPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeC--CEEE
Confidence 6899999999999999999999889999999998642 235688999999999 999999999998764 4578
Q ss_pred EEEeccCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEec
Q 016537 208 LIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DF 273 (387)
++|||+++++|..++. .++...+..++.||+.||+|||++||+||||||+|||++.++ .++|+||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDF 157 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDW 157 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEec
Confidence 9999999999876652 134456788999999999999999999999999999999666 7999999
Q ss_pred ccceeecCCC-------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 274 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 274 G~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+++...... .....+||+.|+|||++.+ ..++.++|||||||++|||+||.+||.
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 9998652110 0112468999999999877 678999999999999999999999984
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=283.10 Aligned_cols=192 Identities=21% Similarity=0.390 Sum_probs=158.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC----------------CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCee
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv 192 (387)
.++|++.++||+|+||.||+|.+.. ++..||+|.+.... ...+.+|++++.++ +||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence 3679999999999999999998632 34579999987532 35688999999999 999999
Q ss_pred EEEEEEEcCCCCCceEEEeccCCCchhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCce
Q 016537 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------------------TLSDYDVRYYIYELLKALDYCHSQGIM 250 (387)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~~~~~~~~~~~~qi~~aL~yLH~~~iv 250 (387)
++++++.+. ...++||||+.+++|..++. .+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999764 34689999999999876542 245667889999999999999999999
Q ss_pred eeccCCCCeeEcCCCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhc--
Q 016537 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSV-- 325 (387)
Q Consensus 251 HrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg-- 325 (387)
||||||+|||++.++ .+||+|||+++........ ....++..|+|||++.+ +.++.++|||||||++|||+++
T Consensus 161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999665 8999999999866443221 22345678999999876 6799999999999999999974
Q ss_pred CCch
Q 016537 326 SPSV 329 (387)
Q Consensus 326 ~~pf 329 (387)
..||
T Consensus 239 ~~p~ 242 (304)
T cd05096 239 EQPY 242 (304)
T ss_pred CCCC
Confidence 4555
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=292.66 Aligned_cols=194 Identities=23% Similarity=0.382 Sum_probs=160.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEE-----eCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... .+.+.+|+++++.+.+||||+++++++.+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 36799999999999999999974 3456789999986432 3567899999999878999999999997654
Q ss_pred CCceEEEeccCCCchhhhcC------------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (387)
..++||||+++|+|..++.
T Consensus 113 -~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 113 -PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred -cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 4679999999998865542
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 224 ------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 224 ------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
.+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCcccc
Confidence 256677888999999999999999999999999999998655 8999999999866433221
Q ss_pred c---ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 N---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 ~---~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
. ...++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 1 1234567999999877 679999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.96 Aligned_cols=194 Identities=24% Similarity=0.443 Sum_probs=166.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.+|++.+.||+|+||.||+|.+..++..||+|.+... ..+.+.+|+++++++ +||||+++++++.+.....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 5789999999999999999999889999999987521 124678899999999 9999999999987655567
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.+++|||+++++|...+ ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccc
Confidence 78999999999987765 3478888999999999999999999999999999999999666 8999999999765321
Q ss_pred ----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 12234568889999999877 678999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=279.44 Aligned_cols=191 Identities=21% Similarity=0.350 Sum_probs=166.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+++++++ +||||+++++++... ...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence 3678899999999999999999899999999998533 235688999999999 999999999999775 346799
Q ss_pred EeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccc
Q 016537 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (387)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 289 (387)
|||++++++... ..+++..+..++.|++.||+|||+++|+|+||||+|||++.++ .++|+|||++...... .....+
T Consensus 78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCC
Confidence 999999988654 4678889999999999999999999999999999999999766 8999999999765433 334567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 8999999999877 6789999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=284.15 Aligned_cols=192 Identities=19% Similarity=0.364 Sum_probs=160.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCe----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
..+|++.+.||+|+||.||+|.+..+++ .||+|.++.. ..+++.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC---
Confidence 3679999999999999999999866555 4899998643 235688899999999 999999999998653
Q ss_pred CceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++++||+.+|++...+. .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEcccccccccc
Confidence 3569999999999876653 367888899999999999999999999999999999998665 79999999998765
Q ss_pred CCCccc---ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKEYN---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...... ...++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 433221 1233567999999876 678999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.67 Aligned_cols=194 Identities=29% Similarity=0.637 Sum_probs=164.5
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
..++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~--~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecC--CeEE
Confidence 4578999999999999999999998899999999986332 34677899999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+||||+.+ ++...+ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCC
Confidence 99999985 554433 3478889999999999999999999999999999999999666 89999999997643222
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 22344678899999998765668899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=272.33 Aligned_cols=191 Identities=30% Similarity=0.564 Sum_probs=165.7
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchH-----HHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~-----~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
|++.+.||+|+||.||++.+..+++.+|+|++...... ...+|+.+++++ +||||+++++++.+. ...+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDD--NYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEES--SEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccc--ccccccc
Confidence 78999999999999999999999999999999765432 234599999999 999999999999873 4567999
Q ss_pred eccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee-cCCCccc
Q 016537 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYN 286 (387)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~-~~~~~~~ 286 (387)
||+.++++..++ ..+++..+..++.|+++||++||+++|+|+||||+||+++.++ .++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 999998887654 4588999999999999999999999999999999999999555 8999999999764 2333445
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||++.....++.++||||||+++|+|++|..||.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~ 200 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE 200 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc
Confidence 66789999999998733678999999999999999999999984
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.50 Aligned_cols=185 Identities=18% Similarity=0.244 Sum_probs=158.7
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCCCceEEEe
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFE 211 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~--~~~~~~~lv~e 211 (387)
..||+|++|.||+|.+ +|+.||||.++... .+.+.+|+.+|+++ +||||+++++++.+ ......++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5699999999999997 68999999986432 25677999999999 99999999999876 44456789999
Q ss_pred ccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccc
Q 016537 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (387)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~ 287 (387)
|+++|+|..++. .+++.....++.|++.||.|||+. +++||||||+|||++.++ .+||+|||+++..... ...
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~--~~~ 179 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP--PFK 179 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc--ccc
Confidence 999999987763 478888899999999999999984 999999999999999666 8999999999865432 234
Q ss_pred cccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+++..|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 5688899999998652 578999999999999999999999994
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=273.15 Aligned_cols=192 Identities=23% Similarity=0.423 Sum_probs=165.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++|++.+.||+|++|.||+|.+..+++.+|+|.+.... ...+.+|+++++++ +||||+++++++.+.. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~--~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDE--T 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCC--e
Confidence 56889999999999999999998889999999875321 24678899999999 9999999999997653 6
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++++||++++++...+ ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||+++.....
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecccc
Confidence 78999999999987665 3478888999999999999999999999999999999999655 8999999999765432
Q ss_pred Ccc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ....++..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 211 23467889999999887 568999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=275.15 Aligned_cols=196 Identities=26% Similarity=0.453 Sum_probs=169.9
Q ss_pred CCCeEEE-eeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCCCceEE
Q 016537 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~--~~~~~~~lv 209 (387)
.++|.+. ++||-|-.|.|..+.++.+++++|+|++... .+..+|+++.-....|||||.++++|++ .+..++.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 4667664 5899999999999999999999999998654 4456788777666799999999999875 345678899
Q ss_pred EeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCC
Q 016537 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~ 282 (387)
||.|+||.|...+. .+++.++..|++||..|+.|||+.+|.||||||+|+|.... +-.+||+|||+|+.-...
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 99999999876652 38999999999999999999999999999999999999533 337899999999987767
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
....+.+-|++|.|||++-. ..|+..+|+||+||++|-|+.|.|||+.
T Consensus 218 ~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 77888899999999999754 6799999999999999999999999964
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=275.91 Aligned_cols=193 Identities=16% Similarity=0.282 Sum_probs=161.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++... ...+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRG--NT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecC--CC
Confidence 467999999999999999999875 346789999987432 24678899999998 999999999998754 45
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+++++|..++. .+++..++.++.|++.||+|||+++++||||||+|||++.++ .++++|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~ 159 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKS 159 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccc
Confidence 789999999999987652 478899999999999999999999999999999999998665 899999998765432
Q ss_pred CCccc--ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..... ...++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 22111 1234567999999877 679999999999999999775 999983
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.94 Aligned_cols=192 Identities=26% Similarity=0.342 Sum_probs=161.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe--CCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
..+|++++.||+|+||.||+|... .++..||+|.+... +...+|+++++++ +||||+++++++... ...+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRWK--STVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEeeC--CEEEEEe
Confidence 367999999999999999999764 34678999988643 3457899999999 999999999988754 4578999
Q ss_pred eccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc---c
Q 016537 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---Y 285 (387)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~---~ 285 (387)
|++.+..+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++....... .
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCcccccccc
Confidence 999864443332 4588999999999999999999999999999999999999666 799999999976543322 2
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
....||..|+|||++.+ ..|+.++|||||||+||||++|+.||..
T Consensus 245 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 245 YGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred cccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 34578999999999876 6789999999999999999999999843
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=289.85 Aligned_cols=189 Identities=22% Similarity=0.380 Sum_probs=160.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
..+|++++.||+|+||.||+|.+..+++.||+|+... .....|+.+++++ +||||+++++++... ...++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVSG--AITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEeC--CeeEEEEEc
Confidence 4679999999999999999999988899999997543 3345799999999 999999999998765 356799999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 289 (387)
+.+..+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++............
T Consensus 139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccccccc
Confidence 9764443332 3488999999999999999999999999999999999999666 79999999997644433444567
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
||..|+|||++.+ ..++.++|||||||++|||+++..++
T Consensus 218 gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 218 GTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 8999999999877 67999999999999999999976554
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=276.88 Aligned_cols=194 Identities=27% Similarity=0.426 Sum_probs=163.4
Q ss_pred CCe-EEEeeeeecCCeeEEEEEE----eCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDY-EVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y-~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++| ++.+.||+|+||+||++.. ..++..+|+|.++.. ....+.+|+++++++ +||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 445 8999999999999987653 346789999998643 245678999999999 999999999998766556
Q ss_pred CceEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 205 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
..+++|||+.+++|..++. .+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+|||+++....+
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCc
Confidence 7889999999999987653 589999999999999999999999999999999999998665 8999999999876543
Q ss_pred Ccc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 221 22345567999999876 678999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.01 Aligned_cols=190 Identities=25% Similarity=0.357 Sum_probs=160.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|+++ +|+||+++++++... ...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~--~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVVG--GLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEEC--CEEEEEEEc
Confidence 457999999999999999999999899999999643 24467899999999 999999999998764 456799999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc---cc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~---~~ 286 (387)
+.+..+..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccccccc
Confidence 9754333332 3488999999999999999999999999999999999999666 799999999987643322 12
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+||..|+|||++.+ ..++.++|||||||+||||++|..+++
T Consensus 321 ~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 3568999999999987 679999999999999999999987764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=294.61 Aligned_cols=193 Identities=21% Similarity=0.387 Sum_probs=161.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCe---E-EEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---K-CIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
++..+.++||+|+||.||+|..+..+. . ||||..+. ....++.+|.++++++ +|||||+++|++.+.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~-- 233 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLE-- 233 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC--
Confidence 556677999999999999999865432 3 89998873 2347789999999999 999999999999765
Q ss_pred CCceEEEeccCCCchhhhcCC----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
.-+++|||+|.||+|..+++. ++..+...++.+.+.||+|||++++|||||-++|+|++.++ .+||+|||+++..
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDFGLSRAG 312 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCccccccCC
Confidence 446799999999999888754 77899999999999999999999999999999999999655 6899999998754
Q ss_pred cCCCccc-ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchhh
Q 016537 280 HPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVLF 331 (387)
Q Consensus 280 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~ 331 (387)
..-.... ..--...|+|||.+.. ..|+.++|||||||++||+++ |..||..
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred cceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCC
Confidence 3111111 1234567999999977 589999999999999999999 7889854
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.39 Aligned_cols=190 Identities=25% Similarity=0.444 Sum_probs=163.5
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCC
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (387)
+.||+|+|+.|-.++.-.++..||||++.++ .+.+..+|++++.+..+|+||++++++|+++. ..|||||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEecccCc
Confidence 5799999999999999999999999999754 45789999999999999999999999998754 467999999999
Q ss_pred chhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc--eEEEEecccceeecCC--------C
Q 016537 217 DFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPG--------K 283 (387)
Q Consensus 217 ~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--~vkl~DFG~a~~~~~~--------~ 283 (387)
.+...+ +.+++.++.+++++|+.||.|||.+||.||||||+|||..+.+. -||||||.++..+.-. .
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 876554 34999999999999999999999999999999999999965442 5899999998654322 2
Q ss_pred cccccccccCCCCchhhc----ccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
...+.+|+..|||||+.. ....|+.++|.||||||||-||+|.+||.+
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 234568999999999973 224699999999999999999999999965
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=275.22 Aligned_cols=191 Identities=31% Similarity=0.617 Sum_probs=161.9
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|++|.||+|.+..+++.||+|.++.. ..+.+.+|+.+++++ +||||+++++++.++ ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQE--SRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeC--CeEEEE
Confidence 588999999999999999999889999999998632 235678999999999 899999999999764 456899
Q ss_pred EeccCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 210 FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
|||+.+ ++..++ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence 999984 554443 3478899999999999999999999999999999999999666 89999999997654322
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 22334668889999998765567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.29 Aligned_cols=197 Identities=26% Similarity=0.479 Sum_probs=167.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----CCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~~~~ 206 (387)
.+.|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+.+++++.+|+||+++++++.... ....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 46788999999999999999999889999999998643 34678899999999878999999999987542 2357
Q ss_pred eEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
+++|||+.++++..++. .+++..+..++.|++.||+|||+++|+||||||+||+++.++ .++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceeccc
Confidence 89999999999877653 378888999999999999999999999999999999999666 799999999986543
Q ss_pred C-CcccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 G-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .......|+..|+|||++.+ ...++.++|||||||++|||++|.+||.
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 2 22344578889999999853 2358889999999999999999999983
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=281.63 Aligned_cols=192 Identities=23% Similarity=0.419 Sum_probs=169.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+-|.++++||+|+||.||+|.++.+|..+|||.+.. ....++.+|+.|++++ +.|++|++||.+... ..+.+||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~--sDLWIVMEY 109 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKH--SDLWIVMEY 109 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhccC--CceEeehhh
Confidence 346788999999999999999999999999998864 3458899999999997 999999999977543 346799999
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cccc
Q 016537 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (387)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~ 287 (387)
|..|+..+++ +.+.+.++..+++..++||+|||...-||||||+.|||++.++ ..||+|||.|-.+.+.. ..++
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhhCc
Confidence 9999987775 4599999999999999999999999999999999999999777 89999999997765433 2366
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..||+.|||||++.. -.|+.++||||||++..||..|+|||.
T Consensus 189 VIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred cccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcc
Confidence 799999999999977 679999999999999999999999984
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=284.92 Aligned_cols=195 Identities=25% Similarity=0.497 Sum_probs=166.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~ 203 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++++ +||||+++++++.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcccc
Confidence 47899999999999999999999889999999998532 235677899999999 9999999999886432 1
Q ss_pred CCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
...++||||+.+.....+...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 172 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCCC
Confidence 34689999998644444444588999999999999999999999999999999999999766 79999999998765544
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 4445678889999999877 679999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=279.96 Aligned_cols=193 Identities=20% Similarity=0.318 Sum_probs=159.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCe--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ....+.+|++++.++.+|+||+++++++.+. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCce
Confidence 689999999999999999999876665 4577776532 2346788999999997899999999998654 4578
Q ss_pred EEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceE
Q 016537 208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~v 268 (387)
+||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~~ 163 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA 163 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-cE
Confidence 9999999999877652 367888999999999999999999999999999999999666 79
Q ss_pred EEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 269 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||+|||+++............++..|+|||.+.+ ..++.++|||||||++|||+| |.+||.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 9999999864322111122233567999999866 668999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=273.87 Aligned_cols=193 Identities=32% Similarity=0.629 Sum_probs=167.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.++.+++.||+|.+... ..+.+.+|+++++++ +|+|++++++++.+. ...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRK--RKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeC--CEEEE
Confidence 4789999999999999999999888999999988532 235578899999999 999999999998764 45679
Q ss_pred EEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
||||++++++..+.. .+++..++.++.|++.||+|||+++++||||||+||+++.++ .++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCccc
Confidence 999999998877653 488999999999999999999999999999999999999666 89999999998765443 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 3345678899999998765568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=275.38 Aligned_cols=195 Identities=33% Similarity=0.647 Sum_probs=163.9
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+..++|++.+.||+|++|.||+|.++.+++.||+|.+.... ...+.+|+++++++ +|+||+++++++.+. ...
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~ 78 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTK--KTL 78 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecC--CeE
Confidence 34578999999999999999999998889999999986432 24567899999999 999999999998754 467
Q ss_pred eEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+.+ ++..++ ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCC
Confidence 899999986 665543 2478889999999999999999999999999999999999666 7999999998654321
Q ss_pred -CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 122333567889999998764568899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=268.31 Aligned_cols=195 Identities=20% Similarity=0.351 Sum_probs=164.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++.+.+..||.|+.|+|++++...+|...|||.+... ..+++...+.++..-.+.|+||+.+|+|..... +.+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHH
Confidence 45667888999999999999999999999999998643 235677777777766468999999999986544 346
Q ss_pred EEeccCC---CchhhhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~---~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
.||.|.. ..|....+.++|..+-++...+++||.||.+ ++|+|||+||+|||+|..+ ++||||||++-++.+...
T Consensus 169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeecccc
Confidence 6666542 3455555679999999999999999999996 5899999999999999666 899999999998888888
Q ss_pred ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+...|.+.|||||.+.- ...|+.++||||||+.|+||.||+.||.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~ 295 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK 295 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence 888899999999999853 2469999999999999999999999994
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=275.21 Aligned_cols=196 Identities=31% Similarity=0.611 Sum_probs=163.5
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+..++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+|+++++.+ +|+||+++++++.+. ...
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--~~~ 78 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTK--ETL 78 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecC--CeE
Confidence 44588999999999999999999998899999999986432 23577899999999 999999999998764 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~- 282 (387)
++||||+.+..+..+. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+|||+++.....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCC
Confidence 8999999755444333 2367888899999999999999999999999999999999666 8999999998754322
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||.+.+...++.++|||||||++|||++|.+||.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 222344678899999998764567889999999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=275.75 Aligned_cols=190 Identities=25% Similarity=0.476 Sum_probs=166.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||++.+..+++.+|+|.+... ..+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDD--SNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcC--CeEE
Confidence 4689999999999999999999889999999998642 235678899999999 899999999998764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|...+ ..+++..+..++.|++.||+|||++||+|+||||+|||++.++ .+||+|||+++.....
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--
Confidence 999999999987665 3488999999999999999999999999999999999999666 7999999999876544
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 334578889999999876 578899999999999999999999983
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.63 Aligned_cols=195 Identities=21% Similarity=0.369 Sum_probs=161.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+.. +++.||+|+++... .+.+.+|+++++++.+|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 3689999999999999999997533 35789999986322 245778999999987899999999988654 3
Q ss_pred CCceEEEeccCCCchhhhcC------------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (387)
...+++|||+++++|..++.
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 46789999999998866541
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc---cccccccCCCC
Q 016537 224 ----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKG 296 (387)
Q Consensus 224 ----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~a 296 (387)
.+++..+..++.||+.||+|||+++|+||||||+|||++.++ .++|+|||+++.+...... ....++..|+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 457788899999999999999999999999999999999665 7999999999876433221 22345667999
Q ss_pred chhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 297 PELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 297 PE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||++.+ ..++.++|||||||+||||++ |..||.
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~ 277 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYP 277 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence 999877 679999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=277.56 Aligned_cols=193 Identities=20% Similarity=0.322 Sum_probs=158.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCe--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.++.++. .+++|.++.. ..+.+.+|++++.++.+||||+++++++.+. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence 578999999999999999999876654 4688887642 2256888999999987799999999998654 4578
Q ss_pred EEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceE
Q 016537 208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~v 268 (387)
++|||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~ 158 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-AS 158 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eE
Confidence 9999999999876652 267788999999999999999999999999999999998665 89
Q ss_pred EEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 269 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||+|||++..............+..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999864322111112223456999999876 678999999999999999997 999983
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.43 Aligned_cols=194 Identities=26% Similarity=0.525 Sum_probs=176.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
...|.+.+.||+|.|+.|..|++..++..||||++.+. ....+.+|+++|+.| +|||||+++.+...+ ..+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~--~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETE--ATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeec--ceeE
Confidence 36799999999999999999999999999999998753 235578999999999 999999999999765 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+|.+.+.+ ..+.+..++.+..|+..|++|||+++|||||||++||||+.+. ++||+|||++..+..+..
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeeccccc
Confidence 999999999987766 3577789999999999999999999999999999999999666 799999999999998888
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+.+|++.|.|||++.+.+..++.+|+||+|++||-|+.|..||.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 8999999999999999997777899999999999999999999995
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=272.80 Aligned_cols=198 Identities=26% Similarity=0.501 Sum_probs=167.1
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCCCCc
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSKTP 206 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~---~~~~~~ 206 (387)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+|+.+++++.+||||+++++++.. ......
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 3478999999999999999999998899999999986532 35678899999998679999999998753 233567
Q ss_pred eEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++||||+++++|..++ ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .++|+|||+++..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~ 174 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 174 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeec
Confidence 8999999999987653 2477888999999999999999999999999999999999766 7999999999876
Q ss_pred cCCC-cccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... ......|+..|+|||++.+ ...++.++|||||||++|||++|++||.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 4332 2234578899999999753 1347889999999999999999999984
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=272.14 Aligned_cols=195 Identities=25% Similarity=0.463 Sum_probs=166.7
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
..++|++.+.||+|+||.||+|.+..+++.+|+|++... ....+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~--~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSR--EKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC--CEEEE
Confidence 347899999999999999999999889999999998643 234577899999999 999999999998764 45679
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
||||+++++|..++ ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccccc
Confidence 99999999997765 3478899999999999999999999999999999999998666 79999999998764332 2
Q ss_pred ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||.+.. ...++.++|||||||++|||++|++||.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 234568889999998742 2457889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=275.29 Aligned_cols=192 Identities=20% Similarity=0.392 Sum_probs=161.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCC-----eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.+.||+|+||.||+|.+...+ ..+|+|.++... ...+.+|++++.++ +||||+++++++.+. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKE--Q 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCC--C
Confidence 57889999999999999999876554 689999986432 35678999999999 999999999998754 4
Q ss_pred CceEEEeccCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC
Q 016537 205 TPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 265 (387)
..+++|||+++++|..++ ..+++..++.++.|++.||+|||+++++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 567999999999987665 2366778899999999999999999999999999999999665
Q ss_pred ceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 162 -~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 162 -TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred -cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 899999999986543321 223456778999999876 678999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=288.66 Aligned_cols=194 Identities=25% Similarity=0.393 Sum_probs=160.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|.+.+.||+|+||.||+|.+... +..||||+++... .+.+.+|+++++++..||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-- 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-- 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--
Confidence 47899999999999999999986432 3579999986432 356889999999995599999999999654
Q ss_pred CCceEEEeccCCCchhhhcC------------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (387)
...++|||||++|+|..++.
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 45789999999998865431
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC
Q 016537 224 ---------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 224 ---------------------------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 264 (387)
.+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 25566778899999999999999999999999999999965
Q ss_pred CceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 265 ~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+ .+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 274 ~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 274 K-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred C-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 5 8999999999865433221 22345678999999877 678999999999999999997 888884
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=270.90 Aligned_cols=194 Identities=24% Similarity=0.426 Sum_probs=166.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.+|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|+||+++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 4789999999999999999999889999999987421 124678899999999 9999999999987765566
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++++||+++++|...+ ..+++..++.++.|++.||.|||+++++|+||||+||+++.++ .++|+|||+++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccc
Confidence 78999999999987665 3478888999999999999999999999999999999998665 7999999999765321
Q ss_pred ----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||.+.+ ..++.++|+|||||++|||++|++||.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 12234568889999999877 668899999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=271.43 Aligned_cols=193 Identities=25% Similarity=0.488 Sum_probs=173.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|.++++||+|+|++|..++++.+.+.||+|++++. .......|-.++.+..+||.+|-++.+|.. +..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 47899999999999999999999999999999998743 224567788888888899999999998855 3457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee-ecCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~-~~~~ 282 (387)
++|.||+++|+|...+ ++++++.++.|..+|+.||+|||++|||+||||.+|+|||.++ ++||+|+|+++. +.++
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~g 405 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCCC
Confidence 7999999999986554 4599999999999999999999999999999999999999887 899999999975 4567
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
....+++||+.|.|||++.+ .+|++.+|+|+|||+++||+.|+.||
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCc
Confidence 77788999999999999998 78999999999999999999999998
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=289.78 Aligned_cols=188 Identities=24% Similarity=0.462 Sum_probs=168.2
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
.+.||.|.||+||-|++..+|+.||||++.+ .....+.+|++||+++ +||.||.+...|+..+ .++.|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~e--rvFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPE--RVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCc--eEEEEehhh
Confidence 4789999999999999999999999999863 3457789999999999 9999999999998764 467999999
Q ss_pred CCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCCCcccc
Q 016537 214 NNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGKEYNV 287 (387)
Q Consensus 214 ~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~~~~~~ 287 (387)
.|.-|+.++ .++++...+.++.||+.||.|||.++|+|+||||+|||+.+. ...+||||||+|+.+........
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 988777665 468999999999999999999999999999999999999643 34799999999999877666677
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+||+.|+|||++.+ +.|+..-|+||.|||+|--++|.-||-
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCC
Confidence 899999999999988 889999999999999999999999983
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=270.36 Aligned_cols=194 Identities=24% Similarity=0.420 Sum_probs=165.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.+|+..+.||+|+||.||+|.+..++..|++|.+... ....+.+|+++++++ +||||+++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 4688899999999999999999888999999987532 124578899999999 9999999999987655567
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++++||+++++|...+ ..+++..++.++.|++.||+|||+++|+||||||+||+++.++ .++|+|||+++.....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccc
Confidence 78999999999987665 3478888999999999999999999999999999999998665 7999999998765321
Q ss_pred ----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||.+.+ ..++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 11223457888999999877 678999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=272.40 Aligned_cols=193 Identities=31% Similarity=0.601 Sum_probs=163.8
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
|++.+.||+|+||.||+|.+..+++.+|+|.++... .....+|+.+++++.+|+|++++++++.+......++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 578899999999999999998899999999986431 2334578999999867999999999998765467899999
Q ss_pred ccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccc
Q 016537 212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288 (387)
Q Consensus 212 ~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~ 288 (387)
|+.++.+..+. ..+++..++.++.|++.||+|||+++++||||||+||+++. +.+||+|||+++...........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence 99865444443 24789999999999999999999999999999999999996 48999999999877555444556
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.++..|+|||.+...+.++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 788999999987554567899999999999999999999983
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=272.46 Aligned_cols=193 Identities=22% Similarity=0.424 Sum_probs=162.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEE----eCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|++.+.||+|+||.||+|.. ..++..||+|.+.... .+.+.+|+++++++ +||||+++++++...+....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCce
Confidence 5789999999999999999974 3568899999986543 35678999999999 99999999998876655678
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccCC
Confidence 89999999999987652 378889999999999999999999999999999999998666 8999999999876443
Q ss_pred Ccc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 283 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
... ....++..|+|||++.+ ..++.++|||||||++|||++|..++
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 321 11223446999999876 67899999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=286.65 Aligned_cols=193 Identities=25% Similarity=0.466 Sum_probs=164.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.-|..++.||-|+||+|.++....+...||+|.+++. .....+.|..||... +.+-||+|+-.|.|. .++|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDk--dnLY 705 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDK--DNLY 705 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccC--CceE
Confidence 3488899999999999999998888999999988643 235678899999998 899999999888664 5678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec----
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH---- 280 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~---- 280 (387)
+||+|++||++..++ .-++|..++.|+.++.+|+++.|..|+|||||||+|||||.++ ++||+|||++.-+.
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceeccc
Confidence 999999999987665 4588999999999999999999999999999999999999877 89999999985331
Q ss_pred -----CCCc-----------c-----------------------cccccccCCCCchhhcccCCCCCccchhhHHHHHHH
Q 016537 281 -----PGKE-----------Y-----------------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAG 321 (387)
Q Consensus 281 -----~~~~-----------~-----------------------~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~e 321 (387)
.+.. . ...+||+.|+|||++.. ..|+..+|+||.||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHH
Confidence 1100 0 01369999999999987 679999999999999999
Q ss_pred HHhcCCchhh
Q 016537 322 MVSVSPSVLF 331 (387)
Q Consensus 322 lltg~~pf~~ 331 (387)
|+.|++||..
T Consensus 864 m~~g~~pf~~ 873 (1034)
T KOG0608|consen 864 MLVGQPPFLA 873 (1034)
T ss_pred HhhCCCCccC
Confidence 9999999953
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=283.18 Aligned_cols=192 Identities=24% Similarity=0.392 Sum_probs=166.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.+|..+.+||+|+||.|.+|..+.+.+.||||++++.- .+--..|-++|.-..+-|.+++++.++...+ .+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD--RLy 426 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--RLY 426 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh--hee
Confidence 67999999999999999999999999999999987421 1223567777776656789999998886543 467
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCC
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~ 283 (387)
+||||+.||+|...++ ++.+..+..|+.+|+-||-|||++|||+||||.+|||+|.++ ++||+|||+++.-- ++.
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIFDGV 505 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccccccCCc
Confidence 9999999999976664 588899999999999999999999999999999999999887 89999999997643 445
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
...+.+||+.|+|||++.- ++|+..+|+||+||+||||+.|++||
T Consensus 506 TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF 550 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF 550 (683)
T ss_pred ceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC
Confidence 5677899999999999865 89999999999999999999999999
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=276.51 Aligned_cols=191 Identities=25% Similarity=0.405 Sum_probs=165.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||+|+||.||++.+..++..+|+|.+... ...++.+|+++++++ +||||+++++++.+. ...++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSD--GEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CEEEEE
Confidence 4689999999999999999999889999999988643 235578899999999 999999999999764 457899
Q ss_pred EeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||+++++|..++ ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++ .+||+|||++...... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-cc
Confidence 9999999998776 347888999999999999999997 5999999999999999665 7999999998765332 22
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 44578899999999876 678999999999999999999999984
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=275.28 Aligned_cols=196 Identities=23% Similarity=0.438 Sum_probs=166.2
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
...+.|+++++||+|+||.||+|.+..+++.+++|.+.... .+.+.+|+.+++.+ +|+||+++++.+... ...+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWD--GKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeC--CeEE
Confidence 34578999999999999999999998889999999987543 35677899999999 999999999988754 4578
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~- 282 (387)
+||||++++++..++ ..+++..++.++.|++.||.|||+++++||||||+||+++.++ .++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceeccccc
Confidence 999999999987654 3478999999999999999999999999999999999998655 8999999998754322
Q ss_pred CcccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||++.+ ...++.++|||||||++|||++|.+||.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 22344568889999999852 2457889999999999999999999984
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=276.95 Aligned_cols=195 Identities=26% Similarity=0.567 Sum_probs=164.5
Q ss_pred CeEEEeeeeecCCeeEEEEEEeC--CCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ...+.+|+.+++++ +||||+++++++.+......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 47899999999999999999987 78999999987522 35678899999999 99999999999987655678
Q ss_pred eEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC----CCceEEEEeccc
Q 016537 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGL 275 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~----~~~~vkl~DFG~ 275 (387)
++||||+++..+..+. ..+++..++.++.|++.||+|||+++|+||||||+||+++. ++ .+||+|||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL 158 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence 9999999875443221 14788899999999999999999999999999999999986 44 899999999
Q ss_pred ceeecCCCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 276 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 276 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
++....... .....++..|+|||++.+...++.++|||||||++|||++|++||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 986543221 23446788899999987755688999999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.68 Aligned_cols=191 Identities=19% Similarity=0.385 Sum_probs=160.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.+..+++ .||+|+++... ...+.+|+.+++.+ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---C
Confidence 4789999999999999999999876665 48999886432 35678899999998 99999999999864 2
Q ss_pred CceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++++||+++|++...+. .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLD 160 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecc
Confidence 3679999999999876653 378899999999999999999999999999999999998655 79999999998765
Q ss_pred CCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 281 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 33221 11234567999999876 678999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=276.49 Aligned_cols=195 Identities=29% Similarity=0.556 Sum_probs=165.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+++++++ +|+||+++++++.+......+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence 478999999999999999999998899999999986332 23456899999999 999999999998766555678
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~- 282 (387)
+||||+.+ ++..++ ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCcc
Confidence 99999986 444332 3478999999999999999999999999999999999999666 8999999999876543
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 223344567889999998765678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=273.52 Aligned_cols=192 Identities=19% Similarity=0.363 Sum_probs=160.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++|++.+.||+|+||.||+|.+. .++..+++|.++... ...+.+|+++++++ +||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC--Cc
Confidence 67899999999999999999853 356789999986422 25678999999999 999999999998764 35
Q ss_pred ceEEEeccCCCchhhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC
Q 016537 206 PSLIFEHVNNTDFKVLYP--------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 265 (387)
.+++|||+.+++|..++. .+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 679999999999876651 256778889999999999999999999999999999999665
Q ss_pred ceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 162 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 162 -HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred -cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 799999999987643321 123345667999999876 678999999999999999999 998883
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=280.45 Aligned_cols=195 Identities=31% Similarity=0.635 Sum_probs=163.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---~~~ 205 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccce
Confidence 47899999999999999999999899999999998642 235577899999999 8999999999876533 234
Q ss_pred ceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
.++++||+.+ ++...+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeeccccc
Confidence 6899999986 444443 3488999999999999999999999999999999999999665 89999999997654322
Q ss_pred c----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .....++..|+|||.+.+...++.++|||||||++|+|++|++||.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 1335788899999997664678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=270.73 Aligned_cols=198 Identities=28% Similarity=0.522 Sum_probs=167.5
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CCCc
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP 206 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---~~~~ 206 (387)
..++|++.+.||+|+||.||+|.++.+++.+|+|.+... ....+.+|+.+++++.+|||++++++++...+ ....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 358899999999999999999999889999999998653 23667889999999878999999999987543 2357
Q ss_pred eEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++||||+++++|..++ ..+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||++...
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~ 178 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 178 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence 8999999999987654 3478889999999999999999999999999999999998666 7999999998765
Q ss_pred cCCC-cccccccccCCCCchhhcccC----CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... ......++..|+|||.+.... .++.++|||||||++|||++|++||.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 4332 223456788899999975422 36789999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=267.77 Aligned_cols=194 Identities=26% Similarity=0.510 Sum_probs=167.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++|++.+.||.|+||.||+|.+..+++.+++|.+... ..+.+.+|+++++++ +||||+++++++.+. ...+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRR--DKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeC--CEEEEE
Confidence 37899999999999999999999888999999998643 346788999999999 999999999988764 457899
Q ss_pred EeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
|||+.++++..++ ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .++|+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhc
Confidence 9999999987765 3588999999999999999999999999999999999999666 79999999997654332 2
Q ss_pred ccccccccCCCCchhhccc--CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||.+.+. ..++.++|+|||||++|||++|++||.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 3445788899999998652 268889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=269.33 Aligned_cols=192 Identities=19% Similarity=0.386 Sum_probs=158.5
Q ss_pred eEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
|++.+.||+|+||.||+|.+..+ +..||+|.++... ...+.+|++.++.+ +||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 45788999999999999987654 3789999986432 24678899999999 99999999998865432
Q ss_pred CCceEEEeccCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 204 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
...+++|||+.++++...+ ..+++..++.++.|++.||.|||+++++||||||+||++++++ .+||+|||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCcc
Confidence 3468999999999986554 2478888999999999999999999999999999999999665 89999999
Q ss_pred cceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 275 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 275 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~ 217 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYP 217 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99876543321 12234567999999866 678999999999999999999 888873
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=270.56 Aligned_cols=192 Identities=27% Similarity=0.572 Sum_probs=164.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|+++.+++.||||.+.. .....+.+|+++++++ +||||+++++++.+. ...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence 579999999999999999999988999999998753 1224678899999999 999999999998765 3567
Q ss_pred EEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
+++||++++++..++ ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~ 157 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceecc
Confidence 999999999987654 2278888999999999999999999999999999999999666 79999999998764
Q ss_pred CCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... .....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 3322 223467888999999876 678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=300.18 Aligned_cols=195 Identities=23% Similarity=0.424 Sum_probs=165.3
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
...+.+..++||+|+||+||+|+.. .+...||||.++... ..+|++|++++..| +|||||+|+|+|...+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGD 562 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCC
Confidence 3467788999999999999999763 335789999998543 46899999999999 9999999999998754
Q ss_pred CCCceEEEeccCCCchhhhcC-------------C----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC
Q 016537 203 SKTPSLIFEHVNNTDFKVLYP-------------T----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------~----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 265 (387)
-.+||+|||..|+|.++++ . +...+...++.||+.|++||-++.+|||||-..|+||. ++
T Consensus 563 --P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg-e~ 639 (774)
T KOG1026|consen 563 --PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG-EN 639 (774)
T ss_pred --eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-cc
Confidence 4669999999999998872 1 66788999999999999999999999999999999999 45
Q ss_pred ceEEEEecccceeecCCCccccc---ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchhh
Q 016537 266 RKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVLF 331 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~ 331 (387)
..|||+|||+++..-..+-+... .-...||+||.|.- ++|+.+||||||||+|||+++ |+.|+..
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccc
Confidence 59999999999866444333222 33567999999987 789999999999999999998 7888854
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.48 Aligned_cols=193 Identities=24% Similarity=0.468 Sum_probs=167.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..+|++.+.||+|+||.||+|.+..+++.+++|.+... ....+.+|+.+++.+ +|+|++++++.+.+. ...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~--~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeC--CEEEEe
Confidence 46899999999999999999999889999999988643 235678899999998 999999999998764 457899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
|||+++++|..++. .+++.++..++.|++.||+|||++||+||||||+|||++.++ .++|+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccccccccC
Confidence 99999999987764 378889999999999999999999999999999999998665 89999999987654332 223
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|+|++|++||.
T Consensus 175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~ 217 (296)
T cd06654 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (296)
T ss_pred cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 4578889999999876 678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=268.22 Aligned_cols=191 Identities=17% Similarity=0.317 Sum_probs=160.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.+.||+|+||.||++.++ ++..+|+|.+... ....+.+|+++++++ +||||+++++++.+. ...++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQ--KPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccC--CCEEEEEE
Confidence 57889999999999999999874 5668999987643 346788999999999 999999999998764 45789999
Q ss_pred ccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc--
Q 016537 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-- 285 (387)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~-- 285 (387)
|+++++|...+. .+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||.++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceecc
Confidence 999999877653 378888999999999999999999999999999999999655 8999999999765332221
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||.+.+ +.++.++|||||||++|||++ |++||.
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~ 203 (256)
T cd05114 159 SGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFE 203 (256)
T ss_pred CCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence 12234557999999876 678999999999999999999 899983
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=268.41 Aligned_cols=191 Identities=17% Similarity=0.323 Sum_probs=160.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.++||+|+||.||+|.+..+ ..+|+|.++.. ..+.+.+|+++++++ +||||+++++++.+ ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEEE
Confidence 36799999999999999999988544 56999998742 346789999999999 99999999998743 3468999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.++++..++. .+++..+..++.|++.||+|||+++++||||||+||+++.++ .++|+|||.++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc
Confidence 9999999877763 267788999999999999999999999999999999999665 7999999999866443321
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 12345567999999876 678999999999999999999 888873
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=274.55 Aligned_cols=194 Identities=30% Similarity=0.564 Sum_probs=165.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.++.+++.+|+|.++... ...+.+|+++++++ +||||+++++++........++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEE
Confidence 67899999999999999999998889999999986432 23567899999999 8999999999988765577899
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
||||+++ ++..++ ..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||++...... .
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLK 161 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCcc
Confidence 9999985 555443 2478999999999999999999999999999999999999665 8999999999876543 2
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+...++.++|+|||||++|||++|.+||.
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 33445678889999998764557889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=274.39 Aligned_cols=192 Identities=31% Similarity=0.608 Sum_probs=162.0
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||+|.+..+|+.+|+|.++.. ....+.+|+++++++ +||||+++++++.+. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSD--KKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccC--CceEEE
Confidence 488999999999999999999989999999998632 124577899999999 999999999998764 457899
Q ss_pred EeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cc
Q 016537 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~ 285 (387)
+||+.++.+..+. ..+++..++.++.||++||.|||+++|+||||||+||+++.++ .+||+|||+++...... ..
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCc
Confidence 9999865443332 3478999999999999999999999999999999999999666 89999999997654332 22
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||++.+...++.++|||||||++|||++|..||.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 345678899999998775567899999999999999999988863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.37 Aligned_cols=192 Identities=17% Similarity=0.332 Sum_probs=159.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.+..++. .+++|.+.... ..++..|+.+++++ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence 3678999999999999999999876665 47777775322 24567788888888 99999999998743 3
Q ss_pred CceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++++||+.+++|..++. .+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceecc
Confidence 4679999999999887762 478889999999999999999999999999999999999655 89999999998764
Q ss_pred CCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 4322 223456678999999876 679999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=265.89 Aligned_cols=191 Identities=25% Similarity=0.463 Sum_probs=165.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|++|.||+|.++.+++.|++|.+.. .....+.+|+++++++ +||||+++++++.+. ...++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDK--GKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccC--CEEEEE
Confidence 47889999999999999999988999999998753 2346678899999999 999999999998754 467899
Q ss_pred EeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence 9999999987765 3477888999999999999999999999999999999999666 799999999987654332
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|+|||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 234568889999999877 678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.32 Aligned_cols=192 Identities=19% Similarity=0.350 Sum_probs=162.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.++||+|+||.||+|.+ .++..||+|.+... ..+.+.+|+.+++++ +|+||+++++++.+. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKE--EPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC--CCcEEEE
Confidence 37899999999999999999987 46678999988643 346788999999999 999999999988654 4568999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.+++|..++. .++...++.++.|++.||+|||+++++||||||+||+++.++ .++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT 159 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCcee
Confidence 9999999877652 367788889999999999999999999999999999999666 8999999999876433211
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 160 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred ccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence 22334567999999876 678899999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.95 Aligned_cols=193 Identities=20% Similarity=0.344 Sum_probs=161.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|.+.+.||+|+||.||++.+. .++..+|+|.+.... .+.+.+|+++++++ +||||+++++++... .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG--D 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--C
Confidence 368999999999999999999752 345679999886432 35688999999999 999999999998754 4
Q ss_pred CceEEEeccCCCchhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceE
Q 016537 205 TPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~v 268 (387)
..++||||+.+++|..++. .+++..++.++.|++.||+|||++|++||||||+|||++.++ .+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~ 159 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV 159 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cE
Confidence 5789999999999876652 278889999999999999999999999999999999999666 89
Q ss_pred EEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 269 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 269 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999976543221 122344678999999876 678999999999999999998 899883
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=270.91 Aligned_cols=196 Identities=31% Similarity=0.618 Sum_probs=163.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---CC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---~~ 205 (387)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+|+.+++.+.+||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999998899999999876332 25678899999999667999999998875432 23
Q ss_pred ceEEEeccCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 206 PSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
.+++|||+++ ++...+ ..+++..++.++.||+.||.|||+++|+||||||+||+++.++..+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 6899999997 454332 2368899999999999999999999999999999999999745589999999997
Q ss_pred eecCC-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 65332 223344677889999998765568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.37 Aligned_cols=193 Identities=19% Similarity=0.365 Sum_probs=158.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.++. ++..+|+|.+... ...++.+|+.+++.+ +||||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG-- 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC--
Confidence 4789999999999999999998642 3568999988532 234578999999998 999999999998654
Q ss_pred CCceEEEeccCCCchhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEE
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl 270 (387)
...++||||+++++|..++.. ++...+..++.|++.||+|||+++++||||||+|||++.++ .++|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~l 160 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI 160 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CEEE
Confidence 457899999999998776532 34567888999999999999999999999999999999665 8999
Q ss_pred EecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 271 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 271 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+|||+++........ ....++..|+|||++.+ +.++.++|||||||++|||++ |.+||.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999998765432211 12345677999999876 678999999999999999999 688873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=267.12 Aligned_cols=191 Identities=20% Similarity=0.421 Sum_probs=164.9
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+|++.+.||+|+||.||++.+..+++.+|+|.++.. ..+.+.+|+.+++.+ +|+||+++++.+.+. ...+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEAD--GHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEE
Confidence 578999999999999999999989999999988532 235678899999999 999999999998764 4678999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
||++++++...+. .+++..++.++.|++.||.|||++||+|+||||+||+++.++ .++|+|||.+....... .
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccc
Confidence 9999998866542 378888999999999999999999999999999999998666 89999999997664332 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCC
Confidence 234578889999999876 668999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=290.71 Aligned_cols=193 Identities=23% Similarity=0.419 Sum_probs=169.8
Q ss_pred CCe-EEEeeeeecCCeeEEEEEEeCCCeEEEEEEec-------ccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~-------~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++| +...+||+|+|-+||+|.|..+|..||--.++ +...++|..|+.+|+.| .||||++++.++.+....+
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCce
Confidence 444 44578999999999999999899888865443 22347899999999999 9999999999999988888
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
+.+|.|.+..|+|..++ +.+....++.|++||++||.|||++. |||||||.+||+|+...+.|||+|+|+|....
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999998776 45788899999999999999999984 99999999999999887899999999998876
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..... ..+|||.|||||++. ..|+..+||||||++++||+|+..||.
T Consensus 198 ~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 198 KSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred ccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 55443 379999999999987 479999999999999999999999994
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=270.33 Aligned_cols=193 Identities=23% Similarity=0.419 Sum_probs=159.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||+|+||.||+|.++.+++.||+|.++... ...+..|+.++.+..+||||+++++++... ...+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 47899999999999999999999999999999986432 345666777655555999999999999764 457899
Q ss_pred EeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
|||+++ ++..++ ..+++..++.++.|++.||+|||++ +++||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence 999985 443222 2478999999999999999999997 999999999999999666 899999999987654
Q ss_pred CCcccccccccCCCCchhhccc---CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+...++..|+|||.+.+. ..++.++|+|||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 4333445788899999987542 347889999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=272.33 Aligned_cols=193 Identities=26% Similarity=0.441 Sum_probs=163.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEE----eCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
..|+++++||+|+||.||+|.+ ..++..||+|.++... ...+.+|+++++++ +||||+++++++.+.....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence 4578999999999999999975 3567899999986432 35688999999999 9999999999988765567
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+++++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||+++.+..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcccccccc
Confidence 889999999999987752 378889999999999999999999999999999999998665 799999999987654
Q ss_pred CCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 282 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
.... ....++..|+|||++.+ ..++.++|||||||++|||+++..|+
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCC
Confidence 3221 23456677999999876 67899999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=271.06 Aligned_cols=194 Identities=32% Similarity=0.640 Sum_probs=161.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|++|.||+|.++.+++.||+|.+... ..+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE--KRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecC--CeEEE
Confidence 5799999999999999999999889999999987532 235678899999999 999999999999764 46789
Q ss_pred EEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
||||+++..+..+.. .+++..++.++.||+.||+|||+++++||||||+||+++.++..+||+|||++...... .
T Consensus 79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999997543333322 24677888999999999999999999999999999999866668999999999765332 2
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+...++.++|||||||++|+|+||.+||.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22345678899999998764568899999999999999999999984
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=267.75 Aligned_cols=192 Identities=19% Similarity=0.368 Sum_probs=163.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.+|.+.+.||+|+||.||+|.++.+++.+|+|.+.... ...+.+|+++++++ +|+||+++++++... ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCC--CCcEEEEE
Confidence 56889999999999999999998889999999987543 35688999999999 999999999998754 45679999
Q ss_pred ccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
|+++++|...+. .+++..++.++.|++.||+|||+++++||||||+|||++.++ .+||+|||++..........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceeec
Confidence 999999877652 378888999999999999999999999999999999998665 89999999997654332111
Q ss_pred --ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 --VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 --~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 162 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred cCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 1223456999999876 678999999999999999998 898873
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=296.49 Aligned_cols=192 Identities=26% Similarity=0.509 Sum_probs=163.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~---~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+-|+++..||.|+||.||+|+.+.++...|.|++..... +.+.-||+||..+ +||+||++++.|...+ .+.++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~en--kLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFEN--KLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccC--ceEEEE
Confidence 345578899999999999999988888888898865443 5677899999997 9999999999776543 456899
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CCcc
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~~~ 285 (387)
|||.||....++ +.+.+.++..+++|++.||.|||+++|||||||+.|||++-+| .++|+|||.+..... -...
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHhhh
Confidence 999999876554 5689999999999999999999999999999999999999888 799999999754322 2233
Q ss_pred cccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 286 NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
..++||++|||||++.. ..+|++++||||||++|.||..+.||-
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH 235 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH 235 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence 56799999999999843 257999999999999999999999995
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=273.27 Aligned_cols=193 Identities=26% Similarity=0.472 Sum_probs=167.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..+|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +|+||+++++++... ...++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--CEEEEe
Confidence 47899999999999999999999889999999998642 235678899999998 999999999998764 457899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-cc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~~ 286 (387)
|||++++++..+.. .+++..+..++.|++.||.|||+.+++||||||+|||++.++ .++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCcC
Confidence 99999999987753 478889999999999999999999999999999999998665 899999999976544332 23
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred cccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4578889999999876 678899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=264.37 Aligned_cols=192 Identities=27% Similarity=0.471 Sum_probs=164.2
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|++|.||++.++.+++.+|+|.+... ..+.+.+|+++++++ +|+|++++++.+... ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence 488999999999999999999888999999998532 235678899999999 999999999987543 3456899
Q ss_pred EeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
|||++++++...+ ..+++.+++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCD 157 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCC
Confidence 9999999987664 2378999999999999999999999999999999999999665 89999999998764322
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 2234567889999999877 678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=269.67 Aligned_cols=193 Identities=21% Similarity=0.363 Sum_probs=166.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|+..+.||.|++|.||+|.+..+++.+|+|.+... ....+.+|+++++++ +||||+++++++.+......++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 4689999999999999999999889999999998643 235688999999999 99999999999877666678899
Q ss_pred EeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
|||+++++|..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccccc
Confidence 9999999987653 2378888999999999999999999999999999999999666 7999999998755432
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred cc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22 23457788999999876 678999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=269.32 Aligned_cols=192 Identities=23% Similarity=0.463 Sum_probs=168.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ...+.+|+++++.+ +|+||+++++++.+. ...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEEC--CeEEEE
Confidence 46888999999999999999998899999999986432 35678999999999 899999999998764 567899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Cccc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~ 286 (387)
+||+.+++|..++. .+++..++.++.|++.||.|||+++++||||+|+||+++.++ .++|+|||+++..... ....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeecccccccc
Confidence 99999999987765 478999999999999999999999999999999999999766 8999999999877544 2334
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 5578888999999877 569999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=271.55 Aligned_cols=194 Identities=23% Similarity=0.475 Sum_probs=165.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++.+ +||||+++++.+.+. ...+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~--~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRR--DKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--CEEEEE
Confidence 367889999999999999999998899999999986543 24567899999999 999999999998764 456799
Q ss_pred EeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cc
Q 016537 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~ 285 (387)
|||+++++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCccccc
Confidence 9999999998765 3588999999999999999999999999999999999999666 79999999987654322 22
Q ss_pred cccccccCCCCchhhc--ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....|+..|+|||++. ....++.++|+|||||++|||++|.+||.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 3457889999999974 22458889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=268.77 Aligned_cols=191 Identities=19% Similarity=0.377 Sum_probs=156.6
Q ss_pred EEEeeeeecCCeeEEEEEEeCCCe--EEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----CCC
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~~~ 205 (387)
.+.+.||+|+||.||+|.+..++. .+|+|.++.. ..+.+.+|+++++.+ +|+||+++++++.... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence 366889999999999999866664 6899987532 235678899999999 9999999999875322 235
Q ss_pred ceEEEeccCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 206 PSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
.+++|||+.++++..++ ..+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence 68999999999987654 1267888999999999999999999999999999999998665 8999999999
Q ss_pred eeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 277 EFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 277 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |++||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 216 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYP 216 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 87644322 122345667999999876 678999999999999999999 788883
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=270.62 Aligned_cols=191 Identities=34% Similarity=0.629 Sum_probs=165.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+|+.+++++ +||||+++++++.+. ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHG--SGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecC--CeeEEE
Confidence 5889999999999999999998899999999986432 35788999999999 899999999998764 457899
Q ss_pred EeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
|||+ +++|..++ ..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPR 155 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCC
Confidence 9999 88887664 3478999999999999999999999999999999999999655 89999999998765433
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+...++.++|||||||++|||++|.++|.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 23455788999999998765567899999999999999999988773
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=254.47 Aligned_cols=193 Identities=21% Similarity=0.398 Sum_probs=165.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++...+..||+|+||.|-+-++..+|+..|+|.++. +..++..+|+.+..+...+|.+|.++|.+.+.. .+.+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEe
Confidence 556667899999999999999999999999999863 334677889998888778999999999776543 35688
Q ss_pred EeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
||.|+ .++..++ ..++|.-+-+++..+..||+|||++ .+||||+||+||||+.++ +||+||||++-.+.+
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLVD 201 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeehh
Confidence 88887 4555444 3488999999999999999999987 899999999999999777 899999999998887
Q ss_pred CCcccccccccCCCCchhhcc---cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+...+...|...|||||.+.. ...|+.++||||||+.+.||.+++.||.
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 777777889999999999843 2469999999999999999999999984
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.28 Aligned_cols=192 Identities=21% Similarity=0.379 Sum_probs=162.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|.+.+.||+|+||.||+|.+.. +++.||+|.++... .+.+.+|+++++++ +|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEG--D 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC--C
Confidence 578899999999999999998743 35789999986432 35788999999999 999999999998765 4
Q ss_pred CceEEEeccCCCchhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCce
Q 016537 205 TPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~ 267 (387)
..++||||+++++|..++. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~ 160 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-V 160 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-e
Confidence 5789999999999877652 257778899999999999999999999999999999999666 8
Q ss_pred EEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 268 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 268 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 99999999976533221 123345678999999877 679999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=272.27 Aligned_cols=191 Identities=34% Similarity=0.632 Sum_probs=163.2
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+++++++ +|+||+++++++.+ ....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence 4788999999999999999998889999999986432 23467899999999 89999999999976 3567
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+ +++|..++. .+++..++.++.||++||.|||++||+|+||||+||+++.++ .++|+|||+++.....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCC
Confidence 8999999 788876653 478899999999999999999999999999999999999666 8999999999876543
Q ss_pred C-cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......++..|+|||.+.+...++.++|||||||++|||++|.+||.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 2 23344567889999998665678899999999999999999988773
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=268.58 Aligned_cols=193 Identities=18% Similarity=0.339 Sum_probs=162.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.++.. +..||+|.+.... ...+.+|+++++.+ +||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC--
Confidence 47899999999999999999988643 3789999986432 24678899999998 999999999998764
Q ss_pred CCceEEEeccCCCchhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEE
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl 270 (387)
...++||||+.+++|..++. .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~kl 160 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKI 160 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEEE
Confidence 55789999999999887653 246678888999999999999999999999999999999766 8999
Q ss_pred EecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 271 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |++||.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 99999976543321 223456778999999876 678999999999999999998 999883
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=279.86 Aligned_cols=195 Identities=22% Similarity=0.383 Sum_probs=159.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ...+.+|+.++.++.+||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 368999999999999999999852 457899999986432 2457889999999978899999999886543
Q ss_pred CCceEEEeccCCCchhhhcC------------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (387)
...+++|||+++++|..++.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 45689999999999876542
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc---ccccc
Q 016537 224 ----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVA 290 (387)
Q Consensus 224 ----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~~g 290 (387)
.++...+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++......... ....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCC
Confidence 145667788999999999999999999999999999999665 8999999999765333221 12234
Q ss_pred ccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 283 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 283 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 567999999876 678999999999999999997 888873
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=270.24 Aligned_cols=197 Identities=25% Similarity=0.473 Sum_probs=165.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----CCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~----~~~~~ 206 (387)
.+.|++.+.||+|+||.||+|.+..+++.+|+|++... ....+..|+.+++++.+|+||+++++++... .....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 46788999999999999999999889999999998543 2356788999999987899999999988542 23567
Q ss_pred eEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
+++|||+.++++..++. .+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++.....
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~~ 173 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhhc
Confidence 89999999998876653 367888899999999999999999999999999999999666 799999999876532
Q ss_pred C-CcccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 G-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .......++..|+|||++.. ...++.++|||||||++|||++|.+||.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 2 22344578889999999752 2458889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=265.88 Aligned_cols=191 Identities=17% Similarity=0.314 Sum_probs=160.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+|+++++++ +||||+++++++.+. ...+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQ--RPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccC--CCcEEEEE
Confidence 67899999999999999999874 45569999886432 46789999999999 999999999998654 35689999
Q ss_pred ccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc-
Q 016537 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN- 286 (387)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~- 286 (387)
|+.++++..++. .+++..++.++.|++.||+|||+++++|+||||+||+++.++ .+||+|||.++.........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceeec
Confidence 999998877652 478889999999999999999999999999999999999665 89999999998654432211
Q ss_pred -ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 -VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 -~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|++||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 159 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~ 203 (256)
T cd05113 159 VGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE 203 (256)
T ss_pred CCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 1234567999999876 578999999999999999999 998873
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=270.99 Aligned_cols=193 Identities=26% Similarity=0.492 Sum_probs=167.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..+|++.+.||.|++|.||+|.+..+++.|++|.+... ..+.+.+|+.+++.+ +||||+++++++.+. ...++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVG--DELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecC--ceEEEE
Confidence 36799999999999999999999889999999988532 346678899999999 999999999998754 457899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-cc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~~ 286 (387)
+||+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccCC
Confidence 99999999987664 478999999999999999999999999999999999998666 799999999876544332 23
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|+|++|++||.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3468889999999876 678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=272.72 Aligned_cols=193 Identities=33% Similarity=0.634 Sum_probs=165.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.++.+++.+|+|.+... ..+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRK--KRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccC--CeEEE
Confidence 4689999999999999999999888999999987532 235678899999999 999999999998654 45789
Q ss_pred EEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
||||++++++..+.. .+++..++.++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccc
Confidence 999999998876653 478999999999999999999999999999999999999665 89999999998764432 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 3445678899999998765567889999999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=264.20 Aligned_cols=192 Identities=24% Similarity=0.483 Sum_probs=168.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
++|++.+.||+|+||.||+|.+..++..+++|.+.... .+.+.+|+++++++ +|+||+++++++.+. ...++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFKN--TDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecC--CcEEEEEec
Confidence 68999999999999999999998888999999987543 57789999999999 999999999998764 567899999
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cccc
Q 016537 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (387)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~ 287 (387)
+.+++|..++ ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++....... ....
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCcccccc
Confidence 9999988765 3478999999999999999999999999999999999999766 79999999998765433 2334
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..++..|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 159 ~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~ 200 (256)
T cd06612 159 VIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYS 200 (256)
T ss_pred ccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 567889999999877 678999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=265.28 Aligned_cols=193 Identities=30% Similarity=0.539 Sum_probs=167.7
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||.|+||.||+|.+..+++.+|+|.+... ..+.+.+|+++++++ +|+||+++++++........+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 488999999999999999999889999999988532 235678899999999 99999999998876656677899
Q ss_pred EeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHH-----HcCceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH-----~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
|||+++++|..++ ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++ .+||+|||++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccccc
Confidence 9999999987665 34788899999999999999999 89999999999999999655 89999999998
Q ss_pred eecCCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....... .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 211 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFT 211 (265)
T ss_pred cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCccc
Confidence 7654443 344578899999999877 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=265.79 Aligned_cols=185 Identities=24% Similarity=0.427 Sum_probs=155.5
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
+.||+|+||.||+|.++.+++.+|+|.+... ....+.+|+++++++ +||||+++++++.+. ...++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQK--QPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC--CCeEEEEeeccC
Confidence 3699999999999999889999999987532 235688999999999 999999999998764 457899999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc---cc
Q 016537 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---VR 288 (387)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~---~~ 288 (387)
++|..++. .+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||++.......... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCC
Confidence 99887752 378888999999999999999999999999999999999666 79999999987654321111 11
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
..+..|+|||.+.+ +.++.++|||||||++|||++ |.+||
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~ 197 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPY 197 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 22346999999876 678999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=266.13 Aligned_cols=198 Identities=24% Similarity=0.467 Sum_probs=167.9
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----CCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~~~ 205 (387)
..++|++.+.||+|++|.||+|.++.+++.+++|++.... ...+.+|+++++++.+|+||+++++++.+.. ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 3588999999999999999999998889999999987443 4678899999999878999999999987643 345
Q ss_pred ceEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
.++||||+++++|..+. ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~ 162 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCcccee
Confidence 78999999999887654 2478889999999999999999999999999999999999665 899999999876
Q ss_pred ecCCC-cccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..... ......++..|+|||++.. ...++.++|||||||+||+|++|++||.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 54322 2234568889999999753 1347789999999999999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=288.63 Aligned_cols=193 Identities=25% Similarity=0.470 Sum_probs=174.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.+++++..||-||||.|=++..+.....+|+|++++ ...+++..|-+||... +.|.||++|..|.+ ..++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyvY 496 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYVY 496 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhhh
Confidence 567788999999999999998866666789998864 2346788899999998 89999999999976 57889
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
++||-|-||.+..+++ .+.+..++.++..+++|++|||++|||+|||||+|.++|.++ -+||.|||+|+.+..+..
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhccCCc
Confidence 9999999999988874 488999999999999999999999999999999999999877 699999999999999999
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
..++|||+.|.|||++.+ +..+.++|.||||+++|||++|.|||..
T Consensus 576 TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999998 7789999999999999999999999953
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=271.41 Aligned_cols=196 Identities=32% Similarity=0.554 Sum_probs=162.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|++.+.||+|+||.||+|.+..+++.||||.+.... ...+.+|+++++++ +||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 368999999999999999999998899999999885321 23567899999999 99999999998875432
Q ss_pred --CCceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 204 --KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...++||||+.+.....+.. .+++.+++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCccc
Confidence 34589999998643333322 478999999999999999999999999999999999999666 899999999976
Q ss_pred ecCCC-----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..... ......++..|+|||.+.+...++.++|||||||++|||++|.+||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 54322 12344677889999998765557889999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=263.87 Aligned_cols=192 Identities=23% Similarity=0.438 Sum_probs=167.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|||++++++.+... ...++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLED--KALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecC--CEEEEE
Confidence 588999999999999999999889999999988542 235788999999999 999999999988653 457899
Q ss_pred EeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|||+++++|..++. .+++..++.++.|++.||+|||+++++|+||||+||+++.++..+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999877653 3788899999999999999999999999999999999986666789999999987755444
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~ 202 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFE 202 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 445678889999999876 568899999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=269.87 Aligned_cols=193 Identities=36% Similarity=0.626 Sum_probs=167.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ..+.+.+|+++++++ +|+||+++++++.+. ...++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRK--GRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEEC--CEEEE
Confidence 4699999999999999999999888999999987632 236788999999999 899999999999764 45789
Q ss_pred EEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
+|||++++.+..+.. .+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCccc
Confidence 999999987765543 378999999999999999999999999999999999999655 89999999998765443
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 33456778899999999874478999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=264.15 Aligned_cols=192 Identities=26% Similarity=0.557 Sum_probs=166.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.+|+|.++. ...+.+.+|+++++++ +|+|++++++++.+. ...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIEN--NELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecC--CeEE
Confidence 679999999999999999999988999999998753 1246788999999999 999999999998764 4568
Q ss_pred EEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
++|||+++++|..++. .+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~ 157 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeecc
Confidence 9999999999876642 368889999999999999999999999999999999999666 79999999997654
Q ss_pred CCC-cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 332 2234568888999999876 678999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=264.04 Aligned_cols=191 Identities=20% Similarity=0.385 Sum_probs=161.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|++|.||+|.+. +++.||+|.++.. ..+.+.+|+++++++ +||||+++++++... ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLE--EPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecC--CCeeeee
Confidence 367999999999999999999974 5678999998753 346788999999999 899999999988764 3567999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.+++|..++. .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||+++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCcc-
Confidence 9999999987753 377889999999999999999999999999999999999666 799999999987653221
Q ss_pred ccccc---ccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 ~~~~g---t~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....+ +..|+|||.+.+ ..++.++|||||||++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 11222 346999999876 678999999999999999999 999883
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=267.91 Aligned_cols=194 Identities=21% Similarity=0.366 Sum_probs=161.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ...+.+|+.+++++ +|+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER-- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--
Confidence 3679999999999999999999876 67889999876332 34688899999999 999999999988764
Q ss_pred CCceEEEeccCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEE
Q 016537 204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLI 271 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~ 271 (387)
...++||||+.+++|..++. .+++..+..++.||+.||+|||+++++||||||+|||++.++ ..+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 34679999999999987652 367888999999999999999999999999999999998543 368999
Q ss_pred ecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 272 DWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 272 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|||+++........ .....+..|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999876322111 12223457999999877 679999999999999999997 999883
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=264.78 Aligned_cols=191 Identities=19% Similarity=0.369 Sum_probs=160.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.++||+|+||.||+|.+ .++..+|+|.+... ....+.+|+.+++++ +|+|++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEe-cCCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEEE
Confidence 36789999999999999999987 46677999998743 346789999999999 99999999998743 3467999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.+++|..++. .+++..++.++.|++.||+|||+++|+||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc
Confidence 9999999877652 378889999999999999999999999999999999999655 8999999999876443211
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence 12234567999999866 678999999999999999999 888884
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=276.60 Aligned_cols=189 Identities=21% Similarity=0.256 Sum_probs=157.1
Q ss_pred EEeeeeec--CCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 138 VVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 138 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++++||+| +|++||++.++.+++.||+|.+.... .+.+.+|+++++.+ +||||+++++++.+.+ ..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~--~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADN--ELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC--EEEEEE
Confidence 46789999 78999999999999999999986432 24577899999998 9999999999997653 567999
Q ss_pred eccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 211 e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
||++++++..++ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++++|||.+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence 999999987765 2378899999999999999999999999999999999999666 799999987543321110
Q ss_pred -------ccccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 -------YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -------~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+. ..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 1123466779999998653 358899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=266.70 Aligned_cols=192 Identities=24% Similarity=0.473 Sum_probs=164.9
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
+|+..+.||+|+||.||+|.+..+++.+|+|.+.... .+.+.+|+++++++ +|+||+++++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCED--SH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccC--Ce
Confidence 3677889999999999999998999999999986422 35688999999999 999999999998754 45
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++||||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++..++|+|||.+......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 67999999999998776 347889999999999999999999999999999999999866657999999999766432
Q ss_pred Cc-----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 11 123467888999999876 678999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=270.17 Aligned_cols=195 Identities=19% Similarity=0.273 Sum_probs=148.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccch--------------HHHHHHHHHHHHhcCCCCeeEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK--------------KKIKREIKILQNLCGGPNIVKLL 195 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~~--------------~~~~~E~~il~~l~~hpniv~l~ 195 (387)
.++|++.++||+|+||.||+|.+..+ +..+|+|+...... .....+...+..+ +|+|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~ 89 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYY 89 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEE
Confidence 36899999999999999999998776 66777776432211 0111223334455 899999999
Q ss_pred EEEEcCCC--CCceEEEeccCCCch--hhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEE
Q 016537 196 DIVRDQQS--KTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (387)
Q Consensus 196 ~~~~~~~~--~~~~lv~e~~~~~~l--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~ 271 (387)
+....... .+.+++++++..... .......++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-RGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-cEEEE
Confidence 97654322 234577777654322 22223467888899999999999999999999999999999998665 79999
Q ss_pred ecccceeecCCC--------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 272 DWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 272 DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|||+|+.+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|++||.
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999998764321 1123469999999999877 679999999999999999999999994
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=267.05 Aligned_cols=191 Identities=25% Similarity=0.475 Sum_probs=167.7
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+|++.+.||.|+||.||+|.+..+++.+|+|.+... ..+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDE--ENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCC--CeEEE
Confidence 488999999999999999999888999999998632 246788999999999 999999999988653 46789
Q ss_pred EEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|+||+.+++|...+. .+++..+..++.|+++||.|||+++++|+||||+||+++.++ .++|+|||++.........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCccc
Confidence 999999999876653 588999999999999999999999999999999999999666 7999999999876555444
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~ 200 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYR 200 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCC
Confidence 55678888999999876 568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.67 Aligned_cols=194 Identities=24% Similarity=0.469 Sum_probs=165.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+.... .+.+.+|+++++++ +||||+++++++.+. ...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYE--NKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecC--CeEEEE
Confidence 367899999999999999999998889999999986443 24678899999999 899999999998764 456899
Q ss_pred EeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
|||++++++..++ ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccc
Confidence 9999999997775 3488999999999999999999999999999999999999666 89999999986543322 2
Q ss_pred ccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.. ...++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~ 209 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence 234568889999999752 2457889999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=262.55 Aligned_cols=191 Identities=24% Similarity=0.458 Sum_probs=165.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++++.||.|+||.||.+++..+++.+++|.+... ....+.+|+++++++ +|+||+++++++.+. ...+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDD--NTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecC--CeEEEE
Confidence 488999999999999999999899999999987532 235688999999999 999999999999764 467899
Q ss_pred EeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
|||+++++|...+. .+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence 99999999887663 378889999999999999999999999999999999999666 79999999998764433
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 2344578899999999877 568889999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=271.66 Aligned_cols=192 Identities=21% Similarity=0.367 Sum_probs=158.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.+|++.++||+|+||.||+|.+.. .+..||+|.++... ...+.+|+.++..+ +||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCC--
Confidence 467788999999999999998753 35789999987432 24578899999998 9999999999987654
Q ss_pred CceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC
Q 016537 205 TPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 265 (387)
..++++||+.++++..++. .+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 4679999999998876641 267778899999999999999999999999999999998665
Q ss_pred ceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 162 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 162 -NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred -ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 799999999876543322 123345678999999876 678999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=268.70 Aligned_cols=192 Identities=24% Similarity=0.461 Sum_probs=162.8
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
-|++.+.||+|+||.||+|.+..++..+++|.+.... .+.+.+|+++++.+ +|||++++++++... ...++|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeC--CEEEEEEE
Confidence 3678889999999999999998889999999986433 35678899999999 999999999998764 45789999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
|++++++...+ ..+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++....... ...
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEccccccccccccccccc
Confidence 99999987654 3478999999999999999999999999999999999998665 79999999987653321 223
Q ss_pred ccccccCCCCchhhc----ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||++. ....++.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 456888999999974 22457889999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=263.43 Aligned_cols=184 Identities=20% Similarity=0.365 Sum_probs=152.9
Q ss_pred eeeecCCeeEEEEEEe--CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccC
Q 016537 141 KVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~--~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~ 214 (387)
.||+|+||.||+|.+. .++..||+|++.... .+.+.+|+.+++++ +||||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999875 345679999986543 25688999999999 99999999998743 35689999999
Q ss_pred CCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc----c
Q 016537 215 NTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N 286 (387)
Q Consensus 215 ~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~----~ 286 (387)
+++|..++. .+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+|||+++........ .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccC
Confidence 999887652 478999999999999999999999999999999999998665 8999999999765433221 1
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 1123467999999876 678999999999999999996 999984
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=257.14 Aligned_cols=205 Identities=20% Similarity=0.276 Sum_probs=168.9
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---QSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~---~~~~ 205 (387)
..++|.+.++||.|||+.||++..-.+++.||+|.+.-. ..+...+|++..+++ +|||+++++++...+ ....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCcee
Confidence 458999999999999999999998899999999988633 346778999999999 999999999866432 3456
Q ss_pred ceEEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 206 PSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
.|++++|...|+|.+.+. .+++.++..|+.++++||++||+.. +.||||||.|||+.+++ .++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccCc
Confidence 789999999998765542 3899999999999999999999998 99999999999998655 8999999998
Q ss_pred eeecCCC----------cccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchhhhccCCCCC
Q 016537 277 EFYHPGK----------EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGLGHS 339 (387)
Q Consensus 277 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~~~~~ 339 (387)
....-.. +......|..|+|||++.- ....+.++|||||||+||+|+.|..||..... .|.+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgS 250 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGS 250 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCe
Confidence 6542111 1123356788999999842 23578899999999999999999999976655 4433
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=268.55 Aligned_cols=193 Identities=20% Similarity=0.396 Sum_probs=160.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||++.+... ...+|+|.+.... ...+.+|+++++++.+|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence 36899999999999999999987543 3789999886432 245788999999987899999999998654
Q ss_pred CCceEEEeccCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC
Q 016537 204 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 264 (387)
...+++|||+.+++|..++ ..+++..++.++.|++.||.|||+++|+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 4578999999999987665 236788899999999999999999999999999999999966
Q ss_pred CceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 265 ~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
+ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 169 ~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~ 235 (293)
T cd05053 169 H-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY 235 (293)
T ss_pred C-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCC
Confidence 5 8999999999866433211 12234567999999876 678999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=270.25 Aligned_cols=194 Identities=24% Similarity=0.388 Sum_probs=161.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.++... .+.+.+|+++++++.+||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 368999999999999999999752 345689999886432 246789999999997799999999998764
Q ss_pred CCceEEEeccCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...+++|||+.+++|..++.. +++..+..++.|++.||.|||+++|+|+||||+|||++.++ .++|+|||+++.
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~ 190 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARD 190 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCccccc
Confidence 457899999999998776532 78899999999999999999999999999999999998555 899999999976
Q ss_pred ecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 279 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 279 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....... ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence 5433221 12345677999999876 678999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=262.87 Aligned_cols=189 Identities=17% Similarity=0.361 Sum_probs=159.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
++|++.+.||+|+||.||++.. .+..+|+|.++... .+.+.+|+.+++++ +|+|++++++++... ....+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEEC
Confidence 6789999999999999999976 47889999987543 35688999999999 999999999986543 3456899999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccc
Q 016537 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (387)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~ 287 (387)
+++++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~~ 158 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--DT 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC--CC
Confidence 99999877653 267888899999999999999999999999999999999666 89999999997654322 22
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..++..|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 159 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 159 GKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred CccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 334567999999876 678999999999999999998 998873
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=269.00 Aligned_cols=192 Identities=20% Similarity=0.340 Sum_probs=161.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.+|.+.+.||+|+||.||+|.+. .++..+++|.++... .+.+.+|+++++++ +|+||+++++++.+. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDG--DP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccC--Cc
Confidence 56899999999999999999853 245678999886543 35688999999999 999999999998754 45
Q ss_pred ceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc
Q 016537 206 PSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 266 (387)
.++||||+++++|..++. .+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~- 160 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL- 160 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-
Confidence 789999999999887652 267788999999999999999999999999999999999666
Q ss_pred eEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 267 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 899999999976543321 123456778999999877 678999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=266.18 Aligned_cols=187 Identities=20% Similarity=0.318 Sum_probs=153.0
Q ss_pred eeeeecCCeeEEEEEEeCCCe--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.++.++. .+++|.++.. ....+.+|++++.++.+||||+++++++... ...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeC
Confidence 358999999999999877765 4688887642 2356788999999998899999999998764 4578999999
Q ss_pred CCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 214 NNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 214 ~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
++++|..++. .+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+|||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg 157 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFG 157 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCC
Confidence 9999876652 267888999999999999999999999999999999999665 89999999
Q ss_pred cceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 275 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
++..............+..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9864321111122233456999999866 678999999999999999997 999983
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=268.47 Aligned_cols=213 Identities=30% Similarity=0.471 Sum_probs=178.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------ 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~------ 201 (387)
...|+.+.+||+|.||+||+|+.+.++++||+|++--. ......+|+.+|..| .|+|++.++++|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence 36788889999999999999999999999998864322 124568999999999 999999999988642
Q ss_pred CCCCceEEEeccCCCchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 202 QSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
+...+|+||.+|++.... ....+++..++..++.+++.||.|+|++.|+|||+|++|+||+.++ .+||+|||+++.
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccccccc
Confidence 233578999999975433 3334588999999999999999999999999999999999999777 899999999976
Q ss_pred ecCC-----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccc
Q 016537 279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTW 344 (387)
Q Consensus 279 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~ 344 (387)
+... ..++.++.|.+|++||.+.|...|+++.|||..|||+.||+||.|.+.. .....|..+.+.|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 5422 3467788899999999999999999999999999999999999999854 4456777888889
Q ss_pred ccc
Q 016537 345 FLR 347 (387)
Q Consensus 345 ~~~ 347 (387)
+.-
T Consensus 254 P~~ 256 (376)
T KOG0669|consen 254 PNV 256 (376)
T ss_pred CCc
Confidence 863
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=263.58 Aligned_cols=184 Identities=20% Similarity=0.375 Sum_probs=153.9
Q ss_pred eeeecCCeeEEEEEE--eCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 141 KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~--~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+||+|+||.||+|.+ +.++..+|+|+++... .+.+.+|+.+++++ +||||+++++++.+ ...++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence 689999999999975 3567899999986432 35688899999999 99999999998853 3457999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc----c
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N 286 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~----~ 286 (387)
.+++|..++ ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecC
Confidence 999987765 3478899999999999999999999999999999999999655 8999999999776433221 1
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 200 (257)
T cd05116 157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK 200 (257)
T ss_pred CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 2233568999999865 678899999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=271.40 Aligned_cols=196 Identities=30% Similarity=0.593 Sum_probs=163.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|++.+.||+|+||.||+|.++.+++.+|+|.+.... ...+.+|+++++++ +||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence 478999999999999999999998899999999875321 24567899999999 99999999998765332
Q ss_pred --CCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 204 --KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...++||||+.+..+..+. ..+++..++.++.|+++||+|||++||+||||||+||+++.++ .++|+|||+++.
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchh
Confidence 3568999999875444433 2589999999999999999999999999999999999999666 899999999976
Q ss_pred ecCCCc------------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...... .+...++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 532211 1234567889999998765568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=271.45 Aligned_cols=192 Identities=23% Similarity=0.386 Sum_probs=164.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.+|+|.+... ..+.+.+|+++++++ +|+||+++++.+.+. ...+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTE--TYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecC--CEEE
Confidence 4689999999999999999999888999999998643 234678899999999 899999999998654 4678
Q ss_pred EEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
+||||+.+++|..++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccc
Confidence 9999999999987753 478889999999999999999999999999999999999665 7999999998654322
Q ss_pred Cc------------------------------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 11 112467888999999877 568999999999999999999999983
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=273.84 Aligned_cols=194 Identities=27% Similarity=0.580 Sum_probs=163.4
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---- 202 (387)
..++|++.+.||+|+||.||+|.+..+++.||+|.++... .+.+.+|+++++++ +||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccc
Confidence 4588999999999999999999998899999999986422 35677899999999 9999999999886432
Q ss_pred CCCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 203 SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
....+++++++ ++++..++ ..+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++...
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccccccc
Confidence 13356777776 56776554 3488999999999999999999999999999999999999766 79999999997643
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 172 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred c--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2 23445788899999998765568899999999999999999999983
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=262.67 Aligned_cols=191 Identities=19% Similarity=0.361 Sum_probs=161.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.++||+|+||.||+|.. .+++.+|+|.+... ....+.+|+.+++++ +|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEEE
Confidence 37899999999999999999986 56788999998743 346789999999999 99999999998743 3478999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.++++...+. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcc
Confidence 9999999877652 378888999999999999999999999999999999999666 7999999999776532211
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 22345667999999876 678899999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=267.83 Aligned_cols=192 Identities=27% Similarity=0.552 Sum_probs=164.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.++.+++.+|||.+... ....+.+|+++++.+ +|+||+++++++.+. ...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--NELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeC--CeEE
Confidence 5688899999999999999999889999999987532 235678899999999 999999999998764 4567
Q ss_pred EEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
++|||+++++|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccc
Confidence 9999999999876642 378889999999999999999999999999999999999666 89999999987654
Q ss_pred CCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 3322 233468889999999876 678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=275.72 Aligned_cols=196 Identities=30% Similarity=0.575 Sum_probs=164.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC------
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~------ 203 (387)
..+|++.+.||.|+||.||+|.++.+++.||+|.+.... .+.+.+|+++++++ +||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence 478999999999999999999999999999999886432 35678899999999 99999999987764322
Q ss_pred ------CCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccc
Q 016537 204 ------KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (387)
Q Consensus 204 ------~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~ 275 (387)
...++||||+.+ ++...+ ..+++..++.++.|++.||.|||++||+||||||+||+++.++..+||+|||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 246799999985 665554 35889999999999999999999999999999999999986666899999999
Q ss_pred ceeecCCC----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 276 AEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 276 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
++...... ......++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 97653321 11234678899999987654668899999999999999999999994
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=265.54 Aligned_cols=192 Identities=33% Similarity=0.636 Sum_probs=164.0
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|+|++++++++.+......++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 67889999999999999999888999999998754 235678899999999 899999999999865346788999
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--c
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--~ 284 (387)
||+++ ++..++ ..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||++....... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCccc
Confidence 99986 555443 2478889999999999999999999999999999999999665 89999999998765443 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+...++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 3445677889999987764568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=265.29 Aligned_cols=192 Identities=20% Similarity=0.368 Sum_probs=161.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.++.+++ .+|+|.+.... ...+.+|+.+++++ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---C
Confidence 3678999999999999999999866654 68999876432 35678899999999 99999999999875 4
Q ss_pred CceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++||||+.++++...+. .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCccccccc
Confidence 5679999999999877653 378999999999999999999999999999999999998666 89999999998765
Q ss_pred CCCcccc---cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....... ..++..|+|||.+.+ ..++.++|+|||||++|||++ |++||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred CcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 4332211 123457999999865 678999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=264.04 Aligned_cols=190 Identities=25% Similarity=0.488 Sum_probs=161.7
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
|.+.+.||+|++|.||+|.+..+++.+|+|.+.... .+.+.+|+++++++ +||||+++++++.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDA-- 78 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC--
Confidence 567789999999999999998889999999875321 14577899999999 999999999998764
Q ss_pred CCceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.+.+++|||+++++|..++. .+++..+..++.|++.||.|||+++++||||||+||++++++ .++|+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLE 157 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCcccc
Confidence 46779999999999877763 478888999999999999999999999999999999998665 89999999997664
Q ss_pred CCC-------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 221 1122357788999999876 678899999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=263.78 Aligned_cols=190 Identities=25% Similarity=0.450 Sum_probs=161.7
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
+|++.+.||+|+||.||+|.+ .+++.+|+|.++... ...+.+|+++++++ +|+||+++++++.+. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDD--NT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecC--Ce
Confidence 467889999999999999987 578899999876321 24578899999999 999999999999764 56
Q ss_pred ceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++ .++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhc
Confidence 789999999999987753 478889999999999999999999999999999999999666 8999999998754211
Q ss_pred -------CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 11233468889999999876 668899999999999999999999984
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=267.68 Aligned_cols=191 Identities=19% Similarity=0.369 Sum_probs=157.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... ...+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQD--GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CC
Confidence 47788999999999999998743 23578899876432 35678899999999 999999999998754 44
Q ss_pred ceEEEeccCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCC
Q 016537 206 PSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~N 258 (387)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 679999999999876642 25677889999999999999999999999999999
Q ss_pred eeEcCCCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 259 ILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||+++++ .+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 158 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 158 VLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9998655 8999999999765433221 22344567999999876 678999999999999999999 998883
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.03 Aligned_cols=192 Identities=23% Similarity=0.361 Sum_probs=151.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-eEEEEE------------------Eecc--cchHHHHHHHHHHHHhcCCCCe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNI 191 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK------------------~l~~--~~~~~~~~E~~il~~l~~hpni 191 (387)
.++|+++++||+|+||+||+|..+... ...++| .+.. .....+.+|+.+|+++ +||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence 368999999999999999998764322 222222 1111 1124578999999999 99999
Q ss_pred eEEEEEEEcCCCCCceEEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC
Q 016537 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 192 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 264 (387)
+++++++.+.+ ..++++|++.+..+..+.. ......++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 226 v~l~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSEA--NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEECC--eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999998754 4679999987655443322 13356788899999999999999999999999999999966
Q ss_pred CceEEEEecccceeecCCCc--ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 265 QRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 265 ~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
+ .+||+|||+++.+..... ....+|+..|+|||++.+ ..++.++|||||||+||||++|..++
T Consensus 304 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 G-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred C-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 6 799999999987654332 234579999999999877 67999999999999999999987544
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=271.04 Aligned_cols=192 Identities=21% Similarity=0.361 Sum_probs=158.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-------CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
++|.+.+.||+|+||.||+|.+.. +...+|+|.++... ...+.+|+++++++.+||||+++++++.+.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~- 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD- 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence 689999999999999999998643 23579999987532 245778999999997899999999998765
Q ss_pred CCCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC
Q 016537 203 SKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~ 263 (387)
...++||||+.+++|..++. .++...++.++.|++.||+|||++|++||||||+|||++.
T Consensus 97 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 97 -GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 35779999999999876652 2667888999999999999999999999999999999996
Q ss_pred CCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 264 ~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |.+||
T Consensus 176 ~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 176 DN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred CC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 65 8999999999765432111 11233467999999877 678999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=262.03 Aligned_cols=192 Identities=26% Similarity=0.484 Sum_probs=164.8
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+|+..+.||+|+||.||+|.+..+++.|++|.+... ..+.+.+|+++++.+ +|+||+++++++.+. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREE--DNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecC--CeE
Confidence 366778999999999999999878999999987532 235688999999999 999999999998754 456
Q ss_pred eEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++++||+++++|..++. .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++ .+||+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc
Confidence 79999999999877753 378888999999999999999999999999999999999666 89999999998765444
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|++||.+.....++.++|+|||||++|+|++|++||.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~ 203 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 34556788899999998663338999999999999999999999983
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=261.10 Aligned_cols=190 Identities=19% Similarity=0.328 Sum_probs=159.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.+.||+|++|.||+|.+..+ ..+|+|.+... ..+.+.+|+++++++ +|+|++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEEE
Confidence 6799999999999999999988544 56899987643 336788999999999 99999999998743 34679999
Q ss_pred ccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc-
Q 016537 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (387)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~- 285 (387)
|+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+||++++++ .++|+|||+++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCcccc
Confidence 999999877653 267888899999999999999999999999999999999665 8999999999876433211
Q ss_pred -cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 -~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|||||||++|||++ |++||.
T Consensus 160 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12245567999999876 678999999999999999999 899884
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=268.27 Aligned_cols=192 Identities=23% Similarity=0.414 Sum_probs=163.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||++.+..+++.|++|.+.... ...+.+|+++++.+ +||||+++++.+... ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETK--RHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecC--CEEE
Confidence 46899999999999999999999999999999886432 24567899999998 999999999998754 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+||||+++++|..++ ..+++..+..++.|++.||+|||+++++||||||+||+++.++ .++|+|||+++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence 999999999998776 3478889999999999999999999999999999999999655 89999999986421110
Q ss_pred ---------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+ ..++.++|+|||||++|||++|..||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0112356778999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=262.96 Aligned_cols=191 Identities=19% Similarity=0.335 Sum_probs=159.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.+|++.+.||+|+||.||+|.++ ++..+|+|.+... ....+.+|+++++++ +||||+++++++.+. ...++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQ--RPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC--CceEEEEe
Confidence 46889999999999999999874 5678999998643 346788999999999 999999999988654 45789999
Q ss_pred ccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc-
Q 016537 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN- 286 (387)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~- 286 (387)
|+++++|..++. .+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceeccccccccc
Confidence 999999877652 368888999999999999999999999999999999999666 79999999997654322111
Q ss_pred -ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 -VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 -~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 159 ~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 159 QGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred CCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 1123346999999876 678999999999999999999 788883
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=270.35 Aligned_cols=194 Identities=22% Similarity=0.377 Sum_probs=164.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++.+-+..||.|+||+|+|-.++..|+..|||.++.. ..+++..|.+...+-.+.||||+++|.+..++.. .+.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc--WiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC--WIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce--eee
Confidence 4555678899999999999999999999999998742 2467888888887777899999999987665443 477
Q ss_pred EeccCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 210 FEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 210 ~e~~~~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
||.|+ .++..++ ..++|.-+-.+...+..||.||.+. .|||||+||+|||++..+ .|||||||++-.+.
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV 219 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence 88887 4554443 3488888888888999999999965 899999999999999766 89999999998887
Q ss_pred CCCcccccccccCCCCchhhcccC-CCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.+...+...|...|||||.+.... .|+.+|||||||++|||+.||+-||..
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 777778889999999999996544 499999999999999999999999854
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=266.59 Aligned_cols=192 Identities=17% Similarity=0.307 Sum_probs=159.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.+|.+.++||+|+||.||++... .++..+|+|.+.... ...+.+|+++++.+ +|+||+++++++.+. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEG--RP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecC--Cc
Confidence 57888999999999999999742 346789999876433 35688999999999 999999999998764 44
Q ss_pred ceEEEeccCCCchhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCce
Q 016537 206 PSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~ 267 (387)
.+++|||+.+++|..++. .+++..++.++.|++.||+|||+++++||||||+|||+++++ .
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-~ 160 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-V 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-C
Confidence 679999999999876652 267788999999999999999999999999999999999655 8
Q ss_pred EEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 268 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 268 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 99999999976543321 122334677999999877 678999999999999999998 899983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=263.91 Aligned_cols=194 Identities=20% Similarity=0.387 Sum_probs=162.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ...+.+|+.+++++ +|+||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-CC
Confidence 4789999999999999999999865 26889999886432 35678899999999 999999999988764 34
Q ss_pred CceEEEeccCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEec
Q 016537 205 TPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DF 273 (387)
..++++||+.++++..++. .+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d~ 161 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITDN 161 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECCC
Confidence 5689999999999876652 367888999999999999999999999999999999998665 8999999
Q ss_pred ccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 274 GLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 274 G~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|+++.+.+.... ....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 999866443221 22345667999999876 678999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.68 Aligned_cols=192 Identities=18% Similarity=0.364 Sum_probs=157.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.++. .+..||+|.++... ...+.+|+.+++++ +||||+++++++.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC--
Confidence 4789999999999999999997642 34589999876332 24577899999999 999999999998764
Q ss_pred CCceEEEeccCCCchhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEE
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl 270 (387)
...++||||+.+++|..+++. .....+..++.|++.||.|||+++|+||||||+|||++.++ .++|
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~~L 160 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKI 160 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cEEE
Confidence 357899999999999877632 24567888999999999999999999999999999999665 8999
Q ss_pred EecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 271 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
+|||+++....... .....++..|+|||.+.+ +.++.++|||||||++|||++ |.+||
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 99999976533221 122344667999999876 678999999999999999999 78887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=263.09 Aligned_cols=191 Identities=18% Similarity=0.332 Sum_probs=160.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|++.+.||+|+||.||+|.++.. ...+|+|.++... ...+.+|+.+++++ +||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKS--RPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecC--Cce
Confidence 6799999999999999999998643 4589999886432 35678899999999 999999999998754 457
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
+++|||+.+++|..++. .+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+|||+++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhccccc
Confidence 89999999999987752 478899999999999999999999999999999999999665 7999999999876422
Q ss_pred -Ccccc--cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 283 -KEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 283 -~~~~~--~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
..... ..++..|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~ 209 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCC
Confidence 11111 234567999999876 678999999999999999998 99988
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.74 Aligned_cols=193 Identities=24% Similarity=0.439 Sum_probs=162.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-----eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.+..++.+.||+|+||.||.|...... ..||||.+++. ....|.+|..+|+++ +|||||+++|++.+ .
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~--~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD--S 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--C
Confidence 456788999999999999999875433 34899988753 457799999999999 99999999999987 3
Q ss_pred CCceEEEeccCCCchhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEec
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DF 273 (387)
...++++|||.+|+|..+++. +...+...++.||++|++||+++++|||||.++|+||+.. ..|||+||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaDF 846 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIADF 846 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEccc
Confidence 456799999999999888742 6788899999999999999999999999999999999966 48999999
Q ss_pred ccceeecCCCcccc---cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 274 GLAEFYHPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 274 G~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|+|+.+.....+.. ..-...|||||.+.. +.++.|+|||||||+|||++| |..||.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCC
Confidence 99985433322211 122356999999987 789999999999999999999 778884
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=274.13 Aligned_cols=195 Identities=30% Similarity=0.632 Sum_probs=165.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~--~~~~ 205 (387)
.++|++.+.||+|+||.||+|.++.+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 37899999999999999999999999999999998642 235677899999999 899999999987643 2346
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++||||+.+ ++..++ ..+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.....
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeeccc
Confidence 7899999974 665554 3478999999999999999999999999999999999999666 8999999999765432
Q ss_pred Cc-----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .....++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 21 1234788899999998665568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=273.28 Aligned_cols=195 Identities=31% Similarity=0.643 Sum_probs=164.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---K 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---~ 204 (387)
.++|.+.+.||+|+||.||+|.+..+++.||||.+... ....+.+|+.+++.+ +|+||+++++++..... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence 46899999999999999999999899999999987632 235677899999999 99999999998765422 3
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++++||+.+ ++...+ ..+++..++.++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSE 160 (337)
T ss_pred cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCC
Confidence 47899999974 554443 3588999999999999999999999999999999999999666 899999999986643
Q ss_pred C-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .......++..|+|||.+.+...++.++|||||||++|+|++|++||.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 3 223445678899999998654468899999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=265.77 Aligned_cols=192 Identities=25% Similarity=0.473 Sum_probs=165.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..|+..+.||.|+||.||+|.+..++..+|+|.+.... ...+.+|+++++++ +|+||+++++++.+. ...++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKG--TKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CEEEEE
Confidence 45778899999999999999998889999999986432 35678899999999 999999999998764 467899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-cc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~~ 286 (387)
|||+++++|..++. .+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCccccc
Confidence 99999999877664 478888999999999999999999999999999999999666 799999999977644332 23
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||++.+ ..++.++|+|||||++|||++|.+||.
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 3467888999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=267.61 Aligned_cols=196 Identities=29% Similarity=0.611 Sum_probs=164.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----- 202 (387)
.++|++.+.||+|+||.||+|.++.+++.||+|.++.. ....+.+|+++++++ +||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhc
Confidence 47899999999999999999999888999999998632 224577899999999 9999999999887643
Q ss_pred ---CCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 203 ---SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 203 ---~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
....++|+||++++.+..+. ..+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCccccc
Confidence 23678999999975444333 2478999999999999999999999999999999999999665 8999999999
Q ss_pred eeecCCC--cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....... ......++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 8764332 22334567789999998664567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=261.77 Aligned_cols=193 Identities=23% Similarity=0.456 Sum_probs=166.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||.|+||+||+|....++..+++|++... ....+.+|+++++.+ +|+||+++++.+... ...+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVG--DELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeC--CEEEEE
Confidence 4789999999999999999998888999999998632 246788999999998 999999999988764 457799
Q ss_pred EeccCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
||++.++++...++ .+++..++.++.|++.||+|||++|++||||||+||++++++ .++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGG 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCc
Confidence 99999999876652 378888999999999999999999999999999999999665 79999999987655432
Q ss_pred cc-----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EY-----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....++..|+|||++.....++.++|+|||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 22 334688899999998764478999999999999999999999983
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=268.78 Aligned_cols=193 Identities=19% Similarity=0.340 Sum_probs=159.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-------CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.++.. ....+.+|+.+++.+.+||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 478999999999999999999752 23457999988642 2356889999999987899999999998764
Q ss_pred CCCCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
...+++|||+.+++|..++. .++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 45679999999999876652 256677888999999999999999999999999999998
Q ss_pred CCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
.++ .+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 172 ~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 172 ENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred CCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 655 899999999987643221 122344567999999877 678999999999999999998 77887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.09 Aligned_cols=192 Identities=18% Similarity=0.347 Sum_probs=159.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCe---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.+|++.+.||+|+||.||+|.+..+++ .||+|.++.. ....+..|+.+++++ +||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKS--RPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCC--Cce
Confidence 568999999999999999999876654 6999998643 235788999999999 999999999998654 456
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+++++|..++. .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccC
Confidence 79999999999877653 378889999999999999999999999999999999998655 8999999998765433
Q ss_pred Ccc---ccccc---ccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 283 KEY---NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 283 ~~~---~~~~g---t~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
... ....+ +..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 221 11111 346999999876 678999999999999999987 999983
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=259.92 Aligned_cols=191 Identities=17% Similarity=0.320 Sum_probs=160.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+ ..+..+|+|.+.... .+.+.+|+++++++ +|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEEE
Confidence 47899999999999999999986 456779999886543 35788999999999 99999999998865 4568999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||++++++..++. .++...++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc
Confidence 9999999877663 256778889999999999999999999999999999998665 8999999999766433221
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||++.+ ..++.++|+|||||++|+|++ |++||.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 12234567999999876 678999999999999999999 899983
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=269.49 Aligned_cols=192 Identities=21% Similarity=0.374 Sum_probs=158.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe-------CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
++|.+.+.||+|+||.||+|.+. .....+|+|.++... ...+.+|+++++++.+||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE- 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence 68999999999999999999753 234579999887432 245788999999986799999999998654
Q ss_pred CCCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC
Q 016537 203 SKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~ 263 (387)
...+++|||+.+++|..++. .++...+..++.|++.||.|||++||+||||||+|||++.
T Consensus 91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 45789999999999876652 2677788899999999999999999999999999999996
Q ss_pred CCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 264 ~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 170 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 170 DN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred CC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 66 8999999999865432211 11223457999999876 678999999999999999999 88887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=266.04 Aligned_cols=192 Identities=20% Similarity=0.357 Sum_probs=160.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC----------------eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCee
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----------------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv 192 (387)
.++|++.++||+|+||.||+|.+...+ ..||+|.+.... .+.+.+|+++++++ +||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence 368999999999999999999875433 568999986432 35678899999999 999999
Q ss_pred EEEEEEEcCCCCCceEEEeccCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCC
Q 016537 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (387)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~N 258 (387)
++++++.+. ...+++|||+.+++|..++. .+++..++.++.|++.||+|||+++|+||||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999998764 45789999999999876652 46788899999999999999999999999999999
Q ss_pred eeEcCCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh--cCCch
Q 016537 259 VMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS--VSPSV 329 (387)
Q Consensus 259 ILl~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt--g~~pf 329 (387)
|+++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 161 CLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred eeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999665 899999999976543321 123345678999999876 678999999999999999998 66676
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=268.58 Aligned_cols=192 Identities=23% Similarity=0.408 Sum_probs=162.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++++.||+|+||.||+|.+..+++.+|+|.++.. ....+.+|+++++++ +|+||+++++.+... ...++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIE--GAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecC--CeEEEE
Confidence 4688999999999999999999889999999988642 135678899999998 999999999988764 467899
Q ss_pred EeccCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 210 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
|||++++++..++. .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC
Confidence 99999999876653 47889999999999999999997 5999999999999999755 8999999999765332
Q ss_pred CcccccccccCCCCchhhccc-----CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 22345678889999998542 235889999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=275.03 Aligned_cols=196 Identities=33% Similarity=0.642 Sum_probs=165.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. .....+.+|+.+++++.+||||+++++++...+....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3789999999999999999999988899999998743 22345778999999987899999999998765556678
Q ss_pred EEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
+||||+.+ +|...+. .+.+..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccccc
Confidence 99999985 6655543 467888888999999999999999999999999999999666 89999999997654332
Q ss_pred ----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+...++.++|||||||++|+|++|++||.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 22345688899999998765668899999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=266.46 Aligned_cols=191 Identities=32% Similarity=0.659 Sum_probs=161.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++++.||.|++|.||+|+++.+++.||||.++.. ....+.+|+++++++ +||||+++++++.+. ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTE--NKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccC--CcEEEE
Confidence 488999999999999999999889999999988632 225688999999999 999999999998654 457899
Q ss_pred EeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
|||+.+ ++..++ ..+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 155 (284)
T ss_pred eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence 999974 555443 3478889999999999999999999999999999999999666 89999999987654332
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+...++.++|||||||++|||+||+.||.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 22334567889999998764557889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=259.80 Aligned_cols=192 Identities=25% Similarity=0.458 Sum_probs=168.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+|++++.++ +|+||+++++++... ...++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccC--CeEEEE
Confidence 36889999999999999999998889999999987542 46788999999999 899999999998764 557899
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||+++++|..++. .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++ .++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCc
Confidence 99999999987763 48899999999999999999999 9999999999999999666 8999999999876544333
Q ss_pred -cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 -~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|++||.
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 24567889999999876 678999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.26 Aligned_cols=193 Identities=27% Similarity=0.496 Sum_probs=165.0
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhc--CCCCeeEEEEEEEcCCCCCceE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~--~hpniv~l~~~~~~~~~~~~~l 208 (387)
.|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++++. .|||++++++++.+. ...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEEE
Confidence 477889999999999999999889999999998532 2356788999999983 399999999988653 45789
Q ss_pred EEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cc
Q 016537 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (387)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~ 285 (387)
||||+++++|..+++ .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcccc
Confidence 999999999877653 478889999999999999999999999999999999999765 89999999998765433 22
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 203 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence 345788899999998764567899999999999999999999984
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=263.29 Aligned_cols=191 Identities=30% Similarity=0.643 Sum_probs=162.0
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+|++.+.||.|++|.||+|.+..+++.||+|.++.. ....+.+|+++++++ +|+||+++++++.+. ...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeC--CcEEEEE
Confidence 588999999999999999999889999999998643 235677899999999 999999999999765 3567999
Q ss_pred eccCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 211 e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
||+.+ ++..++ ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVN 155 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcc
Confidence 99996 544432 2378999999999999999999999999999999999999665 89999999997553321
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|++||++.+...++.++|||||||++|+|++|++||.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22344678889999998765567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=262.05 Aligned_cols=192 Identities=19% Similarity=0.334 Sum_probs=160.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCC---eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|++.+.||+|+||.||+|.+..++ ..+|+|.++... .+.+.+|+.+++++ +||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKS--KPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--Ccc
Confidence 57899999999999999999876443 479999886432 35688999999999 999999999998754 457
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+++++|..++. .+++.++..++.|++.||.|||+++++||||||+|||++.++ .++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccccccc
Confidence 89999999999887763 368888999999999999999999999999999999998665 8999999999876443
Q ss_pred Ccc--c--ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 283 KEY--N--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 283 ~~~--~--~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
... + ...++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 221 1 1122457999999876 678999999999999999887 999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=267.08 Aligned_cols=192 Identities=19% Similarity=0.362 Sum_probs=157.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC----------------CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVK 193 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~ 193 (387)
++|++.+.||+|+||.||++.+.. +...+|+|.+.... ...+.+|+++++++ +|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Confidence 679999999999999999986432 34579999987432 35688999999999 9999999
Q ss_pred EEEEEEcCCCCCceEEEeccCCCchhhhcCC--------------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCe
Q 016537 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (387)
Q Consensus 194 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NI 259 (387)
+++++.+.+ ..+++|||+.+++|..++.. +++..+..++.|++.||+|||++|++||||||+||
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999987653 46799999999998766522 45667899999999999999999999999999999
Q ss_pred eEcCCCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh--cCCchh
Q 016537 260 MIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS--VSPSVL 330 (387)
Q Consensus 260 Ll~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt--g~~pf~ 330 (387)
|++.++ .++|+|||+++.+...... ....++..|++||...+ +.++.++|||||||++|||++ |..||.
T Consensus 162 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 162 LVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 998655 8999999999865433211 12234567999998776 679999999999999999998 667773
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=263.62 Aligned_cols=187 Identities=18% Similarity=0.292 Sum_probs=148.8
Q ss_pred eeeeecCCeeEEEEEEeC--CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
++||+|+||.||+|.... ....+++|.+.... ...+.+|+++++.+ +|+||+++++.+.+. ...++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIES--IPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCC--CceEEEEEeC
Confidence 369999999999997533 34578888775332 24578899999998 999999999998754 4567999999
Q ss_pred CCCchhhhcCC--------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 214 NNTDFKVLYPT--------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 214 ~~~~l~~~~~~--------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
.+++|..++.. ..+..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhe
Confidence 99999876532 34667788999999999999999999999999999999666 899999999865433221
Q ss_pred --ccccccccCCCCchhhcc------cCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 --YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 --~~~~~gt~~y~aPE~~~~------~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.. ...++.++|||||||++|||++ |.+||.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 122345667999999743 1356889999999999999999 777773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=268.12 Aligned_cols=192 Identities=18% Similarity=0.344 Sum_probs=159.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+.... ...+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC---
Confidence 4678999999999999999999876665 57888876432 23678899999999 999999999988643
Q ss_pred CceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++++||+++|++...+. .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLE 160 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEcccccccccc
Confidence 3469999999998876653 367888999999999999999999999999999999998655 79999999998764
Q ss_pred CCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred CcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 33221 22344668999999876 678999999999999999998 888883
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=261.61 Aligned_cols=194 Identities=22% Similarity=0.403 Sum_probs=161.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+.+.....||+|+||.||+|.+..++..|++|.+.... .+.+.+|+.+++++ +|+||+++++++... ...++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSEN--GFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccC--CEEEEEE
Confidence 34444568999999999999998889999999886543 35688999999999 999999999998764 4678999
Q ss_pred eccCCCchhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 211 EHVNNTDFKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~--~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||+.+++|..++. .+ ++..+..++.|++.||+|||+++|+||||||+||+++.+...++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999987653 23 67788889999999999999999999999999999986555899999999976543222
Q ss_pred -ccccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 2334678899999998552 247889999999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=259.00 Aligned_cols=192 Identities=19% Similarity=0.357 Sum_probs=162.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~--~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+. ++..+|||.+.. ...+.+.+|+.+++++ +|+||+++++++.+. ...+++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEE--EPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecC--CceEEEE
Confidence 478999999999999999999974 567899999874 3347789999999999 999999999998654 4568999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+++++|..++. .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++.........
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEYT 159 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhhh
Confidence 9999999877763 378889999999999999999999999999999999999666 8999999999876432211
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 160 AREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred hhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 12234467999999876 678999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=267.86 Aligned_cols=191 Identities=20% Similarity=0.354 Sum_probs=165.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++++.||+|+||+||++.+..+++.+|+|++... ..+.+.+|+++++.+ +||||+++++++.+. ...++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEEEE
Confidence 6788999999999999999999888999999987533 236788999999999 999999999999765 457899
Q ss_pred EeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||+++++|..++ +.+++..++.++.|++.||.|||+ ++++||||||+||+++.++ .++|+|||++...... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINS-IA 159 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhh-cc
Confidence 9999999997665 347888999999999999999997 6999999999999999665 8999999998754322 22
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 160 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~ 203 (284)
T cd06620 160 DTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFA 203 (284)
T ss_pred CccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 34578899999999876 578999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=268.94 Aligned_cols=192 Identities=26% Similarity=0.477 Sum_probs=164.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.... .+.+.+|+++++++ +||||+++++++.+. ...++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKG--TKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccC--CceEEE
Confidence 34667788999999999999998889999999986322 35688999999999 999999999998764 457899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
|||++++++...+. .+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhh
Confidence 99999999877663 478889999999999999999999999999999999998665 89999999997654332 223
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 3467888999999876 678999999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=262.30 Aligned_cols=187 Identities=18% Similarity=0.254 Sum_probs=150.7
Q ss_pred eeeeecCCeeEEEEEEeC--CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.+.. ++..+|+|.++... ...+.+|+.+++++ +||||+++++++.+. ...++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEV--TPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC--CCcEEEEECC
Confidence 369999999999998643 45679999886432 24678899999999 999999999998764 4467999999
Q ss_pred CCCchhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 214 NNTDFKVLYP--------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 214 ~~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
++++|..++. ..++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCccee
Confidence 9999977653 234566778999999999999999999999999999999655 899999999975433221
Q ss_pred --ccccccccCCCCchhhccc------CCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 --YNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 --~~~~~gt~~y~aPE~~~~~------~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.+. ..++.++|||||||++|||++ |.+||.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 1234567789999998542 135789999999999999996 999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=263.59 Aligned_cols=186 Identities=25% Similarity=0.403 Sum_probs=152.6
Q ss_pred eeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHh--cCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l--~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
.||+|+||.||++.+..+++.+|+|.+.... ...+.+|..+++.+ .+||||+.+++++... ...++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 3899999999999998889999999885421 12234444443332 3799999999988764 356799999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 289 (387)
+.+++|...+ ..+++..+..++.|++.||+|||+++|+||||||+|||++.++ .++|+|||++....... .....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccccC-ccCcC
Confidence 9999997665 3489999999999999999999999999999999999999665 89999999997654332 23457
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||.+.+...++.++|||||||++|||++|..||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 89999999998643568899999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=261.93 Aligned_cols=189 Identities=26% Similarity=0.404 Sum_probs=157.3
Q ss_pred CCeEEEeee--eecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKV--GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.+.+ |+|+||.||++..+.++..+|+|.+........ |+.....+.+||||+++++.+...+ ..++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEE
Confidence 456666665 999999999999999999999999865432222 3333333448999999999997654 5789999
Q ss_pred ccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccc
Q 016537 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288 (387)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~ 288 (387)
|+++++|..++. .+++..++.++.|++.||.|||+.|++||||||+||+++.++..++|+|||+++..... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~ 166 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY 166 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence 999999977652 47899999999999999999999999999999999999866657999999999765432 234
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 67889999999876 678999999999999999999999984
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=260.77 Aligned_cols=192 Identities=20% Similarity=0.373 Sum_probs=160.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCe---EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|+..+.||+|+||.||+|.++.++. .+|+|.++... ...+.+|+++++++ +|+|++++++++.+. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKF--KPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccC--CCc
Confidence 578899999999999999999865554 79999886432 35678899999999 999999999998764 456
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+++++|..++. .+++..+..++.|++.||+|||+.+++||||||+||+++.++ .+||+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceecccc
Confidence 79999999999977752 478889999999999999999999999999999999999665 8999999999766433
Q ss_pred Cccc--c--cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 283 KEYN--V--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 283 ~~~~--~--~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... . ...+..|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 2111 1 122346999999876 678999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=267.32 Aligned_cols=191 Identities=20% Similarity=0.377 Sum_probs=157.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC--------------CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD--------------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLL 195 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~ 195 (387)
++|++.++||+|+||.||+|.+..+ ...||+|.++... ...+.+|+++++++ +|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEE
Confidence 6899999999999999999987432 2358999986532 34688999999999 999999999
Q ss_pred EEEEcCCCCCceEEEeccCCCchhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCee
Q 016537 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYP---------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260 (387)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NIL 260 (387)
+++... ...++||||+.+++|..++. .+++..+..++.|++.||.|||+++++||||||+||+
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 998754 45679999999999876652 2567788899999999999999999999999999999
Q ss_pred EcCCCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh--cCCch
Q 016537 261 IDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS--VSPSV 329 (387)
Q Consensus 261 l~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt--g~~pf 329 (387)
++.++ .+||+|||++......... ....++..|+|||++.+ +.++.++|||||||++|||++ +..||
T Consensus 162 l~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 162 VGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred EcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99655 7999999999765433221 22244668999999876 678999999999999999998 55666
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=264.26 Aligned_cols=194 Identities=22% Similarity=0.412 Sum_probs=164.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .+.+.+|+++++.+ +|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCc
Confidence 567888999999999999998643 47899999987543 35789999999999 9999999999988766667
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.+++|||++++++..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 161 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPE 161 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEccccccccccc
Confidence 889999999999887763 378888999999999999999999999999999999999665 899999999987653
Q ss_pred CCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... ....++..|++||.+.+ ..++.++|||||||++|||++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcc
Confidence 3221 12234556999999876 578999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=271.74 Aligned_cols=193 Identities=30% Similarity=0.613 Sum_probs=163.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+++++++ +||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCC
Confidence 36899999999999999999999889999999988632 124578899999999 99999999998865322
Q ss_pred CCceEEEeccCCCchhhhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
...++|+||+.. ++..... .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~- 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA- 169 (342)
T ss_pred ceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC-
Confidence 235799999975 5554443 689999999999999999999999999999999999999766 899999999976432
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+...++.++|||||||++|||++|+.||.
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 23345678889999998764568899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=261.10 Aligned_cols=189 Identities=24% Similarity=0.451 Sum_probs=154.6
Q ss_pred EEEeeeeecCCeeEEEEEEe----CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 137 EVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++.+.||.|.||.||+|.+. ..+..|+||.++.. ..+.+.+|++.++++ +||||++++|++... ...++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~--~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIEN--EPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESS--SSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccccc--ccccc
Confidence 57889999999999999997 34678999999643 246789999999999 999999999999843 33779
Q ss_pred EEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
|+||+.+|+|...+ ..+++..+..++.|++.||.|||+++++|+||+++|||++.++ .+||+|||++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999987654 2478899999999999999999999999999999999999666 89999999998763222
Q ss_pred c---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 284 E---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 284 ~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
. .........|+|||.+.+ ..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~ 207 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFS 207 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred cccccccccccccccccccccc-cccccccccccccccccccccccccccc
Confidence 1 122345677999999877 568999999999999999999 678873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=258.81 Aligned_cols=185 Identities=21% Similarity=0.368 Sum_probs=154.9
Q ss_pred eeeeecCCeeEEEEEEeCCC---eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
++||+|+||.||+|.+...+ ..+|+|.+.... .+.+.+|+++++.+ +|+||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876554 789999987433 35688999999999 99999999998753 346799999
Q ss_pred cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc---
Q 016537 213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN--- 286 (387)
Q Consensus 213 ~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~--- 286 (387)
+.+++|..++. .+++..+..++.|++.||+|||.++++||||||+|||++.++ .+||+|||+++.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccc
Confidence 99999887663 488999999999999999999999999999999999999666 89999999998765443221
Q ss_pred -ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 -VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 -~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~ 200 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG 200 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence 1122356999999876 678999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=265.70 Aligned_cols=193 Identities=25% Similarity=0.468 Sum_probs=166.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++|++.+.||+|+||.||++.+..++..+|+|.+... ..+.+.+|+.+++++ +|||++++++++... ...++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVG--DELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeC--CcEEEE
Confidence 47899999999999999999998888999999998532 235678899999999 999999999998764 456799
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-cc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~~ 286 (387)
+||++++++..++. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccccccc
Confidence 99999999987764 478888999999999999999999999999999999999665 799999999876544322 23
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+ +.++.++|+|||||++|+|++|++||.
T Consensus 174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3468888999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=261.15 Aligned_cols=192 Identities=21% Similarity=0.411 Sum_probs=159.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|.+.+.||+|+||.||+|.+... ...+++|..... ..+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~---~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITEN---P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcCC---C
Confidence 36788999999999999999987543 357899987643 235788999999999 999999999988653 3
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+.+++|..++. .+++..++.++.|++.||+|||+++++||||||+|||++.++ .++|+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeeccc
Confidence 579999999999987763 378889999999999999999999999999999999999665 899999999987644
Q ss_pred CCccc--ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..... ...++..|+|||.+.. ..++.++|||||||++|||++ |.+||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred ccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 32221 2223457999999866 678999999999999999996 999983
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=264.55 Aligned_cols=193 Identities=21% Similarity=0.363 Sum_probs=160.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .+.+.+|+++++++ +||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVG-- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--
Confidence 4789999999999999999998743 57899999986432 35688899999999 999999999998764
Q ss_pred CCceEEEeccCCCchhhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~N 258 (387)
...+++|||+++++|..++. .+++..++.++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 35679999999999876653 25677889999999999999999999999999999
Q ss_pred eeEcCCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 259 VMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 259 ILl~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|+++.++ .++|+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 161 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9998666 899999999876543321 112234566999999876 679999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=275.59 Aligned_cols=193 Identities=23% Similarity=0.365 Sum_probs=158.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|.+.+.||+|+||.||+|++. ..++.||+|+++... ...+.+|+++|.++..||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 367889999999999999999863 345689999997432 246788999999994499999999998764
Q ss_pred CCceEEEeccCCCchhhhcC------------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (387)
...++||||+.+|+|..++.
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 45789999999999866542
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 224 -----------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 224 -----------------------------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
.++...++.++.|++.||+|||+++|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 134556778899999999999999999999999999999
Q ss_pred CCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
.++ .+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 274 ~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 274 EGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred CCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 655 899999999986543221 122356778999999876 678999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=270.11 Aligned_cols=190 Identities=22% Similarity=0.402 Sum_probs=162.9
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
|+....||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++... ...+++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVG--EELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeC--CeEEEEEec
Confidence 34455799999999999999888999999998532 235678999999999 999999999988764 457799999
Q ss_pred cCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cccccc
Q 016537 213 VNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRV 289 (387)
Q Consensus 213 ~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~~~ 289 (387)
++++++..+.. .+++..++.++.|++.||+|||+++++||||||+||+++.++ .++|+|||++....... ......
T Consensus 100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccccccccee
Confidence 99999877663 478899999999999999999999999999999999999666 89999999987554332 223457
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
++..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 179 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 179 GTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred cCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 8899999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=266.48 Aligned_cols=194 Identities=21% Similarity=0.362 Sum_probs=160.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|+..+.||+|+||.||++.+..+++.+|+|.+... ....+.+|+.++.++.+|+||+++++++.+. ...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence 4566778999999999999999889999999988643 2356788999999995599999999988764 345699
Q ss_pred EeccCCC--chhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 210 FEHVNNT--DFKVL-----YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 210 ~e~~~~~--~l~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
|||+... ++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .++|+|||+++....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVD 160 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhcc
Confidence 9998753 22211 13588999999999999999999975 999999999999999665 799999999976554
Q ss_pred CCcccccccccCCCCchhhccc--CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
........++..|+|||++.+. ..++.++|||||||++|||++|++||.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 4444455788899999998764 368999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=258.24 Aligned_cols=188 Identities=19% Similarity=0.371 Sum_probs=161.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.. .++.+|+|.++... .+++.+|+.+++++ +|+||+++++++.+ ....++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence 36788999999999999999986 47889999987543 46788999999999 99999999999876 34577999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+++++|..+++ .+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc--
Confidence 9999999887753 478899999999999999999999999999999999999666 79999999998763222
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
.....+..|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 157 ~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~ 200 (256)
T cd05039 157 DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 200 (256)
T ss_pred ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCC
Confidence 22334567999999876 678899999999999999997 99887
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=258.16 Aligned_cols=186 Identities=23% Similarity=0.427 Sum_probs=159.6
Q ss_pred eeeeecCCeeEEEEEEeCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+.||+|+||.||+|.+... +..+++|.+.... .+.+.+|+++++.+ +|+||+++++++.+ ....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence 4699999999999999765 8899999987533 46788999999999 79999999999876 4567899999
Q ss_pred cCCCchhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 213 VNNTDFKVLY------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 213 ~~~~~l~~~~------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
+++++|..++ ..+++..++.++.|++.||+|||+++++||||||+||+++.++ .++|+|||.+....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~ 156 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVY 156 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccc
Confidence 9999987665 3368899999999999999999999999999999999999665 89999999998765
Q ss_pred CCC---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 432 2233456788999999876 578999999999999999999 589883
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=260.99 Aligned_cols=184 Identities=18% Similarity=0.287 Sum_probs=150.2
Q ss_pred eeeeecCCeeEEEEEEeC------------CCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 140 RKVGRGKYSEVFEGVHCT------------DNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~------------~~~~vavK~l~~~~~---~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
+.||+|+||.||+|.... ....+++|.+..... ..+.+|+.+++.+ +||||+++++++.+. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~--~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRD--V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--C
Confidence 368999999999998532 223688898764432 4677889999998 999999999998764 3
Q ss_pred CceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc------eEEEEecc
Q 016537 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWG 274 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~------~vkl~DFG 274 (387)
..+++|||++++++..++. .+++..++.++.||+.||+|||+++|+||||||+|||++.++. .++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 4579999999998876653 3788889999999999999999999999999999999975442 38999999
Q ss_pred cceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHH-hcCCch
Q 016537 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV-SVSPSV 329 (387)
Q Consensus 275 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ell-tg~~pf 329 (387)
++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 98754322 33467788999999865467899999999999999998 588776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=262.38 Aligned_cols=191 Identities=19% Similarity=0.379 Sum_probs=162.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.+|++.+.||.|+||.||+|.+.. ++.+++|.+.... ...+.+|+++++.+ +|+||+++++++.+. ...++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVG--EPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecC--CCeEEEE
Confidence 578899999999999999999965 8899999987443 36788999999999 999999999998764 4567999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||.+.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYL 160 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCcccc
Confidence 9999999987763 378888999999999999999999999999999999999665 8999999999766433221
Q ss_pred -cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 -~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.
T Consensus 161 ~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 161 SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 22334567999999876 678999999999999999998 899883
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=270.41 Aligned_cols=193 Identities=30% Similarity=0.610 Sum_probs=163.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|++++.||+|+||.||+|.+..+++.||||.+... ....+.+|+++++++ +||||+++++++.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccccc
Confidence 47899999999999999999999889999999998532 124578899999999 99999999998865432
Q ss_pred CCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 204 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
...++||||+ ++++..+. ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccccccccc
Confidence 2357999998 56776555 3588999999999999999999999999999999999999666 799999999976543
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .....++..|+|||.+.+...++.++|+|||||++|+|++|++||.
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 171 E--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred C--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2 2344678899999998764468899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=259.37 Aligned_cols=184 Identities=27% Similarity=0.505 Sum_probs=160.5
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
||.|+||.||+|.+..+++.+|+|.+... ..+.+.+|+++++++ +||||+++++++.+. ...+++|||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence 69999999999999888999999998632 235688999999999 999999999998764 457899999999
Q ss_pred CchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccccccc
Q 016537 216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292 (387)
Q Consensus 216 ~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~ 292 (387)
++|...+. .+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++|+|||+++............++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCc
Confidence 99987753 478889999999999999999999999999999999999766 79999999998765543334457888
Q ss_pred CCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 293 ~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.|++||.+.+ ..++.++|+|||||++|+|++|.+||.
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 193 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFG 193 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcC
Confidence 9999999876 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=269.68 Aligned_cols=192 Identities=20% Similarity=0.343 Sum_probs=158.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC-------CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
.+|++.+.||+|+||.||+|.+... +..+|+|.++... .+.+.+|+++++++.+||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD- 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence 5799999999999999999986432 2478999886422 356889999999987899999999998754
Q ss_pred CCCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC
Q 016537 203 SKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~ 263 (387)
...+++|||+++++|..++. .++...+..++.|++.||.|||++||+||||||+|||++.
T Consensus 91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 45789999999999876652 2556778889999999999999999999999999999996
Q ss_pred CCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 264 ~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |.+||
T Consensus 170 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 170 DN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred CC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 66 8999999999865433211 12233457999999877 678999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=259.10 Aligned_cols=183 Identities=18% Similarity=0.268 Sum_probs=153.2
Q ss_pred eeeeecCCeeEEEEEEeCCC----------eEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 140 RKVGRGKYSEVFEGVHCTDN----------EKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.||+|+||.||+|.+..++ ..+++|.+.... ...+.+|+.+++.+ +||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence 46899999999999997666 458888876433 46788999999999 99999999999876 3357
Q ss_pred EEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc------eEEEEecccce
Q 016537 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWGLAE 277 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~------~vkl~DFG~a~ 277 (387)
+||||+.+++|..++. .++...+..++.|++.||.|||+++|+||||||+|||++.++. .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999987753 4788889999999999999999999999999999999985542 59999999998
Q ss_pred eecCCCcccccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhc-CCch
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSV-SPSV 329 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg-~~pf 329 (387)
.... .....++..|+|||++.+. ..++.++|||||||++|||++| ..||
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~ 207 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence 6543 2334566789999998763 3689999999999999999994 6666
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.54 Aligned_cols=193 Identities=24% Similarity=0.432 Sum_probs=165.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
-++.....||.|.||.||.|.+..+|+..|+|-++-+. .+.+.+|..+|..+ +|||+|+++|+-.+.+. .++
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRek--v~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREK--VYI 1311 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHH--HHH
Confidence 45667789999999999999999999999999876321 25578899999999 99999999998776544 559
Q ss_pred EEeccCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 209 IFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
.||||++|+|..+... .++...+.+..|++.|++|||++|||||||||+||+++.++ .+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhc
Confidence 9999999999887743 56667788899999999999999999999999999999776 89999999998876542
Q ss_pred ---cccccccccCCCCchhhcccC--CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ---EYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ---~~~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+....+||+.|||||++.+.+ ....+.|||||||++.||+||+.|+.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 334568999999999997643 45678999999999999999999984
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=258.74 Aligned_cols=187 Identities=18% Similarity=0.363 Sum_probs=158.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
++|++.+.||+|+||.||++.. +++.+|+|.++.. ....+.+|+.+++++ +|||++++++++... ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~---~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILHN---GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC---CcEEEEEC
Confidence 6799999999999999999874 6788999998643 346788999999999 999999999988643 36799999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccc
Q 016537 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (387)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~ 287 (387)
+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++..... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc--CCC
Confidence 99999876653 367888899999999999999999999999999999998666 8999999999764332 122
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...+..|+|||.+.+ ..++.++|+|||||++|||++ |++||.
T Consensus 157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 234567999999876 678999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=262.30 Aligned_cols=184 Identities=26% Similarity=0.414 Sum_probs=158.5
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
||+|+||+||+|.+..+++.+|+|.+.... ...+.+|+++++++ +||||+++++++... ...++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 689999999999998899999999985321 24467899999999 899999999998764 457899999999
Q ss_pred Cchhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccccc
Q 016537 216 TDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (387)
Q Consensus 216 ~~l~~~~---~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~g 290 (387)
++|...+ . .+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||.+.............+
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccC
Confidence 9987654 2 478899999999999999999999999999999999999666 899999999976654434445567
Q ss_pred ccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 888999999877 568999999999999999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=262.32 Aligned_cols=186 Identities=25% Similarity=0.402 Sum_probs=152.7
Q ss_pred eeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHh--cCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l--~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
.||+|+||.||+|.+..+++.||+|.+.... ...+..|..+++.+ .+||||+++++++.+. ...++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 4899999999999998889999999886421 12233444333322 2799999999988764 457799999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccc
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 289 (387)
+.+++|...+ ..+++..++.++.|++.||+|||+++|+||||||+||+++.++ .++|+|||++....... .....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~~-~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-PHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCccC-CcCcC
Confidence 9999987665 3478999999999999999999999999999999999999665 79999999987654332 23457
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+..|+|||++.+...++.++||||+||++|||++|+.||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 89999999998764568999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=268.60 Aligned_cols=192 Identities=20% Similarity=0.405 Sum_probs=163.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+.|.....||+|+||.||++.+..++..||||.+.... .+.+.+|+.+++.+ +|+||+++++.+... ...++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVG--DELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecC--CeEEEEE
Confidence 33445567999999999999998889999999886432 35678999999999 999999999988764 4578999
Q ss_pred eccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cccc
Q 016537 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (387)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~ 287 (387)
||++++++..++ ..+++..++.++.||+.||+|||+++|+||||||+||+++.++ .++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCce
Confidence 999999987775 3478899999999999999999999999999999999999665 89999999987543322 2234
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 578889999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=263.30 Aligned_cols=184 Identities=17% Similarity=0.295 Sum_probs=151.8
Q ss_pred eeeeecCCeeEEEEEEeCCCe-------EEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 140 RKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~-------~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+.||+|+||.||+|.+...+. .+++|.+.... .+.+.+|+.+++.+ +||||+++++++.... ..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~--~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGD--ESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCC--CcEEE
Confidence 369999999999998755443 48888875432 25678899999998 9999999999997643 46799
Q ss_pred EeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCce-------EEEEeccccee
Q 016537 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEF 278 (387)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~-------vkl~DFG~a~~ 278 (387)
|||+++++|..++. .+++..++.++.||+.||+|||+++|+||||||+|||++.++.. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999977763 37888889999999999999999999999999999999866532 79999999875
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcC-Cch
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVS-PSV 329 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~-~pf 329 (387)
.... ....++..|+|||++.+...++.++|||||||++|||++|. +||
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 5432 33567888999999876556899999999999999999995 554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=263.77 Aligned_cols=191 Identities=24% Similarity=0.397 Sum_probs=165.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||+|+||.||+|.++.+++.+|+|.+... ....+.+|+++++++ +||||+++++++... ...+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecC--CEEEEE
Confidence 3678889999999999999999889999999988643 235688999999999 899999999998765 567899
Q ss_pred EeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||+.+++|..++ ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh
Confidence 9999999988776 347888999999999999999999 9999999999999999765 799999999876543322
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ...++..|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 157 ~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 200 (265)
T cd06605 157 K-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYP 200 (265)
T ss_pred h-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2 2678888999999877 678999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=260.95 Aligned_cols=192 Identities=26% Similarity=0.473 Sum_probs=164.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+-|++.+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+|+.+++++ +||||+++++++.+. ...++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeC--CeEEEE
Confidence 34678899999999999999998889999999876322 25678899999999 999999999998764 457799
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
|||++++++..++. .+++..+..++.|++.|+.|||+++++|+||||+||+++.++ .++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhc
Confidence 99999999887764 478889999999999999999999999999999999999665 79999999987654332 223
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 3467888999999876 678889999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=257.16 Aligned_cols=191 Identities=21% Similarity=0.466 Sum_probs=164.0
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||++.+..+++.+|+|.+... ..+.+.+|+.+++++ +||||+++++++.+. ...++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEEN--GNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCC--CeEEEE
Confidence 588999999999999999999889999999988532 235788999999999 999999999998654 467899
Q ss_pred EeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|||+.++++...+. .+++..+..++.|++.||.|||+++++|+||+|+|||++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence 99999998876552 367888999999999999999999999999999999998666 799999999976543322
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+ +.++.++|+|||||++|+|++|+.||.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 223467888999999876 678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=267.43 Aligned_cols=194 Identities=29% Similarity=0.578 Sum_probs=160.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCC--CeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTD--NEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~--~~~~ 205 (387)
+|++.+.||+|+||.||++.+..+ +..+|+|.+... ..+.+.+|+++++++.+||||+++++..... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478999999999999999999877 889999988632 2356788999999996799999999975432 2345
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++++||+.+ +|...+ ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence 6788888874 555444 3478999999999999999999999999999999999999666 8999999999865432
Q ss_pred Cc-----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .....|+..|+|||++.+...++.++|||||||++|+|++|.+||.
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 21 2334788999999998764578999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=258.51 Aligned_cols=192 Identities=24% Similarity=0.443 Sum_probs=162.0
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-------------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-------------~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
+|.+.+.||.|+||.||+|.+..+++.+|+|.++... .+.+.+|+.+++++ +|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence 4778899999999999999998889999999875211 13577899999999 999999999998764
Q ss_pred CCCCceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 202 QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...++||||+++++|...++ .+++..++.++.|++.||.|||+++++||||||+||+++.++ .++|+|||+++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~ 157 (272)
T cd06629 81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKK 157 (272)
T ss_pred --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeecccccc
Confidence 45779999999999877653 478888999999999999999999999999999999999655 899999999976
Q ss_pred ecCCC---cccccccccCCCCchhhcccC-CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..... ......++..|+|||.+.+.. .++.++|+|||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 53221 123346788899999986532 47899999999999999999999983
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=257.59 Aligned_cols=184 Identities=19% Similarity=0.313 Sum_probs=155.3
Q ss_pred eeeeecCCeeEEEEEEeC-CC--eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+.||+|++|.||+|.+.. .+ ..+|+|.+.... .+.+.+|+++++++ +||||+++++++.+ ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence 468999999999999855 33 368999987543 35788999999999 99999999999876 567899999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc---
Q 016537 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--- 284 (387)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~--- 284 (387)
+++++|...+. .+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence 99999876652 367888999999999999999999999999999999999765 899999999987644221
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
.....++..|+|||.+.+ ..++.++|||||||++|||++ |++||
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~ 201 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPW 201 (257)
T ss_pred cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 112346678999999876 678999999999999999999 99998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=253.11 Aligned_cols=193 Identities=28% Similarity=0.513 Sum_probs=169.0
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|.+.+.||+|++|.||+|.+..+++.+++|.+.... .+.+.+|+++++++ +|+||+++++.+.+......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999998889999999986544 56788999999999 89999999999876533567899
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc--
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-- 284 (387)
+||+.++++..++. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccc
Confidence 99999999887653 578899999999999999999999999999999999999655 899999999987765543
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|++||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 445678889999999876 568999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=257.82 Aligned_cols=192 Identities=27% Similarity=0.471 Sum_probs=164.1
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||+|.+..+++.+++|.++.. ..+.+.+|+++++++ +|+||+++++++.+. ...++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHR--EKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecC--CEEEEE
Confidence 478899999999999999999888999999998643 235788999999999 999999999987654 457799
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc-
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~- 285 (387)
+||+++++|..+.. .+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .+||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcc
Confidence 99999999987763 378888999999999999999999999999999999999655 8999999999776433221
Q ss_pred ----cccccccCCCCchhhcccC--CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 ----NVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ----~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||++.+.. .++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~ 207 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 1246778899999987632 27889999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=263.75 Aligned_cols=190 Identities=26% Similarity=0.459 Sum_probs=160.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~--~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLRE--HTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeC--CeEE
Confidence 5688999999999999999999888999999988532 124678999999999 999999999999764 3467
Q ss_pred EEEeccCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+..+..+ ...+++..+..++.|++.||.|||+++|+||||+|+||+++.++ .++|+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC--
Confidence 99999986543332 23588999999999999999999999999999999999999666 7999999999765433
Q ss_pred ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||++.+ ...++.++|||||||++|||++|.+||.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 34567888999998742 2568889999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=258.00 Aligned_cols=192 Identities=23% Similarity=0.503 Sum_probs=165.2
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||+|.++.++..+|+|.+... ..+.+.+|+++++.+ +|+||+++++.+.+. ...+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~--~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQEN--GRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccC--CeEEEE
Confidence 478999999999999999999889999999998542 345678999999999 999999999988654 457899
Q ss_pred EeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||+.+++|...+. .+++..++.++.|++.||.|||+++++|+||||+||+++.++..++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999877653 2678889999999999999999999999999999999997766789999999976654332
Q ss_pred c-cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 Y-NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~-~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ....|+..|+|||.+.+ ..++.++|+|||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2 23468888999999876 568899999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=254.80 Aligned_cols=185 Identities=24% Similarity=0.400 Sum_probs=154.4
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
+.||+|+||.||+|.. .++..+|+|.+.... ...+.+|+++++++ +||||+++++++... ...++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQR--QPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecC--CccEEEEECCCC
Confidence 3689999999999986 578899999986432 24678899999999 999999999998764 356799999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc--cccc
Q 016537 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRV 289 (387)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~--~~~~ 289 (387)
+++...+. .+.+..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......... ....
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCC
Confidence 99877653 367888999999999999999999999999999999998665 8999999999764433211 1223
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 3567999999876 678999999999999999998 998983
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=265.68 Aligned_cols=193 Identities=32% Similarity=0.618 Sum_probs=163.7
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+.. ...+.+.+|+++++++ +||||+++.+++.... ...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~-~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPL-EDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCC-CcE
Confidence 45889999999999999999999988999999998753 1236678899999999 9999999999886533 457
Q ss_pred eEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
++++||+. +++..+++ .+++..+..++.|+++||.|||+++|+||||||+|||++.++ .++|+|||++..... .
T Consensus 86 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 86 YFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDP--Q 161 (328)
T ss_pred EEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCC--C
Confidence 89999985 46666553 477888889999999999999999999999999999999655 899999999975432 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||.+.+...++.++|||||||++|+|++|++||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2345678889999997664568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=261.22 Aligned_cols=193 Identities=21% Similarity=0.416 Sum_probs=162.2
Q ss_pred CeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
+|++.+.||.|+||.||+|.+. .+++.||+|+++.. ..+++.+|+++++++.+|+||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 4789999999999999999874 47889999998642 2356788999999997799999999988654 4
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+++++|...+ ..+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceeccc
Confidence 577999999999987665 3478888999999999999999999999999999999999766 899999999977544
Q ss_pred CC--cccccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 32 22345688899999998642 346789999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=261.58 Aligned_cols=184 Identities=15% Similarity=0.231 Sum_probs=149.9
Q ss_pred eeeecCCeeEEEEEEeCC------------------------CeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeE
Q 016537 141 KVGRGKYSEVFEGVHCTD------------------------NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVK 193 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~~~------------------------~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~ 193 (387)
.||+|+||.||+|....+ ...|++|++.... ...+.+|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 599999999999975321 2468899886433 24577888899988 9999999
Q ss_pred EEEEEEcCCCCCceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC----
Q 016537 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---- 265 (387)
Q Consensus 194 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---- 265 (387)
+++++.+.. ..++||||+++++|..++. .+++..+..++.|++.||+|||+++|+||||||+|||++..+
T Consensus 81 ~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 81 VHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 999997653 5679999999999877652 378888999999999999999999999999999999997432
Q ss_pred --ceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHH-HhcCCchh
Q 016537 266 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM-VSVSPSVL 330 (387)
Q Consensus 266 --~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~el-ltg~~pf~ 330 (387)
..+|++|||++...... ....++..|+|||.+.+...++.++|||||||++||| ++|++||.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 14899999998654322 2345778899999987646689999999999999999 47898883
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=257.36 Aligned_cols=186 Identities=21% Similarity=0.405 Sum_probs=150.5
Q ss_pred eeeeecCCeeEEEEEEeC---CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+.||+|+||.||+|.+.. ++..+|+|.+... ..+.+.+|+.+++.+ +||||+++++++...+ ...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSE-GSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCC-CCcEEEEec
Confidence 468999999999998643 3468999987532 235678899999998 9999999999876433 456799999
Q ss_pred cCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc----
Q 016537 213 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---- 284 (387)
Q Consensus 213 ~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~---- 284 (387)
+.+++|..++. ...+..+..++.|++.||+|||+++++||||||+|||++.++ .+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeec
Confidence 99999987753 246677888999999999999999999999999999999666 799999999976533211
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhc-CCch
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSV-SPSV 329 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg-~~pf 329 (387)
.....++..|+|||.+.+ ..++.++|||||||++|||++| .+||
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 112345667999999876 6789999999999999999995 5665
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=255.90 Aligned_cols=189 Identities=23% Similarity=0.416 Sum_probs=160.8
Q ss_pred EEEeeeeecCCeeEEEEEEeCCC----eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++.+.||+|+||.||+|.+...+ ..+|+|.+.... .+.+.+|+++++.+ +|+||+++++++.+. ...++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeEE
Confidence 46788999999999999987665 899999987543 45788999999999 999999999998765 45779
Q ss_pred EEeccCCCchhhhcC---C--CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLYP---T--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~--~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+|||+.++++..++. . +++..+..++.|++.||+|||+++++||||||+||+++.++ .++|+|||+++......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceeccccc
Confidence 999999999876653 2 88999999999999999999999999999999999999666 89999999998765442
Q ss_pred cccc--cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 284 EYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 284 ~~~~--~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 2221 235678999999865 678999999999999999998 788873
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=258.05 Aligned_cols=192 Identities=30% Similarity=0.618 Sum_probs=160.6
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEEEEEEEcCCC---CC
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQS---KT 205 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~--~hpniv~l~~~~~~~~~---~~ 205 (387)
|++.+.||+|+||.||+|.++.+++.+|+|.++... ...+.+|+.+++++. +|+|++++++++.+.+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999986321 235667888887763 59999999999876433 23
Q ss_pred ceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.+++|||+.+ ++..++ ..+++..++.++.|++.||.|||+++++|+||||+||+++.++ .+||+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence 7899999986 454433 2478999999999999999999999999999999999999775 89999999998765
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.........++..|+|||++.+ ..++.++|+|||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 5444444567888999999877 678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=254.38 Aligned_cols=191 Identities=18% Similarity=0.382 Sum_probs=160.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+... ....+.+|+++++++ +|||++++++++... ...+++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTER--SPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccC--CceEEEEE
Confidence 57889999999999999999884 4678999988643 346789999999999 999999999998654 45689999
Q ss_pred ccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc--
Q 016537 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-- 285 (387)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~-- 285 (387)
|+.+++|..++. .+++..++.++.|++.||+|||+++++||||||+||+++.++ .++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCccccc
Confidence 999999876652 378888999999999999999999999999999999998555 8999999998765332211
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||.+.+ +.++.++|||||||++|||++ |.+||.
T Consensus 159 ~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 159 TGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred CCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 12234567999999876 678999999999999999998 899983
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.34 Aligned_cols=191 Identities=34% Similarity=0.597 Sum_probs=167.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
+|++.+.||+|++|.||++.+..+++.+++|++... ..+.+.+|+++++++ +|+|++++++++... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence 478889999999999999999888999999998654 346788999999999 899999999998765 45679999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccc
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~ 287 (387)
|+++++|..++ ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||.+...........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeeccccccccccccccc
Confidence 99999988765 3578999999999999999999999999999999999999665 899999999987655443445
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..++..|++||.+.+ ..++.++|+|||||++|+|++|++||.
T Consensus 157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 678889999999876 568899999999999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.97 Aligned_cols=190 Identities=27% Similarity=0.464 Sum_probs=158.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-------
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------- 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~------- 201 (387)
..+|+.++.||+||||.||+++++-+|+.||||.+.-. ...++.+|+..|.+| +|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence 36788899999999999999999999999999988532 236688999999999 999999987621100
Q ss_pred --------------------------------------------------------------------------------
Q 016537 202 -------------------------------------------------------------------------------- 201 (387)
Q Consensus 202 -------------------------------------------------------------------------------- 201 (387)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ----------------------CC--------CCceEEEeccCCCchhhhcCC--C--CHHHHHHHHHHHHHHHHHHHHc
Q 016537 202 ----------------------QS--------KTPSLIFEHVNNTDFKVLYPT--L--SDYDVRYYIYELLKALDYCHSQ 247 (387)
Q Consensus 202 ----------------------~~--------~~~~lv~e~~~~~~l~~~~~~--~--~~~~~~~~~~qi~~aL~yLH~~ 247 (387)
.+ .++|+-||||+..++..+++. + .....+++.+||++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 00 346788999999888877643 3 3667899999999999999999
Q ss_pred CceeeccCCCCeeEcCCCceEEEEecccceeec-------------------CCCcccccccccCCCCchhhcccC--CC
Q 016537 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DY 306 (387)
Q Consensus 248 ~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~~ 306 (387)
|||||||||.||++|.++ .|||+|||+|+... .....+..+||..|+|||++.+.. .|
T Consensus 717 giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999666 89999999997621 112446779999999999998765 69
Q ss_pred CCccchhhHHHHHHHHHh
Q 016537 307 DYSLDLWSLGCMFAGMVS 324 (387)
Q Consensus 307 ~~~sDvwSlGvil~ellt 324 (387)
+.|+|+|||||||+||+.
T Consensus 796 n~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cchhhhHHHHHHHHHHhc
Confidence 999999999999999985
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=258.91 Aligned_cols=192 Identities=19% Similarity=0.367 Sum_probs=160.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.+.||+|+||.||+|+.+. +.+.+++|.+.... .+.+.+|+++++++ +|+||+++++++.+. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREA--E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCC--C
Confidence 678999999999999999998753 34679999886433 25688999999999 999999999998654 4
Q ss_pred CceEEEeccCCCchhhhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEe
Q 016537 205 TPSLIFEHVNNTDFKVLYP------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
..++||||+++++|..++. .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .++|+|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~~ 160 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVSL 160 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEcc
Confidence 5689999999999987652 478889999999999999999999999999999999999766 799999
Q ss_pred cccceeecCCC--cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 273 WGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 273 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||+++...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99986543221 1233455677999999876 568899999999999999999 788873
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=255.91 Aligned_cols=184 Identities=26% Similarity=0.420 Sum_probs=155.0
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccch------HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~------~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.||+|+||.||+|.+..+++.||+|.+..... ..+..|..++....+|+|++++++++... ...++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEecc
Confidence 569999999999999988899999999864321 23445555555445899999999999754 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~g 290 (387)
++++|..++ ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .++|+|||+++.... .....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccCCC
Confidence 999998776 3478999999999999999999999999999999999999665 899999999876432 234467
Q ss_pred ccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+..|+|||.+.+ ..++.++||||||+++|||++|.+||.
T Consensus 156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 888999999877 558999999999999999999999983
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=257.95 Aligned_cols=192 Identities=20% Similarity=0.377 Sum_probs=156.1
Q ss_pred eEEEeeeeecCCeeEEEEEEeC---CCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
|.+.+.||+|+||.||+|.+.. +++.+|||++... ..+.+.+|+++++++ +||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 5677899999999999998643 4789999988643 235678899999999 99999999998865322
Q ss_pred CCceEEEeccCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 204 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
...++++||+.++++..++ ..++...++.++.|++.||+|||+++|+||||||+||+++.+. .+||+|||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECccc
Confidence 2346889999999986543 1367888999999999999999999999999999999998655 79999999
Q ss_pred cceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 275 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 275 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+++....+.. .....++..|++||.+.+ ..++.++|||||||++|||++ |++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~ 217 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYA 217 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence 9986543321 122345567999999876 678899999999999999999 888873
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=260.45 Aligned_cols=190 Identities=36% Similarity=0.711 Sum_probs=160.1
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
|++.+.||.|++|.||+|.++.+++.||+|++.... .+.+.+|+++++++ +|||++++++++.+. ...+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~--~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSE--NKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccC--CeEEEEE
Confidence 567889999999999999998899999999986332 25678899999999 999999999998764 5678999
Q ss_pred eccCCCchhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 211 EHVNNTDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 211 e~~~~~~l~~~~---~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
||++ +++..++ . .+++..++.++.|++.||+|||+++++||||+|+||+++.++ .++|+|||++....... .
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccc
Confidence 9996 4565544 2 478999999999999999999999999999999999999755 89999999997653222 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2334567889999988764567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=278.63 Aligned_cols=192 Identities=27% Similarity=0.408 Sum_probs=164.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
.++|++...+|.|+|+.|-.+.+..+++..++|++... .....+|+.++....+||||+++.+.+.+. ...++|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCC--ceeeeeehh
Confidence 57899999999999999999999999999999999755 344567888888888999999999999764 567799999
Q ss_pred cCCCchhhhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccccc
Q 016537 213 VNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (387)
Q Consensus 213 ~~~~~l~~~~~~--~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~g 290 (387)
+.++.+...+.. ....++..|+++|+.|+.|||++|||||||||+|||++.+.++++|+|||.++..... +...+-
T Consensus 398 l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~ 475 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPAL 475 (612)
T ss_pred ccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccch
Confidence 999977555433 2335777899999999999999999999999999999533348999999999877655 445577
Q ss_pred ccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|..|.|||++.. .+|+.++||||||++||+||+|+.||.
T Consensus 476 t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 476 TLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred hhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 888999999885 889999999999999999999999993
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=260.03 Aligned_cols=191 Identities=29% Similarity=0.581 Sum_probs=161.9
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
|++.+.||+|++|.||+|.+..+++.++||.+.... .....+|+..++++.+|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEEe
Confidence 568899999999999999998889999999886432 234567999999993399999999998763 45789999
Q ss_pred ccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 212 HVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
|+ ++++...+ ..+++..+..++.|++.+|.|||+++++|+||||+||+++.++ .++|+|||+++.........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCCcC
Confidence 99 56665443 2468899999999999999999999999999999999999655 89999999998776555555
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||++.+...++.++|+||||++++||++|++||.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 66788999999998665668899999999999999999999984
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=258.97 Aligned_cols=192 Identities=21% Similarity=0.409 Sum_probs=163.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
..|...+.||+|++|.||++.+..+++.+++|.+... ..+.+.+|+.+++.+ +||||+++++++... ...++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~--~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVG--DELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcC--CeEEEEE
Confidence 3455667999999999999999888999999988532 235678899999999 999999999988764 4567999
Q ss_pred eccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cccc
Q 016537 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (387)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~ 287 (387)
||+.+++|...+. .+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||.+....... ....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCccccc
Confidence 9999999987653 478889999999999999999999999999999999999665 89999999886543322 1233
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..|+..|+|||.+.+ ..++.++|||||||++|||++|++||.
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 175 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred ccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 468889999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=266.61 Aligned_cols=193 Identities=33% Similarity=0.666 Sum_probs=165.2
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CCCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---~~~~ 206 (387)
+|++.+.||+|++|.||+|.+..+++.+|+|.+... ..+.+.+|+.+++.+ +|+||+++++++.+.. ....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 588999999999999999999888999999988643 236788999999999 8999999999887643 2356
Q ss_pred eEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+++|||+.+ ++...+. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDE 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeecccc
Confidence 899999985 5554442 478999999999999999999999999999999999999765 89999999998765543
Q ss_pred ----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+...++.++|+|||||++|+|++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 23445778899999999874478999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=266.68 Aligned_cols=193 Identities=26% Similarity=0.520 Sum_probs=159.8
Q ss_pred CCCeEE-EeeeeecCCeeEEEEEEeCCCeEEEEEEecccch-----------------HHHHHHHHHHHHhcCCCCeeEE
Q 016537 133 QDDYEV-VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNIVKL 194 (387)
Q Consensus 133 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~-----------------~~~~~E~~il~~l~~hpniv~l 194 (387)
.++|.. .+.||+|+||.||+|.+..+++.||+|.++.... ..+.+|+++++++ +|+||+++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 85 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGL 85 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeee
Confidence 356754 4779999999999999988999999998864321 1467899999999 99999999
Q ss_pred EEEEEcCCCCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEE
Q 016537 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (387)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~ 271 (387)
++++... ...++||||+.+ ++...+ ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+
T Consensus 86 ~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~ 161 (335)
T PTZ00024 86 VDVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIA 161 (335)
T ss_pred eEEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEEC
Confidence 9998754 467899999985 555444 3478999999999999999999999999999999999999666 89999
Q ss_pred ecccceeecCC---------------CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 272 DWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 272 DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|||++...... .......++..|+|||.+.+...++.++|||||||++|||++|.+||.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999765411 112233567889999998765567899999999999999999999984
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=260.92 Aligned_cols=205 Identities=26% Similarity=0.537 Sum_probs=169.7
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC---CceEE
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLI 209 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~---~~~lv 209 (387)
-.+.||-|+||.||.+.+..+|+.||+|.+... ..+++.+|+.+|.-+ +|.|+...+++..-..-. .+|.+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHH
Confidence 446799999999999999999999999987532 347889999999988 999999999876433211 23566
Q ss_pred EeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--c
Q 016537 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--~ 284 (387)
.|.|.. +|..++ +.++...++-+++||++||+|||+.+|.||||||.|+|++.+. .+||||||+++..+.+. .
T Consensus 136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhhhh
Confidence 777764 444443 3478889999999999999999999999999999999999666 89999999999876554 4
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCcccccc
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWF 345 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~ 345 (387)
++..+.|.+|+|||++.|...|+.++||||.|||+.||+.++-.|-. ....+|+|+.+.+.
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 56778899999999999989999999999999999999998877732 56778888776663
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.90 Aligned_cols=200 Identities=25% Similarity=0.499 Sum_probs=173.7
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCCC
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---QSKT 205 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~---~~~~ 205 (387)
...+.|++.+.||.|.+|.||+++...+++.+|+|++... ..++++.|.++|+.+++|||++.++|++... ....
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3457899999999999999999999999999999998754 4578889999999999999999999988642 2345
Q ss_pred ceEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
+.||||||.+|+.-++.+ ++.|..+..|+++++.||.+||.+.++|||||=.|||++.++ .|||+|||.+..+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 174 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeeeee
Confidence 789999999999776653 478889999999999999999999999999999999999777 79999999998775
Q ss_pred CC-CcccccccccCCCCchhhcccC----CCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 281 PG-KEYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 281 ~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.. ....+.+||++|||||++.... .|+..+|+||||++..||-.|.||+..
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 44 3446789999999999996533 478899999999999999999999853
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=258.43 Aligned_cols=194 Identities=28% Similarity=0.508 Sum_probs=167.9
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..+.|++.+.||+|++|.||+|.+..++..+++|.+.... ...+.+|+++++.+ +|+|++++++++... ...+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEEEE
Confidence 4577899999999999999999998889999999987544 56788999999999 999999999998765 457899
Q ss_pred EeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
+||+++++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++....... .
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchhh
Confidence 99999999987763 578889999999999999999999999999999999999665 79999999986544322 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|++||.+.+ ..++.++|+|||||++|+|++|+.||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 233457788999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=252.35 Aligned_cols=184 Identities=22% Similarity=0.404 Sum_probs=154.1
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
++||+|+||.||+|.+.. ++.||+|.+... ....+.+|+++++++ +|+||+++++++.+. ...++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQK--QPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence 469999999999999866 999999987643 235788999999999 999999999998764 456799999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc---ccc
Q 016537 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 288 (387)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~ 288 (387)
+++..++. .+++..+..++.|++.||+|||+++++||||||+|||++.++ .++|+|||+++........ ...
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccC
Confidence 99877652 367888899999999999999999999999999999999666 8999999999765422111 112
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
..+..|+|||.+.+ +.++.++|+|||||++|||++ |..||
T Consensus 156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 23456999999876 678999999999999999999 78887
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=258.79 Aligned_cols=191 Identities=37% Similarity=0.707 Sum_probs=162.1
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
|++.+.||+|++|.||+|.+..+++.+++|.+.... ...+.+|+++++++ +|+||+++++++.+. ...++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccC--CCEEEEE
Confidence 567789999999999999998899999999986432 35678899999999 899999999998765 5577999
Q ss_pred eccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 211 EHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 211 e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
||+.+.....+.. .+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||.+....... ...
T Consensus 78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCccccc
Confidence 9998743333322 578899999999999999999999999999999999999665 79999999998765543 333
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...++..|+|||.+.+...++.++|+|||||++|+|++|++||.
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 45678889999998774478999999999999999999999983
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=267.45 Aligned_cols=193 Identities=29% Similarity=0.622 Sum_probs=163.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|++.+.||+|++|.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +|||++++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcccccccc
Confidence 47899999999999999999999889999999987632 235567899999999 99999999987754322
Q ss_pred CCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 204 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
...++|+||+. ++|..++ ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 93 ~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEccccccccccc
Confidence 34789999985 5676655 3588999999999999999999999999999999999999665 799999999976543
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .....++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred c--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2 3445778889999998764568899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=260.30 Aligned_cols=194 Identities=21% Similarity=0.355 Sum_probs=160.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+..+++.||||.++.. ....+.+|+.++.+..+|+||+++++++.+. ...++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEE
Confidence 37899999999999999999999888999999998643 2245667887777775799999999999764 45789
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+|||+.+ ++..++ ..+++..+..++.|++.||+|||+ ++|+||||+|+||+++.++ .+||+|||++..+....
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSK 169 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCC
Confidence 9999875 443333 347888899999999999999997 5999999999999999655 89999999997765444
Q ss_pred cccccccccCCCCchhhccc---CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||.+.+. +.++.++|||||||++|||++|+.||.
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 44445678889999998652 247889999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=249.38 Aligned_cols=191 Identities=25% Similarity=0.538 Sum_probs=165.7
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||++.+..++..+++|.+... ....+.+|+++++.+ +|+|++++++.+.+. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecC--CEEEEE
Confidence 488999999999999999999888999999998642 346688999999999 899999999988765 567899
Q ss_pred EeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
+||+++++|...+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence 9999999987654 3478899999999999999999999999999999999999655 8999999999776444
Q ss_pred C-cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~ 204 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFE 204 (258)
T ss_pred cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCC
Confidence 3 2234578889999999876 668899999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=259.72 Aligned_cols=190 Identities=25% Similarity=0.450 Sum_probs=159.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
..|+..+.||+|+||.||+|++..++..+|+|.+.... ...+.+|+++++++ +|||++++++++.+. ...+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE--HTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CeEE
Confidence 45778899999999999999998899999999986321 24678899999999 999999999998764 3467
Q ss_pred EEEeccCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+..+..+ ...+++..+..++.|++.||.|||+++|+||||+|+||+++.++ .++|+|||++.....
T Consensus 102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC---
Confidence 99999986433322 23478899999999999999999999999999999999998666 799999999875433
Q ss_pred ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||.+.. .+.++.++|||||||++|||++|.+||.
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 234568889999999742 2468889999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=252.86 Aligned_cols=190 Identities=24% Similarity=0.490 Sum_probs=164.9
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|+||.||++.+..+++.+|+|.+... ...++.+|+++++++ +|+||+++++++.+. ...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDG--NKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccC--CEEEEE
Confidence 488999999999999999999889999999998632 234677899999999 899999999988764 557899
Q ss_pred EeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
|||++++++..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence 9999999987665 3478889999999999999999999999999999999999655 7999999999776544
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|++||.+.+ ..++.++|+||||+++|||++|++||.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3334567889999999877 678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=256.50 Aligned_cols=187 Identities=22% Similarity=0.364 Sum_probs=153.7
Q ss_pred eeeeecCCeeEEEEEEeCCC------eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 140 RKVGRGKYSEVFEGVHCTDN------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+.||+|+||.||+|.++... +.+|+|.+... ....+.+|+++++.+ +||||+++++++.+. ...+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLN--EPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCC--CCeEEE
Confidence 36899999999999875433 68999987542 346788999999999 999999999998754 457899
Q ss_pred EeccCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC----ceEEEEeccc
Q 016537 210 FEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGL 275 (387)
Q Consensus 210 ~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~----~~vkl~DFG~ 275 (387)
|||+++++|...+. .+++..+..++.|++.||+|||+++++|+||||+||+++.++ ..++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999876652 256788899999999999999999999999999999998544 2699999999
Q ss_pred ceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 276 AEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 276 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 976543221 112345678999999876 678999999999999999998 999883
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=267.45 Aligned_cols=197 Identities=24% Similarity=0.429 Sum_probs=165.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
.++|-++.+||+|||+.||+|.+...++.||||+-...+ .+...+|.+|.+.| +||.||++|+++.-+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD- 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec-
Confidence 367888999999999999999998889999999853211 14567899999999 999999999999753
Q ss_pred CCCceEEEeccCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHc--CceeeccCCCCeeEcCC--CceEEEEeccc
Q 016537 203 SKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHE--QRKLRLIDWGL 275 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~aL~yLH~~--~ivHrDlKp~NILl~~~--~~~vkl~DFG~ 275 (387)
....|-|+|||+|.+|..+++. +++.+++.|+.||+.||.||.+. .|||-||||.|||+.+. .+.+||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 4556799999999999887754 89999999999999999999986 59999999999999532 23799999999
Q ss_pred ceeecCCCc--------ccccccccCCCCchhhcc---cCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 276 AEFYHPGKE--------YNVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 276 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
++.+.++.. .....||.||++||.+.- ...++.++||||+|||+|..+.|+.||..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 998865432 234579999999999843 23578899999999999999999999943
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=255.17 Aligned_cols=192 Identities=21% Similarity=0.477 Sum_probs=162.0
Q ss_pred CeEEEeeeeecCCeeEEEEEEeC-CCeEEEEEEecccc-------------hHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK-------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~l~~~~-------------~~~~~~E~~il~~l~~hpniv~l~~~~~~ 200 (387)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+.... ..++.+|+.++.+..+||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999876 67899999875211 13466788888764599999999999876
Q ss_pred CCCCCceEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEe
Q 016537 201 QQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
. ...+++|||+.++++..++ ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++ .++|+|
T Consensus 81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~d 157 (269)
T cd08528 81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITD 157 (269)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEec
Confidence 4 4678999999999886554 247888999999999999999996 7899999999999999666 799999
Q ss_pred cccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 273 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
||++.............++..|++||.+.+ ..++.++|||||||++|||++|++||.
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 999987655544455678889999999876 668999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=268.89 Aligned_cols=193 Identities=23% Similarity=0.370 Sum_probs=163.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.+...+.++||+|.||+|.+|.. ..+.+||||.+++.. ++.|.+|+++|.+| +||||++++|+|..++. +++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DeP--icm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDP--LCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCc--hHH
Confidence 46678899999999999999986 446999999998643 47799999999999 99999999999987544 569
Q ss_pred EEeccCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++|||++|+|.+++.. ........++.||+.|++||.+.++|||||.+.|+|+|.+. ++||+|||+++.+-.+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccccccCC
Confidence 9999999999887632 23345567999999999999999999999999999999665 89999999999766555
Q ss_pred cccc---cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh--cCCchhh
Q 016537 284 EYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS--VSPSVLF 331 (387)
Q Consensus 284 ~~~~---~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt--g~~pf~~ 331 (387)
.+.. .+-...|||+|.+.. ++++.++|||+||+++||+++ .+.||..
T Consensus 692 yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred ceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence 4432 355678999999987 789999999999999999876 6788854
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=253.36 Aligned_cols=185 Identities=17% Similarity=0.281 Sum_probs=146.4
Q ss_pred eeeecCCeeEEEEEEeCC--CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccC
Q 016537 141 KVGRGKYSEVFEGVHCTD--NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~~~--~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~ 214 (387)
+||+|+||.||+|....+ ...+++|.++.. ..+.+.+|+.+++.+ +||||+++++.+.+. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEA--IPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCC--CccEEEEecCC
Confidence 599999999999976433 345667776533 235788999999998 999999999998764 45689999999
Q ss_pred CCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC---c
Q 016537 215 NTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E 284 (387)
Q Consensus 215 ~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~---~ 284 (387)
+++|..++. ..++..++.++.|++.||+|||+++++||||||+|||++.++ .++|+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhc
Confidence 999977653 245566788999999999999999999999999999998666 79999999986432211 1
Q ss_pred ccccccccCCCCchhhccc------CCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 285 YNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~------~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
.....++..|+|||++... ..++.++|||||||++|||++ |.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 209 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence 1234678889999997431 245789999999999999997 46676
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=247.62 Aligned_cols=191 Identities=28% Similarity=0.541 Sum_probs=165.9
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+|++.+.||+|++|.||+|.+..+++.+++|.+.... ...+.+|+++++++ +|+|++++++++.+. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETS--DSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeC--CEEEEE
Confidence 4788999999999999999998889999999986443 35688999999999 999999999998764 467899
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-c
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~ 285 (387)
|||+++++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccc
Confidence 99999999887663 488999999999999999999999999999999999999655 899999999987654433 2
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||...+ ..++.++||||||+++|+|++|.+||.
T Consensus 157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 34567888999999876 458899999999999999999999983
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=262.59 Aligned_cols=187 Identities=17% Similarity=0.265 Sum_probs=152.5
Q ss_pred eeeeec--CCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
..||+| +||+||+|.+..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++... ...++||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTG--SWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecC--CceEEEEec
Confidence 456666 99999999998899999999986432 25678899998888 999999999999765 356799999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cc-
Q 016537 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY- 285 (387)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~- 285 (387)
+.++++..++. .+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++++|||.+....... ..
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence 99999877653 378888999999999999999999999999999999999666 79999998653322111 00
Q ss_pred ------cccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 ------NVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ------~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||++.+. ..++.++|||||||++|||++|.+||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 112345669999998652 347899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=263.07 Aligned_cols=193 Identities=22% Similarity=0.338 Sum_probs=164.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCC--CCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQ--SKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l-~~hpniv~l~~~~~~~~--~~~~~lv~ 210 (387)
+..++.++||+|.||.||||.. +++.||||++....+..+.+|-+|+... ..|+||+++++.-+... ..-..||+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4566788999999999999997 5699999999999999999999998864 38999999999765433 33456999
Q ss_pred eccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHc---------CceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~---------~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
+|.+.|+|.+++. .+++.+..+++..+++||+|||+. .|+|||||..|||+..|. .+.|+|||+|..+
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEEe
Confidence 9999999998885 488999999999999999999973 599999999999999777 8999999999888
Q ss_pred cCCCcc---cccccccCCCCchhhcccCCCC-----CccchhhHHHHHHHHHhcCCch
Q 016537 280 HPGKEY---NVRVASRYFKGPELLVDLQDYD-----YSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 280 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~-----~~sDvwSlGvil~elltg~~pf 329 (387)
.++... ...+||..|||||++.+.-... .+.||||+|.+||||+++...+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 766443 3469999999999997643333 4699999999999999987654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=257.50 Aligned_cols=188 Identities=21% Similarity=0.396 Sum_probs=161.1
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccC
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~ 214 (387)
....||+|+||.||++.++.+++.+|+|.+... ....+.+|+.+++++ +|+|++++++++... ...+++|||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeC--CEEEEEEecCC
Confidence 346799999999999999889999999987532 235678899999999 999999999998764 45789999999
Q ss_pred CCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cccccccc
Q 016537 215 NTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVAS 291 (387)
Q Consensus 215 ~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt 291 (387)
++++..+. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ......++
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccccccccccccC
Confidence 99988775 3478889999999999999999999999999999999999665 79999999987654332 22345678
Q ss_pred cCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..|+|||.+.+ ..++.++|+|||||++|||++|.+||.
T Consensus 180 ~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 180 PYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 89999999865 678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=255.09 Aligned_cols=193 Identities=32% Similarity=0.582 Sum_probs=164.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|.+.+.||+|+||.||+|.+..+++.+|+|++... ....+.+|.++++++.+|+||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence 4789999999999999999999889999999998642 2356788999999993399999999988654 4578
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+||||+.+++|...+. .+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccc
Confidence 9999999999876663 478999999999999999999999999999999999999666 79999999987654322
Q ss_pred --------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 --------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+ ..++.++|+|||||++++|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 1123456788999999876 568899999999999999999999983
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=253.89 Aligned_cols=193 Identities=25% Similarity=0.427 Sum_probs=160.5
Q ss_pred CeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
+|++.+.||+|+||.||++.+. .+++.+|||.++.. ..+.+.+|++++.++.+||||+++++.+... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 4789999999999999999863 45788999998632 1245778999999997799999999988654 4
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+.++++...+ ..+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccc
Confidence 577999999999987665 3478889999999999999999999999999999999999665 799999999876543
Q ss_pred CCcc--cccccccCCCCchhhcccC-CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEY--NVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... ....++..|+|||.+.+.. ..+.++||||||+++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 3221 2346788999999986522 36789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=251.05 Aligned_cols=184 Identities=30% Similarity=0.530 Sum_probs=157.5
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
||.|+||.||++.+..+++.+++|.+... ..+.+.+|+++++++ +||||+++++.+... ...+++|||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGK--KNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecC--cEEEEEEecCCC
Confidence 68999999999999888999999998643 235678899999999 899999999988653 457899999999
Q ss_pred Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC---------
Q 016537 216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------- 283 (387)
Q Consensus 216 ~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--------- 283 (387)
++|..++ ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccc
Confidence 9987665 3578999999999999999999999999999999999999766 89999999987543321
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|++||...+ ..++.++|||||||++|||++|..||.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 1233467788999999876 568899999999999999999999983
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=277.63 Aligned_cols=191 Identities=20% Similarity=0.363 Sum_probs=164.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCC---eEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
....+.++||.|.||+|++|+.+..+ ..||||.++. ..+..|..|..||-++ +||||++|.|++.. ..-+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Ccee
Confidence 45788999999999999999987655 5899999984 3457799999999999 99999999999975 3567
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++|.|||++|+|+.+++ ++...+...+++.|+.|++||-++++|||||.+.|||++.+- .+|++|||+++.+.++
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDD 784 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeecccC
Confidence 89999999999998885 377788889999999999999999999999999999999555 8999999999988665
Q ss_pred Cc--cccccc--ccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 283 KE--YNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 283 ~~--~~~~~g--t~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
.+ +++..| ...|.|||.|.- .+++.+|||||+||+|||.++ |+.||
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred CCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcc
Confidence 42 233333 356999999976 789999999999999999776 88888
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=255.58 Aligned_cols=190 Identities=24% Similarity=0.431 Sum_probs=158.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.|...++||+|+||.||+|.+..+++.+++|.+.... ...+.+|+++++++ +|||++++++++.+. ...+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 97 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE--HTAW 97 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEE
Confidence 34667788999999999999998899999999986321 24577899999999 999999999998764 4567
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+..+..+. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.... .
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~---~ 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS---P 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC---C
Confidence 999999865433332 3478889999999999999999999999999999999998666 79999999986432 2
Q ss_pred ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.. ...++.++|||||||++|||++|.+||.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 234578889999999742 2458889999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=280.50 Aligned_cols=140 Identities=29% Similarity=0.514 Sum_probs=124.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|.+++.||+|+||.||+|.+..+++.||||+++... ...+.+|+.+++.+ +||||+++++++... ...+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~~ 80 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSA--NNVY 80 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEEC--CEEE
Confidence 78999999999999999999998899999999986432 25678899999988 999999999988654 4678
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
+||||+.+++|..++. .+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 9999999999887753 478889999999999999999999999999999999999666 89999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=265.32 Aligned_cols=190 Identities=22% Similarity=0.434 Sum_probs=161.9
Q ss_pred eEEEeeeeecCCeeEEEEEEeCC----CeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
..+.+.||.|.||.||+|++..- .--||||..+. .+.+.|..|.-+|+++ +||||++++|+|.+. ...
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~---P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ---PMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc---cee
Confidence 44567899999999999987432 34688998874 4568899999999999 999999999999764 356
Q ss_pred EEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+|||.++.|.|..+++ .++......|+.||+.||+|||+.++|||||-..|||+.... .|||+|||+++.+.++.
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLEDDA 545 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhhccccc
Confidence 9999999999987774 377778889999999999999999999999999999998666 89999999999988776
Q ss_pred ccccccc--ccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchhh
Q 016537 284 EYNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVLF 331 (387)
Q Consensus 284 ~~~~~~g--t~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~ 331 (387)
.+....| ..-|||||-+ ++..++.++|||.|||++||++. |..||..
T Consensus 546 yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 6655544 3459999997 45789999999999999999887 8899854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=254.92 Aligned_cols=192 Identities=18% Similarity=0.291 Sum_probs=159.8
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCC--CCCce
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQ--SKTPS 207 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l-~~hpniv~l~~~~~~~~--~~~~~ 207 (387)
....+..+.+.||+|.||+||+|.+ .|+.||||++....+....+|.+|++.. .+|+||+.+++.-.... .-.++
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 3346788999999999999999998 5889999999988889999999999863 49999999998643322 22467
Q ss_pred EEEeccCCCchhhhcCC--CCHHHHHHHHHHHHHHHHHHHHc--------CceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 208 LIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~aL~yLH~~--------~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
||.+|.+.|+|.+++.+ ++.....+++..++.||++||.. .|.|||||..|||+..++ .+.|+|+|+|.
T Consensus 286 LvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGLAv 364 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAV 364 (513)
T ss_pred EeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeeceeeE
Confidence 99999999999988854 78888999999999999999964 599999999999999766 89999999997
Q ss_pred eecCCC-----cccccccccCCCCchhhcccCC---C--CCccchhhHHHHHHHHHhc
Q 016537 278 FYHPGK-----EYNVRVASRYFKGPELLVDLQD---Y--DYSLDLWSLGCMFAGMVSV 325 (387)
Q Consensus 278 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~---~--~~~sDvwSlGvil~elltg 325 (387)
....+. ..+.++||..|||||++...-. + -..+||||||.++||+.-+
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 665442 3467899999999999854211 1 1358999999999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=257.26 Aligned_cols=191 Identities=25% Similarity=0.480 Sum_probs=160.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch--HHHHHHHHHHHHhcCC-C----CeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGG-P----NIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~--~~~~~E~~il~~l~~h-p----niv~l~~~~~~~~~~~ 205 (387)
.++|++++.+|+|.||.|-++.+..++..||||+++...+ +..+-|+++|+++..+ | -+|.+.++|.. ...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--RGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--cCc
Confidence 5889999999999999999999998899999999986543 5677899999999443 2 26777777754 345
Q ss_pred ceEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC---------------
Q 016537 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--------------- 265 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--------------- 265 (387)
.++|+|.+.-.. .++++ .++...++.+++|++++++|||+.+++|-||||+|||+.+..
T Consensus 166 iCivfellG~S~-~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 166 ICIVFELLGLST-FDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred eEEEEeccChhH-HHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 779999887444 34443 389999999999999999999999999999999999984221
Q ss_pred ----ceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 266 ----RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 266 ----~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
..|+|+|||.|+.... .....+.|..|+|||++.+ -.++..+||||+||||+||.||...|
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred cCCCcceEEEecCCcceecc--CcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec
Confidence 1589999999987543 3367899999999999999 57999999999999999999999988
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=250.98 Aligned_cols=190 Identities=35% Similarity=0.675 Sum_probs=161.6
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... .+.+.+|+.+++++ +|+|++++++++.+. ...++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTE--RKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcC--CceEEEe
Confidence 567789999999999999998889999999987432 35677899999999 899999999998764 5678999
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cc
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~ 285 (387)
||+++ ++..++ ..+++..++.++.|++.||+|||+++|+||||+|+||+++.++ .++|+|||+++...... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCcccc
Confidence 99985 665554 2578999999999999999999999999999999999999655 89999999997654332 23
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||.+.+...++.++|||||||++|||++|.+||.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 344567789999998774478999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=265.54 Aligned_cols=195 Identities=27% Similarity=0.452 Sum_probs=167.5
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcC---CCCeeEEEE
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCG---GPNIVKLLD 196 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~---hpniv~l~~ 196 (387)
....+|..++.+|.|+||.|+.|.++.+...|+||.+.+.. ...+-.||+||..| + |+||+++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLD 636 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhh
Confidence 34467999999999999999999999999999999986432 12345799999999 5 999999999
Q ss_pred EEEcCCCCCceEEEeccC-CCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEe
Q 016537 197 IVRDQQSKTPSLIFEHVN-NTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 197 ~~~~~~~~~~~lv~e~~~-~~~l~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
+|+++ .+.||+||--. +.+|..+ .+.+.|.+++.+.+|++.|+++||+.||||||||-+|+.++.++ .+||+|
T Consensus 637 fFEdd--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klid 713 (772)
T KOG1152|consen 637 FFEDD--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLID 713 (772)
T ss_pred eeecC--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEee
Confidence 99875 45679998654 3455444 46799999999999999999999999999999999999999666 899999
Q ss_pred cccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 273 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
||.|..... +....++||..|.|||++.|.+..+..-|||++|++||.++....||+
T Consensus 714 fgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999976544 456788999999999999886667888999999999999999999984
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=254.93 Aligned_cols=189 Identities=26% Similarity=0.456 Sum_probs=158.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.|+..+.||+|+||.||+|++..+++.+|+|.+... ...++.+|+++++.+ +|+|++++++++.+. ...+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--CeeE
Confidence 5577889999999999999999888999999988532 124577899999999 999999999998764 4567
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+||||+.+ ++...+ ..+++..++.++.|++.||.|||+++++||||||+|||++.++ .++|+|||++......
T Consensus 92 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 92 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc-
Confidence 99999985 443332 3478889999999999999999999999999999999998665 8999999999765432
Q ss_pred cccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....++..|+|||.+.+ ...++.++|||||||++|||++|..||.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 34567889999999752 2457889999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=255.44 Aligned_cols=181 Identities=20% Similarity=0.260 Sum_probs=148.9
Q ss_pred CCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhh
Q 016537 146 KYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220 (387)
Q Consensus 146 ~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~ 220 (387)
++|.||.++...+++.||+|+++.. ..+.+.+|+++++.+ +|+||+++++++.+. ...+++|||+.++++..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVD--SELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecC--CeEEEEEeccCCCCHHH
Confidence 4455666666678999999998643 235788999999999 999999999998764 44679999999999877
Q ss_pred hcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc--------ccc
Q 016537 221 LYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------YNV 287 (387)
Q Consensus 221 ~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~--------~~~ 287 (387)
++. .+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||.+........ ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccccccccccc
Confidence 653 378888999999999999999999999999999999999666 899999999865532211 123
Q ss_pred cccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..++..|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 4567789999998652 358899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.65 Aligned_cols=186 Identities=20% Similarity=0.317 Sum_probs=157.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~ 214 (387)
.++..+.||+|+||.||+|.+..++..||||.+.... .....|+++++++ +|||||++++++.+.. ..++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~l~~l-~HpnIv~~~~~~~~~~--~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIADMGKL-QHPNIVKLIGLCRSEK--GAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-cccHHHHHHHhhC-CCCCcceEEEEEEcCC--CCEEEEeCCC
Confidence 4566788999999999999998899999999986433 2234678899999 9999999999997653 4679999999
Q ss_pred CCchhhhcCCCCHHHHHHHHHHHHHHHHHHH---HcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccccc
Q 016537 215 NTDFKVLYPTLSDYDVRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291 (387)
Q Consensus 215 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt 291 (387)
+++|..+++.+++..+..++.|++.||+||| +.+|+||||||+||+++.+. ..+++ ||........ ....++
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~~---~~~~~t 841 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCTD---TKCFIS 841 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccccC---CCcccc
Confidence 9999999988999999999999999999999 66999999999999998655 55654 6655433221 234678
Q ss_pred cCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..|+|||++.+ ..++.++|||||||++|||+||++||.
T Consensus 842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 99999999876 679999999999999999999999983
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.17 Aligned_cols=190 Identities=25% Similarity=0.478 Sum_probs=158.7
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
+|.+.+.||+|+||.||++.+...+..+++|+++.. ....+..|+.+++++ +||||+++++++.+. ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLER--DAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcC--Cce
Confidence 478999999999999999998777766777776531 223566799999999 999999999988654 346
Q ss_pred eEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++||||+.++++...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++. + .++|+|||+++..
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~ 155 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLL 155 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeec
Confidence 7999999999987654 34788999999999999999999999999999999999984 4 5999999999776
Q ss_pred cCCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 44322 234567888999999866 668889999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=242.89 Aligned_cols=184 Identities=28% Similarity=0.485 Sum_probs=158.7
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
||+|+||.||++.+..+++.+|+|.+.... ...+..|+++++++ +|+||+++++.+.+. ...+++|||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTE--EKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecC--CeeEEEEecCCC
Confidence 699999999999998889999999986432 34788999999999 899999999988653 567899999999
Q ss_pred CchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccccccccc
Q 016537 216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 291 (387)
Q Consensus 216 ~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt 291 (387)
++|...+. .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++...... .......++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCC
Confidence 98876653 478899999999999999999999999999999999999666 8999999999776443 233455678
Q ss_pred cCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..|++||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 88999999876 567889999999999999999999983
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=266.56 Aligned_cols=192 Identities=19% Similarity=0.333 Sum_probs=161.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCC---eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++..+.++||+|.||.|++|.|+.-+ ..||||.++... ...|.+|+.+|.+| +|+|+++|||++.++ -.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~q---p~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLDQ---PA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeeccc---hh
Confidence 45667889999999999999986432 479999997543 36899999999999 999999999999863 36
Q ss_pred eEEEeccCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 207 SLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.||||.+..|+|.+.++. +.......|+.||+.||.||..+++|||||-..|+|+-... .|||||||+.+-+..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLMRALGE 264 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccceeccCC
Confidence 699999999998766543 66677888999999999999999999999999999998655 899999999998876
Q ss_pred CCcccccc----cccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchhh
Q 016537 282 GKEYNVRV----ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVLF 331 (387)
Q Consensus 282 ~~~~~~~~----gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~ 331 (387)
+..+.... -...|.|||.+.. ..++.++|||+|||+||||+| |+.|+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 65544322 2345999999876 789999999999999999999 6778743
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=262.08 Aligned_cols=192 Identities=20% Similarity=0.396 Sum_probs=164.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.+..+..+||-|.||.||.|.|+.-.-.||||.++.. ..++|.+|..+|+.+ +|||+|+++|+|..+ .-.|+|.|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~E--pPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHE--PPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccC--CCeEEEEe
Confidence 4566789999999999999999998999999999854 458999999999999 999999999999764 44679999
Q ss_pred ccCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
||..|+|.++++. ++.....+++.||..|++||..+++|||||-+.|+|+..+. .||++|||+++.+.. +.++
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtg-DTYT 421 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTG-DTYT 421 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhhhcC-Ccee
Confidence 9999998888754 44555677888999999999999999999999999999544 899999999998754 4556
Q ss_pred ccccc---cCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchhh
Q 016537 287 VRVAS---RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVLF 331 (387)
Q Consensus 287 ~~~gt---~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~ 331 (387)
...|. .-|.|||-+.- +.++.|+|||+|||+|||+.| |-.||..
T Consensus 422 AHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 66554 45999999764 678999999999999999998 6777743
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=242.35 Aligned_cols=176 Identities=20% Similarity=0.296 Sum_probs=147.9
Q ss_pred cCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhc--
Q 016537 145 GKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-- 222 (387)
Q Consensus 145 G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-- 222 (387)
|.+|.||+++++.+++.+|+|.+.... ...+|...+... .||||+++++++.+. ...+++|||+.+++|...+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheecC--CeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986543 334555555555 799999999988764 4578999999999987654
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhc
Q 016537 223 -PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (387)
Q Consensus 223 -~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 301 (387)
..+++..+..++.|++.||+|||+++|+||||||+||+++.++ .++++|||.+...... .....++..|+|||.+.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccC
Confidence 3488999999999999999999999999999999999999766 7999999988655432 23345567799999976
Q ss_pred ccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 302 DLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 302 ~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
+ ..++.++||||+||++|||++|.+||
T Consensus 156 ~-~~~~~~~DvwslG~il~el~~g~~~~ 182 (237)
T cd05576 156 I-SEETEACDWWSLGAILFELLTGKTLV 182 (237)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCcchh
Confidence 5 67889999999999999999999887
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=248.77 Aligned_cols=204 Identities=25% Similarity=0.516 Sum_probs=172.0
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---- 202 (387)
...+|.-++.+|.|.- .|.-|.+.-.++.||+|.+.. ...++..+|..++..+ .|+||++++.++.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence 3467888899999998 777888888899999998642 2346778999999999 9999999999987432
Q ss_pred CCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
....|+|||+|....-...+-.+....+..+..|++.|+.|||+.||+||||||+||++..+. .+||+|||+|+.....
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDTD 171 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhcccCcc
Confidence 234679999999765555555678889999999999999999999999999999999999777 8999999999987777
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhhhccCCCCCcccccc
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGLGHSCLNTWF 345 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 345 (387)
...+..+.+.+|+|||++.+.+ |...+||||+||++.||++|.-.|. |......|.
T Consensus 172 ~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~------g~d~idQ~~ 227 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFP------GKDHIDQWN 227 (369)
T ss_pred cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEec------CchHHHHHH
Confidence 6778899999999999999954 9999999999999999999999883 444445554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=268.33 Aligned_cols=196 Identities=19% Similarity=0.286 Sum_probs=140.3
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCC----CeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEE----EcCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIV----RDQQS 203 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~----~~~~~ 203 (387)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+......+...+. .+++. .+.+++.++..+ .....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~-~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRA-CPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhh-chhhHHHHHHhhhcccccccC
Confidence 357899999999999999999999888 899999988644322221111 11222 222232222211 11234
Q ss_pred CCceEEEeccCCCchhhhcCCC-----------------------CHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCee
Q 016537 204 KTPSLIFEHVNNTDFKVLYPTL-----------------------SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~-----------------------~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NIL 260 (387)
...++||||+.+++|..++... .+..+..++.|++.||+|||+++|+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 4578999999999987665321 12345678999999999999999999999999999
Q ss_pred EcCCCceEEEEecccceeecCCC--cccccccccCCCCchhhcccC---------------------CCCCccchhhHHH
Q 016537 261 IDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDLWSLGC 317 (387)
Q Consensus 261 l~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~sDvwSlGv 317 (387)
++.+...+||+|||+|+.+..+. .....++++.|+|||.+.... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 98655589999999998654332 224567899999999763211 2345679999999
Q ss_pred HHHHHHhcCCch
Q 016537 318 MFAGMVSVSPSV 329 (387)
Q Consensus 318 il~elltg~~pf 329 (387)
+||||+++..++
T Consensus 368 iL~el~~~~~~~ 379 (566)
T PLN03225 368 IFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHhCcCCC
Confidence 999999876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=246.04 Aligned_cols=130 Identities=29% Similarity=0.488 Sum_probs=112.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCC-------CCeeEEEEEEEc--C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-------PNIVKLLDIVRD--Q 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~h-------pniv~l~~~~~~--~ 201 (387)
..+|-+.++||.|.|++||+|.+.++.+.||+|+.+.. -.+....||.+|+++..+ .+||+|++.|.. .
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 47899999999999999999999999999999998742 246678899999998544 379999998874 4
Q ss_pred CCCCceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMID 262 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~ 262 (387)
+..+++||+|++....|..+. +.++...++.|++||+.||.|||++ ||||-||||+|||+.
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 456889999999988776654 5699999999999999999999975 999999999999983
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=228.44 Aligned_cols=190 Identities=32% Similarity=0.596 Sum_probs=164.1
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
|.+.+.||.|++|.||+|.+..+++.+++|.+... ..+.+.+|++.++++ +|+|++++++++... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecC--CceEEEEe
Confidence 45778999999999999999877899999998754 456788999999999 999999999988654 45679999
Q ss_pred ccCCCchhhhcCC----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--cc
Q 016537 212 HVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EY 285 (387)
Q Consensus 212 ~~~~~~l~~~~~~----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--~~ 285 (387)
++++++|..++.. +++..+..++.+++.+|.+||+++++|+||+|.||+++.++ .++|+|||.+....... ..
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccc
Confidence 9999888777632 78888999999999999999999999999999999999665 89999999998775443 33
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
....++..|++||...+...++.++|+|+||++++||++|++||
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf 200 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF 200 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence 45577888999999733367888999999999999999999998
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=253.04 Aligned_cols=195 Identities=20% Similarity=0.345 Sum_probs=144.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe----------------CCCeEEEEEEecccch---H--------------HHHHHH
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC----------------TDNEKCIIKILKPVKK---K--------------KIKREI 179 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~l~~~~~---~--------------~~~~E~ 179 (387)
.++|++.++||+|+||.||+|.+. ..++.||||.+..... + ....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 578999999999999999999752 2356799999864221 1 223466
Q ss_pred HHHHHhcCCCC-----eeEEEEEEEcC------CCCCceEEEeccCCCchhhhcCC------------------------
Q 016537 180 KILQNLCGGPN-----IVKLLDIVRDQ------QSKTPSLIFEHVNNTDFKVLYPT------------------------ 224 (387)
Q Consensus 180 ~il~~l~~hpn-----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~~------------------------ 224 (387)
.++.++ +|.+ +++++++|... .....++||||+.+++|..++..
T Consensus 224 ~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777 4444 46777777532 12346899999999998766521
Q ss_pred ---CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccc--ccccCCCCchh
Q 016537 225 ---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPEL 299 (387)
Q Consensus 225 ---~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~--~gt~~y~aPE~ 299 (387)
+.+..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++.....+...... .+++.|+|||+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 23456788999999999999999999999999999999666 7999999999765444333222 34788999999
Q ss_pred hcccCC-------------------CC--CccchhhHHHHHHHHHhcCC-ch
Q 016537 300 LVDLQD-------------------YD--YSLDLWSLGCMFAGMVSVSP-SV 329 (387)
Q Consensus 300 ~~~~~~-------------------~~--~~sDvwSlGvil~elltg~~-pf 329 (387)
+..... |+ .+.||||+||++|||++|.. ||
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 753111 11 24799999999999999875 55
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=251.12 Aligned_cols=195 Identities=26% Similarity=0.486 Sum_probs=165.5
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcC-----CCCeeEEEEEEEcCCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCG-----GPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~-----hpniv~l~~~~~~~~~~ 204 (387)
..++|.+....|+|-|++|..|.+...|..||||++.... .+.-++|++||++|.. --|+++|+..|... .
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk--n 507 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK--N 507 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--c
Confidence 4588999999999999999999998889999999997543 3556789999999932 24788888877654 4
Q ss_pred CceEEEeccCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 205 TPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
++|||+|-+.- +|..+++ .+....++.|+.|+..||..|...||+|.||||+|||++.....+||||||.|..
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 57899998763 4444442 2667889999999999999999999999999999999997777899999999976
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.. ....+.+..+.+|+|||++.| -.|+...|+||.||+||||.||+-.|.+
T Consensus 587 ~~-eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 587 AS-ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cc-cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCC
Confidence 53 445677888899999999999 7899999999999999999999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=244.21 Aligned_cols=197 Identities=30% Similarity=0.560 Sum_probs=171.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC---CCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~l~~-~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.+.|.++++||.|.|+.||++.+.. .++.||+|.+.. ....++.+|++.|..+.++.||+++.+++...+ ...+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd--~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNND--QVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCC--eeEE
Confidence 3678899999999999999998866 688999998864 456889999999999999999999999997654 4669
Q ss_pred EEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec--------
Q 016537 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------- 280 (387)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-------- 280 (387)
||||+++..+..++..++-.+++.|++.++.||.++|.+|||||||||+|+|.+.....-.|+|||+|...+
T Consensus 113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999998776678999999996211
Q ss_pred ---------C--CC---------------c-----------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHH
Q 016537 281 ---------P--GK---------------E-----------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323 (387)
Q Consensus 281 ---------~--~~---------------~-----------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ell 323 (387)
+ +. . ...+.||+.|+|||++.....-+.++||||.|||+..++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0 00 0 012359999999999988888899999999999999999
Q ss_pred hcCCchhh
Q 016537 324 SVSPSVLF 331 (387)
Q Consensus 324 tg~~pf~~ 331 (387)
+++.||+.
T Consensus 273 s~~~PFf~ 280 (418)
T KOG1167|consen 273 SRRYPFFK 280 (418)
T ss_pred cccccccc
Confidence 99999964
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=257.27 Aligned_cols=189 Identities=20% Similarity=0.381 Sum_probs=159.5
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCe----EEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.+..++||+|+||+||+|.+-..++ +||+|++.. ++..++..|+-+|.++ +|||++++++++... .+.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---TLQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---hHH
Confidence 4567899999999999999865554 688888752 3457889999999999 999999999999654 377
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
||++|++.|.|.++. ..+.......|..||++||.|||++++|||||-..|||+..-+ ++||.|||+++.+.++.
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCccc
Confidence 999999999987665 3588888999999999999999999999999999999999666 89999999999887654
Q ss_pred c-cccccc--ccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 284 E-YNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 284 ~-~~~~~g--t~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
. +....| .+-|||=|.+.. ..|+.++|||||||++||++| |..|+.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred ccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 3 333332 345889998876 789999999999999999999 788874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=256.85 Aligned_cols=193 Identities=23% Similarity=0.409 Sum_probs=160.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-------CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
++.++.+.||.|.||.|++|.... ....||||.++.. ..+.+..|+++|+.+..|+||+.++|.|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 344667799999999999997531 2468999998742 346789999999999899999999999987
Q ss_pred CCCceEEEeccCCCchhhhcC--C-----------------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC
Q 016537 203 SKTPSLIFEHVNNTDFKVLYP--T-----------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~--~-----------------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~ 263 (387)
....++|+||+..|+|..+++ + ++..+...++.||+.|++||++.++|||||-+.|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 456789999999999876652 2 677889999999999999999999999999999999995
Q ss_pred CCceEEEEecccceeecCCCccccc--cc--ccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 264 EQRKLRLIDWGLAEFYHPGKEYNVR--VA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 264 ~~~~vkl~DFG~a~~~~~~~~~~~~--~g--t~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+. .+||+|||+|+.......+... .+ ...|||||.+.. ..|+.++|||||||+||||+| |..||.
T Consensus 454 ~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 454 NK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred CC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 54 8999999999976555444322 22 344999999987 789999999999999999999 677774
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=222.05 Aligned_cols=180 Identities=33% Similarity=0.632 Sum_probs=157.7
Q ss_pred CCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhh
Q 016537 146 KYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221 (387)
Q Consensus 146 ~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~ 221 (387)
+||.||+|.+..+++.+|+|++.... .+.+.+|++.++++ +|+|++++++++... ...++++||+.+++|..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 58999999998889999999987543 47889999999999 999999999998764 456799999999998877
Q ss_pred cCC---CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCch
Q 016537 222 YPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298 (387)
Q Consensus 222 ~~~---~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 298 (387)
+.. ++...+..++.+++.++.|||+.+++|+||+|+||+++.++ .++|+|||.+.............++..|++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCCCHH
Confidence 633 78889999999999999999999999999999999999665 89999999998876554555667888999999
Q ss_pred hhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 299 ~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+.+ ..++.++||||||+++++|++|.+||.
T Consensus 157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~ 187 (244)
T smart00220 157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFP 187 (244)
T ss_pred HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9875 678889999999999999999999983
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=226.72 Aligned_cols=194 Identities=19% Similarity=0.350 Sum_probs=158.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
+.|.+.+.||+|.||.+-++.++.+++.+++|.+... ..++|.+|...--.|..|.||+.-+++.... ..+.++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEeec
Confidence 7899999999999999999999999999999988643 4578899987766777899999888754432 346679999
Q ss_pred ccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeE-cCCCceEEEEecccceeecCCCccccc
Q 016537 212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVR 288 (387)
Q Consensus 212 ~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl-~~~~~~vkl~DFG~a~~~~~~~~~~~~ 288 (387)
|++.|+|..-.. .+.+...+.+..|++.||.|+|++++||||||.+|||| +.+...|||||||..+..... ....
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~ 180 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--VKYL 180 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--ehhh
Confidence 999999987664 47888999999999999999999999999999999998 555668999999998753321 1122
Q ss_pred ccccCCCCchhhcccC----CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~----~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
--+..|-+||+..... ...+.+|||.||+++|.++||++|+-
T Consensus 181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 2344588999864311 24678999999999999999999984
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-29 Score=249.72 Aligned_cols=189 Identities=25% Similarity=0.345 Sum_probs=154.2
Q ss_pred EEEeeeeecCCee-EEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 137 EVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 137 ~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
.-.+.+|.|+.|+ ||+|.. +++.||||.+-.....-..+|+..|+.-.+|||||++++.- .+..+.|+..|.|..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCAC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhhh
Confidence 3346789999987 799997 68899999998777788899999999988999999998755 445678899999985
Q ss_pred CchhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC---CC-ceEEEEecccceeecCCCc
Q 016537 216 TDFKVLYPT-------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQ-RKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 216 ~~l~~~~~~-------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---~~-~~vkl~DFG~a~~~~~~~~ 284 (387)
+|.++... ......+..+.|+++||++||+.+||||||||.||||+. ++ ..++|+|||+++.+..+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 44444322 112456778899999999999999999999999999975 23 3789999999999876654
Q ss_pred c----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhc-CCchhh
Q 016537 285 Y----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSV-SPSVLF 331 (387)
Q Consensus 285 ~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg-~~pf~~ 331 (387)
. ....||..|+|||++.+ ..-+.++|||||||++|+.++| .+||..
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred hhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCc
Confidence 3 44578999999999977 4556799999999999999997 899843
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-29 Score=242.70 Aligned_cols=195 Identities=27% Similarity=0.500 Sum_probs=166.9
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.+++|+++.++|.|.||.|||++++.+++..|+|+++-. ..+-+.+|+-+++.. +|||||.++|.+...+. +.+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dk--lwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDK--LWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhhcC--cEE
Confidence 358899999999999999999999999999999998743 345667899888887 99999999998765443 569
Q ss_pred EEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
.||||.+|++++++. .+.+.++....++.+.||+|||+.|-+|||||=.|||+++++ .+|++|||.+..+.... .
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhhh
Confidence 999999999998874 488899999999999999999999999999999999999666 89999999986553221 2
Q ss_pred ccccccccCCCCchhhc--ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+.||++|||||+-. ..+.|...+|||++|+...|+---+||.+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 34578999999999962 23579999999999999999999888864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.46 Aligned_cols=158 Identities=18% Similarity=0.262 Sum_probs=125.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-CCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeE-EEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVK-LLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~-l~~~~~~~~ 202 (387)
.++|.+.+.||+|+||+||+|.++. +++.+|||.+... ....+.+|+++|+++ +|+|++. +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~----- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT----- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc-----
Confidence 3789999999999999999998865 6788899986422 135689999999999 8999885 4432
Q ss_pred CCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeecc-CCCCeeEcCCCceEEEEecccceeecC
Q 016537 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDl-Kp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
...++||||+++++|.... ... ...++.|+++||.|||++||+|||| ||+|||++.++ .+||+|||+|+.+..
T Consensus 91 -~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRR 164 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceeccc
Confidence 2357999999999987432 111 2467889999999999999999999 99999998665 799999999987654
Q ss_pred CCc---------ccccccccCCCCchhhcc
Q 016537 282 GKE---------YNVRVASRYFKGPELLVD 302 (387)
Q Consensus 282 ~~~---------~~~~~gt~~y~aPE~~~~ 302 (387)
... .+...++..|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 331 134567788999999843
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=199.49 Aligned_cols=178 Identities=32% Similarity=0.596 Sum_probs=152.5
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEecccch----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCc
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~----~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~ 217 (387)
||+|++|.||++.+..+++.+++|++..... ..+.+|++.++.+ .|++++++++++... ...++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 6899999999999977799999999986643 6789999999999 899999999998764 45779999999999
Q ss_pred hhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccccccccc
Q 016537 218 FKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASR 292 (387)
Q Consensus 218 l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~ 292 (387)
+..++. .++...++.++.+++.+|.+||+++++|+||+|.||+++.....++|+|||.+....... ......+..
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 887764 478889999999999999999999999999999999999623489999999998765432 123356777
Q ss_pred CCCCchhhcccCCCCCccchhhHHHHHHHH
Q 016537 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGM 322 (387)
Q Consensus 293 ~y~aPE~~~~~~~~~~~sDvwSlGvil~el 322 (387)
.|++||.+.....++.+.|+|++|+++++|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 899999987633788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=204.40 Aligned_cols=194 Identities=18% Similarity=0.366 Sum_probs=156.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-----eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.+++++...+-+|.||.||.|.+.... +.|-+|.++.. ....+..|--.+..+ .|||+..+.+++... .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-c
Confidence 467888899999999999999775332 34555655432 235567788888888 899999999988764 4
Q ss_pred CCceEEEeccCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEe
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
..++.++.++.-|+|+.++. .+...+...++.|++.|++|||++||||.||...|++||+ .-.|||+|
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd-~LqVkltD 439 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD-QLQVKLTD 439 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh-heeEEecc
Confidence 56788999999999988873 2566778888999999999999999999999999999994 45899999
Q ss_pred cccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 273 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 273 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
=.+++-+-+.+-. ........||+||.+.+ ..|+.++|||||||+||||+| |+.|+.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 9999877665422 11234556999999988 789999999999999999999 777773
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=202.35 Aligned_cols=192 Identities=24% Similarity=0.313 Sum_probs=154.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCC-eEEEEEEecccch---HHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCCCCce
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPVKK---KKIKREIKILQNLCG---GPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~l~~~~~---~~~~~E~~il~~l~~---hpniv~l~~~~~~~~~~~~~ 207 (387)
+|++.++||+|+||.||+|.+..++ ..+|+|....... ..+..|+.++..+.. .+++..+++... ....+-+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 8999999999999999999986664 6889998764322 268899999999842 358888888774 2344567
Q ss_pred EEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC----ceEEEEecccce-
Q 016537 208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAE- 277 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~----~~vkl~DFG~a~- 277 (387)
+||+.+. .+|.++. +.++...+..++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||+++
T Consensus 98 iVM~l~G-~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLLG-PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEeccC-ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 8888765 4555544 4588999999999999999999999999999999999997543 479999999998
Q ss_pred -eecCCC--------c-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 278 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 278 -~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
.+.... . .....||..|.++.+..+ .+.+.+.|+||++.++.||+.|..|+
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCC
Confidence 321111 1 123459999999999877 78899999999999999999999886
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=196.10 Aligned_cols=189 Identities=33% Similarity=0.596 Sum_probs=160.0
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCC-CeeEEEEEEEcCCCCCceE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hp-niv~l~~~~~~~~~~~~~l 208 (387)
|.+.+.||.|+||.||++.+. ..+++|.+... ....+.+|+.++..+ .|+ +++++.+.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecC--CEEEE
Confidence 678899999999999999985 78899988632 245688999999999 665 899999998543 33679
Q ss_pred EEeccCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 209 IFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 209 v~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
+++++.++++..+.. .+....+..++.|++.++.|+|+.+++|||+||+||+++..+..++++|||.++.....
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999999885553 58888999999999999999999999999999999999966546999999999865443
Q ss_pred C-------cccccccccCCCCchhhccc--CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......++..|++||.+.+. ..+....|+||+|++++++++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 3 24667899999999998763 478889999999999999999999963
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=189.98 Aligned_cols=169 Identities=15% Similarity=0.198 Sum_probs=130.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---h---HH------HHHHHHHHHHhcCCCCeeEEEEEEEc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---K---KK------IKREIKILQNLCGGPNIVKLLDIVRD 200 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~---~~------~~~E~~il~~l~~hpniv~l~~~~~~ 200 (387)
.++|++++.||.|+||.||++.. ++..+|+|++.+.. . .. +.+|++.+.++ .|++|..+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence 48999999999999999999654 46789999997432 1 12 57899999999 99999999998664
Q ss_pred CC------CCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 201 QQ------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 201 ~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
.. ....+++|||++|.++.++. .+++ ....+++.+|..||+.|++|||+||+||+++.++ ++|+|||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg 179 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLS 179 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECC
Confidence 32 23468999999999987763 2333 2456999999999999999999999999998655 9999999
Q ss_pred cceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHH
Q 016537 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323 (387)
Q Consensus 275 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ell 323 (387)
..+......... ..... ..|+.++|+|+||+++....
T Consensus 180 ~~~~~~e~~a~d-----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKD-----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHH-----------HHHHH-hHhcccccccceeEeehHHH
Confidence 987553222111 12233 56778999999999887543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=232.36 Aligned_cols=140 Identities=12% Similarity=0.199 Sum_probs=106.4
Q ss_pred CCeeEEEEEEEcC-----CCCCceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCe
Q 016537 189 PNIVKLLDIVRDQ-----QSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (387)
Q Consensus 189 pniv~l~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NI 259 (387)
+||+++++++... ....++++||++. ++|..++. .+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777777766211 1234667788775 57766663 388999999999999999999999999999999999
Q ss_pred eEcCC------------------CceEEEEecccceeecCCC-----------------cccccccccCCCCchhhcccC
Q 016537 260 MIDHE------------------QRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLVDLQ 304 (387)
Q Consensus 260 Ll~~~------------------~~~vkl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~ 304 (387)
||+.. ...+|++|||+++...... .....+||++|||||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~ 190 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-S 190 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-C
Confidence 99532 2256777777776432100 0112467889999999877 6
Q ss_pred CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 305 DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 305 ~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.|+.++|||||||+||||++|.+|+.
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchh
Confidence 78999999999999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=181.78 Aligned_cols=194 Identities=22% Similarity=0.366 Sum_probs=158.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|.++++||.|+||.+|.|..-.+|+.||||+-+... ...+..|..+.+.|.+...|..+..+..+ ..+-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeeee
Confidence 478999999999999999999999999999999876443 35677899999999777888888777654 356679999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc--CCCceEEEEecccceeecCCC--
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
.+. -+|+++. +.++...+.-++.|++.-++|+|.+++|||||||+|+|.. .....+.|+|||+|+.+.+..
T Consensus 92 LLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred ccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 875 4454443 5688888999999999999999999999999999999974 334478999999998765432
Q ss_pred ------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+.....||..|.+--...+ .+-+.+.|+-|+|.+|....-|..|+-
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCccc
Confidence 2234578988988777666 566788999999999999999999973
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=177.63 Aligned_cols=179 Identities=17% Similarity=0.127 Sum_probs=136.3
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch-------HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~-------~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+...|++|+||+||.+.. .+.+++.+.+..... ..+.+|+++|++|.+|+++++++++. ..+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence 567899999999997764 677888776653321 25789999999996678999999862 247999
Q ss_pred eccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeecc-CCCCeeEcCCCceEEEEecccceeecCCCcc----
Q 016537 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---- 285 (387)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDl-Kp~NILl~~~~~~vkl~DFG~a~~~~~~~~~---- 285 (387)
||+.|.+|...... ....+..|++.+|+++|++||+|||| ||+|||++.++ .++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 78 SYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHH
Confidence 99999988654321 12357789999999999999999999 79999998665 7999999999865543321
Q ss_pred ----------cccccccCCCCchhhcccCCCC-CccchhhHHHHHHHHHhcCCch
Q 016537 286 ----------NVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 286 ----------~~~~gt~~y~aPE~~~~~~~~~-~~sDvwSlGvil~elltg~~pf 329 (387)
.....++.|+.|+...-....+ ...++++.|+-+|.++||..+.
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0123567788887653322333 5678999999999999999876
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=181.18 Aligned_cols=133 Identities=20% Similarity=0.251 Sum_probs=104.0
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccch------------H-----------------HHHHHHHHHHHhcCCC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------------K-----------------KIKREIKILQNLCGGP 189 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~------------~-----------------~~~~E~~il~~l~~hp 189 (387)
.+.||+|+||.||+|.+. +|+.||||++++... . ...+|++++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 357999999999999985 899999999864311 1 123499999999 666
Q ss_pred CeeEEEEEEEcCCCCCceEEEeccCCCchhhh-c--CCCCHHHHHHHHHHHHHHHHHH-HHcCceeeccCCCCeeEcCCC
Q 016537 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y--PTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~~~~qi~~aL~yL-H~~~ivHrDlKp~NILl~~~~ 265 (387)
++.....+... . .++||||++++++... + ..++...+..++.|++.+|.|| |+.||+||||||+|||++ ++
T Consensus 80 ~v~~p~~~~~~--~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 80 GIPCPEPILLK--S--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCCcEEEec--C--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 66443332211 1 2699999998766432 2 3578888999999999999999 799999999999999998 44
Q ss_pred ceEEEEecccceee
Q 016537 266 RKLRLIDWGLAEFY 279 (387)
Q Consensus 266 ~~vkl~DFG~a~~~ 279 (387)
.++|+|||+|...
T Consensus 155 -~v~LiDFG~a~~~ 167 (190)
T cd05147 155 -KLYIIDVSQSVEH 167 (190)
T ss_pred -cEEEEEccccccC
Confidence 7999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=176.08 Aligned_cols=135 Identities=17% Similarity=0.206 Sum_probs=106.8
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHHHhcCCC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGGP 189 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------------------------~~~~~~E~~il~~l~~hp 189 (387)
.+.||+|++|+||+|.+. +|+.||||++++.. ...+.+|.+.+.++ .|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 467999999999999986 89999999987431 11235789999998 888
Q ss_pred CeeEEEEEEEcCCCCCceEEEeccCCCchh-hhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCC
Q 016537 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLY--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~-~~~--~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~ 265 (387)
++.....+.... .++||||++++++. ..+ ..++..++..++.|++.+|.+||. +||+||||||+|||++ ++
T Consensus 80 ~i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 875544443221 36999999987432 212 246778889999999999999999 9999999999999998 54
Q ss_pred ceEEEEecccceeecC
Q 016537 266 RKLRLIDWGLAEFYHP 281 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~ 281 (387)
.++|+|||+++....
T Consensus 155 -~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 -KPYIIDVSQAVELDH 169 (190)
T ss_pred -CEEEEEcccceecCC
Confidence 799999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=182.00 Aligned_cols=193 Identities=21% Similarity=0.353 Sum_probs=160.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
-.|++.++||+|+||+.+.|..--+++.||||.-.. ...-++..|.+.++.|...++|..++-+- ++..+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhhh
Confidence 468999999999999999999989999999997542 33467888999999998889999887654 445566799998
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC----CCceEEEEecccceeecCCCc
Q 016537 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~----~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+.- +|+++. ++++...+..++.|++.-++|+|++.+|.|||||+|+||.. +...|.|+|||+|+.+.+...
T Consensus 106 LGP-SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 106 LGP-SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hCc-CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 753 443332 67999999999999999999999999999999999999953 333799999999998764432
Q ss_pred --------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 --------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....||..||+--...| .+-+.+.|+-|||-++...|-|..|+-
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred cccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccc
Confidence 234579999999988888 678899999999999999999999983
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=204.38 Aligned_cols=190 Identities=20% Similarity=0.407 Sum_probs=154.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCG---GPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~---hpniv~l~~~~~~~~~~~~~lv 209 (387)
...|.|.++||+|+||+||+|.... ++.||+|+-++....+|.--.+++.+| + -+-|..+...+...+. -+||
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~~~--S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERL-KPQMLPSIMHISSAHVFQNA--SVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhh-chhhhcchHHHHHHHccCCc--ceee
Confidence 4789999999999999999999854 999999999888777776666667776 3 1223333333333333 3599
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc------CCCceEEEEecccc---e
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID------HEQRKLRLIDWGLA---E 277 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~------~~~~~vkl~DFG~a---~ 277 (387)
+||.+.|+|.++.. .+++..+..++.|++.-++.||..+|||+||||+|+||. .+..-++|+|||.+ +
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999988874 388899999999999999999999999999999999993 23336899999998 4
Q ss_pred eecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCC
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~ 327 (387)
.+.++......++|..+-.+|+..| +.+++.+|.|.|..+++-||.|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 4455556677788999999999988 899999999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=169.95 Aligned_cols=134 Identities=19% Similarity=0.243 Sum_probs=103.2
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhc----CCCCeeEEEEEEEcCCC-CCce-EE
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQS-KTPS-LI 209 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~----~hpniv~l~~~~~~~~~-~~~~-lv 209 (387)
.+.||+|+||.||. ++.+... +||++... ..+.+.+|+.+++.+. +||||++++|++.+... ..++ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46799999999996 6566655 68987643 4567899999999983 47999999999987542 2323 68
Q ss_pred Eec--cCCCchhhhcCC--CCHHHHHHHHHHHHHHH-HHHHHcCceeeccCCCCeeEcCC---CceEEEEecccce
Q 016537 210 FEH--VNNTDFKVLYPT--LSDYDVRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAE 277 (387)
Q Consensus 210 ~e~--~~~~~l~~~~~~--~~~~~~~~~~~qi~~aL-~yLH~~~ivHrDlKp~NILl~~~---~~~vkl~DFG~a~ 277 (387)
+|| +.+++|.++++. +.+. ..++.|++.++ +|||+++|+||||||+|||++.. +..++|+||+-++
T Consensus 84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 999 557899888754 3333 35678888888 99999999999999999999742 2379999954443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-21 Score=166.77 Aligned_cols=93 Identities=25% Similarity=0.390 Sum_probs=82.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhccc
Q 016537 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303 (387)
Q Consensus 224 ~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 303 (387)
.+++..++.++.|++.||.|||+++ ||+|||++.++ .+|+ ||+++...... ..|++.|+|||++.+
T Consensus 13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~~- 78 (176)
T smart00750 13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQG- 78 (176)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc----CCCcccccChHHhcC-
Confidence 4899999999999999999999998 99999999665 7888 99998764432 268899999999987
Q ss_pred CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 304 QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 304 ~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..|+.++|||||||++|||++|++||.
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~ 105 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYN 105 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 679999999999999999999999984
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=192.71 Aligned_cols=181 Identities=26% Similarity=0.369 Sum_probs=148.9
Q ss_pred eeecCCeeEEEEEE---eCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 142 VGRGKYSEVFEGVH---CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 142 lG~G~~g~Vy~~~~---~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+|+|.||.|++++. ...+..+|+|++++.. +.....|..++..+.+||.++++.-.+..... .++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k--l~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK--LYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc--hhHhhhhc
Confidence 79999999986542 2457788998875321 22456688888888679999999988866543 56999999
Q ss_pred CCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccccc
Q 016537 214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (387)
Q Consensus 214 ~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~g 290 (387)
.++++..... .+.+...+.+...++.+++++|+.+|+|||+|++||+++.+| ++++.|||+++..-.... .||
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~---~cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI---ACG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh---ccc
Confidence 9998866553 367778889999999999999999999999999999999777 899999999987654432 299
Q ss_pred ccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
|..|||||++. ....++|.||||++++||+||..||..
T Consensus 156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99999999986 367799999999999999999999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=165.99 Aligned_cols=137 Identities=15% Similarity=0.200 Sum_probs=107.7
Q ss_pred CeEEEeeeeecCCeeEEEEE-EeCCCeEEEEEEecccc---------------------------hHHHHHHHHHHHHhc
Q 016537 135 DYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVK---------------------------KKKIKREIKILQNLC 186 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~l~~~~---------------------------~~~~~~E~~il~~l~ 186 (387)
.|.+.+.||+|+||.||+|. +..+|+.||+|+++... ...+.+|+++++++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 47788999999999999998 66789999999986431 02356899999999
Q ss_pred CC--CCeeEEEEEEEcCCCCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcC-ceeeccCCCCee
Q 016537 187 GG--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVM 260 (387)
Q Consensus 187 ~h--pniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~-ivHrDlKp~NIL 260 (387)
.+ ..+.+++++ . ..++||||+++.++.... .......+..++.|++.+|.+||++| |+||||||+||+
T Consensus 108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 44 334455542 1 236999999998775443 23455567889999999999999999 999999999999
Q ss_pred EcCCCceEEEEecccceeec
Q 016537 261 IDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 261 l~~~~~~vkl~DFG~a~~~~ 280 (387)
++ ++ .++|+|||.+....
T Consensus 182 i~-~~-~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DG-KVVIIDVSQSVELD 199 (237)
T ss_pred EE-CC-CEEEEEChhhhccC
Confidence 98 44 79999999997543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-21 Score=195.77 Aligned_cols=188 Identities=28% Similarity=0.430 Sum_probs=146.3
Q ss_pred EEEeeeeecCCeeEEEEEEeCCCeEEEEEEec----cc-ch----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PV-KK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~----~~-~~----~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
...+.+|.|++|.|+.+......+.++.|... +. .. ..+..|+.+-..+ .|+|++..+..+.+.....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~-- 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGIL-- 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccch--
Confidence 45678999999988888776666666666443 11 11 1144566666667 9999988777665543332
Q ss_pred EEEeccCCCchhhhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY-P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
-.||||+. +|..++ . .+...++..+..|++.|++|||..||.|||||++|+++...+ .+||+|||.+..+.-+.+
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcc
Confidence 34999999 776555 3 488899999999999999999999999999999999999666 899999999977654332
Q ss_pred -----ccccccccCCCCchhhcccCCCC-CccchhhHHHHHHHHHhcCCchh
Q 016537 285 -----YNVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -----~~~~~gt~~y~aPE~~~~~~~~~-~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+|+..|+|||++.+ .+|+ ...||||.|+++..|++|+.|+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~-~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG-KEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc-cccCcchhhhhhccceEEEEecCCCccc
Confidence 245689999999999988 5565 56899999999999999999874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.9e-20 Score=171.05 Aligned_cols=144 Identities=22% Similarity=0.325 Sum_probs=105.0
Q ss_pred cCCCCeeEEEEEEEcC-------------------------CCCCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHH
Q 016537 186 CGGPNIVKLLDIVRDQ-------------------------QSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELL 238 (387)
Q Consensus 186 ~~hpniv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~ 238 (387)
..|||||++++.|.+. ....+|+||..++.. |..++ +..+.+..+-++.|++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~t-Lr~yl~~~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQT-LREYLWTRHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhh-HHHHHhcCCCchHHHHHHHHHHH
Confidence 5799999999977543 123456777766543 33222 3466777888999999
Q ss_pred HHHHHHHHcCceeeccCCCCeeEc---CCCceEEEEecccceeecC-------CCcccccccccCCCCchhhcccCC---
Q 016537 239 KALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQD--- 305 (387)
Q Consensus 239 ~aL~yLH~~~ivHrDlKp~NILl~---~~~~~vkl~DFG~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~--- 305 (387)
+|+.|||++||.|||+|.+||||. +....+.|+|||++--.+. ........|...-||||+......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999983 2233678999999732211 111223456777899999743211
Q ss_pred ---CCCccchhhHHHHHHHHHhcCCchhh
Q 016537 306 ---YDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 306 ---~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
| .++|.|+.|.+.||+++...||+.
T Consensus 432 vvny-~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 432 VVNY-EKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eecc-chhhhhhhhhhHHHHhccCCcccc
Confidence 2 379999999999999999999954
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=159.17 Aligned_cols=132 Identities=24% Similarity=0.357 Sum_probs=108.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+.||+|++|.||+|.+ .+..+++|+..... ...+.+|++++..+ .|++++....++.+.. ..++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~--~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPE--NFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCC--CCEE
Confidence 5799999999999986 67788999765321 13577899999999 8888877666655433 4579
Q ss_pred EEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
+|||++|++|..+...... ....++.+++.+|.+||+.+++|||++|+|||++ ++ .++|+|||.+...
T Consensus 77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~~ 144 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEFS 144 (211)
T ss_pred EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccCC
Confidence 9999999999887755444 7788999999999999999999999999999998 44 7999999998763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=155.73 Aligned_cols=134 Identities=19% Similarity=0.335 Sum_probs=105.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-------------------------hHHHHHHHHHHHHhcCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP 189 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-------------------------~~~~~~E~~il~~l~~hp 189 (387)
.|.+.+.||+|+||.||+|.. .+++.+|||++.... .....+|+.++..+ .|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHc
Confidence 367788999999999999987 479999999865321 12356789999988 666
Q ss_pred --CeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCce
Q 016537 190 --NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (387)
Q Consensus 190 --niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~ 267 (387)
.++..++. ...++||||++++++...... .....++.+++.++.++|+.||+||||||+||+++.++ .
T Consensus 94 ~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~ 163 (198)
T cd05144 94 GFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-K 163 (198)
T ss_pred CCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-c
Confidence 44444432 234799999999988765431 34567888999999999999999999999999998655 8
Q ss_pred EEEEecccceeec
Q 016537 268 LRLIDWGLAEFYH 280 (387)
Q Consensus 268 vkl~DFG~a~~~~ 280 (387)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=163.17 Aligned_cols=192 Identities=20% Similarity=0.281 Sum_probs=119.7
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcC---------CCCeeEEEEEEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCG---------GPNIVKLLDIVR 199 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~---------hpniv~l~~~~~ 199 (387)
.+...+.||.|+++.||.+.+..+++.+|+|+.... ..+.+++|.-....+.+ |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 466789999999999999999999999999987421 22445555433322211 212222222222
Q ss_pred cC---------CCC------CceEEEeccCCCchhhhcC------CC----CHHHHHHHHHHHHHHHHHHHHcCceeecc
Q 016537 200 DQ---------QSK------TPSLIFEHVNNTDFKVLYP------TL----SDYDVRYYIYELLKALDYCHSQGIMHRDV 254 (387)
Q Consensus 200 ~~---------~~~------~~~lv~e~~~~~~l~~~~~------~~----~~~~~~~~~~qi~~aL~yLH~~~ivHrDl 254 (387)
-. ... ..+++|+-+. ++|..+.. .. .......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 100 2345666664 45554432 11 11223445589999999999999999999
Q ss_pred CCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhccc-------CCCCCccchhhHHHHHHHHHhcCC
Q 016537 255 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMVSVSP 327 (387)
Q Consensus 255 Kp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~sDvwSlGvil~elltg~~ 327 (387)
||+|++++.++ .+.|+||+....... .......+..|.+||..... -.++.+.|.|+||++||.|+++..
T Consensus 172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG-GVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS--EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC-CEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999776 899999988765332 22223445778899986432 247889999999999999999999
Q ss_pred chh
Q 016537 328 SVL 330 (387)
Q Consensus 328 pf~ 330 (387)
||.
T Consensus 249 Pf~ 251 (288)
T PF14531_consen 249 PFG 251 (288)
T ss_dssp STC
T ss_pred CCC
Confidence 983
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=187.08 Aligned_cols=163 Identities=25% Similarity=0.420 Sum_probs=119.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
.++|+.++.|..|+||-||.++++.+.+.+|+|+-+.. -+.+- ++... +.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn--ilt~a-~npfvv-------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN--ILTFA-GNPFVV-------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc--ccccc-CCccee--------------------
Confidence 37899999999999999999999999999999643211 11111 22222 333333
Q ss_pred cCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC---------
Q 016537 213 VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------- 283 (387)
Q Consensus 213 ~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--------- 283 (387)
.+..++....+.++.. ++.+++|||+.||+|||+||+|.||+.-+ ++|+.|||+++......
T Consensus 136 gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 136 GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcch
Confidence 1111222222233322 37899999999999999999999999655 89999999986542111
Q ss_pred -------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 -------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 -------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....+||+.|+|||++.- +.|+..+|+|++|+|+||.+.|..||+.
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffG 260 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG 260 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccC
Confidence 1134589999999999976 7899999999999999999999999954
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=174.55 Aligned_cols=135 Identities=17% Similarity=0.304 Sum_probs=106.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEe-cc---c-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP---V-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l-~~---~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
..|...+.||+|+||.||+|.+... .+++|.. .. . ..+++.+|+++++.+ +|++++....++.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCC
Confidence 4456689999999999999987433 3333332 11 0 124578899999999 8999988777665533
Q ss_pred CCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++||||+++++|...+. ....++.|++.+|.+||+++++||||||+|||++ ++ .++|+|||+++...
T Consensus 410 --~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~~~ 478 (535)
T PRK09605 410 --EKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKYSD 478 (535)
T ss_pred --CCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCcccccCC
Confidence 3569999999999987653 4577889999999999999999999999999995 44 79999999998643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=151.13 Aligned_cols=128 Identities=20% Similarity=0.364 Sum_probs=99.1
Q ss_pred eeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.||+|+||.||+|.+ ++..+++|...... ..++.+|++++..+ .|+++.....++.+. ...+++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDP--DNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEEC--CCCEEE
Confidence 389999999999985 56789999854321 24567899999999 666544433333333 235699
Q ss_pred EeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
|||++++++......... .++.+++.+|.+||+.|++|+|+||+||+++ ++ .++++|||++...
T Consensus 76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~ 139 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYS 139 (199)
T ss_pred EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcCC
Confidence 999999998776533211 7889999999999999999999999999998 44 7999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-19 Score=182.91 Aligned_cols=190 Identities=21% Similarity=0.388 Sum_probs=138.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHH-HhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQ-NLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~-~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++...+.||++.|=+|.+|++ ..|. |+||++-+.. ...++++++-++ .+.+|||++.+..+... .+..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t--~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT--DKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh--hHHHHHH
Confidence 577889999999999999997 4454 8899875433 234443333222 33589999999887544 3456789
Q ss_pred EeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee--cCCC--
Q 016537 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--HPGK-- 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~--~~~~-- 283 (387)
-+|..+.....+- +-+...+.+.|+.|++.||.-+|..||+|+|||.+||||+.-++ +.|+||..-+-. ..++
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW-~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW-LYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech-hhhhcccccCCccCCCCCcc
Confidence 9998865443332 22567788889999999999999999999999999999997775 789999876432 2121
Q ss_pred ccc----ccccccCCCCchhhcccC---------C-CCCccchhhHHHHHHHHHh-cCCch
Q 016537 284 EYN----VRVASRYFKGPELLVDLQ---------D-YDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 284 ~~~----~~~gt~~y~aPE~~~~~~---------~-~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
..+ +...-..|.|||.+.... . .+++.||||+||+++||++ |+|||
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 111 122334699999985421 1 5678999999999999998 57887
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=143.32 Aligned_cols=133 Identities=20% Similarity=0.309 Sum_probs=96.3
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccch-----HH----------------------HHHHHHHHHHhcCC-CC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KK----------------------IKREIKILQNLCGG-PN 190 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~-----~~----------------------~~~E~~il~~l~~h-pn 190 (387)
.+.||+|+||.||+|.+. +++.||||++..... .. ...|.+.+.++..+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999985 789999999864221 11 13566666666222 23
Q ss_pred eeEEEEEEEcCCCCCceEEEeccCCCchh-hhcCCCCH-HHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCce
Q 016537 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSD-YDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRK 267 (387)
Q Consensus 191 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~~~~~-~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~ 267 (387)
+.+.+++. ..++||||++++.+. ..+..... .+++.++.+++.++.++|. ++|+||||||+||+++ ++ .
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~ 152 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-K 152 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-c
Confidence 45555431 247999999995432 11112222 6678899999999999999 9999999999999999 55 7
Q ss_pred EEEEecccceeec
Q 016537 268 LRLIDWGLAEFYH 280 (387)
Q Consensus 268 vkl~DFG~a~~~~ 280 (387)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=145.54 Aligned_cols=132 Identities=17% Similarity=0.300 Sum_probs=99.5
Q ss_pred eeee-ecCCeeEEEEEEeCCCeEEEEEEeccc----------------chHHHHHHHHHHHHhcCCCCe--eEEEEEEEc
Q 016537 140 RKVG-RGKYSEVFEGVHCTDNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNI--VKLLDIVRD 200 (387)
Q Consensus 140 ~~lG-~G~~g~Vy~~~~~~~~~~vavK~l~~~----------------~~~~~~~E~~il~~l~~hpni--v~l~~~~~~ 200 (387)
..|| .||.|+||.+.. .+..++||.+... ...++.+|++++.+| .|+++ ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4577 788888888875 4778899877421 124578899999999 77774 777776543
Q ss_pred CCCC--CceEEEeccCC-CchhhhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccc
Q 016537 201 QQSK--TPSLIFEHVNN-TDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (387)
Q Consensus 201 ~~~~--~~~lv~e~~~~-~~l~~~~~~--~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~ 275 (387)
.... ..++|||++++ .++..++.. +++. .+.+++.+|.+||++||+||||||+|||++.++ .++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence 2221 23599999997 577766543 3332 357899999999999999999999999998665 799999999
Q ss_pred ceee
Q 016537 276 AEFY 279 (387)
Q Consensus 276 a~~~ 279 (387)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 9764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.1e-16 Score=131.80 Aligned_cols=133 Identities=22% Similarity=0.303 Sum_probs=108.4
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~E~~il~~l~~h-pniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
+++.||+|.++.||++... +..+++|...... ...+.+|+.+++.+.++ .++++++++.... ...+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence 4578999999999999973 3789999886543 35788999999999444 6899998877553 457899999998
Q ss_pred CchhhhcCCCCHHHHHHHHHHHHHHHHHHHHc---CceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 216 ~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
+.+... +......++.+++.+|++||.. +++|+|+||+||+++..+ .++++|||.+...
T Consensus 78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGYG 139 (155)
T ss_pred eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccCC
Confidence 877543 5566677889999999999984 799999999999999644 8999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-17 Score=161.95 Aligned_cols=186 Identities=17% Similarity=0.243 Sum_probs=130.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEE------EEEEcC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLL------DIVRDQ 201 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~------~~~~~~ 201 (387)
....+.+..+.++++.+....-..+ .+.++-|..+..+ .....+++..+....+|++.+..- ..+...
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence 3445566667777777665443222 2233333322222 123344555555443444433321 111111
Q ss_pred ---CCCCceEEEeccCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEe
Q 016537 202 ---QSKTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 202 ---~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
...++++.|++|...+|.+++.. .+......+..|++.|++| ++.+|||+||.||....+. .+||.|
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgD 399 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGD 399 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhh
Confidence 12367899999999999998842 4566788899999999999 9999999999999998666 799999
Q ss_pred cccceeecCCC-------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh
Q 016537 273 WGLAEFYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324 (387)
Q Consensus 273 FG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt 324 (387)
||+........ ..+..+||.+||+||.+.+ +.|+.++||||||+||+||+.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH
Confidence 99987665444 4567799999999999998 789999999999999999998
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.4e-17 Score=143.79 Aligned_cols=186 Identities=16% Similarity=0.227 Sum_probs=141.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.+..++.+|.....|+.|+|++. |..+++|+++. .....|..|+-.|+-+ .||||..+++.|..+ ..+.+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsp--pnlv~ 264 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSP--PNLVI 264 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCC--CCceE
Confidence 44567778999999999999984 44566677653 3346788899888888 999999999999765 45679
Q ss_pred EEeccCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEE--Eecccceee
Q 016537 209 IFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRL--IDWGLAEFY 279 (387)
Q Consensus 209 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl--~DFG~a~~~ 279 (387)
+..||+.|+|...+.. ....++.+++.++++|++|||+.. |.---|....++||.+- +.+| +|--++..
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfq- 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQ- 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeee-
Confidence 9999999999887754 456788999999999999999864 44446888899998664 4443 44333322
Q ss_pred cCCCcccccccccCCCCchhhcccCC--CCCccchhhHHHHHHHHHhcCCchhh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
...+.-.+.||+||.+....+ .-.++|+|||.++||||.|++.||..
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 122345678999999865222 23579999999999999999999943
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-14 Score=142.51 Aligned_cols=138 Identities=18% Similarity=0.291 Sum_probs=94.1
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHH-------------------------------------------H
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------------------------------------K 176 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~-------------------------------------------~ 176 (387)
+.||.|++|+||+|+. .+|+.||||+.++...+.+ .
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999998 5789999999876533322 2
Q ss_pred HHHHHHHHhc---CCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCC--CCHHHHHHHHHHHHH-HHHHHHHcCce
Q 016537 177 REIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLK-ALDYCHSQGIM 250 (387)
Q Consensus 177 ~E~~il~~l~---~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~-aL~yLH~~~iv 250 (387)
+|.+.+.++. .|.+-+.+-.++.+.. ...++||||++|+++.+.... ... ....++.+++. .+..+|..|++
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence 3444344331 1222333333333222 235799999999988655321 111 23345555555 47889999999
Q ss_pred eeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 251 HrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
|+|+||.||+++.++ .++++|||++..+.+
T Consensus 280 H~D~hPgNilv~~~g-~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 280 HADLHPGNIFVLKDG-KIIALDFGIVGRLSE 309 (437)
T ss_pred eCCCCcccEEECCCC-cEEEEeCCCeeECCH
Confidence 999999999998665 799999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.9e-16 Score=159.86 Aligned_cols=196 Identities=24% Similarity=0.378 Sum_probs=154.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-CCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
..|.+.+.||+|+|+.|-...... ....+|+|.+.... ......|..+-+.+.+|+|++.+++...+.+. .+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~--~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS--YL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc--cc
Confidence 457788889999999998876633 34566677664322 23445577777777559999999998876544 45
Q ss_pred EEEeccCCCchhhhc-C----CCCHHHHHHHHHHHHHHHHHHH-HcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 208 LIFEHVNNTDFKVLY-P----TLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-~----~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
+.++|..++++.... . ..+...+..+..|+..++.|+| ..++.||||||+|.+++..+..++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 899999988876555 2 3567788899999999999999 999999999999999986554799999999987755
Q ss_pred -CCc---cccccc-ccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 282 -GKE---YNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 282 -~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.+. ....+| ++.|+|||...+........|+||.|+++.-|++|..|..+
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~ 232 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDF 232 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccc
Confidence 222 244578 99999999988744567889999999999999999999754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-14 Score=143.37 Aligned_cols=145 Identities=21% Similarity=0.318 Sum_probs=116.3
Q ss_pred HHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCC----CCHHHHHHHHHHHHHHHHHHHHcCc-eeeccCCC
Q 016537 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGI-MHRDVKPH 257 (387)
Q Consensus 183 ~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~aL~yLH~~~i-vHrDlKp~ 257 (387)
+.+ .|.|+.+++|.+.++ ...+.|-+||..|++.+.+.. +...-...++++++.||+|||...| .|+.|+..
T Consensus 2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 455 899999999999886 456789999999999888743 6666777888999999999998876 99999999
Q ss_pred CeeEcCCCceEEEEecccceeecCC---CcccccccccCCCCchhhcccC--C----CCCccchhhHHHHHHHHHhcCCc
Q 016537 258 NVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ--D----YDYSLDLWSLGCMFAGMVSVSPS 328 (387)
Q Consensus 258 NILl~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~----~~~~sDvwSlGvil~elltg~~p 328 (387)
|+++| ..+.+||+|||+....... .......-...|.|||.+.+.. . -+.+.||||||++++|+++++.|
T Consensus 79 nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 79 NCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred cceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999 6679999999998765321 1111222345699999986631 1 46679999999999999999999
Q ss_pred hhh
Q 016537 329 VLF 331 (387)
Q Consensus 329 f~~ 331 (387)
|..
T Consensus 158 ~~~ 160 (484)
T KOG1023|consen 158 FDL 160 (484)
T ss_pred ccc
Confidence 954
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-13 Score=118.75 Aligned_cols=128 Identities=21% Similarity=0.259 Sum_probs=96.2
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (387)
++.|+.|.++.||++.. .+..+++|+..... ...+.+|+.+++.+.+...+.+++.+.. . ..++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~--~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--E--TGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--C--CCeEEEEecCCC
Confidence 46789999999999886 47889999876543 2456889999999843333455665432 1 236999999998
Q ss_pred chhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 217 ~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~i-----vHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++... .......+.+++.+|+.||..++ +|+|++|.||+++ ++ .++++|||.+...
T Consensus 77 ~l~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTE-----DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGMN 137 (170)
T ss_pred ccccc-----cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccCC
Confidence 77543 11123456789999999999885 9999999999998 44 6999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.2e-13 Score=132.80 Aligned_cols=143 Identities=13% Similarity=0.241 Sum_probs=91.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHH---------------------------------------
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK--------------------------------------- 174 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~--------------------------------------- 174 (387)
.+|+. +.||.|++|+||+|+.+.+|+.||||++++...+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34555 78999999999999997779999999997542211
Q ss_pred ----HHHHHHHHHHhc---CCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhc--C--CCCHHHHHHHHHHHH-HHHH
Q 016537 175 ----IKREIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--P--TLSDYDVRYYIYELL-KALD 242 (387)
Q Consensus 175 ----~~~E~~il~~l~---~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~~~~~~~~~~~~qi~-~aL~ 242 (387)
+.+|...+.++. .+.+.+.+-.++.+-. ...+|||||++|+.+.+.. . ..... .++...+ .-+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHH
Confidence 223443333331 2334444444444322 2356999999999886531 1 11111 1111111 1123
Q ss_pred HHHHcCceeeccCCCCeeEcCCC---ceEEEEecccceeecC
Q 016537 243 YCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP 281 (387)
Q Consensus 243 yLH~~~ivHrDlKp~NILl~~~~---~~vkl~DFG~a~~~~~ 281 (387)
-+...|++|+|+||.||+++.++ +.++++|||++..+.+
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34568999999999999998654 3799999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.2e-12 Score=110.48 Aligned_cols=133 Identities=17% Similarity=0.249 Sum_probs=97.1
Q ss_pred eeeeecCCeeEEEEEEeC------CCeEEEEEEecccc-------------------------hHH----HHHHHHHHHH
Q 016537 140 RKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK-------------------------KKK----IKREIKILQN 184 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~l~~~~-------------------------~~~----~~~E~~il~~ 184 (387)
..||.|.=+.||.|.... .+..+|||+.+... .+. .++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 35799999874210 111 2489999999
Q ss_pred hcCC-CCeeEEEEEEEcCCCCCceEEEeccCCCchh-hhcC--CCCHHHHHHHHHHHHHHHHHH-HHcCceeeccCCCCe
Q 016537 185 LCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYP--TLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNV 259 (387)
Q Consensus 185 l~~h-pniv~l~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~--~~~~~~~~~~~~qi~~aL~yL-H~~~ivHrDlKp~NI 259 (387)
+... -++.+++++. ..++||||+.++.+. ..++ .+++.....+..+++.+|..| |+.||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8443 5677777642 235999999875331 1121 244456677788999999999 899999999999999
Q ss_pred eEcCCCceEEEEecccceeec
Q 016537 260 MIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 260 Ll~~~~~~vkl~DFG~a~~~~ 280 (387)
|++ ++ .+.|+|||.+....
T Consensus 157 L~~-~~-~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DG-KVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CC-cEEEEECCCceeCC
Confidence 997 34 69999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-12 Score=129.11 Aligned_cols=191 Identities=21% Similarity=0.250 Sum_probs=151.2
Q ss_pred CCeEEEeeeee--cCCeeEEEEEE--eCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGR--GKYSEVFEGVH--CTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~l~-----~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+ +....+-.+|+.-.+++..|+|.++.+..+... .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--G 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC--C
Confidence 45667888999 99999999987 7788899998732 123345567888888887899999987777654 4
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHH----HHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~----aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
..++-+|.|.. ++.... .-+++..++....+... ||.++|..+++|-|+||+||++..+....+++|||+.
T Consensus 192 ~lfiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 45688888874 443332 23788889999999999 9999999999999999999999877458999999999
Q ss_pred eeecCCCccc------ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 277 EFYHPGKEYN------VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 277 ~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
..+.++.-.. ...+...|++||+..+ .++...|+|++|.++.+-..+..++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccc
Confidence 8887654221 1156677999999765 6889999999999999999987665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-12 Score=127.33 Aligned_cols=192 Identities=20% Similarity=0.141 Sum_probs=143.8
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEe-CCCeEEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~l~~~~~-----~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
...+|..+..||.|.|+.|++.... .++..|++|.+..... ..-..|+-+...+..|.++++++..+.... .
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--Q 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--c
Confidence 3467889999999999999988754 6778999997754321 122457767777777889998877665433 3
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++-.|||.+++..... ..+.+...+.+..|++.++.++|+..++|+|+||+||++..++...++.|||++..+.-
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence 44888999998765433 33677888899999999999999999999999999999987655789999999864221
Q ss_pred CcccccccccCCC-CchhhcccCCCCCccchhhHHHHHHHHHhcCC
Q 016537 283 KEYNVRVASRYFK-GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327 (387)
Q Consensus 283 ~~~~~~~gt~~y~-aPE~~~~~~~~~~~sDvwSlGvil~elltg~~ 327 (387)
.........+++ ..|++.....+..+.|++|||.-+.|.+++.+
T Consensus 420 -~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 420 -SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred -ecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 112222333344 35555444678889999999999999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.8e-11 Score=120.04 Aligned_cols=165 Identities=22% Similarity=0.364 Sum_probs=123.3
Q ss_pred EEEEeCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHH
Q 016537 152 EGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228 (387)
Q Consensus 152 ~~~~~~~~~~vavK~l~~~~~---~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~ 228 (387)
.|..+.++..|.|...+.... ...++-++.|+.+ +||||+++++.++.. ...|+|.|-+.- |...++++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~--~~~ylvTErV~P--l~~~lk~l~~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEE--GTLYLVTERVRP--LETVLKELGKE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhccc--CceEEEeecccc--HHHHHHHhHHH
Confidence 466667888888888875544 4567778889998 999999999988764 467899998853 33344556678
Q ss_pred HHHHHHHHHHHHHHHHH-HcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-ccccccccCCCCchhhcccCCC
Q 016537 229 DVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 306 (387)
Q Consensus 229 ~~~~~~~qi~~aL~yLH-~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 306 (387)
.+..-+.||+.||.||| +.+++|++|..+-|+++..+ ..||++|.++........ .....--..|..|+.+.. .
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s-- 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-S-- 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-c--
Confidence 88888999999999998 56899999999999999766 899999998865432221 011111123566766533 1
Q ss_pred CCccchhhHHHHHHHHHhc
Q 016537 307 DYSLDLWSLGCMFAGMVSV 325 (387)
Q Consensus 307 ~~~sDvwSlGvil~elltg 325 (387)
.-..|.|-|||+++|++.|
T Consensus 181 ~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhhHHHHHHHHhCc
Confidence 1357999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.2e-11 Score=100.61 Aligned_cols=128 Identities=20% Similarity=0.340 Sum_probs=91.6
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----------chHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCCce
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----------~~~~~~~E~~il~~l~~-hpniv~l~~~~~~~~~~~~~ 207 (387)
..+++|+=+.+|.+.+ -|..+++|.=.+. ...+..+|..++.++.. .-+...++++ +... ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~--~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDN--GL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCC--CE
Confidence 3578899999999865 3445677753221 12456789999988722 2344455554 3433 34
Q ss_pred EEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 208 LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++|||++|..+++.+... ...++..+-.-+.-||..||||+||.++||++..+ .+.++|||++...
T Consensus 76 I~me~I~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA----RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc----chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence 999999999888665443 24566677777888999999999999999999844 4899999999753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.4e-10 Score=99.16 Aligned_cols=137 Identities=20% Similarity=0.277 Sum_probs=97.2
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.+..|-+|+=+.|+++.+ .|+.++||.-.+ -.+++.++|++.|.++ .--.|.-..-++.|....
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~-- 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGG-- 85 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCC--
Confidence 567788999999999986 678888875321 1236678999999987 332333333334444333
Q ss_pred eEEEeccCCC-chhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCce--EEEEeccccee
Q 016537 207 SLIFEHVNNT-DFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEF 278 (387)
Q Consensus 207 ~lv~e~~~~~-~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~--vkl~DFG~a~~ 278 (387)
.++|||+++. ++..+. ....+.....++..|-+.+.-||.++|||+||..+||++.+++.. +.++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 4999999884 333332 123333346788889999999999999999999999999766654 48999999865
Q ss_pred e
Q 016537 279 Y 279 (387)
Q Consensus 279 ~ 279 (387)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-10 Score=104.52 Aligned_cols=139 Identities=24% Similarity=0.415 Sum_probs=103.7
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC-CCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ-SKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~-hpniv~l~~~~~~~~-~~~~~lv~e~~ 213 (387)
+.||.|..+.||++.. .+|+.+++|+..... ...+.+|.++++.+.+ +.++.+++.+..... ....++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999987 346789999876432 4678899999999843 244677777654322 12457999999
Q ss_pred CCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 016537 214 NNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS--------------------------------------------- 246 (387)
Q Consensus 214 ~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~--------------------------------------------- 246 (387)
++.++.... ..+++.....++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 998876654 346666777778888888888873
Q ss_pred -----------cCceeeccCCCCeeEcCC-CceEEEEecccceee
Q 016537 247 -----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFY 279 (387)
Q Consensus 247 -----------~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~ 279 (387)
..++|+|+++.||+++.+ ...+.|+||+.+...
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 236999999999999863 336889999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.5e-10 Score=98.11 Aligned_cols=122 Identities=24% Similarity=0.385 Sum_probs=81.2
Q ss_pred eEEEEEEeCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHHHhcCC-CCeeEEEEEE
Q 016537 149 EVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNIVKLLDIV 198 (387)
Q Consensus 149 ~Vy~~~~~~~~~~vavK~l~~~~-----------------------------~~~~~~E~~il~~l~~h-pniv~l~~~~ 198 (387)
.||.|.. .++..+|+|+.+... ....++|.+.|.++... -++.+++++-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 678899999874210 13457899999998433 3677777653
Q ss_pred EcCCCCCceEEEeccC--CCchhhhcCC-CCHHHHHHHHHHHHHHHHH-HHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 199 RDQQSKTPSLIFEHVN--NTDFKVLYPT-LSDYDVRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 199 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-~~~~~~~~~~~qi~~aL~y-LH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
. .++||||++ +..+..+... +.......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||
T Consensus 80 ----~--~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 ----R--NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp ----T--TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred ----C--CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 1 359999999 6555544322 2244566777788886555 579999999999999999854 69999999
Q ss_pred cceee
Q 016537 275 LAEFY 279 (387)
Q Consensus 275 ~a~~~ 279 (387)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 98754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.8e-11 Score=125.85 Aligned_cols=194 Identities=21% Similarity=0.268 Sum_probs=140.2
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
..+.+.+.+-+-+|.++.++.+.-...+...+.|.... ...+....+-.++-.. ++|-++...--+ .....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP 878 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP 878 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence 34778899999999999999887766665555554331 1122333333333222 456666554432 23345
Q ss_pred ceEEEeccCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-
Q 016537 206 PSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~- 281 (387)
.+|+++|+.+++|...+.. ...+.++.++..+..+++|||...+.|||++|.|+|+..++ +.++.|||.......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCccccccccccc
Confidence 6799999999998777644 45666788888999999999999999999999999998666 889999984321100
Q ss_pred --------------------C-----------CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 --------------------G-----------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 --------------------~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......++|+.|.+||...+ ......+|+|++|++++|.++|.+||.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00122468899999999988 567789999999999999999999994
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.3e-09 Score=95.54 Aligned_cols=127 Identities=18% Similarity=0.184 Sum_probs=89.6
Q ss_pred EEEEEEeCCCeEEEEEEecccch--------------HHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC---CCCceEEEe
Q 016537 150 VFEGVHCTDNEKCIIKILKPVKK--------------KKIKREIKILQNLCG-GPNIVKLLDIVRDQQ---SKTPSLIFE 211 (387)
Q Consensus 150 Vy~~~~~~~~~~vavK~l~~~~~--------------~~~~~E~~il~~l~~-hpniv~l~~~~~~~~---~~~~~lv~e 211 (387)
|+++.. .|+.+.||....... ..+.+|...+.+|.. .-..++++++.+... ....++|+|
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 555543 567788886643221 147789988888722 123344555544321 234579999
Q ss_pred ccCCC-chhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC------CCceEEEEeccccee
Q 016537 212 HVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------EQRKLRLIDWGLAEF 278 (387)
Q Consensus 212 ~~~~~-~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~------~~~~vkl~DFG~a~~ 278 (387)
++++. ++..+.. .........++.+++..+.-||+.||+|+|+++.|||++. +...+.|+||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99986 6766643 2445667789999999999999999999999999999974 245799999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.1e-08 Score=94.63 Aligned_cols=190 Identities=15% Similarity=0.168 Sum_probs=124.2
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEE----EEcC-CCCCceEEEec
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDI----VRDQ-QSKTPSLIFEH 212 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~----~~~~-~~~~~~lv~e~ 212 (387)
..+.||+|+-+.+|..- .-...+.|++...-...-.+-++.|.+...||-+..=+.+ .... ....+-++|..
T Consensus 15 ~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 15 PGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CCccccCCccceeeecc---hhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 45679999999999642 2223345776432221112223344444456544331111 0111 12224567777
Q ss_pred cCCCc-hhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 213 VNNTD-FKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 213 ~~~~~-l~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
+.+.. ...++ +...+.-..+.++.++.+.+.||++|.+-+|+.++|+|+.+++ .|.|.|-..-.....+
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ng 170 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINANG 170 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeeccCC
Confidence 66542 12222 2255667888899999999999999999999999999999666 7888885554444444
Q ss_pred CcccccccccCCCCchhhc-----ccCCCCCccchhhHHHHHHHHHhc-CCchhhh
Q 016537 283 KEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMVSV-SPSVLFY 332 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~sDvwSlGvil~elltg-~~pf~~~ 332 (387)
......+|...|.+||... + -+-+...|.|.|||++++++.| ++||.+.
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g-~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVG-FERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ceEecccCccccCCHHHhccccccc-cCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 4556678999999999853 2 2345679999999999999987 9999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-08 Score=91.65 Aligned_cols=132 Identities=21% Similarity=0.367 Sum_probs=98.6
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-------c------------------chHHHHHHHHHHHHhcCC-C
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------V------------------KKKKIKREIKILQNLCGG-P 189 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-------~------------------~~~~~~~E~~il~~l~~h-p 189 (387)
..+...||-|.=+.||.|.+ ..|.++|||.-+. . .+...++|.++|.+|..+ -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34678999999999999998 5789999997431 0 113357899999999433 3
Q ss_pred CeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEE
Q 016537 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (387)
Q Consensus 190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vk 269 (387)
.+.+.+++ ....+|||++++..|.... +..+....++..|++-+.-+-..||||+|+.+=||+++.++ .+.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~ 242 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIV 242 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CEE
Confidence 67777764 2346999999997765443 13455556666677777666689999999999999999776 699
Q ss_pred EEecccce
Q 016537 270 LIDWGLAE 277 (387)
Q Consensus 270 l~DFG~a~ 277 (387)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99996554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.1e-08 Score=87.96 Aligned_cols=108 Identities=25% Similarity=0.369 Sum_probs=82.0
Q ss_pred hHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC--CCCceEEEeccCCC-chhhhcCC---CCHHHHHHHHHHHHHHHHHH
Q 016537 172 KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ--SKTPSLIFEHVNNT-DFKVLYPT---LSDYDVRYYIYELLKALDYC 244 (387)
Q Consensus 172 ~~~~~~E~~il~~l~~-hpniv~l~~~~~~~~--~~~~~lv~e~~~~~-~l~~~~~~---~~~~~~~~~~~qi~~aL~yL 244 (387)
..+..+|...+..|.. .-.+++.+++.+... ....++|+|++++. +|..+... ........++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3567888888777722 234556666665422 23347999999875 67777654 56677788999999999999
Q ss_pred HHcCceeeccCCCCeeEcCCC--ceEEEEecccceee
Q 016537 245 HSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFY 279 (387)
Q Consensus 245 H~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a~~~ 279 (387)
|++||+|+|+++.|||++.++ ..+.++||+-++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999998654 36899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.6e-08 Score=95.04 Aligned_cols=162 Identities=16% Similarity=0.251 Sum_probs=122.7
Q ss_pred CCeeEEEEEEeCCCeEEEEEEec---ccchHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCCCceEEEeccCCC-chh
Q 016537 146 KYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFEHVNNT-DFK 219 (387)
Q Consensus 146 ~~g~Vy~~~~~~~~~~vavK~l~---~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~--~~~~~~~lv~e~~~~~-~l~ 219 (387)
-..+.|++..+.+|..|++|++. .........-++.++++ .|.|+|++.+++.. -....+++|++|.++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 44668999999999999999982 23333445567789999 99999999998763 2334578999999864 454
Q ss_pred hhc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 220 VLY------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 220 ~~~------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
+++ ...+|..+|.|+.|+..||.++|+.|+.-+-|.+.+||++.+. +++|.-.|+......
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 432 1267889999999999999999999999999999999998554 788887777766654
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcC
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVS 326 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~ 326 (387)
+. . |.+.+. .+-|.=.||.+++.|.||.
T Consensus 446 d~-----------~--~~le~~----Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 446 DP-----------T--EPLESQ----QQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC-----------C--cchhHH----hhhhHHHHHHHHHHHhhcc
Confidence 43 0 112221 2568889999999999984
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-07 Score=84.13 Aligned_cols=135 Identities=17% Similarity=0.178 Sum_probs=95.4
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEec---------ccchHHHHHHHHHHHHhcCC-CCeeEEE--EEEEcCCCCCceEE
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQNLCGG-PNIVKLL--DIVRDQQSKTPSLI 209 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~---------~~~~~~~~~E~~il~~l~~h-pniv~l~--~~~~~~~~~~~~lv 209 (387)
-|+||-+.|+.... .|..+-+|.-. +.....|.+|+..|.+|... -.+.++. +.-........+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 35688888998765 34467777643 34457789999999988322 1244443 22223333445799
Q ss_pred EeccCCC-chhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC-ceEEEEeccccee
Q 016537 210 FEHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEF 278 (387)
Q Consensus 210 ~e~~~~~-~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~~vkl~DFG~a~~ 278 (387)
+|-+++. +|..++. +.++.....++.+++..++-||+.|+.|+|+.+.|||++.++ ..++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9977754 6665542 245666678999999999999999999999999999998444 2499999987754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.7e-09 Score=95.99 Aligned_cols=144 Identities=21% Similarity=0.263 Sum_probs=104.0
Q ss_pred HHHHHhcCCCCeeEEEEEEEcCC---CCCceEEEeccCCCchhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHcC-
Q 016537 180 KILQNLCGGPNIVKLLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYPT-------LSDYDVRYYIYELLKALDYCHSQG- 248 (387)
Q Consensus 180 ~il~~l~~hpniv~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~aL~yLH~~~- 248 (387)
.-|..+ .|.|||+++.|+.+.. .....++.|||..|++..++++ +.....++|+.||+.||.|||+..
T Consensus 119 dnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 344455 7899999999997643 2356789999999999888743 667778899999999999999874
Q ss_pred -ceeeccCCCCeeEcCCCceEEEEecccceeecCC------CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHH
Q 016537 249 -IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAG 321 (387)
Q Consensus 249 -ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~e 321 (387)
|+|+.+..+-|++..++ -+|+.----. ...+. .......+-++|.+||.=.. ...+.++|||+||+...|
T Consensus 198 piihgnlTc~tifiq~ng-LIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNG-LIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCc-eEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHH
Confidence 99999999999999555 5665421111 11110 11122345677889986322 345678999999999999
Q ss_pred HHhcCC
Q 016537 322 MVSVSP 327 (387)
Q Consensus 322 lltg~~ 327 (387)
|-.+.-
T Consensus 275 mailEi 280 (458)
T KOG1266|consen 275 MAILEI 280 (458)
T ss_pred HHHhee
Confidence 988763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.5e-08 Score=96.12 Aligned_cols=136 Identities=18% Similarity=0.356 Sum_probs=86.5
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHH-------------------------------------------H
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------------------------------------K 176 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~-------------------------------------------~ 176 (387)
+.|+.++-|+||+|+. .+|+.||||+..+.-.+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6789999999999999 4599999999875433222 2
Q ss_pred HHHHHHHHh----cCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhc--C--CCCHHHHHHHHHHHHHH-HHHHHHc
Q 016537 177 REIKILQNL----CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--P--TLSDYDVRYYIYELLKA-LDYCHSQ 247 (387)
Q Consensus 177 ~E~~il~~l----~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~~~~~~~~~~~~qi~~a-L~yLH~~ 247 (387)
+|...+.++ .+.++ +++=.++.+-. ..-+|+|||++|..+.+.. + .+.... ++..++.+ +.-+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhcc-CCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 343333333 12232 22223333222 2346999999998665542 2 233222 22222222 2333458
Q ss_pred CceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 248 ~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
|+.|.|.+|.||+++.++ .+.+.|||+...+.+.
T Consensus 285 gffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEEecCC-cEEEEcCcceecCCHH
Confidence 999999999999999776 8999999999776543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.4e-07 Score=79.76 Aligned_cols=139 Identities=19% Similarity=0.385 Sum_probs=83.9
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-CCeeEEEEEEEcC-CCCCceEEEeccCC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQ-QSKTPSLIFEHVNN 215 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~h-pniv~l~~~~~~~-~~~~~~lv~e~~~~ 215 (387)
++.|+.|..+.||+.... + ..+++|..... ....+.+|..+++.+..+ ..+.+++.+.... .....+++|+++++
T Consensus 2 i~~l~~G~~n~~~~v~~~-~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-D-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEET-T-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEEC-C-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 467999999999999863 3 58999998765 557788999999988444 2356777654332 23346899999999
Q ss_pred Cchhhh----------------c--------CC--CCHHH---------HHHH------------HHHHHH-HHHHHHH-
Q 016537 216 TDFKVL----------------Y--------PT--LSDYD---------VRYY------------IYELLK-ALDYCHS- 246 (387)
Q Consensus 216 ~~l~~~----------------~--------~~--~~~~~---------~~~~------------~~qi~~-aL~yLH~- 246 (387)
..+... + .. ..... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 876660 0 00 00000 0000 111222 2333332
Q ss_pred ------cCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 247 ------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 247 ------~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
..++|+|+.|.|||++.+++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 359999999999999944446689999988653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.5e-07 Score=78.77 Aligned_cols=137 Identities=16% Similarity=0.264 Sum_probs=89.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch---H---------HHHHHHHHHHHhc--CCCCeeEEEEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---K---------KIKREIKILQNLC--GGPNIVKLLDIV 198 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~---~---------~~~~E~~il~~l~--~hpniv~l~~~~ 198 (387)
.++|+..+.+-......|.+-. -+++.+++|..++... + ...+++..+.++. +--..+.++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4778898999888877777655 5789999998765332 1 1223344333331 222333333332
Q ss_pred EcCC---CCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccc
Q 016537 199 RDQQ---SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (387)
Q Consensus 199 ~~~~---~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~ 275 (387)
.... ....+++|||++|..+.+.. .+.+ .+...+.+++.-||+.|+.|+|.+|.|+++..+ .++++||+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~ 180 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG 180 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence 2211 12235899999998765432 2232 234567788999999999999999999999844 489999987
Q ss_pred cee
Q 016537 276 AEF 278 (387)
Q Consensus 276 a~~ 278 (387)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-06 Score=79.20 Aligned_cols=131 Identities=19% Similarity=0.261 Sum_probs=80.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCCCceEEEeccCCCc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~h-pniv~l~~~~~~~~~~~~~lv~e~~~~~~ 217 (387)
..||+|..+.||+. .+..+++|...+. ......+|.++++.+... -.+.+.+++..+... ..+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~--~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR--LGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe--eeeeeeecCCcc
Confidence 46899999999983 2446788887653 346678999999998433 225677777655433 458999999863
Q ss_pred -hhhhc---------------------CCC-----CHHH-HHHHHH----------HHHH-HHHHHHH----cCceeecc
Q 016537 218 -FKVLY---------------------PTL-----SDYD-VRYYIY----------ELLK-ALDYCHS----QGIMHRDV 254 (387)
Q Consensus 218 -l~~~~---------------------~~~-----~~~~-~~~~~~----------qi~~-aL~yLH~----~~ivHrDl 254 (387)
+.... ..+ .... ...+.. .+.. ...+|.. ..++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11110 000 0000 000000 0111 1222221 24789999
Q ss_pred CCCCeeEcCCCceEEEEeccccee
Q 016537 255 KPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 255 Kp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
.|.||+++.++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~--~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG--TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC--cEEEechhcCc
Confidence 99999998544 89999999864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-06 Score=77.41 Aligned_cols=133 Identities=15% Similarity=0.241 Sum_probs=94.8
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----------------------h-----HHHHHHHHHHHHhc-CCCC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------------------K-----KKIKREIKILQNLC-GGPN 190 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----------------------~-----~~~~~E~~il~~l~-~hpn 190 (387)
...|+.|.-+.||+|.. .++..+|+|+++... . ....+|+..|+++. .+-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888899999986 678999999986321 0 11356888888773 2355
Q ss_pred eeEEEEEEEcCCCCCceEEEeccCCCch-hhhcCC--CCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCc
Q 016537 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLYPT--LSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR 266 (387)
Q Consensus 191 iv~l~~~~~~~~~~~~~lv~e~~~~~~l-~~~~~~--~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~ 266 (387)
+.+.+++.. -.|||||+..... .-.++. +...++..+..++++.+.-|-. .++||+||..=|||+. ++
T Consensus 132 vP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~- 203 (268)
T COG1718 132 VPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG- 203 (268)
T ss_pred CCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-
Confidence 666666541 3499999976521 111111 2233577778889999988877 8999999999999998 55
Q ss_pred eEEEEecccceeec
Q 016537 267 KLRLIDWGLAEFYH 280 (387)
Q Consensus 267 ~vkl~DFG~a~~~~ 280 (387)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 79999999987654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.8e-06 Score=73.44 Aligned_cols=125 Identities=24% Similarity=0.324 Sum_probs=90.6
Q ss_pred CCeEEEeeeeecCC-eeEEEEEEeCCCeEEEEEEecc------------------------cchHHHHHHHHHHHHhc--
Q 016537 134 DDYEVVRKVGRGKY-SEVFEGVHCTDNEKCIIKILKP------------------------VKKKKIKREIKILQNLC-- 186 (387)
Q Consensus 134 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~l~~------------------------~~~~~~~~E~~il~~l~-- 186 (387)
.+++.++.||.|.- |.||++.. +|+.||+|+++. .....|..|++...+|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999985 788999999321 00134678998888873
Q ss_pred CCCCe--eEEEEEEEcCC----------------CCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 016537 187 GGPNI--VKLLDIVRDQQ----------------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG 248 (387)
Q Consensus 187 ~hpni--v~l~~~~~~~~----------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ 248 (387)
++.++ |+.+||..-.. .....+|.||+.... .+ ...-+.+|.+-|..+|..|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~----~~~~~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PL----QIRDIPQMLRDLKILHKLG 184 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------cc----chhHHHHHHHHHHHHHHCC
Confidence 33455 99999874220 011246777776543 11 2234567888889999999
Q ss_pred ceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 249 ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
|+-+|+|+.|.. ++ +|+|||.+
T Consensus 185 I~~~Dv~~~ny~---~G---~lvDfs~~ 206 (207)
T PF13095_consen 185 IVPRDVKPRNYR---GG---KLVDFSSS 206 (207)
T ss_pred eeeccCcccccc---CC---EEEecccC
Confidence 999999999986 33 89999865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.2e-08 Score=96.87 Aligned_cols=181 Identities=15% Similarity=0.184 Sum_probs=132.8
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCCCceEEEeccC
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN-IVKLLDIVRDQQSKTPSLIFEHVN 214 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpn-iv~l~~~~~~~~~~~~~lv~e~~~ 214 (387)
+...+.+++|+++.++|.+...+...+ .+.+... ....-++++|.++ +||| .+..++- ++.+.+..++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d--~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLED--YDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCccccccc--CCcccccchhhhhhc
Confidence 455677899999999999875554443 6665433 3445578889998 9999 4444432 344567788999998
Q ss_pred CC-chhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccc
Q 016537 215 NT-DFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (387)
Q Consensus 215 ~~-~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 289 (387)
++ +...... .+.+.+.....+.-++++++||+.-=+||| |||... + ..+..||+....+..........
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~-~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E-EVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c-ccccccccCCcccCcccccccCC
Confidence 87 2211111 133344555667778899999998778999 888874 3 68999999998777665566778
Q ss_pred cccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 290 gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
+++.++|||+... ..+....|+|++|+--.+|--|.+|-
T Consensus 392 ~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCC
Confidence 9999999998766 67899999999998777887787774
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.8e-06 Score=77.10 Aligned_cols=75 Identities=20% Similarity=0.218 Sum_probs=53.5
Q ss_pred eeeecCC-eeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchh
Q 016537 141 KVGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219 (387)
Q Consensus 141 ~lG~G~~-g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~ 219 (387)
.|-.|.+ ..||+... .+..+++|+..........+|+++++.+..+--+.+++++.... ...++|||+++|..+.
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHh
Confidence 3445555 78999864 34678889876543456788999999986665566788776543 3457999999987654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.6e-06 Score=88.61 Aligned_cols=79 Identities=18% Similarity=0.264 Sum_probs=56.6
Q ss_pred EeeeeecCCeeEEEEEEeCCC--eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCe--eEEEEEEEcCC-CCCceEE
Q 016537 139 VRKVGRGKYSEVFEGVHCTDN--EKCIIKILKPV----KKKKIKREIKILQNLCGGPNI--VKLLDIVRDQQ-SKTPSLI 209 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~l~~~----~~~~~~~E~~il~~l~~hpni--v~l~~~~~~~~-~~~~~lv 209 (387)
++.|+.|.+..+|+......+ ..+++|+.... ....+.+|.++|+.+..|.++ .+++.++.+.. ....++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998764322 46777765332 235688999999999546654 78888876532 2346799
Q ss_pred EeccCCCc
Q 016537 210 FEHVNNTD 217 (387)
Q Consensus 210 ~e~~~~~~ 217 (387)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4e-06 Score=71.80 Aligned_cols=129 Identities=20% Similarity=0.316 Sum_probs=90.2
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccC
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~ 214 (387)
.++.+.||+|.+|.||+|.+ .|..+|+|+-+. ..+..+..|.++|..+..----.+++.|-.+ .+.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhc
Confidence 34678899999999999997 466888887664 4457789999999998433333455554322 25699999
Q ss_pred CCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCC--CCeeEcCCCceEEEEeccccee
Q 016537 215 NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP--HNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 215 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp--~NILl~~~~~~vkl~DFG~a~~ 278 (387)
|-.|..+-.... ++-+..+++.---|-..||-|..|.- .||++. ++ .+.|+||..|+.
T Consensus 96 G~~L~~~~~~~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGGD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhccc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchhh
Confidence 987765543322 23344555654456677999999873 466665 44 689999999974
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.6e-05 Score=72.94 Aligned_cols=80 Identities=10% Similarity=0.168 Sum_probs=58.4
Q ss_pred EEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCC-CCCceEEEec
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQ-SKTPSLIFEH 212 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~-~~~~~lv~e~ 212 (387)
.-.+.||.|..+.||+... .++ .+++|..+.. ....+..|.+.|+.|..+ -.+.++++++.+.. ....++|||+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3456799999999999764 233 5677876542 446889999999998554 46889998876532 2346899999
Q ss_pred cCCCch
Q 016537 213 VNNTDF 218 (387)
Q Consensus 213 ~~~~~l 218 (387)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.21 E-value=3e-05 Score=68.79 Aligned_cols=124 Identities=21% Similarity=0.427 Sum_probs=87.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccc-------------------hHHHHHHHHHHHHhc-----CCCCeeEEE
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNIVKLL 195 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-------------------~~~~~~E~~il~~l~-----~hpniv~l~ 195 (387)
..||+|+.=.||. + ..+....||+..+.. .++..+|+.....+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4699999999996 3 455667889987666 567788888887773 268899999
Q ss_pred EEEEcCCCCCceEEEeccCCC------chhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--C
Q 016537 196 DIVRDQQSKTPSLIFEHVNNT------DFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q 265 (387)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~ 265 (387)
|+..+.. .+.+|+|.+.+. +|..+++ .+++ .. ...+-+-..||-+++|+.+||+|.||++... +
T Consensus 84 G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 84 GFVETNL--GLGLVVELIRDADGNISPTLEDYLKEGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEEecCC--ceEEEEEEEECCCCCcCccHHHHHHcCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9997754 356888876543 3444442 2333 22 2333444568889999999999999999532 2
Q ss_pred c-eEEEEe
Q 016537 266 R-KLRLID 272 (387)
Q Consensus 266 ~-~vkl~D 272 (387)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 3 577787
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-05 Score=80.86 Aligned_cols=135 Identities=19% Similarity=0.249 Sum_probs=84.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccchH----------------------------------------HHHHHH
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----------------------------------------KIKREI 179 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~----------------------------------------~~~~E~ 179 (387)
+.||.-+.|+||+|+.+ +|+.||||+-++.-++ .|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 57999999999999995 4999999986542211 123343
Q ss_pred HHHHHhc---CCCC------eeEEEEEEEcCCCCCceEEEeccCCCchhhh---c-CCCCHHHHHHHHHHHHHHHHHHHH
Q 016537 180 KILQNLC---GGPN------IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---Y-PTLSDYDVRYYIYELLKALDYCHS 246 (387)
Q Consensus 180 ~il~~l~---~hpn------iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~---~-~~~~~~~~~~~~~qi~~aL~yLH~ 246 (387)
+...++. .|-+ |.+++--+ ...-+|+||||+|.-+.++ . ..++...+...+.++.. +-+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHh
Confidence 3333221 3344 33333322 1235699999999754333 2 23555544333322211 11224
Q ss_pred cCceeeccCCCCeeEcC---CCceEEEEecccceeecC
Q 016537 247 QGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 247 ~~ivHrDlKp~NILl~~---~~~~vkl~DFG~a~~~~~ 281 (387)
.|++|+|=+|.||+++. .+..+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 68999999999999984 345899999999876643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.6e-07 Score=92.38 Aligned_cols=92 Identities=16% Similarity=0.351 Sum_probs=71.6
Q ss_pred HHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc-----cc-----cccccCCCCchhhcccC
Q 016537 236 ELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NV-----RVASRYFKGPELLVDLQ 304 (387)
Q Consensus 236 qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~-----~~-----~~gt~~y~aPE~~~~~~ 304 (387)
+++.||.|+|+. ++||+.|.|++|.++..+ ..||+-|+++....+...+ +. ......|.|||++.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 445999999976 899999999999999655 8999999998654442221 11 123456999999877 6
Q ss_pred CCCCccchhhHHHHHHHHH-hcCCch
Q 016537 305 DYDYSLDLWSLGCMFAGMV-SVSPSV 329 (387)
Q Consensus 305 ~~~~~sDvwSlGvil~ell-tg~~pf 329 (387)
..+.++|+||+||++|-+. .|++.+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~ 210 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSII 210 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchh
Confidence 7889999999999999999 555554
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=3e-05 Score=70.79 Aligned_cols=74 Identities=11% Similarity=0.162 Sum_probs=46.2
Q ss_pred eeeeecCCe-eEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCC-CCceEEEeccC
Q 016537 140 RKVGRGKYS-EVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQS-KTPSLIFEHVN 214 (387)
Q Consensus 140 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~~-~~~~lv~e~~~ 214 (387)
+.|+.|+.. .||+. +..+++|..... ....+.+|.++++.+..+ --+.++++.....+. ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457767766 48875 235777876543 345788999999988433 134455543322211 23478999999
Q ss_pred CCch
Q 016537 215 NTDF 218 (387)
Q Consensus 215 ~~~l 218 (387)
|.++
T Consensus 78 G~~l 81 (235)
T cd05155 78 GETA 81 (235)
T ss_pred CCCC
Confidence 8665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.6e-05 Score=67.92 Aligned_cols=74 Identities=14% Similarity=0.253 Sum_probs=49.5
Q ss_pred EeeeeecCCeeEEEEEEeC-CCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 139 VRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~-~~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
++.|..|-...||++.... .++.|++|+...... -...+|+.+++.+..+.-.+++++... . .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----C--cEEEEeeCC
Confidence 4567888889999987532 257888997754322 223578999998855444566655432 1 289999998
Q ss_pred Cch
Q 016537 216 TDF 218 (387)
Q Consensus 216 ~~l 218 (387)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=6.7e-05 Score=66.09 Aligned_cols=95 Identities=22% Similarity=0.174 Sum_probs=76.2
Q ss_pred HHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchh-------hhcCCCCHHHHHHHHHHHHHHHHHHHH--
Q 016537 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPTLSDYDVRYYIYELLKALDYCHS-- 246 (387)
Q Consensus 176 ~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~-------~~~~~~~~~~~~~~~~qi~~aL~yLH~-- 246 (387)
..|.-+++.+.+.+++++++|+|. .+++.||...+++. .+ ...++..+.+++.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 357888888855579999999982 24899999977553 22 246788899999999999999998
Q ss_pred -cCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 247 -QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 247 -~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
..+.-.|++++|+-+++++ .+|++|...+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence 4578899999999999665 799999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=68.18 Aligned_cols=129 Identities=22% Similarity=0.232 Sum_probs=76.8
Q ss_pred eeecCCeeEEEEEEeCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCch
Q 016537 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218 (387)
Q Consensus 142 lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~---~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l 218 (387)
+..|-.+.+|+.. .+++.+++|+...... -...+|.++++.+..+.-..+++.... ..+||||++|..+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCccc
Confidence 4567788899876 4567888887643321 135789999999854423345554431 2489999998654
Q ss_pred hhh--------------c---CC-------CCH-HHHHHHHHHH---------HHHHHHHHH--------cCceeeccCC
Q 016537 219 KVL--------------Y---PT-------LSD-YDVRYYIYEL---------LKALDYCHS--------QGIMHRDVKP 256 (387)
Q Consensus 219 ~~~--------------~---~~-------~~~-~~~~~~~~qi---------~~aL~yLH~--------~~ivHrDlKp 256 (387)
... + .. +.. ..+..+..++ ...++.+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 321 0 00 111 1111221111 111222221 1489999999
Q ss_pred CCeeEcCCCceEEEEecccceeec
Q 016537 257 HNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 257 ~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.||+++.++ +.|+||..|..-.
T Consensus 156 ~Nil~~~~~--~~lIDwE~a~~gd 177 (256)
T TIGR02721 156 YNLVVTPQG--LKLIDWEYASDGD 177 (256)
T ss_pred CcEEEeCCC--CEEEeccccCcCC
Confidence 999998654 7899999987544
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00013 Score=68.98 Aligned_cols=138 Identities=13% Similarity=0.201 Sum_probs=84.1
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEEEEEEEc----CCCCCceEEEec
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QQSKTPSLIFEH 212 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hp-niv~l~~~~~~----~~~~~~~lv~e~ 212 (387)
-++.|..|....+|+... ++..+++|+........+..|++++..|..+- .+.+++..... ......++|++|
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 356788888889998764 44578899887655667888999988884331 34555442100 012245789999
Q ss_pred cCCCchhhh-----------c-------CCCC---------HHHH---H--------HHHHHHHHHHHHHHH-------c
Q 016537 213 VNNTDFKVL-----------Y-------PTLS---------DYDV---R--------YYIYELLKALDYCHS-------Q 247 (387)
Q Consensus 213 ~~~~~l~~~-----------~-------~~~~---------~~~~---~--------~~~~qi~~aL~yLH~-------~ 247 (387)
++|..+... + ..+. .+.. . .....+..++.++.+ .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 998654220 0 0000 0000 0 011123334455543 3
Q ss_pred CceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 248 ~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
+++|+|+.|.|||++.++ .+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 699999999999998644 568999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00023 Score=67.41 Aligned_cols=74 Identities=18% Similarity=0.213 Sum_probs=49.0
Q ss_pred EeeeeecCCeeEEEEEEeC------CCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 139 VRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~------~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++.|..|-...||+..... .++.+++|+..... .....+|.+++..+..+--..++++++.+ .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN------GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC------Cchh
Confidence 3456677777899887532 25789999976532 24567899899988554444566665531 1688
Q ss_pred eccCCCch
Q 016537 211 EHVNNTDF 218 (387)
Q Consensus 211 e~~~~~~l 218 (387)
||++|..+
T Consensus 77 e~i~G~~l 84 (302)
T cd05156 77 EFIPSRTL 84 (302)
T ss_pred heeCCCcC
Confidence 99887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00047 Score=67.69 Aligned_cols=74 Identities=16% Similarity=0.249 Sum_probs=52.9
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEec----------ccchHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCCCCc
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILK----------PVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~----------~~~~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~~~~~ 206 (387)
.+.||.|.+..||++.+...++.++||.-. +...++...|.+.|+.+..+ .++++++.+-. ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CCC
Confidence 468999999999999984333689999742 12345677888888886433 45778887632 335
Q ss_pred eEEEeccCCC
Q 016537 207 SLIFEHVNNT 216 (387)
Q Consensus 207 ~lv~e~~~~~ 216 (387)
++||||+++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 6999999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00064 Score=64.94 Aligned_cols=136 Identities=13% Similarity=0.224 Sum_probs=76.0
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEEEEE-----EEcCCCCCceEEEec
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI-----VRDQQSKTPSLIFEH 212 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~h-pniv~l~~~-----~~~~~~~~~~lv~e~ 212 (387)
++.|+.|....+|+... . +..+++|+......+....|+++++.|..+ -.+.+++.. +.. .....+++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~-~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE-LAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee-eCCEEEEEEEe
Confidence 45577788889998764 3 346888987633445666677777777322 123444431 111 12335789999
Q ss_pred cCCCchhh-----h------c-------CCCC----------HH-HH-H-----------HHHHH-HHHHHHHHH-----
Q 016537 213 VNNTDFKV-----L------Y-------PTLS----------DY-DV-R-----------YYIYE-LLKALDYCH----- 245 (387)
Q Consensus 213 ~~~~~l~~-----~------~-------~~~~----------~~-~~-~-----------~~~~q-i~~aL~yLH----- 245 (387)
++|..+.. . + ..++ .+ .. . ..+.+ +...++.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 98864211 1 0 1110 10 00 0 01111 111222332
Q ss_pred --HcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 246 --SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 246 --~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
..++||+|+++.|||++.+. ..-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDR-LSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence 23799999999999998443 457999999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00069 Score=64.41 Aligned_cols=140 Identities=17% Similarity=0.242 Sum_probs=82.6
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-CCeeEEEEEEEc----CCCCCceEE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRD----QQSKTPSLI 209 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~h-pniv~l~~~~~~----~~~~~~~lv 209 (387)
...++.++.|....||+... ++..+++|+.... ....+..|.+++..|.++ -.+.+++..... ......+++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ceeccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 33466778888889998763 3446788987543 245667788888887322 224555442110 112345789
Q ss_pred EeccCCCchhh-----h----------c---CCC----------CHHH---HH----------HHHHHHHHHHHHHHH--
Q 016537 210 FEHVNNTDFKV-----L----------Y---PTL----------SDYD---VR----------YYIYELLKALDYCHS-- 246 (387)
Q Consensus 210 ~e~~~~~~l~~-----~----------~---~~~----------~~~~---~~----------~~~~qi~~aL~yLH~-- 246 (387)
++|++|..... . . ..+ ..+. .. .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 99998854210 0 0 111 0000 00 001123334555543
Q ss_pred -----cCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 247 -----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 247 -----~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
.++||+|+++.||+++.++ .+.|+||+.+..
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~ 217 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFACT 217 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence 5799999999999998654 568999999854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0011 Score=62.98 Aligned_cols=144 Identities=17% Similarity=0.288 Sum_probs=84.7
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCCceEE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~-----~~~~~~~~~E~~il~~l~~-hpniv~l~~~~~~~~~~~~~lv 209 (387)
..+++++..|-.-.+|.... +++.+++. .. ........+|..+++.+.. -.-+.+.+++|.+......+.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34555554555555666554 37778887 22 1223566789999998743 2234556667765443466899
Q ss_pred EeccCCCchhhhcCCC-----------------------------------CHHHHHHHHHH--------------HHHH
Q 016537 210 FEHVNNTDFKVLYPTL-----------------------------------SDYDVRYYIYE--------------LLKA 240 (387)
Q Consensus 210 ~e~~~~~~l~~~~~~~-----------------------------------~~~~~~~~~~q--------------i~~a 240 (387)
|+|++|.......... ...++..+..+ ...-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 9999984221111000 00011111111 1222
Q ss_pred HHHHHHc--------CceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 241 LDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 241 L~yLH~~--------~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
..+|+.+ .++|+|+++.|++++.++ .+-|.||+++..-++..
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGDP~~ 233 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLGDPLE 233 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccCCcHH
Confidence 4455543 489999999999999776 48899999998755443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.002 Score=62.37 Aligned_cols=135 Identities=19% Similarity=0.249 Sum_probs=80.6
Q ss_pred eeeeecCCeeEEEEEEeC----CCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 140 RKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~----~~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
..|-.|-.-.+|++.... .++.+++|+...... -...+|..+++.+..+---.++++.+.. . .|.+|+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--g----~v~efi 115 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--G----RVEEFI 115 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC--c----eEEEee
Confidence 455558888899986532 246889998764322 1126799999988655445566666522 1 578998
Q ss_pred CCCchhhh--c---------------CC--------CC-HHHHHHHHHH-----------------HHHHHHHHH-----
Q 016537 214 NNTDFKVL--Y---------------PT--------LS-DYDVRYYIYE-----------------LLKALDYCH----- 245 (387)
Q Consensus 214 ~~~~l~~~--~---------------~~--------~~-~~~~~~~~~q-----------------i~~aL~yLH----- 245 (387)
++.++... . .. .. ...+..+..+ +...+..|.
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77654211 0 00 11 1122222211 111122222
Q ss_pred ---HcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 246 ---SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 246 ---~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
...++|+|+++.|||++.++..+.|+||..|....
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 12589999999999998654579999999987543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00015 Score=68.08 Aligned_cols=131 Identities=18% Similarity=0.301 Sum_probs=93.6
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEec-------ccc------------------hHHHHHHHHHHHHhcCCC
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVK------------------KKKIKREIKILQNLCGGP 189 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~-------~~~------------------~~~~~~E~~il~~l~~hp 189 (387)
-+.+.+.||-|.=+.||.+.+ ..|+..++|+-+ ..+ +-...+|+..|+.|..|-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467889999999999999987 678888998632 110 112467999999885543
Q ss_pred -CeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceE
Q 016537 190 -NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (387)
Q Consensus 190 -niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~v 268 (387)
-+.+.+++. ..++|||++.+-.+.....-.... .+...++.-+.-|-.+|+||+|..-=||++++++ .+
T Consensus 172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~i 241 (465)
T KOG2268|consen 172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-KI 241 (465)
T ss_pred CCCCCccccc------ceeeHHHhhcccceeeeeecCChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCC-CE
Confidence 244555532 345999999988776554333333 3334455556678899999999999999999665 79
Q ss_pred EEEecccc
Q 016537 269 RLIDWGLA 276 (387)
Q Consensus 269 kl~DFG~a 276 (387)
+++||--.
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999754
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0017 Score=62.54 Aligned_cols=140 Identities=15% Similarity=0.234 Sum_probs=80.1
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
..++ +.|..|-...+|+...... +..|++|+...... -.-.+|..+++.+..+---.++++++. . . +|
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~--G--~i 88 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG--N--G--MI 88 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC--C--c--Ee
Confidence 3444 4455577788998865332 23788998764322 123578889998855444456666652 1 1 68
Q ss_pred EeccCCCchhh--h-----c----------CC--------CC-HHHHHHHHHHH----------------------HHHH
Q 016537 210 FEHVNNTDFKV--L-----Y----------PT--------LS-DYDVRYYIYEL----------------------LKAL 241 (387)
Q Consensus 210 ~e~~~~~~l~~--~-----~----------~~--------~~-~~~~~~~~~qi----------------------~~aL 241 (387)
.+|+++..+.. + . .. .. ...+..+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 88887664421 0 0 00 11 11222222221 1111
Q ss_pred HHHHH----c----CceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 242 DYCHS----Q----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 242 ~yLH~----~----~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..+.. . -++|.|+.+.|||++.++..++++||..|....+
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~ 216 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYR 216 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCcc
Confidence 11111 1 2799999999999975544799999999865443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0021 Score=60.17 Aligned_cols=33 Identities=33% Similarity=0.626 Sum_probs=26.7
Q ss_pred CceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 248 ~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.++|+|+++.|||++.++...-|+||+.+..-.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 489999999999998545345799999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.31 E-value=3.8e-05 Score=83.97 Aligned_cols=152 Identities=11% Similarity=-0.026 Sum_probs=107.5
Q ss_pred HHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhc-CC------CCHHHHHHHHHHHHHHHHHHHHc--
Q 016537 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-PT------LSDYDVRYYIYELLKALDYCHSQ-- 247 (387)
Q Consensus 177 ~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~------~~~~~~~~~~~qi~~aL~yLH~~-- 247 (387)
.|...++.. .|+++.....-.........+.+++|+.+|.+...+ +. +.+.-+.....+.+.+..-+|..
T Consensus 1278 ~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344445555 788888777655544445556899999999876554 21 22233333333436666666654
Q ss_pred ---CceeeccCCCCeeEcCCCceEEEEecccceeecCC-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHH
Q 016537 248 ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323 (387)
Q Consensus 248 ---~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ell 323 (387)
-.+|++||+.|.+|+.+. .+|++++|+.+...+. ......++++.|+.|++... -.++.++|+|..|+-+|++.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHh
Confidence 278999999999998555 7999999999943332 22345577888999998654 56888899999999999999
Q ss_pred hcCCchhh
Q 016537 324 SVSPSVLF 331 (387)
Q Consensus 324 tg~~pf~~ 331 (387)
.|.++|.+
T Consensus 1435 ~~n~~fi~ 1442 (2724)
T KOG1826|consen 1435 DGNAYFIF 1442 (2724)
T ss_pred cccHHHHH
Confidence 99999855
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0044 Score=59.36 Aligned_cols=134 Identities=20% Similarity=0.261 Sum_probs=92.4
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHHHhcCC
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG 188 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------------------------~~~~~~E~~il~~l~~h 188 (387)
+-..|..|.=+.||.|.. .+|..+|||+++..- +-...+|++-|+++ +.
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NN 225 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-Hh
Confidence 446788899999999986 678889999975210 01246788889988 43
Q ss_pred CCeeEEEEEEEcCCCCCceEEEeccCCCchh-hhc--CCCCHHHHHHHHHHHHHHHHHHH-HcCceeeccCCCCeeEcCC
Q 016537 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLY--PTLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 189 pniv~l~~~~~~~~~~~~~lv~e~~~~~~l~-~~~--~~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDlKp~NILl~~~ 264 (387)
-.|.-.--+.. ...+|||+|+...... -.+ -.++...+..+-.|++.-+.-|- .+++||.||.-=|+|+- +
T Consensus 226 aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 226 AGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred cCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 33322111111 2245999999854421 111 13666678888788888887775 46899999999999997 5
Q ss_pred CceEEEEecccceee
Q 016537 265 QRKLRLIDWGLAEFY 279 (387)
Q Consensus 265 ~~~vkl~DFG~a~~~ 279 (387)
+ .+.|+|-+-+...
T Consensus 301 G-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 G-KLYIIDVSQSVEH 314 (520)
T ss_pred C-EEEEEEccccccC
Confidence 5 7999998877543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0013 Score=70.94 Aligned_cols=150 Identities=15% Similarity=0.196 Sum_probs=104.3
Q ss_pred HHHHHHHHHhcCCCCeeEEEEEEEcCCCCC--ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 016537 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKT--PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIM 250 (387)
Q Consensus 176 ~~E~~il~~l~~hpniv~l~~~~~~~~~~~--~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~iv 250 (387)
+.|+..+.++ .|+|++.++.|-....... ..+..++|...++...+ ..++....+.+..++.+||.|+|+....
T Consensus 230 E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 230 EIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 4566677777 9999999999876543222 12334677666655444 4577888899999999999999999777
Q ss_pred eeccCCC---CeeEcCCCceEEEE--ecccceeecCCCcccccccccCCCCchhhcccCCCCC--ccchhhHHHHHHHHH
Q 016537 251 HRDVKPH---NVMIDHEQRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDLWSLGCMFAGMV 323 (387)
Q Consensus 251 HrDlKp~---NILl~~~~~~vkl~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~sDvwSlGvil~ell 323 (387)
|.-|..+ +-..+.++ .+.+. ||+.++................+.++|.... ..+.. ..|+|.+|..+..+.
T Consensus 309 ~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhhh
Confidence 7666555 44444444 55666 8888877655544444455566778888654 33333 369999999999999
Q ss_pred hcCCc
Q 016537 324 SVSPS 328 (387)
Q Consensus 324 tg~~p 328 (387)
.|.++
T Consensus 387 ~~~~i 391 (1351)
T KOG1035|consen 387 QGEDI 391 (1351)
T ss_pred hcCcc
Confidence 88765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0021 Score=57.49 Aligned_cols=114 Identities=18% Similarity=0.271 Sum_probs=58.8
Q ss_pred CeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhh--hcC-----------
Q 016537 159 NEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV--LYP----------- 223 (387)
Q Consensus 159 ~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~--~~~----------- 223 (387)
++.|+|++.... ..-....|..+++.+..+-.-.++++++.+ .+|.+|+++..+.. +..
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~------g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l 75 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN------GRVEEFIEGRTLSPEDFRNPEILKRIAKLL 75 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT------EEEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC------CcEEEEecccccChhhccChHHHHHHHHHH
Confidence 467888888655 334556788888888665556677776532 16789997655321 100
Q ss_pred ----CCC----------HHHHHHH----------------------HHHHHHHHHHHHH--------cCceeeccCCCCe
Q 016537 224 ----TLS----------DYDVRYY----------------------IYELLKALDYCHS--------QGIMHRDVKPHNV 259 (387)
Q Consensus 224 ----~~~----------~~~~~~~----------------------~~qi~~aL~yLH~--------~~ivHrDlKp~NI 259 (387)
..+ ...+..+ ...+..-+..+.+ ..++|.||.+.||
T Consensus 76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni 155 (211)
T PF01633_consen 76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI 155 (211)
T ss_dssp HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence 000 0111111 1112222222222 2489999999999
Q ss_pred eEcCCCceEEEEeccccee
Q 016537 260 MIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 260 Ll~~~~~~vkl~DFG~a~~ 278 (387)
|++..+..++|+||..|..
T Consensus 156 l~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 156 LINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EETSSSSCEEE--GTT-EE
T ss_pred EeccCCCeEEEecHHHHhh
Confidence 9933444899999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0087 Score=57.77 Aligned_cols=72 Identities=17% Similarity=0.283 Sum_probs=47.4
Q ss_pred eeeecCCeeEEEEEEeCCCeEEEEEEec----------ccchHHHHHHHHHHHHhcCC-C-CeeEEEEEEEcCCCCCceE
Q 016537 141 KVGRGKYSEVFEGVHCTDNEKCIIKILK----------PVKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~~~~~~vavK~l~----------~~~~~~~~~E~~il~~l~~h-p-niv~l~~~~~~~~~~~~~l 208 (387)
+||.|....||++.+...++.++||.-. +....+...|.+.|+..... | .+++++.+- .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 5899999999999974334689999632 11235566788888776332 3 466666543 223458
Q ss_pred EEeccCCC
Q 016537 209 IFEHVNNT 216 (387)
Q Consensus 209 v~e~~~~~ 216 (387)
|||+++..
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.015 Score=55.85 Aligned_cols=128 Identities=25% Similarity=0.353 Sum_probs=78.2
Q ss_pred CCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCC-----eeEEEE----EEEcCCCCCceEEEeccCC
Q 016537 146 KYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN-----IVKLLD----IVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 146 ~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpn-----iv~l~~----~~~~~~~~~~~lv~e~~~~ 215 (387)
.-..||+... .+|. +++|+..+. ....+..|++.+..|..+.- +..+-| .+... .+.+-+++|++|
T Consensus 37 ~eN~~f~~~~-~~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~--~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQT-EDGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG--PRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEe-cCCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC--ceeEEEEEecCC
Confidence 4456888775 3344 499998875 66788889999998844311 222222 11111 356678899998
Q ss_pred Cchhh-hc------------------CCC----------CHHH--------------HHHHHHHHHHHHHHHHHc-----
Q 016537 216 TDFKV-LY------------------PTL----------SDYD--------------VRYYIYELLKALDYCHSQ----- 247 (387)
Q Consensus 216 ~~l~~-~~------------------~~~----------~~~~--------------~~~~~~qi~~aL~yLH~~----- 247 (387)
..+.. .. +.+ ..+. -.....++...+..+.+.
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 76652 10 111 1111 001233455555555542
Q ss_pred ---C--ceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 248 ---G--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 248 ---~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
+ +||+|+.|.|||++.+...+.++|||.+.
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 99999999999999665337899999885
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.02 Score=56.13 Aligned_cols=74 Identities=16% Similarity=0.188 Sum_probs=46.1
Q ss_pred EeeeeecCCeeEEEEEEeCCC-eE-----EEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 139 VRKVGRGKYSEVFEGVHCTDN-EK-----CIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~-~~-----vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++.|..|-...+|++...... .. |.++....... -.-.+|+++++.+..+-.-.++++.+.. .++.
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------g~l~ 128 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------FTIQ 128 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------EEEE
Confidence 345666888999998753321 22 44443221111 1235789999999666666777776632 3899
Q ss_pred eccCCCch
Q 016537 211 EHVNNTDF 218 (387)
Q Consensus 211 e~~~~~~l 218 (387)
||++|..+
T Consensus 129 efIeGr~l 136 (383)
T PTZ00384 129 EWVEGNTM 136 (383)
T ss_pred EEeccccC
Confidence 99998754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.019 Score=56.15 Aligned_cols=73 Identities=19% Similarity=0.230 Sum_probs=49.8
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEec---------ccchHHHHHHHHHHHHhcCC-C-CeeEEEEEEEcCCCCCce
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~---------~~~~~~~~~E~~il~~l~~h-p-niv~l~~~~~~~~~~~~~ 207 (387)
++.||.|.-..||++.+...++.++||.-. +-..++..-|.+.|+.+... | ++++++.+-. ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence 678999999999999984345678998632 12236677788888876332 3 4666766432 2345
Q ss_pred EEEeccCC
Q 016537 208 LIFEHVNN 215 (387)
Q Consensus 208 lv~e~~~~ 215 (387)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 89999865
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.026 Score=53.50 Aligned_cols=30 Identities=23% Similarity=0.586 Sum_probs=25.4
Q ss_pred cCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 247 ~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
.+++|+|+.+.||+++. + .+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECccccc
Confidence 47899999999999985 4 588999997754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.024 Score=53.90 Aligned_cols=31 Identities=16% Similarity=0.269 Sum_probs=26.8
Q ss_pred CceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 248 ~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++||+|+.+.|+|++.++ .+.++||..+..-
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhcccC
Confidence 699999999999998665 6899999988653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.091 Score=58.14 Aligned_cols=137 Identities=18% Similarity=0.278 Sum_probs=76.6
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-CC--eeEEEE--------EEEc-CCCCCc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PN--IVKLLD--------IVRD-QQSKTP 206 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~h-pn--iv~l~~--------~~~~-~~~~~~ 206 (387)
+.|+ |..-.+|+... .++..+++|+..+. .......|.+.|..|..+ +. +.+++- .+.+ ......
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4554 34567787764 56778999999754 334555677777766432 22 233332 1111 122245
Q ss_pred eEEEeccCCCchhhhc---------------------CCC---------CH-----------------HHHHHHHHHHHH
Q 016537 207 SLIFEHVNNTDFKVLY---------------------PTL---------SD-----------------YDVRYYIYELLK 239 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---------------------~~~---------~~-----------------~~~~~~~~qi~~ 239 (387)
+.+++|++|..+.... +.+ .+ ...+.++.++++
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 6789999987654310 000 00 111222333333
Q ss_pred HHHH-----HH--HcCceeeccCCCCeeEcCCC--ceEEEEeccccee
Q 016537 240 ALDY-----CH--SQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEF 278 (387)
Q Consensus 240 aL~y-----LH--~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a~~ 278 (387)
.+.- |. ..++||.|+.+.|||++.++ ...-|+|||.+..
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3221 11 14799999999999998653 2334999998853
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.034 Score=52.34 Aligned_cols=77 Identities=16% Similarity=0.201 Sum_probs=50.3
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhc--CCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~--~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
.+-.+.|+.|.-..+|+.. .+++.+.||+-.......+..|.+-|+.|. .--.+++++++....+. .+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEEEEee
Confidence 4456789999999999876 678899999887666678999999999882 33457788887765433 47999999
Q ss_pred CCC
Q 016537 214 NNT 216 (387)
Q Consensus 214 ~~~ 216 (387)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.019 Score=55.88 Aligned_cols=123 Identities=20% Similarity=0.193 Sum_probs=71.6
Q ss_pred eeeeecCCeeEEEEEEe---------------CCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEE-----
Q 016537 140 RKVGRGKYSEVFEGVHC---------------TDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR----- 199 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~---------------~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~----- 199 (387)
..||.|.-++||+|..+ ...+.+|+|+..+.-.+.+...+.||.-...-+|++.-..+..
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v 274 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV 274 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence 36899999999988532 2346799999887666665555555544322222222111100
Q ss_pred ---------------------------------------cCCCCCceEEEeccCCCchhhhcCC--CCHHHHHHHHHHHH
Q 016537 200 ---------------------------------------DQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELL 238 (387)
Q Consensus 200 ---------------------------------------~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~ 238 (387)
.+-.....++-+|..|..+..+.+. .++.-.++++.-..
T Consensus 275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~ 354 (565)
T KOG1236|consen 275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGV 354 (565)
T ss_pred HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHH
Confidence 0001122355567777666655543 44545555555455
Q ss_pred HHHHHH-HHcCceeeccCCCCeeEc
Q 016537 239 KALDYC-HSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 239 ~aL~yL-H~~~ivHrDlKp~NILl~ 262 (387)
.||--+ --.+++|.|+.|.||++.
T Consensus 355 ~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 355 NALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred HHHHHHHHhhcceecccCCCcEEEE
Confidence 554433 335899999999999994
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.13 Score=50.74 Aligned_cols=72 Identities=17% Similarity=0.211 Sum_probs=50.2
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCCCC
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~----------~~~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~~~~ 205 (387)
..+.||.|....||+..+ .+..++||.-.+ ....+...|.+.|+.+... .++.+++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 467899999999999876 345688987431 1334555667777766322 478889988753 2
Q ss_pred ceEEEeccCC
Q 016537 206 PSLIFEHVNN 215 (387)
Q Consensus 206 ~~lv~e~~~~ 215 (387)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 4589999976
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.15 Score=51.05 Aligned_cols=74 Identities=14% Similarity=0.130 Sum_probs=47.4
Q ss_pred EEeeeeecCCeeEEEEEEeCC--------CeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 138 VVRKVGRGKYSEVFEGVHCTD--------NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~--------~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
-++.|..|-.-.+|++..... ++.|.+++...... -.-.+|..+++.+..+---.++++.+. . .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----g--g 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----G--G 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----C--C
Confidence 456777788888998875321 46788988754322 123568888888754433445666552 1 2
Q ss_pred EEEeccCCCc
Q 016537 208 LIFEHVNNTD 217 (387)
Q Consensus 208 lv~e~~~~~~ 217 (387)
.|.||+++..
T Consensus 183 ~I~efi~g~~ 192 (442)
T PTZ00296 183 RIEEWLYGDP 192 (442)
T ss_pred EEEEeeCCcc
Confidence 6789998763
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.22 Score=54.95 Aligned_cols=76 Identities=9% Similarity=0.176 Sum_probs=43.0
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC---CCeeEEEE--------EEEcCCCCCce
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG---PNIVKLLD--------IVRDQQSKTPS 207 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~h---pniv~l~~--------~~~~~~~~~~~ 207 (387)
..|+.+. -.+|+... ++..+++|+.... ....+..|...+..|..+ -.+.+++- .....+..+.+
T Consensus 37 ~~L~s~~-d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~v 113 (972)
T PRK06149 37 TELGSQQ-DRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLRV 113 (972)
T ss_pred EecCCcC-cceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEEE
Confidence 4454333 35787654 2357888998743 345677788888877433 22333332 11112233456
Q ss_pred EEEeccCCCch
Q 016537 208 LIFEHVNNTDF 218 (387)
Q Consensus 208 lv~e~~~~~~l 218 (387)
.+++|++|..+
T Consensus 114 rL~~~l~G~~~ 124 (972)
T PRK06149 114 RLLDYLPGQPL 124 (972)
T ss_pred EEEEecCCccc
Confidence 78899988543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.075 Score=47.70 Aligned_cols=87 Identities=22% Similarity=0.318 Sum_probs=60.3
Q ss_pred hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHc--Cc
Q 016537 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ--GI 249 (387)
Q Consensus 172 ~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~i 249 (387)
..-+.++.+++.++ -.|+++.. + +.....++.|+|..-.. .-..++..=+.+|.-+|+. +.
T Consensus 102 ~~~y~nky~v~Arm---hGilrL~N---D-n~~~yGvIlE~Cy~~~i----------~~~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 102 DALYFNKYRVFARM---HGILRLKN---D-NNYKYGVILERCYKIKI----------NFSNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhhhHHHHh---hheeEeec---C-CCceeEEEEeeccCccc----------chhHHHHHhHHHHHHhhccCCCe
Confidence 35577889999987 36888772 2 34445688899874321 1112222225678888943 69
Q ss_pred eeeccCCCCeeEcCCCceEEEEecccc
Q 016537 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 250 vHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
+|+|-.|+||+-|..+ .+||.|=+..
T Consensus 165 lHGD~np~NiM~D~~G-~lKlVDP~~L 190 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFG-YLKLVDPVCL 190 (308)
T ss_pred ecCCCChhheeecCCC-CEEecChhhh
Confidence 9999999999999777 7999997653
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.25 Score=47.39 Aligned_cols=68 Identities=15% Similarity=0.189 Sum_probs=40.5
Q ss_pred CeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCC-CCeeEEE---E--EEEcCCCCCceEEEeccCCCc
Q 016537 147 YSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-PNIVKLL---D--IVRDQQSKTPSLIFEHVNNTD 217 (387)
Q Consensus 147 ~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~h-pniv~l~---~--~~~~~~~~~~~lv~e~~~~~~ 217 (387)
-..||+... .++..+++|+..+. ....+..|.+.+..|..+ -.++... | +... ....+.++++++|..
T Consensus 38 eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~--~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 38 ENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEH--QGFRFALFPRRGGRA 113 (325)
T ss_pred cceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEE--CCEEEEEEeeeCCCC
Confidence 356888764 45678999988643 356677888888887432 1122211 1 1111 234567888887753
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.011 Score=47.85 Aligned_cols=45 Identities=20% Similarity=0.426 Sum_probs=40.2
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHh
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL 185 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l 185 (387)
+.||.|+.|+||+|+. .+|+.||||+.++.-.+.+...+.+++.+
T Consensus 17 ~PlasASiaQVh~a~l-~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 17 EPLASASIAQVHRARL-KDGEEVAVKVQRPGIEEQIEADLRILRRL 61 (119)
T ss_pred chhhheehhhheeeee-cccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence 5699999999999998 45999999999998888898888888876
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 387 | ||||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-108 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-108 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-108 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-107 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-107 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-107 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-107 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-107 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-106 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-106 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-93 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-93 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-93 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-93 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-93 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-93 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-93 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-93 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-93 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-93 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-93 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-93 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-93 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-93 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-92 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-88 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-88 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-20 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-04 |
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-144
Identities = 174/222 (78%), Positives = 200/222 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 5 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 64
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 65 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-45
Identities = 72/258 (27%), Positives = 122/258 (47%), Gaps = 16/258 (6%)
Query: 85 PPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGR 144
P T + K V++ A +V D + + ++ Y + +G
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 145 GKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203
G + V++ C E IK +L+ K+ RE++I++ L NIV+L
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGE 121
Query: 204 KTPS----LIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
K L+ ++V T ++V TL V+ Y+Y+L ++L Y HS GI HRD
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+ DY S+D+W
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVW 241
Query: 314 SLGCMFAGMVSVSPSVLF 331
S GC+ A ++ P +F
Sbjct: 242 SAGCVLAELLLGQP--IF 257
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
+ Y + +G G + VF+ +E I K+L+ K+ RE++I++ + P
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHP 92
Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELLK 239
N+V L K L+ E+V T ++ Y T+ ++ Y+Y+LL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
+L Y HS GI HRD+KP N+++D L+LID+G A+ G+ + SRY++ PEL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ +Y ++D+WS GC+ A ++ P LF
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQP--LF 242
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 31/215 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
+ YE + K+G G Y VF+ + + IK K REI+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYEL 237
+L+ L PN+V LL++ R ++ L+FE+ ++T L Y + ++ V+ ++
Sbjct: 55 MLKQLKH-PNLVNLLEVFRRKRRLH--LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 296
L+A+++CH +HRDVKP N++I ++L D+G A P Y+ VA+R+++
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
PELLV Y +D+W++GC+FA ++S P L+
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVP--LW 203
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 5e-43
Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 15/211 (7%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQN 184
+ + YE + VG G Y V + + IK K +K REIK+L+
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKAL 241
L N+V LL++ + ++ L+FE V++T L +P L V+ Y+++++ +
Sbjct: 81 LRH-ENLVNLLEVCKKKKRWY--LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 300
+CHS I+HRD+KP N+++ ++L D+G A PG+ Y+ VA+R+++ PELL
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 301 VDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
V Y ++D+W++GC+ M P LF
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEP--LF 225
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-41
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGP 189
E D ++V R G+G + V G + IK I P + + + ++ L L P
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHP 79
Query: 190 NIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELL 238
NIV+L + ++ E+V +T + Y ++ ++++L+
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 239 KALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+++ H S + HRD+KPHNV+++ L+L D+G A+ P + + SRY++
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
PEL+ Q Y ++D+WS+GC+FA M+ P +F
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEP--IF 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 46/238 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
Y + + +G G + V E ++ +K + + K RE+ I++ L NI+KL+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66
Query: 196 DIVRDQQSKTPS------------------------------------LIFEHVNNTDFK 219
D + P +I E+V +T K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 220 VLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
VL ++ + YIY+L +A+ + HS GI HRD+KP N++++ + L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
G A+ P + + SR+++ PEL++ +Y S+DLWS+GC+F ++ P LF
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP--LF 242
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 59/219 (26%), Positives = 112/219 (51%), Gaps = 35/219 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
D Y + K+G G Y EV++ + NE V K+I+ RE+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIREVS 85
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYEL 237
+L+ L NI++L ++ LIFE+ D K P +S ++ ++Y+L
Sbjct: 86 LLKELQH-RNIIELKSVIHHNHRLH--LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYH-PGKEYNVRVASR 292
+ +++CHS+ +HRD+KP N+++ L++ D+GLA + P +++ + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+++ PE+L+ + Y S+D+WS+ C++A M+ +P LF
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP--LF 238
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 34/216 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
+ Y + K+G G Y V++ + + KKI+ REI
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG---------ETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
IL+ L NIVKL D++ ++ L+FEH++ D K L L + ++ +
Sbjct: 53 ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
LL + YCH + ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
P++L+ + Y ++D+WS+GC+FA MV+ +P LF
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP--LF 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-40
Identities = 65/215 (30%), Positives = 116/215 (53%), Gaps = 32/215 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
+ Y + K+G G Y+ V++G + V K+I+ RE+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYEL 237
L++L NIV L DI+ ++S T L+FE+++ D K ++ ++V+ ++++L
Sbjct: 54 LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH Q ++HRD+KP N++I+ L+L D+GLA P K Y+ V + +++
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
P++L+ DY +D+W +GC+F M + P LF
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRP--LF 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-40
Identities = 68/219 (31%), Positives = 117/219 (53%), Gaps = 34/219 (15%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------R 177
G + Y+ + KVG G Y V++ + V K+I+ R
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQG---------RIVALKRIRLDAEDEGIPSTAIR 68
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYY 233
EI +L+ L PNIV L+D++ ++ T L+FE + D K + L D ++ Y
Sbjct: 69 EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFME-KDLKKVLDENKTGLQDSQIKIY 124
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
+Y+LL+ + +CH I+HRD+KP N++I+ + L+L D+GLA + P + Y V +
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+++ P++L+ + Y S+D+WS+GC+FA M++ P LF
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP--LF 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-39
Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 31/209 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE + K+G G Y VF+ + +E V K+++ REI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
+L+ L NIV+L D++ + T L+FE + D K L V+ ++++
Sbjct: 54 LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
LLK L +CHS+ ++HRD+KP N++I+ L+L ++GLA + P + Y+ V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
P++L + Y S+D+WS GC+FA + +
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 41/225 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----------------R 177
YE V ++G G Y V++ V K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60
Query: 178 EIKILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSD 227
E+ +L+ L PN+V+L+D+ ++ L+FEHV+ D + P L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPA 119
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
++ + + L+ LD+ H+ I+HRD+KP N+++ ++L D+GLA Y
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQMALTP 178
Query: 288 RVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMVSVSPSVLF 331
V + +++ PE+L LQ Y +D+WS+GC+FA M P LF
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKP--LF 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-39
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 37/222 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE V ++G G Y +VF+ + + V K+++ RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63
Query: 181 ILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSDYDV 230
+L++L PN+V+L D+ ++ + L+FEHV+ D P + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETI 122
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
+ +++LL+ LD+ HS ++HRD+KP N+++ + ++L D+GLA Y V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVV 181
Query: 291 SRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ +++ PE+L LQ Y +DLWS+GC+FA M P LF
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKP--LF 219
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 37/220 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
++ + K+G G Y+ V++G++ T V K++K REI +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---------YPTLSDYDVRY 232
++ L NIV+L D++ + T L+FE ++ D K L V+Y
Sbjct: 57 MKELKH-ENIVRLYDVIHTENKLT--LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVAS 291
+ ++LL+ L +CH I+HRD+KP N++I+ + L+L D+GLA + P ++ V +
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+++ P++L+ + Y S+D+WS GC+ A M++ P LF
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP--LF 209
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 15/196 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y+ V+K+G G Y EV + + IKI + K+ E+ +L+ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNI+KL D D+++ L+ E D + ++ D I ++L + Y
Sbjct: 95 HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+KP N++++ + ++++D+GL+ + K+ R+ + Y+ PE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210
Query: 303 LQDYDYSLDLWSLGCM 318
+ YD D+WS+G +
Sbjct: 211 RKKYDEKCDVWSIGVI 226
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-39
Identities = 47/199 (23%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
D + RK+G G + +V + + +IK + V ++I+ EI++L++L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYELLKAL 241
PNI+K+ ++ D + ++ E + LS+ V + +++ AL
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y HSQ ++H+D+KP N++ +++ID+GLAE + + + + PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 300 LVDLQDYDYSLDLWSLGCM 318
+D + D+WS G +
Sbjct: 198 F--KRDVTFKCDIWSAGVV 214
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 64/211 (30%), Positives = 113/211 (53%), Gaps = 20/211 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL 185
YE + +G G+++ V++ N+ IK +K + + K REIK+LQ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKAL 241
PNI+ LLD + + + L+F+ + TD +V+ L+ ++ Y+ L+ L
Sbjct: 70 SH-PNIIGLLDAFGHKSNIS--LVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 300
+Y H I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++ PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184
Query: 301 VDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ Y +D+W++GC+ A ++ P
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRVP--FL 213
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
D Y+ R +G+G + EV ++C +K++ K+ + RE+++L+ L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
PNI+KL + D+ L+ E D + S+ D I ++L + Y
Sbjct: 84 DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 244 CHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
H I+HRD+KP N++++ + +R+ID+GL+ + K+ ++ + Y+ PE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200
Query: 302 DLQDYDYSLDLWSLGCM 318
YD D+WS G +
Sbjct: 201 -HGTYDEKCDVWSTGVI 216
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKAL 241
PNI+KL +I+ D S ++ E + L+ S++D I ++ +
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 300 LVDLQDYDYSLDLWSLGCM 318
L YD D+WS G +
Sbjct: 195 L--RGTYDEKCDVWSAGVI 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 45/206 (21%), Positives = 88/206 (42%), Gaps = 21/206 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
+ + +G+G + VF G H + IK+ + + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 244 CHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
GI+HR++KP N+M + Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 301 -------VDLQDYDYSLDLWSLGCMF 319
+ Y ++DLWS+G F
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 63/231 (27%), Positives = 120/231 (51%), Gaps = 19/231 (8%)
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPV 170
++++R + ++ + W Y VG G Y V + EK IK + +P
Sbjct: 2 LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 171 KK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVL 221
+ K+ RE+ +L+++ N++ LLD+ S L+ + TD K++
Sbjct: 62 QSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM 119
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
S+ ++Y +Y++LK L Y HS G++HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADA 178
Query: 282 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
Y V +R+++ PE+++ Y+ ++D+WS+GC+ A M++ LF
Sbjct: 179 EMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT--LF 224
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-38
Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 39/222 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE + K+G+G + EVF+ H +K V KK+ REIK
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPS------LIFEHVNNTDFKVL----YPTLSDYDV 230
ILQ L N+V L++I R + S L+F+ D L + ++
Sbjct: 69 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEI 126
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-----PGKEY 285
+ + LL L Y H I+HRD+K NV+I + L+L D+GLA + Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
RV + +++ PELL+ +DY +DLW GC+ A M + SP
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
DDY++ ++V G G +V E H +KC +K+L K ++E+ GGP+I
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 192 VKLLDIVRDQQSKTPS--LIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKALDYC 244
V +LD+ + +I E + + + ++ + + ++ A+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
HS I HRDVKP N++ +++ L+L D+G A+ + Y+ PE+L
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202
Query: 303 LQDYDYSLDLWSLG 316
+ YD S D+WSLG
Sbjct: 203 PEKYDKSCDMWSLG 216
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-38
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 192
Y ++ +G G VF V +++ IK + P K REIKI++ L NIV
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLK 239
K+ +I+ S+ + ++ L + R ++Y+LL+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 295
L Y HS ++HRD+KP N+ I+ E L++ D+GLA P + + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
P LL+ +Y ++D+W+ GC+FA M++ LF
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT--LF 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-38
Identities = 53/245 (21%), Positives = 101/245 (41%), Gaps = 28/245 (11%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRKV-GRGKY 147
A P + ++ L ++ DDY+V +V G G
Sbjct: 16 APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75
Query: 148 SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207
+V + + EK +K+L+ K +RE+++ P+IV+++D+ + +
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 208 --LIFEHVN------------NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
++ E ++ + F ++ + + + +A+ Y HS I HRD
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 254 VKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 311
VKP N++ ++ L+L D+G A+ + Y+ PE+L + YD S D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCD 245
Query: 312 LWSLG 316
+WSLG
Sbjct: 246 MWSLG 250
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 44/196 (22%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPN 190
+ Y + +GRG++ V V + + + K + K + +K+EI IL N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62
Query: 191 IVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
I+ L + + +I FE +N + F+ L++ ++ Y++++ +AL
Sbjct: 63 ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115
Query: 242 DYCHSQGIMHRDVKPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
+ HS I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 301 VDLQDYDYSLDLWSLG 316
+ D+WSLG
Sbjct: 176 -QHDVVSTATDMWSLG 190
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
+ + +G+G + VF G H + IK+ + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 244 CHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
GI+HR++KP N+M Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 301 -------VDLQDYDYSLDLWSLGCMF 319
+ Y ++DLWS+G F
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----------------PVKKKKIKR 177
+ Y VRK+G G Y EV + + IK++K ++I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FK--VLYPTLSDYDVRYYI 234
EI +L++L PNI+KL D+ D++ L+ E + F+ + + D +
Sbjct: 96 EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++L + Y H I+HRD+KP N++++ + ++++D+GL+ F+ + R+ +
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCM 318
Y+ PE+L + Y+ D+WS G +
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVI 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 13/194 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
Y + +GRG + EV V + K + + K+EI+I+++L P
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
NI++L + D L+ E + V + D + ++L A+ YCH
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 247 QGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+ HRD+KP N + L+LID+GLA + PGK +V + Y+ P++L
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 305 DYDYSLDLWSLGCM 318
Y D WS G M
Sbjct: 183 LYGPECDEWSAGVM 196
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-37
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 22/197 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGP 189
D Y+++ ++G G + V V I P+ K +K EI I+ L P
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108
Query: 190 NIVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
++ L D D+ LI F+ + D+K +S+ +V Y+ + +
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161
Query: 241 LDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
L + H I+H D+KP N+M + +++ID+GLA +P + V A+ F PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 300 LVDLQDYDYSLDLWSLG 316
+ D + + D+W++G
Sbjct: 222 V-DREPVGFYTDMWAIG 237
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-37
Identities = 50/199 (25%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
+ N++ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E++ + + D+WS+G
Sbjct: 188 EIV-NYEPLGLEADMWSIG 205
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 26/210 (12%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
I++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 88 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 303
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D+
Sbjct: 146 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 304 ----------QDYDYSLDLWSLGCMFAGMV 323
D+WSLGC+ M
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMT 233
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 27/251 (10%)
Query: 84 TPPDTLAQKIGKSVRRSGAPSKAR----VYSDINVVRPREYWDYESLTVQWGE-QDDYEV 138
P D ++ G V G + + D V + + + + ++ D Y++
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
++G G + V + K+ +++EI+ + L P +V L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLH 220
Query: 196 DIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
D D +I FE V + K +S+ + Y+ ++ K L + H
Sbjct: 221 DAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE 273
Query: 247 QGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+H D+KP N+M +L+LID+GL P + V + F PE+ + +
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKP 332
Query: 306 YDYSLDLWSLG 316
Y D+WS+G
Sbjct: 333 VGYYTDMWSVG 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 56/271 (20%), Positives = 101/271 (37%), Gaps = 31/271 (11%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
H H P + ++ + + +D + E ++V+
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS--ANECISVKGR-- 56
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG- 187
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 57 -IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCH 245
I++L D Q ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 115 SDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD 302
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 173 QHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 303 ----------LQDYDYSLDLWSLGCMFAGMV 323
D+WSLGC+ M
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
I++L D Q ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 69 DKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 302
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 127 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 303 ---------LQDYDYSLDLWSLGCMFAGMV 323
D+WSLGC+ M
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMT 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 25/215 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
D++ + +G G + +VF+ H D + +IK +K +K +RE+K L L NIV
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------------------PTLSDYDVRY 232
+ + K L+ L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++ K +DY HS+ +++RD+KP N+ + + ++++ D+GL + +
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ PE + QDY +DL++LG + A ++ V
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCD 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 27/237 (11%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
E + + Q Y V R + G Y V GV ++ IK + V
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62
Query: 173 -----------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF 218
K++ REI++L + PNI+ L DI + L+ E + TD
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDL 120
Query: 219 -KVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
+V++ +S ++Y++Y +L L H G++HRD+ P N+++ + + + D+
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFN 179
Query: 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
LA V R+++ PEL++ + + +D+WS GC+ A M + LF
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA--LF 234
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 61/221 (27%), Positives = 116/221 (52%), Gaps = 20/221 (9%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKR 177
E W + Y ++ VG G Y V V K IK + +P + K+ R
Sbjct: 14 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSDYDVR 231
E+++L+++ N++ LLD+ ++ L+ + TD K++ L + ++
Sbjct: 74 ELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQ 131
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVA 290
+ +Y++LK L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA Y V
Sbjct: 132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VV 187
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+R+++ PE++++ Y ++D+WS+GC+ A M++ LF
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT--LF 226
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 62/227 (27%), Positives = 114/227 (50%), Gaps = 33/227 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
YE+V+K+G+G Y V++ + E +K I + ++ REI IL L G
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDYCHS 246
NIV LL+++R + L+F+++ TD V+ L +Y +Y+L+K + Y HS
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------------------ 288
G++HRD+KP N++++ + +++ D+GL+ + +
Sbjct: 128 GGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 289 ----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
VA+R+++ PE+L+ Y +D+WSLGC+ ++ P +F
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP--IF 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 41/197 (20%), Positives = 89/197 (45%), Gaps = 16/197 (8%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLC 186
+ Y + K GRGK++ V + + + ++ K + +I EI +L+
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F----KVLYPTLSDYDVRYYIYELLKAL 241
P ++ L ++ + LI E+ + F L +S+ DV I ++L+ +
Sbjct: 87 SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y H I+H D+KP N+++ + ++++D+G++ E + + + PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 300 LVDLQDYDYSLDLWSLG 316
L + + D+W++G
Sbjct: 205 L-NYDPITTATDMWNIG 220
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 18/227 (7%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
P A + + R E+ S D+Y+V ++G+G +S V VH T +
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFS----DNYDVKEELGKGAFSVVRRCVHKTTGLE 56
Query: 162 CIIKI-----LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216
KI L +K++RE +I + L PNIV+L D ++++ L+F+ V
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH--YLVFDLVTGG 113
Query: 217 ---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLI 271
+ V S+ D + I ++L+++ YCHS GI+HR++KP N+++ + ++L
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
D+GLA + + ++ + + PE+L Y +D+W+ G +
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVI 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 67/278 (24%), Positives = 124/278 (44%), Gaps = 42/278 (15%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSE 149
AQ+ + + + S+ + W D YE+ +G G Y
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 150 VFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204
V E + IK IL+ + K+I REI IL L ++VK+LDIV + +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVE 127
Query: 205 TPS---LIFEHVNNTDF-KVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258
++ E + +DF K+ L++ ++ +Y LL + Y HS GI+HRD+KP N
Sbjct: 128 KFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----------------------------VA 290
+++ + +++ D+GLA + N + V
Sbjct: 187 CLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPS 328
+R+++ PEL++ ++Y ++D+WS+GC+FA ++++
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNI+KL +I+ D S ++ E D + S++D I ++ + Y
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195
Query: 303 LQDYDYSLDLWSLGCM 318
YD D+WS G +
Sbjct: 196 RGTYDEKCDVWSAGVI 211
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 25/224 (11%)
Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQ 183
+ + D+++ +G G Y V H E IK ++P K + REIKIL+
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP-TLSDYDVRYYIYELL 238
+ NI+ + +I R + + +I E + TD +V+ LSD ++Y+IY+ L
Sbjct: 65 HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------- 288
+A+ H ++HRD+KP N++I+ L++ D+GLA N
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 289 -VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
VA+R+++ PE+++ Y ++D+WS GC+ A + P +F
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP--IF 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-36
Identities = 53/226 (23%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
R ++ E + Y+ ++ +G G V IK + +P +
Sbjct: 7 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66
Query: 173 --KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYPTL 225
K+ RE+ +++ + NI+ LL++ Q+S ++ E ++ + +V+ L
Sbjct: 67 HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMEL 124
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+ Y +Y++L + + HS GI+HRD+KP N+++ L+++D+GLA
Sbjct: 125 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMM 183
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
V +RY++ PE+++ Y ++D+WS+GC+ M+ LF
Sbjct: 184 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGV--LF 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------------PVKKKKIKREIK 180
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYEL 237
IL+ + G PNI++L D L+F+ + D+ TLS+ + R + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 298 ELL-----VDLQDYDYSLDLWSLGCM 318
E++ + Y +D+WS G +
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 24/251 (9%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
H H + + L + SV S AP A + D + + + ++L+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWI----DGSNRDALS------ 52
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIV 192
D +EV ++GRG S V+ + +K + K V KK ++ EI +L L PNI+
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNII 111
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
KL +I SL+ E V T D V S+ D + ++L+A+ Y H
Sbjct: 112 KLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 248 GIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
GI+HRD+KP N++ L++ D+GL++ + + PE+L
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CA 226
Query: 306 YDYSLDLWSLG 316
Y +D+WS+G
Sbjct: 227 YGPEVDMWSVG 237
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 59/225 (26%), Positives = 115/225 (51%), Gaps = 20/225 (8%)
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKK 173
++ E W + Y+ + VG G Y V + +K L + K
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSD 227
+ RE+++L+++ N++ LLD+ +S L+ + D ++ L+D
Sbjct: 74 RTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTD 131
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286
V++ IY++L+ L Y HS I+HRD+KP N+ ++ E +L+++D+GLA Y
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY- 189
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
VA+R+++ PE++++ Y+ ++D+WS+GC+ A +++ LF
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT--LF 230
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
D+E + +G+G + +V + + D+ IK ++ K I E+ +L +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y---PTLSDY-----------DVRYYIY 235
+V+ ++++ + +T F + Y TL D +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+ H + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 296 G---------------PELLVDLQDYDYSLDLWSLGCMF 319
E+L Y+ +D++SLG +F
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
+E+ ++G G + V +H E K + L P +++ EI+I++ L P
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLK 239
N+V ++ Q P+ L E+ D K L L + +R + ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 240 ALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
AL Y H I+HRD+KP N+++ ++ ++ID G A+ G+ V + + P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 298 ELLVDLQDYDYSLDLWSLGCMF 319
ELL + + Y ++D WS G +
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLA 213
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
Y+V +G G + V+ G+ +DN IK + + ++ E+ +L+
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 185 LC-GGPNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYIYE 236
+ G +++LLD + P LI E DF L + R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+L+A+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216
Query: 297 PELLVDLQDYD-YSLDLWSLG 316
PE + Y S +WSLG
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLG 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 55/255 (21%), Positives = 92/255 (36%), Gaps = 21/255 (8%)
Query: 71 HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQW 130
H H H L T + RV + Y+ +
Sbjct: 2 HHHHHHSSGVDLGTE--------NLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPES 53
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNL 185
Q ++ + ++G G Y EVF+ D +K P + + E+ + +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALD 242
P V+L ++ L E + + +L + V Y+ + L AL
Sbjct: 114 GQHPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
+ HSQG++H DVKP N+ + R +L D+GL V+ + PELL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 303 LQDYDYSLDLWSLGC 317
Y + D++SLG
Sbjct: 231 --SYGTAADVFSLGL 243
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
+ PNI+ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E++ + + D+WS+G
Sbjct: 188 EIV-NYEPLGLEADMWSIG 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 57/242 (23%), Positives = 111/242 (45%), Gaps = 41/242 (16%)
Query: 121 WDYESLTVQWGE--QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK- 176
+D++ E +D +E KVGRG Y V++ + + K+I+
Sbjct: 5 YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEG 58
Query: 177 --------REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL------- 221
REI +L+ L PN++ L + + L+F++ D +
Sbjct: 59 TGISMSACREIALLRELKH-PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRAS 116
Query: 222 -----YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK---LRLIDW 273
L V+ +Y++L + Y H+ ++HRD+KP N+++ E + +++ D
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 274 GLA-EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329
G A F P K + V + +++ PELL+ + Y ++D+W++GC+FA +++ P
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP-- 234
Query: 330 LF 331
+F
Sbjct: 235 IF 236
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
+D YE+ +G+G +S V ++ ++ +KI+ + + +KRE I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYEL 237
L P+IV+LL+ ++FE ++ S+ +Y+ ++
Sbjct: 83 L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 238 LKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
L+AL YCH I+HRDVKPH V++ ++L +G+A + G RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 295 KGPELLVDLQDYDYSLDLWSLGCM 318
PE++ + Y +D+W G +
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVI 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 61/215 (28%), Positives = 113/215 (52%), Gaps = 18/215 (8%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNL 185
+ Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKA 240
NI+ + DI+R + ++ + + TD K+L LS+ + Y++Y++L+
Sbjct: 83 -RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
L Y HS ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
PE++++ + Y S+D+WS+GC+ A M+S P +F
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRP--IF 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-35
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 18/196 (9%)
Query: 133 QDDYEV---VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
Y++ + +G G +S + VH N+ +KI+ + ++EI L+ G P
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALDY 243
NIVKL ++ DQ L+ E +N + F K + S+ + Y + +L+ A+ +
Sbjct: 67 NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121
Query: 244 CHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 300
H G++HRD+KP N++ E ++++ID+G A P + + ++ PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 301 VDLQDYDYSLDLWSLG 316
+ YD S DLWSLG
Sbjct: 182 -NQNGYDESCDLWSLG 196
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 14/194 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
D+Y+V ++G+G +S V VH T + KI L +K++RE +I + L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNIV+L D ++++ L+F+ V + V S+ D + I ++L+++ YC
Sbjct: 65 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
HS GI+HR++KP N+++ + ++L D+GLA + + ++ + + PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180
Query: 303 LQDYDYSLDLWSLG 316
Y +D+W+ G
Sbjct: 181 KDPYSKPVDIWACG 194
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 48/201 (23%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
D Y+ ++G G+++ V + + + K +K V ++ I+RE+ IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L
Sbjct: 70 EI-QHPNVITLHEVYENKTDVI--LILELV--AGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+ Y HS I H D+KP N+M+ + + ++++ID+GLA G E+ + F
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE++ + + D+WS+G
Sbjct: 185 APEIV-NYEPLGLEADMWSIG 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D YE+ ++G G+++ V + ++ K +K V +++I+RE+ IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
+ PNI+ L DI ++ LI E V + DF +L++ + ++ ++L
Sbjct: 64 EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+ Y HS+ I H D+KP N+M+ + +++LID+G+A G E+ + F
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE++ + + D+WS+G
Sbjct: 179 APEIV-NYEPLGLEADMWSIG 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 55/275 (20%), Positives = 109/275 (39%), Gaps = 22/275 (8%)
Query: 61 RGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREY 120
R L + + +R + D + + ++ + ++
Sbjct: 21 RARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPE 80
Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------- 173
+ Y+ +GRG S V VH + +KI++ ++
Sbjct: 81 DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE 140
Query: 174 ----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLS 226
+RE IL+ + G P+I+ L+D L+F+ + D+ LS
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALS 198
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ + R + LL+A+ + H+ I+HRD+KP N+++D + ++RL D+G + PG++
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLR 257
Query: 287 VRVASRYFKGPELL-----VDLQDYDYSLDLWSLG 316
+ + PE+L Y +DLW+ G
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 50/243 (20%), Positives = 108/243 (44%), Gaps = 25/243 (10%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRK--VGRGK 146
R SK +++ P +D+ +T + G Y V + +G G+
Sbjct: 42 VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101
Query: 147 YSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203
+ +V + K IIK K+++K EI ++ L N+++L D +
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160
Query: 204 KTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
L+ F+ + + + L++ D ++ ++ + + + H I+H D+
Sbjct: 161 IV--LVMEYVDGGELFDRIIDESYN-----LTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 255 KPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
KP N++ ++ + +++++ID+GLA Y P ++ V + F PE++ + + D+W
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMW 272
Query: 314 SLG 316
S+G
Sbjct: 273 SVG 275
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 54/227 (23%), Positives = 108/227 (47%), Gaps = 20/227 (8%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK--- 172
+++ E + Y+ ++ +G G V + IK + +P +
Sbjct: 45 DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104
Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLSD 227
K+ RE+ +++ + NI+ LL++ Q++ L+ E ++ +V+ L
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E 284
+ Y +Y++L + + HS GI+HRD+KP N+++ L+++D+GLA
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTP 222
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
Y V +RY++ PE+++ Y ++D+WS+GC+ MV LF
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKI--LF 263
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKI 181
+D+Y + + +G G EV +K IKI+ K ++ EI+I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 69 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 297 PELLVDLQD--YDYSLDLWSLGCM 318
PE+LV + Y+ ++D WSLG +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 45/207 (21%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 132 EQDDYEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
+ + +G G V+ G+ DN +K + P RE+++L+ PN
Sbjct: 22 GKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPN 79
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
+++ +D+Q + + E T + + + + + L + HS
Sbjct: 80 VIRYFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 248 GIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 299
I+HRD+KPHN++I + K + D+GL + G+ R + + PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 300 LVDL--QDYDYSLDLWSLGCMFAGMVS 324
L + ++ Y++D++S GC+F ++S
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKREIKI 181
+D+Y + + +G G EV +K I+I+ + ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELL 238
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 297 PELLVDLQD--YDYSLDLWSLGCM 318
PE+LV + Y+ ++D WSLG +
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
+Y + +G+G + VF G TD + IK++ E+ +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 185 LCGG---PNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYI 234
+ G P +++LLD +T L+ E D+ L + R +
Sbjct: 91 VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
+++ A+ +CHS+G++HRD+K N++ID + +LID+G H Y +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204
Query: 295 KGPELLVDLQDYD-YSLDLWSLG 316
PE + Y +WSLG
Sbjct: 205 SPPEWISR-HQYHALPATVWSLG 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 48/242 (19%), Positives = 90/242 (37%), Gaps = 57/242 (23%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
Q Y + +G+G Y V + IKI+ P ++IK E+++++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 185 LCGGPNIVKLLDIVRDQQS----------------------------------------- 203
L PNI +L ++ D+Q
Sbjct: 85 LHH-PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263
+ + + L + + + ++ AL Y H+QGI HRD+KP N +
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 264 -EQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG 316
+ +++L+D+GL++ ++ + + YF PE+L + Y D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 317 CM 318
+
Sbjct: 264 VL 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 47/224 (20%), Positives = 92/224 (41%), Gaps = 46/224 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
D+E ++ +GRG + VFE + D+ IK ++ + ++K+ RE+K L L P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------PTLSDY------------- 228
IV+ + ++ + + ++ LY L D+
Sbjct: 64 GIVRYFNAWLEKNTTE-----KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHP 281
+ ++ +A+++ HS+G+MHRD+KP N+ + +++ D+GL E
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTV 177
Query: 282 GKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMF 319
G PE + Y + +D++SLG +
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLIL 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 65/275 (23%), Positives = 122/275 (44%), Gaps = 47/275 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
D+Y + +GRG Y V+ + IK + + + K+I REI IL L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84
Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP--TLSDYDVRYYIYELLKALD 242
I++L D++ ++ E + +D K+ L++ ++ +Y LL +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-------------- 288
+ H GI+HRD+KP N +++ + +++ D+GLA + K+ N+
Sbjct: 144 FIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 289 ---------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGL--- 336
V +R+++ PEL++ ++Y S+D+WS GC+FA ++++ S + +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 337 --GHSCLNTWFLRTCSIPFFP-----LNLLIPICG 364
G SC R LN++ I G
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIG 297
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ + + +G G +SEVF + +K + + ++ EI +L+ +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYC 244
NIV L DI L+ + V + D + ++ D I ++L A+ Y
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H GI+HRD+KP N++ E K+ + D+GL++ G + + + PE+L
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 303 LQDYDYSLDLWSLGCM 318
+ Y ++D WS+G +
Sbjct: 182 -KPYSKAVDCWSIGVI 196
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
+DYEV+ +G G Y + +D + + K + +K+ + E+ +L+ L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
PNIV+ D + D+ + T ++ E+ D L + V + +L AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 296 GPELLVDLQDYDYSLDLWSLGC 317
PE + Y+ D+WSLGC
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGC 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-33
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 48/200 (24%)
Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 74
Query: 193 KLLDIVRDQQSKTPS--LIFEHV------------NNTDFKVLYPTLSDYDVRYYIYELL 238
+++D+ + + ++ E + + F ++ + + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIG 127
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+A+ Y HS I HRDVKP N++ ++ L+L D+G A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------- 167
Query: 297 PELLVDLQDYDYSLDLWSLG 316
E + YD S D+WSLG
Sbjct: 168 KETT--GEKYDKSCDMWSLG 185
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 11/190 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 193
D YEV +G G YS +H N + +KI+ K+ EI+IL PNI+
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 194 LLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L D+ D + ++ E + D + S+ + ++ + K ++Y H+QG++
Sbjct: 81 LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 251 HRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 306
HRD+KP N++ +R+ D+G A+ + F PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197
Query: 307 DYSLDLWSLG 316
D + D+WSLG
Sbjct: 198 DAACDIWSLG 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 19/196 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
++Y++ ++G+G +S V V ++ I L +K++RE +I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDY 243
PNIV+L D + ++ LIF+ V T + V S+ D + I ++L+A+ +
Sbjct: 70 PNIVRLHDSISEEGHH--YLIFDLV--TGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 244 CHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 300
CH G++HR++KP N+++ + ++L D+GLA + + + + PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 301 VDLQDYDYSLDLWSLG 316
Y +DLW+ G
Sbjct: 186 -RKDPYGKPVDLWACG 200
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 43/208 (20%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGG 188
+D Y++ V G G ++ V ++ +++ +KI+ + ++ RE+++L G
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALD 242
N+++L++ ++ L+FE + + + ++ + + ++ ALD
Sbjct: 71 RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNV--------RVASR 292
+ H++GI HRD+KP N++ +H + +++ D+ L + + S
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 293 YFKGPELL----VDLQDYDYSLDLWSLG 316
+ PE++ + YD DLWSLG
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 27/201 (13%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----------PVKKKKIKREIKILQ 183
Y + +G G + V+ V N++ ++K +K K K+ EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIF----EHVNNT---DFKVLYPTLSDYDVRYYIYE 236
+ NI+K+LDI + +H + F +P L + Y +
Sbjct: 85 RVEH-ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
L+ A+ Y + I+HRD+K N++I E ++LID+G A + GK + + +
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 297 PELLVDLQDYD-YSLDLWSLG 316
PE+L+ Y L++WSLG
Sbjct: 198 PEVLMG-NPYRGPELEMWSLG 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 37/219 (16%), Positives = 78/219 (35%), Gaps = 35/219 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
++ + +G G V +K + EIK+L PN++
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72
Query: 193 KLLDIVRDQQSKTPSLIFEH---------VNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
+ + + E + +Y+ + ++ + +
Sbjct: 73 RYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 244 CHSQGIMHRDVKPHNVMID------------HEQRKLRLIDWGLAEFYHPGKEY-----N 286
HS I+HRD+KP N+++ E ++ + D+GL + G+ N
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 287 VRVASRYFKGPELLVDLQD------YDYSLDLWSLGCMF 319
+ ++ PELL + + S+D++S+GC+F
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 125 SLTVQWGEQ-DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKR 177
SL GE+ +D++V +G+G ++ V+ + IK++ K ++++
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP---TLSDYDVRYY 233
E+KI L P+I++L + D S L+ E +N + + L S+ + R++
Sbjct: 61 EVKIHCQLKH-PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------- 284
+++++ + Y HS GI+HRD+ N+++ +++ D+GLA E
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
Y ++ PE+ + D+WSLGCM
Sbjct: 177 NY---IS------PEIATR-SAHGLESDVWSLGCM 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 52/194 (26%), Positives = 102/194 (52%), Gaps = 20/194 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
+Y +++ +G+G +++V H + IKI L P +K+ RE++I++ L P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74
Query: 190 NIVKLLDIVRDQQSKTPS---LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
NIVKL +++ +T LI E+ + D+ V + + + + R +++ A+ Y
Sbjct: 75 NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
CH + I+HRD+K N+++D +++ D+G + + G + + + + PEL
Sbjct: 130 CHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187
Query: 304 QDYD-YSLDLWSLG 316
+ YD +D+WSLG
Sbjct: 188 KKYDGPEVDVWSLG 201
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 36/214 (16%), Positives = 76/214 (35%), Gaps = 33/214 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG 187
++ + K+G G++ VF+ V D IK K V ++ RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 188 GPNIVKLLDIVRDQQSKTPSL-IF-EHVNN-------TDFKVLYPTLSDYDVRYYIYELL 238
++V+ + + I E+ N ++ + + +++ + ++
Sbjct: 70 HSHVVRYFSAWAEDDH----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY------------- 285
+ L Y HS ++H D+KP N+ I + G + + K
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317
V F E+L + + D+++L
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALAL 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
Y R +G+G +++ FE E KI+ KP +++K+ EI I ++L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
++V D + ++ E + L++ + RYY+ +++ Y
Sbjct: 75 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 132 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183
Query: 295 KGPELLVDLQDYDYSLDLWSLGCM 318
PE+L + + + +D+WS+GC+
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCI 204
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
Y R +G+G +++ FE E KI+ KP +++K+ EI I ++L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
++V D + ++ E + L++ + RYY+ +++ Y
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 158 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209
Query: 295 KGPELLVDLQDYDYSLDLWSLGCM 318
PE+L + + + +D+WS+GC+
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCI 230
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-31
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 35/204 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
+D+E+ R +G+GK+ V+ +K+L K + +++RE++I +L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKALD 242
PNI++L D + LI E+ ++ L + YI EL AL
Sbjct: 67 RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 294
YCHS+ ++HRD+KP N+++ +L++ D+G + + +Y +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175
Query: 295 KGPELLVDLQDYDYSLDLWSLGCM 318
PE++ + +D +DLWSLG +
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVL 196
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 43/208 (20%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIK 176
D + + + + Y ++K+G G + + D + +IK + ++++ +
Sbjct: 12 DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR 71
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----YPTLSDYDVR 231
RE+ +L N+ PNIV+ + + S ++ ++ D FK + + +
Sbjct: 72 REVAVLANMKH-PNIVQYRESFEENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVA 290
+ ++ AL + H + I+HRD+K N+ + + ++L D+G+A + E +
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIG 187
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCM 318
+ Y+ PE+ + + Y+ D+W+LGC+
Sbjct: 188 TPYYLSPEICEN-KPYNNKSDIWALGCV 214
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 39/207 (18%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK---------KIKREIKILQNLC 186
Y + +G G Y +V E + + +KILK KKK +K+EI++L+ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK--KKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALD 242
N+++L+D++ +++ + ++ E+ V Y +L+ L+
Sbjct: 65 H-KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE------------YNVRVA 290
Y HSQGI+H+D+KP N+++ L++ G+AE HP +
Sbjct: 124 YLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAF---QP 179
Query: 291 SRYFKGPELLVDLQDYD-YSLDLWSLG 316
PE+ L + + +D+WS G
Sbjct: 180 ------PEIANGLDTFSGFKVDIWSAG 200
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 35/229 (15%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKRE 178
D+ TV+ GE V R + G ++ V+E + +K L + K + I +E
Sbjct: 17 DFVGQTVELGELR-LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75
Query: 179 IKILQNLCGGPNIVKLLD--IVRDQQSKTPSLIF----EHVNNTDFKVLYPT-----LSD 227
+ ++ L G PNIV+ + ++S T F E + L LS
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 228 YDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
V Y+ +A+ + H Q I+HRD+K N+++ Q ++L D+G A +Y
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDY 194
Query: 286 NVRVASR-------------YFKGPELLVDL---QDYDYSLDLWSLGCM 318
+ R ++ PE ++DL D+W+LGC+
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCI 242
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 44/227 (19%), Positives = 93/227 (40%), Gaps = 29/227 (12%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK 173
RE ++ V + Y ++K+G G +S V D +K + + ++
Sbjct: 13 GRENLYFQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS--LIFEHVNNTD-------FKVLYPT 224
+ +RE + + PNI++L+ ++ L+ K
Sbjct: 72 EAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
L++ + + + + + L+ H++G HRD+KP N+++ ++ + L+D G E
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVE 189
Query: 285 YNVRVASR----------YFKGPELLVDLQDY---DYSLDLWSLGCM 318
+ + + ++ PE L +Q + D D+WSLGC+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCV 235
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCG 187
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K + +++ E + D FK + + V Y +L A
Sbjct: 92 -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 300 LVDLQDYDYSLDLWSLGC 317
+ + Y++ D+WSLGC
Sbjct: 208 IHE-NGYNFKSDIWSLGC 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 36/213 (16%), Positives = 78/213 (36%), Gaps = 31/213 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVKKKKIKREIKILQNLCGG 188
V +G G +++V+E N +K ++K+ KP + ++++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 189 --PNIVKLLDIVRDQQSKTPSLIFEHVN--------NTDFKVLYPTLSDYDVRYYIYELL 238
+K Q L+ E + N + V + +L
Sbjct: 125 MQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDH----------EQRKLRLIDWGLA---EFYHPGKEY 285
++ H I+H D+KP N ++ + L LID G + + + G +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
+ + F+ E+L + + ++Y +D + +
Sbjct: 243 TAKCETSGFQCVEMLSN-KPWNYQIDYFGVAAT 274
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 49/205 (23%), Positives = 99/205 (48%), Gaps = 37/205 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
DD+++ R +G+GK+ V+ + +K+L K + +++REI+I +L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVEHQLRREIEIQSHL 71
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALD 242
PNI+++ + D K L+ E + +K L + + ++ EL AL
Sbjct: 72 RH-PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------EYNVRVASRY 293
YCH + ++HRD+KP N+++ + + +L++ D+G + + P +Y +
Sbjct: 129 YCHERKVIHRDIKPENLLMGY-KGELKIADFGWS-VHAPSLRRRTMCGTLDY---LP--- 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCM 318
PE++ + +D +DLW G +
Sbjct: 181 ---PEMIEG-KTHDEKVDLWCAGVL 201
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 57/255 (22%), Positives = 93/255 (36%), Gaps = 26/255 (10%)
Query: 80 RQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVV 139
LA+ T + K R ++P +Y +Y Q
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQP----- 64
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
+VGRG + EV +C +K ++ + E+ L P IV L VR
Sbjct: 65 -RVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRIVPLYGAVR 120
Query: 200 DQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
+ ++ E + L + YY+ + L+ L+Y H++ I+H DVK
Sbjct: 121 EGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSL 310
NV++ + + L D+G A P + Y G PE +V + D +
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKV 237
Query: 311 DLWSLGC----MFAG 321
D+WS C M G
Sbjct: 238 DIWSSCCMMLHMLNG 252
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
Y + +G G + +V H +K +K + K +++REI L+ L P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYC 244
+I+KL D++ TP+ I E+ D+ V +++ + R + +++ A++YC
Sbjct: 70 HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
H I+HRD+KP N+++D + +++ D+GL+ G S + PE++ +
Sbjct: 125 HRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182
Query: 305 DYD-YSLDLWSLG 316
Y +D+WS G
Sbjct: 183 LYAGPEVDVWSCG 195
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-28
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
Y + +G G + +V G H K +KIL ++K KIKREI+ L+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
P+I+KL ++ TP+ F E+V+ D+ + + + + R ++L A+
Sbjct: 71 -PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
DYCH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 125 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 302 DLQDYD-YSLDLWSLG 316
+ Y +D+WS G
Sbjct: 184 G-RLYAGPEVDIWSCG 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 40/224 (17%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK------------------- 173
Y + ++G+G Y V + DN +K+L K +++
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 174 -------KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT- 224
++ +EI IL+ PN+VKL++++ D ++FE VN +V
Sbjct: 75 QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
LS+ R+Y +L+K ++Y H Q I+HRD+KP N+++ E +++ D+G++ +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192
Query: 285 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDLWSLG----CMFAG 321
+ V + F PE L + + + +LD+W++G C G
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 47/193 (24%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNI 191
D Y+ V+ +G G + E +K + + ++REI ++L PNI
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78
Query: 192 VKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
V+ +++ TP+ + E+ + + S+ + R++ +LL + YCH
Sbjct: 79 VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 246 SQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S I HRD+K N ++D +L++ D+G ++ + V + + PE+L+ Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192
Query: 305 DYD-YSLDLWSLG 316
+YD D+WS G
Sbjct: 193 EYDGKIADVWSCG 205
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 34/233 (14%), Positives = 66/233 (28%), Gaps = 44/233 (18%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQN 184
+ ++V + G S VF E +K+ + +++
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 185 L-----------------------CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
L P +L D L+ + D ++L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELL 177
Query: 222 YPTLSDYD----------VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271
+ TL + +L++ S+G++H P N+ I + R L L
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLG 236
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMV 323
D + G + E L + ++L+ W LG +
Sbjct: 237 DVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-27
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 22/197 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 301 VDLQDYD-YSLDLWSLG 316
+++ +D+WS G
Sbjct: 180 KR-REFHAEPVDVWSCG 195
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
Y + +G G + +V G H K +KIL ++K KI+REI+ L+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
P+I+KL ++ TPS IF E+V+ D+ L + + R ++L +
Sbjct: 76 -PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
DYCH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 130 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188
Query: 302 DLQDYD-YSLDLWSLG 316
+ Y +D+WS G
Sbjct: 189 G-RLYAGPEVDIWSSG 203
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 53/232 (22%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC------- 186
Y +VRK+G G +S V+ +N +KI++ K + + EIK+LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 187 ---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD------FKVLYPTLSDY--------- 228
G +I+KLLD F H F+VL L
Sbjct: 81 DSMGANHILKLLD------------HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 229 ---DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR-----KLRLIDWGLAEFY 279
V+ +LL LDY H + GI+H D+KP NV+++ ++++ D G A +Y
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331
+ Y + +R ++ PE+L+ + D+WS C+ + ++ LF
Sbjct: 189 D--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFEL--ITGDFLF 235
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 22/197 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 301 VDLQDYD-YSLDLWSLG 316
+++ +D+WS G
Sbjct: 180 KR-REFHAEPVDVWSCG 195
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 43/190 (22%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLL 195
++GRG + V++G+ + L+ K K K E ++L+ L PNIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91
Query: 196 DIVRDQQSKTPSLIF--EHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG-- 248
D ++ E + + + + + +R + ++LK L + H++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+K N+ I +++ D GLA V + + F PE+ + YD
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208
Query: 309 SLDLWSLGCM 318
S+D+++ G
Sbjct: 209 SVDVYAFGMC 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 41/308 (13%), Positives = 89/308 (28%), Gaps = 67/308 (21%)
Query: 71 HARHQHQRLRQ---LATPPDTLAQKIGKSVRRSGAPSKA-RVYSDINVVRPREYWDYES- 125
H H H R+ P D + +++ + ++ + + + S + + W+
Sbjct: 2 HHHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 61
Query: 126 ---LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIK 176
+ +G+ E E + + ++ K++K
Sbjct: 62 FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------ 230
E+ L+ L G N + +R P + + + D V
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 231 ------------------------------RYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
++++ L H G++H ++P +++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSL 310
+D + L + V SR F+ PEL +S
Sbjct: 239 LDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 311 DLWSLGCM 318
D W+LG +
Sbjct: 295 DAWALGLV 302
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 47/225 (20%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------------------PVKKK 173
+DY ++R + +GK++++ DN+ +K + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----------Y 222
K E++I+ ++ + I+ + +I+E++ N K
Sbjct: 89 DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
+ ++ I +L + Y H++ I HRDVKP N+++D + +++L D+G +E Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMV 203
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDLWSLG----CMFAG 321
K+ + F PE + Y+ +D+WSLG MF
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKREIKILQNLCGGPN 190
+E+V VG G Y +V++G H + IK+ + ++++IK+EI +L+ N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 191 IVKLLDIVRDQQSKTPS----LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 237
I + L+ E + NT TL + + Y E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 296
L+ L + H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 297 PELLVDLQD----YDYSLDLWSLG 316
PE++ ++ YD+ DLWSLG
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLG 221
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 49/205 (23%), Positives = 104/205 (50%), Gaps = 33/205 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
YEV++ +G+G + +V + ++ +K+++ K+ ++ EI+IL++L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 189 PNIVKLLD---------IVRDQQSKTPSL---IFEHVNNTDFKVLYPTLSDYDVRYYIYE 236
N++ +L+ + L ++E + F+ L VR + +
Sbjct: 159 MNVIHMLENFTFRNHICMT------FELLSMNLYELIKKNKFQGFSLPL----VRKFAHS 208
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+L+ LD H I+H D+KP N+++ + R +++ID+G + + H + Y + SR+++
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYR 266
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFA 320
PE+++ Y +D+WSLGC+ A
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILA 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 47/218 (21%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
+DDYE+ +G G + V EK IK + ++ +EI+ + C
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCHH 72
Query: 189 PNIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS 226
PNIV +LDI++ +K L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------------SGVLD 119
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ + + E+L+ L+Y H G +HRDVK N+++ E +++ D+G++ F G +
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDIT 178
Query: 287 VRVASRYFKG------PELLVDLQDYDYSLDLWSLGCM 318
+ F G PE++ ++ YD+ D+WS G
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 28/200 (14%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIV 198
+G+G Y V+ G ++ + IK + + + EI + ++L NIV+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88
Query: 199 RDQQSKTPSLIFEHVNN----TDFKVLYPTLSDYD--VRYYIYELLKALDYCHSQGIMHR 252
+ + E V + + L D + + +Y ++L+ L Y H I+HR
Sbjct: 89 SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 305
D+K NV+I+ L++ D+G + + + + F G PE + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 306 YDYSLDLWSLGC----MFAG 321
Y + D+WSLGC M G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 49/265 (18%), Positives = 96/265 (36%), Gaps = 81/265 (30%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGG 188
D+E ++ +GRG + VFE + D+ IK + + + ++K+ RE+K L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63
Query: 189 PNIVKLLD----------------------------------------IVRDQQSKTPSL 208
P IV+ + I R T +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 209 IFEHVNNTDFKVLY--------PTLSDY-------------DVRYYIYELLKALDYCHSQ 247
+ + ++ LY L D+ + ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 296
G+MHRD+KP N+ + +++ D+GL +E +
Sbjct: 184 GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 297 --PELLVDLQDYDYSLDLWSLGCMF 319
PE + +Y + +D++SLG +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLIL 266
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 48/204 (23%), Positives = 102/204 (50%), Gaps = 29/204 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
YE+ +G+G + +V + + E IKI+K K + + E+++L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 189 PNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 239
IV L +V + S +L ++ + NT+F+ +S R + ++
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFR----GVSLNLTRKFAQQMCT 168
Query: 240 ALDYCHSQ--GIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
AL + + I+H D+KP N+++ + +R ++++D+G + + + SR+++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226
Query: 297 PELLVDLQDYDYSLDLWSLGCMFA 320
PE+L+ + YD ++D+WSLGC+
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILV 249
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-23
Identities = 55/267 (20%), Positives = 107/267 (40%), Gaps = 42/267 (15%)
Query: 69 LSHARHQHQRLRQLATPPDTLAQKIGKSV---RRSGAPSKARVYSDINVVRPREYWDYES 125
+S+ H H + T + Q + R+G+ V P +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEK------ 54
Query: 126 LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREI 179
+ +R++G G + V+ ++E IK + K+ I +E+
Sbjct: 55 ---------LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 180 KILQNLCGGPNIVKLLD-IVRDQQSKTPSL--IFEHVN---NTDFKVLYPTLSDYDVRYY 233
+ LQ PN ++ +R+ + E+ + +V L + ++
Sbjct: 106 RFLQK-LRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 159
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
+ L+ L Y HS ++HRDVK N+++ E ++L D+G A P + V + Y
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANSF---VGTPY 215
Query: 294 FKGPELLVDLQD--YDYSLDLWSLGCM 318
+ PE+++ + + YD +D+WSLG
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGIT 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-23
Identities = 45/195 (23%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNI 191
++ ++V+ K+G G Y V++ +H + IK + ++I +EI I+Q C P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86
Query: 192 VKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYC 244
VK ++ L + E+ +D ++ TL++ ++ + LK L+Y
Sbjct: 87 VKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 303
H +HRD+K N++++ + +L D+G+ + + N + + ++ PE++ +
Sbjct: 142 HFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 199
Query: 304 QDYDYSLDLWSLGCM 318
Y+ D+WSLG
Sbjct: 200 IGYNCVADIWSLGIT 214
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 20/197 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
++ + + K+G+G + EVF+G+ + IKI+ + + I++EI +L C
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79
Query: 189 PNIVKLLD-IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
P + K ++D + L I E++ D + L + + + E+LK LD
Sbjct: 80 PYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLD 133
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
Y HS+ +HRD+K NV++ E +++L D+G+ + + N V + ++ PE++
Sbjct: 134 YLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 302 DLQDYDYSLDLWSLGCM 318
YD D+WSLG
Sbjct: 193 Q-SAYDSKADIWSLGIT 208
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 45/220 (20%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
YE+V +G G + +V E + H + +KI++ V K + + EI +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
V + D I + + FE + +F+ VR+ Y+L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQ----PYPLPHVRHMAYQLC 133
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRK------------------LRLIDWGLAEFYH 280
AL + H + H D+KP N++ + + + +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
+ VA+R+++ PE++++L + D+WS+GC+
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILF 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 45/220 (20%), Positives = 96/220 (43%), Gaps = 45/220 (20%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
YE+V +G G + +V E + H +KI+K V + + + EI++L++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
V++L+ IV + S ++ + F +R Y++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFL----PFRLDHIRKMAYQIC 128
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR------------------KLRLIDWGLAEFYH 280
K++++ HS + H D+KP N++ ++++D+G A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
+ V++R+++ PE+++ L + D+WS+GC+
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILI 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGP 189
+ +E+V ++G G + +V++ + K+++ + + EI+IL C P
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76
Query: 190 NIVKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALD 242
IVKLL D + L + E L L++ ++ ++L+AL+
Sbjct: 77 YIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS+ I+HRD+K NV++ + +RL D+G+ A+ ++ + + + Y+ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 302 DLQ----DYDYSLDLWSLGCM 318
YDY D+WSLG
Sbjct: 191 CETMKDTPYDYKADIWSLGIT 211
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 49/224 (21%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNL----CGGP 189
+ V+RK+G G + V H + + +K+++ +KK + K E IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 190 NIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
NIVK ++ + PSL +E + ++ + ++ Y E+LKA
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK------------------------LRLIDWGLA 276
L+Y + H D+KP N+++D + ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
F ++ + +R ++ PE++++L +D S D+WS GC+ A
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLA 250
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 35/311 (11%), Positives = 81/311 (26%), Gaps = 69/311 (22%)
Query: 71 HARHQH---------QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW 121
H H H Q R + + + + + + + S + + W
Sbjct: 2 HHHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61
Query: 122 ----DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----- 172
+ + +G+ E E + + ++
Sbjct: 62 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121
Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV- 230
K++K E+ L+ L G N + +R P + + + D V
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVL 178
Query: 231 -----------------------------------RYYIYELLKALDYCHSQGIMHRDVK 255
++++ L H G++H ++
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238
Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQD----YD 307
P ++++D + L + G + + +L Q
Sbjct: 239 PVDIVLDQRGG-VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 308 YSLDLWSLGCM 318
++ D W+LG
Sbjct: 296 FAFDTWTLGLA 306
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 43/197 (21%), Positives = 91/197 (46%), Gaps = 21/197 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ + K+G G V + +K++ K +++ + E+ I+++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102
Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
N+V++ +V ++ L + E + TD V L++ + +L+AL
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
Y H+QG++HRD+K ++++ +++L D+G A+ + V + Y+ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 302 DLQDYDYSLDLWSLGCM 318
Y +D+WSLG M
Sbjct: 215 R-SLYATEVDIWSLGIM 230
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 21/197 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ Y K+G+G V+ + ++ I+ + + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
NIV LD +V D+ L + E++ TD V + + + E L+AL+
Sbjct: 78 NIVNYLDSYLVGDE------LWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALE 130
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS ++HRD+K N+++ ++L D+G A+ + + V + Y+ PE +V
Sbjct: 131 FLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VV 188
Query: 302 DLQDYDYSLDLWSLGCM 318
+ Y +D+WSLG M
Sbjct: 189 TRKAYGPKVDIWSLGIM 205
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 39/215 (18%)
Query: 132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQN 184
E YE++ +G+G V + E ++ + ++ E+ + +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81
Query: 185 LCGGPNIVKLLD-IVRDQQ-----------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRY 232
L PNIV + D + S LI H + +++ + Y
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDG--------MNELAIAY 132
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVA 290
+ +LKALDY H G +HR VK +++I K+ L H ++ V
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 291 SRYFKG------PELLV-DLQDYDYSLDLWSLGCM 318
+Y PE+L +LQ YD D++S+G
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCG 187
+D++ + +G G +S V + + IKIL+ +K+ K+ RE ++ L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
P VKL +D + + N + K + + + R+Y E++ AL+Y
Sbjct: 89 HPFFVKLYFTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE 298
H +GI+HRD+KP N++++ + +++ D+G A+ + R S F G PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQYVSPE 202
Query: 299 LLVDLQDYDYSLDLWSLGC----MFAG 321
LL + + S DLW+LGC + AG
Sbjct: 203 LLTE-KSACKSSDLWALGCIIYQLVAG 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 44/201 (21%), Positives = 81/201 (40%), Gaps = 17/201 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPN 190
YEV + G ++ + + ++K L + E + L + P+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS 246
IV++ + V + + E+V K L + Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
G+++ D+KP N+M+ EQ K LID G + + F+ PE++
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK--LIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254
Query: 307 DYSLDLWSLGCMFAGMVSVSP 327
+ D++++G A + P
Sbjct: 255 VAT-DIYTVGRTLAALTLDLP 274
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 31/297 (10%)
Query: 46 PLSQSSRIFTPFGTLRGLASSASLS--HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAP 103
L S IF + LA S S H L + PPD L Q + + ++
Sbjct: 101 RLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPD-LFQPYIEEICQNLRG 159
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
+ + + + W L + +D+ V R +GRG + EV+ +
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVELNIHLTM-NDFSVHRIIGRGGFGEVYGCRKADTGKMYA 218
Query: 164 IKILKPVKKKKIKR---------EIKILQ--NLCGGPNIVKLLDIVRDQQSKTPS---LI 209
+K L KK+IK E +L + P IV + TP I
Sbjct: 219 MKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-----SYAFHTPDKLSFI 270
Query: 210 FEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
+ +N D L S+ D+R+Y E++ L++ H++ +++RD+KP N+++D
Sbjct: 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMV 323
+R+ D GLA K+ + V + + PE+L YD S D +SLGCM ++
Sbjct: 331 -VRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 40/213 (18%), Positives = 79/213 (37%), Gaps = 51/213 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
+D E + ++G G +V++ +K + + K+I ++ ++ P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV+ + + + I E +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKK----RMQGPIPERI--------------- 125
Query: 229 DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
+ ++KAL Y + G++HRDVKP N+++D + +++L D+G++ K +
Sbjct: 126 -LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDKAKDR 183
Query: 288 RVASRYFKGPE----LLVDLQDYDYSLDLWSLG 316
+ PE DYD D+WSLG
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 58/218 (26%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
+D + + ++GRG Y V + VH + +K + ++K++ ++ ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV+ + S +I E +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126
Query: 229 DVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
+ +KAL++ I+HRD+KP N+++D ++L D+G++ +
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGIS------GQLVD 178
Query: 288 RVASRYFKG------PELL---VDLQDYDYSLDLWSLG 316
+A G PE + Q YD D+WSLG
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 60/214 (28%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI----LKPVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G VF+ H K+ +KP + +I RE+++L C P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91
Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
IV L ++ K I E +
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQI-------------- 132
Query: 228 YDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283
+ ++K L Y + IMHRDVKP N++++ + +++L D+G++ G+
Sbjct: 133 --LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS-----GQLID 184
Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
N V +R + PE L Y D+WS+G
Sbjct: 185 SMANSFVGTRSYMSPERL-QGTHYSVQSDIWSMG 217
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 39/228 (17%)
Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
Y + +QW + + R +G+G + EV + K L+ KK+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKR 221
Query: 175 IKR---------EIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD----- 217
IK+ E +IL+ +V L +T L+ +N D
Sbjct: 222 IKKRKGEAMALNEKQILE-KVNSRFVVSLA-----YAYETKDALCLVLTLMNGGDLKFHI 275
Query: 218 FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277
+ + + +Y E+ L+ H + I++RD+KP N+++D +R+ D GLA
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAV 334
Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAG 321
G+ RV + + PE++ + + Y +S D W+LGC M AG
Sbjct: 335 HVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAG 381
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
Y +QW D + R +GRG + EVF + K L KK+
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKR 222
Query: 175 IKR---------EIKILQNLCGGPNIVKL-------------LDIVR--DQQSKTPSLIF 210
+K+ E KIL IV L + I+ D I
Sbjct: 223 LKKRKGYQGAMVEKKILA-KVHSRFIVSLAYAFETKTDLCLVMTIMNGGD--------IR 273
Query: 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
H+ N D P + +Y +++ L++ H + I++RD+KP NV++D + +R+
Sbjct: 274 YHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRI 330
Query: 271 IDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAG 321
D GLA E + + F PELL+ ++YD+S+D ++LG M A
Sbjct: 331 SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAA 385
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 18/156 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKL 194
+ V +K+G G + E+ G + NE IK+ + ++ E + + L G I ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F + T S V +L+ ++Y HS+
Sbjct: 71 YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
+++RDVKP N +I + Q+ + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F S V +++ ++Y HS+
Sbjct: 71 RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 248 GIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFY 279
+HRDVKP N ++ ++ + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
Y++V K+G G S V+ N K IK + K+ +RE+ L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
NIV ++D+ + L+ E++ + LS + ++L + + H
Sbjct: 72 NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
I+HRD+KP N++ID + L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 33/156 (21%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
Y+V R++G G + +FEG + +N++ IK +++ E + + L G I +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
++ PSL E + + S V ++L + H +
Sbjct: 72 YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
+++RD+KP N +I + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 50/230 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
DD+E+++ +GRG +SEV + +KI+ K +KR E +L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
I +L + + + L+ E+ D +L + R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 295
+ A+D H G +HRD+KP N+++D +RL D+G + V S
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSC------LKLRADGTVRSLVAV 224
Query: 296 G------PELL------VDLQDYDYSLDLWSLG-CMFAGMVSVSPSVLFY 332
G PE+L Y D W+LG + +P FY
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP---FY 271
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 48/228 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+D+E+++ +GRG + EV ++ +KIL K + +KR E +L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
I L + + + L+ ++ D +L L + R+Y+ E+
Sbjct: 131 GDSKWITTL------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFK 295
+ A+D H +HRD+KP N+++D +RL D+G + + V S
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSC------LKLMEDGTVQSSVAV 237
Query: 296 G------PELLVDLQD----YDYSLDLWSLG-CMFAGMVSVSPSVLFY 332
G PE+L ++ Y D WSLG CM+ + +P FY
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP---FY 282
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 32/181 (17%), Positives = 64/181 (35%), Gaps = 23/181 (12%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKI 181
+ L G Q + + +K+G G + ++ EK ++K + + E+K
Sbjct: 29 KVLDDMEGNQ--WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKF 86
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIF---EHVNNTDFKV-----LYPTLSDY----- 228
Q + I K ++ + P ++ L L
Sbjct: 87 YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG 146
Query: 229 -----DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPG 282
V +L L+Y H +H D+K N+++ ++ ++ L D+GL+ Y P
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 283 K 283
Sbjct: 207 G 207
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 44/208 (21%), Positives = 86/208 (41%), Gaps = 33/208 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPN 190
D +G+G + + + H E ++K L ++ +E+K+++ L PN
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PN 68
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD------Y 243
++K + ++ + K + I E++ L + D +Y + + A D Y
Sbjct: 69 VLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---------YHPGKEYNVRVASRYF 294
HS I+HRD+ HN ++ E + + + D+GLA + R
Sbjct: 124 LHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 295 KG------PELLVDLQDYDYSLDLWSLG 316
G PE++ + YD +D++S G
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFG 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKI---LQNLC 186
Y + R VGRG +V+E +K++ PV + +++RE + LQ
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
P++V + D + + +N D + L+ + ++ ALD
Sbjct: 94 --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
H+ G HRDVKP N+++ + L+D+G+A
Sbjct: 150 AHAAGATHRDVKPENILVSADDF-AYLVDFGIA 181
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 44/211 (20%), Positives = 83/211 (39%), Gaps = 45/211 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD E + ++GRG Y V + H + K I + ++K++ ++ I P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 190 NIVKL--------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD 229
V LD Q I E +
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI---------------- 110
Query: 230 VRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ ++KAL++ HS+ ++HRDVKP NV+I+ ++++ D+G++ + ++
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDID 169
Query: 289 VASRYFKGPE---LLVDLQDYDYSLDLWSLG 316
+ + PE ++ + Y D+WSLG
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKR---EIKILQNLCG 187
+DYEVV+ +GRG + EV H + + +K+L +K+ E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127
Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELL 238
P +V+L + + ++ E++ D L +S+YD R+Y E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 296
ALD HS G +HRDVKP N+++D L+L D+G + N V G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTC------MKMNKEGMVRCDTAVG 231
Query: 297 ------PELLVD---LQDYDYSLDLWSLG-CMFAGMVSVSPSVLFY 332
PE+L Y D WS+G ++ +V +P FY
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP---FY 274
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 55/288 (19%), Positives = 103/288 (35%), Gaps = 93/288 (32%)
Query: 109 YSDINVVRPREYWDYESLTVQWGE--QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI 166
D P +Y V+ G+ Y V+RK+G G +S V+ + +K+
Sbjct: 10 SDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKV 69
Query: 167 LKPVKK--KKIKREIKILQNLC-------GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217
+K + + EI++L+++ +V+LLD F+
Sbjct: 70 VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD------------FKISGVNG 117
Query: 218 ------FKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
F+VL L + V+ I ++L+ LDY H++ I+H D+KP N
Sbjct: 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177
Query: 259 VMI------------------------------------------------DHEQRKLRL 270
+++ + E+ K+++
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 271 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
D G A K + + +R ++ E+L+ Y+ D+WS CM
Sbjct: 238 ADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACM 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D ++ ++ +G G + V H +KIL V K K E +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
P +VKL + K S ++ E+V + F L S+ R+Y +++
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
+Y HS +++RD+KP N++ID + +++ D+G A K R + G
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFA------KRVKGRTWT--LCGTPEAL 205
Query: 297 -PELLVDLQDYDYSLDLWSLGC----MFAG 321
PE+++ + Y+ ++D W+LG M AG
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAG 234
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 47/221 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +GRG Y++V + +K++K V + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
P +V L T S + E+VN D + L + R+Y E+
Sbjct: 69 HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 176
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSP 327
+A PE+L +DY +S+D W+LG MF M SP
Sbjct: 177 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
+ + RK+G G + E++ G + NE+ IK+ K ++ E KI + L GG I +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F LS V +++ +++ HS+
Sbjct: 69 RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 248 GIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFY 279
+HRD+KP N ++ ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
YE+ +G G SEV D+ +K+L+ P + +RE + L P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 190 NIVKLLDI--VRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
IV + D P ++ E+V+ + + ++ I + +AL++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
H GI+HRDVKP N+MI ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 47/221 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +GRG Y++V + ++++K V + ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
P +V L T S + E+VN D + L + R+Y E+
Sbjct: 112 HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 219
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSP 327
+A PE+L +DY +S+D W+LG MF M SP
Sbjct: 220 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 44/205 (21%), Positives = 72/205 (35%), Gaps = 44/205 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIV 192
+ EV VGRG + V + + IK ++ +K E++ L + PNIV
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNH-PNIV 64
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK---ALD------Y 243
KL L+ E+ LY L + Y L Y
Sbjct: 65 KLYGACL----NPVCLVMEYAEGGS---LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 244 CHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
HS + ++HRD+KP N+++ L++ D+G A +
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGS 166
Query: 297 -----PELLVDLQDYDYSLDLWSLG 316
PE+ +Y D++S G
Sbjct: 167 AAWMAPEVFEG-SNYSEKCDVFSWG 190
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 52/216 (24%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQ 183
++ E +++G+G + V +G D IK L K ++ +RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD 242
NL PNIVKL ++ + P ++ E V D LY L D L+ LD
Sbjct: 79 NLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLMLD 130
Query: 243 ------YCHSQG--IMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYHPGKEYNVRVA 290
Y +Q I+HRD++ N+ + ++ D+GL+ + +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------QQS 179
Query: 291 SRYFKG---------PELLVDLQD-YDYSLDLWSLG 316
G PE + ++ Y D +S
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFA 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+D++ ++ +G+G + +V +KIL+ K+ I + E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
P + L +T + E+ N + F L ++ R+Y E++
Sbjct: 62 TRHPFLTALK-----YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
AL+Y HS+ +++RD+K N+M+D + +++ D+GL KE + + F G
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--FCG 167
Query: 297 ------PELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
PE+L D DY ++D W LG M+ M P FY
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP---FY 206
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 48/225 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
D+ ++ +G+G + +V H + +K+L+ KK +K+ E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELL 238
P +V L S +T + +++N + F L + R+Y E+
Sbjct: 96 VKHPFLVGL------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
AL Y HS I++RD+KP N+++D + + L D+GL E EY
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEY--- 205
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
+A PE+L Q YD ++D W LG ++ + + P FY
Sbjct: 206 LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPP---FY 240
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 56/229 (24%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
D++E +R +G+G + +V + +K+LK K I E +IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 185 LCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYI 234
P + +L TP + E VN D + + + R+Y
Sbjct: 80 ARNHPFLTQL---------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------E 284
E++ AL + H +GI++RD+K NV++DHE +L D+G+ E G +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD 189
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
Y +A PE+L + Y ++D W++G ++ + +P F
Sbjct: 190 Y---IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP---FE 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 35/207 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D +E++R +G+G + +V + +K + ++ + +E++I+Q L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKA 240
P +V L S + ++ + + D L + V+ +I EL+ A
Sbjct: 74 HPFLVNL------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
LDY +Q I+HRD+KP N+++D E + + D+ +A G
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIA------AMLPRETQITTMAGTKPY 180
Query: 297 --PELLVD--LQDYDYSLDLWSLGCMF 319
PE+ Y +++D WSLG
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTA 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 48/225 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
D+ + +G+G + +V +E +KILK K + E ++L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 185 LCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELL 238
P + +L +T + E+VN D + + +Y E+
Sbjct: 77 PGKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
L + S+GI++RD+K NVM+D E +++ D+G+ E G +Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY--- 187
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
+A PE++ Q Y S+D W+ G ++ + +P F
Sbjct: 188 IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP---FE 222
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 47/210 (22%), Positives = 91/210 (43%), Gaps = 38/210 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +G G + V + +K+LK V + K E +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
P I+++ + +I +++ + F +L + ++Y E+ AL
Sbjct: 65 HPFIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
+Y HS+ I++RD+KP N+++D +++ D+G A K + G
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYT--LCGTPDYI 170
Query: 297 -PELLVDLQDYDYSLDLWSLGC----MFAG 321
PE++ + Y+ S+D WS G M AG
Sbjct: 171 APEVVST-KPYNKSIDWWSFGILIYEMLAG 199
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
D+ + +G+G + +V +E +KILK K I+ E ++L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLK 239
P + +L +T + E+VN D + + +Y E+
Sbjct: 399 GKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
L + S+GI++RD+K NVM+D E +++ D+G+ KE V + F G
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KENIWDGVTTKT--FCG 504
Query: 297 ------PELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
PE++ Q Y S+D W+ G ++ + +P F
Sbjct: 505 TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP---FE 543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 48/222 (21%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
+D+ + + +G+G + +VF N+ IK LK V E ++L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
P + + +T + E++N D + +Y E++ L
Sbjct: 77 HPFLTHMF-----CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVRVAS 291
+ HS+GI++RD+K N+++D + +++ D+G+ E +Y +A
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDY---IA- 186
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
PE+L+ Q Y++S+D WS G ++ ++ SP F+
Sbjct: 187 -----PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP---FH 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 22/190 (11%), Positives = 53/190 (27%), Gaps = 38/190 (20%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGP 189
Y ++ G + ++ + + + + + P ++ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
+ ++LD+V + ++ E + + V + S + L A D H G
Sbjct: 92 GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
+ P V + + V +A +
Sbjct: 150 VALSIDHPSRVRVSIDGD--------------------VVLAYPATMPDA--------NP 181
Query: 309 SLDLWSLGCM 318
D+ +G
Sbjct: 182 QDDIRGIGAS 191
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 30/173 (17%), Positives = 65/173 (37%), Gaps = 26/173 (15%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
++V +G+G + ++ + + C++K+ +P + E+K Q
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFKVLY-----PTLSDY-----------DVR 231
I K + + + P N ++ + L V
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 283
+L L+Y H +H D+K N++++++ ++ L+D+GLA Y P
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 60/231 (25%), Positives = 113/231 (48%), Gaps = 47/231 (20%)
Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKP---VKKKK----IKREIKILQ 183
+++E+++ +G G Y +VF + D K +K+LK V+K K + E ++L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 184 NLCGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYE 236
++ P +V L + +T + LI +++N + F L ++++V+ Y+ E
Sbjct: 114 HIRQSPFLVTL------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----YNVRVASR 292
++ AL++ H GI++RD+K N+++D + L D+GL+ KE R
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLS------KEFVADETERAYD- 219
Query: 293 YFKG------PELLVDL-QDYDYSLDLWSLGC-MFAGMVSVSPSVLFYVSG 335
F G P+++ +D ++D WSLG M+ + SP F V G
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDG 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 33/211 (15%)
Query: 126 LTVQWG-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREI 179
+ G + + K+ E+++G ++K+LK K + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYPTLSDYDVRYYIYELL 238
L+ PN++ +L + + P+LI + + + VL + + +
Sbjct: 59 PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAV 114
Query: 239 K-ALD------YCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
K ALD + H+ I + +VMID E R+ + F PG+ Y
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA 173
Query: 289 -VASRYFKGPELLVDLQDYDYSL--DLWSLG 316
VA PE L + D+WS
Sbjct: 174 WVA------PEALQKKPEDTNRRSADMWSFA 198
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 44/223 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+++E ++ +G+G + +V +KILK K+ + + E ++LQN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
P + L +T + E+ N + F L S+ R+Y E++
Sbjct: 205 SRHPFLTALK-----YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY--FKG 296
ALDY HS+ +++RD+K N+M+D + +++ D+GL KE ++ + F G
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLC------KE-GIKDGATMKTFCG 311
Query: 297 ------PELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
PE+L D DY ++D W LG M+ M P FY
Sbjct: 312 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP---FY 350
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 59/231 (25%)
Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKPVKKKKIKR--------EIKIL 182
+E+++ +G+G + +VF + + +D + +K+LK K +K E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80
Query: 183 QNLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRY 232
P IVKL T LI + + D F L ++ DV++
Sbjct: 81 VE-VNHPFIVKL---------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK-------- 283
Y+ EL ALD+ HS GI++RD+KP N+++D E ++L D+GL+ E K
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
EY +A PE++ + + S D WS G MF + P F
Sbjct: 190 VEY---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP---FQ 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 49/241 (20%), Positives = 94/241 (39%), Gaps = 40/241 (16%)
Query: 98 RRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCT 157
P + + D + + + W D + K+G G + V
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPW---CDLNIKEKIGAGSFGTVHRAEWH- 59
Query: 158 DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212
+KIL + RE+ I++ L PNIV + V S++ E+
Sbjct: 60 -GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPP--NLSIVTEY 115
Query: 213 VNNTDFKVLYPTLSDYDVRYYI--YELLK-ALD------YCHSQG--IMHRDVKPHNVMI 261
++ LY L R + L A D Y H++ I+HR++K N+++
Sbjct: 116 LSRGS---LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSL 315
D ++ +++ D+GL+ + + ++S+ G PE+L D + + D++S
Sbjct: 173 D-KKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSF 225
Query: 316 G 316
G
Sbjct: 226 G 226
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 55/230 (23%)
Query: 134 DDYEVVRKVGRGKYSEVF---EGVHCTDNEKCIIKILKP---VKKKK----IKREIKILQ 183
+ +E++R +G+G Y +VF + + +K+LK V+ K K E IL+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 184 NLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYY 233
P IV L T LI E+++ + F L + +Y
Sbjct: 77 E-VKHPFIVDL---------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK--------- 283
+ E+ AL + H +GI++RD+KP N+M++H+ ++L D+GL E H G
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC-MFAGMVSVSPSVLFY 332
EY +A PE+L+ ++ ++D WSLG M+ + P F
Sbjct: 186 EY---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTGAPP---FT 222
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 39/213 (18%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLC 186
VQ + +G+G++ EV+ G E+ +KI +++ RE +I Q +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML 93
Query: 187 GGPNIVKLLDIVRDQQSKTP--SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALD 242
NI+ + L+ + H + + F L + + L
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153
Query: 243 YCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
+ H + I HRD+K N+++ + + D GLA + + + +A +
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDT-IDIAPNHR 211
Query: 295 KG------PELL---VDLQDYDYSL--DLWSLG 316
G PE+L ++++ ++ D++++G
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 125 SLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ- 183
L VQ ++V+++G+G+Y EV+ G EK +K+ ++ RE +I Q
Sbjct: 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQT 85
Query: 184 NLCGGPNIVKLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLK 239
L NI+ + DI LI + H N + + L T D + Y +
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145
Query: 240 ALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
L + H++ I HRD+K N+++ + + D GLA + V +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTN-EVDIPP 203
Query: 292 RYFKG------PELL---VDLQDYDYSL--DLWSLG 316
G PE+L ++ + + D++S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 41/211 (19%), Positives = 80/211 (37%), Gaps = 41/211 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
+ E+ +G+G++ +V+ G + I+++ + K KRE+ +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88
Query: 189 PNIVKLLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD--- 242
N+V + P L I LY + D + + + + A +
Sbjct: 89 ENVVLFMGAC----MSPPHLAIITSLCKGRT---LYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 243 ---YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
Y H++GI+H+D+K NV D+ K+ + D+GL + R G
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 297 ---PELL--------VDLQDYDYSLDLWSLG 316
PE++ D + D+++LG
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 40/203 (19%), Positives = 83/203 (40%), Gaps = 34/203 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
V +++G G + V++G D +K+L P + + K E+ +L+
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD----- 242
NI+ + Q +++ + + LY L + ++ + +L+ A
Sbjct: 80 VNILLFMGYSTAPQ---LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 243 -YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
Y H++ I+HRD+K +N+ + E +++ D+GLA + G
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQL---SGSILWM 189
Query: 297 -PELLVDLQDYDYSL--DLWSLG 316
PE++ YS D+++ G
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFG 212
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 1e-11
Identities = 38/249 (15%), Positives = 68/249 (27%), Gaps = 66/249 (26%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKR 177
+ + K+G G + EVF+ + D+ IKI+ ++I
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 178 EIKILQNLCG--------GPNIVKLLDIVRDQQSKTPSLI-------------------- 209
EI I + L + L + Q S P L+
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 210 ----------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
FE ++ S + +++L +L + HRD+ N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
V++ + Y + S L V + DY S +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 319 FAGMVSVSP 327
F +
Sbjct: 239 FCDVSMDED 247
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 28/204 (13%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIVKLL 195
++ VG+G+Y EV+ G E +KI +K RE ++ + NI+ +
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 196 --DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ---- 247
D+ S LI H + + L T D I + L + H +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 248 ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 297
I HRD+K N+++ + + + D GLA + + V + G P
Sbjct: 129 QGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186
Query: 298 ELL-----VDLQDYDYSLDLWSLG 316
E+L VD D +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 40/229 (17%), Positives = 83/229 (36%), Gaps = 44/229 (19%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181
++ D+ +++ +GRG+Y V++G D +K+ ++ E I
Sbjct: 4 AASEPSLDL---DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNI 58
Query: 182 -----LQNLCGGPNIVKLL--DIVRDQQSKTP-SLIFE-HVNNTDFKVLYPTLSDYDVRY 232
+++ NI + + D + L+ E + N + K L SD+
Sbjct: 59 YRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC 114
Query: 233 YI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
+ + + + L Y H++ I HRD+ NV++ + D+GL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGN 173
Query: 283 KEYNVRVASRYFKG---------PELL------VDLQDYDYSLDLWSLG 316
+ PE+L D + +D+++LG
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 29/175 (16%), Positives = 57/175 (32%), Gaps = 28/175 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVH--------CTDNEKCIIKILKPVKKKKIKREIKILQNLCG 187
+++ R ++E +K +K+ K ++ E Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-----LYPTLSDY------------DV 230
+ K + P+ + V+ ++ L +L V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE 284
LL AL++ H +H +V N+ +D E Q ++ L +G A Y P +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 38/208 (18%), Positives = 80/208 (38%), Gaps = 38/208 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLC 186
+ + +G G + +V+ ++ +K + + +++E K+ L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYI-YELLKALDYC 244
PNI+ L + + L+ E +VL D+ ++ + ++Y
Sbjct: 65 H-PNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 245 HSQG---IMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEFYHPGKEYNVRVASRYF 294
H + I+HRD+K N++I + L++ D+GLA +H + +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-------A 174
Query: 295 KG------PELLVDLQDYDYSLDLWSLG 316
G PE++ + D+WS G
Sbjct: 175 AGAYAWMAPEVIRA-SMFSKGSDVWSYG 201
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGP 189
+D + ++GRG + EVF G DN +K + K K +E +IL+ P
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172
Query: 190 NIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
NIV+L+ + +Q P I E V DF + L + + + ++Y
Sbjct: 173 NIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GPEL 299
S+ +HRD+ N ++ E+ L++ D+G++ G Y R K PE
Sbjct: 229 LESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEA 286
Query: 300 LVDLQDYDYSL--DLWSLG 316
L + YS D+WS G
Sbjct: 287 LNYGR---YSSESDVWSFG 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 36/179 (20%), Positives = 67/179 (37%), Gaps = 23/179 (12%)
Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKRE 178
E+L Q +++ RG++ V++ NE +KI K+ + + E
Sbjct: 14 LGTENLYFQS---MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYE 68
Query: 179 IKILQNLCGGPNIVKLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI- 234
+ L + NI++ + + LI H + L + ++ +I
Sbjct: 69 VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 235 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
+ + L Y H I HRD+K NV++ + D+GLA + GK
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGK 185
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQ 183
E+ + +R +G G + +V + + + +K LKP +K+EI+IL+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELL 238
NL NIVK I + LI E + + K Y ++ Y ++
Sbjct: 79 NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
K +DY S+ +HRD+ NV+++ + ++++ D+GL + KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEY 182
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPN 190
+R +G G + +V D + +K LK P + K+EI IL+ L +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
I+K D + + L+ E+V + + ++ + + ++ + + Y H+Q
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 304
+HRD+ NV++D R +++ D+GLA + Y VR PE L + +
Sbjct: 155 YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 305 DYDYSLDLWSLG 316
+ Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 51/291 (17%), Positives = 106/291 (36%), Gaps = 45/291 (15%)
Query: 63 LASSASLSHARHQHQRLRQLA----TPPDTLAQKIGKSVRRSGAPSKARVYSDINVV--- 115
++ + H H H R R P G + S + N+
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 116 RPREYWDYESLTVQWGEQ-DDYEV---------VRKVGRGKYSEVFEGVHCTDNEKCI-- 163
+ D +L + + + +GRG + V+ G ++ K I
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 164 -IKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
+K L + + + E I+++ PN++ LL I + P ++ ++ + D
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 178
Query: 219 KVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
+ + + D+ + ++ K + + S+ +HRD+ N M+D E+ +++ D+
Sbjct: 179 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 236
Query: 274 GLAEFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDLWSLG 316
GLA + + +V + E L Q + D+WS G
Sbjct: 237 GLARDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFG 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
DYE+ R +G G++ +V +G++ + + IK K ++K +
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
E ++ P+IVKL+ ++ ++ P I E + +V +L +
Sbjct: 66 EALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 120
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y Y+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 163
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 41/221 (18%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 76 HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
+ ++ ++ + + + + + +D E Y + D
Sbjct: 330 IRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS-----TRD 384
Query: 136 YEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKI 181
YE+ R +G G++ +V +G++ + + IK K ++K +E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT 444
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIY 235
++ P+IVKL+ ++ ++ P I E + + + +L + Y Y
Sbjct: 445 MRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAY 498
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 538
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 8e-08
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
Y + R +G G + EV+EGV+ + I +K K K+K
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 62
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
E I++NL P+IVKL+ I+ + P+ I E + + +L +
Sbjct: 63 EAVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y ++ KA+ Y S +HRD+ N+++ ++L D+GL+
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLS 160
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 44/193 (22%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK---PVKKKKIKREIKILQNLCGGPNI 191
+ ++G+G + V + + +K L+ P +++ +REI+IL+ L I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI 86
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + ++ L+ E++ + DF + L + Y ++ K ++Y S+
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY-FK--GPELLVDL 303
+HRD+ N++++ + +++ D+GLA+ K+ Y VR + PE L D
Sbjct: 147 RCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 304 QDYDYSLDLWSLG 316
+ D+WS G
Sbjct: 206 I-FSRQSDVWSFG 217
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 40/230 (17%), Positives = 100/230 (43%), Gaps = 25/230 (10%)
Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEK 161
+ D ++ + ++ + ++D + ++++G+G + V + +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68
Query: 162 CI----IKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214
+K L+ ++ ++ REI+IL++L NIVK + + LI E++
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 215 N---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
D+ + + + Y ++ K ++Y ++ +HRD+ N++++ + ++++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKI 186
Query: 271 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
D+GL + Y V+ PE L + + + + D+WS G
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFG 235
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 42/194 (21%), Positives = 88/194 (45%), Gaps = 18/194 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + PN+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 278
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+LL + + P I E + D+ + +S + Y ++ A++Y
Sbjct: 279 VQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVD 302
+ +HR++ N ++ E +++ D+GL+ G Y +++ + PE L
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 303 LQDYDYSLDLWSLG 316
+ D+W+ G
Sbjct: 394 -NKFSIKSDVWAFG 406
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 35/180 (19%), Positives = 80/180 (44%), Gaps = 17/180 (9%)
Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IK 165
+ D++ + P + + + +GRG + V+ G ++ K I +K
Sbjct: 1 HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59
Query: 166 ILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
L + + + E I+++ PN++ LL I + +P ++ ++ + D +
Sbjct: 60 SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN- 116
Query: 222 Y-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ + D+ + ++ K + Y S+ +HRD+ N M+D E+ +++ D+GLA
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLA 175
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 41/204 (20%), Positives = 84/204 (41%), Gaps = 26/204 (12%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPV----KKKKIKREIKILQN 184
E+ R +G+G + V+ G + + I IK L + + + RE +++
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----VLYPTLSDYDVRYYIYELLKA 240
L PN++ L+ I+ + P ++ ++ + D + D+ + ++ +
Sbjct: 79 LN-HPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
++Y Q +HRD+ N M+D E +++ D+GLA + Y+V+
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHR---HARLPV 192
Query: 297 ----PELLVDLQDYDYSLDLWSLG 316
E L + D+WS G
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFG 215
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 3e-07
Identities = 50/388 (12%), Positives = 110/388 (28%), Gaps = 125/388 (32%)
Query: 60 LRGLASSASLSH---ARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVR 116
+ + S + H ++ +L TL K + V++ + + V+R
Sbjct: 42 PKSILSKEEIDHIIMSKDAVSGTLRLF---WTLLSKQEEMVQK---------FVE-EVLR 88
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK 176
+Y+ L + + Y E + ++ DN+ K V + +
Sbjct: 89 I----NYKFLMSPIKTEQ---RQPSMMTRMYIEQRDRLY-NDNQV-FAK--YNVSRLQPY 137
Query: 177 REIKI-LQNLCGGPNIV--------K--L-LDIVRDQ----------------QSKTPSL 208
+++ L L N++ K + LD+ +P
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 209 IFEHVNN--TDFKVLYPTLSDY---------DVRYYIYELLKALDYCHSQGIMHRDVKPH 257
+ E + + + SD+ ++ + LLK+ Y + ++ +V+
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQNA 256
Query: 258 NV--MIDHEQRKL---RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 312
+ + L R + +F ++ + + D L
Sbjct: 257 KAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISL--------DHHSMTLTPDEVKSL 306
Query: 313 WS--LGCMFAG----MVSVSPSVLFYVSGLGHSC---LNTW------------------- 344
L C +++ +P +S + S L TW
Sbjct: 307 LLKYLDCRPQDLPREVLTTNP---RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 345 ----------FLRTCSIPFFPLNLLIPI 362
S+ FP + IP
Sbjct: 364 NVLEPAEYRKMFDRLSV--FPPSAHIPT 389
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 2e-06
Identities = 26/161 (16%), Positives = 51/161 (31%), Gaps = 36/161 (22%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 179
+ D+E+ Q+ +D V + + F+ D K I+ K EI
Sbjct: 6 HMDFETGEHQYQYKDILSVFED----AFVDNFDCKDVQDMPKSILS----------KEEI 51
Query: 180 KILQNLCGGPNIV----KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS----DYDVR 231
++ + V +L + +Q + E V ++K L + +
Sbjct: 52 D---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 232 YYIYELLKALDYCHSQGIMHRDV---KPHNVMIDHEQRKLR 269
+Y + ++ D +NV KLR
Sbjct: 109 TRMYI------EQRDR--LYNDNQVFAKYNVSRLQPYLKLR 141
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 9e-04
Identities = 42/319 (13%), Positives = 90/319 (28%), Gaps = 84/319 (26%)
Query: 18 TTLFSS-FFAISSNTSSSRTTSVSKILFSPLSQSSRIF-----TPFGTLRGLASS----- 66
TT F +S+ T++ + + +P + + L +
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTP-DEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 67 -----ASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW 121
S+ + + D L I S+ +++ ++V P +
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNC--DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181
L++ W + +V+ V K K ++++ K
Sbjct: 388 PTILLSLIWFDVIKSDVMVVV-----------------NKL-------HKYSLVEKQPK- 422
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH---VNNTDFKVLYP--TLSDYDVRYYIYE 236
+ + + I + + K + H V++ + + L + Y Y
Sbjct: 423 -------ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS 475
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQ-----RKLRL-IDWGLAEFYHPGKEYNVRVA 290
H I H H I+H + R + L + + H +N +
Sbjct: 476 --------H---IGH-----HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 291 SRYFKGPELLVDLQDY-DY 308
L L+ Y Y
Sbjct: 520 I-----LNTLQQLKFYKPY 533
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 41/195 (21%), Positives = 82/195 (42%), Gaps = 22/195 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 241
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
V+L +V S+ P I E+++ + L + ++ + Y
Sbjct: 242 VQLYAVV----SEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLV 301
+HRD++ N+++ E ++ D+GLA EY R +++ K PE +
Sbjct: 297 ERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 354
Query: 302 DLQDYDYSLDLWSLG 316
+ D+WS G
Sbjct: 355 Y-GRFTIKSDVWSFG 368
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
D +E+ K+G G+Y EV+EGV + +K LK ++ ++ +E ++
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
+ + PN+V+LL + + P I E + + Y +S + Y
Sbjct: 64 KEIK-HPNLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMAT 118
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++ A++Y + +HRD+ N ++ E +++ D+GL+ G Y ++
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 30/185 (16%), Positives = 68/185 (36%), Gaps = 34/185 (18%)
Query: 111 DINVVRPREYWDYESLTVQWGEQDDYEVVR----KVGRGKYSEVFEGVHCTDNEKCIIKI 166
D + P + + + V W ++ + + +G+G +++ + + IIK
Sbjct: 311 DETKIIPN--YRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSY--LDFDVIIKE 366
Query: 167 LKP-----------VKKKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHV 213
++K + RE + L + G P + D ++ ++
Sbjct: 367 RVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDNKRIMMSYI 421
Query: 214 NNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
N K + D Y++ + + H ++H D+ N + D + L +ID+
Sbjct: 422 NGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD---KDLYIIDF 473
Query: 274 GLAEF 278
GL +
Sbjct: 474 GLGKI 478
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 41/218 (18%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIK 176
+ +D + R +G+G++ V E ++ + +K+LK ++
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFK---------VLYP 223
RE ++ P++ KL+ + ++K +I + + D
Sbjct: 74 REAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
L + ++ ++ ++Y S+ +HRD+ N M+ E + + D+GL+ + G
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGD 191
Query: 284 EYNVRVASRY-FK--GPELLVDLQDYDYSL--DLWSLG 316
Y AS+ K E L D Y++ D+W+ G
Sbjct: 192 YYRQGCASKLPVKWLALE---SLADNLYTVHSDVWAFG 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 41/194 (21%), Positives = 81/194 (41%), Gaps = 20/194 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 324
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+L +V S+ P I E+++ L + ++ + Y
Sbjct: 325 VQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVD 302
+HRD++ N+++ E ++ D+GLA EY R +++ K PE +
Sbjct: 381 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 438
Query: 303 LQDYDYSLDLWSLG 316
+ D+WS G
Sbjct: 439 -GRFTIKSDVWSFG 451
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 36/215 (16%), Positives = 86/215 (40%), Gaps = 37/215 (17%)
Query: 134 DDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIKRE 178
+D + + +G G++ V EG ++ + +K +K + ++ E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFEHVNNTDFK---------VLYPTLS 226
+++ PN+++LL + + S+ P +I + D +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ ++ ++ ++Y ++ +HRD+ N M+ + + + D+GL++ + G Y
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYR 204
Query: 287 VRVASRY-FK--GPELLVDLQDYDYSL--DLWSLG 316
++ K E L D Y+ D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIE---SLADRVYTSKSDVWAFG 236
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 35/217 (16%), Positives = 75/217 (34%), Gaps = 36/217 (16%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW--DYESLTVQWG 131
H H ++ + L + + A Y + + + +
Sbjct: 4 HHHH-----SSGRENLYFQGKLPEPQFYAEPH--TYEEPGRAGRSFTREIEASRIHI--- 53
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQN 184
+ +G G EV G ++ + IK LK +++ E I+
Sbjct: 54 -------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLK 239
PNI++L +V + ++I E++ N + + + + +
Sbjct: 107 FD-HPNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y G +HRD+ NV++D ++ D+GL+
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLS 198
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 33/172 (19%)
Query: 134 DDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP----VKKKKIKR 177
D++EV R++G+G + V+EGV + IK + ++ +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------VLYPT 224
E +++ ++V+LL +V Q +I E + D K +
Sbjct: 78 EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
S + E+ + Y ++ +HRD+ N M+ E +++ D+G+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMT 185
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 39/193 (20%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILKPVKKKKIK---REIKILQNLCGGPNI 191
++++G+G + V DN + +K L+ ++ ++ REI+IL++L NI
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNI 73
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + + LI E++ D+ + + + Y ++ K ++Y ++
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 303
+HRD+ N++++ + ++++ D+GL + + V+ PE L +
Sbjct: 134 RYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 304 QDYDYSLDLWSLG 316
+ + + D+WS G
Sbjct: 193 K-FSVASDVWSFG 204
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 29/209 (13%), Positives = 72/209 (34%), Gaps = 37/209 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKPV---KKKKIKREIKILQ 183
+D +G+G ++++F+GV + ++K+L + ++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYEL 237
L ++V + +++ E V Y ++ +L
Sbjct: 68 KLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAKQL 122
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI-------DWGLAEFYHPGKEYNVRV- 289
A+ + ++H +V N+++ E+ + D G++ P R+
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 290 --ASRYFKGPELLVDLQDYDYSLDLWSLG 316
PE + + ++ + + D WS G
Sbjct: 183 WVP------PECIENPKNLNLATDKWSFG 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 26/151 (17%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
++ +++++G G++ V G +K++K + + + +E + + L P +
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKL 65
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH 245
VK + + P I E+++N Y L + Y++ + + +
Sbjct: 66 VKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
S +HRD+ N ++D +++ D+G+
Sbjct: 122 SHQFIHRDLAARNCLVD-RDLCVKVSDFGMT 151
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 31/164 (18%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
+++ ++ +G G + V++G+ + EK IK L+ P K+I E ++ ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
P++ +LL I LI + + D+ + + + + ++ K +
Sbjct: 75 D-NPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+Y + ++HRD+ NV++ + +++ D+GLA+ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 43/223 (19%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
+ +E + +GRG + +V E +K+LK + + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------------- 219
E+KIL ++ N+V LL + +I E +
Sbjct: 78 MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ L+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLA 195
Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
+ +Y + +R K PE + D + Y D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 30/159 (18%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
+E+ ++++G G++ V G IK++K + + + E K++
Sbjct: 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVM 73
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYEL 237
NL +V+L + Q+ P I E++ N + + + ++
Sbjct: 74 MNLS-HEKLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+A++Y S+ +HRD+ N +++ +Q +++ D+GL+
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLS 167
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 41/206 (19%), Positives = 89/206 (43%), Gaps = 33/206 (16%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
+D++EV V ++G G++ EV+ G + K +K LK + E ++
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLM 62
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
+ L +V+L +V ++ P I E++ N + L+ +
Sbjct: 63 KQLQ-HQRLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAA 116
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-F 294
++ + + + + +HRD++ N+++ + ++ D+GLA EY R +++
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIE-DNEYTAREGAKFPI 174
Query: 295 K--GPELLVDLQDYDYSL--DLWSLG 316
K PE + +++ D+WS G
Sbjct: 175 KWTAPEAINYGT---FTIKSDVWSFG 197
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 17/155 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQNLC 186
+ + + VG G++ EV G ++K I IK LK +++ E I+
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 187 GGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKAL 241
PNI++L +V + P +I E++ N + + + + + +
Sbjct: 105 -HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y G +HRD+ N++I+ ++ D+GL
Sbjct: 161 KYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLG 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 29/156 (18%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQNL 185
+ +G G++ EV++G+ T + K IK LK ++ E I+
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKA 240
NI++L ++ + P +I E++ N + S + + +
Sbjct: 104 S-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y + +HRD+ N++++ ++ D+GL+
Sbjct: 160 MKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLS 194
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 40/223 (17%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
+E + +G G + +V E + +K+LKP +++ +
Sbjct: 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73
Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQ-------------------SKTPSLIFEHVNNT 216
E+K+L L NIV LL K S I +
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ L D+ + Y++ K + + S+ +HRD+ N+++ R ++ D+GLA
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA 192
Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
Y V+ +R K PE + + Y + D+WS G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 32/164 (19%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
+++ ++ +G G + V++G+ + EK IK L+ P K+I E ++ ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
P++ +LL I + T LI + + D+ + + + + ++ K +
Sbjct: 75 D-NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+Y + ++HRD+ NV++ + +++ D+GLA+ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 35/186 (18%), Positives = 73/186 (39%), Gaps = 40/186 (21%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------VKKKKI------------- 175
+ + +G GK S VF +C++K K VK+K+
Sbjct: 92 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 176 -KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI 234
+ E + LQ L G + K+ + +++ E ++ + + + +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHP-GKEY---NVRV 289
+L+ + + +GI+H D+ +NV++ E + +ID+ + E +E +VR
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRN 257
Query: 290 ASRYFK 295
YF
Sbjct: 258 IITYFS 263
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 24/150 (16%), Positives = 65/150 (43%), Gaps = 13/150 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ V+++G G++ V G + +K IK ++ + ++ E +++ L P +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 65
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYCHS 246
V+L + +Q P + E + + + + + ++ + + Y
Sbjct: 66 VQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++HRD+ N ++ E + +++ D+G+
Sbjct: 123 ACVIHRDLAARNCLVG-ENQVIKVSDFGMT 151
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 35/231 (15%), Positives = 85/231 (36%), Gaps = 15/231 (6%)
Query: 56 PFGTLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVV 115
G A+ +H R++ T + P + + +
Sbjct: 258 SASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFES 317
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILK----P 169
+ + + + + ++G G + V +GV+ ++ IK+LK
Sbjct: 318 PFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK 377
Query: 170 VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTL 225
+++ RE +I+ L P IV+L+ + Q++ L+ E +
Sbjct: 378 ADTEEMMREAQIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEI 433
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+V ++++ + Y + +HR++ NV++ + ++ D+GL+
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLS 483
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 32/167 (19%), Positives = 71/167 (42%), Gaps = 16/167 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ ++ +K+G G++ EV+ + K +K +KP + + E +++ L +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKL 245
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
VKL +V +K P I E + DF + + ++ + + +
Sbjct: 246 VKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
+ +HRD++ N+++ ++ D+GLA EY R ++
Sbjct: 302 QRNYIHRDLRAANILVS-ASLVCKIADFGLARVIE-DNEYTAREGAK 346
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 34/198 (17%), Positives = 71/198 (35%), Gaps = 40/198 (20%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
E +E + +G G + +V + +K+LK
Sbjct: 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E +++ D+G
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFG 202
Query: 275 LAEFYHPGKEYNVRVASR 292
LA + Y R
Sbjct: 203 LARDINNIDYYKKTTNGR 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 28/152 (18%), Positives = 68/152 (44%), Gaps = 17/152 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 77
Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
+LL ++ +++ L + E++ Y L + + ++ +A++Y
Sbjct: 78 QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+HRD+ NV++ E ++ D+GL
Sbjct: 134 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLT 164
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 39/251 (15%), Positives = 83/251 (33%), Gaps = 49/251 (19%)
Query: 72 ARHQHQRLRQLATPPDTLAQKIG----KSVRRSGAPSKARVYSDINVVRPREYWDYESLT 127
+ H H Q L ++I +V + S + + +
Sbjct: 3 SSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPML 62
Query: 128 VQWGEQ-----DDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILK 168
E +E + +G G + +V + +K+LK
Sbjct: 63 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 122
Query: 169 P----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 123 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRA 180
Query: 220 --------------VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E
Sbjct: 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-EN 239
Query: 266 RKLRLIDWGLA 276
+++ D+GLA
Sbjct: 240 NVMKIADFGLA 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 34/195 (17%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNLCGGPN 190
++ +G G + V +GV + E IK+++ + + + + +L +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAH 76
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHS 246
IV+LL + L+ +++ D + L + + ++ K + Y
Sbjct: 77 IVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDL 303
G++HR++ NV++ ++++ D+G+A+ P + + ++ K E +
Sbjct: 134 HGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE---SI 189
Query: 304 QDYDYSL--DLWSLG 316
Y+ D+WS G
Sbjct: 190 HFGKYTHQSDVWSYG 204
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 34/187 (18%), Positives = 64/187 (34%), Gaps = 40/187 (21%)
Query: 117 PREYW--DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILKP--- 169
P Y D+ + Q +G G + +V + D + IK +K
Sbjct: 16 PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 170 -VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK--------- 219
+ E+++L L PNI+ LL + L E+ + +
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123
Query: 220 ---VLYPTLSDYDVRYYIYELLK-ALD------YCHSQGIMHRDVKPHNVMIDHEQRKLR 269
+ + +LL A D Y + +HRD+ N+++ E +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAK 182
Query: 270 LIDWGLA 276
+ D+GL+
Sbjct: 183 IADFGLS 189
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 32/164 (19%), Positives = 66/164 (40%), Gaps = 29/164 (17%)
Query: 134 DDYEVVR--------KVGRGKYSEVFEGVHCTDNEKCI--IKILKP----VKKKKIKREI 179
+ R ++G G + V +GV+ ++ IK+LK +++ RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL- 238
+I+ L P IV+L+ + Q++ L+ E L+ L + +
Sbjct: 62 QIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGP---LHKFLVGKREEIPVSNVAE 114
Query: 239 ------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y + +HRD+ NV++ + ++ D+GL+
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLS 157
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 32/176 (18%), Positives = 67/176 (38%), Gaps = 25/176 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP------VKKKKIKREIKILQN 184
D ++ K+G G + V G + K + +K LKP RE+ + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL------ 238
L N+++L +V K ++ E L L + + + L
Sbjct: 78 LD-HRNLIRLYGVVLTPPMK---MVTELAPLGS---LLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 239 -KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASR 292
+ + Y S+ +HRD+ N+++ + +++ D+GL Y ++ +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 35/213 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
++ + + +G G + +V E K +K+LK +K+ + E+KI+ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSL-IFEHVNNTDFK-----------------VLYPTLS 226
L NIV LL P L I E+ D + T S
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
D+ ++ ++ + + + S+ +HRDV NV++ ++ D+GLA Y
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 287 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
V+ +R K PE + D Y D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
+++G G + V +G + +KILK P K ++ E ++Q L P IV
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 81
Query: 193 KLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+++ I ++++ L+ E + + D ++ ++++ + Y
Sbjct: 82 RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+HRD+ NV++ Q ++ D+GL++ + Y
Sbjct: 139 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 173
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 32/182 (17%), Positives = 68/182 (37%), Gaps = 40/182 (21%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
E +E+ + +G G + +V K +K+LK
Sbjct: 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 119
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+G
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFG 236
Query: 275 LA 276
LA
Sbjct: 237 LA 238
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 28/161 (17%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 249
Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
+LL ++ +++ L + E++ Y L + + ++ +A++Y
Sbjct: 250 QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+HRD+ NV++ E ++ D+GL + ++
Sbjct: 306 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDT 345
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 40/236 (16%), Positives = 81/236 (34%), Gaps = 33/236 (13%)
Query: 69 LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTV 128
+S+ H H + T + Q S +S +++ + + + +Y
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRT--STIMTDYNPNYCFAGK 58
Query: 129 QWGEQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPV----KK 172
D EV +R +G G + EV+EG + + +K L V +
Sbjct: 59 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLY 222
E I+ NIV+ + + ++ E + D K
Sbjct: 119 LDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLA 276
+L+ D+ + ++ Y +HRD+ N ++ R ++ D+G+A
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 28/207 (13%), Positives = 70/207 (33%), Gaps = 38/207 (18%)
Query: 96 SVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEG-- 153
G+ + + + + + D + ++G G + +VF
Sbjct: 11 PTEGKGSGLQGHIIENPQYFSDACVHHIK--------RRDIVLKWELGEGAFGKVFLAEC 62
Query: 154 ---VHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207
+ D +K LK + + RE ++L L +IV+ + + +
Sbjct: 63 HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCT--EGRPLL 119
Query: 208 LIFEHVNNTDFK------------------VLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
++FE++ + D V L + ++ + Y
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+HRD+ N ++ + +++ D+G++
Sbjct: 180 VHRDLATRNCLVG-QGLVVKIGDFGMS 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 33/183 (18%), Positives = 63/183 (34%), Gaps = 31/183 (16%)
Query: 122 DYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP 169
+Y D EV +R +G G + EV+EG + + +K L
Sbjct: 11 NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 170 V----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------ 219
V + E I+ NIV+ + + ++ E + D K
Sbjct: 71 VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILMELMAGGDLKSFLRET 127
Query: 220 ----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDW 273
+L+ D+ + ++ Y +HRD+ N ++ R ++ D+
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 274 GLA 276
G+A
Sbjct: 188 GMA 190
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 46/221 (20%), Positives = 80/221 (36%), Gaps = 42/221 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
++ E + +G G + +V + + +K+LK +++ + E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLYPTLSDYDVRYYI 234
L NIV LL LIFE+ D + R
Sbjct: 105 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 235 YELLKAL----------------DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
E L L ++ + +HRD+ NV++ + +++ D+GLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARD 221
Query: 279 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
Y VR +R K PE L + Y D+WS G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 39.7 bits (92), Expect = 9e-04
Identities = 34/204 (16%), Positives = 66/204 (32%), Gaps = 40/204 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 193
+ + GK + VF D + +KI + + K + + + +
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 194 LLDIVRDQQSK----------------TPSLIFEHVNNTDF-----------KVLYPTLS 226
+ V K P ++V +F L L
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 227 DYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKE 284
+ DV ++++ + + + ++H D+ +N+M K+ ID G A HP E
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDMGQAVTLRHPMAE 225
Query: 285 YN----VRVASRYFK--GPELLVD 302
VR R+F G + +
Sbjct: 226 SYLERDVRNIIRFFSKYGVKADFE 249
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.54 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.81 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.44 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.36 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.44 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.86 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.03 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=394.05 Aligned_cols=192 Identities=28% Similarity=0.509 Sum_probs=173.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||+||+|+++.+++.||||++.. ...+.+.+|+++|+++ +|||||++++++.+. ..+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~y 108 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKLY 108 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEE
Confidence 579999999999999999999999999999999863 2346789999999999 999999999999764 4678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+|||||++|+|..++ ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCC
Confidence 999999999998775 4699999999999999999999999999999999999999766 89999999999875432
Q ss_pred --cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 --~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|||||++.+ +.|+.++|||||||+||||++|++||.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 3456799999999999987 789999999999999999999999994
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=395.99 Aligned_cols=192 Identities=20% Similarity=0.389 Sum_probs=173.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~---~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+.|+++++||+|+||+||+|+++.+|+.||||++.. ...+.+.+|+++|+++ +|||||++++++.+. ..+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEE
Confidence 569999999999999999999999999999999863 2346688999999999 999999999999875 4578999
Q ss_pred eccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccccc
Q 016537 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 287 (387)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~ 287 (387)
|||++|+|..++ ..+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... ...+.
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCC
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccc
Confidence 999999998776 4699999999999999999999999999999999999999776 8999999999887544 34567
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 230 ~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 230 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 899999999999877 789999999999999999999999994
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=398.31 Aligned_cols=194 Identities=20% Similarity=0.454 Sum_probs=166.9
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
..++|+++++||+|+||+||+|+++.+|+.||||++... ..+.+.+|+++|++| +|||||++++++.+. ..+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~--~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEEN--GSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEEC--CEE
Confidence 347999999999999999999999999999999998643 236788999999999 999999999999864 457
Q ss_pred eEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
|+|||||++|+|..++. .+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecC
Confidence 89999999999987752 368899999999999999999999999999999999999766 899999999987654
Q ss_pred CCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... .+..+||+.|||||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 322 345689999999999987 789999999999999999999999994
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=380.19 Aligned_cols=193 Identities=23% Similarity=0.404 Sum_probs=168.9
Q ss_pred CCe-EEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCCC
Q 016537 134 DDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (387)
Q Consensus 134 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~--~~~~ 205 (387)
++| ++.++||+|+||+||+|.+..+++.||+|.+... ..+.+.+|+++|++| +|||||++++++.+. ....
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcE
Confidence 455 7888999999999999999999999999998643 236689999999999 999999999998653 2346
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
++||||||++|+|..++ ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+++.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 78999999999998776 45899999999999999999999998 99999999999998644589999999998643
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......+||+.|||||++.+ .|+.++|||||||+||||+||++||.
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 334566799999999999864 59999999999999999999999993
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=379.72 Aligned_cols=192 Identities=25% Similarity=0.522 Sum_probs=155.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||+||+|+++.+++.||||++... ..+.+.+|+++|+++ +|||||++++++.+. ...+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSK--DEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEE
Confidence 6899999999999999999999999999999998642 235789999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+|||||+ |+|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC--------
T ss_pred EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCCc
Confidence 9999995 5665443 4699999999999999999999999999999999999999666 899999999988776666
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|||||++.+...++.++|||||||+||||++|++||.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence 6778999999999999874445789999999999999999999993
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=398.67 Aligned_cols=192 Identities=20% Similarity=0.389 Sum_probs=174.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~---~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+.|+++++||+|+||.||+|+++.+|+.||||++.. ...+.+.+|+.+|+++ +|||||++++++.+. ..+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEEC--CEEEEEE
Confidence 579999999999999999999999999999999863 3346789999999999 999999999999875 4578999
Q ss_pred eccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccccc
Q 016537 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 287 (387)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~~~ 287 (387)
|||++|+|..++ ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... .....
T Consensus 228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBCC
T ss_pred eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCccccc
Confidence 999999998776 4699999999999999999999999999999999999999776 8999999999887544 34567
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 307 ~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 307 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp CEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 899999999999877 789999999999999999999999994
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=389.70 Aligned_cols=191 Identities=24% Similarity=0.376 Sum_probs=168.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
+.|++.++||+|+||.||+|+++.+|+.||||+++... ...+|+.+++++ +|||||++++++.+. ..+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~~--~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVREG--PWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEET--TEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEEecc
Confidence 67999999999999999999999999999999997543 235799999999 999999999999864 4578999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc------
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE------ 284 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~------ 284 (387)
++|+|..++ ..+++..++.++.||+.||+|||+++||||||||+||||+.++..+||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 999998876 45999999999999999999999999999999999999997765799999999988754432
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|||||++.+ ..|+.++|||||||+||||+||++||.
T Consensus 213 ~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~ 257 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT 257 (336)
T ss_dssp -CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred CCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 123579999999999988 789999999999999999999999994
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=382.46 Aligned_cols=192 Identities=27% Similarity=0.444 Sum_probs=163.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++|++++.||+|+||+||+|++. .+++.||||+++.. ...++.+|+++|+++ +|||||++++++.+. ..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~ 100 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTE--GK 100 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEET--TE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CE
Confidence 67999999999999999999874 46789999998642 235688999999999 999999999999875 45
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.|+|||||++|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccCC
Confidence 78999999999997776 4699999999999999999999999999999999999999766 8999999999865433
Q ss_pred -CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+||+.|||||++.+ ..|+.++|||||||+||||+||++||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 34456799999999999987 789999999999999999999999994
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=386.41 Aligned_cols=198 Identities=30% Similarity=0.597 Sum_probs=170.5
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---- 201 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~---- 201 (387)
...++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+++|++| +|||||++++++...
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccc
Confidence 3357899999999999999999999999999999999643 235678999999999 999999999998643
Q ss_pred CCCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
+...+|+|||||++ +|..++ +.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.
T Consensus 130 ~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~ 207 (398)
T 4b99_A 130 EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARG 207 (398)
T ss_dssp TCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred cCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeee
Confidence 23567999999975 555544 3599999999999999999999999999999999999999666 899999999987
Q ss_pred ecCC-----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 279 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+... ......+||++|||||++.+...|+.++||||+||++|||++|++||..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 6432 2345679999999999998866789999999999999999999999953
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=374.41 Aligned_cols=189 Identities=17% Similarity=0.357 Sum_probs=159.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
+++++.++||+|+||+||+|+++ ..||||+++.. ..+.|.+|+++|+++ +|||||++++++.+ ...+|
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~~i 108 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNLAI 108 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeEEE
Confidence 67889999999999999999863 35899998632 236789999999999 99999999998854 34689
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC--
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-- 282 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-- 282 (387)
|||||++|+|..++ ..+++..+..++.||+.||+|||+++||||||||+||||+.++ .+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecccCCc
Confidence 99999999998765 3489999999999999999999999999999999999999655 8999999999876432
Q ss_pred -CcccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 -KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+||+.|||||++.+ ...|+.++|||||||+||||+||++||.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 22355689999999999864 2458999999999999999999999994
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=375.66 Aligned_cols=193 Identities=20% Similarity=0.364 Sum_probs=166.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|.+.++||+|+||+||+|++. .+++.||||+++... .+.|.+|+++|+++ +|||||+++|++.+. .
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~--~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG--D 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC--C
Confidence 368999999999999999999874 357899999997543 36789999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceE
Q 016537 205 TPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~v 268 (387)
..++|||||++|+|..++. .+++.++..++.||+.||+|||+++||||||||+||||+.++ .+
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~~ 167 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV 167 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-cE
Confidence 5789999999999987762 488999999999999999999999999999999999999665 89
Q ss_pred EEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 269 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 269 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||+|||+|+........ ...+||+.|||||++.+ +.|+.++|||||||+||||+| |++||.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999866443322 23468999999999987 789999999999999999999 899994
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=375.29 Aligned_cols=192 Identities=17% Similarity=0.301 Sum_probs=160.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++|.+.++||+|+||+||+|++. .+++.||||+++... .+.|.+|+++|+++ +|||||+++|+|.+. ..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~--~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEG--RP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CE
Confidence 67889999999999999999874 358899999997543 36789999999999 999999999999764 45
Q ss_pred ceEEEeccCCCchhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCce
Q 016537 206 PSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~ 267 (387)
.++|||||++|+|..++. .+++.++..++.||+.||+|||+++||||||||+||||+.++ .
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~-~ 196 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-V 196 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC-c
Confidence 789999999999987652 378899999999999999999999999999999999999665 8
Q ss_pred EEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 268 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 268 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+||+|||+|+....... ....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCC
Confidence 99999999987654332 234579999999999987 789999999999999999999 899994
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=371.39 Aligned_cols=192 Identities=19% Similarity=0.362 Sum_probs=166.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
+++++.++||+|+||+||+|.+. .+++.||||+++.. ..+.|.+|+.+++++ +|||||+++|+|.+. .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~--~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKD--Q 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEEC--C
Confidence 57889999999999999999863 35789999999643 247899999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC
Q 016537 205 TPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 265 (387)
..++|||||++|+|..++ ..+++.++..++.||+.||+|||+++||||||||+||||+.++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 567999999999998775 2378899999999999999999999999999999999999665
Q ss_pred ceEEEEecccceeecCCC---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 266 RKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.+||+|||+|+...... .....+||+.|||||++.+ +.|+.++|||||||+||||+| |.+||.
T Consensus 183 -~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 183 -NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp -CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred -CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 89999999998764332 2345689999999999987 789999999999999999999 899994
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=377.91 Aligned_cols=195 Identities=28% Similarity=0.469 Sum_probs=171.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.++||+|+||+||+|+++ .+++.||+|.+... ...++.+|+++|+.+.+||||+++++++.+. ...++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEEE
Confidence 68999999999999999999875 35789999988644 4467889999999987899999999999764 467899
Q ss_pred EeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC------
Q 016537 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK------ 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~------ 283 (387)
||||++++|..+++.+++.+++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+...+..
T Consensus 99 mE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~ 178 (361)
T 4f9c_A 99 MPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKF 178 (361)
T ss_dssp EECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGG
T ss_pred EeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccc
Confidence 99999999999999999999999999999999999999999999999999998775689999999998654321
Q ss_pred -----------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+..+||+.|||||++.+...|+.++||||+||++|||++|++||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp C--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 12345899999999999876679999999999999999999999994
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=369.82 Aligned_cols=188 Identities=23% Similarity=0.444 Sum_probs=153.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC------
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~------ 203 (387)
++|++++.||+|+||+||+|+++.+++.||||+++... .+.+.+|+++|++| +|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999999999999999986322 35688999999999 99999999999876432
Q ss_pred ----CCceEEEeccCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEec
Q 016537 204 ----KTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (387)
Q Consensus 204 ----~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DF 273 (387)
.++|+|||||.+|+|..++.. ..+..++.++.||+.||+|||++|||||||||+||||+.++ .+||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccC
Confidence 246899999999999877632 34556889999999999999999999999999999999766 8999999
Q ss_pred ccceeecCCCc-------------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh
Q 016537 274 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324 (387)
Q Consensus 274 G~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt 324 (387)
|+|+.+..+.. .+..+||+.|||||++.+ ..|+.++|||||||+||||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc
Confidence 99987654321 234589999999999987 789999999999999999996
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=373.38 Aligned_cols=195 Identities=21% Similarity=0.350 Sum_probs=168.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.++||+|+||+||+|.+... ++.||||.++... .+.+.+|+++|.++.+|||||+++|+|.+..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~- 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-
Confidence 37899999999999999999998654 3689999997532 3568899999999966699999999986542
Q ss_pred CCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 264 (387)
..+++|||||++|+|..+++ .+++.++..++.||+.||+|||+++||||||||+|||++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 45689999999999987752 27889999999999999999999999999999999999966
Q ss_pred CceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 265 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 265 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+ .+||+|||+|+....+.. ....+||+.|||||++.+ +.|+.++|||||||+||||+| |++||.
T Consensus 222 ~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 222 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp G-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred C-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 5 899999999987654433 234578999999999987 789999999999999999998 899994
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=359.13 Aligned_cols=193 Identities=19% Similarity=0.266 Sum_probs=160.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHH--HHHHhcCCCCeeEEEEEEEcCCCC--CceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIK--ILQNLCGGPNIVKLLDIVRDQQSK--TPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~--il~~l~~hpniv~l~~~~~~~~~~--~~~lv 209 (387)
.+|.+.++||+|+||+||+|++ +|+.||||+++....+.+.+|.+ .+.++ +|||||++++++.+.+.. .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 4688999999999999999987 68999999998766666555544 44567 999999999999865432 46899
Q ss_pred EeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHc--------CceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~--------~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
||||++|+|..++ ..+++..+..++.|++.||+|||++ +||||||||+||||+.++ .+||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccc
Confidence 9999999998876 4588999999999999999999987 999999999999999666 8999999999887
Q ss_pred cCCCcc-----cccccccCCCCchhhcccC-----CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...... ...+||+.|||||++.+.. .|+.++|||||||+||||+||.+||.
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 654322 2458999999999986521 36779999999999999999998873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=386.02 Aligned_cols=193 Identities=26% Similarity=0.422 Sum_probs=168.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHH---HHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKRE---IKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E---~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++++.||+|+||.||+|+++.+|+.||||++.+. ......+| +.+++.+ +|||||++++++.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~-- 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP-- 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS--
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEEC--
Confidence 47899999999999999999999999999999999632 22334445 4444555 899999999999765
Q ss_pred CCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..+|||||||.||+|..++ ..+++..++.|+.||+.||+|||++|||||||||+||||+.++ ++||+|||+|+.+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeecC
Confidence 4678999999999998776 4699999999999999999999999999999999999999776 89999999998875
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ..+.+||+.|||||++.+...|+.++|||||||+||||++|++||.
T Consensus 344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 543 4567999999999999754579999999999999999999999994
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=380.03 Aligned_cols=193 Identities=23% Similarity=0.430 Sum_probs=175.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++|++++.||+|+||.||+|+++.+|+.||+|++.... .+.+.+|+++|+.| +|||||++++++.+. ..++|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECS--SEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEE
Confidence 68999999999999999999999999999999986533 35688999999999 999999999999764 5678999
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC-CceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||++|+|...+ ..+++.+++.++.||+.||+|||+++|+||||||+|||++.+ .+.+||+|||+|+.+.+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999997665 248899999999999999999999999999999999999854 348999999999998887777
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+||+.|||||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 88899999999999988 789999999999999999999999994
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=346.19 Aligned_cols=226 Identities=76% Similarity=1.317 Sum_probs=205.4
Q ss_pred cceeeccCCcCCCCccccccccccccCCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHH
Q 016537 105 KARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQN 184 (387)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~ 184 (387)
.+....+.+...+.++|+++...+.+...++|++.+.||+|+||.||+|.+..+++.||||+++....+.+.+|++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~ 86 (330)
T 3nsz_A 7 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILEN 86 (330)
T ss_dssp CCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHH
T ss_pred ceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHH
Confidence 33445566667788888888888888888999999999999999999999999999999999998888999999999999
Q ss_pred hcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC
Q 016537 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 185 l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 264 (387)
+.+||||+++++++.+......++||||+.++++..+++.+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 87 l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~ 166 (330)
T 3nsz_A 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 166 (330)
T ss_dssp HTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred cCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCC
Confidence 95699999999999886677789999999999999999999999999999999999999999999999999999999977
Q ss_pred CceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 265 QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 265 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+..+||+|||+++............++..|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 167 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 668999999999988777666777899999999999776679999999999999999999999983
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=337.65 Aligned_cols=193 Identities=25% Similarity=0.487 Sum_probs=172.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+++.||+|+++... ...+.+|..+++++.+||||+++++++.+. ...+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~~ 129 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLF 129 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CEEE
Confidence 68999999999999999999999999999999997432 245788999999887999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee-ecCCC
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~-~~~~~ 283 (387)
+||||+++++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+. ...+.
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTC
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccCCC
Confidence 999999999987665 4699999999999999999999999999999999999999766 899999999986 33444
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred ccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 5567799999999999987 789999999999999999999999994
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.94 Aligned_cols=193 Identities=26% Similarity=0.514 Sum_probs=172.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++.+ +||||+++++++.+. ...++
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~l 91 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETE--KTLYL 91 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CEEEE
Confidence 7899999999999999999999999999999998643 235678999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||||++++++..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....+...
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSCGG
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCCcc
Confidence 99999999987765 5699999999999999999999999999999999999999666 8999999999887766667
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+||+.|+|||++.+....+.++|||||||++|||++|++||.
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 215 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 778999999999999874434589999999999999999999994
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.07 Aligned_cols=193 Identities=24% Similarity=0.411 Sum_probs=166.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+++.||||+++.. ....+.+|.++++.+.+||||+++++++.+. ...+
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~~ 100 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DRLF 100 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CEEE
Confidence 7899999999999999999999999999999998643 2356788999999987899999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CC
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~ 283 (387)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNGV 179 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC---
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCCc
Confidence 999999999997665 4699999999999999999999999999999999999999766 899999999986432 33
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 180 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp ------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCC
Confidence 4456789999999999977 679999999999999999999999994
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.21 Aligned_cols=196 Identities=26% Similarity=0.491 Sum_probs=168.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|++++.||+|+||.||+|.+..+++.||||++... ..+++.+|+.+++.+ +||||+++++++.....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccC
Confidence 48899999999999999999999999999999998642 236678999999999 99999999999975432
Q ss_pred CCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
...++||||++++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 218 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----CC
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCCCc
Confidence 35689999999887777777899999999999999999999999999999999999999766 89999999998877666
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
..+..+||+.|+|||++.+ ..|+.++|||||||+||||++|++||..
T Consensus 219 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp CC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 6677899999999999988 6899999999999999999999999943
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=328.66 Aligned_cols=192 Identities=23% Similarity=0.427 Sum_probs=171.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+++.||+|+++.. ....+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--~~~~ 81 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeC--CEEE
Confidence 6899999999999999999999999999999998642 346688999999998 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCC
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~ 283 (387)
+||||+++++|...+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .+.
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCCC
Confidence 999999999987665 4589999999999999999999999999999999999999766 89999999998643 333
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCC
Confidence 4566789999999999877 679999999999999999999999984
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.64 Aligned_cols=196 Identities=23% Similarity=0.408 Sum_probs=174.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++++ +||||+++++++.+......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEE
Confidence 47899999999999999999999989999999998743 246778999999999 8999999999998776667899
Q ss_pred EEeccCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeE----cCCCceEEEEeccccee
Q 016537 209 IFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 209 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl----~~~~~~vkl~DFG~a~~ 278 (387)
||||+++++|..++.. +++..++.++.|++.||+|||++||+||||||+|||+ +. ...+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~-~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFGAARE 165 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTS-CEEEEECCCTTCEE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCC-CceEEEccCCCcee
Confidence 9999999999877643 8999999999999999999999999999999999998 53 34799999999998
Q ss_pred ecCCCcccccccccCCCCchhhcc-------cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...........||+.|+|||++.. ...++.++|||||||++|||++|++||.
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 877666667789999999999862 2578999999999999999999999994
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=337.46 Aligned_cols=194 Identities=27% Similarity=0.434 Sum_probs=170.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++++.||+|+||.||+|+++.+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~ 144 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDD--RYL 144 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECS--SEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEE
Confidence 47899999999999999999999999999999998642 224578999999998 999999999999764 567
Q ss_pred eEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
++||||+++|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCCc
Confidence 8999999999998776 3589999999999999999999999999999999999999766 899999999987755432
Q ss_pred --ccccccccCCCCchhhcccC---CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 --YNVRVASRYFKGPELLVDLQ---DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 --~~~~~gt~~y~aPE~~~~~~---~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+.. .|+.++|||||||+||||++|++||.
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 34678999999999997632 17899999999999999999999994
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.92 Aligned_cols=193 Identities=26% Similarity=0.477 Sum_probs=171.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+++.||+|+++... .+.+.+|..+++++.+||||+++++++.+. ...+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLF 86 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CEEE
Confidence 68999999999999999999999999999999996432 245788999999887899999999999764 4678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CCC
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~~ 283 (387)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .+.
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCCCC
Confidence 999999999997665 4589999999999999999999999999999999999999666 89999999998643 334
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 4566789999999999987 679999999999999999999999994
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=333.14 Aligned_cols=195 Identities=30% Similarity=0.639 Sum_probs=160.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++++.||+|+||.||+|.+..+++.||||++... ...++.+|+.+++++.+||||+++++++...+....++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 7899999999999999999999999999999998532 23567899999999956999999999998766667899
Q ss_pred EEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-----
Q 016537 209 IFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP----- 281 (387)
Q Consensus 209 v~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~----- 281 (387)
|||||++ +|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 89 v~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 89 VFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCCC
T ss_pred EecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCccccccccccccc
Confidence 9999995 665544 4588999999999999999999999999999999999999766 899999999986532
Q ss_pred -----------------CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 -----------------GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+..+||++|+|||++.+...|+.++|||||||++|||++|++||.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 1123446899999999999876679999999999999999999999994
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.92 Aligned_cols=193 Identities=26% Similarity=0.478 Sum_probs=173.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
+.|++.+.||+|+||.||+|.++.+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~ 88 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENR--T 88 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--S
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeC--C
Confidence 78999999999999999999999999999999986432 36789999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc---eEEEEeccccee
Q 016537 205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF 278 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---~vkl~DFG~a~~ 278 (387)
..++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 5789999999999987763 4899999999999999999999999999999999999986553 699999999998
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 877666677789999999999876 679999999999999999999999994
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=325.83 Aligned_cols=194 Identities=22% Similarity=0.391 Sum_probs=172.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|+++.+++.||||+++.. ....+.+|..++..+.+||||+++++++.+. ...
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~~ 93 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENL 93 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CEE
Confidence 47899999999999999999999999999999998642 3456788999999877999999999999764 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-C
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~ 282 (387)
++||||+++|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCC
Confidence 8999999999998776 4689999999999999999999999999999999999999766 899999999986533 2
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence 34456789999999999987 679999999999999999999999984
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.22 Aligned_cols=193 Identities=22% Similarity=0.471 Sum_probs=173.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~~ 91 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDE--EDMF 91 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CEEE
Confidence 7899999999999999999999999999999998632 236788999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTCC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCCc
Confidence 9999999999977763 589999999999999999999999999999999999999666 899999999998877666
Q ss_pred ccccccccCCCCchhhccc--CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 7788999999999998642 458999999999999999999999994
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.52 Aligned_cols=194 Identities=25% Similarity=0.400 Sum_probs=170.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++++.||+|+||.||+|+++.+++.||+|+++... ...+.+|+.++..+ +||||+++++++.+. ...
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~~ 149 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDD--NNL 149 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CEE
Confidence 478999999999999999999999999999999986422 23478999999998 999999999999764 457
Q ss_pred eEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++|||||.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcccC
Confidence 8999999999998776 3489999999999999999999999999999999999999666 8999999999876544
Q ss_pred Ccc--cccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEY--NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~--~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ...+||+.|+|||++.. ...|+.++|||||||++|||++|++||.
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 332 34689999999999862 3568999999999999999999999994
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=317.99 Aligned_cols=195 Identities=27% Similarity=0.526 Sum_probs=168.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHHH
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQN 184 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------------------------~~~~~~E~~il~~ 184 (387)
++|++.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 78999999999999999999999999999999986432 2457899999999
Q ss_pred hcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 185 l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
+ +||||+++++++.+......++||||++++++..+.. .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 93 l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 93 L-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp C-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred C-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9 9999999999998766677899999999999877653 489999999999999999999999999999999999999
Q ss_pred CCCceEEEEecccceeecCCC-cccccccccCCCCchhhcccCC--CCCccchhhHHHHHHHHHhcCCchh
Q 016537 263 HEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.++ .+||+|||+++...... ......||+.|+|||++.+... ++.++|||||||++|||++|++||.
T Consensus 172 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 172 EDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp TTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 666 89999999998765443 2345689999999999876322 4778999999999999999999983
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=326.45 Aligned_cols=194 Identities=22% Similarity=0.358 Sum_probs=171.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++++.||+|+||.||+|+++.+++.||||+++.. ..+.+.+|..++..+.+||||+++++++.+. ...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CEE
Confidence 37899999999999999999999888999999998642 3356788999998877899999999999764 467
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~ 282 (387)
++||||+++++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .+
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCC
Confidence 8999999999997765 4689999999999999999999999999999999999999766 89999999998643 23
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC
Confidence 34456789999999999977 679999999999999999999999994
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=328.87 Aligned_cols=195 Identities=18% Similarity=0.281 Sum_probs=169.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEE-----EeCCCeEEEEEEecccchHHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPVKKKKIKREIKILQNLCG---GPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~---hpniv~l~~~~~~~~~~ 204 (387)
.++|.+.+.||+|+||.||+|. +..+++.||||+++......+.+|+++++++ + |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~~~~~~-- 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL-KPSMQHMFMKFYSAHLFQN-- 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHS-CGGGGGGBCCEEEEEECSS--
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHh-hhhhhhhhhhhheeeecCC--
Confidence 4789999999999999999994 5678899999999988888999999999998 5 899999999997654
Q ss_pred CceEEEeccCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC----------Cc
Q 016537 205 TPSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----------QR 266 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~----------~~ 266 (387)
..++||||+++++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ ..
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 467999999999998776 248999999999999999999999999999999999999861 34
Q ss_pred eEEEEecccceeec---CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 267 KLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 267 ~vkl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.+||+|||+|+.+. ........+||..|+|||++.+ ..|+.++|||||||++|||++|++||..
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999997653 2334456789999999999987 6799999999999999999999999843
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.38 Aligned_cols=194 Identities=23% Similarity=0.438 Sum_probs=173.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+|+++++.+ +||||+++++++.+. ...++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecC--CEEEEEE
Confidence 478999999999999999999999999999999986443 35678999999999 999999999999764 4578999
Q ss_pred eccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC-CceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+++++|...+. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +..+||+|||+++....+...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 9999999977663 48899999999999999999999999999999999999852 448999999999988777666
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 77889999999999877 568999999999999999999999994
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=318.36 Aligned_cols=193 Identities=24% Similarity=0.468 Sum_probs=171.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~---~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++.. ...+.+.+|+.+++++ +||||+++++++.+. ...++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEEC--CEEEEE
Confidence 3679999999999999999999989999999999853 3356788999999999 999999999999864 357899
Q ss_pred EeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
|||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccC
Confidence 9999999998776 3489999999999999999999999999999999999999666 89999999998765443 334
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5689999999999987 679999999999999999999999994
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=332.55 Aligned_cols=194 Identities=26% Similarity=0.392 Sum_probs=170.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++++.||+|+||.||+|+++.+++.||||++++.. ...+.+|..++..+ +||||+++++++.+. ...
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~~ 136 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDE--NYL 136 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeC--CEE
Confidence 478999999999999999999999999999999996421 23478899999998 999999999999764 467
Q ss_pred eEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheeccCC
Confidence 8999999999998775 3589999999999999999999999999999999999999666 8999999999877654
Q ss_pred Cc--ccccccccCCCCchhhcc------cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE--YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~--~~~~~gt~~y~aPE~~~~------~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 43 234689999999999873 2468999999999999999999999994
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=319.79 Aligned_cols=190 Identities=22% Similarity=0.444 Sum_probs=169.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+. ...+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~~ 82 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQIF 82 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeC--CEEE
Confidence 6899999999999999999999999999999998642 345678899999998 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--V 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--C
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC--c
Confidence 999999999998776 4589999999999999999999999999999999999999666 899999999987543 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 345689999999999877 679999999999999999999999984
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=330.55 Aligned_cols=194 Identities=26% Similarity=0.456 Sum_probs=162.5
Q ss_pred CCeEEE-eeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCCCceEEE
Q 016537 134 DDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~--~~~~~~~lv~ 210 (387)
++|.+. +.||+|+||.||+|.++.+++.||||++.. ...+.+|++++.++.+||||+++++++.. .+..+.++||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 678887 789999999999999999999999999964 35678899998777799999999998864 2345678999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCCC
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~~ 283 (387)
|||.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ ++.+||+|||+++......
T Consensus 139 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999977763 38899999999999999999999999999999999999863 3489999999999876655
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 219 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp --------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 5667789999999999876 689999999999999999999999994
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=325.22 Aligned_cols=193 Identities=28% Similarity=0.516 Sum_probs=171.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.++.+++.||+|++.... .+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEEE
Confidence 67999999999999999999999999999999986432 35688999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a~~~~~~~ 283 (387)
||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999986655 3488999999999999999999999999999999999997543 369999999998877665
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 5666789999999999877 679999999999999999999999983
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=320.98 Aligned_cols=192 Identities=22% Similarity=0.452 Sum_probs=169.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+. ...+
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~ 85 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTP--TDIV 85 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEE
Confidence 7899999999999999999999999999999998642 235788999999999 999999999999865 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+. |++...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....+..
T Consensus 86 lv~E~~~-g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 86 MVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEECCCC-EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSBT
T ss_pred EEEECCC-CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCcc
Confidence 9999995 5554443 5689999999999999999999999999999999999999666 899999999988776666
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 6778899999999999873334789999999999999999999994
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=333.95 Aligned_cols=196 Identities=32% Similarity=0.559 Sum_probs=168.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----CCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~----~~~~~~lv 209 (387)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+++|+++ +||||+++++++... +..+.++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEee
Confidence 46999999999999999999998899999999986432 3345799999999 999999999988642 22346799
Q ss_pred EeccCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 210 FEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 210 ~e~~~~~~l~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
|||++++.+..+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++....+.
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 999997543322 24589999999999999999999999999999999999999766689999999999876666
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....++|+.|+|||++.+...|+.++|||||||+||||++|++||..
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 666778999999999997756799999999999999999999999943
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=313.46 Aligned_cols=209 Identities=30% Similarity=0.582 Sum_probs=175.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++.+. ...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeC--CEEEE
Confidence 68999999999999999999999999999999986432 36678999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Cc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~ 284 (387)
||||++++.+..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccc
Confidence 99999976655443 4689999999999999999999999999999999999999666 8999999999876533 33
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh----------hccCCCCCccccccc
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF----------YVSGLGHSCLNTWFL 346 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~----------~~~~~~~~~~~~~~~ 346 (387)
.....||+.|+|||++.+...++.++|||||||++|||++|..||.. .....+.+....|..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 45568899999999998755689999999999999999998888632 233445555555554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.45 Aligned_cols=193 Identities=24% Similarity=0.457 Sum_probs=173.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
+.|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~ 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--T 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--C
Confidence 6799999999999999999999999999999998642 246789999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc---eEEEEeccccee
Q 016537 205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF 278 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---~vkl~DFG~a~~ 278 (387)
..++||||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||+++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 5789999999999987764 4889999999999999999999999999999999999985542 699999999998
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...........||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 776666667789999999999876 679999999999999999999999993
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.33 Aligned_cols=193 Identities=32% Similarity=0.677 Sum_probs=164.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++++.||+|+||.||+|.+ .+++.||+|++.... ...+.+|+++++++ +||||+++++++.+. ...+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSE--RCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCS--SCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccC--CEEE
Confidence 48899999999999999999998 568999999986432 35678999999999 999999999999654 4678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
+||||++++.+..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCCC
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCcc
Confidence 999999974444333 2389999999999999999999999999999999999999766 8999999999876433 3
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+|+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 34556889999999998775678999999999999999999999994
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=323.82 Aligned_cols=193 Identities=27% Similarity=0.470 Sum_probs=169.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++|++.+.||+|+||.||+|.++.+++.||||++... ..+.+.+|+++++.+ +||||+++++++.+. ..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~ 100 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSD--GM 100 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CE
Confidence 6799999999999999999999999999999998532 346789999999999 999999999999764 45
Q ss_pred ceEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEEecccc
Q 016537 206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA 276 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a 276 (387)
.++|||||++++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 78999999999986543 1378999999999999999999999999999999999997543 24999999999
Q ss_pred eeecCCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 87755433 345689999999999877 678999999999999999999999994
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=322.07 Aligned_cols=190 Identities=23% Similarity=0.432 Sum_probs=170.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 117 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SNLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcC--CEEE
Confidence 7899999999999999999999999999999998642 336688999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC--
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCC--
Confidence 999999999997765 4589999999999999999999999999999999999999666 8999999999876433
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 195 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC
Confidence 345689999999999987 679999999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=327.99 Aligned_cols=195 Identities=29% Similarity=0.599 Sum_probs=166.0
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~--- 203 (387)
..++|++.+.||+|+||.||+|.+..+++.||||++... ..+++.+|+++|+++ +||||+++++++.....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence 358999999999999999999999999999999999642 236788999999999 99999999999876432
Q ss_pred CCceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
...++||||+++ +|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTIN 180 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC-
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCccccc
Confidence 457899999985 6665553 389999999999999999999999999999999999999766 89999999998765
Q ss_pred CCC-----------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 281 PGK-----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 281 ~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
... ..+..+||++|+|||++.....|+.++|||||||+||||++|..||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 432 2356789999999999766577999999999999999999988877
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=333.81 Aligned_cols=190 Identities=33% Similarity=0.644 Sum_probs=150.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---~~ 204 (387)
.++|++++.||+|+||.||+|.+..+++.||||++... ..+++.+|+++|+++ +||||+++++++.... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999998642 236788999999999 9999999999986432 24
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+. ++|..++ ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDY 208 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTS
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccC
Confidence 6789999986 4555544 3489999999999999999999999999999999999999766 899999999987542
Q ss_pred CC----------------------------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhc
Q 016537 282 GK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSV 325 (387)
Q Consensus 282 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg 325 (387)
.. ..+..+||++|+|||++.....|+.++|||||||+||||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 234568899999999876556799999999999999999993
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=326.55 Aligned_cols=192 Identities=24% Similarity=0.443 Sum_probs=161.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHH-HHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il-~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|++++.||+|+||.||+|+++.+++.||||+++... ...+.+|..++ +.+ +||||+++++++.+. ...
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~--~~~ 114 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--DKL 114 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECS--SEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeC--CEE
Confidence 68999999999999999999999999999999986432 24456677664 445 999999999999764 467
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~ 282 (387)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccccCC
Confidence 8999999999987665 4589999999999999999999999999999999999999766 89999999998643 33
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 34566789999999999987 679999999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=314.35 Aligned_cols=195 Identities=28% Similarity=0.591 Sum_probs=168.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--------hHHHHHHHHHHHHhc--CCCCeeEEEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--------~~~~~~E~~il~~l~--~hpniv~l~~~~~~~~ 202 (387)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+|+++++++. +||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 478999999999999999999998999999999986322 356778888888773 4999999999997654
Q ss_pred CC---CceEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 203 SK---TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 203 ~~---~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
.. ..++||||+.+ +|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCS
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCc
Confidence 22 46899999985 6655542 289999999999999999999999999999999999998666 89999999
Q ss_pred cceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 275 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+++...........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred cccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9987766666677889999999999987 679999999999999999999999994
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=318.57 Aligned_cols=194 Identities=26% Similarity=0.438 Sum_probs=168.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.+ +||||+++++++.+. ...++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecC--CeEEE
Confidence 378999999999999999999998899999999986432 35678999999999 999999999999764 45689
Q ss_pred EEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--
Q 016537 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-- 283 (387)
||||+++++|...+. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcc
Confidence 999999999987764 489999999999999999999999999999999999999666 89999999998654332
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 209 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 23456899999999999874445789999999999999999999994
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.51 Aligned_cols=194 Identities=22% Similarity=0.421 Sum_probs=165.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC------
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~------ 203 (387)
++|++.+.||+|+||.||+|+++.+++.||||+++. ...+.+.+|+++++++ +||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence 579999999999999999999988999999999863 2346789999999999 99999999999865432
Q ss_pred -------------------------------------------------CCceEEEeccCCCchhhhcCC------CCHH
Q 016537 204 -------------------------------------------------KTPSLIFEHVNNTDFKVLYPT------LSDY 228 (387)
Q Consensus 204 -------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------~~~~ 228 (387)
.+.++|||||++++|..++.. ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 237899999999999877633 4555
Q ss_pred HHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-------------cccccccccCCC
Q 016537 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYFK 295 (387)
Q Consensus 229 ~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-------------~~~~~~gt~~y~ 295 (387)
.++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... .....+||+.|+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 6889999999999999999999999999999999666 89999999998775542 223457999999
Q ss_pred CchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 296 aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|||++.+ ..++.++|||||||++|||++|..|+.
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999987 679999999999999999999998874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.92 Aligned_cols=193 Identities=24% Similarity=0.399 Sum_probs=164.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEED--DCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECS--SEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeC--CeE
Confidence 37899999999999999999999999999999998432 235788999999999 999999999998754 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCcccccccc
Confidence 8999999999998775 4589999999999999999999999999999999999999666 89999999997654332
Q ss_pred --cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 --~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp ---------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2234579999999999987 678999999999999999999999994
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.30 Aligned_cols=195 Identities=23% Similarity=0.402 Sum_probs=174.4
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
...++|++.+.||+|+||.||+|.++.+++.||+|++... ....+.+|+++|+++ +||||+++++++.+. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--D 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeC--C
Confidence 3457899999999999999999999999999999998632 235678999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 205 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
..++||||+++|+|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceec
Confidence 6789999999999976652 289999999999999999999999999999999999999666 8999999999987
Q ss_pred cCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~ 386 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQ 386 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 76666666799999999999987 679999999999999999999999994
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=327.58 Aligned_cols=196 Identities=23% Similarity=0.409 Sum_probs=174.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++++ +||||+++++++.+......++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEE
Confidence 47899999999999999999999989999999998743 246778999999999 9999999999998776667899
Q ss_pred EEeccCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeE----cCCCceEEEEeccccee
Q 016537 209 IFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 209 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl----~~~~~~vkl~DFG~a~~ 278 (387)
||||+++++|..++.. +++..++.++.|++.||+|||++||+||||||+|||+ + +...+||+|||+++.
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARE 165 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTT-SCEEEEECCGGGCEE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCC-CceeEEEecCCCceE
Confidence 9999999999888753 8999999999999999999999999999999999998 5 334799999999998
Q ss_pred ecCCCcccccccccCCCCchhhccc-------CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...........||+.|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 7766666667899999999998641 357789999999999999999999995
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.73 Aligned_cols=193 Identities=24% Similarity=0.452 Sum_probs=172.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++|++.+.||+|+||.||+|.++.+++.+|+|++... ....+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeC--CEEEEEE
Confidence 6899999999999999999999999999999998754 335688999999999 999999999999764 4578999
Q ss_pred eccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC-CceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.+++|...+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++........
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 9999999987763 47899999999999999999999999999999999999743 347999999999987766666
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 208 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred eeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 66789999999999877 678999999999999999999999994
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.20 Aligned_cols=194 Identities=24% Similarity=0.429 Sum_probs=160.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.+. ...++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeC--CEEEEEE
Confidence 47899999999999999999999999999999998743 346788999999999 999999999999764 4578999
Q ss_pred eccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc-eEEEEecccceeecCCCccc
Q 016537 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~-~vkl~DFG~a~~~~~~~~~~ 286 (387)
||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+++.........
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 999999997765 46999999999999999999999999999999999999985542 49999999998655444556
Q ss_pred ccccccCCCCchhhcccCCCC-CccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~-~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+||+.|+|||++.+ ..++ .++|||||||++|||++|++||.
T Consensus 176 ~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp -----CTTSCHHHHHC-SSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcCCCCcCChhhhcC-CCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 6789999999999987 4454 45999999999999999999994
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.87 Aligned_cols=194 Identities=30% Similarity=0.629 Sum_probs=154.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++++.||+|+||.||+|.++.+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTE--NKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCT--TEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEEC--CeEEE
Confidence 36899999999999999999999889999999998643 236788999999999 999999999998754 45789
Q ss_pred EEeccCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 209 IFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 209 v~e~~~~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
||||+++ +|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAF 158 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEET
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceec
Confidence 9999995 665443 2488999999999999999999999999999999999999666 8999999999876
Q ss_pred cCC-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 280 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 280 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
... ......++|+.|+|||++.+...++.++|||||||++|||++|++||..
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 433 2334568899999999997756789999999999999999999999943
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=312.34 Aligned_cols=194 Identities=20% Similarity=0.395 Sum_probs=169.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+++++++ +||||+++++++.+. ...++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKD--KRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecC--CeeEEE
Confidence 47899999999999999999999999999999988643 346788999999999 999999999999864 457799
Q ss_pred EeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||+.+++|..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC-----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceeccccccc
Confidence 9999999998775 3588999999999999999999999999999999999999666 8999999999876433221
Q ss_pred ---------------cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 286 ---------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 286 ---------------~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
...+||+.|+|||++.+ ..++.++|||||||++|||++|.+||..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 14579999999999987 7899999999999999999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=328.58 Aligned_cols=193 Identities=26% Similarity=0.458 Sum_probs=168.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+..+++.+|+|++.... .+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~l 87 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEE--GHHYL 87 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECS--SEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEEC--CEEEE
Confidence 67999999999999999999999999999999986432 35688999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~~ 283 (387)
||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +..+||+|||+++......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999999986654 458999999999999999999999999999999999999842 3479999999998765443
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 3355689999999999876 679999999999999999999999983
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=320.72 Aligned_cols=195 Identities=25% Similarity=0.496 Sum_probs=160.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~---- 203 (387)
.++|++++.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence 37899999999999999999999999999999998642 235678999999999 99999999999976432
Q ss_pred CCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
...++||||++++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 181 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC--------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccccc
Confidence 25789999999765555556799999999999999999999999999999999999999666 89999999998766554
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 5566789999999999987 679999999999999999999999994
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=314.59 Aligned_cols=192 Identities=26% Similarity=0.459 Sum_probs=160.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
++|++.+.||+|+||.||+|++. .+++.||+|+++.. ....+.+|+++++++ +||||+++++++.+.
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcC--
Confidence 68999999999999999999985 57899999998643 224577899999999 999999999999764
Q ss_pred CCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
...++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESI 172 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCcccccc
Confidence 4578999999999987665 4588999999999999999999999999999999999999666 89999999997643
Q ss_pred CC-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC
Confidence 32 23345689999999999877 678999999999999999999999994
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=309.51 Aligned_cols=191 Identities=32% Similarity=0.696 Sum_probs=161.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++++.||+|+||.||+|.+ .+++.||+|++.... ...+.+|+++++++ +||||+++++++.+. ...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccC--CeEEE
Confidence 6899999999999999999998 778999999986432 36788999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
||||+.+ ++..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence 9999996 555443 3588999999999999999999999999999999999999666 8999999999765432 2
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+|+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 33456789999999999775678999999999999999999999984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.93 Aligned_cols=196 Identities=29% Similarity=0.551 Sum_probs=168.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----------
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----------- 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~----------- 201 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+++++.+ +||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTC-CCTTBCCEEEEEEEC-----------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHc-CCCCccchhheeeecCcccccccccc
Confidence 478999999999999999999999999999999986432 3345799999999 999999999998642
Q ss_pred -------------------------CCCCceEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 016537 202 -------------------------QSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGI 249 (387)
Q Consensus 202 -------------------------~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~i 249 (387)
+..+.++||||+++ +|...+ ..+++..++.++.||+.||+|||++||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 23457899999996 443332 458999999999999999999999999
Q ss_pred eeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 250 vHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
+||||||+|||++.+++.+||+|||+++............+|+.|+|||++.+...++.++|||||||++|||++|++||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 99999999999985555899999999998877766677789999999999987566999999999999999999999999
Q ss_pred hh
Q 016537 330 LF 331 (387)
Q Consensus 330 ~~ 331 (387)
..
T Consensus 243 ~~ 244 (383)
T 3eb0_A 243 SG 244 (383)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=320.39 Aligned_cols=194 Identities=29% Similarity=0.586 Sum_probs=164.0
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~--- 203 (387)
..++|++++.||+|+||.||+|.+..+|+.||||++... ..+++.+|+++++++ +||||+++++++.....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcccc
Confidence 347899999999999999999999999999999998532 235678999999999 89999999999976432
Q ss_pred -CCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
...++||||+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecccccc
Confidence 3458999999 67887665 4589999999999999999999999999999999999999766 89999999998754
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ..+..++|++|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 180 S--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp S--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred c--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 3 34567899999999999876679999999999999999999999994
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=334.70 Aligned_cols=194 Identities=25% Similarity=0.389 Sum_probs=172.0
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
..++|++.+.||+|+||.||+|+++.+++.||+|++... ....+.+|+++++++ +||||+++++++.+. ..
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~~ 259 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETK--TD 259 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeC--CE
Confidence 357899999999999999999999889999999998642 235678999999999 999999999998764 45
Q ss_pred ceEEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 206 PSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
.++||||+++++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence 789999999999976642 488999999999999999999999999999999999999766 899999999988
Q ss_pred ecCCCcc-cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....... ...+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~ 390 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFR 390 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCC
Confidence 7655433 34589999999999987 689999999999999999999999994
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.99 Aligned_cols=195 Identities=29% Similarity=0.507 Sum_probs=153.4
Q ss_pred CCeEEE---eeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVV---RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~---~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++|++. +.||+|+||.||+|.++.+++.||||++.......+.+|+.+++.+.+||||+++++++.+. ...++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEE
Confidence 356664 78999999999999999999999999998877788899999999995699999999999764 4578999
Q ss_pred eccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc--eEEEEecccceeecCCC-c
Q 016537 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--~vkl~DFG~a~~~~~~~-~ 284 (387)
||+++++|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+++...... .
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999999987665 45899999999999999999999999999999999999975442 79999999998765433 3
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
....+||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 355678999999999877 6799999999999999999999999953
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.48 Aligned_cols=195 Identities=25% Similarity=0.425 Sum_probs=163.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC--
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK-- 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~-- 204 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+++++++ +||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence 378999999999999999999999999999999996432 24678999999999 999999999998764432
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccc
Confidence 347999999999998775 4589999999999999999999999999999999999999666 899999999986644
Q ss_pred CCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 322 234578999999999987 679999999999999999999999984
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=315.45 Aligned_cols=194 Identities=22% Similarity=0.314 Sum_probs=169.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++++.+||||+++++++.+. ...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEEEE
Confidence 37899999999999999999999999999999998643 3456889999999998999999999998764 45789999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCce-----EEEEecccceeecCC
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-----LRLIDWGLAEFYHPG 282 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~-----vkl~DFG~a~~~~~~ 282 (387)
|+ +++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ . +||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecC
Confidence 99 88887665 4589999999999999999999999999999999999998655 4 999999999876543
Q ss_pred Cc--------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 283 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 283 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 32 245689999999999987 7799999999999999999999999953
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=318.25 Aligned_cols=193 Identities=27% Similarity=0.435 Sum_probs=154.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
++|++.+.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+++++++ +||||+++++++.+. ...++||||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e~ 129 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETP--TEISLVLEL 129 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEECS--SEEEEEECC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEecC--CeEEEEEEe
Confidence 6799999999999999999999889999999999754 346678899999999 999999999999764 457899999
Q ss_pred cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC--CCceEEEEecccceeecCCCcccc
Q 016537 213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNV 287 (387)
Q Consensus 213 ~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~~vkl~DFG~a~~~~~~~~~~~ 287 (387)
+.+++|...+. .+++..++.++.|++.||.|||++||+||||||+|||++. ++..+||+|||+++..........
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 99999977663 3789999999999999999999999999999999999974 244899999999987765555566
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 210 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 210 VCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp ---CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 789999999999987 679999999999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.31 Aligned_cols=193 Identities=28% Similarity=0.483 Sum_probs=168.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|++++.++.+||||+++++++.+. ...++||||+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 98 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDG--KYVYVVTELM 98 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEECCC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcC--CEEEEEEeCC
Confidence 67999999999999999999999999999999996543 33567999999987899999999999764 5678999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC---ceEEEEecccceeecCCC-ccc
Q 016537 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||+..++ ..+||+|||+++...... ...
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 178 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence 999987655 3489999999999999999999999999999999999985443 259999999998765443 345
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 179 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 179 TPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp CSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 6689999999999876 568899999999999999999999994
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.12 Aligned_cols=195 Identities=20% Similarity=0.408 Sum_probs=165.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEE----EeCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~l~~~~~---~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++++.||+|+||.||+|+ +..+++.||||++..... +.+.+|+++++++ +||||+++++++...+...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCc
Confidence 4789999999999999999998 456889999999875443 5688999999999 9999999999987655566
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC----
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccccC
Confidence 789999999999987763 388999999999999999999999999999999999999666 899999999987654
Q ss_pred CCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccC
Confidence 322 233456778999999987 679999999999999999999998873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=315.58 Aligned_cols=196 Identities=33% Similarity=0.560 Sum_probs=168.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----- 202 (387)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+|+++++.+ +||||+++++++.+..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 378999999999999999999999999999999885322 35678999999999 9999999999987643
Q ss_pred -CCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
....++||||+.++.+..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhccc
Confidence 34578999999975444433 3589999999999999999999999999999999999999666 899999999987
Q ss_pred ecCC-----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... .......||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 6422 223456789999999999775678999999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=341.35 Aligned_cols=194 Identities=22% Similarity=0.358 Sum_probs=172.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++++.||+|+||.||+|.++.+++.||||+++.. ....+..|..++..+.+||||+++++++.+. ..+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~~ 417 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRL 417 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CEE
Confidence 47899999999999999999999999999999998642 2356788999999887899999999998653 467
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec-CC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~~ 282 (387)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+... .+
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCTT
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccCC
Confidence 8999999999997776 4699999999999999999999999999999999999999766 89999999998643 33
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCC
Confidence 44566789999999999977 789999999999999999999999994
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=319.36 Aligned_cols=195 Identities=21% Similarity=0.254 Sum_probs=169.3
Q ss_pred CCCCeEEEeeeeec--CCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 132 ~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
..++|++++.||+| +||.||+|++..+++.||||++.... .+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~ 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--N 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--T
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEEC--C
Confidence 34789999999999 99999999999899999999986432 35678899999999 999999999999865 4
Q ss_pred CceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
..++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||.+...
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~ 178 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEEC
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceee
Confidence 578999999999988765 4589999999999999999999999999999999999999666 8999999998654
Q ss_pred cCCC--------cccccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGK--------EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... .....+||..|+|||++.+. ..++.++|||||||++|||++|++||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 3221 12234788999999998763 468999999999999999999999994
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=328.21 Aligned_cols=193 Identities=25% Similarity=0.450 Sum_probs=172.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|.+.+.||+|+||.||+|.+..+|+.||||++... ....+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~--~~~~ 92 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP--SDIF 92 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEE
Confidence 7899999999999999999999889999999998643 235688999999999 999999999999765 4578
Q ss_pred EEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....+..
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhcccccc
Confidence 9999999999987763 489999999999999999999999999999999999999666 899999999998776666
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 6677899999999999874344789999999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=317.96 Aligned_cols=194 Identities=20% Similarity=0.339 Sum_probs=166.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-------CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
.++|++.+.||+|+||.||+|.+. .++..||||+++... .+.+.+|+++++++.+||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 378999999999999999999874 345689999997532 356889999999997899999999999754
Q ss_pred CCCCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
...++||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 160 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred --CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 45789999999999977652 367889999999999999999999999999999999999
Q ss_pred CCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.++ .+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 238 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 238 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp TTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 666 899999999987654322 233456788999999987 679999999999999999999 999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=321.80 Aligned_cols=195 Identities=30% Similarity=0.557 Sum_probs=165.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----CCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~~~~~lv 209 (387)
.+|++.+.||+|+||.||+|.+..+++ +|+|.+.... ....+|+++++.+ +||||+++++++.... ..+.++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEE
Confidence 579999999999999999999866555 7777764332 2334799999999 9999999999986533 2347799
Q ss_pred EeccCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 210 FEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 210 ~e~~~~~~l~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
|||++++.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++....+.
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 999998765433 24689999999999999999999999999999999999998444589999999999887666
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....++|+.|+|||++.+...|+.++|||||||++|||++|++||..
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 667778999999999998756799999999999999999999999953
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.35 Aligned_cols=193 Identities=24% Similarity=0.420 Sum_probs=161.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++++.||+|+||.||+|.+..+++.||||+++.. ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~~~ 223 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DRL 223 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEET--TEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeC--CEE
Confidence 36899999999999999999999999999999998642 224567899999998 999999999999765 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeec-C
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 281 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~-~ 281 (387)
++||||+++++|...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++... .
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC-
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCC
Confidence 8999999999987665 458999999999999999999998 9999999999999999766 89999999997643 2
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 334456789999999999977 789999999999999999999999994
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.31 Aligned_cols=191 Identities=21% Similarity=0.388 Sum_probs=157.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+ +++.||||++.... .+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 110 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQP--PNLS 110 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECST--TCCE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CceE
Confidence 37899999999999999999986 68899999986432 25688999999999 999999999999764 3467
Q ss_pred EEEeccCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 208 LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
+||||+.+++|..++.. +++..++.++.|++.||+|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCccc
Confidence 99999999999877643 888999999999999999999999 99999999999999666 8999999999765
Q ss_pred cCCC-cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred cccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4332 2345689999999999987 678999999999999999999999984
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.30 Aligned_cols=193 Identities=33% Similarity=0.623 Sum_probs=164.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRK--RRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecC--CeEEE
Confidence 68999999999999999999998899999999885432 35577899999999 999999999999764 45679
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Cc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~ 284 (387)
||||++++++..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcccc
Confidence 99999999887664 4589999999999999999999999999999999999999666 8999999999876533 23
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|+..|+|||++.+...++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 3556889999999999875678999999999999999999999984
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=323.72 Aligned_cols=194 Identities=25% Similarity=0.478 Sum_probs=160.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+++|+++ +||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEESS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence 378999999999999999999999999999999986432 12478999999999 999999999998543
Q ss_pred CCCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEEecccc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA 276 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a 276 (387)
..++||||+.+++|...+ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ ..+||+|||++
T Consensus 213 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp ---EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ---ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 367999999999997765 3489999999999999999999999999999999999997433 25999999999
Q ss_pred eeecCCCcccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+...........+||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 88766555567789999999999853 3568889999999999999999999994
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.55 Aligned_cols=193 Identities=25% Similarity=0.459 Sum_probs=172.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.+.||+|+||.||+|.++.+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~ 88 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENR--T 88 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecC--C
Confidence 6799999999999999999999989999999998642 246789999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc---eEEEEeccccee
Q 016537 205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF 278 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---~vkl~DFG~a~~ 278 (387)
..++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 5789999999999987763 4789999999999999999999999999999999999986653 699999999988
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...........|++.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 776655666789999999999876 678999999999999999999999983
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=301.47 Aligned_cols=194 Identities=28% Similarity=0.514 Sum_probs=171.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcC--CEEE
Confidence 478999999999999999999999999999999986432 35678999999999 999999999999754 4567
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEEecccceeecCC
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a~~~~~~ 282 (387)
+||||+.++++...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ ..+||+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999886554 4589999999999999999999999999999999999997544 24999999999887766
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 66666789999999999877 678999999999999999999999983
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.06 Aligned_cols=194 Identities=27% Similarity=0.464 Sum_probs=171.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+++++++ +||||+++++++.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~- 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQ- 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECS-
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeC-
Confidence 68999999999999999999999999999999986432 24567899999999 999999999999764
Q ss_pred CCCceEEEeccCCC-chhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 203 SKTPSLIFEHVNNT-DFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 203 ~~~~~lv~e~~~~~-~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...++||||+.++ ++..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 102 -~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~ 179 (335)
T 3dls_A 102 -GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAY 179 (335)
T ss_dssp -SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred -CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceE
Confidence 4577999999776 776665 3589999999999999999999999999999999999999665 899999999998
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
..........+||+.|+|||++.+...++.++|||||||++|||++|.+||..
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 87666666778999999999998743348899999999999999999999953
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=316.63 Aligned_cols=194 Identities=18% Similarity=0.262 Sum_probs=159.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-----CeEEEEEEecccchHHHHHHHHHHHHhc--------------CCCCeeE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVKKKKIKREIKILQNLC--------------GGPNIVK 193 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~l~~~~~~~~~~E~~il~~l~--------------~hpniv~ 193 (387)
.++|++.+.||+|+||.||+|.+..+ ++.||||++.... ..+.+|+++++++. +||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 47899999999999999999998654 5789999986543 23444444444432 6999999
Q ss_pred EEEEEEcCC--CCCceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc--CCC
Q 016537 194 LLDIVRDQQ--SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQ 265 (387)
Q Consensus 194 l~~~~~~~~--~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~ 265 (387)
+++++.... ..+.++||||+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999987642 24578999999 88987775 4589999999999999999999999999999999999998 454
Q ss_pred ceEEEEecccceeecCCCc--------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 266 RKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+||+|||+++.+..... ....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 192 -~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 192 -QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp -CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred -eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 899999999987643321 133459999999999987 679999999999999999999999995
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=318.20 Aligned_cols=191 Identities=23% Similarity=0.436 Sum_probs=163.1
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
+...+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+. ...++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESK--NDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEEeC
Confidence 33467899999999999999899999999999764 346788999999999 999999999999764 457899999
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc-CCCceEEEEecccceeecCCCcccc
Q 016537 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNV 287 (387)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~-~~~~~vkl~DFG~a~~~~~~~~~~~ 287 (387)
+++++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++ .+...+||+|||+++..........
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999986554 2488999999999999999999999999999999999994 2344899999999998877666667
Q ss_pred cccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 288 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 248 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 789999999999876 678999999999999999999999994
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.57 Aligned_cols=191 Identities=20% Similarity=0.385 Sum_probs=169.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.|+..+.||+|+||.||+|.+..+|+.||||++... ..+.+.+|+.+++++ +||||+++++++... ...++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVG--EELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEEe
Confidence 478888999999999999999889999999998643 346788999999999 999999999999865 35789999
Q ss_pred ccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccccc
Q 016537 212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 288 (387)
Q Consensus 212 ~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~~~ 288 (387)
|+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccc
Confidence 999999988775 488999999999999999999999999999999999999666 89999999998765432 23456
Q ss_pred ccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 289 ~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 89999999999876 678999999999999999999999984
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=316.04 Aligned_cols=195 Identities=21% Similarity=0.367 Sum_probs=166.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEE-----eCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+++++++.+||||+++++++.+..
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-
Confidence 47899999999999999999984 4556899999997532 2568899999999988999999999987643
Q ss_pred CCceEEEeccCCCchhhhcCC-----------------------------------------------------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT----------------------------------------------------------- 224 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~----------------------------------------------------------- 224 (387)
...++||||+.+++|..++..
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 447899999999998766521
Q ss_pred ----------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc---ccccccc
Q 016537 225 ----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVAS 291 (387)
Q Consensus 225 ----------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt 291 (387)
+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....... .....+|
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCCC
Confidence 78888999999999999999999999999999999998665 899999999986643322 2345678
Q ss_pred cCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 259 ~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 297 (359)
T 3vhe_A 259 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 297 (359)
T ss_dssp GGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCC
Confidence 89999999887 679999999999999999998 999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=307.43 Aligned_cols=190 Identities=23% Similarity=0.315 Sum_probs=159.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.++||+|+||+||+|.+..+++.||||++... .......|+..+.++.+||||+++++++.+. ...++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence 6799999999999999999999889999999998542 2234566777777766999999999999764 45789
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||||+.+ ++...+ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 135 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 135 QTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC----
T ss_pred EEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCCC
Confidence 9999954 554443 3589999999999999999999999999999999999998666 899999999988766555
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
.....||+.|+|||++.+ .++.++|||||||++|||++|.+||
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 566789999999999875 6899999999999999999997766
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.27 Aligned_cols=192 Identities=28% Similarity=0.518 Sum_probs=166.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhc----CCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----GGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~----~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|+++++||+|+||.||+|.+..+++.||||+++... ...+..|+++++.+. +||||+++++++... ...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~~~ 111 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--DHM 111 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--TEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--Cee
Confidence 478999999999999999999999999999999997432 356788999999983 399999999999765 457
Q ss_pred eEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC------------------
Q 016537 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------------------ 263 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~------------------ 263 (387)
++||||+ +++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 8999999 778766652 3889999999999999999999999999999999999974
Q ss_pred ------CCceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 264 ------EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 264 ------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 244799999999986433 2345688999999999987 679999999999999999999999994
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=314.74 Aligned_cols=194 Identities=29% Similarity=0.580 Sum_probs=164.4
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC--
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK-- 204 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~-- 204 (387)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.+ +||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCccc
Confidence 3479999999999999999999999999999999986421 36678999999999 999999999999765432
Q ss_pred --CceEEEeccCCCchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 --TPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 --~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+.+ ++...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 119 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 119 FYDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA 196 (371)
T ss_dssp CCCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC-----
T ss_pred ceeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCccccccc
Confidence 23899999995 555444 5699999999999999999999999999999999999999666 899999999986543
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 33456889999999999775679999999999999999999999994
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=299.69 Aligned_cols=191 Identities=28% Similarity=0.507 Sum_probs=170.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~---~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++|++.+.||+|+||.||+|.+..++..+|+|.+.. ...+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDN--TDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--CeEEEEE
Confidence 679999999999999999999999999999999864 3457889999999999 999999999999764 4578999
Q ss_pred eccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeE---cCCCceEEEEecccceeecCCCc
Q 016537 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||+++++|...+ ..+++..++.++.|++.||.|||++||+||||||+|||+ +.+ ..+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTSC
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCccc
Confidence 999999986654 458999999999999999999999999999999999999 534 4899999999988877766
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....||+.|+|||++.+ .++.++|||||||++|||++|++||.
T Consensus 165 ~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC
Confidence 677789999999999865 48999999999999999999999983
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.62 Aligned_cols=190 Identities=23% Similarity=0.355 Sum_probs=162.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEEEEEEcC--CCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQ--QSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l-~~hpniv~l~~~~~~~--~~~~~~lv 209 (387)
.++|++.+.||+|+||.||+|.+ +++.||||++.......+.+|.+++... .+||||+++++++.+. .....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 47899999999999999999987 6899999999887778888888888873 2999999999987643 23457899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------HcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH--------~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
|||+.+++|..+++ .+++..++.++.|++.||+||| +++|+||||||+|||++.++ .+||+|||+++..
T Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMH 163 (301)
T ss_dssp ECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred hhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeeec
Confidence 99999999988774 4889999999999999999999 99999999999999999666 8999999999876
Q ss_pred cCCCcc-----cccccccCCCCchhhcccC-----CCCCccchhhHHHHHHHHHhc
Q 016537 280 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMVSV 325 (387)
Q Consensus 280 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~sDvwSlGvil~elltg 325 (387)
...... ....||+.|+|||++.+.. .++.++|||||||++|||++|
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 544322 3347999999999987632 344689999999999999999
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.54 Aligned_cols=193 Identities=24% Similarity=0.475 Sum_probs=164.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|.+.+.||+|+||.||+|.+..++..+|+|++... ..+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDY--HNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecC--CeEEE
Confidence 37899999999999999999999999999999998643 347789999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceee
Q 016537 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFY 279 (387)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~ 279 (387)
||||+++++|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.+ ...+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999987655 468999999999999999999999999999999999999532 347999999999877
Q ss_pred cCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..........|++.|+|||++. ..++.++|||||||++|||++|+.||.
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 6665566778999999999975 468999999999999999999999983
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=313.58 Aligned_cols=195 Identities=21% Similarity=0.300 Sum_probs=165.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC--CCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQS--KTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~--~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+ .++.||||++..... ....+|+.+++++ +||||+++++++.+... ...++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEE
Confidence 47899999999999999999987 489999999975443 3456688889998 99999999999987542 34689
Q ss_pred EEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHc----------CceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 209 IFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 209 v~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~----------~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
||||+++++|..++ ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCcc
Confidence 99999999998776 4589999999999999999999999 999999999999999665 8999999999
Q ss_pred eeecCCCc---ccccccccCCCCchhhccc----CCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 277 EFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 277 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+....... .....||+.|+|||++.+. ..++.++|||||||++|||++|++||..
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 87754432 2345789999999998752 2456688999999999999999999843
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=313.59 Aligned_cols=193 Identities=31% Similarity=0.646 Sum_probs=159.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchH----HHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~----~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++++.||+|+||.||+|.+..+++.||+|++...... .+.+|+++++++ +||||+++++++.+. ...++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECS--SCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeC--CEEEEE
Confidence 6899999999999999999999889999999998644322 345799999999 999999999999764 457899
Q ss_pred EeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Cc
Q 016537 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~ 284 (387)
|||+++ ++...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCccc
Confidence 999996 554443 3488999999999999999999999999999999999999666 8999999999765432 23
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....+|+.|+|||++.+...++.++|||||||++|||++|++||..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 34567899999999987756789999999999999999999999943
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=315.01 Aligned_cols=194 Identities=27% Similarity=0.579 Sum_probs=153.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~ 203 (387)
.++|++++.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++++ +||||+++++++.... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccC
Confidence 37899999999999999999999999999999998642 236678999999999 8999999999986532 2
Q ss_pred CCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 204 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
...++|+|++ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeeccccccccc
Confidence 4568999999 57776665 3589999999999999999999999999999999999999666 899999999986543
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
..+..+||++|+|||++.+...++.++|||||||++|||++|++||..
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 245568999999999998756799999999999999999999999943
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=300.75 Aligned_cols=194 Identities=24% Similarity=0.402 Sum_probs=171.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------------
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------------ 201 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~------------ 201 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+++++++ +||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccccccc
Confidence 67999999999999999999998899999999997543 5678999999999 999999999988641
Q ss_pred --CCCCceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecc
Q 016537 202 --QSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (387)
Q Consensus 202 --~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG 274 (387)
.....++||||+++++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg 167 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFG 167 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcch
Confidence 123468999999999998776 3588999999999999999999999999999999999999666 89999999
Q ss_pred cceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 275 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+++............+++.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 168 LVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp TCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred hheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 9988776655566789999999999877 6789999999999999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=311.02 Aligned_cols=196 Identities=30% Similarity=0.609 Sum_probs=169.0
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---~~ 204 (387)
..++|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+++++++ +||||+++++++.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence 3478999999999999999999999999999999987432 25678999999999 9999999999987543 24
Q ss_pred CceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
..++||||+.+ +|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCC
Confidence 57899999995 665544 4589999999999999999999999999999999999999666 7999999999876533
Q ss_pred Cc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....+||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 22 2445899999999998765678999999999999999999999994
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=307.71 Aligned_cols=194 Identities=21% Similarity=0.398 Sum_probs=166.1
Q ss_pred CCeEEE-eeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.|.+. +.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+.+||||+++++++.+. ...+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--SEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--CeEE
Confidence 568887 8999999999999999999999999998642 2467899999999997789999999999764 4578
Q ss_pred EEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC--CCceEEEEecccceeec
Q 016537 208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~~vkl~DFG~a~~~~ 280 (387)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++. +.+.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999998775 34889999999999999999999999999999999999985 13489999999999876
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.........|++.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 186 HACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp --------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 6655566789999999999876 679999999999999999999999983
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=309.65 Aligned_cols=193 Identities=18% Similarity=0.320 Sum_probs=163.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.+..++ ..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+. ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRG--RL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGG--GC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--Cc
Confidence 478999999999999999999997544 45999999753 235688999999999 999999999999764 45
Q ss_pred ceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLED 203 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC-
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCccccccc
Confidence 67999999999998776 3588999999999999999999999999999999999999666 899999999987654
Q ss_pred CCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
... .....+|..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 322 122345678999999976 678999999999999999999 999983
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=310.54 Aligned_cols=209 Identities=31% Similarity=0.601 Sum_probs=169.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+++++++ +||||+++++++.+. .
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHK--S 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCT--T
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeC--C
Confidence 478999999999999999999998899999999986421 24678999999999 999999999999654 4
Q ss_pred CceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++||||+++ ++...+. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG 163 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceecc
Confidence 57799999997 5544432 378899999999999999999999999999999999999666 89999999998764
Q ss_pred CC-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccccc
Q 016537 281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFL 346 (387)
Q Consensus 281 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~ 346 (387)
.. ......++|+.|+|||++.+...++.++|||||||++|||++|.+||.. .....+.+....|+.
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 33 3345568999999999987656689999999999999999999999843 223345555555654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=302.09 Aligned_cols=194 Identities=19% Similarity=0.320 Sum_probs=169.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+.+|+|++++++++.+. ...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCC--ceeEEEEE
Confidence 37899999999999999999999899999999998643 3466889999999998899999999998754 45679999
Q ss_pred ccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc----eEEEEecccceeecCCC
Q 016537 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----KLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~----~vkl~DFG~a~~~~~~~ 283 (387)
|+ +++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+++......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 888877653 4899999999999999999999999999999999999975541 39999999998765432
Q ss_pred c--------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 E--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 2 245579999999999877 678999999999999999999999994
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=324.74 Aligned_cols=193 Identities=27% Similarity=0.535 Sum_probs=170.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----------------chHHHHHHHHHHHHhcCCCCeeEEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNIVKLLD 196 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----------------~~~~~~~E~~il~~l~~hpniv~l~~ 196 (387)
.++|++++.||+|+||.||+|.++.+++.||+|++... ..+.+.+|+.+++++ +||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence 37899999999999999999999999999999998642 235688999999999 9999999999
Q ss_pred EEEcCCCCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc--eEEEE
Q 016537 197 IVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLI 271 (387)
Q Consensus 197 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--~vkl~ 271 (387)
++.+. ...++|||||.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+
T Consensus 114 ~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99764 4578999999999986654 56899999999999999999999999999999999999986553 69999
Q ss_pred ecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 272 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|||+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999998877666677889999999999864 68999999999999999999999994
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=310.78 Aligned_cols=194 Identities=27% Similarity=0.512 Sum_probs=172.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
++|++.+.||+|+||.||+|.+..+|+.||||++.... .+.+.+|+.+++++.+||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS- 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence 57999999999999999999998899999999986432 356788999999987899999999998764
Q ss_pred CCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
...++||||+++++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 173 -~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 173 -SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHL 250 (365)
T ss_dssp -SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred -CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCccccc
Confidence 4578999999999987765 4689999999999999999999999999999999999999666 8999999999888
Q ss_pred cCCCcccccccccCCCCchhhccc-----CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDL-----QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.........+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 766666777899999999998631 358899999999999999999999983
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.06 Aligned_cols=193 Identities=26% Similarity=0.484 Sum_probs=166.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+++++++ +||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc
Confidence 67999999999999999999999999999999986432 13478999999999 9999999999986542
Q ss_pred CCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc--eEEEEecccce
Q 016537 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE 277 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--~vkl~DFG~a~ 277 (387)
.++||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++
T Consensus 89 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 ---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp ---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred ---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 68999999999987665 34889999999999999999999999999999999999985542 49999999998
Q ss_pred eecCCCcccccccccCCCCchhhc--ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
............|++.|+|||++. +...++.++|||||||++|||++|.+||.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 876554445667999999999974 23568999999999999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=298.85 Aligned_cols=193 Identities=26% Similarity=0.503 Sum_probs=167.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENK--T 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCC--C
Confidence 5799999999999999999999889999999998643 257789999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc---eEEEEeccccee
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF 278 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---~vkl~DFG~a~~ 278 (387)
..++||||+++++|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++. .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 578999999999998776 45899999999999999999999999999999999999985542 699999999988
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 766555566789999999999876 678999999999999999999999983
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=324.41 Aligned_cols=192 Identities=26% Similarity=0.546 Sum_probs=168.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+++++++ +||||+++++++.+. ...++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~l 98 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS--SSFYI 98 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcC--CEEEE
Confidence 689999999999999999999988999999999853 3356789999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~~ 283 (387)
||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.. ...+||+|||+++......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 99999999986554 568999999999999999999999999999999999999632 3379999999998776666
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.
T Consensus 179 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 6667789999999999875 59999999999999999999999993
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=309.74 Aligned_cols=193 Identities=30% Similarity=0.639 Sum_probs=159.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+..+++.||||+++... .+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 110 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHN--HRLHL 110 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEET--TEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecC--CEEEE
Confidence 78999999999999999999999999999999986433 24567899999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC----CCceEEEEecccceeecC
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~----~~~~vkl~DFG~a~~~~~ 281 (387)
||||+++ +|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++. +...+||+|||+++....
T Consensus 111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9999996 665554 35899999999999999999999999999999999999953 233699999999976543
Q ss_pred C-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......++|..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 2 334556789999999999875668999999999999999999999994
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.71 Aligned_cols=195 Identities=22% Similarity=0.436 Sum_probs=171.3
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
...++|++.+.||+|+||.||+|.+..+++.+|+|++... ..+.+.+|+.+++.+ +||||+++++++.+. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~ 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN--D 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--S
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccC--C
Confidence 3457899999999999999999999889999999998643 236678999999999 999999999999764 4
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceeccc
Confidence 578999999999987765 4589999999999999999999999999999999999999666 899999999987653
Q ss_pred C-CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3 23445678999999999876 678999999999999999999999984
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=309.62 Aligned_cols=194 Identities=24% Similarity=0.460 Sum_probs=164.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~ 102 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDE--QY 102 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccC--Ce
Confidence 6899999999999999999999999999999998532 236788999999999 999999999999764 45
Q ss_pred ceEEEeccCCCchhhhcCC-------------------------------------------CCHHHHHHHHHHHHHHHH
Q 016537 206 PSLIFEHVNNTDFKVLYPT-------------------------------------------LSDYDVRYYIYELLKALD 242 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~-------------------------------------------~~~~~~~~~~~qi~~aL~ 242 (387)
.++||||+++++|...+.. +++..++.++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 7899999999999877631 246678889999999999
Q ss_pred HHHHcCceeeccCCCCeeEcCCCc-eEEEEecccceeecCCC-----cccccccccCCCCchhhccc-CCCCCccchhhH
Q 016537 243 YCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSL 315 (387)
Q Consensus 243 yLH~~~ivHrDlKp~NILl~~~~~-~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSl 315 (387)
|||+++|+||||||+|||++.++. .+||+|||+++.+.... ......||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 999999999999999999985442 79999999998764321 23456799999999998642 568999999999
Q ss_pred HHHHHHHHhcCCchh
Q 016537 316 GCMFAGMVSVSPSVL 330 (387)
Q Consensus 316 Gvil~elltg~~pf~ 330 (387)
||++|||++|++||.
T Consensus 263 G~il~el~~g~~pf~ 277 (345)
T 3hko_A 263 GVLLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHHHSSCSSC
T ss_pred HHHHHHHHHCCCCCC
Confidence 999999999999983
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=310.02 Aligned_cols=196 Identities=27% Similarity=0.481 Sum_probs=158.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC-----CCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS-----KTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~-----~~~ 206 (387)
++|++.+.||+|+||.||+|.+..+++.||||++... ......+|++.+..+ +||||+++++++..... .+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeE
Confidence 7899999999999999999999889999999988543 235667788888888 99999999999875322 236
Q ss_pred eEEEeccCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHH--HcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 207 SLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
++||||+.++.+..+. ..+++..++.++.|++.||.||| ++||+||||||+|||++..++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 7999999987543222 34788999999999999999999 999999999999999996455899999999998
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...........||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 7766666677899999999998775668999999999999999999999994
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=302.06 Aligned_cols=195 Identities=26% Similarity=0.417 Sum_probs=168.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEE----EeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.+.|++.+.||+|+||.||+|+ +..+++.||+|++... ....+.+|+++++++ +||||+++++++.+....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCc
Confidence 3679999999999999999998 4568899999998743 236789999999999 999999999999877667
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIE 177 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECC
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccccccccc
Confidence 788999999999998776 3589999999999999999999999999999999999998666 89999999998775
Q ss_pred CCCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... .....+|..|+|||++.+ ..++.++|||||||++|||++|.+|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 5432 234567888999999877 678899999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=324.78 Aligned_cols=192 Identities=27% Similarity=0.535 Sum_probs=167.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++++.||+|+||.||+|.++.++..||+|++... ....+.+|+.+++.+ +||||+++++++.+. ...++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDK--RNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEEE
Confidence 5799999999999999999999999999999998642 346788999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a~~~~~~~ 283 (387)
|||||.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+||+|||+++......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999986554 4689999999999999999999999999999999999997532 359999999999887766
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.
T Consensus 194 ~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 667788999999999985 469999999999999999999999994
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=306.77 Aligned_cols=196 Identities=20% Similarity=0.365 Sum_probs=171.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEE----eCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.... .+.+.+|+++++++ +||||+++++++.......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCce
Confidence 47899999999999999999984 5688999999997543 35588999999999 9999999999998766777
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECCT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceeccc
Confidence 889999999999987753 489999999999999999999999999999999999998666 899999999987654
Q ss_pred CCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 282 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
... .....++..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 432 233467788999999877 6789999999999999999999999843
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=315.16 Aligned_cols=194 Identities=19% Similarity=0.315 Sum_probs=163.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEE-----eCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+|+.+++++ +||||+++++++.+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecC--
Confidence 37899999999999999999994 456789999998642 235688999999999 999999999998764
Q ss_pred CCceEEEeccCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEE
Q 016537 204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLI 271 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~ 271 (387)
...++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 44679999999999987762 388899999999999999999999999999999999998433 269999
Q ss_pred ecccceeecCC---CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 272 DWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 272 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~ 288 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP 288 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999754322 22234567889999999877 679999999999999999998 999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.98 Aligned_cols=194 Identities=22% Similarity=0.440 Sum_probs=171.3
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++... ..+.+.+|+.+++.+ +||||+++++++.+. ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~ 115 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN--DF 115 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC--Ce
Confidence 347899999999999999999999999999999998643 246688999999999 999999999999764 45
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceecccC
Confidence 78999999999987765 4589999999999999999999999999999999999999666 7999999999876533
Q ss_pred -CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence 33445678999999999877 678999999999999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=306.92 Aligned_cols=194 Identities=31% Similarity=0.588 Sum_probs=165.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 100 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKK--KRWY 100 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecC--CEEE
Confidence 478999999999999999999998899999999985432 34577899999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
+||||++++++..+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC--------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCcc
Confidence 999999999887664 4589999999999999999999999999999999999999666 8999999999765433 3
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......|+..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 33556789999999999775578999999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=324.36 Aligned_cols=192 Identities=28% Similarity=0.546 Sum_probs=171.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+++++++ +||||+++++++.+. ...+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~ 102 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDK--GYFY 102 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CEEE
Confidence 679999999999999999999999999999999853 2356789999999999 999999999999764 4678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC--CCceEEEEecccceeecCC
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~~vkl~DFG~a~~~~~~ 282 (387)
+||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++. +...+||+|||+++.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999987654 45899999999999999999999999999999999999952 3348999999999887766
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 66677789999999999865 58999999999999999999999994
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=306.91 Aligned_cols=192 Identities=20% Similarity=0.371 Sum_probs=160.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeE----EEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+.. ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC---
Confidence 47899999999999999999998777664 57787653 2346789999999999 999999999999764
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++|+||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 168 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHHT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeEcc
Confidence 267999999999987665 3488999999999999999999999999999999999999666 89999999998765
Q ss_pred CCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 43322 23355778999999987 789999999999999999999 999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=306.52 Aligned_cols=193 Identities=20% Similarity=0.355 Sum_probs=167.5
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
..++|++.+.||+|+||.||+|.+ .+++.||||.+.... .+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDER--NEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCT--TCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC--CeEEE
Confidence 357899999999999999999996 578999999986432 46788999999999 999999999998654 45679
Q ss_pred EEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 209 IFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 209 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTE 191 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence 999999999987763 378899999999999999999999999999999999999666 899999999986543
Q ss_pred CC---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCccc
Confidence 22 2234568999999999877 679999999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=317.99 Aligned_cols=196 Identities=26% Similarity=0.571 Sum_probs=153.2
Q ss_pred CCeEE-EeeeeecCCeeEEEEEEe--CCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEV-VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~l~~~~-~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+.|++ .++||+|+||.||+|+++ .+++.||||++.... ...+.+|+++|+++ +||||+++++++.+......++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence 45666 457999999999999975 468899999997543 46788999999999 99999999999987666778999
Q ss_pred EeccCCCchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc---CCCceEEEEeccc
Q 016537 210 FEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGL 275 (387)
Q Consensus 210 ~e~~~~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~---~~~~~vkl~DFG~ 275 (387)
|||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||+. .+.+.+||+|||+
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 9999864433222 1388999999999999999999999999999999999993 2334899999999
Q ss_pred ceeecCC----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 276 AEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 276 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
++..... ......+||+.|+|||++.+...++.++|||||||+||||++|++||.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 9876432 223456899999999999875669999999999999999999999994
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=297.25 Aligned_cols=195 Identities=26% Similarity=0.481 Sum_probs=172.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------------~~~~~~E~~il~~l~~hpniv~l~~~~~~ 200 (387)
.++|++.+.||+|+||.||+|.++.+++.||||++.... .+.+.+|+++++++.+||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999999999999999986432 35678999999999669999999999975
Q ss_pred CCCCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 201 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
. ...++||||+++++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 96 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 172 (298)
T 1phk_A 96 N--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 172 (298)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred C--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchh
Confidence 4 5678999999999987775 3589999999999999999999999999999999999999666 79999999998
Q ss_pred eecCCCcccccccccCCCCchhhc-----ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
............++..|+|||++. ....++.++|||||||++|||++|.+||.
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 877666666678999999999985 23568899999999999999999999983
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=311.08 Aligned_cols=194 Identities=21% Similarity=0.416 Sum_probs=166.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
++|++.+.||+|+||.||+|++. .+++.||||+++.. ..+.+.+|+++++++.+||||+++++++.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence 68999999999999999999984 47899999998632 2356778999999997799999999999764
Q ss_pred CCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
...++||||+++++|..++ ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFV 210 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECC
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeecc
Confidence 4577999999999997765 4589999999999999999999999999999999999999666 89999999998764
Q ss_pred CCC--cccccccccCCCCchhhcc-cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGK--EYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... .....+||+.|+|||++.+ ...++.++|||||||+||||++|+.||.
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 332 2334679999999999875 2357899999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=309.76 Aligned_cols=195 Identities=27% Similarity=0.500 Sum_probs=157.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLLDIV 198 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--------------~~~~~~E~~il~~l~~hpniv~l~~~~ 198 (387)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... .+.+.+|+++++++ +||||+++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 98 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIF 98 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEEC-TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEE
T ss_pred ccceEEeEEeccCCCEEEEEEEC-CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeE
Confidence 48899999999999999999998 458999999985321 26789999999999 999999999998
Q ss_pred EcC---CCCCceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEe
Q 016537 199 RDQ---QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (387)
Q Consensus 199 ~~~---~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~D 272 (387)
... .....++||||+.++.+..+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEEe
Confidence 653 2345789999999654444432 489999999999999999999999999999999999999666 899999
Q ss_pred cccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 273 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
||+++............+++.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 9999876655556667899999999998775679999999999999999999999994
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=297.25 Aligned_cols=192 Identities=18% Similarity=0.356 Sum_probs=166.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+. +++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--SSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--CceEEEE
Confidence 378999999999999999999984 6788999999753 457789999999999 999999999999764 4578999
Q ss_pred eccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--c
Q 016537 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--~ 284 (387)
||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEecccccccccccccccc
Confidence 9999999987763 378999999999999999999999999999999999998665 89999999997654332 1
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 233456778999999876 679999999999999999999 999983
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=312.94 Aligned_cols=195 Identities=25% Similarity=0.460 Sum_probs=167.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhc-------CCCCeeEEEEEEEcC--
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-------GGPNIVKLLDIVRDQ-- 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~-------~hpniv~l~~~~~~~-- 201 (387)
.++|++.+.||+|+||.||+|++..+++.||||++.... .+.+.+|+++++.+. +|+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999999999999999997543 367889999999983 278899999988732
Q ss_pred CCCCceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCC-----------
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQ----------- 265 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~----------- 265 (387)
.....++||||+.++.+..+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 345678999999776665554 3489999999999999999999998 999999999999998554
Q ss_pred -------------------------------------ceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCC
Q 016537 266 -------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308 (387)
Q Consensus 266 -------------------------------------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 308 (387)
..+||+|||+++.... .....+||+.|+|||++.+ ..++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ 272 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNT 272 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHT-SCCCT
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcC-CCCCc
Confidence 2699999999987643 3455689999999999987 67999
Q ss_pred ccchhhHHHHHHHHHhcCCchh
Q 016537 309 SLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 309 ~sDvwSlGvil~elltg~~pf~ 330 (387)
++|||||||+||||++|++||.
T Consensus 273 ~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCC
T ss_pred HHHHHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999994
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.47 Aligned_cols=192 Identities=16% Similarity=0.315 Sum_probs=166.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+ .++..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKE--YPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--CceEEEE
Confidence 47899999999999999999987 56778999999753 457789999999999 899999999998654 4578999
Q ss_pred eccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc-
Q 016537 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~- 285 (387)
||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEEE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhhc
Confidence 9999999877653 489999999999999999999999999999999999999666 8999999999876544322
Q ss_pred -cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 -~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp CCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 22345667999999876 678999999999999999999 999984
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=297.35 Aligned_cols=192 Identities=26% Similarity=0.462 Sum_probs=165.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecC--CEE
Confidence 37899999999999999999999999999999998542 235688999999999 899999999999764 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++||||++++++...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCcc-
Confidence 8999999999987665 4589999999999999999999999999999999999999666 8999999998654332
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 208 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE 208 (279)
T ss_dssp -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC
Confidence 3345678999999999877 678999999999999999999999983
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=307.80 Aligned_cols=193 Identities=22% Similarity=0.382 Sum_probs=165.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... .+.+.+|+++++++ +||||+++++++.+.
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-- 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVG-- 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccC--
Confidence 478999999999999999999987 345899999987542 35688999999999 999999999999764
Q ss_pred CCceEEEeccCCCchhhhc---------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCC
Q 016537 204 KTPSLIFEHVNNTDFKVLY---------------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---------------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp 256 (387)
...++||||+++++|..++ ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 4578999999999997765 3478889999999999999999999999999999
Q ss_pred CCeeEcCCCceEEEEecccceeecCCC---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 257 HNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 257 ~NILl~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+|||++.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 203 ~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 203 RNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999665 89999999997653322 2234567888999999877 679999999999999999999 999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.80 Aligned_cols=196 Identities=29% Similarity=0.561 Sum_probs=162.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--------
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ-------- 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~-------- 201 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+++++++ +||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence 378999999999999999999998889999999986543 35678999999999 999999999988532
Q ss_pred ----CCCCceEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccc
Q 016537 202 ----QSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (387)
Q Consensus 202 ----~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~ 275 (387)
.....++||||+. ++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++..+||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 2345689999998 57776654 4889999999999999999999999999999999999986666899999999
Q ss_pred ceeecCC----CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 276 AEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 276 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
++..... .......++..|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 9876432 123445678999999998765678999999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.22 Aligned_cols=193 Identities=24% Similarity=0.411 Sum_probs=166.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.++.+++.||||+++... ...+.+|+++++++ +||||+++++++.+. ...++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQK--QPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSS--SSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecC--CCcEE
Confidence 478999999999999999999998899999999987532 24578899999999 999999999999654 45789
Q ss_pred EEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||||+++++|..++. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....+..
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCce
Confidence 999999999877653 488999999999999999999999999999999999999666 899999999986543321
Q ss_pred c---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 Y---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 ~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
. ....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~ 317 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYP 317 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 12235667999999876 678999999999999999998 999984
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=303.82 Aligned_cols=194 Identities=22% Similarity=0.363 Sum_probs=166.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+. .++..||+|++... ..+.+.+|+.+++++.+||||+++++++.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence 478999999999999999999973 35678999998643 2367889999999997899999999999764
Q ss_pred CCceEEEeccCCCchhhhcCC--------------------------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT--------------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 257 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~--------------------------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~ 257 (387)
...++||||+++++|..++.. +++..++.++.||+.||+|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 457899999999999776532 678889999999999999999999999999999
Q ss_pred CeeEcCCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 258 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 258 NILl~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|||++.++ .+||+|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|||+| |.+||.
T Consensus 202 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 202 NVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999666 899999999987654332 233456788999999877 679999999999999999998 999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=304.65 Aligned_cols=196 Identities=23% Similarity=0.449 Sum_probs=163.4
Q ss_pred CCCeEEE-eeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.+.|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|++++.++.+||||+++++++.+. ...++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEE
Confidence 3678885 7899999999999999889999999998643 3477899999999976899999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc--eEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--~vkl~DFG~a~~~~~~~ 283 (387)
||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 99999999987765 45899999999999999999999999999999999999986552 39999999997654221
Q ss_pred --------cccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 --------EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 --------~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ...++.++|||||||++|||++|++||.
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 1234569999999999864 1347889999999999999999999994
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=306.72 Aligned_cols=190 Identities=25% Similarity=0.450 Sum_probs=163.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CeEE
Confidence 56999999999999999999998999999999986421 25678999999999 999999999999764 4577
Q ss_pred EEEeccCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.++.+..+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSSB--
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCCC--
Confidence 99999985433322 24689999999999999999999999999999999999999666 8999999999865432
Q ss_pred ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+||+.|+|||++.+ ...++.++|||||||++|||++|++||.
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 35689999999999852 3568999999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=300.29 Aligned_cols=198 Identities=26% Similarity=0.470 Sum_probs=164.8
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----CCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~--~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~----~~~ 205 (387)
..++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++++.+||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 45889999999999999999999988999999999864 345788999999999978999999999997643 456
Q ss_pred ceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.++||||+++++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC---
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceecC
Confidence 78999999999987775 3488999999999999999999999999999999999999666 89999999997654
Q ss_pred CCC-cccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ......|+..|+|||++.+ ...++.++|||||||++|||++|.+||.
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 332 2345578999999999862 2568899999999999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=305.67 Aligned_cols=196 Identities=19% Similarity=0.386 Sum_probs=152.6
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCe---EEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
..++|++.+.||+|+||.||+|.+..++. .||||+++.. ..+.+.+|+++++++ +||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeecccc
Confidence 35789999999999999999999876664 8999998643 346788999999999 99999999999876543
Q ss_pred C----CceEEEeccCCCchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEE
Q 016537 204 K----TPSLIFEHVNNTDFKVLYP---------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (387)
Q Consensus 204 ~----~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl 270 (387)
. ..++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl 178 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCV 178 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEE
Confidence 2 2379999999999877652 488999999999999999999999999999999999999665 8999
Q ss_pred EecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 271 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 271 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+|||+++........ ....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~ 241 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYA 241 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 999999876543322 23456778999999877 679999999999999999999 999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=297.14 Aligned_cols=192 Identities=23% Similarity=0.478 Sum_probs=149.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 87 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDS--NYVY 87 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECS--SEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccC--CeEE
Confidence 67999999999999999999998899999999986432 36788999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~- 282 (387)
+||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC---
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCC
Confidence 999999999987765 3478999999999999999999999999999999999999666 8999999999876532
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......|++.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22344678999999999876 678999999999999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=306.22 Aligned_cols=192 Identities=17% Similarity=0.334 Sum_probs=162.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeE----EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+... ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---C
Confidence 47899999999999999999999777765 777776432 225577899999999 99999999999853 3
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++||||+.+++|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLP 166 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGSC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcccccC
Confidence 477999999999987665 2488899999999999999999999999999999999998666 89999999998765
Q ss_pred CCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 4432 244567788999999977 679999999999999999999 999984
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=299.55 Aligned_cols=195 Identities=29% Similarity=0.510 Sum_probs=168.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.++.+++.||+|.+... ..+.+.+|+++++++ +||||+++++++.+......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 36899999999999999999999889999999998642 235688999999999 999999999988765566788
Q ss_pred EEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHcC-----ceeeccCCCCeeEcCCCceEEEEeccc
Q 016537 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~-----ivHrDlKp~NILl~~~~~~vkl~DFG~ 275 (387)
+||||+++++|..++. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCch
Confidence 9999999999877753 2899999999999999999999999 99999999999999666 899999999
Q ss_pred ceeecCCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 276 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
++....... .....|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 217 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT 217 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 976644322 234578999999999877 678999999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=297.52 Aligned_cols=191 Identities=20% Similarity=0.341 Sum_probs=164.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+++++++ +||||+++++++.+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNP- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCC-
Confidence 478999999999999999999999999999999985322 16788999999999 999999999998543
Q ss_pred CCCceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCc----eEEEEe
Q 016537 203 SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQR----KLRLID 272 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~----~vkl~D 272 (387)
.++||||+.+++|...+ ..+++..++.++.|++.||+|||++| |+||||||+|||++.++. .+||+|
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 26999999999986554 34889999999999999999999999 999999999999985552 399999
Q ss_pred cccceeecCCCcccccccccCCCCchhhcc-cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 273 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
||+++.... ......|++.|+|||++.+ ...++.++|||||||++|||++|+.||.
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999975432 3455689999999999843 2457889999999999999999999984
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.76 Aligned_cols=194 Identities=23% Similarity=0.376 Sum_probs=167.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEE-----eCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .+.+.+|+++++++.+||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-- 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--
Confidence 37899999999999999999985 3467899999997532 366889999999998899999999999764
Q ss_pred CCceEEEeccCCCchhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 204 KTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
...++||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 45679999999999877652 278999999999999999999999999999999999999
Q ss_pred CCCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 180 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 180 HGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp TTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 665 8999999999876544321 23456778999999877 679999999999999999999 999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=296.88 Aligned_cols=194 Identities=21% Similarity=0.328 Sum_probs=164.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+ +|++++..+..+... ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccCC-CCceEEEEE
Confidence 47899999999999999999999899999999998643 346789999999999 776666666655443 356789999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc--CCCceEEEEecccceeecCCCc-
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
|+ +++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++ .++..+||+|||+++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99 78887665 3589999999999999999999999999999999999994 2344899999999987654432
Q ss_pred -------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 245579999999999987 679999999999999999999999994
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=293.06 Aligned_cols=191 Identities=18% Similarity=0.346 Sum_probs=166.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+ .++..||+|.+... ..+.+.+|+++++++ +||||+++++++.+ ...++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEEE
Confidence 47899999999999999999997 56788999998753 457789999999999 99999999999854 3468999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCcccc
Confidence 9999999988875 488999999999999999999999999999999999999665 8999999999876543221
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCc
Confidence 23356778999999876 678999999999999999999 899984
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=312.39 Aligned_cols=191 Identities=25% Similarity=0.458 Sum_probs=159.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~-hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+. +++.||||++... ..+.+.+|+++|+++.+ ||||+++++++... ...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEE
Confidence 56999999999999999999984 4899999998643 23668899999999943 69999999998764 3578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||| +.+++|..++ ..+++..++.++.||+.||+|||+++|+||||||+|||++ ++ .+||+|||+++.+.....
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSSCCC-----
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCccccccCCCc
Confidence 9999 5667776665 4588889999999999999999999999999999999996 44 799999999987654332
Q ss_pred ---ccccccccCCCCchhhccc----------CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 ---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ---~~~~~gt~~y~aPE~~~~~----------~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+. ..++.++|||||||+||||++|++||.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 2456899999999998641 358899999999999999999999994
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.38 Aligned_cols=193 Identities=17% Similarity=0.234 Sum_probs=158.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhc--CCCCeeEEE-------EE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLC--GGPNIVKLL-------DI 197 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~--~hpniv~l~-------~~ 197 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+. +||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999999889999999998632 2367889995544442 899999998 66
Q ss_pred EEcCCC----------C-----CceEEEeccCCCchhhhcC---CCCH-------HHHHHHHHHHHHHHHHHHHcCceee
Q 016537 198 VRDQQS----------K-----TPSLIFEHVNNTDFKVLYP---TLSD-------YDVRYYIYELLKALDYCHSQGIMHR 252 (387)
Q Consensus 198 ~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~~~~-------~~~~~~~~qi~~aL~yLH~~~ivHr 252 (387)
+.+.+. . ..++||||+ +|+|..++. .+++ ..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 665421 0 367999999 578877663 2444 6777899999999999999999999
Q ss_pred ccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhccc----------CCCCCccchhhHHHHHHHH
Q 016537 253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGM 322 (387)
Q Consensus 253 DlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~sDvwSlGvil~el 322 (387)
||||+|||++.++ .+||+|||+++... ......+| +.|+|||++.+. ..++.++|||||||+||||
T Consensus 231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999666 89999999998632 34455677 999999999873 2699999999999999999
Q ss_pred HhcCCchh
Q 016537 323 VSVSPSVL 330 (387)
Q Consensus 323 ltg~~pf~ 330 (387)
++|++||.
T Consensus 307 ltg~~Pf~ 314 (377)
T 3byv_A 307 WCADLPIT 314 (377)
T ss_dssp HHSSCCC-
T ss_pred HHCCCCCc
Confidence 99999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=309.44 Aligned_cols=194 Identities=21% Similarity=0.352 Sum_probs=166.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-------CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
.++|++.+.||+|+||.||+|.+... +..||||+++... ...+.+|+++++++.+||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 37899999999999999999997532 3689999987532 256889999999998899999999999764
Q ss_pred CCCCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
...++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 148 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 148 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred --CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 45679999999999987752 388999999999999999999999999999999999999
Q ss_pred CCCceEEEEecccceeecCCC---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 263 HEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 226 ~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 226 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp TTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 666 89999999998765432 2234466788999999987 679999999999999999999 999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=303.56 Aligned_cols=196 Identities=29% Similarity=0.564 Sum_probs=166.5
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---~~ 204 (387)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+++++++ +||||+++++++.... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccc
Confidence 3589999999999999999999998899999999986432 35677999999999 9999999999886532 25
Q ss_pred CceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
..++||||+.+ +|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 88 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred eEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccc
Confidence 67899999984 665554 4589999999999999999999999999999999999999666 8999999999876432
Q ss_pred Cc-----------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE-----------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....+||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 21 2234789999999998765678999999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.38 Aligned_cols=193 Identities=25% Similarity=0.457 Sum_probs=160.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 87 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP--TDFF 87 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--CeEE
Confidence 7899999999999999999999889999999998643 235788999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC---
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCcc
Confidence 999999999987765 4589999999999999999999999999999999999999666 899999999987765554
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 5566889999999998773334689999999999999999999983
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=295.67 Aligned_cols=192 Identities=18% Similarity=0.324 Sum_probs=163.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++++.||+|+||.||+|.+ .++..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQ--RPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--SSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEecC--CCeEEEE
Confidence 37899999999999999999987 57788999999754 457789999999999 899999999999654 4578999
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc--
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-- 284 (387)
||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHHS
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEcccccccccccccccc
Confidence 999999988775 3489999999999999999999999999999999999999666 899999999976543321
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 178 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 123355678999999987 678999999999999999998 999984
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.64 Aligned_cols=193 Identities=26% Similarity=0.433 Sum_probs=168.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+. ...++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcC--CEEEEE
Confidence 6799999999999999999999889999999998643 236788999999999 999999999999764 456799
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC---
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--- 283 (387)
|||+++++|...+. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEEC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchh
Confidence 99999999987764 388999999999999999999999999999999999999666 79999999998654332
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......|+..|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 209 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 23456789999999998763334788999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=303.68 Aligned_cols=192 Identities=29% Similarity=0.591 Sum_probs=163.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----C
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----K 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~----~ 204 (387)
++|.+.+.||+|+||.||+|.+..+|+.||||++.... .+.+.+|+.+++++ +||||+++++++..... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccce
Confidence 78999999999999999999999999999999986422 35678999999999 99999999999976432 2
Q ss_pred CceEEEeccCCCchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 205 TPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
..++||||+.+ ++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~-- 178 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA-- 178 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC-----
T ss_pred eEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCC--
Confidence 35899999985 665554 4689999999999999999999999999999999999999666 899999999976542
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+++.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 23456789999999998775678999999999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=313.21 Aligned_cols=192 Identities=26% Similarity=0.539 Sum_probs=165.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhc-----CCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~-----~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++++.||+|+||.||+|.+..+++.||||+++... ...+.+|+++++.+. +|+||+++++++... ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--Ce
Confidence 368999999999999999999999999999999997643 356788999998873 567999999999764 45
Q ss_pred ceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc-eEEEEecccceee
Q 016537 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFY 279 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~-~vkl~DFG~a~~~ 279 (387)
.++||||+.+ ++..++ ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. .+||+|||+++..
T Consensus 174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 7899999985 554443 23889999999999999999999999999999999999997662 3999999999764
Q ss_pred cCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .....+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.
T Consensus 253 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 253 HQ--RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TC--CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC--cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 32 3345689999999999987 679999999999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=294.04 Aligned_cols=191 Identities=24% Similarity=0.461 Sum_probs=169.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++++ +||||+++++++.+. ...+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 90 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDR--KRIY 90 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcC--CEEE
Confidence 7899999999999999999999889999999998532 246788999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+++++|...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~-~ 168 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSL-R 168 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSS-C
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCccc-c
Confidence 999999999987665 4589999999999999999999999999999999999999666 8999999999765432 3
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|++.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 169 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 345678999999999887 678999999999999999999999984
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=296.57 Aligned_cols=192 Identities=21% Similarity=0.404 Sum_probs=154.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+... ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---Cc
Confidence 37899999999999999999998543 467999998643 235688999999999 99999999999843 34
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED 168 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCc
Confidence 679999999999887753 488999999999999999999999999999999999999666 899999999987654
Q ss_pred CCcc--cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEY--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 3322 23456678999999876 678999999999999999997 999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=295.23 Aligned_cols=191 Identities=18% Similarity=0.265 Sum_probs=165.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+..+..+.+||||+++++++.+. ...++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~l 88 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHMLI 88 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 6799999999999999999999889999999998742 3466788999999987999999999999764 45789
Q ss_pred EEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC----------------
Q 016537 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---------------- 265 (387)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---------------- 265 (387)
||||+++++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999998776 3489999999999999999999999999999999999997432
Q ss_pred --ceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 266 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 266 --~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
..+||+|||.+...... ....|++.|+|||++.+...++.++|||||||++|||++|.+++
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp -CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 26899999999876543 23468999999999977446778999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.99 Aligned_cols=191 Identities=16% Similarity=0.261 Sum_probs=163.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-------eEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~ 202 (387)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... ..+.+.+|+++++++ +||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCG- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeC-
Confidence 478999999999999999999987766 57999998643 346788999999999 999999999999764
Q ss_pred CCCceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc-------eEEEE
Q 016537 203 SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-------KLRLI 271 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~-------~vkl~ 271 (387)
...++||||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+
T Consensus 85 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 85 -DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp -TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred -CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 34679999999999987763 2889999999999999999999999999999999999986652 19999
Q ss_pred ecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 272 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
|||++..... .....++..|+|||++.+...++.++|||||||++|||++|..|+
T Consensus 164 Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 164 DPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp CCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999865432 234568889999999976567899999999999999999965444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.57 Aligned_cols=193 Identities=18% Similarity=0.365 Sum_probs=165.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .+.+.+|+++++++ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-- 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQD-- 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecC--
Confidence 478999999999999999999873 455899999986432 35678999999999 999999999998664
Q ss_pred CCceEEEeccCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp 256 (387)
...++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 45789999999999977752 178889999999999999999999999999999
Q ss_pred CCeeEcCCCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 257 ~NILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+|||++.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 179 ~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 179 RNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred heEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999665 8999999999876543322 23456778999999877 678999999999999999999 999983
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.21 Aligned_cols=195 Identities=15% Similarity=0.211 Sum_probs=160.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC---CCeEEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCeeEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLL 195 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~l~~~~--------------~~~~~~E~~il~~l~~hpniv~l~ 195 (387)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++.... ...+.+|+.+++.+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 4789999999999999999999976 78899999986432 12355677888888 999999999
Q ss_pred EEEEcC--CCCCceEEEeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC-ceEE
Q 016537 196 DIVRDQ--QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLR 269 (387)
Q Consensus 196 ~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~~vk 269 (387)
+++.+. +....++||||+ +++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 998762 245678999999 899988775 489999999999999999999999999999999999998543 2799
Q ss_pred EEecccceeecCCC--------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 270 LIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 270 l~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+|||+++.+.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999998764322 1244578999999999987 679999999999999999999999994
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=295.57 Aligned_cols=192 Identities=26% Similarity=0.473 Sum_probs=170.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+.|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+. ...++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEE
Confidence 6799999999999999999999889999999998643 347789999999999 999999999999764 457899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
|||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....... ...
T Consensus 99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp EECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCCBC
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCccccccC
Confidence 99999999987764 488999999999999999999999999999999999999666 89999999998765443 234
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...|+..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 178 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 5678999999999877 678999999999999999999999984
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.33 Aligned_cols=193 Identities=21% Similarity=0.330 Sum_probs=161.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+++++.+ +|++++..+..+... ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEEEE
Confidence 47899999999999999999999999999999987543 335688999999999 676666666655443 355689999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeE---cCCCceEEEEecccceeecCCCc
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|+ +++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||+++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCTTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCccc
Confidence 99 88887664 358999999999999999999999999999999999999 5444 899999999987654422
Q ss_pred --------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 --------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 234578999999999987 679999999999999999999999994
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=293.03 Aligned_cols=194 Identities=23% Similarity=0.384 Sum_probs=168.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~--~~~~ 205 (387)
...|++.+.||+|+||.||+|.+..++..||+|.+... ..+.+.+|+.+++++ +||||+++++++... ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence 35689999999999999999999999999999998643 235688999999999 999999999998653 3456
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.++||||+++++|..++ ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+.+.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 78999999999998776 45899999999999999999999999 99999999999998445589999999997543
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus 184 ~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 184 AS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp TT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 33 3345679999999998764 58999999999999999999999983
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.39 Aligned_cols=188 Identities=21% Similarity=0.341 Sum_probs=157.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+ .++.||+|.+... ..+.+.+|+++++++ +||||+++++++.+ ..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN----PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT----TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC----CcEEEEE
Confidence 47899999999999999999987 4789999998654 346789999999999 99999999998753 3679999
Q ss_pred ccCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---cCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 212 HVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 212 ~~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
|+++++|..++. .+++..+..++.|++.||+|||+ +||+||||||+|||++.++..+||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999987763 26788899999999999999999 899999999999999877756899999999765432
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 160 --~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp -------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred --cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 234578999999999877 679999999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=310.65 Aligned_cols=194 Identities=16% Similarity=0.171 Sum_probs=149.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhc-CCCCeeEEE-------EEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC-GGPNIVKLL-------DIVR 199 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~-~hpniv~l~-------~~~~ 199 (387)
.+|++.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.+. +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999998899999999997632 355678877777774 499988755 5554
Q ss_pred cCCC---------------CCceEEEeccCCCchhhhcC----CCCHHHH------HHHHHHHHHHHHHHHHcCceeecc
Q 016537 200 DQQS---------------KTPSLIFEHVNNTDFKVLYP----TLSDYDV------RYYIYELLKALDYCHSQGIMHRDV 254 (387)
Q Consensus 200 ~~~~---------------~~~~lv~e~~~~~~l~~~~~----~~~~~~~------~~~~~qi~~aL~yLH~~~ivHrDl 254 (387)
.... ...++||||++ ++|..++. .+.+..+ ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 3322 23689999999 78877763 2444444 566699999999999999999999
Q ss_pred CCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhcc-cCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 255 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 255 Kp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
||+|||++.++ .+||+|||+++.... ......+++.|+|||++.+ ...++.++|||||||+||||++|++||..
T Consensus 221 kp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999666 899999999986532 2224567799999999864 24689999999999999999999999953
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.24 Aligned_cols=190 Identities=17% Similarity=0.354 Sum_probs=164.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+ .++.||||+++.. ..+.+.+|+++++++ +||||+++++++.+.. ...++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTT-SCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCC-CceEEEEE
Confidence 47899999999999999999987 4789999999754 347789999999999 9999999999987643 35789999
Q ss_pred ccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
|+.+++|..++. .+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--~~ 344 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD 344 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC------
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCccccccc--cc
Confidence 999999987763 268889999999999999999999999999999999999666 8999999999864332 22
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||++.+ ..++.++|||||||+||||++ |+.||.
T Consensus 345 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 345 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp --CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3367788999999977 679999999999999999998 999984
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=303.95 Aligned_cols=191 Identities=25% Similarity=0.457 Sum_probs=157.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~~~~ 205 (387)
.++|++++.||+|+||.||+|.+ .+++.||||++.... .+.+.+|+++++++ +| |||+++++++.+. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~--~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITD--QY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECS--SE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeC--CE
Confidence 47899999999999999999988 578999999986332 25678999999999 54 9999999999764 46
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
.++||| +.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++.....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC---
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeecccccccCcc
Confidence 789999 5567776665 4589999999999999999999999999999999999997 44 7999999999876544
Q ss_pred Cc---ccccccccCCCCchhhcc----------cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE---YNVRVASRYFKGPELLVD----------LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. ....+||+.|+|||++.+ ...++.++|||||||++|||++|++||.
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 32 235689999999999854 2468889999999999999999999994
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=316.02 Aligned_cols=191 Identities=17% Similarity=0.320 Sum_probs=165.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+ .++..||||+++.. ..+.+.+|+++|+++ +||||+++++++.+ ...++||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~---~~~~lv~ 261 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYIIT 261 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEeC---CccEEEE
Confidence 47899999999999999999998 46788999999753 457899999999999 99999999999853 3578999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
||+.+++|..++. .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCcee
Confidence 9999999987764 478889999999999999999999999999999999999666 899999999987643211
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.. ..++.++|||||||+||||++ |++||.
T Consensus 341 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 122345678999999876 679999999999999999999 999984
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=306.47 Aligned_cols=193 Identities=20% Similarity=0.305 Sum_probs=166.7
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ...+.+|+++++++ +||||+++++++.+. ...+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 103 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TERL 103 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECCS--SCCE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEecC--CceE
Confidence 457899999999999999999986 578999999987533 23688999999999 999999999999764 3467
Q ss_pred EEEeccCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHc---CceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
+||||+.+++|..++. .+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~ 182 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 182 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSCE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCcccc
Confidence 9999999999987763 288899999999999999999999 999999999999999665 89999999998
Q ss_pred eecCCCc--ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCccc
Confidence 7653322 344568999999999877 678999999999999999999999994
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=297.94 Aligned_cols=192 Identities=23% Similarity=0.425 Sum_probs=159.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 110 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEID--GQLY 110 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeC--CeEE
Confidence 78999999999999999999998899999999986432 26688999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+||||+++++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC---------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccccc
Confidence 999999999998776 4589999999999999999999999999999999999999666 89999999997654432
Q ss_pred -cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......++..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 2234578999999999877 678999999999999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=297.81 Aligned_cols=192 Identities=24% Similarity=0.429 Sum_probs=166.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+. ...++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYEST--THYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccC--CEEEEEE
Confidence 6799999999999999999999889999999998753 235688999999999 999999999999764 4578999
Q ss_pred eccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc--CCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+++++|...+ ..+++..++.++.|++.||.|||++||+||||||+|||+. .++..+||+|||+++.... ...
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~ 164 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIM 164 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTT
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Ccc
Confidence 999999987664 4589999999999999999999999999999999999992 2344899999999976433 233
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....|++.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp HHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 45678999999999876 678999999999999999999999984
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.08 Aligned_cols=195 Identities=21% Similarity=0.368 Sum_probs=166.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... .+.+.+|+.+++++.+||||+++++++... .
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-C
Confidence 478999999999999999999863 466899999987532 356889999999997899999999998754 3
Q ss_pred CCceEEEeccCCCchhhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYPT-------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 264 (387)
...++||||+.+++|..++.. +++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 457899999999999877632 6788999999999999999999999999999999999865
Q ss_pred CceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 265 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 265 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+ .+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 185 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 185 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp G-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred C-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 5 899999999987644332 234567888999999877 679999999999999999998 999984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=290.50 Aligned_cols=191 Identities=18% Similarity=0.376 Sum_probs=157.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.+ +++.+|||+++.. ..+.+.+|+++++.+ +||||+++++++.+. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKE--PN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC----
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecC--Cc
Confidence 47899999999999999999997 4889999998632 235688999999999 999999999999764 45
Q ss_pred ceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---ceeeccCCCCeeEcCC-------CceEEEEec
Q 016537 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------QRKLRLIDW 273 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDlKp~NILl~~~-------~~~vkl~DF 273 (387)
.++||||+++++|..++ +.+++..++.++.|++.||.|||++| |+||||||+|||++.+ ...+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 67999999999998876 45899999999999999999999999 8999999999999852 347999999
Q ss_pred ccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 274 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|+++...... .....|++.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp CC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred Cccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9998665433 234578999999999877 678999999999999999999999994
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.42 Aligned_cols=193 Identities=21% Similarity=0.417 Sum_probs=148.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~i-l~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ..+...|... ++.+ +||||+++++++.+. ...+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~--~~~~ 82 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFRE--GDVW 82 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SSEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeecc--CCEE
Confidence 378999999999999999999999999999999986432 1233334444 5555 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
+||||+++ ++..++ ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYL 160 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcccc
Confidence 99999986 543332 3589999999999999999999998 999999999999999666 8999999999877
Q ss_pred cCCCcccccccccCCCCchhh---cccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELL---VDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..........|++.|+|||++ .....++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 665555566899999999997 233578999999999999999999999984
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=300.13 Aligned_cols=193 Identities=23% Similarity=0.394 Sum_probs=166.5
Q ss_pred CeEEEeeeeecCCeeEEEEEE----eCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.|++++.||+|+||.||++.+ ..+++.||||+++... .+.+.+|+++++++ +||||+++++++.+......
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceE
Confidence 359999999999999988764 3478999999997543 35688999999999 89999999999988766778
Q ss_pred eEEEeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
++||||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTCS
T ss_pred EEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCcccccccccccc
Confidence 89999999999988774 489999999999999999999999999999999999999665 899999999988765432
Q ss_pred ----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 ----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 233467788999999977 678899999999999999999999984
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.89 Aligned_cols=193 Identities=19% Similarity=0.368 Sum_probs=168.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.++.++..||||+++.. ..+.+.+|+++|+++ +||||+++++++.+. ...++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecC--CcEEEEE
Confidence 46799999999999999999999888999999999753 457899999999999 999999999999764 4568999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
||+.+++|..++. .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++........
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCEE
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCcee
Confidence 9999999987762 378899999999999999999999999999999999998655 8999999999876543221
Q ss_pred --cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 --~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....++..|+|||++.+ ..++.++|||||||+||||++ |.+||.
T Consensus 375 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 22345678999999876 678999999999999999999 999984
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=300.60 Aligned_cols=194 Identities=20% Similarity=0.343 Sum_probs=164.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-------CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
.++|++.+.||+|+||.||+|.+. .++..||+|+++... .+.+.+|+++++++.+||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999975 356789999987532 356889999999998899999999999764
Q ss_pred CCCCceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
...++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 114 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 114 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp --SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 45789999999999987752 278889999999999999999999999999999999999
Q ss_pred CCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.++ .+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 192 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 192 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp TTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 666 899999999987654332 223456778999999877 678999999999999999999 999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=299.37 Aligned_cols=195 Identities=30% Similarity=0.636 Sum_probs=165.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-CCCeEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEEEEEEEc---C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD---Q 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~--~hpniv~l~~~~~~---~ 201 (387)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... ...+.+|+.+++.+. +||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 378999999999999999999985 678999999986422 245678888887764 89999999999862 2
Q ss_pred CCCCceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
.....++||||+.+ +|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~ 167 (326)
T 1blx_A 90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLA 167 (326)
T ss_dssp SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSC
T ss_pred CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCccc
Confidence 33567899999994 665554 2388999999999999999999999999999999999999666 8999999999
Q ss_pred eeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+............++..|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 87655444556788999999999877 679999999999999999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=301.01 Aligned_cols=195 Identities=22% Similarity=0.343 Sum_probs=150.5
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEc------CCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRD------QQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~------~~~~ 204 (387)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++.+||||+++++++.. ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 68999999999999999999998899999999885433 35678999999999569999999999853 2233
Q ss_pred CceEEEeccCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 205 TPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
..++||||+. |+|..++ ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCccc
Confidence 4689999997 4554433 34899999999999999999999999 99999999999999666 8999999999
Q ss_pred eeecCCCcc-------------cccccccCCCCchhhc--ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+........ ....+++.|+|||++. ....++.++|||||||++|||++|++||.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 876543221 1456899999999983 22568889999999999999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=297.64 Aligned_cols=196 Identities=17% Similarity=0.344 Sum_probs=157.1
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeC---CCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
..++|++.+.||+|+||.||+|.+.. ++..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence 34789999999999999999998865 4568999998643 235688999999999 99999999999986543
Q ss_pred C---CceEEEeccCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEE
Q 016537 204 K---TPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (387)
Q Consensus 204 ~---~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~ 271 (387)
. ..++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~ 189 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVA 189 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEe
Confidence 3 458999999999997765 3488999999999999999999999999999999999999665 89999
Q ss_pred ecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 272 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 272 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 251 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYP 251 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence 9999987644321 233456788999999977 679999999999999999999 888883
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=296.73 Aligned_cols=193 Identities=20% Similarity=0.370 Sum_probs=168.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+..++..||+|++.... .+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--CCEEEEE
Confidence 478999999999999999999999899999999987543 46788999999999 999999999998654 4578999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSSE
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCccc
Confidence 9999999987762 388999999999999999999999999999999999998665 899999999986654332
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~ 214 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP 214 (288)
T ss_dssp EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 233456778999999877 679999999999999999999 999984
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=300.32 Aligned_cols=194 Identities=23% Similarity=0.327 Sum_probs=166.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCe-----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+..+++ .||+|.+... ..+.+.+|+++++++.+||||+++++++.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--
Confidence 4889999999999999999999866554 8999998753 2466889999999997899999999999764
Q ss_pred CCceEEEeccCCCchhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 266 (387)
...++||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~- 201 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH- 201 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG-
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC-
Confidence 45789999999999877652 368889999999999999999999999999999999998655
Q ss_pred eEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 267 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 899999999986543322 123456778999999877 679999999999999999999 999984
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.24 Aligned_cols=193 Identities=20% Similarity=0.348 Sum_probs=154.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|+++ .++..||||.++.. ..+.+.+|+.+++++ +||||+++++++.+. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKS--KP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--Cc
Confidence 367899999999999999999886 45778999998643 235688999999999 999999999999754 45
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+++++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLED 199 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCcccccccc
Confidence 789999999999987763 488999999999999999999999999999999999999666 899999999987654
Q ss_pred CCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp --------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred CCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 3221 12234678999999877 679999999999999999998 999984
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=295.62 Aligned_cols=193 Identities=24% Similarity=0.447 Sum_probs=166.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.+. ...++|||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e 104 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKN--TDLWIVME 104 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEEEEee
Confidence 47899999999999999999999888999999998754 347789999999999 999999999999764 45689999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
|+++++|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ...
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCBC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhccccC
Confidence 99999988765 3589999999999999999999999999999999999999666 89999999998765432 234
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...|+..|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 184 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 184 TVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 5578999999999877 678999999999999999999999984
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.71 Aligned_cols=192 Identities=23% Similarity=0.395 Sum_probs=162.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.+... +..||+|.+... ..+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~---~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEE---P 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSS---S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC---C
Confidence 37899999999999999999987543 346999998753 346788999999999 999999999998643 3
Q ss_pred ceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIED 165 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC--
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCccccc
Confidence 57999999999987766 3489999999999999999999999999999999999999666 899999999986644
Q ss_pred CCc--ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
... .....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp -------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 322 233456778999999876 678999999999999999998 999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=298.37 Aligned_cols=192 Identities=23% Similarity=0.345 Sum_probs=160.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCC--CCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l-~~hpniv~l~~~~~~~~~--~~~~lv~ 210 (387)
++|++.+.||+|+||.||+|.+ +++.||||++.........+|.+++..+ .+||||+++++++.+... ...++||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 6899999999999999999987 4899999999877667777777776654 389999999999886533 5678999
Q ss_pred eccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHc--------CceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~--------~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
||+.+++|..++ ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus 115 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~ 193 (337)
T 3mdy_A 115 DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFI 193 (337)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred eccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceeec
Confidence 999999998776 3588999999999999999999998 999999999999999666 89999999997764
Q ss_pred CCCcc-----cccccccCCCCchhhcccCCCCCc------cchhhHHHHHHHHHhcCCch
Q 016537 281 PGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 281 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~------sDvwSlGvil~elltg~~pf 329 (387)
..... ....||+.|+|||++.+ ..++.. +|||||||++|||++|..|+
T Consensus 194 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 194 SDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp ---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred cccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 43322 24579999999999876 444444 99999999999999995443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.84 Aligned_cols=197 Identities=21% Similarity=0.336 Sum_probs=164.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~--~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++.+ +||||+++++++... .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeE
Confidence 47899999999999999999999899999999988543 346688999999999 999999999998642 234678
Q ss_pred EEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
+||||+.+++|..++ ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence 999999999987655 3389999999999999999999999999999999999998666 89999999987643
Q ss_pred CCCc----------ccccccccCCCCchhhcccC--CCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 281 PGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 281 ~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.... .....|++.|+|||++.+.. .++.++|||||||++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 2111 12345789999999986522 368899999999999999999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=306.27 Aligned_cols=192 Identities=24% Similarity=0.414 Sum_probs=167.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET--TEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC--CEEEE
Confidence 47899999999999999999999989999999998643 235688999999999 999999999999864 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||||+++++|..++ ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||++...... .
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~ 186 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 186 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-C
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccccc-c
Confidence 99999999998776 3589999999999999999999996 999999999999999766 8999999999755322 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 187 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp ----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred ccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 344678999999999987 679999999999999999999999984
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=299.80 Aligned_cols=192 Identities=19% Similarity=0.368 Sum_probs=158.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeE----EEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~l~~----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++++.||+|+||.||+|.+..+++. ||+|.+.. ...+.+.+|+.+++++ +||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS--
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC--
Confidence 47899999999999999999999777764 46776642 3457889999999999 9999999999997642
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.++++||+.++++..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 168 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC-----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEcc
Confidence 67999999999987765 3488999999999999999999999999999999999998666 89999999998764
Q ss_pred CCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4322 223356778999999987 779999999999999999999 999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.20 Aligned_cols=194 Identities=19% Similarity=0.319 Sum_probs=160.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHH--HhcCCCCeeEEEEEEEc---CCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ--NLCGGPNIVKLLDIVRD---QQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~--~l~~hpniv~l~~~~~~---~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+ +++.||||++.......+..|.+++. .+ +||||+++++.+.. ......+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceEE
Confidence 47899999999999999999976 78999999998777677766666654 35 99999999986543 2233567
Q ss_pred EEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHc---------CceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 208 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 208 lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---------~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
+||||+++++|..++ ...++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeeccce
Confidence 999999999998776 3468888999999999999999999 999999999999999666 8999999999
Q ss_pred eeecCCC---------cccccccccCCCCchhhccc------CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+.+.... .....+||+.|+|||++.+. ..++.++|||||||++|||++|..||.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 8764321 12345799999999998652 245678999999999999999987774
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=295.65 Aligned_cols=196 Identities=24% Similarity=0.459 Sum_probs=164.9
Q ss_pred CCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 131 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
...++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHD--GKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC---CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeC--CeEE
Confidence 3457899999999999999999999889999999998643 346788999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~- 282 (387)
+||||++++++..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccccccc
Confidence 999999999987664 4589999999999999999999999999999999999999666 8999999997543211
Q ss_pred CcccccccccCCCCchhhc----ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......|+..|+|||++. ....++.++|||||||++|||++|.+||.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence 1223457899999999984 23578999999999999999999999984
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=290.69 Aligned_cols=189 Identities=16% Similarity=0.296 Sum_probs=162.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+ +++.+|+|+++... .+.+.+|+.+++++ +||||+++++++.+......++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEe
Confidence 6899999999999999999997 48899999987432 35688999999999 9999999999998765567889
Q ss_pred EEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 209 IFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 209 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
||||+++++|..++. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQ- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCTTS-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceeeec-
Confidence 999999999987763 2789999999999999999999999 99999999999999665 79999998875432
Q ss_pred CCcccccccccCCCCchhhcccC--CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+|+.|+|||++.+.. .++.++|||||||++|||++|+.||.
T Consensus 165 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 165 ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp ---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred ---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 23457889999999987621 23337999999999999999999984
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=298.43 Aligned_cols=195 Identities=20% Similarity=0.396 Sum_probs=166.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEE----eCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++++.||+|+||.||+|.+ ..+++.||+|++.... .+.+.+|+++++++ +||||+++++++.......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCc
Confidence 36799999999999999999984 5678999999987543 35688999999999 9999999999987765567
Q ss_pred ceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhccc
Confidence 88999999999998765 2488999999999999999999999999999999999999666 899999999987654
Q ss_pred CCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 432 123456778999999877 568899999999999999999999884
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=295.09 Aligned_cols=195 Identities=25% Similarity=0.431 Sum_probs=164.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++++ +||||+++++++.+......
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeE
Confidence 6899999999999999999999889999999998643 236788999999999 99999999999876666678
Q ss_pred eEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+.++....+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTT
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCcc
Confidence 9999999987333221 3588999999999999999999999999999999999999666 8999999999876432
Q ss_pred ---CcccccccccCCCCchhhcccC-CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 ---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ---~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......|+..|+|||++.+.. .++.++|||||||++|||++|+.||.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 2234557899999999987522 24779999999999999999999984
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=292.80 Aligned_cols=190 Identities=16% Similarity=0.345 Sum_probs=152.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+ +..+|+|+++.. ..+.+.+|+++++++ +||||++++++... ...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---~~~~ 95 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQLA 95 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCE
T ss_pred ccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeeccC---CccE
Confidence 47899999999999999999985 335999998632 236688999999999 99999999997643 3467
Q ss_pred EEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-
Q 016537 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~- 282 (387)
+||||+.+++|...+. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC---------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceecccccccc
Confidence 9999999999977663 488899999999999999999999999999999999999666 8999999999765432
Q ss_pred --CcccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 --KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......|++.|+|||++.. ...++.++|||||||++|||++|+.||.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 22344578999999999862 2568889999999999999999999983
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=303.57 Aligned_cols=193 Identities=19% Similarity=0.216 Sum_probs=163.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC--------CCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeE-----------
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK----------- 193 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~----------- 193 (387)
.++|++.+.||+|+||.||+|.+.. .++.||+|++... +.+.+|+++++++ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCcc
Confidence 4789999999999999999999976 4889999998754 5688999999999 8999887
Q ss_pred ----EEEEEEcCCCCCceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC
Q 016537 194 ----LLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (387)
Q Consensus 194 ----l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 264 (387)
+++++... ....++||||+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 118 ~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 118 AIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp SCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred CccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 66666652 45678999999 89988775 358999999999999999999999999999999999999955
Q ss_pred C-ceEEEEecccceeecCCCc--------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 265 Q-RKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 265 ~-~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
+ ..+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 4 2799999999976643221 234578999999999877 6799999999999999999999999953
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=312.06 Aligned_cols=191 Identities=17% Similarity=0.327 Sum_probs=161.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.++ .+..||||+++.. ..+.+.+|+++++++ +||||+++++++.+ ...++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEEe
Confidence 478999999999999999999984 4577999999753 357899999999999 99999999999864 3478999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
||+.+++|..++. .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCcee
Confidence 9999999987764 388999999999999999999999999999999999998655 899999999987643321
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|||||||+||||++ |++||.
T Consensus 337 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence 123346678999999876 679999999999999999999 999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=300.46 Aligned_cols=194 Identities=23% Similarity=0.430 Sum_probs=150.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++++ +||||+++++++...+ ..++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~--~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKD--ELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSS--CEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecC--CcEE
Confidence 47899999999999999999998888999999988643 235678899999998 9999999999998654 4679
Q ss_pred EEeccCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 209 IFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 209 v~e~~~~~~l~~~~~-----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
||||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 169 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSA 169 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccchh
Confidence 999999999877653 388999999999999999999999999999999999999666 89999999997
Q ss_pred eecCCC------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...... ......|++.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 654332 12345789999999998654568999999999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=295.78 Aligned_cols=193 Identities=26% Similarity=0.546 Sum_probs=157.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+. ...
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~ 107 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--NEL 107 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CcE
Confidence 36899999999999999999999889999999998642 235688999999999 999999999999864 457
Q ss_pred eEEEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++||||+++++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeee
Confidence 7999999999987765 2388999999999999999999999999999999999999666 8999999999766
Q ss_pred cCCC-cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 4432 2234578999999999877 678999999999999999999999984
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=301.19 Aligned_cols=193 Identities=20% Similarity=0.320 Sum_probs=163.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEE--EEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKC--IIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..++..+ |+|.++.. ..+.+.+|+++++++.+||||+++++++.+. ...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--CceE
Confidence 68999999999999999999998888765 89988642 3356889999999987899999999999764 4578
Q ss_pred EEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceE
Q 016537 208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~v 268 (387)
+||||+++++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~ 181 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA 181 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-eE
Confidence 9999999999877652 478999999999999999999999999999999999998665 89
Q ss_pred EEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 269 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
||+|||+++............++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9999999975433333344567788999999876 678999999999999999998 999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.13 Aligned_cols=192 Identities=17% Similarity=0.339 Sum_probs=165.7
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+. +++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--CCeEEEE
Confidence 378999999999999999999984 7789999999754 457789999999999 999999999999764 4577999
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC--c
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--~ 284 (387)
||+++++|..++ ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++...... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEcccccccccccccccc
Confidence 999999988765 3478999999999999999999999999999999999998665 89999999997654321 1
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE 207 (267)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCC
Confidence 123456778999999876 678999999999999999999 899984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.78 Aligned_cols=192 Identities=26% Similarity=0.550 Sum_probs=169.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++++ +||||+++++++.+. ...++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 98 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS--SSFYI 98 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCC--CeEEE
Confidence 6899999999999999999999889999999998532 346789999999999 999999999999764 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC--ceEEEEecccceeecCCC
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~~vkl~DFG~a~~~~~~~ 283 (387)
||||+.++++...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ ..+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999886554 4689999999999999999999999999999999999997543 269999999998776555
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......+++.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 5556678999999999865 48999999999999999999999983
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=296.77 Aligned_cols=193 Identities=19% Similarity=0.342 Sum_probs=164.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+. .+++.||+|.+.... ...+.+|+.+++++ +||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-- 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG-- 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS--
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccC--
Confidence 478999999999999999999876 357899999986432 34678999999999 999999999999664
Q ss_pred CCceEEEeccCCCchhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEE
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl 270 (387)
...++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~kl 179 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI 179 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eEEE
Confidence 45679999999999877652 358889999999999999999999999999999999999666 8999
Q ss_pred EecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 271 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 99999976543321 123456788999999877 679999999999999999999 889884
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=289.62 Aligned_cols=192 Identities=20% Similarity=0.369 Sum_probs=164.0
Q ss_pred CCCeEEEe-eeeecCCeeEEEEEEe--CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|.+.+ .||+|+||.||+|.+. .++..||+|+++.. ..+.+.+|+++++++ +||||+++++++.. ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---EA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---CC
Confidence 36788877 9999999999999863 46788999999753 236688999999999 99999999999843 34
Q ss_pred ceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGA 162 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTT
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeecc
Confidence 78999999999998776 2488999999999999999999999999999999999999666 899999999987654
Q ss_pred CCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 4322 22345788999999876 678999999999999999999 999984
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.93 Aligned_cols=192 Identities=20% Similarity=0.358 Sum_probs=159.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.+|++.+.||+|+||.||+|.+..+ ...+|+|.+.... .+.+.+|+.+++++ +||||+++++++.+. ....
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCce
Confidence 5689999999999999999987433 3468999986432 36688999999999 999999999987654 3457
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECccccccccccc
Confidence 89999999999987763 378899999999999999999999999999999999999665 8999999999866433
Q ss_pred Cc-----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 283 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
.. .....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 233456788999999977 679999999999999999999 56665
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.38 Aligned_cols=192 Identities=19% Similarity=0.328 Sum_probs=162.6
Q ss_pred CCCeEEEe-eeeecCCeeEEEEEE--eCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVR-KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+ .||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+++++.+ +||||+++++++.. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---E 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECC---C
Confidence 36899998 999999999999965 4567899999986432 46788999999999 99999999999843 3
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRA 169 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeecc
Confidence 467999999999998775 3489999999999999999999999999999999999999666 899999999987654
Q ss_pred CCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 4322 22345678999999876 668899999999999999999 999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=294.97 Aligned_cols=193 Identities=18% Similarity=0.317 Sum_probs=158.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC----eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ....+.+|+++++++ +||||+++++++.+. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKY--K 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecC--C
Confidence 478999999999999999999986543 46999998743 235678999999999 999999999998653 4
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++||||+++++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE 198 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhhc
Confidence 578999999999998775 3488999999999999999999999999999999999999665 89999999998765
Q ss_pred CCCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 43221 22345678999999876 679999999999999999999 999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.03 Aligned_cols=194 Identities=28% Similarity=0.518 Sum_probs=165.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhc----------CCCCeeEEEEEEEc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGPNIVKLLDIVRD 200 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~----------~hpniv~l~~~~~~ 200 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++++. .||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 478999999999999999999999999999999997543 466789999999883 28999999999875
Q ss_pred CC--CCCceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcC-----CCce
Q 016537 201 QQ--SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDH-----EQRK 267 (387)
Q Consensus 201 ~~--~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~-----~~~~ 267 (387)
.. ....++||||+ +++|..++ ..+++..++.++.||+.||+|||++ ||+||||||+|||++. +...
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 42 23678999999 67776654 2388999999999999999999998 9999999999999952 2237
Q ss_pred EEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 268 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 177 ~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 177 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred EEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999987543 3345688999999999987 679999999999999999999999995
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.78 Aligned_cols=190 Identities=22% Similarity=0.414 Sum_probs=167.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch--------------------HHHHHHHHHHHHhcCCCCeeE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNIVK 193 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~--------------------~~~~~E~~il~~l~~hpniv~ 193 (387)
++|++.+.||+|+||.||+|.+ +++.||+|++..... +.+.+|+++++++ +||||++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~ 107 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLT 107 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcce
Confidence 7899999999999999999998 899999999863211 7889999999999 9999999
Q ss_pred EEEEEEcCCCCCceEEEeccCCCchhhh------c-----CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeE
Q 016537 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL------Y-----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMI 261 (387)
Q Consensus 194 l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl 261 (387)
+++++.+. ...++||||+++++|..+ + ..+++..++.++.|++.||.|||+ +||+||||||+|||+
T Consensus 108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 99999765 457899999999998876 3 348899999999999999999999 999999999999999
Q ss_pred cCCCceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCC-ccchhhHHHHHHHHHhcCCchh
Q 016537 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 262 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~sDvwSlGvil~elltg~~pf~ 330 (387)
+.++ .+||+|||++...... ......|+..|+|||++.+...++. ++|||||||++|||++|.+||.
T Consensus 186 ~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 186 DKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9666 8999999999876544 3455678999999999877435665 9999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.63 Aligned_cols=189 Identities=26% Similarity=0.451 Sum_probs=158.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---------
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--------- 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~--------- 202 (387)
++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++++ +||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhccc
Confidence 6799999999999999999999889999999998643 236688999999999 9999999999886532
Q ss_pred --CCCceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 203 --SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 203 --~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
....++||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~ 163 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLA 163 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcch
Confidence 345789999999999987763 367788999999999999999999999999999999999666 8999999999
Q ss_pred eeecCC---------------CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh
Q 016537 277 EFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324 (387)
Q Consensus 277 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt 324 (387)
+..... .......|+..|+|||++.+...++.++|||||||++|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 765422 122445789999999999875578999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.48 Aligned_cols=190 Identities=17% Similarity=0.354 Sum_probs=157.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+. ....++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEEe
Confidence 37899999999999999999987 4889999998754 346789999999999 999999999987653 345789999
Q ss_pred ccCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
|+++++|..++.. +++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--~~ 172 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD 172 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccccccc--cc
Confidence 9999999877642 78889999999999999999999999999999999999666 8999999999765432 23
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 173 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 173 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred CCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 3467888999999876 678999999999999999998 999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.28 Aligned_cols=194 Identities=22% Similarity=0.361 Sum_probs=164.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.++||+|+||.||+|.+..+++.||||++... ....+.+|+++++.+.+|+++..+..++.+ ....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEE
Confidence 37899999999999999999999899999999988643 345688999999999555666666665544 345689999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc--CCCceEEEEecccceeecCCCc-
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
|+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+||||+ .+...+||+|||+++.+.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99 78887665 3589999999999999999999999999999999999993 2344899999999987754432
Q ss_pred -------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 -------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....||..|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 125689999999999987 679999999999999999999999994
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=294.52 Aligned_cols=190 Identities=20% Similarity=0.300 Sum_probs=163.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCC--CCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l-~~hpniv~l~~~~~~~~~--~~~~lv~ 210 (387)
++|++.+.||+|+||.||+|.+ +++.||||++.......+.+|.+++..+ .+||||+++++++..... ...++||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 6799999999999999999987 5899999999877778889999999883 399999999999986542 2678999
Q ss_pred eccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHH--------HcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH--------~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
||+.+++|..++ ..+++..++.++.|++.||.||| +++|+||||||+|||++.++ .+||+|||+++...
T Consensus 120 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~ 198 (342)
T 1b6c_B 120 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHD 198 (342)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEEE
T ss_pred eecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceecc
Confidence 999999998776 35889999999999999999999 89999999999999999666 89999999998775
Q ss_pred CCCc-----ccccccccCCCCchhhcccCC-----CCCccchhhHHHHHHHHHhcC
Q 016537 281 PGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDLWSLGCMFAGMVSVS 326 (387)
Q Consensus 281 ~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~sDvwSlGvil~elltg~ 326 (387)
.... .....|++.|+|||++.+... ++.++|||||||++|||++|.
T Consensus 199 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~ 254 (342)
T 1b6c_B 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 254 (342)
T ss_dssp TTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred ccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence 5432 244578999999999876322 236899999999999999993
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=293.22 Aligned_cols=191 Identities=21% Similarity=0.464 Sum_probs=162.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEE-eCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCC------CeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVH-CTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGP------NIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hp------niv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+++++.+ +|+ +++++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~-- 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHH-- 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEET--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccC--
Confidence 37899999999999999999998 5678999999997543 36688999999988 554 599999999764
Q ss_pred CCceEEEeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--------------
Q 016537 204 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------------- 264 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-------------- 264 (387)
...++||||+ ++++..++. .+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 4678999999 566655442 47899999999999999999999999999999999999853
Q ss_pred ----CceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 265 ----QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 265 ----~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 23699999999986433 3345688999999999987 679999999999999999999999994
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.52 Aligned_cols=191 Identities=17% Similarity=0.327 Sum_probs=164.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.+.||+|+||.||+|.+. .+..||||+++.. ..+.+.+|+++|+++ +||||+++++++.+ ...++||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEee
Confidence 467999999999999999999984 4577999999753 357899999999999 99999999999864 3478999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
||+.+++|..++. .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCcee
Confidence 9999999987764 388999999999999999999999999999999999998655 899999999986543211
Q ss_pred -ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 285 -~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....++..|+|||++.+ ..++.++|||||||+||||++ |+.||.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~ 466 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYP 466 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred cccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 122345678999999876 679999999999999999999 999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.14 Aligned_cols=193 Identities=20% Similarity=0.352 Sum_probs=153.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
..|++.+.||+|+||.||+|.+..++ ..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+.+ ...
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~-~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSE-GSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCS-SCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCC-CCe
Confidence 45889999999999999999875432 46899988642 246788999999999 9999999999876533 456
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+++++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccccccc
Confidence 79999999999988763 377888999999999999999999999999999999999666 8999999999865433
Q ss_pred Cc-----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 283 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.. .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 21 133456778999999877 679999999999999999999 677773
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.66 Aligned_cols=195 Identities=26% Similarity=0.467 Sum_probs=167.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---------~~~~~~E~~il~~l~-~hpniv~l~~~~~~~~ 202 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++++. .|+||+++++++.+.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~- 120 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 120 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-
Confidence 478999999999999999999999999999999986432 245678999999994 269999999999764
Q ss_pred CCCceEEEeccCC-Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 203 SKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 203 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...++|||++.+ ++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++.
T Consensus 121 -~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 121 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred -CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 457799999986 7777665 45899999999999999999999999999999999999984445899999999987
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... ......|++.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 200 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 200 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp CCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 6543 33456799999999998774445788999999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=299.64 Aligned_cols=192 Identities=25% Similarity=0.461 Sum_probs=164.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCC-----eeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~~hpn-----iv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+|+.+++.+.+|+| |+++++++... ..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--NH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--TE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--Cc
Confidence 478999999999999999999998899999999997543 3567789999998855664 99999998764 45
Q ss_pred ceEEEeccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHH--HcCceeeccCCCCeeEcC-CCceEEEEecccce
Q 016537 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAE 277 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDlKp~NILl~~-~~~~vkl~DFG~a~ 277 (387)
.++||||+.+ +|..++ ..+++..++.++.|++.||.||| +.||+||||||+|||++. +...+||+|||+++
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 7899999986 665443 34889999999999999999999 579999999999999953 33479999999998
Q ss_pred eecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 210 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 210 QLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp ETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 7643 3345689999999999987 679999999999999999999999994
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=297.12 Aligned_cols=195 Identities=27% Similarity=0.487 Sum_probs=145.9
Q ss_pred CCCeEEEe-eeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCCCceEE
Q 016537 133 QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~--~~~~~~lv 209 (387)
.++|++.+ .||+|+||.||+|.++.+++.||||++... ....+|+..+.++.+||||+++++++... .....++|
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 37899965 699999999999999989999999998654 33445555554445999999999998752 23457899
Q ss_pred EeccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCC
Q 016537 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~ 282 (387)
|||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.+ ...+||+|||+++.....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 99999999877762 48899999999999999999999999999999999999753 236999999999865433
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||..
T Consensus 185 -~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 185 -ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred -ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 3345678999999999866 6788999999999999999999999943
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=295.08 Aligned_cols=192 Identities=25% Similarity=0.481 Sum_probs=162.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-eEEEEEEeccc--chHHHHHHHHHHHHhcCCCC------eeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV--KKKKIKREIKILQNLCGGPN------IVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~l~~~--~~~~~~~E~~il~~l~~hpn------iv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++.. ..+.+.+|+++++++ .|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~-- 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFH-- 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEET--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeC--
Confidence 378999999999999999999997766 79999999753 346678899999998 5554 89999988764
Q ss_pred CCceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC----------------
Q 016537 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---------------- 263 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---------------- 263 (387)
...++||||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 4578999999766655443 24889999999999999999999999999999999999932
Q ss_pred --CCceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 264 --EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 264 --~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 234799999999986433 3345689999999999987 679999999999999999999999994
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.64 Aligned_cols=194 Identities=19% Similarity=0.316 Sum_probs=159.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEE-----EeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|. +..+++.||||.+... ....+.+|+.+++++ +||||+++++++.+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-- 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQS-- 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCC--
Confidence 3789999999999999999998 4567889999998632 235688999999999 999999999998764
Q ss_pred CCceEEEeccCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEE
Q 016537 204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLI 271 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~ 271 (387)
...++||||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.+ +..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 44679999999999987752 27888999999999999999999999999999999999843 3369999
Q ss_pred ecccceeecCCC---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 272 DWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 272 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999997553322 2234567889999999877 679999999999999999998 999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=286.61 Aligned_cols=192 Identities=19% Similarity=0.351 Sum_probs=161.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCe---EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
-.|++.+.||+|+||.||+|.+..++. .+|+|.+.... .+.+.+|+.+++++ +||||+++++++.+.+ ...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPE-GLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS-SCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCC-CCc
Confidence 357788999999999999999765544 79999987432 35678999999999 9999999999997643 345
Q ss_pred eEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDR 177 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCC
Confidence 79999999999987763 478899999999999999999999999999999999999666 8999999999765332
Q ss_pred C-----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 283 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 283 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCC
Confidence 1 2234567888999999877 67899999999999999999955554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.99 Aligned_cols=192 Identities=19% Similarity=0.361 Sum_probs=160.7
Q ss_pred CCCeEEEe-eeeecCCeeEEEEEEeC--CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVR-KVGRGKYSEVFEGVHCT--DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.+++.+.+ +||+|+||.||+|.+.. ++..||||+++.. ..+.+.+|+++|+++ +||||+++++++.+ ..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---EA 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---SS
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---CC
Confidence 45677766 89999999999998753 5667999999753 357899999999999 99999999999975 34
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+.+++|..++. .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGA 488 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC-
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccC
Confidence 789999999999987763 388999999999999999999999999999999999999666 899999999987643
Q ss_pred CCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ....++..|+|||++.+ ..++.++|||||||+||||++ |++||.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp -------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3221 12245678999999976 689999999999999999998 999994
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=292.48 Aligned_cols=194 Identities=21% Similarity=0.356 Sum_probs=142.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|++.+.||+|+||.||+|.++.+++.||||++.... ...+..|+..+.+..+||||+++++++.+. ...++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceEE
Confidence 378999999999999999999998899999999986532 244566666444444999999999999764 45779
Q ss_pred EEeccCCCchhhh--------cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 209 IFEHVNNTDFKVL--------YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 209 v~e~~~~~~l~~~--------~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
||||+.+ ++..+ ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQL 176 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC-
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceec
Confidence 9999997 44332 24588999999999999999999999 999999999999999666 8999999999877
Q ss_pred cCCCcccccccccCCCCchhhc---ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..........|++.|+|||++. ....++.++|||||||++|||++|+.||.
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 6555555568999999999983 22568999999999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=289.49 Aligned_cols=192 Identities=23% Similarity=0.411 Sum_probs=161.8
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
|.....||+|+||.||+|.+..+++.||+|.+.... .+.+.+|+.+++.+ +||||+++++++.+. ...++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSEN--GFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeC--CcEEEEEEe
Confidence 334458999999999999999999999999986432 46788999999999 999999999999764 457899999
Q ss_pred cCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cc
Q 016537 213 VNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (387)
Q Consensus 213 ~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~ 285 (387)
+++++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.+++.+||+|||+++...... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 99999877652 356888899999999999999999999999999999998645589999999998765432 23
Q ss_pred cccccccCCCCchhhccc-CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....|+..|+|||++.+. ..++.++|||||||++|||++|++||.
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 456789999999998652 237899999999999999999999984
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=318.33 Aligned_cols=190 Identities=18% Similarity=0.318 Sum_probs=158.4
Q ss_pred CeEEE-eeeeecCCeeEEEEEEe--CCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 135 DYEVV-RKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 135 ~y~~~-~~lG~G~~g~Vy~~~~~--~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
.+.+. ++||+|+||.||+|.+. .+++.||||+++... .+.+.+|+++++++ +||||+++++++.+. ..
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~---~~ 444 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE---SW 444 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---SE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---CE
Confidence 34443 48999999999999653 456899999997432 46789999999999 999999999999643 36
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++||||+.+++|..++ +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+..+.
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC--
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCc
Confidence 7999999999998775 3588999999999999999999999999999999999999666 89999999998765433
Q ss_pred c----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 284 ~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
. .....++..|+|||++.+ ..++.++|||||||+||||++ |+.||.
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp -----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 223356778999999976 679999999999999999998 999994
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=289.74 Aligned_cols=187 Identities=22% Similarity=0.328 Sum_probs=160.3
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
|...+.||+|+||.||+|.+ +++.||+|++... ..+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 107 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDG--DDLCL 107 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecC--CceEE
Confidence 44458899999999999985 6889999998632 246788999999999 999999999999764 45679
Q ss_pred EEeccCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 209 IFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 209 v~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKF 186 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSC
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccc
Confidence 999999999877652 388999999999999999999999999999999999999665 8999999999876543
Q ss_pred Cc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .....|++.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 22 234578999999999865 48899999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=292.15 Aligned_cols=195 Identities=26% Similarity=0.462 Sum_probs=161.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---------hHHHHHHHHHHHHhc---CCCCeeEEEEEEEc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC---GGPNIVKLLDIVRD 200 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---------~~~~~~E~~il~~l~---~hpniv~l~~~~~~ 200 (387)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.++.++. +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 378999999999999999999998899999999986432 233567999999885 79999999999876
Q ss_pred CCCCCceEEEec-cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 201 QQSKTPSLIFEH-VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 201 ~~~~~~~lv~e~-~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
. ...++|||| +.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+++.+||+|||++
T Consensus 110 ~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 Q--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred C--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4 446799999 7888887765 358999999999999999999999999999999999999844448999999999
Q ss_pred eeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+..... ......|+..|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 876543 34556789999999998764444568999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.25 Aligned_cols=194 Identities=20% Similarity=0.304 Sum_probs=155.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++.....+.+.+|+++++++.+||||+++++++.+. ...++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CeEEEEEec
Confidence 3567778999999999998754 4679999999998777778899999999876899999999998754 567899999
Q ss_pred cCCCchhhhcCCC----------CHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC------------CceEEE
Q 016537 213 VNNTDFKVLYPTL----------SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------QRKLRL 270 (387)
Q Consensus 213 ~~~~~l~~~~~~~----------~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~------------~~~vkl 270 (387)
|. ++|..++... .+..++.++.||+.||+|||++||+||||||+|||++.+ ...+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 97 5887766321 223456799999999999999999999999999999743 237999
Q ss_pred EecccceeecCCCc-----ccccccccCCCCchhhcc------cCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 271 IDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 271 ~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
+|||+++....+.. ....+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||.
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 99999988755432 234579999999999864 2468999999999999999999 999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=286.90 Aligned_cols=192 Identities=18% Similarity=0.315 Sum_probs=155.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-CC--eEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~--~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-
Confidence 4789999999999999999998743 23 36899988642 236788999999999 9999999999987542
Q ss_pred CCceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
.++||||+.+++|...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 95 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 --MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL 171 (291)
T ss_dssp --CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred --ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccc
Confidence 67999999999987665 3488999999999999999999999999999999999998666 8999999999876
Q ss_pred cCCCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 280 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 280 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...... ....++..|+|||++.+ ..++.++|||||||++|||++ |++||.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 544321 23456778999999876 678899999999999999999 999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=295.13 Aligned_cols=189 Identities=20% Similarity=0.239 Sum_probs=158.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhc--------CCCCeeEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNIVKL 194 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~--------~hpniv~l 194 (387)
++|++.+.||+|+||+||+|++ +++.||||++.... .+.+.+|+++++.+. +||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 6788999999999999999997 68999999987432 277899999999984 48888888
Q ss_pred EEEEEcC----------------------------CCCCceEEEeccCCCc-hhhhc-CCCCHHHHHHHHHHHHHHHHHH
Q 016537 195 LDIVRDQ----------------------------QSKTPSLIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKALDYC 244 (387)
Q Consensus 195 ~~~~~~~----------------------------~~~~~~lv~e~~~~~~-l~~~~-~~~~~~~~~~~~~qi~~aL~yL 244 (387)
.+++... .....++||||+.+|+ +..+. +.+++..++.++.||+.||+||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 8875421 1457899999999985 44443 3478999999999999999999
Q ss_pred H-HcCceeeccCCCCeeEcCCC-------------------ceEEEEecccceeecCCCcccccccccCCCCchhhcccC
Q 016537 245 H-SQGIMHRDVKPHNVMIDHEQ-------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304 (387)
Q Consensus 245 H-~~~ivHrDlKp~NILl~~~~-------------------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 304 (387)
| ++||+||||||+|||++.++ ..+||+|||+|+..... ..+||+.|+|||++.+.
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~- 252 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGD- 252 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCC-
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCC-
Confidence 9 99999999999999998654 27999999999876543 45899999999999863
Q ss_pred CCCCccchhhHHHH-HHHHHhcCCchh
Q 016537 305 DYDYSLDLWSLGCM-FAGMVSVSPSVL 330 (387)
Q Consensus 305 ~~~~~sDvwSlGvi-l~elltg~~pf~ 330 (387)
. +.++||||||++ .+++++|..||.
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred C-ccceehhhhhCCCCcccccccCCCc
Confidence 3 889999998777 888999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=302.35 Aligned_cols=193 Identities=21% Similarity=0.321 Sum_probs=154.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~ 213 (387)
.+|++.+.||+|+||+||.. ...+++.||||++.......+.+|+++|+++.+||||+++++++.+. ...++|||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEEEEECC
Confidence 57999999999999997643 33688999999997766566789999999987899999999998764 4578999999
Q ss_pred CCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC----CceEEEEecccceeecCCC--
Q 016537 214 NNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK-- 283 (387)
Q Consensus 214 ~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~----~~~vkl~DFG~a~~~~~~~-- 283 (387)
.+ +|..++. ...+..++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++......
T Consensus 101 ~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 101 AA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp SE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 85 6655542 24555678899999999999999999999999999999532 2258899999998765432
Q ss_pred --cccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 284 --EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 284 --~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.....+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||.
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 2345679999999999864 2567889999999999999999 899883
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=286.75 Aligned_cols=193 Identities=22% Similarity=0.362 Sum_probs=143.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch----HHHHHHH-HHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREI-KILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~----~~~~~E~-~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++++.||+|+||.||+|.+..+++.||||++..... .+...|. .+++.+ +||||+++++++.+. ...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN--TDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS--SEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--CcEE
Confidence 3789999999999999999999988999999999865321 2333344 455555 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
+||||+ ++.+..+. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCC
Confidence 999999 44444333 4689999999999999999999995 999999999999999666 8999999999876655
Q ss_pred CcccccccccCCCCchhhc----ccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......+++.|+|||++. ....++.++|||||||++|||++|+.||.
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 5555668999999999985 22568899999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.40 Aligned_cols=191 Identities=23% Similarity=0.350 Sum_probs=163.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC---
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK--- 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~--- 204 (387)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ...+.+|+++++++ +||||+++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCc
Confidence 3789999999999999999999965 78999999986432 35678999999999 999999999999865432
Q ss_pred CceEEEeccCCCchhhhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 205 TPSLIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
..++||||+++++|...+. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC-
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC-
Confidence 2589999999999977654 58999999999999999999999999999999999999854 7999999999876543
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
...+||+.|+|||++.+ .++.++|||||||+||||++|.+||..
T Consensus 235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcc
Confidence 45679999999999875 358899999999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=283.43 Aligned_cols=192 Identities=25% Similarity=0.460 Sum_probs=156.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~-hpniv~l~~~~~~~~~~~~ 206 (387)
.++|++.+.||+|+||.||+|.+ .+++.||||++... ..+.+.+|+++++++.+ ||||+++++++.+. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SEE
T ss_pred cceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CEE
Confidence 46799999999999999999998 46889999998632 23668899999999943 69999999998764 457
Q ss_pred eEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
++||| +.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++ ++ .+||+|||+++......
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCC-----
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEEeeccccccccCcc
Confidence 89999 5667776654 4588999999999999999999999999999999999997 44 89999999998765432
Q ss_pred c---ccccccccCCCCchhhccc----------CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~---~~~~~gt~~y~aPE~~~~~----------~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .....|++.|+|||++.+. ..++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 2 2345789999999998641 368889999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=310.54 Aligned_cols=192 Identities=21% Similarity=0.409 Sum_probs=161.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|++.+.||+|+||.||+|.+..+ +..||+|.++... .+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---Cc
Confidence 47899999999999999999998543 4679999986432 36688999999999 99999999999843 34
Q ss_pred ceEEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED 543 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCCC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecCC
Confidence 689999999999987763 478899999999999999999999999999999999999666 899999999987654
Q ss_pred CCcc--cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEY--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 3322 23456778999999876 679999999999999999997 999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.70 Aligned_cols=195 Identities=25% Similarity=0.442 Sum_probs=169.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEc----CCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD----QQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~----~~~~~ 205 (387)
++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++++ +||||+++++++.+ .....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999999889999999998643 245688999999999 99999999998754 12456
Q ss_pred ceEEEeccCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc--eEEEEecccce
Q 016537 206 PSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE 277 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--~vkl~DFG~a~ 277 (387)
.++||||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 689999999999987763 3788999999999999999999999999999999999986542 48999999998
Q ss_pred eecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
............|+..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 8766666667789999999999877 689999999999999999999999994
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=286.66 Aligned_cols=190 Identities=19% Similarity=0.345 Sum_probs=158.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||.||+|.+.. .+|+|+++.. ..+.+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 105 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSP--PHLA 105 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECS--SCEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--CceE
Confidence 4789999999999999999998743 4899998632 235577899999999 999999999999865 3478
Q ss_pred EEEeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC--
Q 016537 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 281 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-- 281 (387)
+||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++ ++ .+||+|||+++....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCcccccccc
Confidence 9999999999988874 378999999999999999999999999999999999998 44 799999999865431
Q ss_pred ----CCcccccccccCCCCchhhcc--------cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 ----GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ----~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
........|+..|+|||++.+ ...++.++|||||||++|||++|+.||.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 244 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 122234568899999999864 2357889999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=275.47 Aligned_cols=166 Identities=13% Similarity=0.158 Sum_probs=145.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.++.++ +||||+++++++.+. ...+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTR--AGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEEC--CcEE
Confidence 78999999999999999999998889999999997532 26788999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 208 LIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 208 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
+||||+++++|..+++. ....++..++.|++.||+|||++||+||||||+|||++.++ .+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~------------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA------------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC------------
T ss_pred EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc------------
Confidence 99999999999887754 56677889999999999999999999999999999999666 78888543
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
|++ .++.++|||||||++|||++|+.||.
T Consensus 175 -------~~~--------~~~~~~Di~slG~il~elltg~~Pf~ 203 (286)
T 3uqc_A 175 -------TMP--------DANPQDDIRGIGASLYALLVNRWPLP 203 (286)
T ss_dssp -------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred -------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 222 36789999999999999999999994
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=275.21 Aligned_cols=173 Identities=27% Similarity=0.465 Sum_probs=149.9
Q ss_pred CCeEEE-eeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCCCceEEE
Q 016537 134 DDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~--~~~~~~~lv~ 210 (387)
++|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|++++.++.+||||+++++++.+ ......++||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 678887 789999999999999999999999999864 35678899999666699999999999865 2345678999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCCC
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~~ 283 (387)
||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +..+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-- 172 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-- 172 (299)
T ss_dssp CCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc--
Confidence 9999999877652 48899999999999999999999999999999999999863 34799999999975321
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..++.++|||||||++|||++|++||.
T Consensus 173 --------------------~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 173 --------------------EKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp --------------------CGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------------------ccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 346779999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=291.87 Aligned_cols=192 Identities=15% Similarity=0.204 Sum_probs=146.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCC-CCee-------------
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG-PNIV------------- 192 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~h-pniv------------- 192 (387)
..+|.+.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+ .| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence 35688999999999999999999999999999998722 236788999999988 55 3211
Q ss_pred --------EEEEEEEcCC---CCCceEEEeccCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 016537 193 --------KLLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMH 251 (387)
Q Consensus 193 --------~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~aL~yLH~~~ivH 251 (387)
.+..++.... ....+++|+.+ +++|..++. .+++..+..++.||+.||+|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111111111 22344556554 467765552 2566778888899999999999999999
Q ss_pred eccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhc---------ccCCCCCccchhhHHHHHHHH
Q 016537 252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDLWSLGCMFAGM 322 (387)
Q Consensus 252 rDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~sDvwSlGvil~el 322 (387)
|||||+|||++.++ .+||+|||+++.... .....+| +.|+|||++. ....++.++|||||||++|||
T Consensus 235 rDiKp~NILl~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 235 TYLRPVDIVLDQRG-GVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp SCCCGGGEEECTTC-CEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCC-eEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999776 799999999986432 2455677 9999999983 224588899999999999999
Q ss_pred HhcCCchh
Q 016537 323 VSVSPSVL 330 (387)
Q Consensus 323 ltg~~pf~ 330 (387)
++|+.||.
T Consensus 311 ltg~~Pf~ 318 (413)
T 3dzo_A 311 WCADLPNT 318 (413)
T ss_dssp HHSSCCCC
T ss_pred HHCCCCCC
Confidence 99999994
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-34 Score=292.15 Aligned_cols=185 Identities=20% Similarity=0.152 Sum_probs=130.7
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-------------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
...+.|+.|.+..++..-.|+.+++|++... +.+++.+|+++|+++.+|+||+++++++++. ...
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence 4567788888887777778999999998532 1256899999999998899999999999765 457
Q ss_pred eEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-Ccc
Q 016537 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~~~ 285 (387)
||||||++|++|.+.+..........++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+..... ...
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CCS
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCccc
Confidence 89999999999998875433333446899999999999999999999999999999776 8999999999876543 334
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
...+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred cCceechhhccHHHhCC--CCCCcccccccccchhhhccccchh
Confidence 56789999999999876 4677899999999998887766554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=254.81 Aligned_cols=180 Identities=17% Similarity=0.195 Sum_probs=140.1
Q ss_pred EEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
...+.||+|+||.||+|. ..++.+++|...... .+++.+|+++++++ +||||+++..++.+. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDL--DN 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEET--TT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeC--Cc
Confidence 345789999999999994 467888999864321 24578999999999 999999554444433 34
Q ss_pred ceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
.++||||+++++|..++.. +..++.|++.||+|||+++|+||||||+|||++. .+||+|||+++.......
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence 5799999999999988866 6789999999999999999999999999999995 799999999998754322
Q ss_pred -------ccccccccCCCCchhhcc-cCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 285 -------YNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 285 -------~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
....+||+.|||||++.+ ...|+..+|+|+..+-..+.+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 135689999999999864 134777899999999999988887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=211.20 Aligned_cols=157 Identities=18% Similarity=0.233 Sum_probs=123.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---------------------chHHHHHHHHHHHHhcCCCCe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNI 191 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---------------------~~~~~~~E~~il~~l~~hpni 191 (387)
...|++.+.||+|+||.||+|.+ .+++.||+|+++.. ....+.+|+++++++ + |
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~- 163 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G- 163 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence 35577889999999999999999 88999999998632 234588999999999 4 4
Q ss_pred eEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEE
Q 016537 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (387)
Q Consensus 192 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~ 271 (387)
+++.+++.. ...++||||+++++|.. +. ......++.|++.||.|||++||+||||||+|||++ ++ .+||+
T Consensus 164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~---~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~ 234 (282)
T 1zar_A 164 LAVPKVYAW---EGNAVLMELIDAKELYR-VR---VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWII 234 (282)
T ss_dssp SSSCCEEEE---ETTEEEEECCCCEEGGG-CC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEEC
T ss_pred CCcCeEEec---cceEEEEEecCCCcHHH-cc---hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEE
Confidence 555555433 33589999999999987 32 234557999999999999999999999999999999 55 89999
Q ss_pred ecccceeecCCCcccccccccCCCCchhhcc---------cCCCCCccchhhH
Q 016537 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVD---------LQDYDYSLDLWSL 315 (387)
Q Consensus 272 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~sDvwSl 315 (387)
|||+|+.. ..++|||.+.. .+.|+..+|+|.+
T Consensus 235 DFG~a~~~------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 235 DFPQSVEV------------GEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CCTTCEET------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred ECCCCeEC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999743 34688998742 0235666777653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.1e-23 Score=188.34 Aligned_cols=135 Identities=18% Similarity=0.199 Sum_probs=107.8
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeE--EEEEEecccc---------------------------hHHHHHHHHHHHHh
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPVK---------------------------KKKIKREIKILQNL 185 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~l~~~~---------------------------~~~~~~E~~il~~l 185 (387)
-|++.+.||+|+||.||+|.+..+|+. ||||+++... ...+.+|+++|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778988 9999875321 12578999999999
Q ss_pred cCCCC--eeEEEEEEEcCCCCCceEEEeccCC-C----chhhhcCCCCHHHHHHHHHHHHHHHHHHH-HcCceeeccCCC
Q 016537 186 CGGPN--IVKLLDIVRDQQSKTPSLIFEHVNN-T----DFKVLYPTLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPH 257 (387)
Q Consensus 186 ~~hpn--iv~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDlKp~ 257 (387)
.|++ ++.++++ ...++||||+.+ | .|.......++..+..++.|++.||.||| ++||+||||||+
T Consensus 128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 6665 3444442 135799999953 3 55555444445578889999999999999 999999999999
Q ss_pred CeeEcCCCceEEEEecccceee
Q 016537 258 NVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 258 NILl~~~~~~vkl~DFG~a~~~ 279 (387)
|||++. .++|+|||+|...
T Consensus 201 NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS---SEEECCCTTCEET
T ss_pred HEEEcC---cEEEEECcccccC
Confidence 999985 6999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=166.87 Aligned_cols=135 Identities=16% Similarity=0.241 Sum_probs=100.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----------------h--------HHHHHHHHHHHHhcCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------K--------KKIKREIKILQNLCGG 188 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----------------~--------~~~~~E~~il~~l~~h 188 (387)
.-|++.+.||+|++|.||+|.+ .+|+.||||+++... . -...+|...|.++ .+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence 3489999999999999999997 579999999875210 0 0124577778877 44
Q ss_pred CCe--eEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc
Q 016537 189 PNI--VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (387)
Q Consensus 189 pni--v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 266 (387)
.++ ...++.. ..+|||||+++..+..+.. . .....+..|++.+|.+||++|||||||||.|||++.++.
T Consensus 173 ~gv~vp~p~~~~------~~~LVME~i~G~~L~~l~~-~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 173 EGFPVPEPIAQS------RHTIVMSLVDALPMRQVSS-V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TTCSCCCEEEEE------TTEEEEECCSCEEGGGCCC-C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred cCCCCCeeeecc------CceEEEEecCCccHhhhcc-c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 333 3333321 1369999999988876543 2 234567899999999999999999999999999975541
Q ss_pred ---------eEEEEecccceee
Q 016537 267 ---------KLRLIDWGLAEFY 279 (387)
Q Consensus 267 ---------~vkl~DFG~a~~~ 279 (387)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3889999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=2.6e-13 Score=124.39 Aligned_cols=139 Identities=18% Similarity=0.234 Sum_probs=111.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~---~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+.|++...+|.|+.+.||++.. .++.+++|+... .....+.+|+++++.+..+..+.+++++..+. ...++||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEEE
Confidence 4688889999999999999874 468899999864 33456899999999996678888999988753 4567999
Q ss_pred eccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 016537 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS-------------------------------------------- 246 (387)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~-------------------------------------------- 246 (387)
||++|.++...... ......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99999998765422 22334678899999999998
Q ss_pred ---------------cCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 247 ---------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 247 ---------------~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
..++|+|++|.|||++. +..+.|+||+.+...
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcccC
Confidence 45899999999999984 435679999988653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=3.4e-12 Score=116.12 Aligned_cols=137 Identities=18% Similarity=0.160 Sum_probs=100.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hp-niv~l~~~~~~~~~~~~~lv~e~ 212 (387)
.++.+....+.|..+.||++.. .+|..+++|+........+.+|+++++.+..+. .+.+++++..+. ...++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEe
Confidence 3455544444666799999864 567789999987654466889999999995552 256788877654 346799999
Q ss_pred cCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 016537 213 VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG-------------------------------------------- 248 (387)
Q Consensus 213 ~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-------------------------------------------- 248 (387)
++|.++. ..... ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 97 VPGQDLL--SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp CSSEETT--TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cCCcccC--cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 9998884 22222 2356677888888888643
Q ss_pred --------------ceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 249 --------------IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 249 --------------ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
++|+|++|.|||++. +..+.|+|||.+...
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcccC
Confidence 999999999999984 435679999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.3e-11 Score=118.44 Aligned_cols=141 Identities=21% Similarity=0.352 Sum_probs=107.8
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEec--ccc----hHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCC-CCceEE
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVK----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQS-KTPSLI 209 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~--~~~----~~~~~~E~~il~~l~~-hpniv~l~~~~~~~~~-~~~~lv 209 (387)
.++.|+.|.++.||++.. .+..+++|+.. ... ...+.+|.++++.|.. +..+++++.++.+... ...++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 457799999999999875 35678888775 322 3567899999999943 3568889988765422 346799
Q ss_pred EeccCCCchh-hhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 016537 210 FEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------ 246 (387)
Q Consensus 210 ~e~~~~~~l~-~~~~~~~~~~~~~~~~qi~~aL~yLH~------------------------------------------ 246 (387)
|||++|..+. .....+++.+...++.+++..|..||+
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9999998874 345567888888999999999999997
Q ss_pred ----------------cCceeeccCCCCeeEcCCCc-eEEEEecccceeec
Q 016537 247 ----------------QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYH 280 (387)
Q Consensus 247 ----------------~~ivHrDlKp~NILl~~~~~-~vkl~DFG~a~~~~ 280 (387)
..++|+|+++.|||++.++. .+.|+||+.+....
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 35899999999999986653 46899999997643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.29 E-value=9.4e-12 Score=116.68 Aligned_cols=187 Identities=17% Similarity=0.215 Sum_probs=125.4
Q ss_pred eeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCC--eeEEEEEEEcCCC-CCceEEEeccCC
Q 016537 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN--IVKLLDIVRDQQS-KTPSLIFEHVNN 215 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpn--iv~l~~~~~~~~~-~~~~lv~e~~~~ 215 (387)
+.++.|....||++. ..+++|+.... ....+.+|.++|+.+..+.. +.+++........ ...++||++++|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999853 45888886543 34678899999998844433 4455544322211 245789999999
Q ss_pred Cchhh-hcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 016537 216 TDFKV-LYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------------ 246 (387)
Q Consensus 216 ~~l~~-~~~~~~~~~~~~~~~qi~~aL~yLH~------------------------------------------------ 246 (387)
..+.. ....++..+...++.+++..|..||+
T Consensus 101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 88763 34567788888888999999999986
Q ss_pred ----------cCceeeccCCCCeeEcCC-CceEEEEecccceeecCCCcccccccccCCCCchhh----cccCC------
Q 016537 247 ----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL----VDLQD------ 305 (387)
Q Consensus 247 ----------~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~------ 305 (387)
..++|+|++|.||+++.+ +..+.|+||+.+....+............-..|+.. ..++.
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~ 260 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV 260 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence 136999999999999864 446889999999765443221111100000122221 11110
Q ss_pred ---CCCccchhhHHHHHHHHHhcCCchhh
Q 016537 306 ---YDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 306 ---~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....+.|++|.++|.+.+|.++|..
T Consensus 261 ~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 261 LEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 11236899999999999999999853
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=6.3e-08 Score=90.71 Aligned_cols=138 Identities=19% Similarity=0.272 Sum_probs=97.6
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCC--CeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGP--NIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hp--niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
++.++.|....||+. +..+++|+-... ....+.+|.++|+.|..|- .+.+++.+... .....++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCC
Confidence 345788999999986 466788885432 3467889999999994431 35667766653 23456799999999
Q ss_pred Cchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------------
Q 016537 216 TDFKV-LYPTLSDYDVRYYIYELLKALDYCHSQ----------------------------------------------- 247 (387)
Q Consensus 216 ~~l~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~----------------------------------------------- 247 (387)
..+.. ....++..+...++.++...|..||+.
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 88764 234455566666666666666666642
Q ss_pred -------------CceeeccCCCCeeEcC---CCceEEEEecccceeecCC
Q 016537 248 -------------GIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 248 -------------~ivHrDlKp~NILl~~---~~~~vkl~DFG~a~~~~~~ 282 (387)
.++|+|+++.|||++. ++..+.|+||+.+....+.
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~ 228 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPD 228 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGG
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHH
Confidence 3599999999999986 3434589999998765443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=5.5e-08 Score=88.96 Aligned_cols=136 Identities=14% Similarity=0.109 Sum_probs=96.9
Q ss_pred eeeecCCe-eEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchh
Q 016537 141 KVGRGKYS-EVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219 (387)
Q Consensus 141 ~lG~G~~g-~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~ 219 (387)
.+..|..| .||+.....++..+++|+-.......+.+|...|+.|..+--+.++++++.+.+ ..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEEEEeeCCcccc
Confidence 34556555 699887766778899998876666788999999999966655788888887653 467999999998765
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------------------
Q 016537 220 VLYPTLSDYDVRYYIYELLKALDYCHSQ---------------------------------------------------- 247 (387)
Q Consensus 220 ~~~~~~~~~~~~~~~~qi~~aL~yLH~~---------------------------------------------------- 247 (387)
...... ......+..++...|.-||..
T Consensus 109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 543221 122233445555555555530
Q ss_pred ------CceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 248 ------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 248 ------~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
.++|+|+.+.|||++. +..+-|+||+.+....
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVGIAD 225 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEEEE
T ss_pred cccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccccCC
Confidence 2789999999999984 4356799999987644
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=2.8e-07 Score=87.82 Aligned_cols=84 Identities=12% Similarity=0.103 Sum_probs=58.7
Q ss_pred eEEEeee-eecCCeeEEEEEEe--C----CCeEEEEEEecccc------hHHHHHHHHHHHHhcCC--CCeeEEEEEEEc
Q 016537 136 YEVVRKV-GRGKYSEVFEGVHC--T----DNEKCIIKILKPVK------KKKIKREIKILQNLCGG--PNIVKLLDIVRD 200 (387)
Q Consensus 136 y~~~~~l-G~G~~g~Vy~~~~~--~----~~~~vavK~l~~~~------~~~~~~E~~il~~l~~h--pniv~l~~~~~~ 200 (387)
....+.| +.|....+|+.... . ++..+++|+..... ...+.+|..+++.|..+ -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 88999999987653 1 26688999865432 25678999999988554 357788887754
Q ss_pred CCC-CCceEEEeccCCCchh
Q 016537 201 QQS-KTPSLIFEHVNNTDFK 219 (387)
Q Consensus 201 ~~~-~~~~lv~e~~~~~~l~ 219 (387)
... ...++||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 321 3457999999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2e-06 Score=83.28 Aligned_cols=75 Identities=16% Similarity=0.215 Sum_probs=49.9
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----------chHHHHHHHHHHHHhcCC-C-CeeEEEEEEEcCCCCC
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKT 205 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----------~~~~~~~E~~il~~l~~h-p-niv~l~~~~~~~~~~~ 205 (387)
..+.||.|..+.||++....+++.+++|...+. ...++..|.++|+.+..+ + .+.+++.+. . ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Cc
Confidence 356899999999999976556788999976432 224567899999987443 3 344566542 2 23
Q ss_pred ceEEEeccCCC
Q 016537 206 PSLIFEHVNNT 216 (387)
Q Consensus 206 ~~lv~e~~~~~ 216 (387)
.++|||++.+.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 46999999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.8e-05 Score=74.26 Aligned_cols=135 Identities=14% Similarity=0.213 Sum_probs=78.1
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEEEEE------EEcCCCCCceEEEe
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI------VRDQQSKTPSLIFE 211 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~h-pniv~l~~~------~~~~~~~~~~lv~e 211 (387)
++.|+.|..+.||++.. ++..+++|+... ....+..|..+++.|..+ -.+.+++.. ... ....+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~--~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH--GSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE--TTEEEEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE--CCEEEEEEE
Confidence 34567778899999875 344589999875 334556677777766321 133444431 111 234579999
Q ss_pred ccCCCchh---------------hhc---CCC--C----------HH-H-------------------------------
Q 016537 212 HVNNTDFK---------------VLY---PTL--S----------DY-D------------------------------- 229 (387)
Q Consensus 212 ~~~~~~l~---------------~~~---~~~--~----------~~-~------------------------------- 229 (387)
|++|..+. .+. ..+ + .+ .
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986431 110 111 1 00 0
Q ss_pred HHHHHHHHHHHHHHHHH-------------cCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 230 VRYYIYELLKALDYCHS-------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 230 ~~~~~~qi~~aL~yLH~-------------~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
+..+..++..++.+|+. ..++|+|+++.|||++.++ .+.|+||+.+...
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~g 253 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENE-QIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGG-CEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCC-cEEEEehhhcccC
Confidence 01111223445666653 4799999999999997554 7899999998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.8e-05 Score=70.68 Aligned_cols=76 Identities=18% Similarity=0.207 Sum_probs=59.6
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
-.+.|+.|....+|+... ++..+++|+........+..|.+.|+.|..+ ..+++++.+.... ...++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEeccC
Confidence 457789999999999864 5678889987666667789999999988543 5688888877653 456799999998
Q ss_pred Cc
Q 016537 216 TD 217 (387)
Q Consensus 216 ~~ 217 (387)
..
T Consensus 116 ~~ 117 (312)
T 3jr1_A 116 SK 117 (312)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.83 E-value=6.3e-05 Score=69.75 Aligned_cols=70 Identities=9% Similarity=0.022 Sum_probs=44.8
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEecc-CC
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV-NN 215 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~-~~ 215 (387)
++.|+.|....+|++ ..+++|+...... ....+|..+++.+..+.-..+++++. .+. .++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~--~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PAT--GVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTT--CCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCC--CEEEEeecCCC
Confidence 567899999999998 4578888754321 12357888888774443335666543 222 34899999 65
Q ss_pred Cch
Q 016537 216 TDF 218 (387)
Q Consensus 216 ~~l 218 (387)
..+
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.81 E-value=4.5e-05 Score=74.36 Aligned_cols=79 Identities=13% Similarity=0.123 Sum_probs=48.0
Q ss_pred HcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccccccc--ccCCCCchhhcccC--CCCCccchhhHHHHHHH
Q 016537 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAG 321 (387)
Q Consensus 246 ~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~--~~~~~sDvwSlGvil~e 321 (387)
...++|+|+++.|||++.++ +.|+||+.+..-.+......... ...|.+|+...... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45799999999999998554 89999999986543322211111 12355555432100 01123445577788888
Q ss_pred HHhcC
Q 016537 322 MVSVS 326 (387)
Q Consensus 322 lltg~ 326 (387)
++++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.76 E-value=9.2e-05 Score=72.48 Aligned_cols=74 Identities=14% Similarity=0.127 Sum_probs=52.7
Q ss_pred EEeeeeecCCeeEEEEEEeC-------CCeEEEEEEecccch-HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 138 VVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~l~~~~~-~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
-++.|+.|....||++.... ++..+++|+...... ..+.+|..+++.|..+.-.+++++.+.+ .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC------CEE
Confidence 35678889999999998642 257899998854222 5667899999988555444677776531 289
Q ss_pred EeccCCCc
Q 016537 210 FEHVNNTD 217 (387)
Q Consensus 210 ~e~~~~~~ 217 (387)
+||++|..
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.74 E-value=5.1e-05 Score=71.35 Aligned_cols=138 Identities=14% Similarity=0.128 Sum_probs=72.9
Q ss_pred eeeeecCCee-EEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCCCceEEEeccCCCc
Q 016537 140 RKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (387)
Q Consensus 140 ~~lG~G~~g~-Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~h-pniv~l~~~~~~~~~~~~~lv~e~~~~~~ 217 (387)
+.|+.|.... +|+... .++..+++|...+.....+..|+.+++.+..+ -.+.+++.+. .... +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcc
Confidence 4465555444 666542 23667777765443324566788888887443 2356677653 2222 58999987654
Q ss_pred hhhhc----------------------C----CCC---HHHHH-------H-HH------------HHHHHHHHHHH---
Q 016537 218 FKVLY----------------------P----TLS---DYDVR-------Y-YI------------YELLKALDYCH--- 245 (387)
Q Consensus 218 l~~~~----------------------~----~~~---~~~~~-------~-~~------------~qi~~aL~yLH--- 245 (387)
+...+ . .++ ..... . +. ..+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 42111 0 011 11100 0 00 01112223331
Q ss_pred ---HcCceeeccCCCCeeEcCC---CceEEEEecccceeecCC
Q 016537 246 ---SQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 246 ---~~~ivHrDlKp~NILl~~~---~~~vkl~DFG~a~~~~~~ 282 (387)
...++|+|+.+.|||++.+ ...+.|+||+.+..-.+.
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~ 221 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA 221 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence 2369999999999999853 136899999999765443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=7.8e-05 Score=69.58 Aligned_cols=140 Identities=19% Similarity=0.227 Sum_probs=80.1
Q ss_pred eEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCC-CeeEEEEEEEcC-----CCCCceE
Q 016537 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQ-----QSKTPSL 208 (387)
Q Consensus 136 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-~~~~~~~~E~~il~~l~~hp-niv~l~~~~~~~-----~~~~~~l 208 (387)
..-++.|+.|....||+... .++ .+++|+... .....+..|..+++.|..+. .+.+++... +. .....++
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEE
T ss_pred ceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEE
Confidence 34567788899899999875 333 688998875 24466778998888884431 133443210 00 0123568
Q ss_pred EEeccCCCchhh---------------h---cCCC--------C--HHHH--HH-----------HHHHHHHHHHHHHH-
Q 016537 209 IFEHVNNTDFKV---------------L---YPTL--------S--DYDV--RY-----------YIYELLKALDYCHS- 246 (387)
Q Consensus 209 v~e~~~~~~l~~---------------~---~~~~--------~--~~~~--~~-----------~~~qi~~aL~yLH~- 246 (387)
+|+|++|..+.. + ...+ . .+.. .. +...+...++.+++
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999998754211 0 0111 0 0110 00 00123445556653
Q ss_pred ------cCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 247 ------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 247 ------~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
.+++|+|+++.|||++.++ .+.|+||+.+...
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~g 218 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACND 218 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccCc
Confidence 3699999999999998543 4579999988653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00039 Score=63.93 Aligned_cols=77 Identities=14% Similarity=0.125 Sum_probs=55.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~~~~~~l 208 (387)
....-++.+|.|..+.||+... .+|+.+++|+..... ...+..|.+.|+.|... --+++++++. . .++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~--~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D--RTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T--TEE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C--ceE
Confidence 3456778999999999999987 688999999864322 34678999999998443 2345565542 1 358
Q ss_pred EEeccCCCc
Q 016537 209 IFEHVNNTD 217 (387)
Q Consensus 209 v~e~~~~~~ 217 (387)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00027 Score=67.93 Aligned_cols=134 Identities=12% Similarity=0.177 Sum_probs=82.3
Q ss_pred eeeeecCCeeEEEEEEeC-------CCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 140 RKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
+.|..|-...+|++.... +++.+++|+.... ......+|.++++.|..+.-..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccEE
Confidence 467778888899987632 3578999986432 345667899999988655445677776532 2899
Q ss_pred eccCCCchhh--hc----------------C-------CCC--HHHHHHHHHHHHH-------------------HHHHH
Q 016537 211 EHVNNTDFKV--LY----------------P-------TLS--DYDVRYYIYELLK-------------------ALDYC 244 (387)
Q Consensus 211 e~~~~~~l~~--~~----------------~-------~~~--~~~~~~~~~qi~~-------------------aL~yL 244 (387)
||++|..+.. +. . ... ...+..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865421 00 0 011 2344445443321 23344
Q ss_pred HH--------cCceeeccCCCCeeEcCC---CceEEEEecccceee
Q 016537 245 HS--------QGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFY 279 (387)
Q Consensus 245 H~--------~~ivHrDlKp~NILl~~~---~~~vkl~DFG~a~~~ 279 (387)
.+ ..++|+|+.+.|||++.+ ...+.|+||..+...
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 32 248999999999999865 237899999998654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0005 Score=67.78 Aligned_cols=75 Identities=16% Similarity=0.165 Sum_probs=49.7
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchH--HHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCC
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~--~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 215 (387)
-++.|+.|-...+|++.....+..+++|+....... ...+|..+++.|..+.-..++++++. . .+||||+++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~--G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT----N--GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET----T--EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC----C--eEEEEeeCC
Confidence 356788899999999987433578999987543211 12689999999955444467777662 1 269999987
Q ss_pred Cch
Q 016537 216 TDF 218 (387)
Q Consensus 216 ~~l 218 (387)
..+
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0004 Score=64.85 Aligned_cols=73 Identities=14% Similarity=0.216 Sum_probs=47.7
Q ss_pred eeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCC-----CCCceEEEec
Q 016537 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQ-----SKTPSLIFEH 212 (387)
Q Consensus 141 ~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~h-pniv~l~~~~~~~~-----~~~~~lv~e~ 212 (387)
.|+ |....||+... .+|+.+++|+..+. ....+..|..+++.|..+ -.+++++.. +.. ....+++|++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence 456 78889998754 45667999998643 456788899998888433 124455443 111 1234679999
Q ss_pred cCCCc
Q 016537 213 VNNTD 217 (387)
Q Consensus 213 ~~~~~ 217 (387)
++|..
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 98754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00063 Score=64.85 Aligned_cols=73 Identities=14% Similarity=0.125 Sum_probs=45.3
Q ss_pred EeeeeecCCeeEEEEEEeC--------CCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 139 VRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++.|+.|....+|++.... .+..+++|+...... .....|.++++.|..+.-..++++.. . ..+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence 4678888889999987632 126888998754322 12467888888885443345676544 1 248
Q ss_pred EEeccCCCc
Q 016537 209 IFEHVNNTD 217 (387)
Q Consensus 209 v~e~~~~~~ 217 (387)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0088 Score=56.29 Aligned_cols=71 Identities=10% Similarity=0.144 Sum_probs=42.8
Q ss_pred eecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCC--CCeeEEEEEEEc----CCCCCceEEEeccCCC
Q 016537 143 GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRD----QQSKTPSLIFEHVNNT 216 (387)
Q Consensus 143 G~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~h--pniv~l~~~~~~----~~~~~~~lv~e~~~~~ 216 (387)
|.|....||+... .++ .+++|+..... ...|+.+++.|..+ |++++.+..... ......+++|+|++|.
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 3344678999874 345 89999876543 25677777776332 224555532100 0124467899999986
Q ss_pred ch
Q 016537 217 DF 218 (387)
Q Consensus 217 ~l 218 (387)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.008 Score=58.47 Aligned_cols=74 Identities=12% Similarity=0.139 Sum_probs=50.2
Q ss_pred EEeeeeecCCeeEEEEEEeCC-------CeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 138 VVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
-++.|..|-...+|+...... +..+++++...... -...+|.++++.|..+.-..++++.+ . ..+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCE
Confidence 346677888899999886421 57899998654321 22368999998885554456676643 1 258
Q ss_pred EEeccCCCc
Q 016537 209 IFEHVNNTD 217 (387)
Q Consensus 209 v~e~~~~~~ 217 (387)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.02 Score=55.12 Aligned_cols=31 Identities=29% Similarity=0.555 Sum_probs=25.2
Q ss_pred ceeeccCCCCeeEc-----CCCceEEEEecccceee
Q 016537 249 IMHRDVKPHNVMID-----HEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 249 ivHrDlKp~NILl~-----~~~~~vkl~DFG~a~~~ 279 (387)
++|+|+.+.|||+. .+...+.++||.+|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 68999999999993 23447999999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.86 E-value=0.57 Score=40.92 Aligned_cols=91 Identities=10% Similarity=0.021 Sum_probs=54.6
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcccccccccCCCCchhhc
Q 016537 223 PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (387)
Q Consensus 223 ~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 301 (387)
..+.++++|.++.|.+.+|.-+-. +.-..+=+-|..|++..+| .|.+.+ +.+. .....+.+||...
T Consensus 44 ~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------~~~~~~~~pe~~~ 110 (229)
T 2yle_A 44 QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------AGEPPPVAGKLGY 110 (229)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C-----------------------CCSS
T ss_pred CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------ccccCCCChhhcc
Confidence 579999999999999999877622 1112333345788887666 555442 1110 1122356888753
Q ss_pred ccCCCCCccchhhHHHHHHHHHhcCCc
Q 016537 302 DLQDYDYSLDLWSLGCMFAGMVSVSPS 328 (387)
Q Consensus 302 ~~~~~~~~sDvwSlGvil~elltg~~p 328 (387)
...+.+.=|||||++||.-+--..|
T Consensus 111 --~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 111 --SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 2456778899999999998875433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.03 E-value=0.1 Score=51.29 Aligned_cols=59 Identities=12% Similarity=0.147 Sum_probs=18.3
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEE------EEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCII------KILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~ 200 (387)
+.+.|| ||.||+|.+......||+ |..+. .....+.+|..+++.+ +|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEEe
Confidence 345666 999999998655567888 66543 1224577888888888 99999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 387 | ||||
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-33 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-28 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-23 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-21 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 240 bits (612), Expect = 2e-77
Identities = 174/225 (77%), Positives = 200/225 (88%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 4 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 64 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A M+
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-42
Identities = 50/217 (23%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REI 179
YE +T +D +E++ ++G G + +V++ + + K++ +++++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIY 235
IL + PNIVKLLD + + ++ E + L++ ++
Sbjct: 61 DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
+ L AL+Y H I+HRD+K N++ + ++L D+G++ + + + + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 295 KGPELLV----DLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE+++ + YDY D+WSLG M + P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (373), Expect = 9e-42
Identities = 49/199 (24%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPN 190
D Y+++ ++G G + V V + K + P+ K +K EI I+ L P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
++ L D D+ LI E ++ + +S+ +V Y+ + + L + H
Sbjct: 88 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
I+H D+KP N+M + ++ +++ID+GLA +P + V A+ F PE++ D +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204
Query: 306 YDYSLDLWSLGCMFAGMVS 324
+ D+W++G + ++S
Sbjct: 205 VGFYTDMWAIGVLGYVLLS 223
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (364), Expect = 3e-41
Identities = 52/215 (24%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIK 180
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
IL+ + G PNI++L D L+F+ + + F L TLS+ + R + L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 298 ELL-----VDLQDYDYSLDLWSLGCMFAGMVSVSP 327
E++ + Y +D+WS G + +++ SP
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 6e-41
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+E+ R +G+GK+ V+ +K+L + + +++RE++I +L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
PNI++L D LI E+ + YI EL AL YC
Sbjct: 66 -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS+ ++HRD+KP N+++ L++ D+G + + P + + PE++ +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179
Query: 305 DYDYSLDLWSLGCMFAGMVSVSP 327
+D +DLWSLG + + P
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKP 202
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-41
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G VF+ H K++ P + +I RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
IV S+ EH++ + + + + ++K L Y
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+ IMHRDVKP N++++ ++L D+G++ N V +R + PE L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179
Query: 306 YDYSLDLWSLGCMFAGMVS 324
Y D+WS+G M
Sbjct: 180 YSVQSDIWSMGLSLVEMAV 198
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 1e-40
Identities = 45/199 (22%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPN 190
D Y++ ++G G + V K + K+ +++EI+ + L P
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
+V L D D +I+E ++ + + +S+ + Y+ ++ K L + H
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+H D+KP N+M ++ +L+LID+GL P + V + F PE+ +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201
Query: 306 YDYSLDLWSLGCMFAGMVS 324
Y D+WS+G + ++S
Sbjct: 202 VGYYTDMWSVGVLSYILLS 220
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-40
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 12/206 (5%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
++ Y + +G G + V++ C E IK + K+ RE++I++ L NI
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75
Query: 192 VKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKAL 241
V+L K L+ ++V T ++V TL V+ Y+Y+L ++L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSVSP 327
DY S+D+WS GC+ A ++ P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-40
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
N+VK R + L E+ + + F + P + + D + + ++L+ + Y H
Sbjct: 64 NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 303
GI HRD+KP N+++D L++ D+GLA + N + + PELL
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 304 QDYDYSLDLWSLGCMFAGMVS 324
+ + +D+WS G + M++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLA 201
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-40
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 193 KLLDIVRDQQS--KTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCH 245
+++D+ + + K ++ E ++ + F + ++ + + + +A+ Y H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
S I HRDVKP N++ L+L D+G A+ + Y+ PE+L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSP 327
+ YD S D+WSLG + ++ P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP 211
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 3e-39
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
+DYEV+ +G G Y + +D + + K L +K+ + E+ +L+ L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY------PTLSDYDVRYYIYELLKAL 241
PNIV+ D + D+ + T ++ E+ D V+ L + V + +L AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE + Y+ D+WSLGC+ + ++ P
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMP 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-39
Identities = 45/198 (22%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ Y + +GRG++ V V + + + K +K + +K+EI IL NI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
+ L + + +IFE ++ D F+ + L++ ++ Y++++ +AL + HS
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 248 GIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180
Query: 307 DYSLDLWSLGCMFAGMVS 324
+ D+WSLG + ++S
Sbjct: 181 STATDMWSLGTLVYVLLS 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 4e-38
Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 14/206 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCH 245
NI+ + DI+R +Q K L+ + +K+L LS+ + Y++Y++L+ L Y H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
S ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ + Y S+D+WS+GC+ A M+S P
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRP 211
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 8e-38
Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCG 187
+ +R++G G + V+ ++E IK + K + I +E++ LQ L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PN ++ + T L+ E+ + +V L + ++ + L+ L Y
Sbjct: 75 -PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS ++HRDVK N+++ ++L D+G A P + V + Y+ PE+++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187
Query: 305 D--YDYSLDLWSLGCMFAGMVS 324
+ YD +D+WSLG +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAE 209
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQ 183
+ Y+V +G G + V+ G+ +DN IK ++ + ++ E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKA 240
+ G +++LLD S L F + L + R + +++L+A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R + PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWI 181
Query: 301 VDLQDYDYSLDLWSLGCMFAGMVS 324
+ + S +WSLG + MV
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVC 205
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-37
Identities = 44/198 (22%), Positives = 89/198 (44%), Gaps = 11/198 (5%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGP 189
+ Y K+G+G V+ + ++ I+ + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
NIV LD ++ E++ + + + + E L+AL++ HS
Sbjct: 78 NIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
++HRD+K N+++ + ++L D+G + + + V + Y+ PE++ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193
Query: 307 DYSLDLWSLGCMFAGMVS 324
+D+WSLG M M+
Sbjct: 194 GPKVDIWSLGIMAIEMIE 211
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-37
Identities = 55/218 (25%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKK 174
++ E W + Y ++ VG G Y V V K IK L + K+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL-YPTLSDYD 229
RE+++L+++ N++ LLD+ ++ L+ + K++ + L +
Sbjct: 64 AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
+++ +Y++LK L Y H+ GI+HRD+KP N+ ++ + +++D+GLA E V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+R+++ PE++++ Y ++D+WS+GC+ A M++
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (334), Expect = 2e-36
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGG 188
+D Y+ +G G +SEV + IK + K+ ++ EI +L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCH 245
PNIV L DI LI + V+ + F + ++ D I+++L A+ Y H
Sbjct: 67 PNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
GI+HRD+KP N++ E K+ + D+GL++ PG + + + PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSP 327
+ Y ++D WS+G + ++ P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-36
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCG 187
+D++ + +G G +S V + + IKIL+ K + RE ++ L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYC 244
P VKL +D + + N + + + + R+Y E++ AL+Y
Sbjct: 68 -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 301
H +GI+HRD+KP N++++ + +++ D+G A+ P + N V + + PELL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 302 DLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ + S DLW+LGC+ +V+ P
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLP 208
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
YE + K+G+G + EVF+ H +K +K + +K+ REIKILQ L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68
Query: 189 PNIVKLLDIVRDQQSK------TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLK 239
N+V L++I R + S + L+F+ + +L + +++ + LL
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 294
L Y H I+HRD+K NV+I + L+L D+GLA + K Y RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+ PELL+ +DY +DLW GC+ A M + SP
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-35
Identities = 58/222 (26%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PV 170
RP ++ E W + Y+ + VG G Y V + +K L +
Sbjct: 1 RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 171 KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTPSLIFEHVNNTDFKVLY--PTL 225
K+ RE+++L+++ N++ LLD+ +S + H+ D + L
Sbjct: 60 HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+D V++ IY++L+ L Y HS I+HRD+KP N+ ++ + +++D+GLA H E
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
VA+R+++ PE++++ Y+ ++D+WS+GC+ A +++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-35
Identities = 61/199 (30%), Positives = 111/199 (55%), Gaps = 10/199 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
++++ V K+G G Y V++ + E +K ++ + + REI +L+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHS 246
PNIVKLLD++ + F H + F + ++ Y+++LL+ L +CHS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
++HRD+KP N++I+ E ++L D+GLA + P + Y V + +++ PE+L+ +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 306 YDYSLDLWSLGCMFAGMVS 324
Y ++D+WSLGC+FA MV+
Sbjct: 180 YSTAVDIWSLGCIFAEMVT 198
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 130 bits (327), Expect = 5e-35
Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+ V R +GRG + EV+ + +K L + + E +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 188 G--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
G P IV + S I + +N D + S+ D+R+Y E++ L+
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
+ H++ +++RD+KP N+++D E +R+ D GLA + K + + + PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179
Query: 303 LQDYDYSLDLWSLGCMFAGMVS 324
YD S D +SLGCM ++
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLR 201
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (321), Expect = 6e-35
Identities = 61/203 (30%), Positives = 113/203 (55%), Gaps = 14/203 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
+ Y + K+G G Y V++ + E +K ++ K REI IL+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
NIVKL D++ ++ L+FEH++ K+L L + ++ +LL + YCH
Sbjct: 60 SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 304
+ ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++ P++L+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 305 DYDYSLDLWSLGCMFAGMVSVSP 327
Y ++D+WS+GC+FA MV+ +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTP 199
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-35
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLCG 187
YE V ++G G Y +VF+ +K ++ RE+ +L++L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 188 G--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELL 238
PN+V+L D+ ++ + L+FEHV+ L P + ++ +++LL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
+ LD+ HS ++HRD+KP N+++ + +L D+GLA Y V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+L+ Y +DLWS+GC+FA M P
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-34
Identities = 49/235 (20%), Positives = 99/235 (42%), Gaps = 20/235 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+ + + +G+G + +VF N+ IK LK + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
P + + + +++ + E++N D +Y E++ L +
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
HS+GI++RD+K N+++D + ++ D+G+ E + N + + PE+L+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177
Query: 304 QDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGLGHSCLNTWFLRTCSIPFFPLNL 358
Q Y++S+D WS G + M+ F+ G + PF+P L
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQS--PFH----GQDEEELFHSIRMDNPFYPRWL 226
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-34
Identities = 60/200 (30%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
YE + K+G G Y VF+ + +E +K ++ + REI +L+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
NIV+L D++ + T L+FE + F L V+ ++++LLK L +CH
Sbjct: 61 KNIVRLHDVLHSDKKLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S+ ++HRD+KP N++I+ +L ++GLA F P + Y+ V + +++ P++L +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 305 DYDYSLDLWSLGCMFAGMVS 324
Y S+D+WS GC+FA + +
Sbjct: 178 LYSTSIDMWSAGCIFAELAN 197
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-34
Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN 190
+ ++GRG + V++G+ + L+ K +++ K E ++L+ L PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 191 IVKLLDIVRD--QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
IV+ D + K L+ E + + K + + +R + ++LK L + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 246 SQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
++ I+HRD+K N+ I +++ D GLA V + + F PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186
Query: 304 QDYDYSLDLWSLGCMFAGMVS 324
+ YD S+D+++ G M +
Sbjct: 187 EKYDESVDVYAFGMCMLEMAT 207
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (310), Expect = 2e-33
Identities = 47/209 (22%), Positives = 85/209 (40%), Gaps = 16/209 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
D YE+ +G G SEV + +K+L+ P + +RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 187 GGPNIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
P IV + D + P ++ E+V+ + + ++ I + +AL
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
++ H GI+HRDVKP N+MI I +A+ + + + + + PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
D D++SLGC+ +++ P
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-33
Identities = 48/206 (23%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQN 184
D Y+ ++G G+++ V + + + K +K + ++ I+RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L +
Sbjct: 70 IQ-HPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 242 DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
Y HS I H D+KP N+M+ + ++++ID+GLA G E+ + F PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMVS 324
++ + + D+WS+G + ++S
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLS 211
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-33
Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGG 188
E + +G G+++ V++ N+ IK +K + + REIK+LQ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCH 245
PNI+ LLD + SL+F+ + ++ L+ ++ Y+ L+ L+Y H
Sbjct: 60 PNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
I+HRD+KP+N+++D E L+L D+GLA F P + Y +V +R+++ PELL +
Sbjct: 118 QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 305 DYDYSLDLWSLGCMFAGMVSVSP 327
Y +D+W++GC+ A ++ P
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVP 199
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-33
Identities = 34/205 (16%), Positives = 85/205 (41%), Gaps = 22/205 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKALDYC 244
NI+ + Q +++ + + + L+ + + + +DY
Sbjct: 64 VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLV 301
H++ I+HRD+K +N+ + + +++ D+GLA + S + PE++
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 302 DLQD--YDYSLDLWSLGCMFAGMVS 324
Y + D+++ G + +++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMT 204
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (306), Expect = 1e-32
Identities = 37/205 (18%), Positives = 84/205 (40%), Gaps = 19/205 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKKKKIKREIKILQNLCGGPNIVKL 194
Y+V R++G G + +FEG + +N++ IK + +++ E + + L G I +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMH 251
++ L+ + + + +L S V ++L + H + +++
Sbjct: 67 YYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 252 RDVKPHNVMID----HEQRKLRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 299
RD+KP N +I + ++D+G+ +FY +E + +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVS 324
+ ++ DL +LG +F +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLR 208
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 6e-32
Identities = 46/242 (19%), Positives = 88/242 (36%), Gaps = 17/242 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + ++ E + + F S V +++ ++Y HS+
Sbjct: 67 TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 250 MHRDVKPHNVMIDHEQRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 299
+HRDVKP N ++ ++ + ID+GLA+ Y + + + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGLGHSCLNTWFLRTCSIPFFPLNLL 359
+ + DL SLG + S + + S P L
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 360 IP 361
P
Sbjct: 244 YP 245
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-32
Identities = 50/218 (22%), Positives = 103/218 (47%), Gaps = 12/218 (5%)
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKK 173
+++ E + Y+ ++ +G G V + IK L K
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYD 229
+ RE+ +++ + NI+ LL++ Q++ + L+ E ++ +V+ L
Sbjct: 62 RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
+ Y +Y++L + + HS GI+HRD+KP N+++ + +++D+GLA V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSP 327
+RY++ PE+++ Y ++D+WS+GC+ MV
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 9e-32
Identities = 34/197 (17%), Positives = 86/197 (43%), Gaps = 14/197 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLV 63
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
+LL ++ +++ ++ E++ L L + + ++ +A++Y
Sbjct: 64 QLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
+HRD+ NV++ + ++ D+GL + + + + PE L + + +
Sbjct: 123 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFS 178
Query: 308 YSLDLWSLGCMFAGMVS 324
D+WS G + + S
Sbjct: 179 TKSDVWSFGILLWEIYS 195
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-31
Identities = 48/229 (20%), Positives = 90/229 (39%), Gaps = 42/229 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILK----PVKKKKIKREIKILQN 184
++ E + +G G + +V ++ + +K+LK +++ + E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--------------------- 222
L NIV LL S LIFE+ D L
Sbjct: 97 LGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 223 ----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
L+ D+ + Y++ K +++ + +HRD+ NV++ H + +++ D+GLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARD 213
Query: 279 YHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
Y VR + PE L + Y D+WS G + + S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFS 261
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 8e-31
Identities = 45/201 (22%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
D ++ ++ +G G + V H +KIL K K+K E +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCHS 246
P +VKL +D + + + + S+ R+Y +++ +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+++RD+KP N++ID + +++ D+G A+ + PE+++ + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215
Query: 307 DYSLDLWSLGCMFAGMVSVSP 327
+ ++D W+LG + M + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYP 236
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-30
Identities = 34/199 (17%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ ++V ++G G++ EV+ G + + K +K LK + E +++ L +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRL 70
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+L +V + +I E++ N L+ + ++ + + +
Sbjct: 71 VRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDLQD 305
+ +HRD++ N+++ + ++ D+GLA + A K ++
Sbjct: 128 RNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 306 YDYSLDLWSLGCMFAGMVS 324
+ D+WS G + +V+
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (290), Expect = 3e-30
Identities = 41/198 (20%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
D++++R +G G + V + +K+LK + + E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
P I+++ +D Q + + E + ++Y E+ AL+Y HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ I++RD+KP N+++D + +++ D+G A++ + + PE++ + Y
Sbjct: 123 KDIIYRDLKPENILLD-KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-KPY 178
Query: 307 DYSLDLWSLGCMFAGMVS 324
+ S+D WS G + M++
Sbjct: 179 NKSIDWWSFGILIYEMLA 196
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-30
Identities = 34/207 (16%), Positives = 74/207 (35%), Gaps = 21/207 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVK------KKKIKREIKILQN 184
D ++ K+G G + V G + K + +K LKP RE+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
L N+++L +V K ++ E + Y ++ +
Sbjct: 68 LDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGP 297
+ Y S+ +HRD+ N+++ +++ D+GL ++ V +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ + + ++ D W G M +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-30
Identities = 37/201 (18%), Positives = 78/201 (38%), Gaps = 9/201 (4%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D++ ++ +G+G + +V +KIL+ E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 188 GPNIVKLLDIVRDQQSK-TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
P + L + ++ R+Y E++ AL+Y HS
Sbjct: 65 -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ +++RD+K N+M+D + +++ D+GL + +++ DY
Sbjct: 124 RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 307 DYSLDLWSLGCMFAGMVSVSP 327
++D W LG + M+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRL 203
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-29
Identities = 47/239 (19%), Positives = 107/239 (44%), Gaps = 17/239 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-------KKKIKREIKILQ 183
+++E+++ +G G Y +VF + + +K+LK + + E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALD 242
++ P +V L + + L + + + ++++V+ Y+ E++ AL+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 299
+ H GI++RD+K N+++D + L D+GL++ + + Y+ Y +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLFYVSGLGHSCLNTWFLRTCSIPFFPLNL 358
+D ++D WSLG + +++ + F V G +S S P +P +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGAS--PFTVDGEKNSQAEISRRILKSEPPYPQEM 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-29
Identities = 34/199 (17%), Positives = 81/199 (40%), Gaps = 14/199 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ V+++G G++ V G + +K IK ++ + ++ E +++ L P +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKL 62
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD----FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
V+L + +Q L+FE + + + + + ++ + + Y
Sbjct: 63 VQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDLQD 305
++HRD+ N ++ Q +++ D+G+ F + + + PE+
Sbjct: 121 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR 178
Query: 306 YDYSLDLWSLGCMFAGMVS 324
Y D+WS G + + S
Sbjct: 179 YSSKSDVWSFGVLMWEVFS 197
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (277), Expect = 1e-28
Identities = 37/237 (15%), Positives = 86/237 (36%), Gaps = 28/237 (11%)
Query: 107 RVYSDINVVRPREYWDYESLTVQWGEQ---DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
+++ D P + D ++ ++ ++ + +G G++ EV G ++ I
Sbjct: 1 KIFID-----PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI 55
Query: 164 IKILKPVKK-------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216
+K +K + E I+ PN++ L +V S +I E + N
Sbjct: 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTK--STPVMIITEFMENG 112
Query: 217 DFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272
+ + + + + Y +HRD+ N++++ ++ D
Sbjct: 113 SLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV-CKVSD 171
Query: 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMVS 324
+GL+ F ++ K P + + + D+WS G + ++S
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-28
Identities = 35/199 (17%), Positives = 84/199 (42%), Gaps = 14/199 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
D ++++G G++ V G IK++K + + + E K++ NL +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKL 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
V+L + Q + +I E++ N + ++ +A++Y S+
Sbjct: 62 VQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDLQD 305
+HRD+ N +++ + +++ D+GL+ + + + + PE+L+
Sbjct: 120 QFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SK 177
Query: 306 YDYSLDLWSLGCMFAGMVS 324
+ D+W+ G + + S
Sbjct: 178 FSSKSDIWAFGVLMWEIYS 196
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 38/216 (17%), Positives = 79/216 (36%), Gaps = 29/216 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
+D + +G G + +V + D + I + + E+++L L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------------------FKVLYPTLSDY 228
PNI+ LL + L E+ + + TLS
Sbjct: 70 HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ ++ ++ + +DY + +HRD+ N+++ E ++ D+GL+ + +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ E L Y + D+WS G + +VS
Sbjct: 187 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVS 221
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-28
Identities = 38/203 (18%), Positives = 84/203 (41%), Gaps = 17/203 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 186
+ E+ R +G G++ +V +G++ + + +K K +K +E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
P+IVKL+ ++ + +I E + + +L + Y Y+L AL
Sbjct: 66 DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPELLV 301
Y S+ +HRD+ NV++ ++L D+GL+ + Y + +
Sbjct: 123 YLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 302 DLQDYDYSLDLWSLGCMFAGMVS 324
+ + + + D+W G ++
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILM 204
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (274), Expect = 4e-28
Identities = 36/198 (18%), Positives = 79/198 (39%), Gaps = 10/198 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNI 191
D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + PN+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNL 75
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
V+LL + + F L +S + Y ++ A++Y +
Sbjct: 76 VQLLGVCTREPPFYIITEF-MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQDY 306
+HRD+ N ++ E +++ D+GL+ + + +
Sbjct: 135 NFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 307 DYSLDLWSLGCMFAGMVS 324
D+W+ G + + +
Sbjct: 194 SIKSDVWAFGVLLWEIAT 211
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-28
Identities = 34/200 (17%), Positives = 79/200 (39%), Gaps = 16/200 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKL 74
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+L +V ++ ++ E+++ L + ++ + Y
Sbjct: 75 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQ 304
+HRD++ N+++ E ++ D+GLA + + PE +
Sbjct: 132 MNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G 189
Query: 305 DYDYSLDLWSLGCMFAGMVS 324
+ D+WS G + + +
Sbjct: 190 RFTIKSDVWSFGILLTELTT 209
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-27
Identities = 43/223 (19%), Positives = 81/223 (36%), Gaps = 35/223 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVK----KKKIKREIKILQN 184
+ + +G G + +V E + +K+LKP ++ + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---------------------FKVLYP 223
L NIV LL +I E+ D +
Sbjct: 83 LGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
L D+ + Y++ K + + S+ +HRD+ N+++ H + ++ D+GLA
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDS 199
Query: 284 EYNVRVASRYFKG--PELLVDLQDYDYSLDLWSLGCMFAGMVS 324
Y V+ +R + Y + D+WS G + S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 41/208 (19%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 132 EQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCI--IKILKPVKKKK----IKREIKILQN 184
++D+ + ++G G + V +GV+ ++ IK+LK +K + RE +I+
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKA 240
L P IV+L+ + + + L+ E K L + +V ++++
Sbjct: 66 L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
+ Y + +HRD+ NV++ + ++ D+GL++ Y +
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMVS 324
PE + + + D+WS G +S
Sbjct: 181 PECINF-RKFSSRSDVWSYGVTMWEALS 207
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-27
Identities = 36/207 (17%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKK----IKREIKILQN 184
+ +++ ++ +G G + V++G+ + E IK L+ K I E ++ +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
+ P++ +LL I T LI + + + + + ++ K
Sbjct: 68 VDN-PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 297
++Y + ++HRD+ NV++ Q +++ D+GLA+ ++ +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVS 324
E ++ + Y + D+WS G +++
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMT 208
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (260), Expect = 3e-26
Identities = 43/230 (18%), Positives = 80/230 (34%), Gaps = 42/230 (18%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQ 183
+++ E VR +G G + VF+ +K+LK + +RE ++
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------------ 219
PNIVKLL + + L+FE++ D
Sbjct: 72 EFDN-PNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
P LS + ++ + Y + +HRD+ N ++ E +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLS 187
Query: 277 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ Y A P + Y D+W+ G + + S
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-25
Identities = 38/200 (19%), Positives = 81/200 (40%), Gaps = 20/200 (10%)
Query: 140 RKVGRGKYSEVFEGVHC--TDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
+++G G + V +G + + +KILK P K ++ E ++Q L P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGI 249
+++ I ++++ L+ E + D ++ ++++ + Y
Sbjct: 72 RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 305
+HRD+ NV++ Q ++ D+GL++ + Y + PE +
Sbjct: 129 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186
Query: 306 YDYSLDLWSLGCMFAGMVSV 325
+ D+WS G + S
Sbjct: 187 FSSKSDVWSFGVLMWEAFSY 206
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 9e-25
Identities = 39/217 (17%), Positives = 82/217 (37%), Gaps = 26/217 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 192
+ +G+G++ EV+ G E+ +KI +++ RE +I Q + NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 193 KLLDIVRDQQSKTPS--LIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKALDYCHSQ- 247
+ L+ ++ + F L T++ + L + H +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 248 -------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 295
I HRD+K N+++ + D GLA + + N RV ++ +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 296 GPELL-----VDLQDYDYSLDLWSLGCMFAGMVSVSP 327
PE+L + + D++++G +F +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 3e-24
Identities = 36/207 (17%), Positives = 79/207 (38%), Gaps = 21/207 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNL 185
+ +G G++ EV++G+ T + K IK LK ++ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKAL 241
NI++L ++ + +I E++ N S + + + +
Sbjct: 67 SH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGP 297
Y + +HRD+ N++++ ++ D+GL+ E + + P
Sbjct: 124 KYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMVS 324
E + + S D+WS G + +++
Sbjct: 183 EAISYRKFTSAS-DVWSFGIVMWEVMT 208
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 5e-24
Identities = 39/201 (19%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKK----KKIKREIKILQNLCGGPNIV 192
+GRG + V+ G ++ K I +K L + + E I+++ PN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 91
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG 248
LL I + P ++ ++ + D + + D+ + ++ K + + S+
Sbjct: 92 SLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-----FKGPELLVDL 303
+HRD+ N M+D + +++ D+GLA + + +V + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208
Query: 304 QDYDYSLDLWSLGCMFAGMVS 324
Q + D+WS G + +++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMT 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.4 bits (241), Expect = 3e-23
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNL-------- 185
Y +VRK+G G +S V+ +N +KI++ V + + EIK+LQ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 186 --CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF------KVLYPTLSDYDVRYYIYEL 237
G +I+KLLD + ++ + K + + V+ +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 238 LKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 293
L LDY GI+H D+KP NV+++ LI +A+ + S R
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
++ PE+L+ + D+WS C+ +++
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELIT 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 9e-23
Identities = 42/224 (18%), Positives = 87/224 (38%), Gaps = 37/224 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVKKKK----IKREIKIL 182
D + + +G G + +V ++ K +K+LK +K + E++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------------YP 223
+ + NI+ LL +I E+ + + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
LS D+ Y++ + ++Y S+ +HRD+ NV++ + ++ D+GLA H
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHID 189
Query: 284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
Y + PE L D + Y + D+WS G + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 232
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 2e-22
Identities = 38/216 (17%), Positives = 81/216 (37%), Gaps = 30/216 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQN 184
+ + R++G+G + V+EGV + IK + + + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------YPTLSDYDVR 231
++V+LL +V Q + +I E + D K S +
Sbjct: 80 F-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 288
E+ + Y ++ +HRD+ N M+ + +++ D+G+ + Y
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKG 195
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ + PE L D + D+WS G + + +
Sbjct: 196 LLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.6 bits (224), Expect = 4e-22
Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 34/203 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------------VKKKKIKREIKILQ 183
+ + +G GK S VF +C++K K + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 184 NLCGGPNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
+ KL + + + +++ E ++ + + + + +L+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 296
+ +GI+H D+ +NV++ E +ID+ + E G +VR YF
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREILERDVRNIITYFS- 173
Query: 297 PELLVDLQDYDYSLDLWSLGCMF 319
+ Y D+ S
Sbjct: 174 -------RTYRTEKDINSAIDRI 189
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 5e-21
Identities = 40/223 (17%), Positives = 88/223 (39%), Gaps = 36/223 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKP----VKKKKIKREIKILQN 184
D ++ + +GRG + +V E +K+LK + + + E+KIL +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------------VLYPTL 225
+ N+V LL +I E + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA + +Y
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDY 190
Query: 286 ----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS 324
+ R+ ++ + + Y D+WS G + + S
Sbjct: 191 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 231
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 82.56 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=385.66 Aligned_cols=229 Identities=76% Similarity=1.315 Sum_probs=212.6
Q ss_pred CCCcceeeccCCcCCCCccccccccccccCCCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHH
Q 016537 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181 (387)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~i 181 (387)
.+++.+++.+.+...+.++|+++...+.+...++|+++++||+|+||+||+|+++.+++.||||+++....+++.+|+++
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~i 82 (328)
T d3bqca1 3 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI 82 (328)
T ss_dssp CCCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHH
T ss_pred CCCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHH
Confidence 45677788888888899999999888888889999999999999999999999999999999999998888899999999
Q ss_pred HHHhcCCCCeeEEEEEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeE
Q 016537 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (387)
Q Consensus 182 l~~l~~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl 261 (387)
|+++.+||||+++++++........++|||||.+++|..+.+.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi 162 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence 99996799999999999877777889999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCceEEEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 262 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+.++..+||+|||+|+...+.......++|+.|+|||++.+...++.++||||+||++|||++|+.||.
T Consensus 163 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp ETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 977768999999999988777777788999999999999876678999999999999999999999984
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=372.70 Aligned_cols=193 Identities=26% Similarity=0.442 Sum_probs=169.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
++|++++.||+|+||+||+|+++.+++.||||++.... .+.+.+|+++|+++ +||||+++++++.+. ...++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~--~~~~iv 81 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYLF 81 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC--ceeEEE
Confidence 68999999999999999999999999999999986432 35688999999999 999999999999875 457899
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC---
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~--- 283 (387)
||||++|+|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEEC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCccc
Confidence 99999999987764 489999999999999999999999999999999999999666 89999999998765432
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+..+||+.|||||++.+...++.++|||||||+||||++|++||.
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 23556899999999999874445788999999999999999999993
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=365.77 Aligned_cols=191 Identities=26% Similarity=0.466 Sum_probs=171.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.+.||+|+||+||+|+++.+++.||+|++.. ...+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~ 82 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TRVY 82 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEEC--CEEE
Confidence 689999999999999999999999999999999853 2346788999999999 999999999999864 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+|||||++|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~-~ 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS-R 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCC-C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCC-c
Confidence 999999999997765 4699999999999999999999999999999999999999766 8999999999876443 3
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~ 205 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE 205 (263)
T ss_dssp CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCC
Confidence 456789999999999987 679999999999999999999999993
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=369.72 Aligned_cols=194 Identities=29% Similarity=0.511 Sum_probs=160.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|++++.||+|+||+||+|+++.+|+.||||.+.... .+.+.+|+++++++ +|||||++++++.+.....+++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEE
Confidence 68999999999999999999999999999999986432 35588999999999 9999999999998766667889
Q ss_pred EEeccCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeeccCCCCeeEcCCCceEEEEecccc
Q 016537 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (387)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~-----ivHrDlKp~NILl~~~~~~vkl~DFG~a 276 (387)
|||||++|+|..++ ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccce
Confidence 99999999998765 35899999999999999999999976 99999999999999766 8999999999
Q ss_pred eeecCCCc-ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 277 EFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 277 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
+.+..+.. ....+||+.|+|||++.+ ..|+.++|||||||++|||+||++||.
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence 87655433 355789999999999877 679999999999999999999999993
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=371.89 Aligned_cols=193 Identities=24% Similarity=0.468 Sum_probs=173.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~---~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++|+++++||+|+||+||+|.++.+|+.||||+++. ...+.+.+|+++++++ +|||||++++++.+. ...++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEEC--CEEEEE
Confidence 3679999999999999999999999999999999863 2346789999999999 999999999999875 457899
Q ss_pred EeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-ccc
Q 016537 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (387)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~~ 286 (387)
||||++|+|..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+..+. ...
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccccccc
Confidence 9999999998775 4589999999999999999999999999999999999999766 89999999998875443 345
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+||+.|+|||++.+ +.|+.++|||||||++|||++|++||.
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC
Confidence 6789999999999987 789999999999999999999999994
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=367.14 Aligned_cols=192 Identities=28% Similarity=0.509 Sum_probs=169.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||+||+|+++.+++.||||++.. ...+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECS--SEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEEC--CEEE
Confidence 679999999999999999999999999999999863 2336789999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+|||||++|+|..++ +.+++..++.++.|++.||+|||++|||||||||+|||++.++ .+||+|||+|+.+....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCc
Confidence 999999999987664 4699999999999999999999999999999999999999666 89999999998775432
Q ss_pred --cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 --~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC
Confidence 2345689999999999987 689999999999999999999999994
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=367.57 Aligned_cols=194 Identities=24% Similarity=0.459 Sum_probs=170.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.+.|++++.||+|+||+||+|+++.+++.||||+++.. ..+.+.+|+++|+++ +|||||++++++.+. ...++|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CeEEEE
Confidence 36799999999999999999999999999999998643 336788999999999 999999999999875 457899
Q ss_pred EeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
||||++|+|..++ +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...... .
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCccc
Confidence 9999999987664 3589999999999999999999999999999999999999766 89999999997654322 2
Q ss_pred ccccccccCCCCchhhcc----cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.. ...|+.++|||||||+||||++|++||.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~ 216 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence 345689999999999842 2568999999999999999999999994
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=370.49 Aligned_cols=192 Identities=23% Similarity=0.429 Sum_probs=173.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+++.||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+. ..++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~~ 81 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccc--cccc
Confidence 6899999999999999999999999999999998632 346788999999999 999999999999764 4678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC-CC
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~-~~ 283 (387)
+|||||++|+|..++ ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCCc
Confidence 999999999997665 4589999999999999999999999999999999999999776 899999999987644 34
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ +.|+.++|||||||+||||++|++||.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC
Confidence 4566799999999999987 789999999999999999999999994
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=375.13 Aligned_cols=192 Identities=24% Similarity=0.414 Sum_probs=170.0
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
.++|+++++||+|+||+||+|++..+|+.||+|+++.. ....+.+|+.+|+++ +|||||++++++.+. ...++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECS--SEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEE
Confidence 47899999999999999999999999999999998642 246788999999999 999999999999875 45789
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|||||++|+|..++ ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~-~ 159 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 159 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-T
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC-c
Confidence 99999999998776 359999999999999999999997 5999999999999999766 8999999999866433 2
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+..+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.
T Consensus 160 ~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 345799999999999988 789999999999999999999999994
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=357.80 Aligned_cols=193 Identities=23% Similarity=0.404 Sum_probs=167.7
Q ss_pred CCe-EEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCCC
Q 016537 134 DDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (387)
Q Consensus 134 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~--~~~~ 205 (387)
++| ++.++||+|+||+||+|.++.+++.||+|.+... ..+.+.+|+++|+++ +|||||++++++.+. ....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCE
Confidence 445 6778999999999999999999999999998643 235688999999999 999999999998753 3456
Q ss_pred ceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
+++|||||++|+|..++ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 78999999999998765 45899999999999999999999998 99999999999997555589999999998644
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. ......+||+.|+|||++.+ .|+.++|||||||+||||++|++||.
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 3 33456789999999999864 59999999999999999999999993
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=368.23 Aligned_cols=193 Identities=27% Similarity=0.467 Sum_probs=155.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
+.|++.+.||+|+||+||+|+++.+++.||||++... ....+.+|+++|+++ +|||||++++++.+. ...++|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESG--GHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECS--SEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence 6799999999999999999999999999999998643 235678999999999 999999999999764 457899
Q ss_pred EeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC--CCceEEEEecccceeecCCCc
Q 016537 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~~vkl~DFG~a~~~~~~~~ 284 (387)
||||++|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||+.. +++.+||+|||+|+....+..
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 9999999997765 35899999999999999999999999999999999999953 344899999999998776666
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 166 ~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp -------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 677899999999999987 689999999999999999999999994
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-48 Score=370.30 Aligned_cols=193 Identities=23% Similarity=0.430 Sum_probs=174.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++|++++.||+|+||.||+|+++.+|+.||||++.... .+.+.+|+++|+++ +|||||++++++.+. ...++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEE
Confidence 68999999999999999999999999999999986543 35678999999999 999999999999874 4578999
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC-CceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||++|+|...+ ..+++..++.++.||+.||+|||++|||||||||+|||++.+ ++.+||+|||+|+.+......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999997665 248999999999999999999999999999999999999643 348999999999988777777
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+||+.|||||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 183 ~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp EEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 78899999999999987 679999999999999999999999994
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.3e-48 Score=369.80 Aligned_cols=193 Identities=24% Similarity=0.447 Sum_probs=174.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++|++++.||+|+||.||+|++..+|+.||||+++... ...+.+|+++|+++ +|||||++++++.+. ...++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEE
Confidence 67999999999999999999999999999999987533 35678999999999 999999999999764 4578999
Q ss_pred eccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC-CCceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||++|+|...+. .+++.+++.++.||+.||+|||++||+||||||+||||+. +.+.+||+|||+|+....+...
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 9999999976542 4899999999999999999999999999999999999973 3348999999999998877777
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred eeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 78899999999999987 789999999999999999999999994
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=358.78 Aligned_cols=193 Identities=24% Similarity=0.456 Sum_probs=174.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~---------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+++|+++ +|||||++++++.+. .
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--T 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--C
Confidence 6799999999999999999999999999999998532 246789999999999 999999999999765 4
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCc---eEEEEeccccee
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF 278 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---~vkl~DFG~a~~ 278 (387)
..++|||||++|+|..++ +.+++..++.++.|++.||+|||+++|+||||||+|||++.++. .+||+|||+|+.
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 578999999999998765 46999999999999999999999999999999999999986553 599999999998
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+.......||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 877777777899999999999987 679999999999999999999999994
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-47 Score=363.07 Aligned_cols=190 Identities=22% Similarity=0.442 Sum_probs=170.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeC--Ceee
Confidence 679999999999999999999999999999999863 2346788999999999 999999999999764 4678
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+|||||.++++..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSSC--
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEeccc--
Confidence 999999999987665 4578899999999999999999999999999999999999666 8999999999876533
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~ 202 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY 202 (316)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCC
Confidence 346789999999999977 679999999999999999999999994
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-48 Score=363.21 Aligned_cols=190 Identities=25% Similarity=0.444 Sum_probs=167.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
+.|++++.||+|+||+||+|++..+++.||||++.... .+.+.+|+++|+++ +|||||++++++.+. ...+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEEC--CEEE
Confidence 35999999999999999999999999999999986432 24688999999999 999999999999764 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+|||||.+|++..+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC---
Confidence 999999999886543 4699999999999999999999999999999999999999666 899999999986543
Q ss_pred ccccccccCCCCchhhcc--cCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ .+.|+.++|||||||++|||++|++||.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 345689999999999864 2468999999999999999999999994
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=366.26 Aligned_cols=195 Identities=26% Similarity=0.446 Sum_probs=172.8
Q ss_pred CCeEEEe-eeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCCCceEEE
Q 016537 134 DDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~--~~~~~~~lv~ 210 (387)
++|++++ .||+|+||.||+|++..+++.||||+++. ...+.+|++++.++.+|||||++++++.+ .....+|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 6899886 59999999999999999999999999864 36678999998777699999999999875 2345679999
Q ss_pred eccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC--CceEEEEecccceeecCCC
Q 016537 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~~vkl~DFG~a~~~~~~~ 283 (387)
|||++|+|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+|+......
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC
Confidence 9999999987652 48899999999999999999999999999999999999853 3379999999999887777
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
.....+||+.|+|||++.+ ..|+.++|||||||+||||+||++||..
T Consensus 169 ~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 7778899999999999877 6799999999999999999999999943
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-47 Score=365.29 Aligned_cols=190 Identities=23% Similarity=0.432 Sum_probs=171.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||.||+|+++.+|+.||||++... ..+.+.+|+++|+.+ +||||+++++++.+. ...+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~ 117 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SNLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccc--cccc
Confidence 6899999999999999999999999999999998632 235688999999999 999999999999764 4577
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
+||||+.+|++...+ ..+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC--
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeecccc--
Confidence 999999999987665 4699999999999999999999999999999999999999766 8999999999886533
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|||||++.+ ..|+.++|||||||+||||+||++||.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCC
Confidence 346789999999999987 789999999999999999999999994
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-47 Score=355.57 Aligned_cols=191 Identities=20% Similarity=0.383 Sum_probs=167.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.++||+|+||+||+|.++.+++.||||+++.. ..+++.+|+++|+++ +|||||++++++.+. ...++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeC--CeeEEEee
Confidence 6899999999999999999999999999999998643 457899999999999 999999999999764 45679999
Q ss_pred ccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc-
Q 016537 212 HVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (387)
Q Consensus 212 ~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~- 285 (387)
||++|++..++ ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+....+...
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCcee
Confidence 99999987665 3478899999999999999999999999999999999999665 8999999999876544322
Q ss_pred -cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 286 -~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
....|+..|+|||++.+ ..|+.++|||||||++|||++|..||
T Consensus 173 ~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 33457889999999887 68999999999999999999977665
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=348.43 Aligned_cols=189 Identities=18% Similarity=0.353 Sum_probs=165.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.+.||+|+||.||+|.+ .+++.||||+++.. ..+.+.+|+++++++ +|||||++++++.+ ...++|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEEEE
Confidence 6899999999999999999998 56789999999743 457899999999999 99999999998854 24679999
Q ss_pred ccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc--
Q 016537 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (387)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-- 284 (387)
|+++|+|...+. .+++..+..++.||+.||.|||+++|+||||||+||||+.++ .+||+|||+|+.......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEEC
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEEccCCcccc
Confidence 999999977653 389999999999999999999999999999999999999665 899999999998765432
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
.....||+.|+|||++.+ +.|+.++|||||||+||||+||..|+
T Consensus 167 ~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 234578899999999876 67999999999999999999965544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=353.21 Aligned_cols=190 Identities=16% Similarity=0.348 Sum_probs=159.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~-----~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
.++|++.+.||+|+||+||+|++ +..||||+++. ...+.+.+|+++|+++ +|||||++++++.+ ...+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~~ 79 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQLA 79 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEEE
Confidence 47899999999999999999975 33599999863 2346788999999999 99999999998754 3468
Q ss_pred EEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC
Q 016537 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~ 283 (387)
+|||||++|+|..++ ..+++..+..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+|+......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC-----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeeccccC
Confidence 999999999997765 3489999999999999999999999999999999999999666 89999999998764332
Q ss_pred ---cccccccccCCCCchhhccc--CCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ---EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
......||+.|||||++.+. ..|+.++|||||||+||||+||+.||.
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 23456899999999998642 358999999999999999999999994
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-46 Score=349.57 Aligned_cols=195 Identities=24% Similarity=0.412 Sum_probs=164.1
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC--C
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--K 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~--~ 204 (387)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+|+++++++ +||||+++++++.+.+. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence 378999999999999999999999999999999996422 25688999999998 99999999999876543 3
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++|||||++++|.... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.++....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC-
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhcc
Confidence 478999999999987655 4689999999999999999999999999999999999999666 799999999876543
Q ss_pred CC----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||+||++||.
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCC
Confidence 32 2345689999999999977 679999999999999999999999993
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-46 Score=346.94 Aligned_cols=193 Identities=26% Similarity=0.481 Sum_probs=172.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------------~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
++|++.+.||+|+||+||+|++..+++.||||++.... .+.+.+|+.+++++..||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 78999999999999999999999999999999986421 245789999999995599999999999764
Q ss_pred CCCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...++|||||++|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 83 --~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 --TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQ 159 (277)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred --cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchheeE
Confidence 5678999999999997766 4589999999999999999999999999999999999999666 899999999998
Q ss_pred ecCCCcccccccccCCCCchhhcc-----cCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
...+......+||..|+|||.+.+ ...++.++||||+||+||||++|++||
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf 215 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence 877766677899999999999853 235788999999999999999999999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=354.53 Aligned_cols=205 Identities=29% Similarity=0.559 Sum_probs=172.1
Q ss_pred EEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 138 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--------~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+++|+++ +|||||++++++.+. ...++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~--~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHK--SNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCT--TCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccC--Cceeeh
Confidence 5688999999999999999999999999986322 24688999999999 999999999999765 457899
Q ss_pred EeccCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-cc
Q 016537 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (387)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~~ 285 (387)
|||+.++++..+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccc
Confidence 99999998776653 488999999999999999999999999999999999999666 89999999998765433 33
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh---------hccCCCCCccccccc
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF---------YVSGLGHSCLNTWFL 346 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~---------~~~~~~~~~~~~~~~ 346 (387)
...+||+.|+|||++.+...|+.++|||||||++|||++|++||.. .....+.+....|..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 4568999999999987756789999999999999999999999843 233445555555543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=356.84 Aligned_cols=194 Identities=23% Similarity=0.436 Sum_probs=174.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~--~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++++.||+|+||+||+|.++.+++.||||+++.... ..+.+|+++|+.+ +|||||++++++.+. ...|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEE
Confidence 3789999999999999999999999999999999975543 4578999999999 999999999999875 4578999
Q ss_pred eccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC-CceEEEEecccceeecCCCcc
Q 016537 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (387)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~~vkl~DFG~a~~~~~~~~~ 285 (387)
|||++++|...+. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999987653 48999999999999999999999999999999999999754 337999999999988776666
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+++.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 77889999999999877 679999999999999999999999994
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=346.75 Aligned_cols=191 Identities=18% Similarity=0.367 Sum_probs=156.4
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~--~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
.++|++.++||+|+||.||+|++ .+++.||||+++. ...+++.+|+++++++ +|||||+++|++.+. ...++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~--~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEE-TTTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEE-CCCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccC--CceEEEE
Confidence 36899999999999999999998 4678899999874 3457899999999999 999999999999764 4567999
Q ss_pred eccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc-
Q 016537 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (387)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~- 285 (387)
||+++|+|..++ ..+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++........
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCcee
Confidence 999999987764 2378889999999999999999999999999999999999665 8999999999876544322
Q ss_pred -cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhc-CCch
Q 016537 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSV-SPSV 329 (387)
Q Consensus 286 -~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg-~~pf 329 (387)
....||..|+|||++.+ ..|+.++|||||||+||||+|+ .+||
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 34578999999999987 6799999999999999999995 5555
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-46 Score=362.51 Aligned_cols=192 Identities=26% Similarity=0.429 Sum_probs=166.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc------hHHHHHH---HHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKRE---IKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~E---~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.++||+|+||.||+|+++.+|+.||||++.... ...+.+| +++++.+ +|||||++++++.+. .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~--~ 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP--D 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS--S
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC--C
Confidence 78999999999999999999999999999999986321 2334455 4555555 799999999999765 4
Q ss_pred CceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
..++|||||++|+|..++ ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+..
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCC
Confidence 578999999999998765 3588999999999999999999999999999999999999666 899999999987654
Q ss_pred CCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 282 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
. .....+||+.|+|||++.+...|+.++|||||||+||||+||++||.
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 4 34556899999999999764679999999999999999999999994
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=356.55 Aligned_cols=193 Identities=22% Similarity=0.407 Sum_probs=170.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~------~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++++.||+|+||+||+|+++.+++.||||+++. ...+.+.+|..++.+..+||||+++++++.+. ...|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 689999999999999999999999999999999963 22356778888776544999999999999875 4578
Q ss_pred EEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
+|||||++|+|..++ ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccccc
Confidence 999999999998776 4689999999999999999999999999999999999999666 8999999999866543 3
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 3455789999999999987 789999999999999999999999994
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=353.92 Aligned_cols=194 Identities=23% Similarity=0.376 Sum_probs=166.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-----eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.++||+|+||+||+|++..++ ..||+|.+... ....+.+|+.++.++.+|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 378999999999999999999986554 37999988542 2357889999999987899999999999765
Q ss_pred CCceEEEeccCCCchhhhcC--------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYP--------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 257 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~--------------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~ 257 (387)
...++|||||++|+|..++. .+++..++.++.||+.||+|||+++||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 45789999999999987652 2688899999999999999999999999999999
Q ss_pred CeeEcCCCceEEEEecccceeecCCCcc---cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 258 NVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 258 NILl~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
|||++.++ .+||+|||+|+........ ....||+.|||||++.+ +.|+.++|||||||+||||+| |++||.
T Consensus 194 Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 194 NVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999666 8999999999876544332 34567999999999887 789999999999999999998 899983
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-46 Score=352.02 Aligned_cols=192 Identities=18% Similarity=0.320 Sum_probs=154.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCe---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|++.+.||+|+||+||+|.++.+++ .||||.+... ..+.+.+|+++|+++ +|||||+++|++.+. ...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKS--TPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--SSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC--CEE
Confidence 679999999999999999999876654 6889987542 235789999999999 999999999999664 457
Q ss_pred eEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++|||||++|+|..++ ..+++.++..++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+.....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccCC
Confidence 8999999999997754 2488999999999999999999999999999999999999666 8999999999876544
Q ss_pred Ccc------cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 283 KEY------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 283 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
... ....||+.|+|||++.+ +.|+.++|||||||+||||+| |++||.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp --------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCC
Confidence 322 12357889999999877 789999999999999999998 899984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=347.23 Aligned_cols=192 Identities=20% Similarity=0.368 Sum_probs=164.9
Q ss_pred CCCeEEEe-eeeecCCeeEEEEEEeC--CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 133 QDDYEVVR-KVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 133 ~~~y~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
.++|.+.+ +||+|+||+||+|.++. ++..||||+++... .+++.+|+++|+++ +|||||++++++.++ .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~---~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE---A 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC---e
Confidence 36788888 49999999999998753 45689999986432 36789999999999 999999999998653 3
Q ss_pred ceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++|||||++|+|..++ ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhcccc
Confidence 68999999999998764 2489999999999999999999999999999999999999666 899999999988755
Q ss_pred CCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 282 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... ....||+.|+|||++.+ +.++.++|||||||++|||+| |++||.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 4322 34468889999999877 679999999999999999998 899994
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=356.87 Aligned_cols=194 Identities=32% Similarity=0.579 Sum_probs=171.3
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----CCCCceEEE
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLIF 210 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~----~~~~~~lv~ 210 (387)
+|+.+++||+|+||+||+|+++.+++.||||+++... ....+|+++|+++ +||||+++++++... +..++++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6999999999999999999999999999999996543 3345799999999 999999999998643 344678999
Q ss_pred eccCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 211 e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
|||+++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.......
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 999987544432 35899999999999999999999999999999999999997766899999999998877777
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+|+..|+|||++.+...|+.++||||+||++|||++|++||.
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 7778999999999998876689999999999999999999999994
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=345.18 Aligned_cols=196 Identities=26% Similarity=0.467 Sum_probs=167.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQQ 202 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---------~~~~~~E~~il~~l~-~hpniv~l~~~~~~~~ 202 (387)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..++.+|+.+++++. .|||||++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 368999999999999999999999999999999986421 234678999999983 389999999999765
Q ss_pred CCCceEEEeccCC-Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccccee
Q 016537 203 SKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (387)
Q Consensus 203 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~ 278 (387)
...++||||+.+ +++..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+.
T Consensus 82 -~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred -CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 457799999976 4554443 46999999999999999999999999999999999999986656899999999987
Q ss_pred ecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchhh
Q 016537 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVLF 331 (387)
Q Consensus 279 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~ 331 (387)
... ...+..+||+.|+|||++.+...++.++|||||||+||||++|++||..
T Consensus 161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 543 3445678999999999998745567889999999999999999999943
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=346.48 Aligned_cols=196 Identities=30% Similarity=0.611 Sum_probs=168.3
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCC-CeEEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCeeEEEEEEEcC---
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQ--- 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~l~~~-----~~~~~~~E~~il~~l~--~hpniv~l~~~~~~~--- 201 (387)
.++|+++++||+|+||+||+|++..+ ++.||||+++.. ....+.+|+.+|+.|. +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 37899999999999999999999654 678999998632 2345678888887763 799999999998642
Q ss_pred CCCCceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccce
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~ 277 (387)
.....+++|||+.++.+.... ..+++..++.++.|++.||+|||+++||||||||+|||++.++ .+||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhh
Confidence 234678999999998765332 3488999999999999999999999999999999999999666 89999999998
Q ss_pred eecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 278 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCC
Confidence 7766666677899999999999987 789999999999999999999999994
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=347.62 Aligned_cols=193 Identities=32% Similarity=0.639 Sum_probs=169.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|+++++||+|+||+||+|++..+++.||||+++.. ....+.+|+++|+++ +||||+++++++.+. ...++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~--~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTE--NKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccc--cceeE
Confidence 6899999999999999999999999999999998632 246788999999999 999999999999875 45789
Q ss_pred EEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC-C
Q 016537 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (387)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~-~ 283 (387)
||||+.++.+.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSB
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcc
Confidence 99999987654432 3589999999999999999999999999999999999999666 8999999999876543 3
Q ss_pred cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.....++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 44566899999999998775667899999999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=341.35 Aligned_cols=185 Identities=19% Similarity=0.347 Sum_probs=158.1
Q ss_pred eeeeecCCeeEEEEEEeC--CCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 140 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
++||+|+||+||+|.+.. +++.||||+++.. ..+.+.+|+++|+++ +|||||++++++.++ ..++||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~---~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE---SWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS---SEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC---CEEEEEEc
Confidence 579999999999998753 4578999998642 236789999999999 999999999998643 35799999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCcc----
Q 016537 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---- 285 (387)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~---- 285 (387)
|++|+|..++ ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+........
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC-
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhccccccccccc
Confidence 9999998765 4589999999999999999999999999999999999999666 8999999999877544322
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....||+.|+|||++.+ ..|+.++|||||||++|||+| |++||.
T Consensus 168 ~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 168 THGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp ---CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 23468899999999877 679999999999999999998 899994
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=338.31 Aligned_cols=191 Identities=18% Similarity=0.334 Sum_probs=167.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~--~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.++||+|+||+||+|++ .+++.||||+++. ...+.+.+|+.+++++ +||||++++|++.+. ...++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~--~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQ--RPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCS--SSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeC--CceEEEEE
Confidence 6788999999999999999998 5788999999874 3457899999999999 999999999999764 45789999
Q ss_pred ccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc--c
Q 016537 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--Y 285 (387)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~--~ 285 (387)
|+.+|++..+. ..+++..++.++.|+++||+|||++||+||||||+|||++.++ .+||+|||+++....... .
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCceee
Confidence 99999987663 3588999999999999999999999999999999999999666 899999999987654432 2
Q ss_pred cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 286 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
....+|..|+|||++.+ ..|+.++|||||||++|||+| |+.||.
T Consensus 159 ~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~ 203 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE 203 (258)
T ss_dssp CCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCC
Confidence 34578899999999987 779999999999999999998 799984
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=344.27 Aligned_cols=192 Identities=19% Similarity=0.368 Sum_probs=160.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCe----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
.++|++++.||+|+||+||+|.+..+|+ +||+|.++.. ..+.+.+|+++++++ +|||||++++++.+.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---
Confidence 3679999999999999999999877765 6888887532 346799999999999 999999999999764
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++++||+.++++...+ ..+++..++.++.||+.||+|||+++||||||||+|||++.++ .+||+|||+|+...
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecc
Confidence 356899999999876543 3588999999999999999999999999999999999999666 89999999998765
Q ss_pred CCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.... .....||..|+|||++.+ +.|+.++|||||||+||||+| |.+||.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~ 215 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 215 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCC
Confidence 4432 233468999999999987 689999999999999999999 788874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=338.89 Aligned_cols=189 Identities=17% Similarity=0.334 Sum_probs=158.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.+.||+|+||+||+|+++ +++.||||+++.. ..+.+.+|+.+++++ +|||||++++++.+. ..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~---~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE---PIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS---SCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEecC---CeEEEEE
Confidence 68999999999999999999985 5567999999743 347899999999999 999999999998542 3679999
Q ss_pred ccCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc--
Q 016537 212 HVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (387)
Q Consensus 212 ~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~-- 284 (387)
|+.+|++...+ +.+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC---------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhhccCCCcee
Confidence 99999877665 3489999999999999999999999999999999999999665 899999999987654432
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
.....||+.|+|||++.+ +.++.++|||||||+||||++|..|+
T Consensus 171 ~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp -----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred eccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 234578999999999987 78999999999999999999976555
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=339.62 Aligned_cols=191 Identities=18% Similarity=0.318 Sum_probs=156.0
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCC----eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~ 205 (387)
+.|++.++||+|+||.||+|.++.++ ..||||.+.... ...+.+|+++++++ +|||||+++|++.+. ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~--~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKY--KP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecC--Cc
Confidence 57999999999999999999987554 479999986432 35688999999999 999999999999754 45
Q ss_pred ceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecC
Q 016537 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (387)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~ 281 (387)
.++|||||.++++.... ..+++.++..++.|++.||+|||+++|+||||||+||||+.++ .+||+|||+|+....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhcccC
Confidence 67999999999876654 4588999999999999999999999999999999999999666 899999999987654
Q ss_pred CCc----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCch
Q 016537 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSV 329 (387)
Q Consensus 282 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf 329 (387)
... .....||..|+|||++.+ +.|+.++|||||||+||||++|..|+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp -----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCc
Confidence 322 223467889999999877 78999999999999999999966555
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=345.90 Aligned_cols=194 Identities=29% Similarity=0.585 Sum_probs=163.6
Q ss_pred CCCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---
Q 016537 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (387)
Q Consensus 132 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~--- 203 (387)
..++|+++++||+|+||+||+|.++.+|+.||||+++... .+.+.+|+++|+++ +|||||++++++...+.
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccc
Confidence 3589999999999999999999999999999999986422 35678999999999 99999999999976432
Q ss_pred -CCceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
...++||||+. .++..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 95 ~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred cceEEEEEeccc-ccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceeccC
Confidence 35689999994 5555443 4699999999999999999999999999999999999999766 89999999998754
Q ss_pred CCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
...+..+||+.|+|||++.+...++.++||||+||++|||++|++||.
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred --CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 344667899999999999876678999999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=335.85 Aligned_cols=191 Identities=21% Similarity=0.384 Sum_probs=154.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCc
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~ 206 (387)
++|++.+.||+|+||.||+|++..+ +..||||.++... .+.+.+|+++++++ +||||+++++++.+ ...
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CeE
Confidence 6899999999999999999998644 3578899886422 35688999999999 99999999999853 357
Q ss_pred eEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
++||||+.+|++..++ ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccCC
Confidence 8999999999987653 3488999999999999999999999999999999999999666 8999999999876543
Q ss_pred Cc--ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 283 KE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 283 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.. .....||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCC
Confidence 32 244567899999999977 789999999999999999998 899984
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-44 Score=336.33 Aligned_cols=192 Identities=32% Similarity=0.661 Sum_probs=165.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|+++++||+|+||+||+|++ .+++.||||+++... .+.+.+|+.+|+++ +||||+++++++.+. ...++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccC--CceeE
Confidence 6899999999999999999998 578999999986432 36789999999999 999999999999865 45679
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
+|||+.++++..+. +.+++..++.++.||+.||+|||+++||||||||+|||++.++ .+||+|||.|....... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccc
Confidence 99999998876664 3489999999999999999999999999999999999999766 89999999998765432 3
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+++.|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 3556789999999999876778999999999999999999999994
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=338.77 Aligned_cols=193 Identities=21% Similarity=0.375 Sum_probs=157.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.++||+|+||.||+|.+.. +++.||||+++.. ..+.+.+|..++.++.+|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-CC
Confidence 689999999999999999999754 3468999998643 2356788889999987899999999988654 34
Q ss_pred CceEEEeccCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCC
Q 016537 205 TPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 265 (387)
..++|||||++|+|..++. .+++..++.++.||+.||+|||+++||||||||+||||+.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 5789999999999987752 278889999999999999999999999999999999999665
Q ss_pred ceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcC-Cch
Q 016537 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVS-PSV 329 (387)
Q Consensus 266 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~-~pf 329 (387)
.+||+|||+|+....... ....+||+.|+|||++.+ +.|+.++|||||||++|||+||. +||
T Consensus 172 -~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 172 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp -CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred -cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCC
Confidence 899999999987644332 234579999999999987 78999999999999999999974 566
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=342.12 Aligned_cols=196 Identities=30% Similarity=0.602 Sum_probs=165.8
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC--CCc
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--KTP 206 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~--~~~ 206 (387)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+++|+++ +||||+++++++..... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccce
Confidence 478999999999999999999999999999999997433 35678999999999 99999999999875432 123
Q ss_pred eEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-
Q 016537 207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 207 ~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~- 283 (387)
+++++|+.+++|..++ +.+++..++.++.|++.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCc
Confidence 4566777889988775 4699999999999999999999999999999999999999666 89999999998764432
Q ss_pred ---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 ---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 ---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.....++.++||||+||++|||++|++||.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 23456799999999998665678999999999999999999999983
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=337.68 Aligned_cols=195 Identities=33% Similarity=0.562 Sum_probs=166.8
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC------
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ------ 202 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~------ 202 (387)
++|+++++||+|+||+||+|+++.+|+.||||++... ....+.+|+++|+++ +||||+++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeeccccccccc
Confidence 7899999999999999999999999999999998532 236788999999999 9999999999886532
Q ss_pred CCCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
....++||||+.++++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~~ 167 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAF 167 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeeec
Confidence 34578999999988876554 3588999999999999999999999999999999999999766 8999999999876
Q ss_pred cCCC-----cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.... .....+||+.|+|||++.+...|+.++|||||||++|||++|++||.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 5322 22345799999999999876679999999999999999999999984
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=342.66 Aligned_cols=194 Identities=26% Similarity=0.501 Sum_probs=162.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----CCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~----~~~ 204 (387)
++|+++++||+|+||+||+|+++.+|+.||||++... ...++.+|+.+|+++ +||||+++++++... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 6899999999999999999999999999999999642 235688999999999 999999999999754 235
Q ss_pred CceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc
Q 016537 205 TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~ 284 (387)
..|+|||||.++++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+++.......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC---------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhccccccc
Confidence 7789999999998988888999999999999999999999999999999999999999766 799999999988777666
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.+..++|+.|+|||++.+ ..++.++||||+||++|||++|++||.
T Consensus 175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCC
Confidence 777889999999999988 689999999999999999999999994
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=331.84 Aligned_cols=191 Identities=18% Similarity=0.313 Sum_probs=155.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCC---CeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~l~~~------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.+.||+|+||+||+|++..+ ...||||+++.. ..+.+.+|+.+|+++ +||||++++|++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS---
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec---
Confidence 6799999999999999999987543 247899988642 236789999999999 999999999999653
Q ss_pred CceEEEeccCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
..++||||++++++...+ ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhcc
Confidence 467999999999876554 4589999999999999999999999999999999999999766 89999999998875
Q ss_pred CCCcc----cccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 281 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
..... ....|+..|+|||++.+ ..++.++|||||||++|||+| |++||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 44332 23467788999999987 779999999999999999998 899983
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-44 Score=336.10 Aligned_cols=193 Identities=21% Similarity=0.374 Sum_probs=164.5
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
.++|++.+.||+|+||+||+|+++. +++.||||+++... .+++.+|+++|+++ +||||+++++++.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~-- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVG-- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC--
Confidence 4789999999999999999999753 46789999986432 36689999999999 999999999999764
Q ss_pred CCceEEEeccCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCC
Q 016537 204 KTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp 256 (387)
...+++|||+.+|+|..++. .+++..+..++.|++.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 45679999999999887652 267888999999999999999999999999999
Q ss_pred CCeeEcCCCceEEEEecccceeecCCC---cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcC-Cchh
Q 016537 257 HNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVS-PSVL 330 (387)
Q Consensus 257 ~NILl~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~-~pf~ 330 (387)
+|||++.++ .+||+|||+|+...+.. ......+++.|+|||.+.+ ..|+.++|||||||+||||++|. +||.
T Consensus 169 ~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 169 RNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999665 89999999998664432 2234578899999999987 78999999999999999999995 6663
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=327.47 Aligned_cols=190 Identities=17% Similarity=0.353 Sum_probs=158.2
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEe
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e 211 (387)
.++|++.+.||+|+||.||+|.+ .|+.||||+++... .+.+.+|+++++++ +||||++++|++.+.. ...++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-CcEEEEEe
Confidence 36899999999999999999997 47889999997543 47799999999999 9999999999986543 34689999
Q ss_pred ccCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCccc
Q 016537 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (387)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~~~ 286 (387)
|+++|+|..++. .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~--~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCCC--Cc
Confidence 999999987753 289999999999999999999999999999999999999766 8999999999875433 33
Q ss_pred ccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 287 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
...++..|+|||++.+ +.++.++|||||||++|||+| |++||.
T Consensus 159 ~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 159 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 4577889999999987 689999999999999999998 688773
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=331.13 Aligned_cols=192 Identities=22% Similarity=0.366 Sum_probs=165.2
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe-----CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.++||+|+||.||+|++. .+++.||||+++.. ....+.+|+.+++++.+|||||++++++.+. .
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--G 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--C
Confidence 78999999999999999999864 45679999999743 2356889999999997899999999999764 4
Q ss_pred CceEEEeccCCCchhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC
Q 016537 205 TPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~ 263 (387)
..++|||||++|++..++. .+++..++.++.||+.||+|||+++||||||||+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 4679999999999877652 3788899999999999999999999999999999999996
Q ss_pred CCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCch
Q 016537 264 EQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSV 329 (387)
Q Consensus 264 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf 329 (387)
++ .+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |.+||
T Consensus 181 ~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 181 GR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp TT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCC
Confidence 66 899999999987654332 234578999999999987 789999999999999999999 55555
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=336.35 Aligned_cols=192 Identities=20% Similarity=0.337 Sum_probs=163.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeE--EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCce
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~ 207 (387)
++|++.++||+|+||.||+|.++.++.. ||||.++.. ..+.+.+|+++|.++.+|||||++++++.+. ...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeE
Confidence 7899999999999999999999888764 677776532 3357899999999986799999999999864 4578
Q ss_pred EEEeccCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceE
Q 016537 208 LIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (387)
Q Consensus 208 lv~e~~~~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~v 268 (387)
+||||+++|+|..++ ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~~ 166 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA 166 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-ce
Confidence 999999999998775 3478899999999999999999999999999999999999666 89
Q ss_pred EEEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcC-Cch
Q 016537 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVS-PSV 329 (387)
Q Consensus 269 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~-~pf 329 (387)
||+|||+|+............||..|+|||.+.+ +.|+.++|||||||++|||++|. +||
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCC
Confidence 9999999987655555556678999999999977 67999999999999999999975 556
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=325.80 Aligned_cols=193 Identities=30% Similarity=0.603 Sum_probs=169.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~l 208 (387)
++|+++++||+|+||+||+|++..+++.||||+++.. ...++.+|+.+|+++ +||||+++++++.+.. ..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~--~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDK--KLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS--EEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccccc--ceeE
Confidence 6899999999999999999999999999999998633 236788999999998 9999999999998754 5679
Q ss_pred EEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCC-c
Q 016537 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (387)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~-~ 284 (387)
|+|++.++++..+. +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.|+...... .
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCcc
Confidence 99999999876654 4588999999999999999999999999999999999999666 89999999998875443 3
Q ss_pred ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....++..|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 3455678889999998875668999999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=329.31 Aligned_cols=194 Identities=21% Similarity=0.353 Sum_probs=161.9
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCC-------eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~ 201 (387)
.++|++.++||+|+||.||+|++..++ ..||||+++... ..++.+|...+.++.+|||||++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 378999999999999999999876544 479999986432 356788999999987899999999999764
Q ss_pred CCCCceEEEeccCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEc
Q 016537 202 QSKTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 262 (387)
...++|||||.+|++..++ ..+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus 92 --~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 92 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp --SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 4578999999999998776 2378999999999999999999999999999999999999
Q ss_pred CCCceEEEEecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHh-cCCchh
Q 016537 263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVS-VSPSVL 330 (387)
Q Consensus 263 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~ 330 (387)
.++ .+||+|||+++....... .....+++.|+|||.+.+ +.|+.++|||||||++|||++ |.+||.
T Consensus 170 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 170 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp TTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 776 899999999987654432 334678899999999987 789999999999999999998 688873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.1e-43 Score=325.95 Aligned_cols=193 Identities=20% Similarity=0.329 Sum_probs=165.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEEec
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~e~ 212 (387)
++|++.+.||+|+||+||+|++..+|+.||||++... ....+.+|+++++.+.+|+|++.+++++.+. ...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEEEEEe
Confidence 6899999999999999999999999999999998543 3456788999999996779999999998764 456799999
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCC----CceEEEEecccceeecCCC-
Q 016537 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK- 283 (387)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~----~~~vkl~DFG~a~~~~~~~- 283 (387)
+. ++|..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+|+......
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 LG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred cC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 95 5654443 358999999999999999999999999999999999999642 3479999999998765332
Q ss_pred -------cccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 284 -------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 284 -------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 2234579999999999987 789999999999999999999999994
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-42 Score=326.44 Aligned_cols=193 Identities=21% Similarity=0.299 Sum_probs=160.9
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCCCceEEEe
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN-IVKLLDIVRDQQSKTPSLIFE 211 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~~hpn-iv~l~~~~~~~~~~~~~lv~e 211 (387)
++|++.+.||+|+||.||+|++..+++.||||++... ...++.+|+++++.+ +|+| |+.+.++..+ ....++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l-~~~~~i~~~~~~~~~--~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE--GDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHS-TTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHc-cCCCcccEEEEEEec--CCEEEEEEE
Confidence 6899999999999999999999999999999998643 335688999999999 5555 5555554444 345679999
Q ss_pred ccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcC--CCceEEEEecccceeecCCCc--
Q 016537 212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKE-- 284 (387)
Q Consensus 212 ~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~~vkl~DFG~a~~~~~~~~-- 284 (387)
|+.++....+. +.+++..+..++.|++.||+|||++||+||||||+|||++. .+..+||+|||+|+.+.....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 99766554332 46899999999999999999999999999999999999853 233799999999988754332
Q ss_pred ------ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 ------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCccc
Confidence 234579999999999987 679999999999999999999999994
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=329.06 Aligned_cols=193 Identities=20% Similarity=0.277 Sum_probs=161.4
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHH--HHhcCCCCeeEEEEEEEcCCC--CCceEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKIL--QNLCGGPNIVKLLDIVRDQQS--KTPSLI 209 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il--~~l~~hpniv~l~~~~~~~~~--~~~~lv 209 (387)
.+|.+.++||+|+||.||+|++ +|+.||||+++....+.+.+|.+++ .++ +||||+++++++.+.+. ...++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence 4688999999999999999986 6899999999877666666665554 456 89999999999986543 356899
Q ss_pred EeccCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHH--------cCceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~aL~yLH~--------~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
||||++|+|..+++ .+++..+..++.|++.||+|||+ +|||||||||+||||+.++ .+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCccccc
Confidence 99999999987774 58899999999999999999996 5999999999999999666 8999999999887
Q ss_pred cCCCc-----ccccccccCCCCchhhcccC-----CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 280 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 280 ~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
..... ....+||+.|+|||++.+.. .++.++|||||||+||||+||.+||.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 55432 23468999999999986522 25678999999999999999998873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=334.87 Aligned_cols=194 Identities=27% Similarity=0.593 Sum_probs=165.6
Q ss_pred CCCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CC
Q 016537 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (387)
Q Consensus 133 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~---~~ 204 (387)
.++|+++++||+|+||+||+|++..+|+.||||+++... .+++.+|+++|+++ +|||||++++++.... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccC
Confidence 478999999999999999999999999999999986432 35678999999999 9999999999986432 23
Q ss_pred CceEEEeccCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCC
Q 016537 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~ 282 (387)
..+++|+|+.+++|..++ +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD-- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CCT--
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhcccC--
Confidence 345778888999998776 4599999999999999999999999999999999999999776 89999999997643
Q ss_pred CcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 283 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.......|++.|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 344567899999999998876678999999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=329.33 Aligned_cols=194 Identities=21% Similarity=0.416 Sum_probs=166.3
Q ss_pred CCeEEEeeeeecCCeeEEEEEEe---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~l~~~-------~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~ 203 (387)
++|++++.||+|+||+||+|++. .+|+.||||+++.. ..+.+.+|+++++++.+||||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 78999999999999999999873 46899999998532 2356789999999996669999999999875
Q ss_pred CCceEEEeccCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeec
Q 016537 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (387)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~ 280 (387)
...+++|||+.+++|...+ +.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECC
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhhc
Confidence 4578999999999997665 4588999999999999999999999999999999999999776 89999999998764
Q ss_pred CCC--cccccccccCCCCchhhcccC-CCCCccchhhHHHHHHHHHhcCCchh
Q 016537 281 PGK--EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 281 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
... ......|++.|+|||.+.+.. .++.++|||||||+||||++|++||.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 332 234568999999999997533 47889999999999999999999994
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=323.90 Aligned_cols=191 Identities=19% Similarity=0.350 Sum_probs=163.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~----~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~ 204 (387)
++|++.+.||+|+||.||+|.++. +++.||||+++... ...+.+|+++++++ +||||+++++++... .
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~ 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG--Q 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS--S
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecC--C
Confidence 789999999999999999998752 35789999997432 24578999999999 999999999999654 4
Q ss_pred CceEEEeccCCCchhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEE
Q 016537 205 TPSLIFEHVNNTDFKVLY-------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (387)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~ 271 (387)
..++||||+.+|++..++ ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-~~Kl~ 175 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIG 175 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEEC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-eEEEe
Confidence 567999999999987764 2357888999999999999999999999999999999999665 89999
Q ss_pred ecccceeecCCCc---ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcC-Cch
Q 016537 272 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVS-PSV 329 (387)
Q Consensus 272 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~-~pf 329 (387)
|||+|+....... .....+++.|+|||.+.+ ..++.++|||||||+||||+||. +||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCC
Confidence 9999986643322 233468899999999987 77999999999999999999985 666
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=322.95 Aligned_cols=190 Identities=19% Similarity=0.364 Sum_probs=159.0
Q ss_pred EEEeeeeecCCeeEEEEEEeCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEE
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~l~~~----~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv 209 (387)
.+.++||+|+||+||+|.+..++ ..||||.++.. ..+++.+|+++|+++ +||||++++|++.+.+ ...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSE-GSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETT-TEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecC-CceEEE
Confidence 34678999999999999985543 36899998632 236789999999999 9999999999987543 457899
Q ss_pred EeccCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEecccceeecCCCc-
Q 016537 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (387)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~~~~~~- 284 (387)
||||+++++..++. ..++..+..++.|++.||.|||+++|+||||||+||||+.++ .+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhccccccc
Confidence 99999999987653 366788899999999999999999999999999999999655 899999999987654322
Q ss_pred ----ccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 285 ----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 285 ----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
.....||..|+|||.+.+ ..++.++|||||||+||||+||..||.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred cceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 223468899999999877 689999999999999999999877764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-38 Score=301.21 Aligned_cols=194 Identities=26% Similarity=0.466 Sum_probs=162.1
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc--hHHHHHHHHHHHHhc----------CCCCeeEEEEEEEcC
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGPNIVKLLDIVRDQ 201 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~E~~il~~l~----------~hpniv~l~~~~~~~ 201 (387)
++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+++++++. .|+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 46999999999999999999999999999999997543 366788999998872 358899999998766
Q ss_pred CCCCceEEEeccCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeccCCCCeeEcCCCc-----eEE
Q 016537 202 QSKTPSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR-----KLR 269 (387)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~-----~vk 269 (387)
.....+++|+++..+..... ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++. .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 55666777777765542211 2458899999999999999999998 89999999999999975442 489
Q ss_pred EEecccceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHHHHHHHhcCCchh
Q 016537 270 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMVSVSPSVL 330 (387)
Q Consensus 270 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvil~elltg~~pf~ 330 (387)
++|||.+..... .....+||+.|+|||++.+ ..|+.++||||+||+++||++|++||.
T Consensus 173 l~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 173 IADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp ECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred Eeeccccccccc--ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCC
Confidence 999999986542 3356789999999999887 779999999999999999999999984
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.2e-26 Score=202.22 Aligned_cols=165 Identities=17% Similarity=0.212 Sum_probs=120.7
Q ss_pred EEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---------------------hHHHHHHHHHHHHhcCCCCeeEEE
Q 016537 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNIVKLL 195 (387)
Q Consensus 137 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---------------------~~~~~~E~~il~~l~~hpniv~l~ 195 (387)
.+.++||+|+||+||+|.+ .+|+.||||+++... .....+|...+.++ .|.+++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEE
Confidence 5789999999999999998 578999999875211 12345688899998 899999988
Q ss_pred EEEEcCCCCCceEEEeccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeccCCCCeeEcCCCceEEEEeccc
Q 016537 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (387)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~~vkl~DFG~ 275 (387)
++.. .+++|||+++..+.. ++...+..++.|++.+|+|||++||+||||||+|||+++ + .++|+|||.
T Consensus 81 ~~~~------~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-E-GIWIIDFPQ 148 (191)
T ss_dssp EEET------TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-T-EEEECCCTT
T ss_pred EecC------CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-C-CEEEEECCC
Confidence 7531 259999999876644 445566788999999999999999999999999999984 4 589999999
Q ss_pred ceeecCCCcccccccccCCCCchhhcccCCCCCccchhhHHHH
Q 016537 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318 (387)
Q Consensus 276 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlGvi 318 (387)
|................. ...+.+ . +.|+.++|+||+.--
T Consensus 149 a~~~~~~~~~~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 149 SVEVGEEGWREILERDVR-NIITYF-S-RTYRTEKDINSAIDR 188 (191)
T ss_dssp CEETTSTTHHHHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred cccCCCCCcHHHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHH
Confidence 976543321110000000 001222 2 468889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=4.7e-07 Score=80.04 Aligned_cols=139 Identities=18% Similarity=0.232 Sum_probs=91.6
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
..|++.+..+.++.+.||+.. .++..+++|+..... ...+.+|...++.+..+--+.+++.+..+. ...++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEE
Confidence 456666665555567899875 566778888875432 345788999999886565577888777654 4567999
Q ss_pred eccCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 016537 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS-------------------------------------------- 246 (387)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~aL~yLH~-------------------------------------------- 246 (387)
+++++..+........ ....++.++...++.||+
T Consensus 90 ~~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred Eecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 9999987754332211 111223334444444442
Q ss_pred ---------c------CceeeccCCCCeeEcCCCceEEEEecccceee
Q 016537 247 ---------Q------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (387)
Q Consensus 247 ---------~------~ivHrDlKp~NILl~~~~~~vkl~DFG~a~~~ 279 (387)
. .++|+|+.|.|||++. +..+-|+||+.+...
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecC-CceEEEeechhcccC
Confidence 1 2789999999999984 434569999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=6.8e-06 Score=71.91 Aligned_cols=76 Identities=17% Similarity=0.137 Sum_probs=53.9
Q ss_pred eeeecCC-eeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCCCceEEEeccCCCch
Q 016537 141 KVGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218 (387)
Q Consensus 141 ~lG~G~~-g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~h-pniv~l~~~~~~~~~~~~~lv~e~~~~~~l 218 (387)
.+..|.. +.||+... .++..+++|.-.......+..|...++.+..+ -.+.+++.+..+. ...++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecccc
Confidence 3445553 67898875 56777889988776666788899999887443 2366777776654 456799999988665
Q ss_pred h
Q 016537 219 K 219 (387)
Q Consensus 219 ~ 219 (387)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=9.4e-06 Score=76.28 Aligned_cols=75 Identities=15% Similarity=0.194 Sum_probs=49.8
Q ss_pred EeeeeecCCeeEEEEEEeCCCeEEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCCCCc
Q 016537 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 206 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~----------~~~~~~~~E~~il~~l~~h--pniv~l~~~~~~~~~~~~ 206 (387)
.+.||.|....||++.+..+++.++||.-.+ ....+...|.+.|+.+..+ ..+++++.+. .. ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~--~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--MA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--TT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CC--CC
Confidence 5679999999999998766788899996432 1224566788888877444 3466666543 22 34
Q ss_pred eEEEeccCCCc
Q 016537 207 SLIFEHVNNTD 217 (387)
Q Consensus 207 ~lv~e~~~~~~ 217 (387)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 69999998653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.46 E-value=0.00022 Score=66.62 Aligned_cols=74 Identities=14% Similarity=0.144 Sum_probs=52.4
Q ss_pred EeeeeecCCeeEEEEEEeC-------CCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCCceEEE
Q 016537 139 VRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (387)
Q Consensus 139 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~l~~-~~~~~~~~E~~il~~l~~hpniv~l~~~~~~~~~~~~~lv~ 210 (387)
++.|+.|-.-.+|++.... ..+.|++++... .......+|..+++.+..+.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEE
Confidence 3678889999999988743 235677777652 2334567899999998666555688887632 3899
Q ss_pred eccCCCch
Q 016537 211 EHVNNTDF 218 (387)
Q Consensus 211 e~~~~~~l 218 (387)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.38 E-value=7.9e-05 Score=67.79 Aligned_cols=67 Identities=13% Similarity=0.262 Sum_probs=42.9
Q ss_pred eeEEEEEEeCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCC-CeeEEEE-----EEEcCCCCCceEEEeccCCCc
Q 016537 148 SEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLD-----IVRDQQSKTPSLIFEHVNNTD 217 (387)
Q Consensus 148 g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~E~~il~~l~~hp-niv~l~~-----~~~~~~~~~~~lv~e~~~~~~ 217 (387)
-.||++.. .+|+.+++|+.++. ..+++..|.+.+..|..+. -++..+. .+. .....+.+++++.|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEEEEeecCCcC
Confidence 46999876 67888999998764 4577889999998884331 1111111 111 1234567888888643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.0018 Score=57.85 Aligned_cols=50 Identities=12% Similarity=0.193 Sum_probs=32.4
Q ss_pred CeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEeccc-chHHHHHHHHHHHHhc
Q 016537 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLC 186 (387)
Q Consensus 135 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~E~~il~~l~ 186 (387)
+..-.+.|..|---+.|+... ++..+++|+.... ..+.+..|++++..|.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred CceEeecCCCCcccCeEEEEE--CCCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence 445556677888888999875 3345899998653 4566777888888873
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=82.56 E-value=3.1 Score=35.97 Aligned_cols=139 Identities=16% Similarity=0.226 Sum_probs=76.7
Q ss_pred CCeEEEeeeeecCCeeEEEEEEeCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEEE-----------------
Q 016537 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD----------------- 196 (387)
Q Consensus 134 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~E~~il~~l~~hpniv~l~~----------------- 196 (387)
++++-++.=-.|+-|..|. . .++..++||.-.....+.+-.|++..-.+ .-|..+-+.-
T Consensus 69 ~~~K~i~~s~~Gs~Gv~FV-~--~e~gaiVlK~s~tta~E~y~~eLAr~LGv-pvPqmRvI~~~~~E~~~~~~~~l~~~e 144 (342)
T d1cjaa_ 69 QQFKGIERSEKGTEGLFFV-E--TESGVFIVKRSTNIESETFCSLLCMRLGL-HAPKVRVVSSNSEEGTNMLECLAAIDK 144 (342)
T ss_dssp GGEEEEEECCSTTSCEEEE-E--ESSCEEEEECCTTHHHHHHHHHHHHHHTC-CCCCEEEEESSSHHHHHHHHHHHHHCS
T ss_pred HhhhceEEeecCCceEEEE-E--cCCceEEEecCCchHHHHHHHHHHHHhCC-CCCceEEecCCCHHHHHHHHHHhcCCC
Confidence 5666666666677776664 2 34667788875444445555665555555 5566544330
Q ss_pred ---EEEcCCCCCceEEEeccCCCchhhhcCCC-CHHHHHHHHHHH--HHHHH-HHHHc---Cceeecc-CCCCeeEcCCC
Q 016537 197 ---IVRDQQSKTPSLIFEHVNNTDFKVLYPTL-SDYDVRYYIYEL--LKALD-YCHSQ---GIMHRDV-KPHNVMIDHEQ 265 (387)
Q Consensus 197 ---~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~qi--~~aL~-yLH~~---~ivHrDl-Kp~NILl~~~~ 265 (387)
........-..++|||.+|..+....... ++......+.++ +-++. +++.. .+.+|+- .++||+++.++
T Consensus 145 ~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~ 224 (342)
T d1cjaa_ 145 SFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERG 224 (342)
T ss_dssp SSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBT
T ss_pred hhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEecCC
Confidence 00011122346899999988775543321 111111222222 22333 34432 3456522 88999999888
Q ss_pred ceEEEEecccc
Q 016537 266 RKLRLIDWGLA 276 (387)
Q Consensus 266 ~~vkl~DFG~a 276 (387)
..+..+|=|..
T Consensus 225 ~~~~~IDs~i~ 235 (342)
T d1cjaa_ 225 ATVVPIDSKII 235 (342)
T ss_dssp TCEEECSCCCC
T ss_pred cEEEEecCCcc
Confidence 78888886655
|